    <div id="main">
      <div class="panel">
        <h1>Sanger Institute - Publications 2014</h1><p>Number of papers published in 2014: <strong>583</strong></p><ul class="references"><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">The Population Structure of Vibrio cholerae from the Chandigarh Region of Northern India.</h4>
<p class="authors"><span class="author">Abd El Ghany M</span>, <span class="author">Chander J</span>, <span class="author">Mutreja A</span>, <span class="author">Rashid M</span>, <span class="author">Hill-Cawthorne GA</span>, <span class="author">Ali S</span>, <span class="author">Naeem R</span>, <span class="author">Thomson NR</span>, <span class="author">Dougan G</span> and <span class="author">Pain A</span></p>
<p class="affiliation">Pathogen Genomics Laboratory, Computational Bioscience Research Center, King Abdullah University of Science and Technology (KAUST), Thuwal, Kingdom of Saudi Arabia.</p><p class="abstract"><strong>Background</strong>: Cholera infection continues to be a threat to global public health. The current cholera pandemic associated with Vibrio cholerae El Tor has now been ongoing for over half a century.</p><p class="abstract">Thirty-eight V. cholerae El Tor isolates associated with a cholera outbreak in 2009 from the Chandigarh region of India were characterised by a combination of microbiology, molecular typing and whole-genome sequencing. The genomic analysis indicated that two clones of V. cholera circulated in the region and caused disease during this time. These clones fell into two distinct sub-clades that map independently onto wave 3 of the phylogenetic tree of seventh pandemic V. cholerae El Tor. Sequence analyses of the cholera toxin gene, the Vibrio seventh Pandemic Island II (VSPII) and SXT element correlated with this phylogenetic position of the two clades on the El Tor tree. The clade 2 isolates, characterized by a drug-resistant profile and the expression of a distinct cholera toxin, are closely related to the recent V. cholerae isolated elsewhere, including Haiti, but fell on a distinct branch of the tree, showing they were independent outbreaks. Multi-Locus Sequence Typing (MLST) distinguishes two sequence types among the 38 isolates, that did not correspond to the clades defined by whole-genome sequencing. Multi-Locus Variable-length tandem-nucleotide repeat Analysis (MLVA) identified 16 distinct clusters.</p><p class="abstract">The use of whole-genome sequencing enabled the identification of two clones of V. cholerae that circulated during the 2009 Chandigarh outbreak. These clones harboured a similar structure of ICEVchHai1 but differed mainly in the structure of CTX phage and VSPII. The limited capacity of MLST and MLVA to discriminate between the clones that circulated in the 2009 Chandigarh outbreak highlights the value of whole-genome sequencing as a route to the identification of further genetic markers to subtype V. cholerae isolates.</p>
<p class="publication"><span class="title">PLoS neglected tropical diseases</span>&nbsp;<span class="year">2014</span>;<span class="volume">8</span>;<span class="number">7</span>;<span class="pagerange">e2981</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25058483">25058483</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4109905">4109905</a>; DOI: <a href="http://dx.doi.org/10.1371%2Fjournal.pntd.0002981">10.1371/journal.pntd.0002981</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Towards a molecular systems model of coronary artery disease.</h4>
<p class="authors"><span class="author">Abraham G</span>, <span class="author">Bhalala OG</span>, <span class="author">de Bakker PI</span>, <span class="author">Ripatti S</span> and <span class="author">Inouye M</span></p>
<p class="affiliation">Medical Systems Biology, Department of Pathology and Department of Microbiology &amp; Immunology, The University of Melbourne, Parkville, Victoria, 3010, Australia.</p><p class="abstract">Coronary artery disease (CAD) is a complex disease driven by myriad interactions of genetics and environmental factors. Traditionally, studies have analyzed only 1 disease factor at a time, providing useful but limited understanding of the underlying etiology. Recent advances in cost-effective and high-throughput technologies, such as single nucleotide polymorphism (SNP) genotyping, exome/genome/RNA sequencing, gene expression microarrays, and metabolomics assays have enabled the collection of millions of data points in many thousands of individuals. In order to make sense of such &#39;omics&#39; data, effective analytical methods are needed. We review and highlight some of the main results in this area, focusing on integrative approaches that consider multiple modalities simultaneously. Such analyses have the potential to uncover the genetic basis of CAD, produce genomic risk scores (GRS) for disease prediction, disentangle the complex interactions underlying disease, and predict response to treatment.</p>
<p class="publication"><span class="title">Current cardiology reports</span>&nbsp;<span class="year">2014</span>;<span class="volume">16</span>;<span class="number">6</span>;<span class="pagerange">488</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24743898">24743898</a>; DOI: <a href="http://dx.doi.org/10.1007%2Fs11886-014-0488-1">10.1007/s11886-014-0488-1</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Editorial overview: cancer genomics: kill it. Kill it dead.</h4>
<p class="authors"><span class="author">Adams D</span> and <span class="author">McDermott U</span></p>
<p class="affiliation">Experimental Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire CB10 1HH, UK. Electronic address: <a href="mailto:%64%61%31%40%73%61%6E%67%65%72.%61%63.%75%6B">&#100;&#97;&#49;&#64;&#115;&#97;&#110;&#103;&#101;&#114;&#46;&#97;&#99;&#46;&#117;&#107;</a>.</p>
<p class="grants">Funded by: Cancer Research UK: <span class="grant">13031</span></p>
<p class="publication"><span class="title">Current opinion in genetics &amp; development</span>&nbsp;<span class="year">2014</span>;<span class="volume">24</span>;<span class="pagerange">v-vi</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24569083">24569083</a>; DOI: <a href="http://dx.doi.org/10.1016%2Fj.gde.2013.12.006">10.1016/j.gde.2013.12.006</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Histopathology reveals correlative and unique phenotypes in a high-throughput mouse phenotyping screen.</h4>
<p class="authors"><span class="author">Adissu HA</span>, <span class="author">Estabel J</span>, <span class="author">Sunter D</span>, <span class="author">Tuck E</span>, <span class="author">Hooks Y</span>, <span class="author">Carragher DM</span>, <span class="author">Clarke K</span>, <span class="author">Karp NA</span>, <span class="author">Project SM</span>, <span class="author">Newbigging S</span>, <span class="author">Jones N</span>, <span class="author">Morikawa L</span>, <span class="author">White JK</span> and <span class="author">McKerlie C</span></p>
<p class="affiliation">Centre for Modeling Human Disease, Toronto Centre for Phenogenomics, 25 Orde Street, Toronto, ON M5T 3H7, Canada.</p><p class="abstract">The Mouse Genetics Project (MGP) at the Wellcome Trust Sanger Institute aims to generate and phenotype over 800 genetically modified mouse lines over the next 5 years to gain a better understanding of mammalian gene function and provide an invaluable resource to the scientific community for follow-up studies. Phenotyping includes the generation of a standardized biobank of paraffin-embedded tissues for each mouse line, but histopathology is not routinely performed. In collaboration with the Pathology Core of the Centre for Modeling Human Disease (CMHD) we report the utility of histopathology in a high-throughput primary phenotyping screen. Histopathology was assessed in an unbiased selection of 50 mouse lines with (n=30) or without (n=20) clinical phenotypes detected by the standard MGP primary phenotyping screen. Our findings revealed that histopathology added correlating morphological data in 19 of 30 lines (63.3%) in which the primary screen detected a phenotype. In addition, seven of the 50 lines (14%) presented significant histopathology findings that were not associated with or predicted by the standard primary screen. Three of these seven lines had no clinical phenotype detected by the standard primary screen. Incidental and strain-associated background lesions were present in all mutant lines with good concordance to wild-type controls. These findings demonstrate the complementary and unique contribution of histopathology to high-throughput primary phenotyping of mutant mice.</p>
<p class="grants">Funded by: NHGRI NIH HHS: <span class="grant">U54 HG006364</span>; NIH HHS: <span class="grant">U42 OD011175</span></p>
<p class="publication"><span class="title">Disease models &amp; mechanisms</span>&nbsp;<span class="year">2014</span>;<span class="volume">7</span>;<span class="number">5</span>;<span class="pagerange">515-24</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24652767">24652767</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4007403">4007403</a>; DOI: <a href="http://dx.doi.org/10.1242%2Fdmm.015263">10.1242/dmm.015263</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">H3Africa: a tipping point for a revolution in bioinformatics, genomics and health research in Africa.</h4>
<p class="authors"><span class="author">Adoga MP</span>, <span class="author">Fatumo SA</span> and <span class="author">Agwale SM</span></p>
<p class="affiliation">Computational and Evolutionary Biology/Bioinformatics, Faculty of Life Sciences, University of Manchester, Manchester, UK ; Microbiology Unit, Department of Biological Sciences, Nasarawa State University, Keffi, Nigeria.</p><p class="abstract"><strong>Background</strong>: A multi-million dollar research initiative involving the National Institutes of Health (NIH), Wellcome Trust and African scientists has been launched. The initiative, referred to as H3Africa, is an acronym that stands for Human Heredity and Health in Africa. Here, we outline what this initiative is set to achieve and the latest commitments of the key players as at October 2013.</p><p class="abstract"><strong>Findings</strong>: The initiative has so far been awarded over $74 million in research grants. During the first set of awards announced in 2012, the NIH granted $5 million a year for a period of five years, while the Wellcome Trust doled out at least $12 million over the period to the research consortium. This was in addition to Wellcome Trust&#39;s provision of administrative support, scientific consultation and advanced training, all in collaboration with the African Society for Human Genetics. In addition, during the second set of awards announced in October 2013, the NIH awarded to the laudable initiative 10 new grants of up to $17 million over the next four years.</p><p class="abstract"><strong>Conclusions</strong>: H3Africa is poised to transform the face of research in genomics, bioinformatics and health in Africa. The capacity of African scientists will be enhanced through training and the better research facilities that will be acquired. Research collaborations between Africa and the West will grow and all stakeholders, including the funding partners, African scientists, scientists across the globe, physicians and patients will be the eventual winners.</p>
<p class="publication"><span class="title">Source code for biology and medicine</span>&nbsp;<span class="year">2014</span>;<span class="volume">9</span>;<span class="pagerange">10</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24829612">24829612</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4019950">4019950</a>; DOI: <a href="http://dx.doi.org/10.1186%2F1751-0473-9-10">10.1186/1751-0473-9-10</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Allelic expression mapping across cellular lineages to establish impact of non-coding SNPs.</h4>
<p class="authors"><span class="author">Adoue V</span>, <span class="author">Schiavi A</span>, <span class="author">Light N</span>, <span class="author">Alml&ouml;f JC</span>, <span class="author">Lundmark P</span>, <span class="author">Ge B</span>, <span class="author">Kwan T</span>, <span class="author">Caron M</span>, <span class="author">R&ouml;nnblom L</span>, <span class="author">Wang C</span>, <span class="author">Chen SH</span>, <span class="author">Goodall AH</span>, <span class="author">Cambien F</span>, <span class="author">Deloukas P</span>, <span class="author">Ouwehand WH</span>, <span class="author">Syv&auml;nen AC</span> and <span class="author">Pastinen T</span></p>
<p class="affiliation">Institute National de la Sant&eacute; et de la Recherche M&eacute;dicale (INSERM), U1043, Toulouse, France.</p><p class="abstract">Most complex disease-associated genetic variants are located in non-coding regions and are therefore thought to be regulatory in nature. Association mapping of differential allelic expression (AE) is a powerful method to identify SNPs with direct cis-regulatory impact (cis-rSNPs). We used AE mapping to identify cis-rSNPs regulating gene expression in 55 and 63 HapMap lymphoblastoid cell lines from a Caucasian and an African population, respectively, 70 fibroblast cell lines, and 188 purified monocyte samples and found 40-60% of these cis-rSNPs to be shared across cell types. We uncover a new class of cis-rSNPs, which disrupt footprint-derived de novo motifs that are predominantly bound by repressive factors and are implicated in disease susceptibility through overlaps with GWAS SNPs. Finally, we provide the proof-of-principle for a new approach for genome-wide functional validation of transcription factor-SNP interactions. By perturbing NF&kappa;B action in lymphoblasts, we identified 489 cis-regulated transcripts with altered AE after NF&kappa;B perturbation. Altogether, we perform a comprehensive analysis of cis-variation in four cell populations and provide new tools for the identification of functional variants associated to complex diseases.</p>
<p class="publication"><span class="title">Molecular systems biology</span>&nbsp;<span class="year">2014</span>;<span class="volume">10</span>;<span class="number">10</span>;<span class="pagerange">754</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25326100">25326100</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Human african trypanosomiasis research gets a boost: unraveling the tsetse genome.</h4>
<p class="authors"><span class="author">Aksoy S</span>, <span class="author">Attardo G</span>, <span class="author">Berriman M</span>, <span class="author">Christoffels A</span>, <span class="author">Lehane M</span>, <span class="author">Masiga D</span> and <span class="author">Toure Y</span></p>
<p class="affiliation">Yale School of Public Health, Department of Epidemiology and Public Health, New Haven, Connecticut, United States of America.</p>
<p class="publication"><span class="title">PLoS neglected tropical diseases</span>&nbsp;<span class="year">2014</span>;<span class="volume">8</span>;<span class="number">4</span>;<span class="pagerange">e2624</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24762859">24762859</a>; DOI: <a href="http://dx.doi.org/10.1371%2Fjournal.pntd.0002624">10.1371/journal.pntd.0002624</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Rare variants in NR2F2 cause congenital heart defects in humans.</h4>
<p class="authors"><span class="author">Al Turki S</span>, <span class="author">Manickaraj AK</span>, <span class="author">Mercer CL</span>, <span class="author">Gerety SS</span>, <span class="author">Hitz MP</span>, <span class="author">Lindsay S</span>, <span class="author">D&#39;Alessandro LC</span>, <span class="author">Swaminathan GJ</span>, <span class="author">Bentham J</span>, <span class="author">Arndt AK</span>, <span class="author">Low J</span>, <span class="author">Breckpot J</span>, <span class="author">Gewillig M</span>, <span class="author">Thienpont B</span>, <span class="author">Abdul-Khaliq H</span>, <span class="author">Harnack C</span>, <span class="author">Hoff K</span>, <span class="author">Kramer HH</span>, <span class="author">Schubert S</span>, <span class="author">Siebert R</span>, <span class="author">Toka O</span>, <span class="author">Cosgrove C</span>, <span class="author">Watkins H</span>, <span class="author">Lucassen AM</span>, <span class="author">O&#39;Kelly IM</span>, <span class="author">Salmon AP</span>, <span class="author">Bu&#39;lock FA</span>, <span class="author">Granados-Riveron J</span>, <span class="author">Setchfield K</span>, <span class="author">Thornborough C</span>, <span class="author">Brook JD</span>, <span class="author">Mulder B</span>, <span class="author">Klaassen S</span>, <span class="author">Bhattacharya S</span>, <span class="author">Devriendt K</span>, <span class="author">Fitzpatrick DF</span>, <span class="author">UK10K&nbsp;Consortium</span>, <span class="author">Wilson DI</span>, <span class="author">Mital S</span> and <span class="author">Hurles ME</span></p>
<p class="affiliation">Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, UK; Department of Pathology, King Abdulaziz Medical City, P.O. Box 22490, Riyadh 11426, Saudi Arabia.</p><p class="abstract">Congenital heart defects (CHDs) are the most common birth defect worldwide and are a leading cause of neonatal mortality. Nonsyndromic atrioventricular septal defects (AVSDs) are an important subtype of CHDs for which the genetic architecture is poorly understood. We performed exome sequencing in 13 parent-offspring trios and 112 unrelated individuals with nonsyndromic AVSDs and identified five rare missense variants (two of which arose de novo) in the highly conserved gene NR2F2, a very significant enrichment (p = 7.7 &times; 10(-7)) compared to 5,194 control subjects. We identified three additional CHD-affected families with other variants in NR2F2 including a de novo balanced chromosomal translocation, a de novo substitution disrupting a splice donor site, and a 3 bp duplication that cosegregated in a multiplex family. NR2F2 encodes a pleiotropic developmental transcription factor, and decreased dosage of NR2F2 in mice has been shown to result in abnormal development of atrioventricular septa. Via luciferase assays, we showed that all six coding sequence variants observed in individuals significantly alter the activity of NR2F2 on target promoters.</p>
<p class="grants">Funded by: Medical Research Council; Wellcome Trust: <span class="grant">WT098051</span></p>
<p class="publication"><span class="title">American journal of human genetics</span>&nbsp;<span class="year">2014</span>;<span class="volume">94</span>;<span class="number">4</span>;<span class="pagerange">574-85</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24702954">24702954</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC3980509">3980509</a>; DOI: <a href="http://dx.doi.org/10.1016%2Fj.ajhg.2014.03.007">10.1016/j.ajhg.2014.03.007</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Mutational signatures: the patterns of somatic mutations hidden in cancer genomes.</h4>
<p class="authors"><span class="author">Alexandrov LB</span> and <span class="author">Stratton MR</span></p>
<p class="affiliation">Cancer Genome Project, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire CB10 1SA, United Kingdom. Electronic address: <a href="mailto:%6C%61%32%40%73%61%6E%67%65%72.%61%63.%75%6B">&#108;&#97;&#50;&#64;&#115;&#97;&#110;&#103;&#101;&#114;&#46;&#97;&#99;&#46;&#117;&#107;</a>.</p><p class="abstract">All cancers originate from a single cell that starts to behave abnormally due to the acquired somatic mutations in its genome. Until recently, the knowledge of the mutational processes that cause these somatic mutations has been very limited. Recent advances in sequencing technologies and the development of novel mathematical approaches have allowed deciphering the patterns of somatic mutations caused by different mutational processes. Here, we summarize our current understanding of mutational patterns and mutational signatures in light of both the somatic cell paradigm of cancer research and the recent developments in the field of cancer genomics.</p>
<p class="grants">Funded by: Wellcome Trust: <span class="grant">098051</span></p>
<p class="publication"><span class="title">Current opinion in genetics &amp; development</span>&nbsp;<span class="year">2014</span>;<span class="volume">24</span>;<span class="pagerange">52-60</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24657537">24657537</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC3990474">3990474</a>; DOI: <a href="http://dx.doi.org/10.1016%2Fj.gde.2013.11.014">10.1016/j.gde.2013.11.014</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Reading between the lines; understanding drug response in the post genomic era.</h4>
<p class="authors"><span class="author">Alifrangis CC</span> and <span class="author">McDermott U</span></p>
<p class="affiliation">Cambridge Institute of Medical Research, University of Cambridge, Cambridge, UK; Cancer Genome Project, Wellcome Trust Sanger Institute, Cambridge, UK; Dept of Medical Oncology, Charing Cross Hospital, London, UK. Electronic address: <a href="mailto:%63%61%34%40%73%61%6E%67%65%72.%61%63.%75%6B">&#99;&#97;&#52;&#64;&#115;&#97;&#110;&#103;&#101;&#114;&#46;&#97;&#99;&#46;&#117;&#107;</a>.</p><p class="abstract">Following the fanfare of initial, often dramatic, success with small molecule inhibitors in the treatment of defined genomic subgroups, it can be argued that the extension of targeted therapeutics to the majority of patients with solid cancers has stalled. Despite encouraging FDA approval rates, the attrition rates of these compounds remains high in early stage clinical studies, with single agent studies repeatedly showing poor efficacy In striking contrast, our understanding of the complexity of solid neoplasms has increased in huge increments, following the publication of large-scale genomic and transcriptomic datasets from large collaborations such as the International Cancer Genome Consortium (ICGC http://www.icgc.org/) and The Cancer Genome Atlas (TCGA http://cancergenome.nih.gov/). However, there remains a clear disconnect between these rich datasets describing the genomic complexity of cancer, including both intra- and inter-tumour heterogeneity, and what a treating oncologist can consider to be a clinically &quot;actionable&quot; mutation profile. Our understanding of these data is in its infancy and we still find difficulties ascribing characteristics to tumours that consistently predict therapeutic response for the majority of small molecule inhibitors. This article will seek to explore the recent studies of the patterns and impact of mutations in drug resistance, and demonstrate how we may use this data to reshape our thinking about biological pathways, critical dependencies and their therapeutic interruption.</p>
<p class="publication"><span class="title">Molecular oncology</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24957465">24957465</a>; DOI: <a href="http://dx.doi.org/10.1016%2Fj.molonc.2014.05.014">10.1016/j.molonc.2014.05.014</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Plasmodium falciparum founder populations in Western Cambodia have reduced artemisinin sensitivity in vitro.</h4>
<p class="authors"><span class="author">Amaratunga C</span>, <span class="author">Witkowski B</span>, <span class="author">Dek D</span>, <span class="author">Try V</span>, <span class="author">Khim N</span>, <span class="author">Miotto O</span>, <span class="author">M&eacute;nard D</span> and <span class="author">Fairhurst RM</span></p>
<p class="affiliation">Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.</p><p class="abstract">Reduced Plasmodium falciparum sensitivity to short-course artemisinin (ART) monotherapy manifests as a long parasite clearance half-life. We recently defined three parasite founder populations with long half-life in Pursat, Western Cambodia, where reduced ART sensitivity is prevalent. Using the ring-stage survival assay, we show that these founder populations have reduced ART sensitivity in vitro at the early-ring stage of parasite development, and that a genetically admixed population contains subsets of parasites with normal or reduced ART sensitivity.</p>
<p class="publication"><span class="title">Antimicrobial agents and chemotherapy</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24867977">24867977</a>; DOI: <a href="http://dx.doi.org/10.1128%2FAAC.03055-14">10.1128/AAC.03055-14</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">A syndromic form of Pierre Robin sequence is caused by 5q23 deletions encompassing FBN2 and PHAX.</h4>
<p class="authors"><span class="author">Ansari M</span>, <span class="author">Rainger JK</span>, <span class="author">Murray JE</span>, <span class="author">Hanson I</span>, <span class="author">Firth HV</span>, <span class="author">Mehendale F</span>, <span class="author">Amiel J</span>, <span class="author">Gordon CT</span>, <span class="author">Percesepe A</span>, <span class="author">Mazzanti L</span>, <span class="author">Fryer A</span>, <span class="author">Ferrari P</span>, <span class="author">Devriendt K</span>, <span class="author">Temple IK</span> and <span class="author">FitzPatrick DR</span></p>
<p class="affiliation">MRC Human Genetics Unit, MRC Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh EH4 2XU, U.K.</p><p class="abstract">Pierre Robin sequence (PRS) is an etiologically distinct subgroup of cleft palate. We aimed to define the critical genomic interval from five different 5q22-5q31 deletions associated with PRS or PRS-associated features and assess each gene within the region as a candidate for the PRS component of the phenotype. Clinical array-based comparative genome hybridisation (aCGH) data were used to define a 2.08 Mb minimum region of overlap among four de novo deletions and one mother-son inherited deletion associated with at least one component of PRS. Commonly associated anomalies were talipes equinovarus (TEV), finger contractures and crumpled ear helices. Expression analysis of the orthologous genes within the PRS critical region in embryonic mice showed that the strongest candidate genes were FBN2 and PHAX. Targeted aCGH of the critical region and sequencing of these genes in a cohort of 25 PRS patients revealed no plausible disease-causing mutations. In conclusion, deletion of &sim;2 Mb on 5q23 region causes a clinically recognisable subtype of PRS. Haploinsufficiency for FBN2 accounts for the digital and auricular features. A possible critical region for TEV is distinct and telomeric to the PRS region. The molecular basis of PRS in these cases remains undetermined but haploinsufficiency for PHAX is a plausible mechanism.</p>
<p class="publication"><span class="title">European journal of medical genetics</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25195018">25195018</a>; DOI: <a href="http://dx.doi.org/10.1016%2Fj.ejmg.2014.08.007">10.1016/j.ejmg.2014.08.007</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">A molecular marker of artemisinin-resistant Plasmodium falciparum malaria.</h4>
<p class="authors"><span class="author">Ariey F</span>, <span class="author">Witkowski B</span>, <span class="author">Amaratunga C</span>, <span class="author">Beghain J</span>, <span class="author">Langlois AC</span>, <span class="author">Khim N</span>, <span class="author">Kim S</span>, <span class="author">Duru V</span>, <span class="author">Bouchier C</span>, <span class="author">Ma L</span>, <span class="author">Lim P</span>, <span class="author">Leang R</span>, <span class="author">Duong S</span>, <span class="author">Sreng S</span>, <span class="author">Suon S</span>, <span class="author">Chuor CM</span>, <span class="author">Bout DM</span>, <span class="author">M&eacute;nard S</span>, <span class="author">Rogers WO</span>, <span class="author">Genton B</span>, <span class="author">Fandeur T</span>, <span class="author">Miotto O</span>, <span class="author">Ringwald P</span>, <span class="author">Le Bras J</span>, <span class="author">Berry A</span>, <span class="author">Barale JC</span>, <span class="author">Fairhurst RM</span>, <span class="author">Benoit-Vical F</span>, <span class="author">Mercereau-Puijalon O</span> and <span class="author">M&eacute;nard D</span></p>
<p class="affiliation">1] Institut Pasteur, Parasite Molecular Immunology Unit, 75724 Paris Cedex 15, France [2] Centre National de la Recherche Scientifique, Unit&eacute; de Recherche Associ&eacute;e 2581, 75724 Paris Cedex 15, France [3] Institut Pasteur, Genetics and Genomics of Insect Vectors Unit, 75724 Paris Cedex 15, France (F.A.); Institut Pasteur, Functional Genetics of Infectious Diseases Unit, 75724 Paris Cedex 15, France (J.B.); Centre de Physiopathologie de Toulouse-Purpan, Institut National de la Sant&eacute; et de la Recherche M&eacute;dicale UMR1043, Centre National de la Recherche Scientifique UMR5282, Universit&eacute; Toulouse III, 31024 Toulouse Cedex 3, France Institut Pasteur, Unit&eacute; de Biologie et G&eacute;n&eacute;tique du Paludisme, Team Malaria Targets and Drug Development, 75724 Paris Cedex 15, France (J.-C.B.).</p><p class="abstract">Plasmodium falciparum resistance to artemisinin derivatives in southeast Asia threatens malaria control and elimination activities worldwide. To monitor the spread of artemisinin resistance, a molecular marker is urgently needed. Here, using whole-genome sequencing of an artemisinin-resistant parasite line from Africa and clinical parasite isolates from Cambodia, we associate mutations in the PF3D7_1343700 kelch propeller domain (&#39;K13-propeller&#39;) with artemisinin resistance in vitro and in vivo. Mutant K13-propeller alleles cluster in Cambodian provinces where resistance is prevalent, and the increasing frequency of a dominant mutant K13-propeller allele correlates with the recent spread of resistance in western Cambodia. Strong correlations between the presence of a mutant allele, in vitro parasite survival rates and in vivo parasite clearance rates indicate that K13-propeller mutations are important determinants of artemisinin resistance. K13-propeller polymorphism constitutes a useful molecular marker for large-scale surveillance efforts to contain artemisinin resistance in the Greater Mekong Subregion and prevent its global spread.</p>
<p class="grants">Funded by: Medical Research Council: <span class="grant">G0600718</span>; Wellcome Trust: <span class="grant">090770/Z/09/Z</span>, <span class="grant">098051</span></p>
<p class="publication"><span class="title">Nature</span>&nbsp;<span class="year">2014</span>;<span class="volume">505</span>;<span class="number">7481</span>;<span class="pagerange">50-5</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24352242">24352242</a>; DOI: <a href="http://dx.doi.org/10.1038%2Fnature12876">10.1038/nature12876</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Lipoprotein(a) Levels, Genotype, and Incident Aortic Valve Stenosis: A Prospective Mendelian Randomization Study and Replication in a Case-Control Cohort.</h4>
<p class="authors"><span class="author">Arsenault BJ</span>, <span class="author">Boekholdt SM</span>, <span class="author">Dub&eacute; MP</span>, <span class="author">Rh&eacute;aume E</span>, <span class="author">Wareham NJ</span>, <span class="author">Khaw KT</span>, <span class="author">Sandhu MS</span> and <span class="author">Tardif JC</span></p>
<p class="affiliation">From the Montreal Heart Institute Research Center, Montreal, Quebec, Canada (B.J.A., M.-P.D., &Eacute;.R., J.-C.T.); Department of Medicine, Faculty of Medicine, University of Montreal, Montreal, Quebec, Canada (B.J.A., M.-P.D., &Eacute;.R., J.-C.T.); Department of Cardiology, Academic Medical Center, Amsterdam, The Netherlands (S.M.B.); MRC Epidemiology Unit (N.J.W.) and Department of Public Health and Primary Care (K.-T.K., M.S.S.), University of Cambridge, Cambridge, United Kingdom; and Genetic Epidemiology Group, Wellcome Trust Sanger Institute, Hinxton, United Kingdom (M.S.S.).</p><p class="abstract"><strong>Background</strong>: Although a previous study has suggested that a genetic variant in the LPA region was associated with the presence of aortic valve stenosis (AVS), no prospective study has suggested a role for lipoprotein(a) levels in the pathophysiology of AVS. Our objective was to determine whether lipoprotein(a) levels and a common genetic variant that is strongly associated with lipoprotein(a) levels are associated with an increased risk of developing AVS.</p><p class="abstract">Serum lipoprotein(a) levels were measured in 17&thinsp;553 participants of the European Prospective Investigation into Cancer (EPIC)-Norfolk study. Among these study participants, 118 developed AVS during a mean follow-up of 11.7 years. The rs10455872 genetic variant in LPA was genotyped in 14&thinsp;735 study participants, who simultaneously had lipoprotein(a) level measurements, and in a replication study of 379 patients with echocardiography-confirmed AVS and 404 controls. In EPIC-Norfolk, compared with participants in the bottom lipoprotein(a) tertile, those in the top lipoprotein(a) tertile had a higher risk of AVS (hazard ratio, 1.57; 95% confidence interval, 1.02-2.42) after adjusting for age, sex, and smoking. Compared with rs10455872 AA homozygotes, carriers of 1 or 2 G alleles were at increased risk of AVS (hazard ratio, 1.78; 95% confidence interval, 1.11-2.87, versus hazard ratio, 4.83; 95% confidence interval, 1.77-13.20, respectively). In the replication study, the genetic variant rs10455872 also showed a positive association with AVS (odds ratio, 1.57; 95% confidence interval, 1.10-2.26).</p><p class="abstract"><strong>Conclusions</strong>: Patients with high lipoprotein(a) levels are at increased risk for AVS. The rs10455872 variant, which is associated with higher lipoprotein(a) levels, is also associated with increased risk of AVS, suggesting that this association may be causal.</p>
<p class="publication"><span class="title">Circulation. Cardiovascular genetics</span>&nbsp;<span class="year">2014</span>;<span class="volume">7</span>;<span class="number">3</span>;<span class="pagerange">304-10</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24704946">24704946</a>; DOI: <a href="http://dx.doi.org/10.1161%2FCIRCGENETICS.113.000400">10.1161/CIRCGENETICS.113.000400</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Spread of artemisinin resistance in Plasmodium falciparum malaria.</h4>
<p class="authors"><span class="author">Ashley EA</span>, <span class="author">Dhorda M</span>, <span class="author">Fairhurst RM</span>, <span class="author">Amaratunga C</span>, <span class="author">Lim P</span>, <span class="author">Suon S</span>, <span class="author">Sreng S</span>, <span class="author">Anderson JM</span>, <span class="author">Mao S</span>, <span class="author">Sam B</span>, <span class="author">Sopha C</span>, <span class="author">Chuor CM</span>, <span class="author">Nguon C</span>, <span class="author">Sovannaroth S</span>, <span class="author">Pukrittayakamee S</span>, <span class="author">Jittamala P</span>, <span class="author">Chotivanich K</span>, <span class="author">Chutasmit K</span>, <span class="author">Suchatsoonthorn C</span>, <span class="author">Runcharoen R</span>, <span class="author">Hien TT</span>, <span class="author">Thuy-Nhien NT</span>, <span class="author">Thanh NV</span>, <span class="author">Phu NH</span>, <span class="author">Htut Y</span>, <span class="author">Han KT</span>, <span class="author">Aye KH</span>, <span class="author">Mokuolu OA</span>, <span class="author">Olaosebikan RR</span>, <span class="author">Folaranmi OO</span>, <span class="author">Mayxay M</span>, <span class="author">Khanthavong M</span>, <span class="author">Hongvanthong B</span>, <span class="author">Newton PN</span>, <span class="author">Onyamboko MA</span>, <span class="author">Fanello CI</span>, <span class="author">Tshefu AK</span>, <span class="author">Mishra N</span>, <span class="author">Valecha N</span>, <span class="author">Phyo AP</span>, <span class="author">Nosten F</span>, <span class="author">Yi P</span>, <span class="author">Tripura R</span>, <span class="author">Borrmann S</span>, <span class="author">Bashraheil M</span>, <span class="author">Peshu J</span>, <span class="author">Faiz MA</span>, <span class="author">Ghose A</span>, <span class="author">Hossain MA</span>, <span class="author">Samad R</span>, <span class="author">Rahman MR</span>, <span class="author">Hasan MM</span>, <span class="author">Islam A</span>, <span class="author">Miotto O</span>, <span class="author">Amato R</span>, <span class="author">MacInnis B</span>, <span class="author">Stalker J</span>, <span class="author">Kwiatkowski DP</span>, <span class="author">Bozdech Z</span>, <span class="author">Jeeyapant A</span>, <span class="author">Cheah PY</span>, <span class="author">Sakulthaew T</span>, <span class="author">Chalk J</span>, <span class="author">Intharabut B</span>, <span class="author">Silamut K</span>, <span class="author">Lee SJ</span>, <span class="author">Vihokhern B</span>, <span class="author">Kunasol C</span>, <span class="author">Imwong M</span>, <span class="author">Tarning J</span>, <span class="author">Taylor WJ</span>, <span class="author">Yeung S</span>, <span class="author">Woodrow CJ</span>, <span class="author">Flegg JA</span>, <span class="author">Das D</span>, <span class="author">Smith J</span>, <span class="author">Venkatesan M</span>, <span class="author">Plowe CV</span>, <span class="author">Stepniewska K</span>, <span class="author">Guerin PJ</span>, <span class="author">Dondorp AM</span>, <span class="author">Day NP</span>, <span class="author">White NJ</span> and <span class="author">Tracking Resistance to Artemisinin Collaboration (TRAC)</span></p>
<p class="affiliation">The authors&#39; affiliations are listed in the Appendix.</p><p class="abstract"><strong>Background</strong>: Artemisinin resistance in Plasmodium falciparum has emerged in Southeast Asia and now poses a threat to the control and elimination of malaria. Mapping the geographic extent of resistance is essential for planning containment and elimination strategies.</p><p class="abstract"><strong>Methods</strong>: Between May 2011 and April 2013, we enrolled 1241 adults and children with acute, uncomplicated falciparum malaria in an open-label trial at 15 sites in 10 countries (7 in Asia and 3 in Africa). Patients received artesunate, administered orally at a daily dose of either 2 mg per kilogram of body weight per day or 4 mg per kilogram, for 3 days, followed by a standard 3-day course of artemisinin-based combination therapy. Parasite counts in peripheral-blood samples were measured every 6 hours, and the parasite clearance half-lives were determined.</p><p class="abstract"><strong>Results</strong>: The median parasite clearance half-lives ranged from 1.9 hours in the Democratic Republic of Congo to 7.0 hours at the Thailand-Cambodia border. Slowly clearing infections (parasite clearance half-life &gt;5 hours), strongly associated with single point mutations in the &quot;propeller&quot; region of the P. falciparum kelch protein gene on chromosome 13 (kelch13), were detected throughout mainland Southeast Asia from southern Vietnam to central Myanmar. The incidence of pretreatment and post-treatment gametocytemia was higher among patients with slow parasite clearance, suggesting greater potential for transmission. In western Cambodia, where artemisinin-based combination therapies are failing, the 6-day course of antimalarial therapy was associated with a cure rate of 97.7% (95% confidence interval, 90.9 to 99.4) at 42 days.</p><p class="abstract"><strong>Conclusions</strong>: Artemisinin resistance to P. falciparum, which is now prevalent across mainland Southeast Asia, is associated with mutations in kelch13. Prolonged courses of artemisinin-based combination therapies are currently efficacious in areas where standard 3-day treatments are failing. (Funded by the U.K. Department of International Development and others; ClinicalTrials.gov number, NCT01350856.).</p>
<p class="grants">Funded by: Wellcome Trust</p>
<p class="publication"><span class="title">The New England journal of medicine</span>&nbsp;<span class="year">2014</span>;<span class="volume">371</span>;<span class="number">5</span>;<span class="pagerange">411-23</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25075834">25075834</a>; DOI: <a href="http://dx.doi.org/10.1056%2FNEJMoa1314981">10.1056/NEJMoa1314981</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Draft genome sequences of the type strains of Shigella flexneri held at Public Health England: comparison of classical phenotypic and novel molecular assays with whole genome sequence.</h4>
<p class="authors"><span class="author">Ashton PM</span>, <span class="author">Baker KS</span>, <span class="author">Gentle A</span>, <span class="author">Wooldridge DJ</span>, <span class="author">Thomson NR</span>, <span class="author">Dallman TJ</span> and <span class="author">Jenkins C</span></p>
<p class="affiliation">Gastrointestinal Bacteria Reference Unit, Public Health England, 61 Colindale Ave, NW9 5HT London, England. <a href="mailto:%63%6C%61%69%72%65.%6A%65%6E%6B%69%6E%73%40%70%68%65.%67%6F%76.%75%6B">&#99;&#108;&#97;&#105;&#114;&#101;&#46;&#106;&#101;&#110;&#107;&#105;&#110;&#115;&#64;&#112;&#104;&#101;&#46;&#103;&#111;&#118;&#46;&#117;&#107;</a>.</p><p class="abstract"><strong>Background</strong>: Public Health England (PHE) holds a collection of Shigella flexneri Type strains isolated between 1949 and 1972 representing 15 established serotypes and one provisional type, E1037. In this study, the genomes of all 16 PHE Type strains were sequenced using the Illumina HiSeq platform. The relationship between core genome phylogeny and serotype was examined.</p><p class="abstract"><strong>Results</strong>: The most common target gene for the detection of Shigella species in clinical PCR assays, ipaH, was detected in all genomes. The type-specific target genes were correctly identified in each genome sequence. In contrast to the S. flexneri in serotype 5 strain described by Sun et al. (2012), the two PHE serotype 5 Type strains possessed an additional oac gene and were differentiated by the presence (serotype 5b) or absence (serotype 5a) of gtrX. The somatic antigen structure and phylogenetic relationship were broadly congruent for strains expressing serotype specific antigens III, IV and V, but not for those expressing I and II. The whole genome phylogenies of the 15 isolates sequenced showed that the serotype 6 Type Strain was phylogenetically distinct from the other S. flexneri serotypes sequenced. The provisional serotype E1037 fell within the serotype 4 clade, being most closely related to the Serotype 4a Type Strain.</p><p class="abstract"><strong>Conclusions</strong>: The S. flexneri genome sequences were used to evaluate phylogenetic relationships between Type strains and validate genotypic and phenotypic assays. The analysis confirmed that the PHE S. flexneri Type strains are phenotypically and genotypically distinct. Novel variants will continue to be added to this archive.</p>
<p class="publication"><span class="title">Gut pathogens</span>&nbsp;<span class="year">2014</span>;<span class="volume">6</span>;<span class="number">1</span>;<span class="pagerange">7</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24684748">24684748</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC3972513">3972513</a>; DOI: <a href="http://dx.doi.org/10.1186%2F1757-4749-6-7">10.1186/1757-4749-6-7</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">estMOI: estimating multiplicity of infection using parasite deep sequencing data.</h4>
<p class="authors"><span class="author">Assefa SA</span>, <span class="author">Preston MD</span>, <span class="author">Campino S</span>, <span class="author">Ocholla H</span>, <span class="author">Sutherland CJ</span> and <span class="author">Clark TG</span></p>
<p class="affiliation">London School of Hygiene and Tropical Medicine, WC1E 7HT, London, UK, Wellcome Trust Sanger Institute, CB10 1SA, Hinxton, UK and Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Box 30096 BT3, Blantyre, Malawia.</p>
<p class="abstract">Summary: Individuals living in endemic areas generally harbour multiple parasite strains. Multiplicity of infection (MOI) can be an indicator of immune status and transmission intensity. It has a potentially confounding effect on a number of population genetic analyses, which often assume isolates are clonal. Polymerase chain reaction-based approaches to estimate MOI can lack sensitivity. For example, in the human malaria parasite Plasmodium falciparum, genotyping of the merozoite surface protein (MSP1/2) genes is a standard method for assessing MOI, despite the apparent problem of underestimation. The availability of deep coverage data from massively parallizable sequencing technologies means that MOI can be detected genome wide by considering the abundance of heterozygous genotypes. Here, we present a method to estimate MOI, which considers unique combinations of polymorphisms from sequence reads. The method is implemented within the estMOI software. When applied to clinical P.falciparum isolates from three continents, we find that multiple infections are common, especially in regions with high transmission.Availability and implementation: estMOI is freely available from http://pathogenseq.lshtm.ac.uk.

Contact: <a href="mailto:%73%61%6D%75%65%6C.%61%73%73%65%66%61%40%6C%73%68%74%6D.%61%63.%75%6B">&#115;&#97;&#109;&#117;&#101;&#108;&#46;&#97;&#115;&#115;&#101;&#102;&#97;&#64;&#108;&#115;&#104;&#116;&#109;&#46;&#97;&#99;&#46;&#117;&#107;</a> SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online.</p>
<p class="publication"><span class="title">Bioinformatics (Oxford, England)</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24443379">24443379</a>; DOI: <a href="http://dx.doi.org/10.1093%2Fbioinformatics%2Fbtu005">10.1093/bioinformatics/btu005</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Epistasis between the haptoglobin common variant and &alpha;+thalassemia influences risk of severe malaria in Kenyan children.</h4>
<p class="authors"><span class="author">Atkinson SH</span>, <span class="author">Uyoga SM</span>, <span class="author">Nyatichi E</span>, <span class="author">Macharia AW</span>, <span class="author">Nyutu G</span>, <span class="author">Ndila C</span>, <span class="author">Kwiatkowski DP</span>, <span class="author">Rockett KA</span> and <span class="author">Williams TN</span></p>
<p class="affiliation">Department of Paediatrics, Oxford University Hospitals National Health Service Trust, University of Oxford, and.</p><p class="abstract">Haptoglobin (Hp) scavenges free hemoglobin following malaria-induced hemolysis. Few studies have investigated the relationship between the common Hp variants and the risk of severe malaria, and their results are inconclusive. We conducted a case-control study of 996 children with severe Plasmodium falciparum malaria and 1220 community controls and genotyped for Hp, hemoglobin (Hb) S heterozygotes, and &alpha;(+)thalassemia. Hb S heterozygotes and &alpha;(+)thalassemia homozygotes were protected from severe malaria (odds ratio [OR], 0.12; 95% confidence interval [CI], 0.07-0.18 and OR, 0.69; 95% CI, 0.53-0.91, respectively). The risk of severe malaria also varied by Hp genotype: Hp2-1 was associated with the greatest protection against severe malaria and Hp2-2 with the greatest risk. Meta-analysis of the current and published studies suggests that Hp2-2 is associated with increased risk of severe malaria compared with Hp2-1. We found a significant interaction between Hp genotype and &alpha;(+)thalassemia in predicting risk of severe malaria: Hp2-1 in combination with heterozygous or homozygous &alpha;(+)thalassemia was associated with protection from severe malaria (OR, 0.73; 95% CI, 0.54-0.99 and OR, 0.48; 95% CI, 0.32-0.73, respectively), but &alpha;(+)thalassemia in combination with Hp2-2 was not protective. This epistatic interaction together with varying frequencies of &alpha;(+)thalassemia across Africa may explain the inconsistent relationship between Hp genotype and malaria reported in previous studies.</p>
<p class="publication"><span class="title">Blood</span>&nbsp;<span class="year">2014</span>;<span class="volume">123</span>;<span class="number">13</span>;<span class="pagerange">2008-16</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24478401">24478401</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC3968387">3968387</a>; DOI: <a href="http://dx.doi.org/10.1182%2Fblood-2013-10-533489">10.1182/blood-2013-10-533489</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Transcriptionally active chromatin recruits homologous recombination at DNA double-strand breaks.</h4>
<p class="authors"><span class="author">Aymard F</span>, <span class="author">Bugler B</span>, <span class="author">Schmidt CK</span>, <span class="author">Guillou E</span>, <span class="author">Caron P</span>, <span class="author">Briois S</span>, <span class="author">Iacovoni JS</span>, <span class="author">Daburon V</span>, <span class="author">Miller KM</span>, <span class="author">Jackson SP</span> and <span class="author">Legube G</span></p>
<p class="affiliation">1] Laboratoire de Biologie Cellulaire et Mol&eacute;culaire du Contr&ocirc;le de la Prolif&eacute;ration, Universit&eacute; de Toulouse, Universit&eacute; Paul Sabatier, Toulouse, France. [2] CNRS, Laboratoire de Biologie Cellulaire et Mol&eacute;culaire du Contr&ocirc;le de la Prolif&eacute;ration, Toulouse, France.</p><p class="abstract">Although both homologous recombination (HR) and nonhomologous end joining can repair DNA double-strand breaks (DSBs), the mechanisms by which one of these pathways is chosen over the other remain unclear. Here we show that transcriptionally active chromatin is preferentially repaired by HR. Using chromatin immunoprecipitation-sequencing (ChIP-seq) to analyze repair of multiple DSBs induced throughout the human genome, we identify an HR-prone subset of DSBs that recruit the HR protein RAD51, undergo resection and rely on RAD51 for efficient repair. These DSBs are located in actively transcribed genes and are targeted to HR repair via the transcription elongation-associated mark trimethylated histone H3 K36. Concordantly, depletion of SETD2, the main H3 K36 trimethyltransferase, severely impedes HR at such DSBs. Our study thereby demonstrates a primary role in DSB repair of the chromatin context in which a break occurs.</p>
<p class="grants">Funded by: Cancer Research UK: <span class="grant">11224</span>, <span class="grant">C6/A11226</span>; Wellcome Trust</p>
<p class="publication"><span class="title">Nature structural &amp; molecular biology</span>&nbsp;<span class="year">2014</span>;<span class="volume">21</span>;<span class="number">4</span>;<span class="pagerange">366-74</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24658350">24658350</a>; DOI: <a href="http://dx.doi.org/10.1038%2Fnsmb.2796">10.1038/nsmb.2796</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Revisiting the thrifty gene hypothesis via 65 loci associated with susceptibility to type 2 diabetes.</h4>
<p class="authors"><span class="author">Ayub Q</span>, <span class="author">Moutsianas L</span>, <span class="author">Chen Y</span>, <span class="author">Panoutsopoulou K</span>, <span class="author">Colonna V</span>, <span class="author">Pagani L</span>, <span class="author">Prokopenko I</span>, <span class="author">Ritchie GR</span>, <span class="author">Tyler-Smith C</span>, <span class="author">McCarthy MI</span>, <span class="author">Zeggini E</span> and <span class="author">Xue Y</span></p>
<p class="affiliation">The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton CB10 1HH, UK.</p><p class="abstract">We have investigated the evidence for positive selection in samples of African, European, and East Asian ancestry at 65 loci associated with susceptibility to type 2 diabetes (T2D) previously identified through genome-wide association studies. Selection early in human evolutionary history is predicted to lead to ancestral risk alleles shared between populations, whereas late selection would result in population-specific signals at derived risk alleles. By using a wide variety of tests based on the site frequency spectrum, haplotype structure, and population differentiation, we found no global signal of enrichment for positive selection when we considered all T2D risk loci collectively. However, in a locus-by-locus analysis, we found nominal evidence for positive selection at 14 of the loci. Selection favored the protective and risk alleles in similar proportions, rather than the risk alleles specifically as predicted by the thrifty gene hypothesis, and may not be related to influence on diabetes. Overall, we conclude that past positive selection has not been a powerful influence driving the prevalence of T2D risk alleles.</p>
<p class="grants">Funded by: Department of Health: <span class="grant">NF-SI-0611-10099</span>; Wellcome Trust: <span class="grant">090532</span>, <span class="grant">098051</span>, <span class="grant">098381</span>, <span class="grant">WT090367MA</span></p>
<p class="publication"><span class="title">American journal of human genetics</span>&nbsp;<span class="year">2014</span>;<span class="volume">94</span>;<span class="number">2</span>;<span class="pagerange">176-85</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24412096">24412096</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC3928649">3928649</a>; DOI: <a href="http://dx.doi.org/10.1016%2Fj.ajhg.2013.12.010">10.1016/j.ajhg.2013.12.010</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Novel mutations in penicillin-binding protein genes in clinical Staphylococcus aureus isolates that are methicillin resistant on susceptibility testing, but lack the mec gene.</h4>
<p class="authors"><span class="author">Ba X</span>, <span class="author">Harrison EM</span>, <span class="author">Edwards GF</span>, <span class="author">Holden MT</span>, <span class="author">Larsen AR</span>, <span class="author">Petersen A</span>, <span class="author">Skov RL</span>, <span class="author">Peacock SJ</span>, <span class="author">Parkhill J</span>, <span class="author">Paterson GK</span> and <span class="author">Holmes MA</span></p>
<p class="affiliation">Department of Veterinary Medicine, University of Cambridge, Cambridge, UK.</p><p class="abstract"><strong>Objectives</strong>: Methicillin-resistant Staphylococcus aureus (MRSA) is an important global health problem. MRSA resistance to &beta;-lactam antibiotics is mediated by the mecA or mecC genes, which encode an alternative penicillin-binding protein (PBP) 2a that has a low affinity to &beta;-lactam antibiotics. Detection of mec genes or PBP2a is regarded as the gold standard for the diagnosis of MRSA. We identified four MRSA isolates that lacked mecA or mecC genes, but were still phenotypically resistant to pencillinase-resistant &beta;-lactam antibiotics.</p><p class="abstract"><strong>Methods</strong>: The four human S. aureus isolates were investigated by whole genome sequencing and a range of phenotypic assays.</p><p class="abstract"><strong>Results</strong>: We identified a number of amino acid substitutions present in the endogenous PBPs 1, 2 and 3 that were found in the resistant isolates but were absent in closely related susceptible isolates and which may be the basis of resistance. Of particular interest are three identical amino acid substitutions in PBPs 1, 2 and 3, occurring independently in isolates from at least two separate multilocus sequence types. Two different non-conservative substitutions were also present in the same amino acid of PBP1 in two isolates from two different sequence types.</p><p class="abstract"><strong>Conclusions</strong>: This work suggests that phenotypically resistant MRSA could be misdiagnosed using molecular methods alone and provides evidence of alternative mechanisms for &beta;-lactam resistance in MRSA that may need to be considered by diagnostic laboratories.</p>
<p class="grants">Funded by: Medical Research Council: <span class="grant">G1001787</span></p>
<p class="publication"><span class="title">The Journal of antimicrobial chemotherapy</span>&nbsp;<span class="year">2014</span>;<span class="volume">69</span>;<span class="number">3</span>;<span class="pagerange">594-7</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24216768">24216768</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC3922151">3922151</a>; DOI: <a href="http://dx.doi.org/10.1093%2Fjac%2Fdkt418">10.1093/jac/dkt418</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Demystifying Escherichia coli pathovars.</h4>
<p class="authors"><span class="author">Baker KS</span></p>
<p class="affiliation">Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1SA, UK.</p>
<p class="publication"><span class="title">Nature reviews. Microbiology</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25482288">25482288</a>; DOI: <a href="http://dx.doi.org/10.1038%2Fnrmicro3411">10.1038/nrmicro3411</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">TB or not TB? Genomic portraits provide answers.</h4>
<p class="authors"><span class="author">Baker KS</span> and <span class="author">Ellington MJ</span></p>
<p class="affiliation">Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1SA, UK.</p>
<p class="publication"><span class="title">Nature reviews. Microbiology</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24801935">24801935</a>; DOI: <a href="http://dx.doi.org/10.1038%2Fnrmicro3273">10.1038/nrmicro3273</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Poxviruses in Bats &hellip; so What?</h4>
<p class="authors"><span class="author">Baker KS</span> and <span class="author">Murcia PR</span></p>
<p class="affiliation">Wellcome Trust Sanger Institute, Hinxton, CB10 1SA, UK. <a href="mailto:%6B%62%31%34%40%73%61%6E%67%65%72.%61%63.%75%6B">&#107;&#98;&#49;&#52;&#64;&#115;&#97;&#110;&#103;&#101;&#114;&#46;&#97;&#99;&#46;&#117;&#107;</a>.</p><p class="abstract">Poxviruses are important pathogens of man and numerous domestic and wild animal species. Cross species (including zoonotic) poxvirus infections can have drastic consequences for the recipient host. Bats are a diverse order of mammals known to carry lethal viral zoonoses such as Rabies, Hendra, Nipah, and SARS. Consequent targeted research is revealing bats to be infected with a rich diversity of novel viruses. Poxviruses were recently identified in bats and the settings in which they were found were dramatically different. Here, we review the natural history of poxviruses in bats and highlight the relationship of the viruses to each other and their context in the Poxviridae family. In addition to considering the zoonotic potential of these viruses, we reflect on the broader implications of these findings. Specifically, the potential to explore and exploit this newfound relationship to study coevolution and cross species transmission together with fundamental aspects of poxvirus host tropism as well as bat virology and immunology.</p>
<p class="publication"><span class="title">Viruses</span>&nbsp;<span class="year">2014</span>;<span class="volume">6</span>;<span class="number">4</span>;<span class="pagerange">1564-77</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24704730">24704730</a>; DOI: <a href="http://dx.doi.org/10.3390%2Fv6041564">10.3390/v6041564</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Gene conversion violates the stepwise mutation model for microsatellites in y-chromosomal palindromic repeats.</h4>
<p class="authors"><span class="author">Balaresque P</span>, <span class="author">King TE</span>, <span class="author">Parkin EJ</span>, <span class="author">Heyer E</span>, <span class="author">Carvalho-Silva D</span>, <span class="author">Kraaijenbrink T</span>, <span class="author">de Knijff P</span>, <span class="author">Tyler-Smith C</span> and <span class="author">Jobling MA</span></p>
<p class="affiliation">UMR5288 CNRS/UPS-AMIS-Universit&eacute; Paul Sabatier, Toulouse, France; Department of Genetics, University of Leicester, Leicester, UK.</p><p class="abstract">The male-specific region of the human Y chromosome (MSY) contains eight large inverted repeats (palindromes), in which high-sequence similarity between repeat arms is maintained by gene conversion. These palindromes also harbor microsatellites, considered to evolve via a stepwise mutation model (SMM). Here, we ask whether gene conversion between palindrome microsatellites contributes to their mutational dynamics. First, we study the duplicated tetranucleotide microsatellite DYS385a,b lying in palindrome P4. We show, by comparing observed data with simulated data under a SMM within haplogroups, that observed heteroallelic combinations in which the modal repeat number difference between copies was large, can give rise to homoallelic combinations with zero-repeats difference, equivalent to many single-step mutations. These are unlikely to be generated under a strict SMM, suggesting the action of gene conversion. Second, we show that the intercopy repeat number difference for a large set of duplicated microsatellites in all palindromes in the MSY reference sequence is significantly reduced compared with that for nonpalindrome-duplicated microsatellites, suggesting that the former are characterized by unusual evolutionary dynamics. These observations indicate that gene conversion violates the SMM for microsatellites in palindromes, homogenizing copies within individual Y chromosomes, but increasing overall haplotype diversity among chromosomes within related groups.</p>
<p class="grants">Funded by: Wellcome Trust: <span class="grant">087576</span></p>
<p class="publication"><span class="title">Human mutation</span>&nbsp;<span class="year">2014</span>;<span class="volume">35</span>;<span class="number">5</span>;<span class="pagerange">609-17</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24610746">24610746</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4233959">4233959</a>; DOI: <a href="http://dx.doi.org/10.1002%2Fhumu.22542">10.1002/humu.22542</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Toward male individualization with rapidly mutating y-chromosomal short tandem repeats.</h4>
<p class="authors"><span class="author">Ballantyne KN</span>, <span class="author">Ralf A</span>, <span class="author">Aboukhalid R</span>, <span class="author">Achakzai NM</span>, <span class="author">Anjos MJ</span>, <span class="author">Ayub Q</span>, <span class="author">Bala&#x17E;ic J</span>, <span class="author">Ballantyne J</span>, <span class="author">Ballard DJ</span>, <span class="author">Berger B</span>, <span class="author">Bobillo C</span>, <span class="author">Bouabdellah M</span>, <span class="author">Burri H</span>, <span class="author">Capal T</span>, <span class="author">Caratti S</span>, <span class="author">C&aacute;rdenas J</span>, <span class="author">Cartault F</span>, <span class="author">Carvalho EF</span>, <span class="author">Carvalho M</span>, <span class="author">Cheng B</span>, <span class="author">Coble MD</span>, <span class="author">Comas D</span>, <span class="author">Corach D</span>, <span class="author">D&#39;Amato ME</span>, <span class="author">Davison S</span>, <span class="author">de Knijff P</span>, <span class="author">De Ungria MC</span>, <span class="author">Decorte R</span>, <span class="author">Dobosz T</span>, <span class="author">Dupuy BM</span>, <span class="author">Elmrghni S</span>, <span class="author">Gliwi&#x144;ski M</span>, <span class="author">Gomes SC</span>, <span class="author">Grol L</span>, <span class="author">Haas C</span>, <span class="author">Hanson E</span>, <span class="author">Henke J</span>, <span class="author">Henke L</span>, <span class="author">Herrera-Rodr&iacute;guez F</span>, <span class="author">Hill CR</span>, <span class="author">Holmlund G</span>, <span class="author">Honda K</span>, <span class="author">Immel UD</span>, <span class="author">Inokuchi S</span>, <span class="author">Jobling MA</span>, <span class="author">Kaddura M</span>, <span class="author">Kim JS</span>, <span class="author">Kim SH</span>, <span class="author">Kim W</span>, <span class="author">King TE</span>, <span class="author">Klausriegler E</span>, <span class="author">Kling D</span>, <span class="author">Kova&#x10D;evi&#x107; L</span>, <span class="author">Kovatsi L</span>, <span class="author">Krajewski P</span>, <span class="author">Kravchenko S</span>, <span class="author">Larmuseau MH</span>, <span class="author">Lee EY</span>, <span class="author">Lessig R</span>, <span class="author">Livshits LA</span>, <span class="author">Marjanovi&#x107; D</span>, <span class="author">Minarik M</span>, <span class="author">Mizuno N</span>, <span class="author">Moreira H</span>, <span class="author">Morling N</span>, <span class="author">Mukherjee M</span>, <span class="author">Munier P</span>, <span class="author">Nagaraju J</span>, <span class="author">Neuhuber F</span>, <span class="author">Nie S</span>, <span class="author">Nilasitsataporn P</span>, <span class="author">Nishi T</span>, <span class="author">Oh HH</span>, <span class="author">Olofsson J</span>, <span class="author">Onofri V</span>, <span class="author">Palo JU</span>, <span class="author">Pamjav H</span>, <span class="author">Parson W</span>, <span class="author">Petlach M</span>, <span class="author">Phillips C</span>, <span class="author">Ploski R</span>, <span class="author">Prasad SP</span>, <span class="author">Primorac D</span>, <span class="author">Purnomo GA</span>, <span class="author">Purps J</span>, <span class="author">Rangel-Villalobos H</span>, <span class="author">R&#x119;ba&#x142;a K</span>, <span class="author">Rerkamnuaychoke B</span>, <span class="author">Gonzalez DR</span>, <span class="author">Robino C</span>, <span class="author">Roewer L</span>, <span class="author">Rosa A</span>, <span class="author">Sajantila A</span>, <span class="author">Sala A</span>, <span class="author">Salvador JM</span>, <span class="author">Sanz P</span>, <span class="author">Schmitt C</span>, <span class="author">Sharma AK</span>, <span class="author">Silva DA</span>, <span class="author">Shin KJ</span>, <span class="author">Sijen T</span>, <span class="author">Sirker M</span>, <span class="author">Siv&aacute;kov&aacute; D</span>, <span class="author">Skaro V</span>, <span class="author">Solano-Matamoros C</span>, <span class="author">Souto L</span>, <span class="author">Stenzl V</span>, <span class="author">Sudoyo H</span>, <span class="author">Syndercombe-Court D</span>, <span class="author">Tagliabracci A</span>, <span class="author">Taylor D</span>, <span class="author">Tillmar A</span>, <span class="author">Tsybovsky IS</span>, <span class="author">Tyler-Smith C</span>, <span class="author">van der Gaag KJ</span>, <span class="author">Vanek D</span>, <span class="author">V&ouml;lgyi A</span>, <span class="author">Ward D</span>, <span class="author">Willemse P</span>, <span class="author">Yap EP</span>, <span class="author">Yong RY</span>, <span class="author">Pajni&#x10D; IZ</span> and <span class="author">Kayser M</span></p>
<p class="affiliation">Department of Forensic Molecular Biology, Erasmus MC University Medical Centre Rotterdam, Rotterdam, The Netherlands; Office of the Chief Forensic Scientist, Victoria Police Forensic Services Department, Macleod, Victoria, Australia.</p><p class="abstract">Relevant for various areas of human genetics, Y-chromosomal short tandem repeats (Y-STRs) are commonly used for testing close paternal relationships among individuals and populations, and for male lineage identification. However, even the widely used 17-loci Yfiler set cannot resolve individuals and populations completely. Here, 52 centers generated quality-controlled data of 13 rapidly mutating (RM) Y-STRs in 14,644 related and unrelated males from 111 worldwide populations. Strikingly, &gt;99% of the 12,272 unrelated males were completely individualized. Haplotype diversity was extremely high (global: 0.9999985, regional: 0.99836-0.9999988). Haplotype sharing between populations was almost absent except for six (0.05%) of the 12,156 haplotypes. Haplotype sharing within populations was generally rare (0.8% nonunique haplotypes), significantly lower in urban (0.9%) than rural (2.1%) and highest in endogamous groups (14.3%). Analysis of molecular variance revealed 99.98% of variation within populations, 0.018% among populations within groups, and 0.002% among groups. Of the 2,372 newly and 156 previously typed male relative pairs, 29% were differentiated including 27% of the 2,378 father-son pairs. Relative to Yfiler, haplotype diversity was increased in 86% of the populations tested and overall male relative differentiation was raised by 23.5%. Our study demonstrates the value of RM Y-STRs in identifying and separating unrelated and related males and provides a reference database.</p>
<p class="publication"><span class="title">Human mutation</span>&nbsp;<span class="year">2014</span>;<span class="volume">35</span>;<span class="number">8</span>;<span class="pagerange">1021-32</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24917567">24917567</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4145662">4145662</a>; DOI: <a href="http://dx.doi.org/10.1002%2Fhumu.22599">10.1002/humu.22599</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Multi-species, multi-transcription factor binding highlights conserved control of tissue-specific biological pathways.</h4>
<p class="authors"><span class="author">Ballester B</span>, <span class="author">Medina-Rivera A</span>, <span class="author">Schmidt D</span>, <span class="author">Gonz&agrave;lez-Porta M</span>, <span class="author">Carlucci M</span>, <span class="author">Chen X</span>, <span class="author">Chessman K</span>, <span class="author">Faure AJ</span>, <span class="author">Funnell AP</span>, <span class="author">Goncalves A</span>, <span class="author">Kutter C</span>, <span class="author">Lukk M</span>, <span class="author">Menon S</span>, <span class="author">McLaren WM</span>, <span class="author">Stefflova K</span>, <span class="author">Watt S</span>, <span class="author">Weirauch MT</span>, <span class="author">Crossley M</span>, <span class="author">Marioni JC</span>, <span class="author">Odom DT</span>, <span class="author">Flicek P</span> and <span class="author">Wilson MD</span></p>
<p class="affiliation">European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Trust Genome Campus, Cambridge, United Kingdom.</p><p class="abstract">As exome sequencing gives way to genome sequencing, the need to interpret the function of regulatory DNA becomes increasingly important. To test whether evolutionary conservation of cis-regulatory modules (CRMs) gives insight into human gene regulation, we determined transcription factor (TF) binding locations of four liver-essential TFs in liver tissue from human, macaque, mouse, rat, and dog. Approximately, two thirds of the TF-bound regions fell into CRMs. Less than half of the human CRMs were found as a CRM in the orthologous region of a second species. Shared CRMs were associated with liver pathways and disease loci identified by genome-wide association studies. Recurrent rare human disease causing mutations at the promoters of several blood coagulation and lipid metabolism genes were also identified within CRMs shared in multiple species. This suggests that multi-species analyses of experimentally determined combinatorial TF binding will help identify genomic regions critical for tissue-specific gene control.</p>
<p class="publication"><span class="title">eLife</span>&nbsp;<span class="year">2014</span>;<span class="volume">3</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25279814">25279814</a>; DOI: <a href="http://dx.doi.org/10.7554%2FeLife.02626">10.7554/eLife.02626</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Mutations in KPTN cause macrocephaly, neurodevelopmental delay, and seizures.</h4>
<p class="authors"><span class="author">Baple EL</span>, <span class="author">Maroofian R</span>, <span class="author">Chioza BA</span>, <span class="author">Izadi M</span>, <span class="author">Cross HE</span>, <span class="author">Al-Turki S</span>, <span class="author">Barwick K</span>, <span class="author">Skrzypiec A</span>, <span class="author">Pawlak R</span>, <span class="author">Wagner K</span>, <span class="author">Coblentz R</span>, <span class="author">Zainy T</span>, <span class="author">Patton MA</span>, <span class="author">Mansour S</span>, <span class="author">Rich P</span>, <span class="author">Qualmann B</span>, <span class="author">Hurles ME</span>, <span class="author">Kessels MM</span> and <span class="author">Crosby AH</span></p>
<p class="affiliation">Monogenic Molecular Genetics, University of Exeter Medical School, St. Luke&#39;s Campus, Magdalen Road, Exeter EX1 2LU, UK.</p><p class="abstract">The proper development of neuronal circuits during neuromorphogenesis and neuronal-network formation is critically dependent on a coordinated and intricate series of molecular and cellular cues and responses. Although the cortical actin cytoskeleton is known to play a key role in neuromorphogenesis, relatively little is known about the specific molecules important for this process. Using linkage analysis and whole-exome sequencing on samples from families from the Amish community of Ohio, we have demonstrated that mutations in KPTN, encoding kaptin, cause a syndrome typified by macrocephaly, neurodevelopmental delay, and seizures. Our immunofluorescence analyses in primary neuronal cell cultures showed that endogenous and GFP-tagged kaptin associates with dynamic actin cytoskeletal structures and that this association is lost upon introduction of the identified mutations. Taken together, our studies have identified kaptin alterations responsible for macrocephaly and neurodevelopmental delay and define kaptin as a molecule crucial for normal human neuromorphogenesis.</p>
<p class="grants">Funded by: Medical Research Council: <span class="grant">G1001931</span>, <span class="grant">G1002279</span>; Wellcome Trust: <span class="grant">WT098051</span></p>
<p class="publication"><span class="title">American journal of human genetics</span>&nbsp;<span class="year">2014</span>;<span class="volume">94</span>;<span class="number">1</span>;<span class="pagerange">87-94</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24239382">24239382</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC3882725">3882725</a>; DOI: <a href="http://dx.doi.org/10.1016%2Fj.ajhg.2013.10.001">10.1016/j.ajhg.2013.10.001</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Transposon mutagenesis identifies genes driving hepatocellular carcinoma in a chronic hepatitis B mouse model.</h4>
<p class="authors"><span class="author">Bard-Chapeau EA</span>, <span class="author">Nguyen AT</span>, <span class="author">Rust AG</span>, <span class="author">Sayadi A</span>, <span class="author">Lee P</span>, <span class="author">Chua BQ</span>, <span class="author">New LS</span>, <span class="author">de Jong J</span>, <span class="author">Ward JM</span>, <span class="author">Chin CK</span>, <span class="author">Chew V</span>, <span class="author">Toh HC</span>, <span class="author">Abastado JP</span>, <span class="author">Benoukraf T</span>, <span class="author">Soong R</span>, <span class="author">Bard FA</span>, <span class="author">Dupuy AJ</span>, <span class="author">Johnson RL</span>, <span class="author">Radda GK</span>, <span class="author">Chan EC</span>, <span class="author">Wessels LF</span>, <span class="author">Adams DJ</span>, <span class="author">Jenkins NA</span> and <span class="author">Copeland NG</span></p>
<p class="affiliation">Institute Molecular and Cell Biology, Agency for Science, Technology and Research (A*STAR), Biopolis, Singapore.</p><p class="abstract">The most common risk factor for developing hepatocellular carcinoma (HCC) is chronic infection with hepatitis B virus (HBV). To better understand the evolutionary forces driving HCC, we performed a near-saturating transposon mutagenesis screen in a mouse HBV model of HCC. This screen identified 21 candidate early stage drivers and a very large number (2,860) of candidate later stage drivers that were enriched for genes that are mutated, deregulated or functioning in signaling pathways important for human HCC, with a striking 1,199 genes being linked to cellular metabolic processes. Our study provides a comprehensive overview of the genetic landscape of HCC.</p>
<p class="grants">Funded by: Cancer Research UK: <span class="grant">13031</span>; Wellcome Trust</p>
<p class="publication"><span class="title">Nature genetics</span>&nbsp;<span class="year">2014</span>;<span class="volume">46</span>;<span class="number">1</span>;<span class="pagerange">24-32</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24316982">24316982</a>; DOI: <a href="http://dx.doi.org/10.1038%2Fng.2847">10.1038/ng.2847</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">A genome wide association study of mathematical ability reveals an association at chromosome 3q29, a locus associated with autism and learning difficulties: a preliminary study.</h4>
<p class="authors"><span class="author">Baron-Cohen S</span>, <span class="author">Murphy L</span>, <span class="author">Chakrabarti B</span>, <span class="author">Craig I</span>, <span class="author">Mallya U</span>, <span class="author">Lakato&scaron;ov&aacute; S</span>, <span class="author">Rehnstrom K</span>, <span class="author">Peltonen L</span>, <span class="author">Wheelwright S</span>, <span class="author">Allison C</span>, <span class="author">Fisher SE</span> and <span class="author">Warrier V</span></p>
<p class="affiliation">Autism Research Centre, Department of Psychiatry, University of Cambridge, Cambridgeshire, United Kingdom; CLASS Clinic, Cambridgeshire and Peterborough NHS Foundation Trust (CPFT), Cambridgeshire, United Kingdom.</p><p class="abstract">Mathematical ability is heritable, but few studies have directly investigated its molecular genetic basis. Here we aimed to identify specific genetic contributions to variation in mathematical ability. We carried out a genome wide association scan using pooled DNA in two groups of U.K. samples, based on end of secondary/high school national academic exam achievement: high (n&#x200A;=&#x200A;419) versus low (n&#x200A;=&#x200A;183) mathematical ability while controlling for their verbal ability. Significant differences in allele frequencies between these groups were searched for in 906,600 SNPs using the Affymetrix GeneChip Human Mapping version 6.0 array. After meeting a threshold of p&lt;1.5&times;10-5, 12 SNPs from the pooled association analysis were individually genotyped in 542 of the participants and analyzed to validate the initial associations (lowest p-value 1.14 &times;10-6). In this analysis, one of the SNPs (rs789859) showed significant association after Bonferroni correction, and four (rs10873824, rs4144887, rs12130910 rs2809115) were nominally significant (lowest p-value 3.278 &times; 10-4). Three of the SNPs of interest are located within, or near to, known genes (FAM43A, SFT2D1, C14orf64). The SNP that showed the strongest association, rs789859, is located in a region on chromosome 3q29 that has been previously linked to learning difficulties and autism. rs789859 lies 1.3 kbp downstream of LSG1, and 700 bp upstream of FAM43A, mapping within the potential promoter/regulatory region of the latter. To our knowledge, this is only the second study to investigate the association of genetic variants with mathematical ability, and it highlights a number of interesting markers for future study.</p>
<p class="publication"><span class="title">PloS one</span>&nbsp;<span class="year">2014</span>;<span class="volume">9</span>;<span class="number">5</span>;<span class="pagerange">e96374</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24801482">24801482</a>; DOI: <a href="http://dx.doi.org/10.1371%2Fjournal.pone.0096374">10.1371/journal.pone.0096374</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Global population structure and evolution of Bordetella pertussis and their relationship with vaccination.</h4>
<p class="authors"><span class="author">Bart MJ</span>, <span class="author">Harris SR</span>, <span class="author">Advani A</span>, <span class="author">Arakawa Y</span>, <span class="author">Bottero D</span>, <span class="author">Bouchez V</span>, <span class="author">Cassiday PK</span>, <span class="author">Chiang CS</span>, <span class="author">Dalby T</span>, <span class="author">Fry NK</span>, <span class="author">Gaillard ME</span>, <span class="author">van Gent M</span>, <span class="author">Guiso N</span>, <span class="author">Hallander HO</span>, <span class="author">Harvill ET</span>, <span class="author">He Q</span>, <span class="author">van der Heide HG</span>, <span class="author">Heuvelman K</span>, <span class="author">Hozbor DF</span>, <span class="author">Kamachi K</span>, <span class="author">Karataev GI</span>, <span class="author">Lan R</span>, <span class="author">Luty&#x142;ska A</span>, <span class="author">Maharjan RP</span>, <span class="author">Mertsola J</span>, <span class="author">Miyamura T</span>, <span class="author">Octavia S</span>, <span class="author">Preston A</span>, <span class="author">Quail MA</span>, <span class="author">Sintchenko V</span>, <span class="author">Stefanelli P</span>, <span class="author">Tondella ML</span>, <span class="author">Tsang RS</span>, <span class="author">Xu Y</span>, <span class="author">Yao SM</span>, <span class="author">Zhang S</span>, <span class="author">Parkhill J</span> and <span class="author">Mooi FR</span></p><p class="abstract">Bordetella pertussis causes pertussis, a respiratory disease that is most severe for infants. Vaccination was introduced in the 1950s, and in recent years, a resurgence of disease was observed worldwide, with significant mortality in infants. Possible causes for this include the switch from whole-cell vaccines (WCVs) to less effective acellular vaccines (ACVs), waning immunity, and pathogen adaptation. Pathogen adaptation is suggested by antigenic divergence between vaccine strains and circulating strains and by the emergence of strains with increased pertussis toxin production. We applied comparative genomics to a worldwide collection of 343 B. pertussis strains isolated between 1920 and 2010. The global phylogeny showed two deep branches; the largest of these contained 98% of all strains, and its expansion correlated temporally with the first descriptions of pertussis outbreaks in Europe in the 16th century. We found little evidence of recent geographical clustering of the strains within this lineage, suggesting rapid strain flow between countries. We observed that changes in genes encoding proteins implicated in protective immunity that are included in ACVs occurred after the introduction of WCVs but before the switch to ACVs. Furthermore, our analyses consistently suggested that virulence-associated genes and genes coding for surface-exposed proteins were involved in adaptation. However, many of the putative adaptive loci identified have a physiological role, and further studies of these loci may reveal less obvious ways in which B. pertussis and the host interact. This work provides insight into ways in which pathogens may adapt to vaccination and suggests ways to improve pertussis vaccines. IMPORTANCE Whooping cough is mainly caused by Bordetella pertussis, and current vaccines are targeted against this organism. Recently, there have been increasing outbreaks of whooping cough, even where vaccine coverage is high. Analysis of the genomes of 343 B. pertussis isolates from around the world over the last 100 years suggests that the organism has emerged within the last 500 years, consistent with historical records. We show that global transmission of new strains is very rapid and that the worldwide population of B. pertussis is evolving in response to vaccine introduction, potentially enabling vaccine escape.</p>
<p class="grants">Funded by: Wellcome Trust: <span class="grant">098051</span></p>
<p class="publication"><span class="title">mBio</span>&nbsp;<span class="year">2014</span>;<span class="volume">5</span>;<span class="number">2</span>;<span class="pagerange">e01074</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24757216">24757216</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC3994516">3994516</a>; DOI: <a href="http://dx.doi.org/10.1128%2FmBio.01074-14">10.1128/mBio.01074-14</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Capturing needles in haystacks: a comparison of B-cell receptor sequencing methods.</h4>
<p class="authors"><span class="author">Bashford-Rogers RJ</span>, <span class="author">Palser AL</span>, <span class="author">Idris SF</span>, <span class="author">Carter L</span>, <span class="author">Epstein M</span>, <span class="author">Callard RE</span>, <span class="author">Douek DC</span>, <span class="author">Vassiliou GS</span>, <span class="author">Follows GA</span>, <span class="author">Hubank M</span> and <span class="author">Kellam P</span></p>
<p class="affiliation">Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1SA, UK. <a href="mailto:%70%6B%35%40%73%61%6E%67%65%72.%61%63.%75%6B">&#112;&#107;&#53;&#64;&#115;&#97;&#110;&#103;&#101;&#114;&#46;&#97;&#99;&#46;&#117;&#107;</a>.</p><p class="abstract"><strong>Background</strong>: Deep-sequencing methods are rapidly developing in the field of B-cell receptor (BCR) and T-cell receptor (TCR) diversity. These promise to revolutionise our understanding of adaptive immune dynamics, identify novel antibodies, and allow monitoring of minimal residual disease. However, different methods for BCR and TCR enrichment and amplification have been proposed. Here we perform the first systematic comparison between different methods of enrichment, amplification and sequencing for generating BCR and TCR repertoires using large sample numbers.</p><p class="abstract"><strong>Results</strong>: Resampling from the same RNA or cDNA pool results in highly correlated and reproducible repertoires, but resampling low frequency clones leads to stochastic variance. Repertoires generated by different sequencing methods (454 Roche and Illumina MiSeq) and amplification methods (multiplex PCR, 5&#39; Rapid amplification of cDNA ends (5&#39;RACE), and RNA-capture) are highly correlated, and resulting IgHV gene frequencies between the different methods were not significantly different. Read length has an impact on captured repertoire structure, and ultimately full-length BCR sequences are most informative for repertoire analysis as diversity outside of the CDR is very useful for phylogenetic analysis. Additionally, we show RNA-based BCR repertoires are more informative than using DNA.</p><p class="abstract"><strong>Conclusions</strong>: Repertoires generated by different sequencing and amplification methods are consistent, but we show that read lengths, depths and error profiles should be considered in experimental design, and multiple sampling approaches could be employed to minimise stochastic sampling variation. This detailed investigation of immune repertoire sequencing methods is essential for informing basic and clinical research.</p>
<p class="publication"><span class="title">BMC immunology</span>&nbsp;<span class="year">2014</span>;<span class="volume">15</span>;<span class="number">1</span>;<span class="pagerange">29</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25189176">25189176</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4243823">4243823</a>; DOI: <a href="http://dx.doi.org/10.1186%2Fs12865-014-0029-0">10.1186/s12865-014-0029-0</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Considerations when investigating lncRNA function in vivo.</h4>
<p class="authors"><span class="author">Bassett AR</span>, <span class="author">Akhtar A</span>, <span class="author">Barlow DP</span>, <span class="author">Bird AP</span>, <span class="author">Brockdorff N</span>, <span class="author">Duboule D</span>, <span class="author">Ephrussi A</span>, <span class="author">Ferguson-Smith AC</span>, <span class="author">Gingeras TR</span>, <span class="author">Haerty W</span>, <span class="author">Higgs DR</span>, <span class="author">Miska EA</span> and <span class="author">Ponting CP</span></p>
<p class="affiliation">Andrew R Bassett is in the MRC Functional Genomics Unit, Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford, United Kingdom. <a href="mailto:%61%6E%64%72%65%77.%62%61%73%73%65%74%74%40%70%61%74%68.%6F%78.%61%63.%75%6B">&#97;&#110;&#100;&#114;&#101;&#119;&#46;&#98;&#97;&#115;&#115;&#101;&#116;&#116;&#64;&#112;&#97;&#116;&#104;&#46;&#111;&#120;&#46;&#97;&#99;&#46;&#117;&#107;</a>.</p><p class="abstract">Although a small number of the vast array of animal long non-coding RNAs (lncRNAs) have known effects on cellular processes examined in vitro, the extent of their contributions to normal cell processes throughout development, differentiation and disease for the most part remains less clear. Phenotypes arising from deletion of an entire genomic locus cannot be unequivocally attributed either to the loss of the lncRNA per se or to the associated loss of other overlapping DNA regulatory elements. The distinction between cis- or trans-effects is also often problematic. We discuss the advantages and challenges associated with the current techniques for studying the in vivo function of lncRNAs in the light of different models of lncRNA molecular mechanism, and reflect on the design of experiments to mutate lncRNA loci. These considerations should assist in the further investigation of these transcriptional products of the genome.</p>
<p class="grants">Funded by: Cancer Research UK: <span class="grant">11832</span>; Medical Research Council: <span class="grant">G1000801</span>, <span class="grant">G1000801B</span>, <span class="grant">MC_U137761446</span>, <span class="grant">MC_UU_12009/4</span>, <span class="grant">MC_UU_12021/1</span>; NHGRI NIH HHS: <span class="grant">U54 HG007004-2.</span>; Wellcome Trust: <span class="grant">095606</span></p>
<p class="publication"><span class="title">eLife</span>&nbsp;<span class="year">2014</span>;<span class="volume">3</span>;<span class="pagerange">e03058</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25124674">25124674</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4132285">4132285</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">A Common Control Group - Optimising the Experiment Design to Maximise Sensitivity.</h4>
<p class="authors"><span class="author">Bate S</span> and <span class="author">Karp NA</span></p>
<p class="affiliation">Statistical Science Europe, GlaxoSmithKline Pharmaceuticals, Stevenage, United Kingdom.</p><p class="abstract">Methods for choosing an appropriate sample size in animal experiments have received much attention in the statistical and biological literature. Due to ethical constraints the number of animals used is always reduced where possible. However, as the number of animals decreases so the risk of obtaining inconclusive results increases. By using a more efficient experimental design we can, for a given number of animals, reduce this risk. In this paper two popular cases are considered, where planned comparisons are made to compare treatments back to control and when researchers plan to make all pairwise comparisons. By using theoretical and empirical techniques we show that for studies where all pairwise comparisons are made the traditional balanced design, as suggested in the literature, maximises sensitivity. For studies that involve planned comparisons of the treatment groups back to the control group, which are inherently more sensitive due to the reduced multiple testing burden, the sensitivity is maximised by increasing the number of animals in the control group while decreasing the number in the treated groups.</p>
<p class="publication"><span class="title">PloS one</span>&nbsp;<span class="year">2014</span>;<span class="volume">9</span>;<span class="number">12</span>;<span class="pagerange">e114872</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25504147">25504147</a>; DOI: <a href="http://dx.doi.org/10.1371%2Fjournal.pone.0114872">10.1371/journal.pone.0114872</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">No Evidence for Genome-Wide Interactions on Plasma Fibrinogen by Smoking, Alcohol Consumption and Body Mass Index: Results from Meta-Analyses of 80,607 Subjects.</h4>
<p class="authors"><span class="author">Baumert J</span>, <span class="author">Huang J</span>, <span class="author">McKnight B</span>, <span class="author">Sabater-Lleal M</span>, <span class="author">Steri M</span>, <span class="author">Chu AY</span>, <span class="author">Trompet S</span>, <span class="author">Lopez LM</span>, <span class="author">Fornage M</span>, <span class="author">Teumer A</span>, <span class="author">Tang W</span>, <span class="author">Rudnicka AR</span>, <span class="author">M&auml;larstig A</span>, <span class="author">Hottenga J</span>, <span class="author">Kavousi M</span>, <span class="author">Lahti J</span>, <span class="author">Tanaka T</span>, <span class="author">Hayward C</span>, <span class="author">Huffman JE</span>, <span class="author">Morange P</span>, <span class="author">Rose LM</span>, <span class="author">Basu S</span>, <span class="author">Rumley A</span>, <span class="author">Stott DJ</span>, <span class="author">Buckley BM</span>, <span class="author">de Craen AJ</span>, <span class="author">Sanna S</span>, <span class="author">Masala M</span>, <span class="author">Biffar R</span>, <span class="author">Homuth G</span>, <span class="author">Silveira A</span>, <span class="author">Sennblad B</span>, <span class="author">Goel A</span>, <span class="author">Watkins H</span>, <span class="author">M&uuml;ller-Nurasyid M</span>, <span class="author">R&uuml;ckerl R</span>, <span class="author">Taylor K</span>, <span class="author">Chen M</span>, <span class="author">de Geus EJ</span>, <span class="author">Hofman A</span>, <span class="author">Witteman JC</span>, <span class="author">de Maat MP</span>, <span class="author">Palotie A</span>, <span class="author">Davies G</span>, <span class="author">Siscovick DS</span>, <span class="author">Kolcic I</span>, <span class="author">Wild SH</span>, <span class="author">Song J</span>, <span class="author">McArdle WL</span>, <span class="author">Ford I</span>, <span class="author">Sattar N</span>, <span class="author">Schlessinger D</span>, <span class="author">Grotevendt A</span>, <span class="author">Franzosi MG</span>, <span class="author">Illig T</span>, <span class="author">Waldenberger M</span>, <span class="author">Lumley T</span>, <span class="author">Tofler GH</span>, <span class="author">Willemsen G</span>, <span class="author">Uitterlinden AG</span>, <span class="author">Rivadeneira F</span>, <span class="author">R&auml;ikk&ouml;nen K</span>, <span class="author">Chasman DI</span>, <span class="author">Folsom AR</span>, <span class="author">Lowe GD</span>, <span class="author">Westendorp RG</span>, <span class="author">Slagboom PE</span>, <span class="author">Cucca F</span>, <span class="author">Wallaschofski H</span>, <span class="author">Strawbridge RJ</span>, <span class="author">Seedorf U</span>, <span class="author">Koenig W</span>, <span class="author">Bis JC</span>, <span class="author">Mukamal KJ</span>, <span class="author">van Dongen J</span>, <span class="author">Widen E</span>, <span class="author">Franco OH</span>, <span class="author">Starr JM</span>, <span class="author">Liu K</span>, <span class="author">Ferrucci L</span>, <span class="author">Polasek O</span>, <span class="author">Wilson JF</span>, <span class="author">Oudot-Mellakh T</span>, <span class="author">Campbell H</span>, <span class="author">Navarro P</span>, <span class="author">Bandinelli S</span>, <span class="author">Eriksson J</span>, <span class="author">Boomsma DI</span>, <span class="author">Dehghan A</span>, <span class="author">Clarke R</span>, <span class="author">Hamsten A</span>, <span class="author">Boerwinkle E</span>, <span class="author">Jukema JW</span>, <span class="author">Naitza S</span>, <span class="author">Ridker PM</span>, <span class="author">V&ouml;lzke H</span>, <span class="author">Deary IJ</span>, <span class="author">Reiner AP</span>, <span class="author">Tr&eacute;gou&euml;t D</span>, <span class="author">O&#39;Donnell CJ</span>, <span class="author">Strachan DP</span>, <span class="author">Peters A</span> and <span class="author">Smith NL</span></p>
<p class="affiliation">Institute of Epidemiology II, Helmholtz Zentrum M&uuml;nchen, German Research Center for Environmental Health, Neuherberg, Germany.</p><p class="abstract">Plasma fibrinogen is an acute phase protein playing an important role in the blood coagulation cascade having strong associations with smoking, alcohol consumption and body mass index (BMI). Genome-wide association studies (GWAS) have identified a variety of gene regions associated with elevated plasma fibrinogen concentrations. However, little is yet known about how associations between environmental factors and fibrinogen might be modified by genetic variation. Therefore, we conducted large-scale meta-analyses of genome-wide interaction studies to identify possible interactions of genetic variants and smoking status, alcohol consumption or BMI on fibrinogen concentration. The present study included 80,607 subjects of European ancestry from 22 studies. Genome-wide interaction analyses were performed separately in each study for about 2.6 million single nucleotide polymorphisms (SNPs) across the 22 autosomal chromosomes. For each SNP and risk factor, we performed a linear regression under an additive genetic model including an interaction term between SNP and risk factor. Interaction estimates were meta-analysed using a fixed-effects model. No genome-wide significant interaction with smoking status, alcohol consumption or BMI was observed in the meta-analyses. The most suggestive interaction was found for smoking and rs10519203, located in the LOC123688 region on chromosome 15, with a p value of 6.2&times;10-8. This large genome-wide interaction study including 80,607 participants found no strong evidence of interaction between genetic variants and smoking status, alcohol consumption or BMI on fibrinogen concentrations. Further studies are needed to yield deeper insight in the interplay between environmental factors and gene variants on the regulation of fibrinogen concentrations.</p>
<p class="publication"><span class="title">PloS one</span>&nbsp;<span class="year">2014</span>;<span class="volume">9</span>;<span class="number">12</span>;<span class="pagerange">e111156</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25551457">25551457</a>; DOI: <a href="http://dx.doi.org/10.1371%2Fjournal.pone.0111156">10.1371/journal.pone.0111156</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Efficacy of a Plasmodium vivax malaria vaccine using ChAd63 and modified vaccinia Ankara expressing thrombospondin-related anonymous protein as assessed with transgenic Plasmodium berghei parasites.</h4>
<p class="authors"><span class="author">Bauza K</span>, <span class="author">Malinauskas T</span>, <span class="author">Pfander C</span>, <span class="author">Anar B</span>, <span class="author">Jones EY</span>, <span class="author">Billker O</span>, <span class="author">Hill AV</span> and <span class="author">Reyes-Sandoval A</span></p>
<p class="affiliation">The Jenner Institute, University of Oxford, Oxford, United Kingdom.</p><p class="abstract">Plasmodium vivax is the world&#39;s most widely distributed malaria parasite and a potential cause of morbidity and mortality for approximately 2.85 billion people living mainly in Southeast Asia and Latin America. Despite this dramatic burden, very few vaccines have been assessed in humans. The clinically relevant vectors modified vaccinia virus Ankara (MVA) and the chimpanzee adenovirus ChAd63 are promising delivery systems for malaria vaccines due to their safety profiles and proven ability to induce protective immune responses against Plasmodium falciparum thrombospondin-related anonymous protein (TRAP) in clinical trials. Here, we describe the development of new recombinant ChAd63 and MVA vectors expressing P. vivax TRAP (PvTRAP) and show their ability to induce high antibody titers and T cell responses in mice. In addition, we report a novel way of assessing the efficacy of new candidate vaccines against P. vivax using a fully infectious transgenic Plasmodium berghei parasite expressing P. vivax TRAP to allow studies of vaccine efficacy and protective mechanisms in rodents. Using this model, we found that both CD8+ T cells and antibodies mediated protection against malaria using virus-vectored vaccines. Our data indicate that ChAd63 and MVA expressing PvTRAP are good preerythrocytic-stage vaccine candidates with potential for future clinical application.</p>
<p class="grants">Funded by: Medical Research Council; Wellcome Trust: <span class="grant">090532</span>, <span class="grant">095540</span>, <span class="grant">097395</span>, <span class="grant">WT098051</span></p>
<p class="publication"><span class="title">Infection and immunity</span>&nbsp;<span class="year">2014</span>;<span class="volume">82</span>;<span class="number">3</span>;<span class="pagerange">1277-86</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24379295">24379295</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC3957994">3957994</a>; DOI: <a href="http://dx.doi.org/10.1128%2FIAI.01187-13">10.1128/IAI.01187-13</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Phenotypic and functional analyses show stem cell-derived hepatocyte-like cells better mimic fetal rather than adult hepatocytes.</h4>
<p class="authors"><span class="author">Baxter M</span>, <span class="author">Withey S</span>, <span class="author">Harrison S</span>, <span class="author">Segeritz CP</span>, <span class="author">Zhang F</span>, <span class="author">Atkinson-Dell R</span>, <span class="author">Rowe C</span>, <span class="author">Gerrard DT</span>, <span class="author">Sison-Young R</span>, <span class="author">Jenkins R</span>, <span class="author">Henry J</span>, <span class="author">Berry AA</span>, <span class="author">Mohamet L</span>, <span class="author">Best M</span>, <span class="author">Fenwick SW</span>, <span class="author">Malik H</span>, <span class="author">Kitteringham NR</span>, <span class="author">Goldring CE</span>, <span class="author">Hanley KP</span>, <span class="author">Vallier L</span> and <span class="author">Hanley NA</span></p>
<p class="affiliation">Centre for Endocrinology &amp; Diabetes, Institute of Human Development, Faculty of Medical &amp; Human Sciences, University of Manchester, Manchester Academic Health Science Centre, AV Hill Building, Oxford Road, Manchester, UK.</p><p class="abstract">Hepatocyte-like cells (HLCs) differentiated from pluripotent stem cells by the use of soluble factors can model human liver function and toxicity. However, at present HLC maturity and whether any deficit represents a true fetal state or aberrant differentiation is unclear and compounded by comparison to potentially deteriorated adult hepatocytes. Therefore, we generated HLCs from multiple lineages and two different protocols for direct comparison with fresh fetal and adult hepatocytes.</p><p class="abstract"><strong>Methods</strong>: Protocols were developed for robust differentiation. Multiple transcript, protein and functional analyses compared HLCs to fresh human fetal and adult hepatocytes.</p><p class="abstract"><strong>Results</strong>: HLCs were comparable to those of other laboratories by multiple parameters. Transcriptional changes during differentiation mimicked human embryogenesis and showed more similarity to pericentral than periportal hepatocytes. Unbiased proteomics demonstrated greater proximity to liver than 30 other human organs or tissues. However, by comparison to fresh material HLC maturity was proven by transcript, protein and function to be fetal-like and short of the adult phenotype. Expression of 81% of phase 1 enzymes in HLCs was significantly upregulated and half were statistically no different from in fetal hepatocytes. HLCs secreted albumin and metabolized testosterone (CYP3A) and dextrorphan (CYP2D6) like fetal hepatocytes. In seven bespoke tests devised by principal components analysis to distinguish fetal from adult hepatocytes HLCs from two different source laboratories consistently demonstrated fetal characteristics.</p><p class="abstract"><strong>Conclusions</strong>: HLCs from different sources are broadly comparable with unbiased proteomic evidence for faithful differentiation down the liver lineage. This current phenotype mimics human fetal rather than adult hepatocytes.</p>
<p class="publication"><span class="title">Journal of hepatology</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25457200">25457200</a>; DOI: <a href="http://dx.doi.org/10.1016%2Fj.jhep.2014.10.016">10.1016/j.jhep.2014.10.016</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Cancer evolution: mathematical models and computational inference.</h4>
<p class="authors"><span class="author">Beerenwinkel N</span>, <span class="author">Schwarz RF</span>, <span class="author">Gerstung M</span> and <span class="author">Markowetz F</span></p>
<p class="affiliation">Department of Biosystems Science and Engineering, ETH Zurich, 4058 Basel, Switzerland; SIB Swiss Institute of Bioinformatics, 4058 Basel, Switzerland; <a href="mailto:%6E%69%6B%6F.%62%65%65%72%65%6E%77%69%6E%6B%65%6C%40%62%73%73%65.%65%74%68%7A.%63%68">&#110;&#105;&#107;&#111;&#46;&#98;&#101;&#101;&#114;&#101;&#110;&#119;&#105;&#110;&#107;&#101;&#108;&#64;&#98;&#115;&#115;&#101;&#46;&#101;&#116;&#104;&#122;&#46;&#99;&#104;</a>.</p><p class="abstract">Cancer is a somatic evolutionary process characterized by the accumulation of mutations, which contribute to tumor growth, clinical progression, immune escape, and drug resistance development. Evolutionary theory can be used to analyze the dynamics of tumor cell populations and to make inference about the evolutionary history of a tumor from molecular data. We review recent approaches to modeling the evolution of cancer, including population dynamics models of tumor initiation and progression, phylogenetic methods to model the evolutionary relationship between tumor subclones, and probabilistic graphical models to describe dependencies among mutations. Evolutionary modeling helps to understand how tumors arise and will also play an increasingly important prognostic role in predicting disease progression and the outcome of medical interventions, such as targeted therapy.</p>
<p class="publication"><span class="title">Systematic biology</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25293804">25293804</a>; DOI: <a href="http://dx.doi.org/10.1093%2Fsysbio%2Fsyu081">10.1093/sysbio/syu081</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Genome sequencing of normal cells reveals developmental lineages and mutational processes.</h4>
<p class="authors"><span class="author">Behjati S</span>, <span class="author">Huch M</span>, <span class="author">van Boxtel R</span>, <span class="author">Karthaus W</span>, <span class="author">Wedge DC</span>, <span class="author">Tamuri AU</span>, <span class="author">Martincorena I</span>, <span class="author">Petljak M</span>, <span class="author">Alexandrov LB</span>, <span class="author">Gundem G</span>, <span class="author">Tarpey PS</span>, <span class="author">Roerink S</span>, <span class="author">Blokker J</span>, <span class="author">Maddison M</span>, <span class="author">Mudie L</span>, <span class="author">Robinson B</span>, <span class="author">Nik-Zainal S</span>, <span class="author">Campbell P</span>, <span class="author">Goldman N</span>, <span class="author">van de Wetering M</span>, <span class="author">Cuppen E</span>, <span class="author">Clevers H</span> and <span class="author">Stratton MR</span></p>
<p class="affiliation">1] Cancer Genome Project, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire CB10&nbsp;1SA, UK [2] Department of Paediatrics, University of Cambridge, Hills Road, Cambridge CB2&nbsp;2XY, UK.</p><p class="abstract">The somatic mutations present in the genome of a cell accumulate over the lifetime of a multicellular organism. These mutations can provide insights into the developmental lineage tree, the number of divisions that each cell has undergone and the mutational processes that have been operative. Here we describe whole genomes of clonal lines derived from multiple tissues of healthy mice. Using somatic base substitutions, we reconstructed the early cell divisions of each animal, demonstrating the contributions of embryonic cells to adult tissues. Differences were observed between tissues in the numbers and types of mutations accumulated by each cell, which likely reflect differences in the number of cell divisions they have undergone and varying contributions of different mutational processes. If somatic mutation rates are similar to those in mice, the results indicate that precise insights into development and mutagenesis of normal human cells will be possible.</p>
<p class="publication"><span class="title">Nature</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25043003">25043003</a>; DOI: <a href="http://dx.doi.org/10.1038%2Fnature13448">10.1038/nature13448</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">A Pathogenic Mosaic TP53 Mutation in Two Germ Layers Detected by Next Generation Sequencing.</h4>
<p class="authors"><span class="author">Behjati S</span>, <span class="author">Maschietto M</span>, <span class="author">Williams RD</span>, <span class="author">Side L</span>, <span class="author">Hubank M</span>, <span class="author">West R</span>, <span class="author">Pearson K</span>, <span class="author">Sebire N</span>, <span class="author">Tarpey P</span>, <span class="author">Futreal A</span>, <span class="author">Brooks T</span>, <span class="author">Stratton MR</span> and <span class="author">Anderson J</span></p>
<p class="affiliation">Cancer Genome Project, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire, United Kingdom; Department of Paediatrics, University of Cambridge, Cambridge, United Kingdom.</p><p class="abstract"><strong>Background</strong>: Li-Fraumeni syndrome is caused by germline TP53 mutations and is clinically characterized by a predisposition to a range of cancers, most commonly sarcoma, brain tumours and leukemia. Pathogenic mosaic TP53 mutations have only rarely been described.</p><p class="abstract">We describe a 2 years old child presenting with three separate cancers over a 6 month period; two soft tissue mesenchymal tumors and an aggressive metastatic neuroblastoma. As conventional testing of blood DNA by Sanger sequencing for mutations in TP53, ALK, and SDH was negative, whole exome sequencing of the blood DNA of the patient and both parents was performed to screen more widely for cancer predisposing mutations. In the patient&#39;s but not the parents&#39; DNA we found a c.743 G&gt;A, p.Arg248Gln (CCDS11118.1) TP53 mutation in 3-20% of sequencing reads, a level that would not generally be detectable by Sanger sequencing. Homozygosity for this mutation was detected in all tumor samples analyzed, and germline mosaicism was demonstrated by analysis of the child&#39;s newborn blood spot DNA. The occurrence of separate tumors derived from different germ layers suggests that this de novo mutation occurred early in embryogenesis, prior to gastrulation.</p><p class="abstract"><strong>Conclusion</strong>: The case demonstrates pathogenic mosaicim, detected by next generation deep sequencing, that arose in the early stages of embryogenesis.</p>
<p class="publication"><span class="title">PloS one</span>&nbsp;<span class="year">2014</span>;<span class="volume">9</span>;<span class="number">5</span>;<span class="pagerange">e96531</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24810334">24810334</a>; DOI: <a href="http://dx.doi.org/10.1371%2Fjournal.pone.0096531">10.1371/journal.pone.0096531</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Recurrent PTPRB and PLCG1 mutations in angiosarcoma.</h4>
<p class="authors"><span class="author">Behjati S</span>, <span class="author">Tarpey PS</span>, <span class="author">Sheldon H</span>, <span class="author">Martincorena I</span>, <span class="author">Van Loo P</span>, <span class="author">Gundem G</span>, <span class="author">Wedge DC</span>, <span class="author">Ramakrishna M</span>, <span class="author">Cooke SL</span>, <span class="author">Pillay N</span>, <span class="author">Vollan HK</span>, <span class="author">Papaemmanuil E</span>, <span class="author">Koss H</span>, <span class="author">Bunney TD</span>, <span class="author">Hardy C</span>, <span class="author">Joseph OR</span>, <span class="author">Martin S</span>, <span class="author">Mudie L</span>, <span class="author">Butler A</span>, <span class="author">Teague JW</span>, <span class="author">Patil M</span>, <span class="author">Steers G</span>, <span class="author">Cao Y</span>, <span class="author">Gumbs C</span>, <span class="author">Ingram D</span>, <span class="author">Lazar AJ</span>, <span class="author">Little L</span>, <span class="author">Mahadeshwar H</span>, <span class="author">Protopopov A</span>, <span class="author">Al Sannaa GA</span>, <span class="author">Seth S</span>, <span class="author">Song X</span>, <span class="author">Tang J</span>, <span class="author">Zhang J</span>, <span class="author">Ravi V</span>, <span class="author">Torres KE</span>, <span class="author">Khatri B</span>, <span class="author">Halai D</span>, <span class="author">Roxanis I</span>, <span class="author">Baumhoer D</span>, <span class="author">Tirabosco R</span>, <span class="author">Amary MF</span>, <span class="author">Boshoff C</span>, <span class="author">McDermott U</span>, <span class="author">Katan M</span>, <span class="author">Stratton MR</span>, <span class="author">Futreal PA</span>, <span class="author">Flanagan AM</span>, <span class="author">Harris A</span> and <span class="author">Campbell PJ</span></p>
<p class="affiliation">1] Cancer Genome Project, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, UK. [2] Department of Paediatrics, University of Cambridge, Cambridge, UK. [3].</p><p class="abstract">Angiosarcoma is an aggressive malignancy that arises spontaneously or secondarily to ionizing radiation or chronic lymphoedema. Previous work has identified aberrant angiogenesis, including occasional somatic mutations in angiogenesis signaling genes, as a key driver of angiosarcoma. Here we employed whole-genome, whole-exome and targeted sequencing to study the somatic changes underpinning primary and secondary angiosarcoma. We identified recurrent mutations in two genes, PTPRB and PLCG1, which are intimately linked to angiogenesis. The endothelial phosphatase PTPRB, a negative regulator of vascular growth factor tyrosine kinases, harbored predominantly truncating mutations in 10 of 39 tumors (26%). PLCG1, a signal transducer of tyrosine kinases, encoded a recurrent, likely activating p.Arg707Gln missense variant in 3 of 34 cases (9%). Overall, 15 of 39 tumors (38%) harbored at least one driver mutation in angiogenesis signaling genes. Our findings inform and reinforce current therapeutic efforts to target angiogenesis signaling in angiosarcoma.</p>
<p class="grants">Funded by: NCI NIH HHS: <span class="grant">K08 CA160443</span>; Wellcome Trust: <span class="grant">077012/Z/05/Z</span>, <span class="grant">093867</span>, <span class="grant">098051</span></p>
<p class="publication"><span class="title">Nature genetics</span>&nbsp;<span class="year">2014</span>;<span class="volume">46</span>;<span class="number">4</span>;<span class="pagerange">376-9</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24633157">24633157</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4032873">4032873</a>; DOI: <a href="http://dx.doi.org/10.1038%2Fng.2921">10.1038/ng.2921</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Keeping 53BP1 out of focus in mitosis.</h4>
<p class="authors"><span class="author">Belotserkovskaya R</span> and <span class="author">Jackson SP</span></p>
<p class="affiliation">The Wellcome Trust and Cancer Research UK Gurdon Institute and Department of Biochemistry, University of Cambridge, Cambridge, CB2 1QN, England, UK.</p><p class="abstract">A recent study published in Science reveals the mechanism and biological importance of DNA damage response abrogation in mitotic cells.</p>
<p class="publication"><span class="title">Cell research</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24810302">24810302</a>; DOI: <a href="http://dx.doi.org/10.1038%2Fcr.2014.62">10.1038/cr.2014.62</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Split reality for novel tick virus.</h4>
<p class="authors"><span class="author">Bennett HM</span></p>
<p class="affiliation">Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1SA, UK.</p>
<p class="publication"><span class="title">Nature reviews. Microbiology</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24909108">24909108</a>; DOI: <a href="http://dx.doi.org/10.1038%2Fnrmicro3297">10.1038/nrmicro3297</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">The genome of the sparganosis tapeworm Spirometra erinaceieuropaei isolated from the biopsy of a migrating brain lesion.</h4>
<p class="authors"><span class="author">Bennett HM</span>, <span class="author">Mok H</span>, <span class="author">Gkrania-Klotsas E</span>, <span class="author">Tsai IJ</span>, <span class="author">Stanley EJ</span>, <span class="author">Antoun NM</span>, <span class="author">Coghlan A</span>, <span class="author">Harsha B</span>, <span class="author">Traini A</span>, <span class="author">Ribeiro DM</span>, <span class="author">Steinbass S</span>, <span class="author">Lucas SB</span>, <span class="author">Allinson K</span>, <span class="author">Price SJ</span>, <span class="author">Santarius TS</span>, <span class="author">Carmichael AJ</span>, <span class="author">Chiodini PL</span>, <span class="author">Holroyd N</span>, <span class="author">Dean AF</span> and <span class="author">Berriman M</span></p><p class="abstract">BackgroundSparganosis is an infection with a larval Diphyllobothriidea tapeworm. From a rare cerebral case presented at a clinic in the UK, DNA was recovered from a biopsy sample and used to determine the causative species as Spirometra erinaceieuropaei through sequencing of the cox1 gene. From the same DNA, we have produced a draft genome, the first of its kind for this species, and used it to perform a comparative genomics analysis and to investigate known and potential tapeworm drug targets in this tapeworm.ResultsThe 1.26Gb draft genome of S. erinaceieuropaei is currently the largest reported for any flatworm. Through investigation of &szlig;-tubulin genes, we predict that S. erinaceieuropaei larvae are insensitive to the tapeworm drug albendazole. We find that many putative tapeworm drug targets are also present in S. erinaceieuropaei, allowing possible cross application of new drugs. In comparison to other sequenced tapeworm species we observe expansion of protease classes, and of Kuntiz-type protease inhibitors. Expanded gene families in this tapeworm also include those that are involved in processes that add post-translational diversity to the protein landscape, intracellular transport, transcriptional regulation and detoxification.ConclusionsThe S. erinaceieuropaei genome begins to give us insight into an order of tapeworms previously uncharacterized at the genome-wide level. From a single clinical case we have begun to sketch a picture of the characteristics of these organisms. Finally, our work represents a significant technological achievement as we present a draft genome sequence of a rare tapeworm, and from a small amount of starting material.</p>
<p class="publication"><span class="title">Genome biology</span>&nbsp;<span class="year">2014</span>;<span class="volume">15</span>;<span class="number">11</span>;<span class="pagerange">510</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25413302">25413302</a>; DOI: <a href="http://dx.doi.org/10.1186%2FPREACCEPT-2413673241432389">10.1186/PREACCEPT-2413673241432389</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">A High-Definition View of Functional Genetic Variation from Natural Yeast Genomes.</h4>
<p class="authors"><span class="author">Bergstr&ouml;m A</span>, <span class="author">Simpson JT</span>, <span class="author">Salinas F</span>, <span class="author">Barr&eacute; B</span>, <span class="author">Parts L</span>, <span class="author">Zia A</span>, <span class="author">Nguyen Ba AN</span>, <span class="author">Moses AM</span>, <span class="author">Louis EJ</span>, <span class="author">Mustonen V</span>, <span class="author">Warringer J</span>, <span class="author">Durbin R</span> and <span class="author">Liti G</span></p>
<p class="affiliation">Institute for Research on Cancer and Ageing, Nice (IRCAN), University of Nice, Nice, France.</p>
<p class="abstract">The question of how genetic variation in a population influences phenotypic variation and evolution is of major importance in modern biology. Yet much is still unknown about the relative functional importance of different forms of genome variation and how they are shaped by evolutionary processes. Here we address these questions by population level sequencing of 42 strains from the budding yeast Saccharomyces cerevisiae and its closest relative S. paradoxus. We find that genome content variation, in the form of presence or absence as well as copy number of genetic material, is higher within S. cerevisiae than within S. paradoxus, despite genetic distances as measured in single-nucleotide polymorphisms being vastly smaller within the former species. This genome content variation, as well as loss-of-function variation in the form of premature stop codons and frameshifting indels, is heavily enriched in the subtelomeres, strongly reinforcing the relevance of these regions to functional evolution. Genes affected by these likely functional forms of variation are enriched for functions mediating interaction with the external environment (sugar transport and metabolism, flocculation, metal transport, and metabolism). Our results and analyses provide a comprehensive view of genomic diversity in budding yeast and expose surprising and pronounced differences between the variation within S. cerevisiae and that within S. paradoxus. We also believe that the sequence data and de novo assemblies will constitute a useful resource for further evolutionary and population genomics studies.</p>
<p class="publication"><span class="title">Molecular biology and evolution</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24425782">24425782</a>; DOI: <a href="http://dx.doi.org/10.1093%2Fmolbev%2Fmsu037">10.1093/molbev/msu037</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Izumo meets Juno: preventing polyspermy in fertilization.</h4>
<p class="authors"><span class="author">Bianchi E</span> and <span class="author">Wright GJ</span></p>
<p class="affiliation">Cell Surface Signalling Laboratory; Wellcome Trust Sanger Institute; Cambridge, UK.</p>
<p class="publication"><span class="title">Cell cycle (Georgetown, Tex.)</span>&nbsp;<span class="year">2014</span>;<span class="volume">13</span>;<span class="number">13</span>;<span class="pagerange">2019-20</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24906131">24906131</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4111690">4111690</a>; DOI: <a href="http://dx.doi.org/10.4161%2Fcc.29461">10.4161/cc.29461</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Juno is the egg Izumo receptor and is essential for mammalian fertilization.</h4>
<p class="authors"><span class="author">Bianchi E</span>, <span class="author">Doe B</span>, <span class="author">Goulding D</span> and <span class="author">Wright GJ</span></p>
<p class="affiliation">Cell Surface Signalling Laboratory, Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK.</p><p class="abstract">Fertilization occurs when sperm and egg recognize each other and fuse to form a new, genetically distinct organism. The molecular basis of sperm-egg recognition is unknown, but is likely to require interactions between receptor proteins displayed on their surface. Izumo1 is an essential sperm cell-surface protein, but its receptor on the egg has not been described. Here we identify folate receptor 4 (Folr4) as the receptor for Izumo1 on the mouse egg, and propose to rename it Juno. We show that the Izumo1-Juno interaction is conserved within several mammalian species, including humans. Female mice lacking Juno are infertile and Juno-deficient eggs do not fuse with normal sperm. Rapid shedding of Juno from the oolemma after fertilization suggests a mechanism for the membrane block to polyspermy, ensuring eggs normally fuse with just a single sperm. Our discovery of an essential receptor pair at the nexus of conception provides opportunities for the rational development of new fertility treatments and contraceptives.</p>
<p class="grants">Funded by: Wellcome Trust: <span class="grant">098051</span></p>
<p class="publication"><span class="title">Nature</span>&nbsp;<span class="year">2014</span>;<span class="volume">508</span>;<span class="number">7497</span>;<span class="pagerange">483-7</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24739963">24739963</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC3998876">3998876</a>; DOI: <a href="http://dx.doi.org/10.1038%2Fnature13203">10.1038/nature13203</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">A loss of function screen of identified genome-wide association study Loci reveals new genes controlling hematopoiesis.</h4>
<p class="authors"><span class="author">Bielczyk-Maczy&#x144;ska E</span>, <span class="author">Serbanovic-Canic J</span>, <span class="author">Ferreira L</span>, <span class="author">Soranzo N</span>, <span class="author">Stemple DL</span>, <span class="author">Ouwehand WH</span> and <span class="author">Cvejic A</span></p>
<p class="affiliation">Department of Haematology, University of Cambridge, Cambridge, United Kingdom; Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, United Kingdom; NHS Blood and Transplant, Cambridge, United Kingdom.</p><p class="abstract">The formation of mature cells by blood stem cells is very well understood at the cellular level and we know many of the key transcription factors that control fate decisions. However, many upstream signalling and downstream effector processes are only partially understood. Genome wide association studies (GWAS) have been particularly useful in providing new directions to dissect these pathways. A GWAS meta-analysis identified 68 genetic loci controlling platelet size and number. Only a quarter of those genes, however, are known regulators of hematopoiesis. To determine function of the remaining genes we performed a medium-throughput genetic screen in zebrafish using antisense morpholino oligonucleotides (MOs) to knock down protein expression, followed by histological analysis of selected genes using a wide panel of different hematopoietic markers. The information generated by the initial knockdown was used to profile phenotypes and to position candidate genes hierarchically in hematopoiesis. Further analysis of brd3a revealed its essential role in differentiation but not maintenance and survival of thrombocytes. Using the from-GWAS-to-function strategy we have not only identified a series of genes that represent novel regulators of thrombopoiesis and hematopoiesis, but this work also represents, to our knowledge, the first example of a functional genetic screening strategy that is a critical step toward obtaining biologically relevant functional data from GWA study for blood cell traits.</p>
<p class="publication"><span class="title">PLoS genetics</span>&nbsp;<span class="year">2014</span>;<span class="volume">10</span>;<span class="number">7</span>;<span class="pagerange">e1004450</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25010335">25010335</a>; DOI: <a href="http://dx.doi.org/10.1371%2Fjournal.pgen.1004450">10.1371/journal.pgen.1004450</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">A quantitative 14-3-3 interaction screen connects the nuclear exosome targeting complex to the DNA damage response.</h4>
<p class="authors"><span class="author">Blasius M</span>, <span class="author">Wagner SA</span>, <span class="author">Choudhary C</span>, <span class="author">Bartek J</span> and <span class="author">Jackson SP</span></p>
<p class="affiliation">The Gurdon Institute, Department of Biochemistry, University of Cambridge, Cambridge CB2 1QN, United Kingdom; Genome Integrity Unit, Danish Cancer Society Research Centre, 2100 Copenhagen, Denmark;</p><p class="abstract">RNA metabolism is altered following DNA damage, but the underlying mechanisms are not well understood. Through a 14-3-3 interaction screen for DNA damage-induced protein interactions in human cells, we identified protein complexes connected to RNA biology. These include the nuclear exosome targeting (NEXT) complex that regulates turnover of noncoding RNAs termed promoter upstream transcripts (PROMPTs). We show that the NEXT subunit RBM7 is phosphorylated upon DNA damage by the MAPKAPK2 kinase and establish that this mediates 14-3-3 binding and decreases PROMPT binding. These findings and our observation that cells lacking RBM7 display DNA damage hypersensitivity link PROMPT turnover to the DNA damage response.</p>
<p class="publication"><span class="title">Genes &amp; development</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25189701">25189701</a>; DOI: <a href="http://dx.doi.org/10.1101%2Fgad.246272.114">10.1101/gad.246272.114</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Recombination: genomic mix &#39;n&#39; match.</h4>
<p class="authors"><span class="author">Boinett CJ</span> and <span class="author">Cain AK</span></p>
<p class="affiliation">Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1SA, UK.</p>
<p class="publication"><span class="title">Nature reviews. Microbiology</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25383603">25383603</a>; DOI: <a href="http://dx.doi.org/10.1038%2Fnrmicro3388">10.1038/nrmicro3388</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Heterogeneity of genomic evolution and mutational profiles in multiple myeloma.</h4>
<p class="authors"><span class="author">Bolli N</span>, <span class="author">Avet-Loiseau H</span>, <span class="author">Wedge DC</span>, <span class="author">Van Loo P</span>, <span class="author">Alexandrov LB</span>, <span class="author">Martincorena I</span>, <span class="author">Dawson KJ</span>, <span class="author">Iorio F</span>, <span class="author">Nik-Zainal S</span>, <span class="author">Bignell GR</span>, <span class="author">Hinton JW</span>, <span class="author">Li Y</span>, <span class="author">Tubio JM</span>, <span class="author">McLaren S</span>, <span class="author">O&#39; Meara S</span>, <span class="author">Butler AP</span>, <span class="author">Teague JW</span>, <span class="author">Mudie L</span>, <span class="author">Anderson E</span>, <span class="author">Rashid N</span>, <span class="author">Tai YT</span>, <span class="author">Shammas MA</span>, <span class="author">Sperling AS</span>, <span class="author">Fulciniti M</span>, <span class="author">Richardson PG</span>, <span class="author">Parmigiani G</span>, <span class="author">Magrangeas F</span>, <span class="author">Minvielle S</span>, <span class="author">Moreau P</span>, <span class="author">Attal M</span>, <span class="author">Facon T</span>, <span class="author">Futreal PA</span>, <span class="author">Anderson KC</span>, <span class="author">Campbell PJ</span> and <span class="author">Munshi NC</span></p>
<p class="affiliation">1] Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK [2] Department of Haematology, University of Cambridge, CIMR, Cambridge CB2 0XY, UK.</p>
<p class="abstract">Multiple myeloma is an incurable plasma cell malignancy with a complex and incompletely understood molecular pathogenesis. Here we use whole-exome sequencing, copy-number profiling and cytogenetics to analyse 84 myeloma samples. Most cases have a complex subclonal structure and show clusters of subclonal variants, including subclonal driver mutations. Serial sampling reveals diverse patterns of clonal evolution, including linear evolution, differential clonal response and branching evolution. Diverse processes contribute to the mutational repertoire, including kataegis and somatic hypermutation, and their relative contribution changes over time. We find heterogeneity of mutational spectrum across samples, with few recurrent genes. We identify new candidate genes, including truncations of SP140, LTB, ROBO1 and clustered missense mutations in EGR1. The myeloma genome is heterogeneous across the cohort, and exhibits diversity in clonal admixture and in dynamics of evolution, which may impact prognostic stratification, therapeutic approaches and assessment of disease response to treatment.</p>
<p class="publication"><span class="title">Nature communications</span>&nbsp;<span class="year">2014</span>;<span class="volume">5</span>;<span class="pagerange">2997</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24429703">24429703</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC3905727">3905727</a>; DOI: <a href="http://dx.doi.org/10.1038%2Fncomms3997">10.1038/ncomms3997</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Characterization of gene mutations and copy number changes in acute myeloid leukemia using a rapid target enrichment protocol.</h4>
<p class="authors"><span class="author">Bolli N</span>, <span class="author">Manes N</span>, <span class="author">McKerrel T</span>, <span class="author">Chi J</span>, <span class="author">Park N</span>, <span class="author">Gundem G</span>, <span class="author">Quail MA</span>, <span class="author">Sathiaseelan V</span>, <span class="author">Herman B</span>, <span class="author">Crawley C</span>, <span class="author">Craig JI</span>, <span class="author">Conte N</span>, <span class="author">Grove C</span>, <span class="author">Papaemmanuil E</span>, <span class="author">Campbell PJ</span>, <span class="author">Varela I</span>, <span class="author">Costeas P</span> and <span class="author">Vassiliou GS</span></p>
<p class="affiliation">Wellcome Trust Sanger Institute;</p><p class="abstract">Prognostic stratification is critical for making therapeutic decisions and maximizing survival of patients with acute myeloid leukemia. Advances in the genomics of acute myeloid leukemia have identified several recurrent gene mutations whose prognostic impact is being deciphered. We used HaloPlex target enrichment and Illumina-based next generation sequencing to study 24 recurrently mutated genes in 42 samples of acute myeloid leukemia with a normal karyotype. Read depth varied between and within genes for the same sample, but was predictable and highly consistent across samples. Consequently, we were able to detect copy number changes, such as an interstitial deletion of BCOR, three MLL partial tandem duplications, and a novel KRAS amplification. With regards to coding mutations, we identified likely oncogenic variants in 41/42 samples. NPM1 mutations were the most frequent, followed by FLT3, DNMT3A and TET2. NPM1 and FLT3 indels were reported with good efficiency. We also showed that DNMT3A mutations can persist post-chemotherapy and in 2 cases studied at diagnosis and relapse, we were able to delineate the dynamics of tumor evolution and give insights into order of acquisition of variants. HaloPlex is a quick and reliable target enrichment method that can aid diagnosis and prognostic stratification of acute myeloid leukemia patients.</p>
<p class="publication"><span class="title">Haematologica</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25381129">25381129</a>; DOI: <a href="http://dx.doi.org/10.3324%2Fhaematol.2014.113381">10.3324/haematol.2014.113381</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">The Scramble Conversion Tool.</h4>
<p class="authors"><span class="author">Bonfield JK</span></p>
<p class="affiliation">Wellcome Trust Sanger Institute <a href="mailto:%6A%6B%62%40%73%61%6E%67%65%72.%61%63.%75%6B">&#106;&#107;&#98;&#64;&#115;&#97;&#110;&#103;&#101;&#114;&#46;&#97;&#99;&#46;&#117;&#107;</a>.</p><p class="abstract"><strong>Motivation</strong>: The reference CRAM file format implementation is in Java. We present &quot;Scramble&quot;: a new C implementation of SAM, BAM and CRAM file I/O.</p><p class="abstract"><strong>Results</strong>: The C API for CRAM is 1.5-1.7x slower than BAM at decoding, but 1.8-2.6x faster at encoding. We see file size savings of 34-55%. Availability: Source code is available from http://sourceforge.net/projects/staden/files/io_lib/ under the BSD software licence.</p><p class="abstract"><strong>Contact</strong>: <a href="mailto:%6A%6B%62%40%73%61%6E%67%65%72.%61%63.%75%6B">&#106;&#107;&#98;&#64;&#115;&#97;&#110;&#103;&#101;&#114;&#46;&#97;&#99;&#46;&#117;&#107;</a>.</p>
<p class="publication"><span class="title">Bioinformatics (Oxford, England)</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24930138">24930138</a>; DOI: <a href="http://dx.doi.org/10.1093%2Fbioinformatics%2Fbtu390">10.1093/bioinformatics/btu390</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">A genome-wide association study of anorexia nervosa.</h4>
<p class="authors"><span class="author">Boraska V</span>, <span class="author">Franklin CS</span>, <span class="author">Floyd JA</span>, <span class="author">Thornton LM</span>, <span class="author">Huckins LM</span>, <span class="author">Southam L</span>, <span class="author">Rayner NW</span>, <span class="author">Tachmazidou I</span>, <span class="author">Klump KL</span>, <span class="author">Treasure J</span>, <span class="author">Lewis CM</span>, <span class="author">Schmidt U</span>, <span class="author">Tozzi F</span>, <span class="author">Kiezebrink K</span>, <span class="author">Hebebrand J</span>, <span class="author">Gorwood P</span>, <span class="author">Adan RA</span>, <span class="author">Kas MJ</span>, <span class="author">Favaro A</span>, <span class="author">Santonastaso P</span>, <span class="author">Fern&aacute;ndez-Aranda F</span>, <span class="author">Gratacos M</span>, <span class="author">Rybakowski F</span>, <span class="author">Dmitrzak-Weglarz M</span>, <span class="author">Kaprio J</span>, <span class="author">Keski-Rahkonen A</span>, <span class="author">Raevuori A</span>, <span class="author">Van Furth EF</span>, <span class="author">Slof-Op &#39;t Landt MC</span>, <span class="author">Hudson JI</span>, <span class="author">Reichborn-Kjennerud T</span>, <span class="author">Knudsen GP</span>, <span class="author">Monteleone P</span>, <span class="author">Kaplan AS</span>, <span class="author">Karwautz A</span>, <span class="author">Hakonarson H</span>, <span class="author">Berrettini WH</span>, <span class="author">Guo Y</span>, <span class="author">Li D</span>, <span class="author">Schork NJ</span>, <span class="author">Komaki G</span>, <span class="author">Ando T</span>, <span class="author">Inoko H</span>, <span class="author">Esko T</span>, <span class="author">Fischer K</span>, <span class="author">M&auml;nnik K</span>, <span class="author">Metspalu A</span>, <span class="author">Baker JH</span>, <span class="author">Cone RD</span>, <span class="author">Dackor J</span>, <span class="author">DeSocio JE</span>, <span class="author">Hilliard CE</span>, <span class="author">O&#39;Toole JK</span>, <span class="author">Pantel J</span>, <span class="author">Szatkiewicz JP</span>, <span class="author">Taico C</span>, <span class="author">Zerwas S</span>, <span class="author">Trace SE</span>, <span class="author">Davis OS</span>, <span class="author">Helder S</span>, <span class="author">B&uuml;hren K</span>, <span class="author">Burghardt R</span>, <span class="author">de Zwaan M</span>, <span class="author">Egberts K</span>, <span class="author">Ehrlich S</span>, <span class="author">Herpertz-Dahlmann B</span>, <span class="author">Herzog W</span>, <span class="author">Imgart H</span>, <span class="author">Scherag A</span>, <span class="author">Scherag S</span>, <span class="author">Zipfel S</span>, <span class="author">Boni C</span>, <span class="author">Ramoz N</span>, <span class="author">Versini A</span>, <span class="author">Brandys MK</span>, <span class="author">Danner UN</span>, <span class="author">de Kovel C</span>, <span class="author">Hendriks J</span>, <span class="author">Koeleman BP</span>, <span class="author">Ophoff RA</span>, <span class="author">Strengman E</span>, <span class="author">van Elburg AA</span>, <span class="author">Bruson A</span>, <span class="author">Clementi M</span>, <span class="author">Degortes D</span>, <span class="author">Forzan M</span>, <span class="author">Tenconi E</span>, <span class="author">Docampo E</span>, <span class="author">Escaram&iacute;s G</span>, <span class="author">Jim&eacute;nez-Murcia S</span>, <span class="author">Lissowska J</span>, <span class="author">Rajewski A</span>, <span class="author">Szeszenia-Dabrowska N</span>, <span class="author">Slopien A</span>, <span class="author">Hauser J</span>, <span class="author">Karhunen L</span>, <span class="author">Meulenbelt I</span>, <span class="author">Slagboom PE</span>, <span class="author">Tortorella A</span>, <span class="author">Maj M</span>, <span class="author">Dedoussis G</span>, <span class="author">Dikeos D</span>, <span class="author">Gonidakis F</span>, <span class="author">Tziouvas K</span>, <span class="author">Tsitsika A</span>, <span class="author">Papezova H</span>, <span class="author">Slachtova L</span>, <span class="author">Martaskova D</span>, <span class="author">Kennedy JL</span>, <span class="author">Levitan RD</span>, <span class="author">Yilmaz Z</span>, <span class="author">Huemer J</span>, <span class="author">Koubek D</span>, <span class="author">Merl E</span>, <span class="author">Wagner G</span>, <span class="author">Lichtenstein P</span>, <span class="author">Breen G</span>, <span class="author">Cohen-Woods S</span>, <span class="author">Farmer A</span>, <span class="author">McGuffin P</span>, <span class="author">Cichon S</span>, <span class="author">Giegling I</span>, <span class="author">Herms S</span>, <span class="author">Rujescu D</span>, <span class="author">Schreiber S</span>, <span class="author">Wichmann HE</span>, <span class="author">Dina C</span>, <span class="author">Sladek R</span>, <span class="author">Gambaro G</span>, <span class="author">Soranzo N</span>, <span class="author">Julia A</span>, <span class="author">Marsal S</span>, <span class="author">Rabionet R</span>, <span class="author">Gaborieau V</span>, <span class="author">Dick DM</span>, <span class="author">Palotie A</span>, <span class="author">Ripatti S</span>, <span class="author">Wid&eacute;n E</span>, <span class="author">Andreassen OA</span>, <span class="author">Espeseth T</span>, <span class="author">Lundervold A</span>, <span class="author">Reinvang I</span>, <span class="author">Steen VM</span>, <span class="author">Le Hellard S</span>, <span class="author">Mattingsdal M</span>, <span class="author">Ntalla I</span>, <span class="author">Bencko V</span>, <span class="author">Foretova L</span>, <span class="author">Janout V</span>, <span class="author">Navratilova M</span>, <span class="author">Gallinger S</span>, <span class="author">Pinto D</span>, <span class="author">Scherer SW</span>, <span class="author">Aschauer H</span>, <span class="author">Carlberg L</span>, <span class="author">Schosser A</span>, <span class="author">Alfredsson L</span>, <span class="author">Ding B</span>, <span class="author">Klareskog L</span>, <span class="author">Padyukov L</span>, <span class="author">Courtet P</span>, <span class="author">Guillaume S</span>, <span class="author">Jaussent I</span>, <span class="author">Finan C</span>, <span class="author">Kalsi G</span>, <span class="author">Roberts M</span>, <span class="author">Logan DW</span>, <span class="author">Peltonen L</span>, <span class="author">Ritchie GR</span>, <span class="author">Barrett JC</span>, <span class="author">Wellcome Trust Case Control Consortium 3</span>, <span class="author">Estivill X</span>, <span class="author">Hinney A</span>, <span class="author">Sullivan PF</span>, <span class="author">Collier DA</span>, <span class="author">Zeggini E</span> and <span class="author">Bulik CM</span></p>
<p class="affiliation">1] Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK [2] University of Split School of Medicine, Split, Croatia.</p><p class="abstract">Anorexia nervosa (AN) is a complex and heritable eating disorder characterized by dangerously low body weight. Neither candidate gene studies nor an initial genome-wide association study (GWAS) have yielded significant and replicated results. We performed a GWAS in 2907 cases with AN from 14 countries (15 sites) and 14&thinsp;860 ancestrally matched controls as part of the Genetic Consortium for AN (GCAN) and the Wellcome Trust Case Control Consortium 3 (WTCCC3). Individual association analyses were conducted in each stratum and meta-analyzed across all 15 discovery data sets. Seventy-six (72 independent) single nucleotide polymorphisms were taken forward for in silico (two data sets) or de novo (13 data sets) replication genotyping in 2677 independent AN cases and 8629 European ancestry controls along with 458 AN cases and 421 controls from Japan. The final global meta-analysis across discovery and replication data sets comprised 5551 AN cases and 21&thinsp;080 controls. AN subtype analyses (1606 AN restricting; 1445 AN binge-purge) were performed. No findings reached genome-wide significance. Two intronic variants were suggestively associated: rs9839776 (P=3.01 &times; 10(-7)) in SOX2OT and rs17030795 (P=5.84 &times; 10(-6)) in PPP3CA. Two additional signals were specific to Europeans: rs1523921 (P=5.76 &times; 10(-)(6)) between CUL3 and FAM124B and rs1886797 (P=8.05 &times; 10(-)(6)) near SPATA13. Comparing discovery with replication results, 76% of the effects were in the same direction, an observation highly unlikely to be due to chance (P=4 &times; 10(-6)), strongly suggesting that true findings exist but our sample, the largest yet reported, was underpowered for their detection. The accrual of large genotyped AN case-control samples should be an immediate priority for the field.</p>
<p class="grants">Funded by: Department of Health: <span class="grant">NF-SI-0512-10074</span>; Medical Research Council: <span class="grant">MR/K500999/1</span>; NCATS NIH HHS: <span class="grant">UL1TR000083</span>; NCI NIH HHS: <span class="grant">3P50CA093459</span>, <span class="grant">5P50CA097007</span>, <span class="grant">5R01CA133996</span>, <span class="grant">U24 CA074783</span>; NCRR NIH HHS: <span class="grant">U54 RR0252204-01</span>; NIAAA NIH HHS: <span class="grant">AA-00145</span>, <span class="grant">AA-09203</span>, <span class="grant">AA-12502</span>, <span class="grant">AA15416</span>, <span class="grant">K02AA018755</span>; NICHD NIH HHS: <span class="grant">K12HD001441</span>; NIEHS NIH HHS: <span class="grant">5R01ES011740</span>; NIMH NIH HHS: <span class="grant">MH066117</span>, <span class="grant">MH066122</span>, <span class="grant">MH066145</span>, <span class="grant">MH066146</span>, <span class="grant">MH066147</span>, <span class="grant">MH066193</span>, <span class="grant">MH0662</span>, <span class="grant">MH066287</span>, <span class="grant">MH066288</span>, <span class="grant">MH066296</span>, <span class="grant">T32 MH076694</span>; Wellcome Trust: <span class="grant">090532</span>, <span class="grant">WT088827/Z/09</span>, <span class="grant">WT088984</span></p>
<p class="publication"><span class="title">Molecular psychiatry</span>&nbsp;<span class="year">2014</span>;<span class="volume">19</span>;<span class="number">10</span>;<span class="pagerange">1085-94</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24514567">24514567</a>; DOI: <a href="http://dx.doi.org/10.1038%2Fmp.2013.187">10.1038/mp.2013.187</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Pre-Columbian mycobacterial genomes reveal seals as a source of New World human tuberculosis.</h4>
<p class="authors"><span class="author">Bos KI</span>, <span class="author">Harkins KM</span>, <span class="author">Herbig A</span>, <span class="author">Coscolla M</span>, <span class="author">Weber N</span>, <span class="author">Comas I</span>, <span class="author">Forrest SA</span>, <span class="author">Bryant JM</span>, <span class="author">Harris SR</span>, <span class="author">Schuenemann VJ</span>, <span class="author">Campbell TJ</span>, <span class="author">Majander K</span>, <span class="author">Wilbur AK</span>, <span class="author">Guichon RA</span>, <span class="author">Wolfe Steadman DL</span>, <span class="author">Cook DC</span>, <span class="author">Niemann S</span>, <span class="author">Behr MA</span>, <span class="author">Zumarraga M</span>, <span class="author">Bastida R</span>, <span class="author">Huson D</span>, <span class="author">Nieselt K</span>, <span class="author">Young D</span>, <span class="author">Parkhill J</span>, <span class="author">Buikstra JE</span>, <span class="author">Gagneux S</span>, <span class="author">Stone AC</span> and <span class="author">Krause J</span></p>
<p class="affiliation">1] Department of Archaeological Sciences, University of T&uuml;bingen, Ruemelinstra&szlig;e 23, 72070 T&uuml;bingen, Germany [2].</p><p class="abstract">Modern strains of Mycobacterium tuberculosis from the Americas are closely related to those from Europe, supporting the assumption that human tuberculosis was introduced post-contact. This notion, however, is incompatible with archaeological evidence of pre-contact tuberculosis in the New World. Comparative genomics of modern isolates suggests that M. tuberculosis attained its worldwide distribution following human dispersals out of Africa during the Pleistocene epoch, although this has yet to be confirmed with ancient calibration points. Here we present three 1,000-year-old mycobacterial genomes from Peruvian human skeletons, revealing that a member of the M. tuberculosis complex caused human disease before contact. The ancient strains are distinct from known human-adapted forms and are most closely related to those adapted to seals and sea lions. Two independent dating approaches suggest a most recent common ancestor for the M. tuberculosis complex less than 6,000 years ago, which supports a Holocene dispersal of the disease. Our results implicate sea mammals as having played a role in transmitting the disease to humans across the ocean.</p>
<p class="grants">Funded by: Medical Research Council: <span class="grant">974668</span>; NIAID NIH HHS: <span class="grant">AI090928</span>; Wellcome Trust: <span class="grant">098051</span></p>
<p class="publication"><span class="title">Nature</span>&nbsp;<span class="year">2014</span>;<span class="volume">514</span>;<span class="number">7523</span>;<span class="pagerange">494-7</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25141181">25141181</a>; DOI: <a href="http://dx.doi.org/10.1038%2Fnature13591">10.1038/nature13591</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Multiplex PCR Assay for Unequivocal Differentiation of Actinobacillus pleuropneumoniae Serovars 1 to 3, 5 to 8, 10, and 12.</h4>
<p class="authors"><span class="author">Boss&eacute; JT</span>, <span class="author">Li Y</span>, <span class="author">Angen O</span>, <span class="author">Weinert LA</span>, <span class="author">Chaudhuri RR</span>, <span class="author">Holden MT</span>, <span class="author">Williamson SM</span>, <span class="author">Maskell DJ</span>, <span class="author">Tucker AW</span>, <span class="author">Wren BW</span>, <span class="author">Rycroft AN</span>, <span class="author">Langford PR</span> and <span class="author">BRaDP1T consortium</span></p>
<p class="affiliation">Section of Paediatrics, Department of Medicine, Imperial College London, St. Mary&#39;s Campus, London, United Kingdom.</p><p class="abstract">An improved multiplex PCR, using redesigned primers targeting the serovar 3 capsule locus, which differentiates serovars 3, 6, and 8 Actinobacillus pleuropneumoniae isolates, is described. The new primers eliminate an aberrant serovar 3-indicative amplicon found in some serovar 6 clinical isolates. Furthermore, we have developed a new multiplex PCR for the detection of serovars 1 to 3, 5 to 8, 10, and 12 along with apxIV, thus extending the utility of this diagnostic PCR to cover a broader range of isolates.</p>
<p class="publication"><span class="title">Journal of clinical microbiology</span>&nbsp;<span class="year">2014</span>;<span class="volume">52</span>;<span class="number">7</span>;<span class="pagerange">2380-5</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24759717">24759717</a>; DOI: <a href="http://dx.doi.org/10.1128%2FJCM.00685-14">10.1128/JCM.00685-14</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Human immunodeficiency virus Tat associates with a specific set of cellular RNAs.</h4>
<p class="authors"><span class="author">Bouwman RD</span>, <span class="author">Palser A</span>, <span class="author">Parry CM</span>, <span class="author">Coulter E</span>, <span class="author">Rasaiyaah J</span>, <span class="author">Kellam P</span> and <span class="author">Jenner RG</span></p>
<p class="affiliation">MRC Centre for Medical Molecular Virology, Division of Infection and Immunity, University College London, London WC1E 6BT, UK. <a href="mailto:%72.%6A%65%6E%6E%65%72%40%75%63%6C.%61%63.%75%6B">&#114;&#46;&#106;&#101;&#110;&#110;&#101;&#114;&#64;&#117;&#99;&#108;&#46;&#97;&#99;&#46;&#117;&#107;</a>.</p><p class="abstract"><strong>Background</strong>: Human Immunodeficiency Virus 1 (HIV-1) exhibits a wide range of interactions with the host cell but whether viral proteins interact with cellular RNA is not clear. A candidate interacting factor is the trans-activator of transcription (Tat) protein. Tat is required for expression of virus genes but activates transcription through an unusual mechanism; binding to an RNA stem-loop, the transactivation response element (TAR), with the host elongation factor P-TEFb. HIV-1 Tat has also been shown to alter the expression of host genes during infection, contributing to viral pathogenesis but, whether Tat also interacts with cellular RNAs is unknown.</p><p class="abstract"><strong>Results</strong>: Using RNA immunoprecipitation coupled with microarray analysis, we have discovered that HIV-1 Tat is associated with a specific set of human mRNAs in T cells. mRNAs bound by Tat share a stem-loop structural element and encode proteins with common biological roles. In contrast, we do not find evidence that Tat associates with microRNAs or the RNA-induced silencing complex (RISC). The interaction of Tat with cellular RNA requires an intact RNA binding domain and Tat RNA binding is linked to an increase in RNA abundance in cell lines and during infection of primary CD4+ T cells by HIV.</p><p class="abstract"><strong>Conclusions</strong>: We conclude that Tat interacts with a specific set of human mRNAs in T cells, many of which show changes in abundance in response to Tat and HIV infection. This work uncovers a previously unrecognised interaction between HIV and its host that may contribute to viral alteration of the host cellular environment.</p>
<p class="grants">Funded by: Medical Research Council: <span class="grant">G0802068</span>; Wellcome Trust</p>
<p class="publication"><span class="title">Retrovirology</span>&nbsp;<span class="year">2014</span>;<span class="volume">11</span>;<span class="pagerange">53</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24990269">24990269</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4086691">4086691</a>; DOI: <a href="http://dx.doi.org/10.1186%2F1742-4690-11-53">10.1186/1742-4690-11-53</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Expression of a single-chain human leukocyte antigen-DRA/DRB3*01:01 molecule and differential binding of a monoclonal antibody in the presence of specifically bound human platelet antigen-1a peptide.</h4>
<p class="authors"><span class="author">Bouwmans EE</span>, <span class="author">Smethurst PA</span>, <span class="author">Garner SF</span>, <span class="author">Ouwehand WH</span> and <span class="author">Morley SL</span></p>
<p class="affiliation">Department of Haematology, University of Cambridge, Cambridge, UK.</p><p class="abstract"><strong>Background</strong>: Studies show that 1 in 1200 neonates have a low platelet (PLT) count due to alloimmunization against human PLT antigen (HPA)-1a (&beta;3 -L33). This mainly occurs in HPA-1a-negative mothers who are positive for the human leukocyte antigen (HLA)-DRB3*01:01 allele, but only about one-third of cases will mount an effective alloimmune response. The development of specific treatment modalities requires that the mechanisms driving the maternal alloimmune response against the fetal PLTs be further explored. An antibody reagent that has a different binding affinity to HLA-DRA/DRB3*01:01 with and without the &beta;3 -L33 peptide would be a valuable reagent to study peptide presentation on maternal antigen-presenting cells.</p><p class="abstract">To identify such antibodies, HLA-DRA/DRB3*01:01 was recombinantly expressed in Drosophila&#x2005;S2 cells. To delineate the epitope of interesting antibodies, seven mutant HLA-DRA/DRB3*01:01 molecules were generated by site-directed mutagenesis introducing naturally occurring amino acid changes encoded by DRB3*02 and DRB3*03 alleles.</p><p class="abstract"><strong>Results</strong>: The murine monoclonal antibody (MoAb) DA2 showed robust binding by enzyme-linked immunosorbent assay to recombinant HLA-DRA/DRB3*01:01, but binding was reduced in the presence of &beta;3 -L33 peptide. The binding affinity of DA2 to the mutant HLA-DRA/DRB3*0101 in which serine at Position 60 of the &beta;1-chain was replaced by tyrosine was greatly enhanced. Interestingly the binding of DA2 to the mutant was not reduced by the presence of &beta;3 -L33 peptide.</p><p class="abstract"><strong>Conclusion</strong>: The results of this study generate a molecular model of the interaction of the HLA-DRA/DRB3*01:01 molecule with MoAb DA2. This will inform functional studies with the recombinant Class II molecules.</p>
<p class="grants">Funded by: Department of Health: <span class="grant">NF-SI-0510-10214</span></p>
<p class="publication"><span class="title">Transfusion</span>&nbsp;<span class="year">2014</span>;<span class="volume">54</span>;<span class="number">6</span>;<span class="pagerange">1478-85</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24308361">24308361</a>; DOI: <a href="http://dx.doi.org/10.1111%2Ftrf.12502">10.1111/trf.12502</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Whole-exome sequencing in an extended family with myocardial infarction unmasks familial hypercholesterolemia.</h4>
<p class="authors"><span class="author">Br&aelig;nne I</span>, <span class="author">Reiz B</span>, <span class="author">Medack A</span>, <span class="author">Kleinecke M</span>, <span class="author">Fischer M</span>, <span class="author">Tuna S</span>, <span class="author">Hengstenberg C</span>, <span class="author">Deloukas P</span>, <span class="author">Erdmann J</span>, <span class="author">Schunkert H</span> and <span class="author">Cardiogenics consortium</span></p>
<p class="affiliation">Institute for Integrative and Experimental Genomics, University of L&uuml;beck, 23562 L&uuml;beck, Germany. <a href="mailto:%6A%65%61%6E%65%74%74%65.%65%72%64%6D%61%6E%6E%40%69%69%65%67.%75%6E%69-%6C%75%65%62%65%63%6B.%64%65">&#106;&#101;&#97;&#110;&#101;&#116;&#116;&#101;&#46;&#101;&#114;&#100;&#109;&#97;&#110;&#110;&#64;&#105;&#105;&#101;&#103;&#46;&#117;&#110;&#105;&#45;&#108;&#117;&#101;&#98;&#101;&#99;&#107;&#46;&#100;&#101;</a>.</p><p class="abstract"><strong>Background</strong>: Familial hypercholesterolemia (FH) is an autosomal-dominant disease leading to markedly elevated low-density lipoprotein (LDL) cholesterol levels and increased risk for premature myocardial infarction (MI). Mutation carriers display variable LDL cholesterol levels, which may obscure the diagnosis. We examined by whole-exome sequencing a family in which multiple myocardial infarctions occurred at a young age with unclear etiology.</p><p class="abstract"><strong>Methods</strong>: Whole-exome sequencing of three affected family members, validation of the identified variant with Sanger-sequencing, and subsequent co-segregation analysis in the family.</p><p class="abstract"><strong>Results</strong>: The index patient (LDL cholesterol 188&nbsp;mg/dL) was referred for molecular-genetic investigations. He had coronary artery bypass graft (CABG) at the age of 59&nbsp;years; 12 out of 15 1st, 2nd and 3rd degree relatives were affected with coronary artery disease (CAD) and/or premature myocardial infarction (MI). We sequenced the whole-exome of the patient and two cousins with premature MI. After filtering, we were left with a potentially disease causing variant in the LDL receptor (LDLR) gene, which we validated by Sanger-sequencing (nucleotide substitution in the acceptor splice-site of exon 10, c.1359-1G&thinsp;&gt;&thinsp;A). Sequencing of all family members available for genetic analysis revealed co-segregation of the variant with CAD (LOD 3.0) and increased LDLC (&gt;190&nbsp;mg/dL), following correction for statin treatment (LOD 4.3). Interestingly, mutation carriers presented with highly variable corrected (183-354&nbsp;mg/dL) and on-treatment LDL levels (116-274&nbsp;mg/dL) such that the diagnosis of FH in this family was made only after the molecular-genetic analysis.</p><p class="abstract"><strong>Conclusion</strong>: Even in families with unusual clustering of CAD FH remains to be underdiagnosed, which underscores the need for implementation of systematic screening programs. Whole-exome sequencing may facilitate identification of disease-causing variants in families with unclear etiology of MI and enable preventive treatment of mutation carriers in a more timely fashion.</p>
<p class="publication"><span class="title">BMC cardiovascular disorders</span>&nbsp;<span class="year">2014</span>;<span class="volume">14</span>;<span class="number">1</span>;<span class="pagerange">108</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25154303">25154303</a>; DOI: <a href="http://dx.doi.org/10.1186%2F1471-2261-14-108">10.1186/1471-2261-14-108</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">DECIPHER: database for the interpretation of phenotype-linked plausibly pathogenic sequence and copy-number variation.</h4>
<p class="authors"><span class="author">Bragin E</span>, <span class="author">Chatzimichali EA</span>, <span class="author">Wright CF</span>, <span class="author">Hurles ME</span>, <span class="author">Firth HV</span>, <span class="author">Bevan AP</span> and <span class="author">Swaminathan GJ</span></p>
<p class="affiliation">Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1SD, UK and Cambridge University Department of Medical Genetics, Addenbrooke&#39;s Hospital, Cambridge CB2 2QQ, UK.</p><p class="abstract">The DECIPHER database (https://decipher.sanger.ac.uk/) is an accessible online repository of genetic variation with associated phenotypes that facilitates the identification and interpretation of pathogenic genetic variation in patients with rare disorders. Contributing to DECIPHER is an international consortium of &gt;200 academic clinical centres of genetic medicine and &ge;1600 clinical geneticists and diagnostic laboratory scientists. Information integrated from a variety of bioinformatics resources, coupled with visualization tools, provides a comprehensive set of tools to identify other patients with similar genotype-phenotype characteristics and highlights potentially pathogenic genes. In a significant development, we have extended DECIPHER from a database of just copy-number variants to allow upload, annotation and analysis of sequence variants such as single nucleotide variants (SNVs) and InDels. Other notable developments in DECIPHER include a purpose-built, customizable and interactive genome browser to aid combined visualization and interpretation of sequence and copy-number variation against informative datasets of pathogenic and population variation. We have also introduced several new features to our deposition and analysis interface. This article provides an update to the DECIPHER database, an earlier instance of which has been described elsewhere [Swaminathan et al. (2012) DECIPHER: web-based, community resource for clinical interpretation of rare variants in developmental disorders. Hum. Mol. Genet., 21, R37-R44].</p>
<p class="grants">Funded by: Wellcome Trust: <span class="grant">WT077008</span></p>
<p class="publication"><span class="title">Nucleic acids research</span>&nbsp;<span class="year">2014</span>;<span class="volume">42</span>;<span class="number">Database issue</span>;<span class="pagerange">D993-D1000</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24150940">24150940</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC3965078">3965078</a>; DOI: <a href="http://dx.doi.org/10.1093%2Fnar%2Fgkt937">10.1093/nar/gkt937</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">The genomic substrate for adaptive radiation in African cichlid fish.</h4>
<p class="authors"><span class="author">Brawand D</span>, <span class="author">Wagner CE</span>, <span class="author">Li YI</span>, <span class="author">Malinsky M</span>, <span class="author">Keller I</span>, <span class="author">Fan S</span>, <span class="author">Simakov O</span>, <span class="author">Ng AY</span>, <span class="author">Lim ZW</span>, <span class="author">Bezault E</span>, <span class="author">Turner-Maier J</span>, <span class="author">Johnson J</span>, <span class="author">Alcazar R</span>, <span class="author">Noh HJ</span>, <span class="author">Russell P</span>, <span class="author">Aken B</span>, <span class="author">Alf&ouml;ldi J</span>, <span class="author">Amemiya C</span>, <span class="author">Azzouzi N</span>, <span class="author">Baroiller JF</span>, <span class="author">Barloy-Hubler F</span>, <span class="author">Berlin A</span>, <span class="author">Bloomquist R</span>, <span class="author">Carleton KL</span>, <span class="author">Conte MA</span>, <span class="author">D&#39;Cotta H</span>, <span class="author">Eshel O</span>, <span class="author">Gaffney L</span>, <span class="author">Galibert F</span>, <span class="author">Gante HF</span>, <span class="author">Gnerre S</span>, <span class="author">Greuter L</span>, <span class="author">Guyon R</span>, <span class="author">Haddad NS</span>, <span class="author">Haerty W</span>, <span class="author">Harris RM</span>, <span class="author">Hofmann HA</span>, <span class="author">Hourlier T</span>, <span class="author">Hulata G</span>, <span class="author">Jaffe DB</span>, <span class="author">Lara M</span>, <span class="author">Lee AP</span>, <span class="author">MacCallum I</span>, <span class="author">Mwaiko S</span>, <span class="author">Nikaido M</span>, <span class="author">Nishihara H</span>, <span class="author">Ozouf-Costaz C</span>, <span class="author">Penman DJ</span>, <span class="author">Przybylski D</span>, <span class="author">Rakotomanga M</span>, <span class="author">Renn SC</span>, <span class="author">Ribeiro FJ</span>, <span class="author">Ron M</span>, <span class="author">Salzburger W</span>, <span class="author">Sanchez-Pulido L</span>, <span class="author">Santos ME</span>, <span class="author">Searle S</span>, <span class="author">Sharpe T</span>, <span class="author">Swofford R</span>, <span class="author">Tan FJ</span>, <span class="author">Williams L</span>, <span class="author">Young S</span>, <span class="author">Yin S</span>, <span class="author">Okada N</span>, <span class="author">Kocher TD</span>, <span class="author">Miska EA</span>, <span class="author">Lander ES</span>, <span class="author">Venkatesh B</span>, <span class="author">Fernald RD</span>, <span class="author">Meyer A</span>, <span class="author">Ponting CP</span>, <span class="author">Streelman JT</span>, <span class="author">Lindblad-Toh K</span>, <span class="author">Seehausen O</span> and <span class="author">Di Palma F</span></p>
<p class="affiliation">1] Broad Institute of MIT and Harvard, Cambridge, Massachusetts 02142, USA [2] MRC Functional Genomics Unit, University of Oxford, Oxford OX1 3QX, UK [3].</p><p class="abstract">Cichlid fishes are famous for large, diverse and replicated adaptive radiations in the Great Lakes of East Africa. To understand the molecular mechanisms underlying cichlid phenotypic diversity, we sequenced the genomes and transcriptomes of five lineages of African cichlids: the Nile tilapia (Oreochromis niloticus), an ancestral lineage with low diversity; and four members of the East African lineage: Neolamprologus brichardi/pulcher (older radiation, Lake Tanganyika), Metriaclima zebra (recent radiation, Lake Malawi), Pundamilia nyererei (very recent radiation, Lake Victoria), and Astatotilapia burtoni (riverine species around Lake Tanganyika). We found an excess of gene duplications in the East African lineage compared to tilapia and other teleosts, an abundance of non-coding element divergence, accelerated coding sequence evolution, expression divergence associated with transposable element insertions, and regulation by novel microRNAs. In addition, we analysed sequence data from sixty individuals representing six closely related species from Lake Victoria, and show genome-wide diversifying selection on coding and regulatory variants, some of which were recruited from ancient polymorphisms. We conclude that a number of molecular mechanisms shaped East African cichlid genomes, and that amassing of standing variation during periods of relaxed purifying selection may have been important in facilitating subsequent evolutionary diversification.</p>
<p class="publication"><span class="title">Nature</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25186727">25186727</a>; DOI: <a href="http://dx.doi.org/10.1038%2Fnature13726">10.1038/nature13726</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Phosphoinositide metabolism links cGMP-dependent protein kinase G to essential Ca&sup2;&#x207A; signals at key decision points in the life cycle of malaria parasites.</h4>
<p class="authors"><span class="author">Brochet M</span>, <span class="author">Collins MO</span>, <span class="author">Smith TK</span>, <span class="author">Thompson E</span>, <span class="author">Sebastian S</span>, <span class="author">Volkmann K</span>, <span class="author">Schwach F</span>, <span class="author">Chappell L</span>, <span class="author">Gomes AR</span>, <span class="author">Berriman M</span>, <span class="author">Rayner JC</span>, <span class="author">Baker DA</span>, <span class="author">Choudhary J</span> and <span class="author">Billker O</span></p>
<p class="affiliation">Wellcome Trust Sanger Institute, Hinxton, Cambridge, United Kingdom.</p><p class="abstract">Many critical events in the Plasmodium life cycle rely on the controlled release of Ca&sup2;&#x207A; from intracellular stores to activate stage-specific Ca&sup2;&#x207A;-dependent protein kinases. Using the motility of Plasmodium berghei ookinetes as a signalling paradigm, we show that the cyclic guanosine monophosphate (cGMP)-dependent protein kinase, PKG, maintains the elevated level of cytosolic Ca&sup2;&#x207A; required for gliding motility. We find that the same PKG-dependent pathway operates upstream of the Ca&sup2;&#x207A; signals that mediate activation of P. berghei gametocytes in the mosquito and egress of Plasmodium falciparum merozoites from infected human erythrocytes. Perturbations of PKG signalling in gliding ookinetes have a marked impact on the phosphoproteome, with a significant enrichment of in vivo regulated sites in multiple pathways including vesicular trafficking and phosphoinositide metabolism. A global analysis of cellular phospholipids demonstrates that in gliding ookinetes PKG controls phosphoinositide biosynthesis, possibly through the subcellular localisation or activity of lipid kinases. Similarly, phosphoinositide metabolism links PKG to egress of P. falciparum merozoites, where inhibition of PKG blocks hydrolysis of phosphatidylinostitol (4,5)-bisphosphate. In the face of an increasing complexity of signalling through multiple Ca&sup2;&#x207A; effectors, PKG emerges as a unifying factor to control multiple cellular Ca&sup2;&#x207A; signals essential for malaria parasite development and transmission.</p>
<p class="grants">Funded by: Medical Research Council: <span class="grant">G0501670</span>, <span class="grant">G10000779</span>; Wellcome Trust: <span class="grant">079643/Z/06/Z</span>, <span class="grant">WT093228</span>, <span class="grant">WT094752</span>, <span class="grant">WT098051</span></p>
<p class="publication"><span class="title">PLoS biology</span>&nbsp;<span class="year">2014</span>;<span class="volume">12</span>;<span class="number">3</span>;<span class="pagerange">e1001806</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24594931">24594931</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC3942320">3942320</a>; DOI: <a href="http://dx.doi.org/10.1371%2Fjournal.pbio.1001806">10.1371/journal.pbio.1001806</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Genetic interactions affecting human gene expression identified by variance association mapping.</h4>
<p class="authors"><span class="author">Brown AA</span>, <span class="author">Buil A</span>, <span class="author">Vi&ntilde;uela A</span>, <span class="author">Lappalainen T</span>, <span class="author">Zheng HF</span>, <span class="author">Richards JB</span>, <span class="author">Small KS</span>, <span class="author">Spector TD</span>, <span class="author">Dermitzakis ET</span> and <span class="author">Durbin R</span></p>
<p class="affiliation">Informatics , Wellcome Trust Sanger Institute , Cambridge , United Kingdom.</p><p class="abstract">Non-additive interaction between genetic variants, or epistasis, is a possible explanation for the gap between heritability of complex traits and the variation explained by identified genetic loci. Interactions give rise to genotype dependent variance, and therefore the identification of variance quantitative trait loci can be an intermediate step to discover both epistasis and gene by environment effects (GxE). Using RNA-sequence data from lymphoblastoid cell lines (LCLs) from the TwinsUK cohort, we identify a candidate set of 508 variance associated SNPs. Exploiting the twin design we show that GxE plays a role in ~70% of these associations. Further investigation of these loci reveals 57 epistatic interactions that replicated in a smaller dataset, explaining on average 4.3% of phenotypic variance. In 24 cases, more variance is explained by the interaction than their additive contributions. Using molecular phenotypes in this way may provide a route to uncovering genetic interactions underlying more complex traits.</p>
<p class="publication"><span class="title">eLife</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24771767">24771767</a>; DOI: <a href="http://dx.doi.org/10.7554%2FeLife.01381">10.7554/eLife.01381</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Cis and trans effects of human genomic variants on gene expression.</h4>
<p class="authors"><span class="author">Bryois J</span>, <span class="author">Buil A</span>, <span class="author">Evans DM</span>, <span class="author">Kemp JP</span>, <span class="author">Montgomery SB</span>, <span class="author">Conrad DF</span>, <span class="author">Ho KM</span>, <span class="author">Ring S</span>, <span class="author">Hurles M</span>, <span class="author">Deloukas P</span>, <span class="author">Davey Smith G</span> and <span class="author">Dermitzakis ET</span></p>
<p class="affiliation">Department of Genetic Medicine and Development, University of Geneva Medical School, Geneva, Switzerland; Institute of Genetics and Genomics in Geneva (iGE3), Geneva, Switzerland; Swiss Institute of Bioinformatics (SIB), Geneva, Switzerland.</p><p class="abstract">Gene expression is a heritable cellular phenotype that defines the function of a cell and can lead to diseases in case of misregulation. In order to detect genetic variations affecting gene expression, we performed association analysis of single nucleotide polymorphisms (SNPs) and copy number variants (CNVs) with gene expression measured in 869 lymphoblastoid cell lines of the Avon Longitudinal Study of Parents and Children (ALSPAC) cohort in cis and in trans. We discovered that 3,534 genes (false discovery rate (FDR)&#x200A;=&#x200A;5%) are affected by an expression quantitative trait locus (eQTL) in cis and 48 genes are affected in trans. We observed that CNVs are more likely to be eQTLs than SNPs. In addition, we found that variants associated to complex traits and diseases are enriched for trans-eQTLs and that trans-eQTLs are enriched for cis-eQTLs. As a variant affecting both a gene in cis and in trans suggests that the cis gene is functionally linked to the trans gene expression, we looked specifically for trans effects of cis-eQTLs. We discovered that 26 cis-eQTLs are associated to 92 genes in trans with the cis-eQTLs of the transcriptions factors BATF3 and HMX2 affecting the most genes. We then explored if the variation of the level of expression of the cis genes were causally affecting the level of expression of the trans genes and discovered several causal relationships between variation in the level of expression of the cis gene and variation of the level of expression of the trans gene. This analysis shows that a large sample size allows the discovery of secondary effects of human variations on gene expression that can be used to construct short directed gene regulatory networks.</p>
<p class="publication"><span class="title">PLoS genetics</span>&nbsp;<span class="year">2014</span>;<span class="volume">10</span>;<span class="number">7</span>;<span class="pagerange">e1004461</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25010687">25010687</a>; DOI: <a href="http://dx.doi.org/10.1371%2Fjournal.pgen.1004461">10.1371/journal.pgen.1004461</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Gene-gene and gene-environment interactions detected by transcriptome sequence analysis in twins.</h4>
<p class="authors"><span class="author">Buil A</span>, <span class="author">Brown AA</span>, <span class="author">Lappalainen T</span>, <span class="author">Vi&ntilde;uela A</span>, <span class="author">Davies MN</span>, <span class="author">Zheng HF</span>, <span class="author">Richards JB</span>, <span class="author">Glass D</span>, <span class="author">Small KS</span>, <span class="author">Durbin R</span>, <span class="author">Spector TD</span> and <span class="author">Dermitzakis ET</span></p>
<p class="affiliation">1] Department of Genetic Medicine and Development, University of Geneva Medical School, Geneva, Switzerland. [2] Institute of Genetics and Genomics in Geneva, University of Geneva, Geneva, Switzerland. [3] Swiss Institute of Bioinformatics, Geneva, Switzerland.</p><p class="abstract">Understanding the genetic architecture of gene expression is an intermediate step in understanding the genetic architecture of complex diseases. RNA sequencing technologies have improved the quantification of gene expression and allow measurement of allele-specific expression (ASE). ASE is hypothesized to result from the direct effect of cis regulatory variants, but a proper estimation of the causes of ASE has not been performed thus far. In this study, we take advantage of a sample of twins to measure the relative contributions of genetic and environmental effects to ASE, and we find substantial effects from gene &times; gene (G&times;G) and gene &times; environment (G&times;E) interactions. We propose a model where ASE requires genetic variability in cis, a difference in the sequence of both alleles, but where the magnitude of the ASE effect depends on trans genetic and environmental factors that interact with the cis genetic variants.</p>
<p class="publication"><span class="title">Nature genetics</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25436857">25436857</a>; DOI: <a href="http://dx.doi.org/10.1038%2Fng.3162">10.1038/ng.3162</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">A multi-country outbreak of Salmonella Newport gastroenteritis in Europe associated with watermelon from Brazil, confirmed by whole genome sequencing: October 2011 to January 2012.</h4>
<p class="authors"><span class="author">Byrne L</span>, <span class="author">Fisher I</span>, <span class="author">Peters T</span>, <span class="author">Mather A</span>, <span class="author">Thomson N</span>, <span class="author">Rosner B</span>, <span class="author">Bernard H</span>, <span class="author">McKeown P</span>, <span class="author">Cormican M</span>, <span class="author">Cowden J</span>, <span class="author">Aiyedun V</span>, <span class="author">Lane C</span> and <span class="author">On Behalf Of The International Outbreak Control Team C</span></p>
<p class="affiliation">Gastrointestinal, Emerging and Zoonotic Infections, Centre for Infectious Disease Surveillance and Control, Public Health England, Colindale, London, United Kingdom.</p>
<p class="publication"><span class="title">Euro surveillance : bulletin Europ&eacute;en sur les maladies transmissibles = European communicable disease bulletin</span>&nbsp;<span class="year">2014</span>;<span class="volume">19</span>;<span class="number">31</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25138971">25138971</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Genome-wide analysis of cold adaptation in indigenous Siberian populations.</h4>
<p class="authors"><span class="author">Cardona A</span>, <span class="author">Pagani L</span>, <span class="author">Antao T</span>, <span class="author">Lawson DJ</span>, <span class="author">Eichstaedt CA</span>, <span class="author">Yngvadottir B</span>, <span class="author">Shwe MT</span>, <span class="author">Wee J</span>, <span class="author">Romero IG</span>, <span class="author">Raj S</span>, <span class="author">Metspalu M</span>, <span class="author">Villems R</span>, <span class="author">Willerslev E</span>, <span class="author">Tyler-Smith C</span>, <span class="author">Malyarchuk BA</span>, <span class="author">Derenko MV</span> and <span class="author">Kivisild T</span></p>
<p class="affiliation">Department of Archaeology and Anthropology, University of Cambridge, Cambridge, United Kingdom.</p><p class="abstract">Following the dispersal out of Africa, where hominins evolved in warm environments for millions of years, our species has colonised different climate zones of the world, including high latitudes and cold environments. The extent to which human habitation in (sub-)Arctic regions has been enabled by cultural buffering, short-term acclimatization and genetic adaptations is not clearly understood. Present day indigenous populations of Siberia show a number of phenotypic features, such as increased basal metabolic rate, low serum lipid levels and increased blood pressure that have been attributed to adaptation to the extreme cold climate. In this study we introduce a dataset of 200 individuals from ten indigenous Siberian populations that were genotyped for 730,525 SNPs across the genome to identify genes and non-coding regions that have undergone unusually rapid allele frequency and long-range haplotype homozygosity change in the recent past. At least three distinct population clusters could be identified among the Siberians, each of which showed a number of unique signals of selection. A region on chromosome 11 (chr11:66-69 Mb) contained the largest amount of clustering of significant signals and also the strongest signals in all the different selection tests performed. We present a list of candidate cold adaption genes that showed significant signals of positive selection with our strongest signals associated with genes involved in energy regulation and metabolism (CPT1A, LRP5, THADA) and vascular smooth muscle contraction (PRKG1). By employing a new method that paints phased chromosome chunks by their ancestry we distinguish local Siberian-specific long-range haplotype signals from those introduced by admixture.</p>
<p class="grants">Funded by: Wellcome Trust: <span class="grant">098051</span></p>
<p class="publication"><span class="title">PloS one</span>&nbsp;<span class="year">2014</span>;<span class="volume">9</span>;<span class="number">5</span>;<span class="pagerange">e98076</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24847810">24847810</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4029955">4029955</a>; DOI: <a href="http://dx.doi.org/10.1371%2Fjournal.pone.0098076">10.1371/journal.pone.0098076</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Single nucleotide polymorphisms with cis-regulatory effects on long non-coding transcripts in human primary monocytes.</h4>
<p class="authors"><span class="author">Carlsson Alml&ouml;f J</span>, <span class="author">Lundmark P</span>, <span class="author">Lundmark A</span>, <span class="author">Ge B</span>, <span class="author">Pastinen T</span>, <span class="author">Cardiogenics Consortium</span>, <span class="author">Goodall AH</span>, <span class="author">Cambien F</span>, <span class="author">Deloukas P</span>, <span class="author">Ouwehand WH</span> and <span class="author">Syv&auml;nen AC</span></p>
<p class="affiliation">Department of Medical Sciences, Molecular Medicine and Science for Life Laboratory, Uppsala University, Uppsala, Sweden.</p><p class="abstract">We applied genome-wide allele-specific expression analysis of monocytes from 188 samples. Monocytes were purified from white blood cells of healthy blood donors to detect cis-acting genetic variation that regulates the expression of long non-coding RNAs. We analysed 8929 regions harboring genes for potential long non-coding RNA that were retrieved from data from the ENCODE project. Of these regions, 60% were annotated as intergenic, which implies that they do not overlap with protein-coding genes. Focusing on the intergenic regions, and using stringent analysis of the allele-specific expression data, we detected robust cis-regulatory SNPs in 258 out of 489 informative intergenic regions included in the analysis. The cis-regulatory SNPs that were significantly associated with allele-specific expression of long non-coding RNAs were enriched to enhancer regions marked for active or bivalent, poised chromatin by histone modifications. Out of the lncRNA regions regulated by cis-acting regulatory SNPs, 20% (n&#x200A;=&#x200A;52) were co-regulated with the closest protein coding gene. We compared the identified cis-regulatory SNPs with those in the catalog of SNPs identified by genome-wide association studies of human diseases and traits. This comparison identified 32 SNPs in loci from genome-wide association studies that displayed a strong association signal with allele-specific expression of non-coding RNAs in monocytes, with p-values ranging from 6.7&times;10-7 to 9.5&times;10-89. The identified cis-regulatory SNPs are associated with diseases of the immune system, like multiple sclerosis and rheumatoid arthritis.</p>
<p class="publication"><span class="title">PloS one</span>&nbsp;<span class="year">2014</span>;<span class="volume">9</span>;<span class="number">7</span>;<span class="pagerange">e102612</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25025429">25025429</a>; DOI: <a href="http://dx.doi.org/10.1371%2Fjournal.pone.0102612">10.1371/journal.pone.0102612</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Rabbit genome analysis reveals a polygenic basis for phenotypic change during domestication.</h4>
<p class="authors"><span class="author">Carneiro M</span>, <span class="author">Rubin CJ</span>, <span class="author">Di Palma F</span>, <span class="author">Albert FW</span>, <span class="author">Alf&ouml;ldi J</span>, <span class="author">Barrio AM</span>, <span class="author">Pielberg G</span>, <span class="author">Rafati N</span>, <span class="author">Sayyab S</span>, <span class="author">Turner-Maier J</span>, <span class="author">Younis S</span>, <span class="author">Afonso S</span>, <span class="author">Aken B</span>, <span class="author">Alves JM</span>, <span class="author">Barrell D</span>, <span class="author">Bolet G</span>, <span class="author">Boucher S</span>, <span class="author">Burbano HA</span>, <span class="author">Campos R</span>, <span class="author">Chang JL</span>, <span class="author">Duranthon V</span>, <span class="author">Fontanesi L</span>, <span class="author">Garreau H</span>, <span class="author">Heiman D</span>, <span class="author">Johnson J</span>, <span class="author">Mage RG</span>, <span class="author">Peng Z</span>, <span class="author">Queney G</span>, <span class="author">Rogel-Gaillard C</span>, <span class="author">Ruffier M</span>, <span class="author">Searle S</span>, <span class="author">Villafuerte R</span>, <span class="author">Xiong A</span>, <span class="author">Young S</span>, <span class="author">Forsberg-Nilsson K</span>, <span class="author">Good JM</span>, <span class="author">Lander ES</span>, <span class="author">Ferrand N</span>, <span class="author">Lindblad-Toh K</span> and <span class="author">Andersson L</span></p>
<p class="affiliation">CIBIO/InBIO, Centro de Investiga&ccedil;&atilde;o em Biodiversidade e Recursos Gen&eacute;ticos, Campus Agr&aacute;rio de Vair&atilde;o, Universidade do Porto, 4485-661, Vair&atilde;o, Portugal.</p><p class="abstract">The genetic changes underlying the initial steps of animal domestication are still poorly understood. We generated a high-quality reference genome for the rabbit and compared it to resequencing data from populations of wild and domestic rabbits. We identified more than 100 selective sweeps specific to domestic rabbits but only a relatively small number of fixed (or nearly fixed) single-nucleotide polymorphisms (SNPs) for derived alleles. SNPs with marked allele frequency differences between wild and domestic rabbits were enriched for conserved noncoding sites. Enrichment analyses suggest that genes affecting brain and neuronal development have often been targeted during domestication. We propose that because of a truly complex genetic background, tame behavior in rabbits and other domestic animals evolved by shifts in allele frequencies at many loci, rather than by critical changes at only a few domestication loci.</p>
<p class="grants">Funded by: NHGRI NIH HHS: <span class="grant">U54 HG003067</span>; Wellcome Trust: <span class="grant">WT095908</span>, <span class="grant">WT098051</span></p>
<p class="publication"><span class="title">Science (New York, N.Y.)</span>&nbsp;<span class="year">2014</span>;<span class="volume">345</span>;<span class="number">6200</span>;<span class="pagerange">1074-9</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25170157">25170157</a>; DOI: <a href="http://dx.doi.org/10.1126%2Fscience.1253714">10.1126/science.1253714</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Exome sequencing improves genetic diagnosis of structural fetal abnormalities revealed by ultrasound.</h4>
<p class="authors"><span class="author">Carss KJ</span>, <span class="author">Hillman SC</span>, <span class="author">Parthiban V</span>, <span class="author">McMullan DJ</span>, <span class="author">Maher ER</span>, <span class="author">Kilby MD</span> and <span class="author">Hurles ME</span></p>
<p class="affiliation">Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire, CB10 1SA, UK.</p><p class="abstract">The genetic aetiology of non-aneuploid fetal structural abnormalities is typically investigated by karyotyping and array-based detection of microscopically detectable rearrangements, and submicroscopic copy number variants (CNVs), which collectively yield a pathogenic finding in up to 10% of cases. We propose that exome sequencing may substantially increase the identification of underlying aetiologies.We performed exome sequencing on a cohort of 30 non-aneuploid fetuses and neonates (along with their parents) with diverse structural abnormalities first identified by prenatal ultrasound. We identified candidate pathogenic variants with a range of inheritance models, and evaluated these in the context of detailed phenotypic information.We identified 35 de novo single nucleotide variants (SNVs), small indels, deletions or duplications, of which three (accounting for 10% of the cohort) are highly likely to be causative. These are de novo missense variants in FGFR3 and COL2A1, and a de novo 16&middot;8 kb deletion that includes most of OFD1. In five further cases (17%) we identified de novo or inherited recessive or X-linked variants in plausible candidate genes, which require additional validation to determine pathogenicity.Our diagnostic yield of 10% is comparable to, and supplementary to, the diagnostic yield of existing microarray testing for large chromosomal rearrangements and targeted CNV detection. The de novo nature of these events could enable couples to be counselled as to their low recurrence risk. This study outlines the way for a substantial improvement in the diagnostic yield of prenatal genetic abnormalities through the application of next generation sequencing.</p>
<p class="publication"><span class="title">Human molecular genetics</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24476948">24476948</a>; DOI: <a href="http://dx.doi.org/10.1093%2Fhmg%2Fddu038">10.1093/hmg/ddu038</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Evolution and transmission of drug-resistant tuberculosis in a Russian population.</h4>
<p class="authors"><span class="author">Casali N</span>, <span class="author">Nikolayevskyy V</span>, <span class="author">Balabanova Y</span>, <span class="author">Harris SR</span>, <span class="author">Ignatyeva O</span>, <span class="author">Kontsevaya I</span>, <span class="author">Corander J</span>, <span class="author">Bryant J</span>, <span class="author">Parkhill J</span>, <span class="author">Nejentsev S</span>, <span class="author">Horstmann RD</span>, <span class="author">Brown T</span> and <span class="author">Drobniewski F</span></p>
<p class="affiliation">Public Health England (PHE) National Mycobacterium Reference Laboratory, Clinical TB and HIV Group, Blizard Institute, Queen Mary University of London, London, UK.</p>
<p class="abstract">The molecular mechanisms determining the transmissibility and prevalence of drug-resistant tuberculosis in a population were investigated through whole-genome sequencing of 1,000 prospectively obtained patient isolates from Russia. Two-thirds belonged to the Beijing lineage, which was dominated by two homogeneous clades. Multidrug-resistant (MDR) genotypes were found in 48% of isolates overall and in 87% of the major clades. The most common rpoB mutation was associated with fitness-compensatory mutations in rpoA or rpoC, and a new intragenic compensatory substitution was identified. The proportion of MDR cases with extensively drug-resistant (XDR) tuberculosis was 16% overall, with 65% of MDR isolates harboring eis mutations, selected by kanamycin therapy, which may drive the expansion of strains with enhanced virulence. The combination of drug resistance and compensatory mutations displayed by the major clades confers clinical resistance without compromising fitness and transmissibility, showing that, in addition to weaknesses in the tuberculosis control program, biological factors drive the persistence and spread of MDR and XDR tuberculosis in Russia and beyond.</p>
<p class="publication"><span class="title">Nature genetics</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24464101">24464101</a>; DOI: <a href="http://dx.doi.org/10.1038%2Fng.2878">10.1038/ng.2878</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Whole-genome sequencing reveals clonal expansion of multiresistant Staphylococcus haemolyticus in European hospitals.</h4>
<p class="authors"><span class="author">Cavanagh JP</span>, <span class="author">Hjerde E</span>, <span class="author">Holden MT</span>, <span class="author">Kahlke T</span>, <span class="author">Klingenberg C</span>, <span class="author">Fl&aelig;gstad T</span>, <span class="author">Parkhill J</span>, <span class="author">Bentley SD</span> and <span class="author">Sollid JU</span></p>
<p class="affiliation">Department of Paediatrics, University Hospital of North Norway, Troms&oslash;, Norway Department of Clinical Medicine, UiT The Arctic University of Norway, Troms&oslash;, Norway <a href="mailto:%70%61%75%6C%69%6E%65.%63%61%76%61%6E%61%67%68%40%75%69%74.%6E%6F">&#112;&#97;&#117;&#108;&#105;&#110;&#101;&#46;&#99;&#97;&#118;&#97;&#110;&#97;&#103;&#104;&#64;&#117;&#105;&#116;&#46;&#110;&#111;</a>.</p><p class="abstract"><strong>Objectives</strong>: Staphylococcus haemolyticus is an emerging cause of nosocomial infections, primarily affecting immunocompromised patients. A comparative genomic analysis was performed on clinical S. haemolyticus isolates to investigate their genetic relationship and explore the coding sequences with respect to antimicrobial resistance determinants and putative hospital adaptation.</p><p class="abstract"><strong>Methods</strong>: Whole-genome sequencing was performed on 134 isolates of S. haemolyticus from geographically diverse origins (Belgium, 2; Germany, 10; Japan, 13; Norway, 54; Spain, 2; Switzerland, 43; UK, 9; USA, 1). Each genome was individually assembled. Protein coding sequences (CDSs) were predicted and homologous genes were categorized into three types: Type I, core genes, homologues present in all strains; Type II, unique core genes, homologues shared by only a subgroup of strains; and Type III, unique genes, strain-specific CDSs. The phylogenetic relationship between the isolates was built from variable sites in the form of single nucleotide polymorphisms (SNPs) in the core genome and used to construct a maximum likelihood phylogeny.</p><p class="abstract"><strong>Results</strong>: SNPs in the genome core regions divided the isolates into one major group of 126 isolates and one minor group of isolates with highly diverse genomes. The major group was further subdivided into seven clades (A-G), of which four (A-D) encompassed isolates only from Europe. Antimicrobial multiresistance was observed in 77.7% of the collection. High levels of homologous recombination were detected in genes involved in adherence, staphylococcal host adaptation and bacterial cell communication.</p><p class="abstract"><strong>Conclusions</strong>: The presence of several successful and highly resistant clones underlines the adaptive potential of this opportunistic pathogen.</p>
<p class="publication"><span class="title">The Journal of antimicrobial chemotherapy</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25038069">25038069</a>; DOI: <a href="http://dx.doi.org/10.1093%2Fjac%2Fdku271">10.1093/jac/dku271</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Found in translation.</h4>
<p class="authors"><span class="author">Chappell L</span></p>
<p class="affiliation">Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1SA, UK.</p>
<p class="publication"><span class="title">Nature reviews. Microbiology</span>&nbsp;<span class="year">2014</span>;<span class="volume">12</span>;<span class="number">4</span>;<span class="pagerange">238</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24608332">24608332</a>; DOI: <a href="http://dx.doi.org/10.1038%2Fnrmicro3243">10.1038/nrmicro3243</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Spinster homolog 2 (spns2) deficiency causes early onset progressive hearing loss.</h4>
<p class="authors"><span class="author">Chen J</span>, <span class="author">Ingham N</span>, <span class="author">Kelly J</span>, <span class="author">Jadeja S</span>, <span class="author">Goulding D</span>, <span class="author">Pass J</span>, <span class="author">Mahajan VB</span>, <span class="author">Tsang SH</span>, <span class="author">Nijnik A</span>, <span class="author">Jackson IJ</span>, <span class="author">White JK</span>, <span class="author">Forge A</span>, <span class="author">Jagger D</span> and <span class="author">Steel KP</span></p>
<p class="affiliation">Wellcome Trust Sanger Institute, Hinxton, Cambridge, United Kingdom; Wolfson Centre for Age-Related Diseases, King&#39;s College London, London, United Kingdom.</p><p class="abstract">Spinster homolog 2 (Spns2) acts as a Sphingosine-1-phosphate (S1P) transporter in zebrafish and mice, regulating heart development and lymphocyte trafficking respectively. S1P is a biologically active lysophospholipid with multiple roles in signalling. The mechanism of action of Spns2 is still elusive in mammals. Here, we report that Spns2-deficient mice rapidly lost auditory sensitivity and endocochlear potential (EP) from 2 to 3 weeks old. We found progressive degeneration of sensory hair cells in the organ of Corti, but the earliest defect was a decline in the EP, suggesting that dysfunction of the lateral wall was the primary lesion. In the lateral wall of adult mutants, we observed structural changes of marginal cell boundaries and of strial capillaries, and reduced expression of several key proteins involved in the generation of the EP (Kcnj10, Kcnq1, Gjb2 and Gjb6), but these changes were likely to be secondary. Permeability of the boundaries of the stria vascularis and of the strial capillaries appeared normal. We also found focal retinal degeneration and anomalies of retinal capillaries together with anterior eye defects in Spns2 mutant mice. Targeted inactivation of Spns2 in red blood cells, platelets, or lymphatic or vascular endothelial cells did not affect hearing, but targeted ablation of Spns2 in the cochlea using a Sox10-Cre allele produced a similar auditory phenotype to the original mutation, suggesting that local Spns2 expression is critical for hearing in mammals. These findings indicate that Spns2 is required for normal maintenance of the EP and hence for normal auditory function, and support a role for S1P signalling in hearing.</p>
<p class="publication"><span class="title">PLoS genetics</span>&nbsp;<span class="year">2014</span>;<span class="volume">10</span>;<span class="number">10</span>;<span class="pagerange">e1004688</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25356849">25356849</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4214598">4214598</a>; DOI: <a href="http://dx.doi.org/10.1371%2Fjournal.pgen.1004688">10.1371/journal.pgen.1004688</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">A reduction in Ptprq associated with specific features of the deafness phenotype of the miR-96 mutant mouse diminuendo.</h4>
<p class="authors"><span class="author">Chen J</span>, <span class="author">Johnson SL</span>, <span class="author">Lewis MA</span>, <span class="author">Hilton JM</span>, <span class="author">Huma A</span>, <span class="author">Marcotti W</span> and <span class="author">Steel KP</span></p>
<p class="affiliation">Wellcome Trust Sanger Institute, Cambridge, UK; Wolfson Centre for Age-Related Diseases, King's College London, Guy's Campus, London, SE1 1UL, UK.</p>
<p class="abstract">miR-96 is a microRNA, a non-coding RNA gene which regulates a wide array of downstream genes. The miR-96 mouse mutant diminuendo exhibits deafness and arrested hair cell functional and morphological differentiation. We have previously shown that several genes are markedly downregulated in the diminuendo organ of Corti; one of these is Ptprq, a gene known to be important for maturation and maintenance of hair cells. In order to study the contribution that downregulation of Ptprq makes to the diminuendo phenotype, we carried out microarrays, scanning electron microscopy and single hair cell electrophysiology to compare diminuendo mutants (heterozygous and homozygous) with mice homozygous for a functional null allele of Ptprq. In terms of both morphology and electrophysiology, the auditory phenotype of mice lacking Ptprq resembles that of diminuendo heterozygotes, while diminuendo homozygotes are more severely affected. A comparison of transcriptomes indicates there is a broad similarity between diminuendo homozygotes and Ptprq-null mice. The reduction in Ptprq observed in diminuendo mice appears to be a major contributor to the morphological, transcriptional and electrophysiological phenotype, but does not account for the complete diminuendo phenotype.</p>
<p class="publication"><span class="title">The European journal of neuroscience</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24446963">24446963</a>; DOI: <a href="http://dx.doi.org/10.1111%2Fejn.12484">10.1111/ejn.12484</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Transcriptional diversity during lineage commitment of human blood progenitors.</h4>
<p class="authors"><span class="author">Chen L</span>, <span class="author">Kostadima M</span>, <span class="author">Martens JH</span>, <span class="author">Canu G</span>, <span class="author">Garcia SP</span>, <span class="author">Turro E</span>, <span class="author">Downes K</span>, <span class="author">Macaulay IC</span>, <span class="author">Bielczyk-Maczynska E</span>, <span class="author">Coe S</span>, <span class="author">Farrow S</span>, <span class="author">Poudel P</span>, <span class="author">Burden F</span>, <span class="author">Jansen SB</span>, <span class="author">Astle WJ</span>, <span class="author">Attwood A</span>, <span class="author">Bariana T</span>, <span class="author">de Bono B</span>, <span class="author">Breschi A</span>, <span class="author">Chambers JC</span>, <span class="author">BRIDGE Consortium</span>, <span class="author">Choudry FA</span>, <span class="author">Clarke L</span>, <span class="author">Coupland P</span>, <span class="author">van der Ent M</span>, <span class="author">Erber WN</span>, <span class="author">Jansen JH</span>, <span class="author">Favier R</span>, <span class="author">Fenech ME</span>, <span class="author">Foad N</span>, <span class="author">Freson K</span>, <span class="author">van Geet C</span>, <span class="author">Gomez K</span>, <span class="author">Guigo R</span>, <span class="author">Hampshire D</span>, <span class="author">Kelly AM</span>, <span class="author">Kerstens HH</span>, <span class="author">Kooner JS</span>, <span class="author">Laffan M</span>, <span class="author">Lentaigne C</span>, <span class="author">Labalette C</span>, <span class="author">Martin T</span>, <span class="author">Meacham S</span>, <span class="author">Mumford A</span>, <span class="author">N&uuml;rnberg S</span>, <span class="author">Palumbo E</span>, <span class="author">van der Reijden BA</span>, <span class="author">Richardson D</span>, <span class="author">Sammut SJ</span>, <span class="author">Slodkowicz G</span>, <span class="author">Tamuri AU</span>, <span class="author">Vasquez L</span>, <span class="author">Voss K</span>, <span class="author">Watt S</span>, <span class="author">Westbury S</span>, <span class="author">Flicek P</span>, <span class="author">Loos R</span>, <span class="author">Goldman N</span>, <span class="author">Bertone P</span>, <span class="author">Read RJ</span>, <span class="author">Richardson S</span>, <span class="author">Cvejic A</span>, <span class="author">Soranzo N</span>, <span class="author">Ouwehand WH</span>, <span class="author">Stunnenberg HG</span>, <span class="author">Frontini M</span> and <span class="author">Rendon A</span></p>
<p class="affiliation">Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1SA, UK. Department of Haematology, University of Cambridge, Cambridge Biomedical Campus, Cambridge CB2 0PT, UK. National Health Service (NHS) Blood and Transplant, Cambridge Biomedical Campus, Cambridge CB2 0PT, UK.</p><p class="abstract">Blood cells derive from hematopoietic stem cells through stepwise fating events. To characterize gene expression programs driving lineage choice, we sequenced RNA from eight primary human hematopoietic progenitor populations representing the major myeloid commitment stages and the main lymphoid stage. We identified extensive cell type-specific expression changes: 6711 genes and 10,724 transcripts, enriched in non-protein-coding elements at early stages of differentiation. In addition, we found 7881 novel splice junctions and 2301 differentially used alternative splicing events, enriched in genes involved in regulatory processes. We demonstrated experimentally cell-specific isoform usage, identifying nuclear factor I/B (NFIB) as a regulator of megakaryocyte maturation-the platelet precursor. Our data highlight the complexity of fating events in closely related progenitor populations, the understanding of which is essential for the advancement of transplantation and regenerative medicine.</p>
<p class="grants">Funded by: British Heart Foundation: <span class="grant">FS/12/27/29405</span>, <span class="grant">RG/09/12/28096</span>, <span class="grant">RP-PG-0310-1002</span>; Cancer Research UK: <span class="grant">14953</span>, <span class="grant">C45041/A14953</span>; Medical Research Council: <span class="grant">MR/K023489/1</span>; Wellcome Trust: <span class="grant">082961/Z/07/Z</span>, <span class="grant">084183/Z/07/Z</span>, <span class="grant">095908</span>, <span class="grant">WT091310</span>, <span class="grant">WT098051</span></p>
<p class="publication"><span class="title">Science (New York, N.Y.)</span>&nbsp;<span class="year">2014</span>;<span class="volume">345</span>;<span class="number">6204</span>;<span class="pagerange">1251033</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25258084">25258084</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4254742">4254742</a>; DOI: <a href="http://dx.doi.org/10.1126%2Fscience.1251033">10.1126/science.1251033</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Mutations in SGOL1 cause a novel cohesinopathy affecting heart and gut rhythm.</h4>
<p class="authors"><span class="author">Chetaille P</span>, <span class="author">Preuss C</span>, <span class="author">Burkhard S</span>, <span class="author">C&ocirc;t&eacute; JM</span>, <span class="author">Houde C</span>, <span class="author">Castilloux J</span>, <span class="author">Pich&eacute; J</span>, <span class="author">Gosset N</span>, <span class="author">Leclerc S</span>, <span class="author">W&uuml;nnemann F</span>, <span class="author">Thibeault M</span>, <span class="author">Gagnon C</span>, <span class="author">Galli A</span>, <span class="author">Tuck E</span>, <span class="author">Hickson GR</span>, <span class="author">Amine NE</span>, <span class="author">Boufaied I</span>, <span class="author">Lemyre E</span>, <span class="author">de Santa Barbara P</span>, <span class="author">Faure S</span>, <span class="author">Jonzon A</span>, <span class="author">Cameron M</span>, <span class="author">Dietz HC</span>, <span class="author">Gallo-McFarlane E</span>, <span class="author">Benson DW</span>, <span class="author">Moreau C</span>, <span class="author">Labuda D</span>, <span class="author">FORGE Canada Consortium</span>, <span class="author">Zhan SH</span>, <span class="author">Shen Y</span>, <span class="author">Jomphe M</span>, <span class="author">Jones SJ</span>, <span class="author">Bakkers J</span> and <span class="author">Andelfinger G</span></p>
<p class="affiliation">Department of Pediatrics, Centre M&egrave;re Enfants Soleil, Centre Hospitalier de l&#39;Universit&eacute; (CHU) de Qu&eacute;bec, Quebec City, Quebec, Canada.</p><p class="abstract">The pacemaking activity of specialized tissues in the heart and gut results in lifelong rhythmic contractions. Here we describe a new syndrome characterized by Chronic Atrial and Intestinal Dysrhythmia, termed CAID syndrome, in 16 French Canadians and 1 Swede. We show that a single shared homozygous founder mutation in SGOL1, a component of the cohesin complex, causes CAID syndrome. Cultured dermal fibroblasts from affected individuals showed accelerated cell cycle progression, a higher rate of senescence and enhanced activation of TGF-&beta; signaling. Karyotypes showed the typical railroad appearance of a centromeric cohesion defect. Tissues derived from affected individuals displayed pathological changes in both the enteric nervous system and smooth muscle. Morpholino-induced knockdown of sgol1 in zebrafish recapitulated the abnormalities seen in humans with CAID syndrome. Our findings identify CAID syndrome as a novel generalized dysrhythmia, suggesting a new role for SGOL1 and the cohesin complex in mediating the integrity of human cardiac and gut rhythm.</p>
<p class="publication"><span class="title">Nature genetics</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25282101">25282101</a>; DOI: <a href="http://dx.doi.org/10.1038%2Fng.3113">10.1038/ng.3113</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Generation and characterization of influenza A viruses with altered polymerase fidelity.</h4>
<p class="authors"><span class="author">Cheung PP</span>, <span class="author">Watson SJ</span>, <span class="author">Choy KT</span>, <span class="author">Fun Sia S</span>, <span class="author">Wong DD</span>, <span class="author">Poon LL</span>, <span class="author">Kellam P</span>, <span class="author">Guan Y</span>, <span class="author">Malik Peiris JS</span> and <span class="author">Yen HL</span></p>
<p class="affiliation">Li Ka Shing Faculty of Medicine, Centre of Influenza Research, School of Public Health, The University of Hong Kong, No. 21 Sassoon Road, Pokfulam, Hong Kong SAR, China.</p><p class="abstract">Genetic diversity of influenza A viruses (IAV) acquired through the error-prone RNA-dependent RNA polymerase (RdRP) or through genetic reassortment enables perpetuation of IAV in humans through epidemics or pandemics. Here, to assess the biological significance of genetic diversity acquired through RdRP, we characterize an IAV fidelity variant derived from passaging a seasonal H3N2 virus in the presence of ribavirin, a purine analogue that increases guanosine-to-adenosine mutations. We demonstrate that a single PB1-V43I mutation increases selectivity to guanosine in A/Wuhan/359/95 (H3N2) and A/Vietnam/1203/04 (H5N1) viruses. The H5N1 PB1-V43I-recombinant virus replicates to comparable titres as the wild-type virus in vitro or in the mouse lungs. However, a decrease in viral population diversity at day 3 post inoculation is associated with a tenfold reduced lethality and neurotropism in mice. Applying a fidelity variant with reduced mutational frequency, we provide direct experimental evidence for the role of genetic diversity in IAV pathogenesis.</p>
<p class="publication"><span class="title">Nature communications</span>&nbsp;<span class="year">2014</span>;<span class="volume">5</span>;<span class="pagerange">4794</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25183443">25183443</a>; DOI: <a href="http://dx.doi.org/10.1038%2Fncomms5794">10.1038/ncomms5794</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Dense genomic sampling identifies highways of pneumococcal recombination.</h4>
<p class="authors"><span class="author">Chewapreecha C</span>, <span class="author">Harris SR</span>, <span class="author">Croucher NJ</span>, <span class="author">Turner C</span>, <span class="author">Marttinen P</span>, <span class="author">Cheng L</span>, <span class="author">Pessia A</span>, <span class="author">Aanensen DM</span>, <span class="author">Mather AE</span>, <span class="author">Page AJ</span>, <span class="author">Salter SJ</span>, <span class="author">Harris D</span>, <span class="author">Nosten F</span>, <span class="author">Goldblatt D</span>, <span class="author">Corander J</span>, <span class="author">Parkhill J</span>, <span class="author">Turner P</span> and <span class="author">Bentley SD</span></p>
<p class="affiliation">Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK.</p><p class="abstract">Evasion of clinical interventions by Streptococcus pneumoniae occurs through selection of non-susceptible genomic variants. We report whole-genome sequencing of 3,085 pneumococcal carriage isolates from a 2.4-km(2) refugee camp. This sequencing provides unprecedented resolution of the process of recombination and its impact on population evolution. Genomic recombination hotspots show remarkable consistency between lineages, indicating common selective pressures acting at certain loci, particularly those associated with antibiotic resistance. Temporal changes in antibiotic consumption are reflected in changes in recombination trends, demonstrating rapid spread of resistance when selective pressure is high. The highest frequencies of receipt and donation of recombined DNA fragments were observed in non-encapsulated lineages, implying that this largely overlooked pneumococcal group, which is beyond the reach of current vaccines, may have a major role in genetic exchange and the adaptation of the species as a whole. These findings advance understanding of pneumococcal population dynamics and provide information for the design of future intervention strategies.</p>
<p class="grants">Funded by: Wellcome Trust: <span class="grant">098051</span></p>
<p class="publication"><span class="title">Nature genetics</span>&nbsp;<span class="year">2014</span>;<span class="volume">46</span>;<span class="number">3</span>;<span class="pagerange">305-9</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24509479">24509479</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC3970364">3970364</a>; DOI: <a href="http://dx.doi.org/10.1038%2Fng.2895">10.1038/ng.2895</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Comprehensive identification of single nucleotide polymorphisms associated with beta-lactam resistance within pneumococcal mosaic genes.</h4>
<p class="authors"><span class="author">Chewapreecha C</span>, <span class="author">Marttinen P</span>, <span class="author">Croucher NJ</span>, <span class="author">Salter SJ</span>, <span class="author">Harris SR</span>, <span class="author">Mather AE</span>, <span class="author">Hanage WP</span>, <span class="author">Goldblatt D</span>, <span class="author">Nosten FH</span>, <span class="author">Turner C</span>, <span class="author">Turner P</span>, <span class="author">Bentley SD</span> and <span class="author">Parkhill J</span></p>
<p class="affiliation">The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, United Kingdom.</p><p class="abstract">Traditional genetic association studies are very difficult in bacteria, as the generally limited recombination leads to large linked haplotype blocks, confounding the identification of causative variants. Beta-lactam antibiotic resistance in Streptococcus pneumoniae arises readily as the bacteria can quickly incorporate DNA fragments encompassing variants that make the transformed strains resistant. However, the causative mutations themselves are embedded within larger recombined blocks, and previous studies have only analysed a limited number of isolates, leading to the description of &quot;mosaic genes&quot; as being responsible for resistance. By comparing a large number of genomes of beta-lactam susceptible and non-susceptible strains, the high frequency of recombination should break up these haplotype blocks and allow the use of genetic association approaches to identify individual causative variants. Here, we performed a genome-wide association study to identify single nucleotide polymorphisms (SNPs) and indels that could confer beta-lactam non-susceptibility using 3,085 Thai and 616 USA pneumococcal isolates as independent datasets for the variant discovery. The large sample sizes allowed us to narrow the source of beta-lactam non-susceptibility from long recombinant fragments down to much smaller loci comprised of discrete or linked SNPs. While some loci appear to be universal resistance determinants, contributing equally to non-susceptibility for at least two classes of beta-lactam antibiotics, some play a larger role in resistance to particular antibiotics. All of the identified loci have a highly non-uniform distribution in the populations. They are enriched not only in vaccine-targeted, but also non-vaccine-targeted lineages, which may raise clinical concerns. Identification of single nucleotide polymorphisms underlying resistance will be essential for future use of genome sequencing to predict antibiotic sensitivity in clinical microbiology.</p>
<p class="grants">Funded by: Wellcome Trust: <span class="grant">083735/Z/07Z</span>, <span class="grant">098051</span></p>
<p class="publication"><span class="title">PLoS genetics</span>&nbsp;<span class="year">2014</span>;<span class="volume">10</span>;<span class="number">8</span>;<span class="pagerange">e1004547</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25101644">25101644</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4125147">4125147</a>; DOI: <a href="http://dx.doi.org/10.1371%2Fjournal.pgen.1004547">10.1371/journal.pgen.1004547</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Calreticulin mutations in myeloproliferative neoplasms and new methodology for their detection and monitoring.</h4>
<p class="authors"><span class="author">Chi J</span>, <span class="author">Manoloukos M</span>, <span class="author">Pierides C</span>, <span class="author">Nicolaidou V</span>, <span class="author">Nicolaou K</span>, <span class="author">Kleopa M</span>, <span class="author">Vassiliou G</span> and <span class="author">Costeas P</span></p>
<p class="affiliation">The Center for the Study of Haematological Malignancies, Nicosia, Cyprus.</p><p class="abstract">The diagnosis of the BCR-ABL-negative myeloproliferative neoplasms (MPN), namely polycythemia vera, essential thombocythemia and primary myelofibrosis has relied significantly on the detection of known causative mutations in the JAK2 or MPL genes, which account for the majority of MPN patients. However, around 30&nbsp;% of patients with MPN, primarily essential thombocythemia and primary myelofibrosis, lack mutations in these two genes making it difficult to reach a confident diagnosis in these cases. The recent discovery of frameshift mutations in CALR in approximately 70&nbsp;% of MPN patients lacking the JAK2 and MPL mutations offers a reliable diagnostic marker for the latter group. A review of the current literature, plus unpublished data from our laboratory, shows that 55 different CALR insertion/deletion mutations have been identified so far in MPN patients. Among these 55 variants reported to date, a 52-base pair deletion and a 5-base pair insertion are by far the most prominent representing 50 and 35&nbsp;%, respectively, of all cases with CALR mutations. In this paper, we describe a high-resolution melting (HRM) analysis and a Taqman&reg; Real-Time PCR (RQ-PCR) assay and we propose a new clinical laboratory diagnostic algorithm for CALR mutation analysis. According to this algorithm, samples can go through front-line screening with HMR or fragment analysis, followed by the newly developed RQ-PCR to both discriminate and quantify the two most common mutations in CALR gene.</p>
<p class="publication"><span class="title">Annals of hematology</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25349114">25349114</a>; DOI: <a href="http://dx.doi.org/10.1007%2Fs00277-014-2232-8">10.1007/s00277-014-2232-8</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Calreticulin gene exon 9 frameshift mutations in patients with thrombocytosis.</h4>
<p class="authors"><span class="author">Chi J</span>, <span class="author">Nicolaou KA</span>, <span class="author">Nicolaidou V</span>, <span class="author">Koumas L</span>, <span class="author">Mitsidou A</span>, <span class="author">Pierides C</span>, <span class="author">Manoloukos M</span>, <span class="author">Barbouti K</span>, <span class="author">Melanthiou F</span>, <span class="author">Prokopiou C</span>, <span class="author">Vassiliou GS</span> and <span class="author">Costeas P</span></p>
<p class="affiliation">The Center for the Study of Haematological Malignancies, Nicosia, Cyprus.</p>
<p class="grants">Funded by: Wellcome Trust: <span class="grant">095663</span></p>
<p class="publication"><span class="title">Leukemia</span>&nbsp;<span class="year">2014</span>;<span class="volume">28</span>;<span class="number">5</span>;<span class="pagerange">1152-4</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24365789">24365789</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4017256">4017256</a>; DOI: <a href="http://dx.doi.org/10.1038%2Fleu.2013.382">10.1038/leu.2013.382</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">International glossina genome initiative 2004-2014: a driver for post-genomic era research on the african continent.</h4>
<p class="authors"><span class="author">Christoffels A</span>, <span class="author">Masiga D</span>, <span class="author">Berriman M</span>, <span class="author">Lehane M</span>, <span class="author">Tour&eacute; Y</span> and <span class="author">Aksoy S</span></p>
<p class="affiliation">South African Medical Research Council Bioinformatics Unit, South African National Bioinformatics Institute, University of the Western Cape, Bellville, South Africa.</p>
<p class="publication"><span class="title">PLoS neglected tropical diseases</span>&nbsp;<span class="year">2014</span>;<span class="volume">8</span>;<span class="number">8</span>;<span class="pagerange">e3024</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25144472">25144472</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4140670">4140670</a>; DOI: <a href="http://dx.doi.org/10.1371%2Fjournal.pntd.0003024">10.1371/journal.pntd.0003024</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Generation of Antigenic Diversity in Plasmodium falciparum by Structured Rearrangement of Var Genes During Mitosis.</h4>
<p class="authors"><span class="author">Claessens A</span>, <span class="author">Hamilton WL</span>, <span class="author">Kekre M</span>, <span class="author">Otto TD</span>, <span class="author">Faizullabhoy A</span>, <span class="author">Rayner JC</span> and <span class="author">Kwiatkowski D</span></p>
<p class="affiliation">Malaria Programme, Wellcome Trust Sanger Institute, Hinxton, United Kingdom.</p><p class="abstract">The most polymorphic gene family in P. falciparum is the &sim;60 var genes distributed across parasite chromosomes, both in the subtelomeres and in internal regions. They encode hypervariable surface proteins known as P. falciparum erythrocyte membrane protein 1 (PfEMP1) that are critical for pathogenesis and immune evasion in Plasmodium falciparum. How var gene sequence diversity is generated is not currently completely understood. To address this, we constructed large clone trees and performed whole genome sequence analysis to study the generation of novel var gene sequences in asexually replicating parasites. While single nucleotide polymorphisms (SNPs) were scattered across the genome, structural variants (deletions, duplications, translocations) were focused in and around var genes, with considerable variation in frequency between strains. Analysis of more than 100 recombination events involving var exon 1 revealed that the average nucleotide sequence identity of two recombining exons was only 63% (range: 52.7-72.4%) yet the crossovers were error-free and occurred in such a way that the resulting sequence was in frame and domain architecture was preserved. Var exon 1, which encodes the immunologically exposed part of the protein, recombined in up to 0.2% of infected erythrocytes in vitro per life cycle. The high rate of var exon 1 recombination indicates that millions of new antigenic structures could potentially be generated each day in a single infected individual. We propose a model whereby var gene sequence polymorphism is mainly generated during the asexual part of the life cycle.</p>
<p class="publication"><span class="title">PLoS genetics</span>&nbsp;<span class="year">2014</span>;<span class="volume">10</span>;<span class="number">12</span>;<span class="pagerange">e1004812</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25521112">25521112</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4270465">4270465</a>; DOI: <a href="http://dx.doi.org/10.1371%2Fjournal.pgen.1004812">10.1371/journal.pgen.1004812</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">From cheek swabs to consensus sequences: an A to Z protocol for high-throughput DNA sequencing of complete human mitochondrial genomes.</h4>
<p class="authors"><span class="author">Clarke AC</span>, <span class="author">Prost S</span>, <span class="author">Stanton JA</span>, <span class="author">White WT</span>, <span class="author">Kaplan ME</span>, <span class="author">Matisoo-Smith EA</span> and <span class="author">Genographic Consortium</span></p>
<p class="affiliation">Department of Anatomy, University of Otago, Dunedin, New Zealand. <a href="mailto:%41.%43.%43%6C%61%72%6B%65%40%77%61%72%77%69%63%6B.%61%63.%75%6B">&#65;&#46;&#67;&#46;&#67;&#108;&#97;&#114;&#107;&#101;&#64;&#119;&#97;&#114;&#119;&#105;&#99;&#107;&#46;&#97;&#99;&#46;&#117;&#107;</a>.</p><p class="abstract"><strong>Background</strong>: Next-generation DNA sequencing (NGS) technologies have made huge impacts in many fields of biological research, but especially in evolutionary biology. One area where NGS has shown potential is for high-throughput sequencing of complete mtDNA genomes (of humans and other animals). Despite the increasing use of NGS technologies and a better appreciation of their importance in answering biological questions, there remain significant obstacles to the successful implementation of NGS-based projects, especially for new users.</p><p class="abstract"><strong>Results</strong>: Here we present an &#39;A to Z&#39; protocol for obtaining complete human mitochondrial (mtDNA) genomes - from DNA extraction to consensus sequence. Although designed for use on humans, this protocol could also be used to sequence small, organellar genomes from other species, and also nuclear loci. This protocol includes DNA extraction, PCR amplification, fragmentation of PCR products, barcoding of fragments, sequencing using the 454 GS FLX platform, and a complete bioinformatics pipeline (primer removal, reference-based mapping, output of coverage plots and SNP calling).</p><p class="abstract"><strong>Conclusions</strong>: All steps in this protocol are designed to be straightforward to implement, especially for researchers who are undertaking next-generation sequencing for the first time. The molecular steps are scalable to large numbers (hundreds) of individuals and all steps post-DNA extraction can be carried out in 96-well plate format. Also, the protocol has been assembled so that individual &#39;modules&#39; can be swapped out to suit available resources.</p>
<p class="publication"><span class="title">BMC genomics</span>&nbsp;<span class="year">2014</span>;<span class="volume">15</span>;<span class="pagerange">68</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24460871">24460871</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC3922791">3922791</a>; DOI: <a href="http://dx.doi.org/10.1186%2F1471-2164-15-68">10.1186/1471-2164-15-68</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Adaptive introgression between Anopheles sibling species eliminates a major genomic island but not reproductive isolation.</h4>
<p class="authors"><span class="author">Clarkson CS</span>, <span class="author">Weetman D</span>, <span class="author">Essandoh J</span>, <span class="author">Yawson AE</span>, <span class="author">Maslen G</span>, <span class="author">Manske M</span>, <span class="author">Field SG</span>, <span class="author">Webster M</span>, <span class="author">Ant&atilde;o T</span>, <span class="author">MacInnis B</span>, <span class="author">Kwiatkowski D</span> and <span class="author">Donnelly MJ</span></p>
<p class="affiliation">1] Department of Vector Biology, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool L3 5QA, UK [2].</p><p class="abstract">Adaptive introgression can provide novel genetic variation to fuel rapid evolutionary responses, though it may be counterbalanced by potential for detrimental disruption of the recipient genomic background. We examine the extent and impact of recent introgression of a strongly selected insecticide-resistance mutation (Vgsc-1014F) located within one of two exceptionally large genomic islands of divergence separating the Anopheles gambiae species pair. Here we show that transfer of the Vgsc mutation results in homogenization of the entire genomic island region (~1.5% of the genome) between species. Despite this massive disruption, introgression is clearly adaptive with a dramatic rise in frequency of Vgsc-1014F and no discernable impact on subsequent reproductive isolation between species. Our results show (1) how resilience of genomes to massive introgression can permit rapid adaptive response to anthropogenic selection and (2) that even extreme prominence of genomic islands of divergence can be an unreliable indicator of importance in speciation.</p>
<p class="grants">Funded by: NIAID NIH HHS: <span class="grant">R01AI082734</span>; Wellcome Trust: <span class="grant">WT094960MA</span></p>
<p class="publication"><span class="title">Nature communications</span>&nbsp;<span class="year">2014</span>;<span class="volume">5</span>;<span class="pagerange">4248</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24963649">24963649</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4086683">4086683</a>; DOI: <a href="http://dx.doi.org/10.1038%2Fncomms5248">10.1038/ncomms5248</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">A Selective Sweep on a Deleterious Mutation in CPT1A in Arctic Populations.</h4>
<p class="authors"><span class="author">Clemente FJ</span>, <span class="author">Cardona A</span>, <span class="author">Inchley CE</span>, <span class="author">Peter BM</span>, <span class="author">Jacobs G</span>, <span class="author">Pagani L</span>, <span class="author">Lawson DJ</span>, <span class="author">Ant&atilde;o T</span>, <span class="author">Vicente M</span>, <span class="author">Mitt M</span>, <span class="author">DeGiorgio M</span>, <span class="author">Faltyskova Z</span>, <span class="author">Xue Y</span>, <span class="author">Ayub Q</span>, <span class="author">Szpak M</span>, <span class="author">M&auml;gi R</span>, <span class="author">Eriksson A</span>, <span class="author">Manica A</span>, <span class="author">Raghavan M</span>, <span class="author">Rasmussen M</span>, <span class="author">Rasmussen S</span>, <span class="author">Willerslev E</span>, <span class="author">Vidal-Puig A</span>, <span class="author">Tyler-Smith C</span>, <span class="author">Villems R</span>, <span class="author">Nielsen R</span>, <span class="author">Metspalu M</span>, <span class="author">Malyarchuk B</span>, <span class="author">Derenko M</span> and <span class="author">Kivisild T</span></p>
<p class="affiliation">Department of Archaeology and Anthropology, University of Cambridge, Cambridge CB2 3QG, UK.</p><p class="abstract">Arctic populations live in an environment characterized by extreme cold and the absence of plant foods for much of the year and are likely to have undergone genetic adaptations to these environmental conditions in the time they have been living there. Genome-wide selection scans based on genotype data from native Siberians have previously highlighted a 3 Mb chromosome 11 region containing 79&nbsp;protein-coding genes as the strongest candidates for positive selection in Northeast Siberians. However, it was not possible to determine which of the genes might be driving the selection signal. Here, using whole-genome high-coverage sequence data, we identified the most likely causative variant as a nonsynonymous G&gt;A transition (rs80356779; c.1436C&gt;T [p.Pro479Leu] on the reverse strand) in CPT1A, a key regulator of mitochondrial long-chain fatty-acid oxidation. Remarkably, the derived allele is associated with hypoketotic hypoglycemia and high infant mortality yet occurs at high frequency in Canadian and Greenland Inuits and was also found at 68% frequency in our Northeast Siberian sample. We provide evidence of one of the strongest selective sweeps reported in humans; this sweep&nbsp;has driven this variant to high frequency in circum-Arctic populations within the last 6-23 ka despite associated deleterious consequences, possibly as a result of the selective advantage it originally provided to either a high-fat diet or a cold environment.</p>
<p class="grants">Funded by: European Research Council: <span class="grant">261213</span></p>
<p class="publication"><span class="title">American journal of human genetics</span>&nbsp;<span class="year">2014</span>;<span class="volume">95</span>;<span class="number">5</span>;<span class="pagerange">584-589</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25449608">25449608</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4225582">4225582</a>; DOI: <a href="http://dx.doi.org/10.1016%2Fj.ajhg.2014.09.016">10.1016/j.ajhg.2014.09.016</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">KLF2 mutation is the most frequent somatic change in splenic marginal zone lymphoma and identifies a subset with distinct genotype.</h4>
<p class="authors"><span class="author">Clipson A</span>, <span class="author">Wang M</span>, <span class="author">de Leval L</span>, <span class="author">Ashton-Key M</span>, <span class="author">Wotherspoon A</span>, <span class="author">Vassiliou G</span>, <span class="author">Bolli N</span>, <span class="author">Grove C</span>, <span class="author">Moody S</span>, <span class="author">Ibarz LE</span>, <span class="author">Gundem G</span>, <span class="author">Brugger K</span>, <span class="author">Xue X</span>, <span class="author">Mi E</span>, <span class="author">Bench A</span>, <span class="author">Scott M</span>, <span class="author">Liu H</span>, <span class="author">Follows G</span>, <span class="author">Robles EF</span>, <span class="author">Martinez Climent JA</span>, <span class="author">Oscier D</span>, <span class="author">Watkins AJ</span> and <span class="author">Du MQ</span></p>
<p class="affiliation">Division of Molecular Histopathology, Department of Pathology, University of Cambridge, Cambridge, UK.</p><p class="abstract">To characterise the genetics of splenic marginal zone lymphoma (SMZL), we performed whole exome sequencing of 16 cases and identified novel recurrent inactivating mutations in KLF2, a gene whose deficiency was previously shown to cause splenic marginal zone hyperplasia in mice. KLF2 mutation was found in 40 (42%) of 96 SMZLs, but rarely in other B-cell lymphomas. The majority of KLF2 mutations were frameshift indels or nonsense changes, with missense mutations clustered in the C-terminal zinc finger domains. Functional assays showed that these mutations inactivated the ability of KLF2 to suppress NF-&kappa;B activation by TLR, BCR, BAFFR and TNFR signalling. Further extensive investigations revealed common and distinct genetic changes between SMZL with and without KLF2 mutation. IGHV1-2 rearrangement and 7q deletion were primarily seen in SMZL with KLF2 mutation, while MYD88 and TP53 mutations were nearly exclusively found in those without KLF2 mutation. NOTCH2, TRAF3, TNFAIP3 and CARD11 mutations were observed in SMZL both with and without KLF2 mutation. Taken together, KLF2 mutation is the most common genetic change in SMZL and identifies a subset with a distinct genotype characterised by multi-genetic changes. These different genetic changes may deregulate various signalling pathways and generate cooperative oncogenic properties, thereby contributing to lymphomagenesis.Leukemia accepted article preview online, 27 November 2014. doi:10.1038/leu.2014.330.</p>
<p class="publication"><span class="title">Leukemia</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25428260">25428260</a>; DOI: <a href="http://dx.doi.org/10.1038%2Fleu.2014.330">10.1038/leu.2014.330</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">PolyTB: A genomic variation map for Mycobacterium tuberculosis.</h4>
<p class="authors"><span class="author">Coll F</span>, <span class="author">Preston M</span>, <span class="author">Guerra-Assun&ccedil;&atilde;o JA</span>, <span class="author">Hill-Cawthorn G</span>, <span class="author">Harris D</span>, <span class="author">Perdig&atilde;o J</span>, <span class="author">Viveiros M</span>, <span class="author">Portugal I</span>, <span class="author">Drobniewski F</span>, <span class="author">Gagneux S</span>, <span class="author">Glynn JR</span>, <span class="author">Pain A</span>, <span class="author">Parkhill J</span>, <span class="author">McNerney R</span>, <span class="author">Martin N</span> and <span class="author">Clark TG</span></p>
<p class="affiliation">Faculty of Infectious and Tropical Diseases, London School of Hygiene &amp; Tropical Medicine, WC1E 7HT London, UK. Electronic address: <a href="mailto:%66%72%61%6E%63%65%73%63.%63%6F%6C%6C%40%6C%73%68%74%6D.%61%63.%75%6B">&#102;&#114;&#97;&#110;&#99;&#101;&#115;&#99;&#46;&#99;&#111;&#108;&#108;&#64;&#108;&#115;&#104;&#116;&#109;&#46;&#97;&#99;&#46;&#117;&#107;</a>.</p><p class="abstract">Tuberculosis (TB) caused by Mycobacterium tuberculosis (Mtb) is the second major cause of death from an infectious disease worldwide. Recent advances in DNA sequencing are leading to the ability to generate whole genome information in clinical isolates of M.&nbsp;tuberculosis complex (MTBC). The identification of informative genetic variants such as phylogenetic markers and those associated with drug resistance or virulence will help barcode Mtb in the context of epidemiological, diagnostic and clinical studies. Mtb genomic datasets are increasingly available as raw sequences, which are potentially difficult and computer intensive to process, and compare across studies. Here we have processed the raw sequence data (&gt;1500 isolates, eight studies) to compile a catalogue of SNPs (n&nbsp;=&nbsp;74,039, 63% non-synonymous, 51.1% in more than one isolate, i.e. non-private), small indels (n&nbsp;=&nbsp;4810) and larger structural variants (n&nbsp;=&nbsp;800). We have developed the PolyTB web-based tool (http://pathogenseq.lshtm.ac.uk/polytb) to visualise the resulting variation and important meta-data (e.g. in silico inferred strain-types, location) within geographical map and phylogenetic views. This resource will allow researchers to identify polymorphisms within candidate genes of interest, as well as examine the genomic diversity and distribution of strains. PolyTB source code is freely available to researchers wishing to develop similar tools for their pathogen of interest.</p>
<p class="publication"><span class="title">Tuberculosis (Edinburgh, Scotland)</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24637013">24637013</a>; DOI: <a href="http://dx.doi.org/10.1016%2Fj.tube.2014.02.005">10.1016/j.tube.2014.02.005</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Confident and sensitive phosphoproteomics using combinations of collision induced dissociation and electron transfer dissociation.</h4>
<p class="authors"><span class="author">Collins MO</span>, <span class="author">Wright JC</span>, <span class="author">Jones M</span>, <span class="author">Rayner JC</span> and <span class="author">Choudhary JS</span></p>
<p class="affiliation">Proteomic Mass Spectrometry, The Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK.</p><p class="abstract">We present a workflow using an ETD-optimised version of Mascot Percolator and a modified version of SLoMo (turbo-SLoMo) for analysis of phosphoproteomic data. We have benchmarked this against several database searching algorithms and phosphorylation site localisation tools and show that it offers highly sensitive and confident phosphopeptide identification and site assignment with PSM-level statistics, enabling rigorous comparison of data acquisition methods. We analysed the Plasmodium falciparum schizont phosphoproteome using for the first time, a data-dependent neutral loss-triggered-ETD (DDNL) strategy and a conventional decision-tree method. At a posterior error probability threshold of 0.01, similar numbers of PSMs were identified using both methods with a 73% overlap in phosphopeptide identifications. The false discovery rate associated with spectral pairs where DDNL CID/ETD identified the same phosphopeptide was &lt;1%. 72% of phosphorylation site assignments using turbo-SLoMo without any score filtering, were identical and 99.8% of these cases are associated with a the false localisation rate of &lt;5%. We show that DDNL acquisition is a useful approach for phosphoproteomics and results in increased confidence in phosphopeptide identification without compromising sensitivity or duty cycle. Furthermore, the combination of Mascot Percolator and turbo-SLoMo represents a robust workflow for phosphoproteomic data analysis using CID and ETD fragmentation.</p><p class="abstract">Protein phosphorylation is a ubiquitous post-translational modification that regulates protein function. Mass spectrometry-based approaches have revolutionised its analysis on a large-scale but phosphorylation sites are often identified by single phosphopeptides and therefore require more rigorous data analysis to unsure that sites are identified with high confidence for follow up experiments to investigate their biological significance. The coverage and confidence of phosphoproteomic experiments can be enhanced by the use of multiple complementary fragmentation methods. Here we have benchmarked a data analysis pipeline for analysis of phosphoproteomic data generated using CID and ETD fragmentation and used it to demonstrate the utility of a data-dependent neutral loss triggered ETD fragmentation strategy for high confidence phosphopeptide identification and phosphorylation site localisation.</p>
<p class="publication"><span class="title">Journal of proteomics</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24657495">24657495</a>; DOI: <a href="http://dx.doi.org/10.1016%2Fj.jprot.2014.03.010">10.1016/j.jprot.2014.03.010</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Human genomic regions with exceptionally high levels of population differentiation identified from 911 whole-genome sequences.</h4>
<p class="authors"><span class="author">Colonna V</span>, <span class="author">Ayub Q</span>, <span class="author">Chen Y</span>, <span class="author">Pagani L</span>, <span class="author">Luisi P</span>, <span class="author">Pybus M</span>, <span class="author">Garrison E</span>, <span class="author">Xue Y</span>, <span class="author">Tyler-Smith C</span>, <span class="author">1000 Genomes Project Consortium</span>, <span class="author">Abecasis GR</span>, <span class="author">Auton A</span>, <span class="author">Brooks LD</span>, <span class="author">DePristo MA</span>, <span class="author">Durbin RM</span>, <span class="author">Handsaker RE</span>, <span class="author">Kang HM</span>, <span class="author">Marth GT</span> and <span class="author">McVean GA</span></p><p class="abstract"><strong>Background</strong>: Population differentiation has proved to be effective for identifying loci under geographically localized positive selection, and has the potential to identify loci subject to balancing selection. We have previously investigated the pattern of genetic differentiation among human populations at 36.8 million genomic variants to identify sites in the genome showing high frequency differences. Here, we extend this dataset to include additional variants, survey sites with low levels of differentiation, and evaluate the extent to which highly differentiated sites are likely to result from selective or other processes.</p><p class="abstract"><strong>Results</strong>: We demonstrate that while sites with low differentiation represent sampling effects rather than balancing selection, sites showing extremely high population differentiation are enriched for positive selection events and that one half may be the result of classic selective sweeps. Among these, we rediscover known examples, where we actually identify the established functional SNP, and discover novel examples including the genes ABCA12, CALD1 and ZNF804, which we speculate may be linked to adaptations in skin, calcium metabolism and defense, respectively.</p><p class="abstract"><strong>Conclusions</strong>: We identify known and many novel candidate regions for geographically restricted positive selection, and suggest several directions for further research.</p>
<p class="grants">Funded by: Wellcome Trust: <span class="grant">098051</span></p>
<p class="publication"><span class="title">Genome biology</span>&nbsp;<span class="year">2014</span>;<span class="volume">15</span>;<span class="number">6</span>;<span class="pagerange">R88</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24980144">24980144</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4197830">4197830</a>; DOI: <a href="http://dx.doi.org/10.1186%2Fgb-2014-15-6-r88">10.1186/gb-2014-15-6-r88</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Processed pseudogenes acquired somatically during cancer development.</h4>
<p class="authors"><span class="author">Cooke SL</span>, <span class="author">Shlien A</span>, <span class="author">Marshall J</span>, <span class="author">Pipinikas CP</span>, <span class="author">Martincorena I</span>, <span class="author">Tubio JM</span>, <span class="author">Li Y</span>, <span class="author">Menzies A</span>, <span class="author">Mudie L</span>, <span class="author">Ramakrishna M</span>, <span class="author">Yates L</span>, <span class="author">Davies H</span>, <span class="author">Bolli N</span>, <span class="author">Bignell GR</span>, <span class="author">Tarpey PS</span>, <span class="author">Behjati S</span>, <span class="author">Nik-Zainal S</span>, <span class="author">Papaemmanuil E</span>, <span class="author">Teixeira VH</span>, <span class="author">Raine K</span>, <span class="author">O&#39;Meara S</span>, <span class="author">Dodoran MS</span>, <span class="author">Teague JW</span>, <span class="author">Butler AP</span>, <span class="author">Iacobuzio-Donahue C</span>, <span class="author">Santarius T</span>, <span class="author">Grundy RG</span>, <span class="author">Malkin D</span>, <span class="author">Greaves M</span>, <span class="author">Munshi N</span>, <span class="author">Flanagan AM</span>, <span class="author">Bowtell D</span>, <span class="author">Martin S</span>, <span class="author">Larsimont D</span>, <span class="author">Reis-Filho JS</span>, <span class="author">Boussioutas A</span>, <span class="author">Taylor JA</span>, <span class="author">Hayes ND</span>, <span class="author">Janes SM</span>, <span class="author">Futreal PA</span>, <span class="author">Stratton MR</span>, <span class="author">McDermott U</span>, <span class="author">Campbell PJ</span> and <span class="author">ICGC Breast Cancer Group</span></p>
<p class="affiliation">Cancer Genome Project, Wellcome Trust Sanger Institute, Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK.</p><p class="abstract">Cancer evolves by mutation, with somatic reactivation of retrotransposons being one such mutational process. Germline retrotransposition can cause processed pseudogenes, but whether this occurs somatically has not been evaluated. Here we screen sequencing data from 660 cancer samples for somatically acquired pseudogenes. We find 42 events in 17 samples, especially non-small cell lung cancer (5/27) and colorectal cancer (2/11). Genomic features mirror those of germline LINE element retrotranspositions, with frequent target-site duplications (67%), consensus TTTTAA sites at insertion points, inverted rearrangements (21%), 5&#39; truncation (74%) and polyA tails (88%). Transcriptional consequences include expression of pseudogenes from UTRs or introns of target genes. In addition, a somatic pseudogene that integrated into the promoter and first exon of the tumour suppressor gene, MGA, abrogated expression from that allele. Thus, formation of processed pseudogenes represents a new class of mutation occurring during cancer development, with potentially diverse functional consequences depending on genomic context.</p>
<p class="grants">Funded by: Cancer Research UK; NCI NIH HHS: <span class="grant">P01 CA155258</span>; Wellcome Trust: <span class="grant">077012/Z/05/Z</span>, <span class="grant">091730</span></p>
<p class="publication"><span class="title">Nature communications</span>&nbsp;<span class="year">2014</span>;<span class="volume">5</span>;<span class="pagerange">3644</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24714652">24714652</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC3996531">3996531</a>; DOI: <a href="http://dx.doi.org/10.1038%2Fncomms4644">10.1038/ncomms4644</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Detection and correction of artefacts in estimation of rare copy number variants and analysis of rare deletions in type 1 diabetes.</h4>
<p class="authors"><span class="author">Cooper NJ</span>, <span class="author">Shtir CJ</span>, <span class="author">Smyth DJ</span>, <span class="author">Guo H</span>, <span class="author">Swafford AD</span>, <span class="author">Zanda M</span>, <span class="author">Hurles M</span>, <span class="author">Walker NM</span>, <span class="author">Plagnol V</span>, <span class="author">Cooper JD</span>, <span class="author">Howson JM</span>, <span class="author">Burren OS</span>, <span class="author">Onengut-Gumuscu S</span>, <span class="author">Rich SS</span> and <span class="author">Todd JA</span></p>
<p class="affiliation">JDRF/Wellcome Trust Diabetes and Inflammation Laboratory, Department of Medical Genetics, NIHR Cambridge Biomedical Research Centre, Cambridge Institute for Medical Research, University of Cambridge, Wellcome Trust/MRC Building, Cambridge Biomedical Campus, Cambridge, CB2 0XY, UK.</p><p class="abstract">Copy number variants (CNVs) have been proposed as a possible source of &#39;missing heritability&#39; in complex human diseases. Two studies of type 1 diabetes (T1D) found null associations with common copy number polymorphisms, but CNVs of low frequency and high penetrance could still play a role. We used the Log-R-Ratio intensity data from a dense single nucleotide polymorphism (SNP) array, ImmunoChip, to detect rare CNV deletions (rDELs) and duplications (rDUPs) in 6,808 T1D cases, 9,954 controls, and 2,206 families with T1D-affected offspring. Initial analyses detected CNV associations. However, these were shown to be false positive findings, failing replication with PCR. We developed a pipeline of quality control (QC) tests that were calibrated using systematic testing of sensitivity and specificity. The case-control odds ratios (OR) of CNV burden on T1D risk resulting from this QC pipeline converged on unity, suggesting no global frequency difference in rDELs or rDUPs. There was evidence that deletions could impact T1D risk for a small minority of cases, with enrichment for rDELs longer than 400 kb (OR=1.57, p=0.005). There were also 18 de novo rDELs detected in affected offspring but none for unaffected siblings (p=0.03). No specific CNV regions showed robust evidence for association with T1D, although frequencies were lower than expected (most less than 0.1%), substantially reducing statistical power, which was examined in detail. We present an R-package, plumbCNV, which provides an automated approach for quality control (QC) and detection of rare CNVs that can facilitate equivalent analyses of large-scale SNP array datasets.</p>
<p class="publication"><span class="title">Human molecular genetics</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25424174">25424174</a>; DOI: <a href="http://dx.doi.org/10.1093%2Fhmg%2Fddu581">10.1093/hmg/ddu581</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Genomic identification of a novel co-trimoxazole resistance genotype and its prevalence amongst Streptococcus pneumoniae in Malawi.</h4>
<p class="authors"><span class="author">Cornick JE</span>, <span class="author">Harris SR</span>, <span class="author">Parry CM</span>, <span class="author">Moore MJ</span>, <span class="author">Jassi C</span>, <span class="author">Kamng&#39;ona A</span>, <span class="author">Kulohoma B</span>, <span class="author">Heyderman RS</span>, <span class="author">Bentley SD</span> and <span class="author">Everett DB</span></p>
<p class="affiliation">Malawi-Liverpool-Wellcome Clinical Research Programme, University of Malawi, College of Medicine, Blantyre, Malawi.</p>
<p class="abstract">Objectives: This study aimed to define the molecular basis of co-trimoxazole resistance in Malawian pneumococci under the dual selective pressure of widespread co-trimoxazole and sulfadoxine/pyrimethamine use.

Methods: We measured the trimethoprim and sulfamethoxazole MICs and analysed folA and folP nucleotide and translated amino acid sequences for 143 pneumococci isolated from carriage and invasive disease in Malawi (2002-08).

Results: Pneumococci were highly resistant to both trimethoprim and sulfamethoxazole (96%, 137/143). Sulfamethoxazole-resistant isolates showed a 3 or 6 bp insertion in the sulphonamide-binding site of folP. The trimethoprim-resistant isolates fell into three genotypic groups based on dihydrofolate reductase (encoded by folA) mutations: Ile-100-Leu (10%), the Ile-100-Leu substitution together with a residue 92 substitution (56%) and those with a novel uncharacterized resistance genotype (34%). The nucleotide sequence divergence and dN/dS of folA and folP remained stable from 2004 onwards.

Conclusions: S. pneumoniae exhibit almost universal co-trimoxazole resistance in vitro and in silico that we believe is driven by extensive co-trimoxazole and sulfadoxine/pyrimethamine use. More than one-third of pneumococci employ a novel mechanism of co-trimoxazole resistance. Resistance has now reached a point of stabilizing evolution. The use of co-trimoxazole to prevent pneumococcal infection in HIV/AIDS patients in sub-Saharan Africa should be re-evaluated.</p>
<p class="publication"><span class="title">The Journal of antimicrobial chemotherapy</span>&nbsp;<span class="year">2014</span>;<span class="volume">69</span>;<span class="number">2</span>;<span class="pagerange">368-74</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24080503">24080503</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC3886935">3886935</a>; DOI: <a href="http://dx.doi.org/10.1093%2Fjac%2Fdkt384">10.1093/jac/dkt384</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">BioJS: an open source standard for biological visualisation - its status in 2014.</h4>
<p class="authors"><span class="author">Corpas M</span>, <span class="author">Jimenez R</span>, <span class="author">Carbon SJ</span>, <span class="author">Garc&iacute;a A</span>, <span class="author">Garcia L</span>, <span class="author">Goldberg T</span>, <span class="author">Gomez J</span>, <span class="author">Kalderimis A</span>, <span class="author">Lewis SE</span>, <span class="author">Mulvany I</span>, <span class="author">Pawlik A</span>, <span class="author">Rowland F</span>, <span class="author">Salazar G</span>, <span class="author">Schreiber F</span>, <span class="author">Sillitoe I</span>, <span class="author">Spooner WH</span>, <span class="author">Thanki AS</span>, <span class="author">Villaveces JM</span>, <span class="author">Yachdav G</span> and <span class="author">Hermjakob H</span></p>
<p class="affiliation">The Genome Analysis Centre, Norwich Research Park, Norwich, NR4 7UH, UK.</p><p class="abstract">BioJS is a community-based standard and repository of functional components to represent biological information on the web. The development of BioJS has been prompted by the growing need for bioinformatics visualisation tools to be easily shared, reused and discovered. Its modular architecture makes it easy for users to find a specific functionality without needing to know how it has been built, while components can be extended or created for implementing new functionality. The BioJS community of developers currently provides a range of functionality that is open access and freely available. A registry has been set up that categorises and provides installation instructions and testing facilities at http://www.ebi.ac.uk/tools/biojs/. The source code for all components is available for ready use at https://github.com/biojs/biojs.</p>
<p class="publication"><span class="title">F1000Research</span>&nbsp;<span class="year">2014</span>;<span class="volume">3</span>;<span class="pagerange">55</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25075290">25075290</a>; DOI: <a href="http://dx.doi.org/10.12688%2Ff1000research.3-55.v1">10.12688/f1000research.3-55.v1</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Full genome virus detection in fecal samples using sensitive nucleic Acid preparation, deep sequencing, and a novel iterative sequence classification algorithm.</h4>
<p class="authors"><span class="author">Cotten M</span>, <span class="author">Oude Munnink B</span>, <span class="author">Canuti M</span>, <span class="author">Deijs M</span>, <span class="author">Watson SJ</span>, <span class="author">Kellam P</span> and <span class="author">van der Hoek L</span></p>
<p class="affiliation">Wellcome Trust Sanger Institute, Hinxton, United Kingdom.</p><p class="abstract">We have developed a full genome virus detection process that combines sensitive nucleic acid preparation optimised for virus identification in fecal material with Illumina MiSeq sequencing and a novel post-sequencing virus identification algorithm. Enriched viral nucleic acid was converted to double-stranded DNA and subjected to Illumina MiSeq sequencing. The resulting short reads were processed with a novel iterative Python algorithm SLIM for the identification of sequences with homology to known viruses. De novo assembly was then used to generate full viral genomes. The sensitivity of this process was demonstrated with a set of fecal samples from HIV-1 infected patients. A quantitative assessment of the mammalian, plant, and bacterial virus content of this compartment was generated and the deep sequencing data were sufficient to assembly 12 complete viral genomes from 6 virus families. The method detected high levels of enteropathic viruses that are normally controlled in healthy adults, but may be involved in the pathogenesis of HIV-1 infection and will provide a powerful tool for virus detection and for analyzing changes in the fecal virome associated with HIV-1 progression and pathogenesis.</p>
<p class="publication"><span class="title">PloS one</span>&nbsp;<span class="year">2014</span>;<span class="volume">9</span>;<span class="number">4</span>;<span class="pagerange">e93269</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24695106">24695106</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC3973683">3973683</a>; DOI: <a href="http://dx.doi.org/10.1371%2Fjournal.pone.0093269">10.1371/journal.pone.0093269</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Deep sequencing of norovirus genomes defines evolutionary patterns in an urban tropical setting.</h4>
<p class="authors"><span class="author">Cotten M</span>, <span class="author">Petrova V</span>, <span class="author">Phan MV</span>, <span class="author">Rabaa MA</span>, <span class="author">Watson SJ</span>, <span class="author">Ong SH</span>, <span class="author">Kellam P</span> and <span class="author">Baker S</span></p>
<p class="affiliation">The Wellcome Trust Sanger Institute, Hinxton, United Kingdom.</p><p class="abstract"><strong>Unlabelled</strong>: Norovirus is a highly transmissible infectious agent that causes epidemic gastroenteritis in susceptible children and adults. Norovirus infections can be severe and can be initiated from an exceptionally small number of viral particles. Detailed genome sequence data are useful for tracking norovirus transmission and evolution. To address this need, we have developed a whole-genome deep-sequencing method that generates entire genome sequences from small amounts of clinical specimens. This novel approach employs an algorithm for reverse transcription and PCR amplification primer design using all of the publically available norovirus sequence data. Deep sequencing and de novo assembly were used to generate norovirus genomes from a large set of diarrheal patients attending three hospitals in Ho Chi Minh City, Vietnam, over a 2.5-year period. Positive-selection analysis and direct examination of protein changes in the virus over time identified codons in the regions encoding proteins VP1, p48 (NS1-2), and p22 (NS4) under positive selection and expands the known targets of norovirus evolutionary pressure.</p><p class="abstract"><strong>Importance</strong>: The high transmissibility and rapid evolutionary rate of norovirus, combined with a short-lived host immune responses, are thought to be the reasons why the virus causes the majority of pediatric viral diarrhea cases. The evolutionary patterns of this RNA virus have been described in detail for only a portion of the virus genome and never for a virus from a detailed urban tropical setting. We provide a detailed sequence description of the noroviruses circulating in three Ho Chi Minh City hospitals over a 2.5-year period. This study identified patterns of virus change in known sites of host immune response and identified three additional regions of the virus genome under selection that were not previously recognized. In addition, the method described here provides a robust full-genome sequencing platform for community-based virus surveillance.</p>
<p class="grants">Funded by: Wellcome Trust: <span class="grant">WT/093724</span></p>
<p class="publication"><span class="title">Journal of virology</span>&nbsp;<span class="year">2014</span>;<span class="volume">88</span>;<span class="number">19</span>;<span class="pagerange">11056-69</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25056894">25056894</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4178781">4178781</a>; DOI: <a href="http://dx.doi.org/10.1128%2FJVI.01333-14">10.1128/JVI.01333-14</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Spread, circulation, and evolution of the Middle East respiratory syndrome coronavirus.</h4>
<p class="authors"><span class="author">Cotten M</span>, <span class="author">Watson SJ</span>, <span class="author">Zumla AI</span>, <span class="author">Makhdoom HQ</span>, <span class="author">Palser AL</span>, <span class="author">Ong SH</span>, <span class="author">Al Rabeeah AA</span>, <span class="author">Alhakeem RF</span>, <span class="author">Assiri A</span>, <span class="author">Al-Tawfiq JA</span>, <span class="author">Albarrak A</span>, <span class="author">Barry M</span>, <span class="author">Shibl A</span>, <span class="author">Alrabiah FA</span>, <span class="author">Hajjar S</span>, <span class="author">Balkhy HH</span>, <span class="author">Flemban H</span>, <span class="author">Rambaut A</span>, <span class="author">Kellam P</span> and <span class="author">Memish ZA</span></p><p class="abstract"><strong>Unlabelled</strong>: The Middle East respiratory syndrome coronavirus (MERS-CoV) was first documented in the Kingdom of Saudi Arabia (KSA) in 2012 and, to date, has been identified in 180 cases with 43% mortality. In this study, we have determined the MERS-CoV evolutionary rate, documented genetic variants of the virus and their distribution throughout the Arabian peninsula, and identified the genome positions under positive selection, important features for monitoring adaptation of MERS-CoV to human transmission and for identifying the source of infections. Respiratory samples from confirmed KSA MERS cases from May to September 2013 were subjected to whole-genome deep sequencing, and 32 complete or partial sequences (20 were &ge; 99% complete, 7 were 50 to 94% complete, and 5 were 27 to 50% complete) were obtained, bringing the total available MERS-CoV genomic sequences to 65. An evolutionary rate of 1.12 &times; 10(-3) substitutions per site per year (95% credible interval [95% CI], 8.76 &times; 10(-4); 1.37 &times; 10(-3)) was estimated, bringing the time to most recent common ancestor to March 2012 (95% CI, December 2011; June 2012). Only one MERS-CoV codon, spike 1020, located in a domain required for cell entry, is under strong positive selection. Four KSA MERS-CoV phylogenetic clades were found, with 3 clades apparently no longer contributing to current cases. The size of the population infected with MERS-CoV showed a gradual increase to June 2013, followed by a decline, possibly due to increased surveillance and infection control measures combined with a basic reproduction number (R0) for the virus that is less than 1.</p><p class="abstract"><strong>Importance</strong>: MERS-CoV adaptation toward higher rates of sustained human-to-human transmission appears not to have occurred yet. While MERS-CoV transmission currently appears weak, careful monitoring of changes in MERS-CoV genomes and of the MERS epidemic should be maintained. The observation of phylogenetically related MERS-CoV in geographically diverse locations must be taken into account in efforts to identify the animal source and transmission of the virus.</p>
<p class="grants">Funded by: Wellcome Trust</p>
<p class="publication"><span class="title">mBio</span>&nbsp;<span class="year">2014</span>;<span class="volume">5</span>;<span class="number">1</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24549846">24549846</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC3944817">3944817</a>; DOI: <a href="http://dx.doi.org/10.1128%2FmBio.01062-13">10.1128/mBio.01062-13</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">The genome and life-stage specific transcriptomes of Globodera pallida elucidate key aspects of plant parasitism by a cyst nematode.</h4>
<p class="authors"><span class="author">Cotton JA</span>, <span class="author">Lilley CJ</span>, <span class="author">Jones LM</span>, <span class="author">Kikuchi T</span>, <span class="author">Reid AJ</span>, <span class="author">Thorpe P</span>, <span class="author">Tsai IJ</span>, <span class="author">Beasley H</span>, <span class="author">Blok V</span>, <span class="author">Cock PJ</span>, <span class="author">Eves-van den Akker S</span>, <span class="author">Holroyd N</span>, <span class="author">Hunt M</span>, <span class="author">Mantelin S</span>, <span class="author">Naghra H</span>, <span class="author">Pain A</span>, <span class="author">Palomares-Rius JE</span>, <span class="author">Zarowiecki M</span>, <span class="author">Berriman M</span>, <span class="author">Jones JT</span> and <span class="author">Urwin PE</span></p><p class="abstract"><strong>Background</strong>: Globodera pallida is a devastating pathogen of potato crops, making it one of the most economically important plant parasitic nematodes. It is also an important model for the biology of cyst nematodes. Cyst nematodes and root-knot nematodes are the two most important plant parasitic nematode groups and together represent a global threat to food security.</p><p class="abstract"><strong>Results</strong>: We present the complete genome sequence of G. pallida, together with transcriptomic data from most of the nematode life cycle, particularly focusing on the life cycle stages involved in root invasion and establishment of the biotrophic feeding site. Despite the relatively close phylogenetic relationship with root-knot nematodes, we describe a very different gene family content between the two groups and in particular extensive differences in the repertoire of effectors, including an enormous expansion of the SPRY domain protein family in G. pallida, which includes the SPRYSEC family of effectors. This highlights the distinct biology of cyst nematodes compared to the root-knot nematodes that were, until now, the only sedentary plant parasitic nematodes for which genome information was available. We also present in-depth descriptions of the repertoires of other genes likely to be important in understanding the unique biology of cyst nematodes and of potential drug targets and other targets for their control.</p><p class="abstract"><strong>Conclusions</strong>: The data and analyses we present will be central in exploiting post-genomic approaches in the development of much-needed novel strategies for the control of G. pallida and related pathogens.</p>
<p class="publication"><span class="title">Genome biology</span>&nbsp;<span class="year">2014</span>;<span class="volume">15</span>;<span class="number">3</span>;<span class="pagerange">R43</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24580726">24580726</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4054857">4054857</a>; DOI: <a href="http://dx.doi.org/10.1186%2Fgb-2014-15-3-r43">10.1186/gb-2014-15-3-r43</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Genome-wide association study of sexual maturation in males and females highlights a role for body mass and menarche loci in male puberty.</h4>
<p class="authors"><span class="author">Cousminer DL</span>, <span class="author">Stergiakouli E</span>, <span class="author">Berry DJ</span>, <span class="author">Ang W</span>, <span class="author">Groen-Blokhuis MM</span>, <span class="author">K&ouml;rner A</span>, <span class="author">Siitonen N</span>, <span class="author">Ntalla I</span>, <span class="author">Marinelli M</span>, <span class="author">Perry JR</span>, <span class="author">Kettunen J</span>, <span class="author">Jansen R</span>, <span class="author">Surakka I</span>, <span class="author">Timpson NJ</span>, <span class="author">Ring S</span>, <span class="author">Mcmahon G</span>, <span class="author">Power C</span>, <span class="author">Wang C</span>, <span class="author">K&auml;h&ouml;nen M</span>, <span class="author">Viikari J</span>, <span class="author">Lehtim&auml;ki T</span>, <span class="author">Middeldorp CM</span>, <span class="author">Hulshoff Pol HE</span>, <span class="author">Neef M</span>, <span class="author">Weise S</span>, <span class="author">Pahkala K</span>, <span class="author">Niinikoski H</span>, <span class="author">Zeggini E</span>, <span class="author">Panoutsopoulou K</span>, <span class="author">Bustamante M</span>, <span class="author">Penninx BW</span>, <span class="author">ReproGen Consortium</span>, <span class="author">Murabito J</span>, <span class="author">Torrent M</span>, <span class="author">Dedoussis GV</span>, <span class="author">Kiess W</span>, <span class="author">Boomsma DI</span>, <span class="author">Pennell CE</span>, <span class="author">Raitakari OT</span>, <span class="author">Hypp&ouml;nen E</span>, <span class="author">Davey Smith G</span>, <span class="author">Ripatti S</span>, <span class="author">McCarthy MI</span>, <span class="author">Wid&eacute;n E</span> and <span class="author">Early Growth Genetics Consortium</span></p>
<p class="affiliation">Institute for Molecular Medicine Finland (FIMM).</p><p class="abstract">Little is known about genes regulating male puberty. Further, while many identified pubertal timing variants associate with age at menarche, a late manifestation of puberty, and body mass, little is known about these variants&#39; relationship to pubertal initiation or tempo. To address these questions, we performed genome-wide association meta-analysis in over 11 000 European samples with data on early pubertal traits, male genital and female breast development, measured by the Tanner scale. We report the first genome-wide significant locus for male sexual development upstream of myocardin-like 2 (MKL2) (P = 8.9 &times; 10(-9)), a menarche locus tagging a developmental pathway linking earlier puberty with reduced pubertal growth (P = 4.6 &times; 10(-5)) and short adult stature (p = 7.5 &times; 10(-6)) in both males and females. Furthermore, our results indicate that a proportion of menarche loci are important for pubertal initiation in both sexes. Consistent with epidemiological correlations between increased prepubertal body mass and earlier pubertal timing in girls, body mass index (BMI)-increasing alleles correlated with earlier breast development. In boys, some BMI-increasing alleles associated with earlier, and others with delayed, sexual development; these genetic results mimic the controversy in epidemiological studies, some of which show opposing correlations between prepubertal BMI and male puberty. Our results contribute to our understanding of the pubertal initiation program in both sexes and indicate that although mechanisms regulating pubertal onset in males and females may largely be shared, the relationship between body mass and pubertal timing in boys may be complex and requires further genetic studies.</p>
<p class="grants">Funded by: CCR NIH HHS: <span class="grant">NIMH 1RC2MH089995-01</span>; Canadian Institutes of Health Research: <span class="grant">MOP-82893</span>; Department of Health: <span class="grant">NF-SI-0611-10219</span>; Medical Research Council: <span class="grant">G0000934</span>, <span class="grant">MC_UP_A620_1014</span>, <span class="grant">MC_UU_12011/1</span>, <span class="grant">MC_UU_12013/3</span>, <span class="grant">U1475000001</span>; NIDDK NIH HHS: <span class="grant">U01 DK062418</span>; NIMH NIH HHS: <span class="grant">RC2 MH089951</span>; Wellcome Trust: <span class="grant">068545/Z/02</span>, <span class="grant">076113</span>, <span class="grant">090532</span>, <span class="grant">092731</span>, <span class="grant">098051</span></p>
<p class="publication"><span class="title">Human molecular genetics</span>&nbsp;<span class="year">2014</span>;<span class="volume">23</span>;<span class="number">16</span>;<span class="pagerange">4452-64</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24770850">24770850</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4168307">4168307</a>; DOI: <a href="http://dx.doi.org/10.1093%2Fhmg%2Fddu150">10.1093/hmg/ddu150</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Quantitation of malaria parasite-erythrocyte cell-cell interactions using optical tweezers.</h4>
<p class="authors"><span class="author">Crick AJ</span>, <span class="author">Theron M</span>, <span class="author">Tiffert T</span>, <span class="author">Lew VL</span>, <span class="author">Cicuta P</span> and <span class="author">Rayner JC</span></p>
<p class="affiliation">Cavendish Laboratory, University of Cambridge, Cambridge, United Kingdom.</p><p class="abstract">Erythrocyte invasion by Plasmodium falciparum merozoites is an essential step for parasite survival and hence the pathogenesis of malaria. Invasion has been studied intensively, but our cellular understanding has been limited by the fact that it occurs very rapidly: invasion is generally complete within 1 min, and shortly thereafter the merozoites, at least in in vitro culture, lose their invasive capacity. The rapid nature of the process, and hence the narrow time window in which measurements can be taken, have limited the tools available to quantitate invasion. Here we employ optical tweezers to study individual invasion events for what we believe is the first time, showing that newly released P. falciparum merozoites, delivered via optical tweezers to a target erythrocyte, retain their ability to invade. Even spent merozoites, which had lost the ability to invade, retain the ability to adhere to erythrocytes, and furthermore can still induce transient local membrane deformations in the erythrocyte membrane. We use this technology to measure the strength of the adhesive force between merozoites and erythrocytes, and to probe the cellular mode of action of known invasion inhibitory treatments. These data add to our understanding of the erythrocyte-merozoite interactions that occur during invasion, and demonstrate the power of optical tweezers technologies in unraveling the blood-stage biology of malaria.</p>
<p class="grants">Funded by: Wellcome Trust: <span class="grant">098051</span></p>
<p class="publication"><span class="title">Biophysical journal</span>&nbsp;<span class="year">2014</span>;<span class="volume">107</span>;<span class="number">4</span>;<span class="pagerange">846-53</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25140419">25140419</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4142257">4142257</a>; DOI: <a href="http://dx.doi.org/10.1016%2Fj.bpj.2014.07.010">10.1016/j.bpj.2014.07.010</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Evidence for soft selective sweeps in the evolution of pneumococcal multidrug-resistance and vaccine escape.</h4>
<p class="authors"><span class="author">Croucher NJ</span>, <span class="author">Chewapreecha C</span>, <span class="author">Hanage WP</span>, <span class="author">Harris SR</span>, <span class="author">McGee L</span>, <span class="author">van der Linden M</span>, <span class="author">Song JH</span>, <span class="author">Ko KS</span>, <span class="author">de Lencastre H</span>, <span class="author">Turner C</span>, <span class="author">Yang F</span>, <span class="author">S&aacute;-Le&atilde;o R</span>, <span class="author">Beall B</span>, <span class="author">Klugman KP</span>, <span class="author">Parkhill J</span>, <span class="author">Turner P</span> and <span class="author">Bentley SD</span></p>
<p class="affiliation">Center for Communicable Disease Dynamics, Department of Epidemiology, Harvard School of Public Health, 677 Huntington Avenue, Boston, MA 02115, USA. Pathogen Genomics, The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, CB10 1SA, UK.</p><p class="abstract">The multidrug-resistant Streptococcus pneumoniae Taiwan(19F)-14, or PMEN14, clone was first observed with a 19F serotype, which is targeted by the heptavalent polysaccharide conjugate vaccine (PCV7). However, &#39;vaccine escape&#39; PMEN14 isolates with a 19A serotype became an increasingly important cause of disease post-PCV7. Whole genome sequencing was used to characterise the recent evolution 173 pneumococci of, or related to, PMEN14. This suggested PMEN14 is a single lineage that originated in the late 1980s in parallel with the acquisition of multiple resistances by close relatives. One of the four detected serotype switches to 19A generated representatives of the sequence type (ST) 320 isolates that have been highly successful post-PCV7. A second produced an ST236 19A genotype with reduced resistance to &beta;-lactams owing to alteration of pbp1a and pbp2x sequences through the same recombination that caused the change in serotype. A third, which generated a mosaic capsule biosynthesis locus, resulted in serotype 19A ST271 isolates. The rapid diversification through homologous recombination seen in the global collection was similarly observed in the absence of vaccination in isolates from the Maela refugee camp in Thailand. This sample also allowed variation to be observed within carriage through longitudinal sampling. This suggests some pneumococcal genotypes generate a pool of standing variation that is sufficiently extensive to result in &#39;soft&#39; selective sweeps: the emergence of multiple related mutants in parallel upon a change in selection pressure, such as vaccine introduction. The subsequent competition between these mutants makes this phenomenon difficult to detect without deep sampling of individual lineages.</p>
<p class="publication"><span class="title">Genome biology and evolution</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24916661">24916661</a>; DOI: <a href="http://dx.doi.org/10.1093%2Fgbe%2Fevu120">10.1093/gbe/evu120</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Diversification of bacterial genome content through distinct mechanisms over different timescales.</h4>
<p class="authors"><span class="author">Croucher NJ</span>, <span class="author">Coupland PG</span>, <span class="author">Stevenson AE</span>, <span class="author">Callendrello A</span>, <span class="author">Bentley SD</span> and <span class="author">Hanage WP</span></p>
<p class="affiliation">1] Centre for Communicable Disease Dynamics, Harvard School of Public Health, 677 Huntington Avenue, Boston, Massachusetts 02115, USA [2] Department of Infectious Disease Epidemiology, St. Mary&#39;s Campus, Imperial College, London W2 1PG, UK.</p><p class="abstract">Bacterial populations often consist of multiple co-circulating lineages. Determining how such population structures arise requires understanding what drives bacterial diversification. Using 616 systematically sampled genomes, we show that Streptococcus pneumoniae lineages are typically characterized by combinations of infrequently transferred stable genomic islands: those moving primarily through transformation, along with integrative and conjugative elements and phage-related chromosomal islands. The only lineage containing extensive unique sequence corresponds to a set of atypical unencapsulated isolates that may represent a distinct species. However, prophage content is highly variable even within lineages, suggesting frequent horizontal transmission that would necessitate rapidly diversifying anti-phage mechanisms to prevent these viruses sweeping through populations. Correspondingly, two loci encoding Type I restriction-modification systems able to change their specificity over short timescales through intragenomic recombination are ubiquitous across the collection. Hence short-term pneumococcal variation is characterized by movement of phage and intragenomic rearrangements, with the slower transfer of stable loci distinguishing lineages.</p>
<p class="publication"><span class="title">Nature communications</span>&nbsp;<span class="year">2014</span>;<span class="volume">5</span>;<span class="pagerange">5471</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25407023">25407023</a>; DOI: <a href="http://dx.doi.org/10.1038%2Fncomms6471">10.1038/ncomms6471</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Rapid phylogenetic analysis of large samples of recombinant bacterial whole genome sequences using Gubbins.</h4>
<p class="authors"><span class="author">Croucher NJ</span>, <span class="author">Page AJ</span>, <span class="author">Connor TR</span>, <span class="author">Delaney AJ</span>, <span class="author">Keane JA</span>, <span class="author">Bentley SD</span>, <span class="author">Parkhill J</span> and <span class="author">Harris SR</span></p>
<p class="affiliation">Pathogen Genomics, The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1SA, UK Center for Communicable Disease Dynamics, Harvard School of Public Health, 677 Longwood Avenue, Boston, MA 02115, USA Department of Infectious Disease Epidemiology, Imperial College London, St. Mary&#39;s Campus, Norfolk Place, London W2 1PG, UK.</p><p class="abstract">The emergence of new sequencing technologies has facilitated the use of bacterial whole genome alignments for evolutionary studies and outbreak analyses. These datasets, of increasing size, often include examples of multiple different mechanisms of horizontal sequence transfer resulting in substantial alterations to prokaryotic chromosomes. The impact of these processes demands rapid and flexible approaches able to account for recombination when reconstructing isolates&#39; recent diversification. Gubbins is an iterative algorithm that uses spatial scanning statistics to identify loci containing elevated densities of base substitutions suggestive of horizontal sequence transfer while concurrently constructing a maximum likelihood phylogeny based on the putative point mutations outside these regions of high sequence diversity. Simulations demonstrate the algorithm generates highly accurate reconstructions under realistically parameterized models of bacterial evolution, and achieves convergence in only a few hours on alignments of hundreds of bacterial genome sequences. Gubbins is appropriate for reconstructing the recent evolutionary history of a variety of haploid genotype alignments, as it makes no assumptions about the underlying mechanism of recombination. The software is freely available for download at github.com/sanger-pathogens/Gubbins, implemented in Python and C and supported on Linux and Mac OS X.</p>
<p class="publication"><span class="title">Nucleic acids research</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25414349">25414349</a>; DOI: <a href="http://dx.doi.org/10.1093%2Fnar%2Fgku1196">10.1093/nar/gku1196</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Ensembl 2015.</h4>
<p class="authors"><span class="author">Cunningham F</span>, <span class="author">Amode MR</span>, <span class="author">Barrell D</span>, <span class="author">Beal K</span>, <span class="author">Billis K</span>, <span class="author">Brent S</span>, <span class="author">Carvalho-Silva D</span>, <span class="author">Clapham P</span>, <span class="author">Coates G</span>, <span class="author">Fitzgerald S</span>, <span class="author">Gil L</span>, <span class="author">Gir&oacute;n CG</span>, <span class="author">Gordon L</span>, <span class="author">Hourlier T</span>, <span class="author">Hunt SE</span>, <span class="author">Janacek SH</span>, <span class="author">Johnson N</span>, <span class="author">Juettemann T</span>, <span class="author">K&auml;h&auml;ri AK</span>, <span class="author">Keenan S</span>, <span class="author">Martin FJ</span>, <span class="author">Maurel T</span>, <span class="author">McLaren W</span>, <span class="author">Murphy DN</span>, <span class="author">Nag R</span>, <span class="author">Overduin B</span>, <span class="author">Parker A</span>, <span class="author">Patricio M</span>, <span class="author">Perry E</span>, <span class="author">Pignatelli M</span>, <span class="author">Riat HS</span>, <span class="author">Sheppard D</span>, <span class="author">Taylor K</span>, <span class="author">Thormann A</span>, <span class="author">Vullo A</span>, <span class="author">Wilder SP</span>, <span class="author">Zadissa A</span>, <span class="author">Aken BL</span>, <span class="author">Birney E</span>, <span class="author">Harrow J</span>, <span class="author">Kinsella R</span>, <span class="author">Muffato M</span>, <span class="author">Ruffier M</span>, <span class="author">Searle SM</span>, <span class="author">Spudich G</span>, <span class="author">Trevanion SJ</span>, <span class="author">Yates A</span>, <span class="author">Zerbino DR</span> and <span class="author">Flicek P</span></p>
<p class="affiliation">European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1SD, UK.</p><p class="abstract">Ensembl (http://www.ensembl.org) is a genomic interpretation system providing the most up-to-date annotations, querying tools and access methods for chordates and key model organisms. This year we released updated annotation (gene models, comparative genomics, regulatory regions and variation) on the new human assembly, GRCh38, although we continue to support researchers using the GRCh37.p13 assembly through a dedicated site (http://grch37.ensembl.org). Our Regulatory Build has been revamped to identify regulatory regions of interest and to efficiently highlight their activity across disparate epigenetic data sets. A number of new interfaces allow users to perform large-scale comparisons of their data against our annotations. The REST server (http://rest.ensembl.org), which allows programs written in any language to query our databases, has moved to a full service alongside our upgraded website tools. Our online Variant Effect Predictor tool has been updated to process more variants and calculate summary statistics. Lastly, the WiggleTools package enables users to summarize large collections of data sets and view them as single tracks in Ensembl. The Ensembl code base itself is more accessible: it is now hosted on our GitHub organization page (https://github.com/Ensembl) under an Apache 2.0 open source license.</p>
<p class="publication"><span class="title">Nucleic acids research</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25352552">25352552</a>; DOI: <a href="http://dx.doi.org/10.1093%2Fnar%2Fgku1010">10.1093/nar/gku1010</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Time between sputum sample collection and storage significantly influences bacterial sequence composition from Cystic Fibrosis respiratory infections.</h4>
<p class="authors"><span class="author">Cuthbertson L</span>, <span class="author">Rogers GB</span>, <span class="author">Walker AW</span>, <span class="author">Oliver A</span>, <span class="author">Hafiz T</span>, <span class="author">Hoffman LR</span>, <span class="author">Carroll MP</span>, <span class="author">Parkhill J</span>, <span class="author">Bruce KD</span> and <span class="author">van der Gast CJ</span></p>
<p class="affiliation">NERC Centre for Ecology &amp; Hydrology, Wallingford, OX10 8BB, UK Institute of Pharmaceutical Science, Molecular Microbiology Research Laboratory, King&#39;s College London, London, SE1 9NH, UK.</p><p class="abstract">Spontaneously expectorated sputum is traditionally used as the sampling method for the investigation of lower airway infections. Whilst guidelines exist for the handling of these samples for culture-based diagnostic microbiology, there is no comparable consensus on their handling prior to culture-independent analysis. The increasing incorporation of culture-independent approaches in diagnostic microbiology means it is of critical importance to assess potential biases. The aim of this study was to assess the impact of delayed freezing on culture-independent microbiological analyses, and to identify acceptable parameters for sample handling. Sputum samples from eight adult cystic fibrosis (CF) patients were collected and aliquoted into sterile Bijou bottles. Aliquots were stored at room temperature before freezing at -80&deg;C for increasing intervals up to 72 hour period. Samples were treated with propidium monoazide, to distinguish live from dead cells, prior to DNA extraction, and 16S rRNA gene pyrosequencing was used to characterise the bacterial composition. Substantial variation was observed in samples with high diversity bacterial communities over time, whereas low diversity communities dominated by recognised CF pathogens varied little regardless of time to freezing. Partitioning into common and rare species demonstrated that the rare species drove changes in similarity. The percentage abundance of anaerobes over the study significantly decreased after 12 hours at room temperature (P=0.008). Failure to stabilise samples at -80&deg;C within 12 hours of collection results in significant changes in the detected community composition.</p>
<p class="publication"><span class="title">Journal of clinical microbiology</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24920767">24920767</a>; DOI: <a href="http://dx.doi.org/10.1128%2FJCM.00764-14">10.1128/JCM.00764-14</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Implications of multiple freeze-thawing on respiratory samples for culture-independent analyses.</h4>
<p class="authors"><span class="author">Cuthbertson L</span>, <span class="author">Rogers GB</span>, <span class="author">Walker AW</span>, <span class="author">Oliver A</span>, <span class="author">Hoffman LR</span>, <span class="author">Carroll MP</span>, <span class="author">Parkhill J</span>, <span class="author">Bruce KD</span> and <span class="author">van der Gast CJ</span></p>
<p class="affiliation">NERC Centre for Ecology &amp; Hydrology, Wallingford, OX10 8BB, UK; Institute of Pharmaceutical Science, Molecular Microbiology Research Laboratory, King&#39;s College London, London SE1 9NH, UK.</p><p class="abstract"><strong>Background</strong>: Best practice when performing culture-independent microbiological analysis of sputum samples involves their rapid freezing and storage at -80&deg;C. However, accessing biobanked collections can mean that material has been passed through repeated freeze-thaw cycles. The aim of this study was to determine the impact of these cycles on microbial community profiles.</p><p class="abstract"><strong>Methods</strong>: Sputum was collected from eight adults with cystic fibrosis, and each sample was subjected to six freeze-thaw cycles. Following each cycle, an aliquot was removed and treated with propidium monoazide (PMA) prior to DNA extraction and 16S rRNA gene pyrosequencing.</p><p class="abstract"><strong>Results</strong>: The impact of freeze-thaw cycles was greatest on rare members of the microbiota, with variation beyond that detected with within-sample repeat analysis observed after three cycles.</p><p class="abstract"><strong>Conclusion</strong>: Four or more freeze thaw cycles result in a significant distortion of microbiota profiles from CF sputum.</p>
<p class="publication"><span class="title">Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25459563">25459563</a>; DOI: <a href="http://dx.doi.org/10.1016%2Fj.jcf.2014.10.004">10.1016/j.jcf.2014.10.004</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">From genome-wide association study hits to new insights into experimental hematology.</h4>
<p class="authors"><span class="author">Cvejic A</span></p>
<p class="affiliation">Department of Haematology, University of Cambridge, UK; Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK. Electronic address: <a href="mailto:%61%73%38%38%39%40%63%61%6D.%61%63.%75%6B">&#97;&#115;&#56;&#56;&#57;&#64;&#99;&#97;&#109;&#46;&#97;&#99;&#46;&#117;&#107;</a>.</p><p class="abstract">Despite significant improvements in our knowledge of the mechanisms of normal and pathological hematopoiesis, our current understanding is most likely an oversimplification of the complexity of regulatory networks at play. Thus, considerable efforts have been made to catalogue the total sum of germline alterations in individual genomes affecting human hematopoiesis. These efforts ultimately led to the discovery of a large number of new genes not previously implicated in blood formation. Although identification of novel genes is important in revealing the profiles of genetic variations associated with normal hematopoiesis, further functional studies are necessary to improve our understanding of the mechanism(s) involved in these processes. In this review, we summarize the knowledge gained from genome-wide association studies to elucidate the relationship between genetics and blood cell traits. We discuss the most important recent advances, with an emphasis on functional follow-up studies that have been particularly useful in providing an insight into novel regulatory processes that influence blood cell formation and function. We also discuss potential future directions and&nbsp;challenges in the field.</p>
<p class="publication"><span class="title">Experimental hematology</span>&nbsp;<span class="year">2014</span>;<span class="volume">42</span>;<span class="number">8</span>;<span class="pagerange">630-636</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24746874">24746874</a>; DOI: <a href="http://dx.doi.org/10.1016%2Fj.exphem.2014.04.005">10.1016/j.exphem.2014.04.005</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Streptococcus agalactiae clones infecting humans were selected and fixed through the extensive use of tetracycline.</h4>
<p class="authors"><span class="author">Da Cunha V</span>, <span class="author">Davies MR</span>, <span class="author">Douarre PE</span>, <span class="author">Rosinski-Chupin I</span>, <span class="author">Margarit I</span>, <span class="author">Spinali S</span>, <span class="author">Perkins T</span>, <span class="author">Lechat P</span>, <span class="author">Dmytruk N</span>, <span class="author">Sauvage E</span>, <span class="author">Ma L</span>, <span class="author">Romi B</span>, <span class="author">Tichit M</span>, <span class="author">Lopez-Sanchez MJ</span>, <span class="author">Descorps-Declere S</span>, <span class="author">Souche E</span>, <span class="author">Buchrieser C</span>, <span class="author">Trieu-Cuot P</span>, <span class="author">Moszer I</span>, <span class="author">Clermont D</span>, <span class="author">Maione D</span>, <span class="author">Bouchier C</span>, <span class="author">McMillan DJ</span>, <span class="author">Parkhill J</span>, <span class="author">Telford JL</span>, <span class="author">Dougan G</span>, <span class="author">Walker MJ</span>, <span class="author">DEVANI Consortium</span>, <span class="author">Holden MT</span>, <span class="author">Poyart C</span> and <span class="author">Glaser P</span></p>
<p class="affiliation">1] Institut Pasteur, Unit&eacute; de Biologie des Bacteries Pathog&egrave;nes &agrave; Gram-positif, Paris 75015, France [2] CNRS UMR3525, Paris 75015, France [3] Institut Pasteur, Bioinformatics platform, Paris 75015, France [4].</p><p class="abstract">Streptococcus agalactiae (Group B Streptococcus, GBS) is a commensal of the digestive and genitourinary tracts of humans that emerged as the leading cause of bacterial neonatal infections in Europe and North America during the 1960s. Due to the lack of epidemiological and genomic data, the reasons for this emergence are unknown. Here we show by comparative genome analysis and phylogenetic reconstruction of 229 isolates that the rise of human GBS infections corresponds to the selection and worldwide dissemination of only a few clones. The parallel expansion of the clones is preceded by the insertion of integrative and conjugative elements conferring tetracycline resistance (TcR). Thus, we propose that the use of tetracycline from 1948 onwards led in humans to the complete replacement of a diverse GBS population by only few TcR clones particularly well adapted to their host, causing the observed emergence of GBS diseases in neonates.</p>
<p class="grants">Funded by: Wellcome Trust: <span class="grant">098051</span></p>
<p class="publication"><span class="title">Nature communications</span>&nbsp;<span class="year">2014</span>;<span class="volume">5</span>;<span class="pagerange">4544</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25088811">25088811</a>; DOI: <a href="http://dx.doi.org/10.1038%2Fncomms5544">10.1038/ncomms5544</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Structure and computational analysis of a novel protein with metallopeptidase-like and circularly permuted winged-helix-turn-helix domains reveals a possible role in modified polysaccharide biosynthesis.</h4>
<p class="authors"><span class="author">Das D</span>, <span class="author">Murzin AG</span>, <span class="author">Rawlings ND</span>, <span class="author">Finn RD</span>, <span class="author">Coggill P</span>, <span class="author">Bateman A</span>, <span class="author">Godzik A</span> and <span class="author">Aravind L</span></p>
<p class="affiliation">Joint Center for Structural Genomics, La Jolla, CA, USA. <a href="mailto:%64%65%62%61%6E%75%40%73%6C%61%63.%73%74%61%6E%66%6F%72%64.%65%64%75">&#100;&#101;&#98;&#97;&#110;&#117;&#64;&#115;&#108;&#97;&#99;&#46;&#115;&#116;&#97;&#110;&#102;&#111;&#114;&#100;&#46;&#101;&#100;&#117;</a>.</p><p class="abstract"><strong>Background</strong>: CA_C2195 from Clostridium acetobutylicum is a protein of unknown function. Sequence analysis predicted that part of the protein contained a metallopeptidase-related domain. There are over 200 homologs of similar size in large sequence databases such as UniProt, with pairwise sequence identities in the range of ~40-60%. CA_C2195 was chosen for crystal structure determination for structure-based function annotation of novel protein sequence space.</p><p class="abstract"><strong>Results</strong>: The structure confirmed that CA_C2195 contained an N-terminal metallopeptidase-like domain. The structure revealed two extra domains: an &alpha;+&beta; domain inserted in the metallopeptidase-like domain and a C-terminal circularly permuted winged-helix-turn-helix domain.</p><p class="abstract"><strong>Conclusions</strong>: Based on our sequence and structural analyses using the crystal structure of CA_C2195 we provide a view into the possible functions of the protein. From contextual information from gene-neighborhood analysis, we propose that rather than being a peptidase, CA_C2195 and its homologs might play a role in biosynthesis of a modified cell-surface carbohydrate in conjunction with several sugar-modification enzymes. These results provide the groundwork for the experimental verification of the function.</p>
<p class="grants">Funded by: Medical Research Council: <span class="grant">MC_U105192716</span>; NIGMS NIH HHS: <span class="grant">R01GM101457</span>, <span class="grant">U54 GM094586</span>; Wellcome Trust: <span class="grant">WT077044/Z/05/Z</span></p>
<p class="publication"><span class="title">BMC bioinformatics</span>&nbsp;<span class="year">2014</span>;<span class="volume">15</span>;<span class="pagerange">75</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24646163">24646163</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4000134">4000134</a>; DOI: <a href="http://dx.doi.org/10.1186%2F1471-2105-15-75">10.1186/1471-2105-15-75</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Emergence of scarlet fever Streptococcus pyogenes emm12 clones in Hong Kong is associated with toxin acquisition and multidrug resistance.</h4>
<p class="authors"><span class="author">Davies MR</span>, <span class="author">Holden MT</span>, <span class="author">Coupland P</span>, <span class="author">Chen JH</span>, <span class="author">Venturini C</span>, <span class="author">Barnett TC</span>, <span class="author">Zakour NL</span>, <span class="author">Tse H</span>, <span class="author">Dougan G</span>, <span class="author">Yuen KY</span> and <span class="author">Walker MJ</span></p>
<p class="affiliation">1] Australian Infectious Diseases Research Centre, School of Chemistry and Molecular Biosciences, University of Queensland, St. Lucia, Queensland, Australia. [2] Wellcome Trust Sanger Institute, Hinxton, UK.</p><p class="abstract">A scarlet fever outbreak began in mainland China and Hong Kong in 2011 (refs. 1-6). Macrolide- and tetracycline-resistant Streptococcus pyogenes emm12 isolates represent the majority of clinical cases. Recently, we identified two mobile genetic elements that were closely associated with emm12 outbreak isolates: the integrative and conjugative element ICE-emm12, encoding genes for tetracycline and macrolide resistance, and prophage &Phi;HKU.vir, encoding the superantigens SSA and SpeC, as well as the DNase Spd1 (ref. 4). Here we sequenced the genomes of 141 emm12 isolates, including 132 isolated in Hong Kong between 2005 and 2011. We found that the introduction of several ICE-emm12 variants, &Phi;HKU.vir and a new prophage, &Phi;HKU.ssa, occurred in three distinct emm12 lineages late in the twentieth century. Acquisition of ssa and transposable elements encoding multidrug resistance genes triggered the expansion of scarlet fever-associated emm12 lineages in Hong Kong. The occurrence of multidrug-resistant ssa-harboring scarlet fever strains should prompt heightened surveillance within China and abroad for the dissemination of these mobile genetic elements.</p>
<p class="publication"><span class="title">Nature genetics</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25401300">25401300</a>; DOI: <a href="http://dx.doi.org/10.1038%2Fng.3147">10.1038/ng.3147</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">The correlation between reading and mathematics ability at age twelve has a substantial genetic component.</h4>
<p class="authors"><span class="author">Davis OS</span>, <span class="author">Band G</span>, <span class="author">Pirinen M</span>, <span class="author">Haworth CM</span>, <span class="author">Meaburn EL</span>, <span class="author">Kovas Y</span>, <span class="author">Harlaar N</span>, <span class="author">Docherty SJ</span>, <span class="author">Hanscombe KB</span>, <span class="author">Trzaskowski M</span>, <span class="author">Curtis CJ</span>, <span class="author">Strange A</span>, <span class="author">Freeman C</span>, <span class="author">Bellenguez C</span>, <span class="author">Su Z</span>, <span class="author">Pearson R</span>, <span class="author">Vukcevic D</span>, <span class="author">Langford C</span>, <span class="author">Deloukas P</span>, <span class="author">Hunt S</span>, <span class="author">Gray E</span>, <span class="author">Dronov S</span>, <span class="author">Potter SC</span>, <span class="author">Tashakkori-Ghanbaria A</span>, <span class="author">Edkins S</span>, <span class="author">Bumpstead SJ</span>, <span class="author">Blackwell JM</span>, <span class="author">Bramon E</span>, <span class="author">Brown MA</span>, <span class="author">Casas JP</span>, <span class="author">Corvin A</span>, <span class="author">Duncanson A</span>, <span class="author">Jankowski JA</span>, <span class="author">Markus HS</span>, <span class="author">Mathew CG</span>, <span class="author">Palmer CN</span>, <span class="author">Rautanen A</span>, <span class="author">Sawcer SJ</span>, <span class="author">Trembath RC</span>, <span class="author">Viswanathan AC</span>, <span class="author">Wood NW</span>, <span class="author">Barroso I</span>, <span class="author">Peltonen L</span>, <span class="author">Dale PS</span>, <span class="author">Petrill SA</span>, <span class="author">Schalkwyk LS</span>, <span class="author">Craig IW</span>, <span class="author">Lewis CM</span>, <span class="author">Price TS</span>, <span class="author">Wellcome Trust Case Control Consortium</span>, <span class="author">Donnelly P</span>, <span class="author">Plomin R</span> and <span class="author">Spencer CC</span></p>
<p class="affiliation">1] Department of Genetics, Evolution and Environment, UCL Genetics Institute, University College London, London WC1E 6BT, UK [2] King&#39;s College London, Social Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, London SE5 8AF, UK [3].</p><p class="abstract">Dissecting how genetic and environmental influences impact on learning is helpful for maximizing numeracy and literacy. Here we show, using twin and genome-wide analysis, that there is a substantial genetic component to children&#39;s ability in reading and mathematics, and estimate that around one half of the observed correlation in these traits is due to shared genetic effects (so-called Generalist Genes). Thus, our results highlight the potential role of the learning environment in contributing to differences in a child&#39;s cognitive abilities at age twelve.</p>
<p class="publication"><span class="title">Nature communications</span>&nbsp;<span class="year">2014</span>;<span class="volume">5</span>;<span class="pagerange">4204</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25003214">25003214</a>; DOI: <a href="http://dx.doi.org/10.1038%2Fncomms5204">10.1038/ncomms5204</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Recurrent mutations, including NPM1c, activate a BRD4-dependent core transcriptional program in acute myeloid leukemia.</h4>
<p class="authors"><span class="author">Dawson MA</span>, <span class="author">Gudgin EJ</span>, <span class="author">Horton SJ</span>, <span class="author">Giotopoulos G</span>, <span class="author">Meduri E</span>, <span class="author">Robson S</span>, <span class="author">Cannizzaro E</span>, <span class="author">Osaki H</span>, <span class="author">Wiese M</span>, <span class="author">Putwain S</span>, <span class="author">Fong CY</span>, <span class="author">Grove C</span>, <span class="author">Craig J</span>, <span class="author">Dittmann A</span>, <span class="author">Lugo D</span>, <span class="author">Jeffrey P</span>, <span class="author">Drewes G</span>, <span class="author">Lee K</span>, <span class="author">Bullinger L</span>, <span class="author">Prinjha RK</span>, <span class="author">Kouzarides T</span>, <span class="author">Vassiliou GS</span> and <span class="author">Huntly BJ</span></p>
<p class="affiliation">1] Department of Haematology, Cambridge Institute for Medical Research and Addenbrookes Hospital, University of Cambridge, Cambridge, UK [2] Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute, Cambridge, UK [3] Gurdon Institute and Department of Pathology, University of Cambridge, Cambridge UK.</p><p class="abstract">Recent evidence suggests that inhibition of bromodomain and extra-terminal (BET) epigenetic readers may have clinical utility against acute myeloid leukemia (AML). Here we validate this hypothesis, demonstrating the efficacy of the BET inhibitor I-BET151 across a variety of AML subtypes driven by disparate mutations. We demonstrate that a common &#39;core&#39; transcriptional program, which is HOX gene independent, is downregulated in AML and underlies sensitivity to I-BET treatment. This program is enriched for genes that contain &#39;super-enhancers&#39;, recently described regulatory elements postulated to control key oncogenic driver genes. Moreover, our program can independently classify AML patients into distinct cytogenetic and molecular subgroups, suggesting that it contains biomarkers of sensitivity and response. We focus AML with mutations of the Nucleophosmin gene (NPM1) and show evidence to suggest that wild-type NPM1 has an inhibitory influence on BRD4 that is relieved upon NPM1c mutation and cytosplasmic dislocation. This leads to the upregulation of the core transcriptional program facilitating leukemia development. This program is abrogated by I-BET therapy and by nuclear restoration of NPM1. Finally, we demonstrate the efficacy of I-BET151 in a unique murine model and in primary patient samples of NPM1c AML. Taken together, our data support the use of BET inhibitors in clinical trials in AML.</p>
<p class="grants">Funded by: Cancer Research UK; Wellcome Trust: <span class="grant">079249</span>, <span class="grant">092096</span>, <span class="grant">095663</span>, <span class="grant">100140</span></p>
<p class="publication"><span class="title">Leukemia</span>&nbsp;<span class="year">2014</span>;<span class="volume">28</span>;<span class="number">2</span>;<span class="pagerange">311-20</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24220271">24220271</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC3918873">3918873</a>; DOI: <a href="http://dx.doi.org/10.1038%2Fleu.2013.338">10.1038/leu.2013.338</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Spatial and temporal diversity in genomic instability processes defines lung cancer evolution.</h4>
<p class="authors"><span class="author">de Bruin EC</span>, <span class="author">McGranahan N</span>, <span class="author">Mitter R</span>, <span class="author">Salm M</span>, <span class="author">Wedge DC</span>, <span class="author">Yates L</span>, <span class="author">Jamal-Hanjani M</span>, <span class="author">Shafi S</span>, <span class="author">Murugaesu N</span>, <span class="author">Rowan AJ</span>, <span class="author">Gr&ouml;nroos E</span>, <span class="author">Muhammad MA</span>, <span class="author">Horswell S</span>, <span class="author">Gerlinger M</span>, <span class="author">Varela I</span>, <span class="author">Jones D</span>, <span class="author">Marshall J</span>, <span class="author">Voet T</span>, <span class="author">Van Loo P</span>, <span class="author">Rassl DM</span>, <span class="author">Rintoul RC</span>, <span class="author">Janes SM</span>, <span class="author">Lee SM</span>, <span class="author">Forster M</span>, <span class="author">Ahmad T</span>, <span class="author">Lawrence D</span>, <span class="author">Falzon M</span>, <span class="author">Capitanio A</span>, <span class="author">Harkins TT</span>, <span class="author">Lee CC</span>, <span class="author">Tom W</span>, <span class="author">Teefe E</span>, <span class="author">Chen SC</span>, <span class="author">Begum S</span>, <span class="author">Rabinowitz A</span>, <span class="author">Phillimore B</span>, <span class="author">Spencer-Dene B</span>, <span class="author">Stamp G</span>, <span class="author">Szallasi Z</span>, <span class="author">Matthews N</span>, <span class="author">Stewart A</span>, <span class="author">Campbell P</span> and <span class="author">Swanton C</span></p>
<p class="affiliation">Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London WC1E 6BT, UK.</p><p class="abstract">Spatial and temporal dissection of the genomic changes occurring during the evolution of human non-small cell lung cancer (NSCLC) may help elucidate the basis for its dismal prognosis. We sequenced 25 spatially distinct regions from seven operable NSCLCs and found evidence of branched evolution, with driver mutations arising before and after subclonal diversification. There was pronounced intratumor heterogeneity in copy number alterations, translocations, and mutations associated with APOBEC cytidine deaminase activity. Despite maintained carcinogen exposure, tumors from smokers showed a relative decrease in smoking-related mutations over time, accompanied by an increase in APOBEC-associated mutations. In tumors from former smokers, genome-doubling occurred within a smoking-signature context before subclonal diversification, which suggested that a long period of tumor latency had preceded clinical detection. The regionally separated driver mutations, coupled with the relentless and heterogeneous nature of the genome instability processes, are likely to confound treatment success in NSCLC.</p>
<p class="grants">Funded by: Cancer Research UK; Medical Research Council</p>
<p class="publication"><span class="title">Science (New York, N.Y.)</span>&nbsp;<span class="year">2014</span>;<span class="volume">346</span>;<span class="number">6206</span>;<span class="pagerange">251-6</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25301630">25301630</a>; DOI: <a href="http://dx.doi.org/10.1126%2Fscience.1253462">10.1126/science.1253462</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Genome sequencing of disease and carriage isolates of nontypeable Haemophilus influenzae identifies discrete population structure.</h4>
<p class="authors"><span class="author">De Chiara M</span>, <span class="author">Hood D</span>, <span class="author">Muzzi A</span>, <span class="author">Pickard DJ</span>, <span class="author">Perkins T</span>, <span class="author">Pizza M</span>, <span class="author">Dougan G</span>, <span class="author">Rappuoli R</span>, <span class="author">Moxon ER</span>, <span class="author">Soriani M</span> and <span class="author">Donati C</span></p>
<p class="affiliation">Novartis Vaccines, 53100 Siena, Italy.</p><p class="abstract">One of the main hurdles for the development of an effective and broadly protective vaccine against nonencapsulated isolates of Haemophilus influenzae (NTHi) lies in the genetic diversity of the species, which renders extremely difficult the identification of cross-protective candidate antigens. To assess whether a population structure of NTHi could be defined, we performed genome sequencing of a collection of diverse clinical isolates representative of both carriage and disease and of the diversity of the natural population. Analysis of the distribution of polymorphic sites in the core genome and of the composition of the accessory genome defined distinct evolutionary clades and supported a predominantly clonal evolution of NTHi, with the majority of genetic information transmitted vertically within lineages. A correlation between the population structure and the presence of selected surface-associated proteins and lipooligosaccharide structure, known to contribute to virulence, was found. This high-resolution, genome-based population structure of NTHi provides the foundation to obtain a better understanding, of NTHi adaptation to the host as well as its commensal and virulence behavior, that could facilitate intervention strategies against disease caused by this important human pathogen.</p>
<p class="publication"><span class="title">Proceedings of the National Academy of Sciences of the United States of America</span>&nbsp;<span class="year">2014</span>;<span class="volume">111</span>;<span class="number">14</span>;<span class="pagerange">5439-44</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24706866">24706866</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC3986186">3986186</a>; DOI: <a href="http://dx.doi.org/10.1073%2Fpnas.1403353111">10.1073/pnas.1403353111</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Chromatin landscapes of retroviral and transposon integration profiles.</h4>
<p class="authors"><span class="author">de Jong J</span>, <span class="author">Akhtar W</span>, <span class="author">Badhai J</span>, <span class="author">Rust AG</span>, <span class="author">Rad R</span>, <span class="author">Hilkens J</span>, <span class="author">Berns A</span>, <span class="author">van Lohuizen M</span>, <span class="author">Wessels LF</span> and <span class="author">de Ridder J</span></p>
<p class="affiliation">Computational Cancer Biology Group, Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, The Netherlands; Netherlands Consortium for Systems Biology, Amsterdam, The Netherlands.</p><p class="abstract">The ability of retroviruses and transposons to insert their genetic material into host DNA makes them widely used tools in molecular biology, cancer research and gene therapy. However, these systems have biases that may strongly affect research outcomes. To address this issue, we generated very large datasets consisting of [Formula: see text] to [Formula: see text] unselected integrations in the mouse genome for the Sleeping Beauty (SB) and piggyBac (PB) transposons, and the Mouse Mammary Tumor Virus (MMTV). We analyzed [Formula: see text] (epi)genomic features to generate bias maps at both local and genome-wide scales. MMTV showed a remarkably uniform distribution of integrations across the genome. More distinct preferences were observed for the two transposons, with PB showing remarkable resemblance to bias profiles of the Murine Leukemia Virus. Furthermore, we present a model where target site selection is directed at multiple scales. At a large scale, target site selection is similar across systems, and defined by domain-oriented features, namely expression of proximal genes, proximity to CpG islands and to genic features, chromatin compaction and replication timing. Notable differences between the systems are mainly observed at smaller scales, and are directed by a diverse range of features. To study the effect of these biases on integration sites occupied under selective pressure, we turned to insertional mutagenesis (IM) screens. In IM screens, putative cancer genes are identified by finding frequently targeted genomic regions, or Common Integration Sites (CISs). Within three recently completed IM screens, we identified 7%-33% putative false positive CISs, which are likely not the result of the oncogenic selection process. Moreover, results indicate that PB, compared to SB, is more suited to tag oncogenes.</p>
<p class="publication"><span class="title">PLoS genetics</span>&nbsp;<span class="year">2014</span>;<span class="volume">10</span>;<span class="number">4</span>;<span class="pagerange">e1004250</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24721906">24721906</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC3983033">3983033</a>; DOI: <a href="http://dx.doi.org/10.1371%2Fjournal.pgen.1004250">10.1371/journal.pgen.1004250</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Synaptic, transcriptional and chromatin genes disrupted in autism.</h4>
<p class="authors"><span class="author">De Rubeis S</span>, <span class="author">He X</span>, <span class="author">Goldberg AP</span>, <span class="author">Poultney CS</span>, <span class="author">Samocha K</span>, <span class="author">Cicek AE</span>, <span class="author">Kou Y</span>, <span class="author">Liu L</span>, <span class="author">Fromer M</span>, <span class="author">Walker S</span>, <span class="author">Singh T</span>, <span class="author">Klei L</span>, <span class="author">Kosmicki J</span>, <span class="author">Shih-Chen F</span>, <span class="author">Aleksic B</span>, <span class="author">Biscaldi M</span>, <span class="author">Bolton PF</span>, <span class="author">Brownfeld JM</span>, <span class="author">Cai J</span>, <span class="author">Campbell NG</span>, <span class="author">Carracedo A</span>, <span class="author">Chahrour MH</span>, <span class="author">Chiocchetti AG</span>, <span class="author">Coon H</span>, <span class="author">Crawford EL</span>, <span class="author">Curran SR</span>, <span class="author">Dawson G</span>, <span class="author">Duketis E</span>, <span class="author">Fernandez BA</span>, <span class="author">Gallagher L</span>, <span class="author">Geller E</span>, <span class="author">Guter SJ</span>, <span class="author">Hill RS</span>, <span class="author">Ionita-Laza J</span>, <span class="author">Jimenz Gonzalez P</span>, <span class="author">Kilpinen H</span>, <span class="author">Klauck SM</span>, <span class="author">Kolevzon A</span>, <span class="author">Lee I</span>, <span class="author">Lei I</span>, <span class="author">Lei J</span>, <span class="author">Lehtim&auml;ki T</span>, <span class="author">Lin CF</span>, <span class="author">Ma&#39;ayan A</span>, <span class="author">Marshall CR</span>, <span class="author">McInnes AL</span>, <span class="author">Neale B</span>, <span class="author">Owen MJ</span>, <span class="author">Ozaki N</span>, <span class="author">Parellada M</span>, <span class="author">Parr JR</span>, <span class="author">Purcell S</span>, <span class="author">Puura K</span>, <span class="author">Rajagopalan D</span>, <span class="author">Rehnstr&ouml;m K</span>, <span class="author">Reichenberg A</span>, <span class="author">Sabo A</span>, <span class="author">Sachse M</span>, <span class="author">Sanders SJ</span>, <span class="author">Schafer C</span>, <span class="author">Schulte-R&uuml;ther M</span>, <span class="author">Skuse D</span>, <span class="author">Stevens C</span>, <span class="author">Szatmari P</span>, <span class="author">Tammimies K</span>, <span class="author">Valladares O</span>, <span class="author">Voran A</span>, <span class="author">Li-San W</span>, <span class="author">Weiss LA</span>, <span class="author">Willsey AJ</span>, <span class="author">Yu TW</span>, <span class="author">Yuen RK</span>, <span class="author">DDD Study</span>, <span class="author">Homozygosity Mapping Collaborative for Autism</span>, <span class="author">UK10K Consortium</span>, <span class="author">Cook EH</span>, <span class="author">Freitag CM</span>, <span class="author">Gill M</span>, <span class="author">Hultman CM</span>, <span class="author">Lehner T</span>, <span class="author">Palotie A</span>, <span class="author">Schellenberg GD</span>, <span class="author">Sklar P</span>, <span class="author">State MW</span>, <span class="author">Sutcliffe JS</span>, <span class="author">Walsh CA</span>, <span class="author">Scherer SW</span>, <span class="author">Zwick ME</span>, <span class="author">Barett JC</span>, <span class="author">Cutler DJ</span>, <span class="author">Roeder K</span>, <span class="author">Devlin B</span>, <span class="author">Daly MJ</span> and <span class="author">Buxbaum JD</span></p><p class="abstract">The genetic architecture of autism spectrum disorder involves the interplay of common and rare variants and their impact on hundreds of genes. Using exome sequencing, here we show that analysis of rare coding variation in 3,871 autism cases and 9,937 ancestry-matched or parental controls implicates 22 autosomal genes at a false discovery rate (FDR) &lt; 0.05, plus a set of 107 autosomal genes strongly enriched for those likely to affect risk (FDR &lt;&nbsp;0.30). These 107 genes, which show unusual evolutionary constraint against mutations, incur de novo loss-of-function mutations in over 5% of autistic subjects. Many of the genes implicated encode proteins for synaptic formation, transcriptional regulation and chromatin-remodelling pathways. These include voltage-gated ion channels regulating the propagation of action potentials, pacemaking and excitability-transcription coupling, as well as histone-modifying enzymes and chromatin remodellers-most prominently those that mediate post-translational lysine methylation/demethylation modifications of histones.</p>
<p class="grants">Funded by: Howard Hughes Medical Institute; NCATS NIH HHS: <span class="grant">UL1TR000445</span>; NCRR NIH HHS: <span class="grant">5UL1 RR024975</span>; NHGRI NIH HHS: <span class="grant">U54 HG003067</span>; NICHD NIH HHS: <span class="grant">P30 HD15052</span>, <span class="grant">P50 HD055751</span>; NIMH NIH HHS: <span class="grant">MH077139</span>, <span class="grant">MH089482</span>, <span class="grant">MH095034</span>, <span class="grant">R01 MH061009</span>, <span class="grant">R01 MH089482</span>, <span class="grant">R01MH083565</span>, <span class="grant">R01MH089208</span>, <span class="grant">R37 MH057881</span>, <span class="grant">RC2MH089952</span>, <span class="grant">U01 MH100239</span>, <span class="grant">U01MH100209</span>, <span class="grant">U01MH100229</span>, <span class="grant">U01MH100233</span>, <span class="grant">U01MH100239</span>; Wellcome Trust: <span class="grant">WT091310</span>, <span class="grant">WT098051</span></p>
<p class="publication"><span class="title">Nature</span>&nbsp;<span class="year">2014</span>;<span class="volume">515</span>;<span class="number">7526</span>;<span class="pagerange">209-15</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25363760">25363760</a>; DOI: <a href="http://dx.doi.org/10.1038%2Fnature13772">10.1038/nature13772</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Whole genome sequencing confirms that Burkholderia pseudomallei multilocus sequence types common to both Cambodia and Australia are due to homoplasy.</h4>
<p class="authors"><span class="author">De Smet B</span>, <span class="author">Sarovich DS</span>, <span class="author">Price EP</span>, <span class="author">Mayo M</span>, <span class="author">Theobald V</span>, <span class="author">Kham C</span>, <span class="author">Heng S</span>, <span class="author">Phe T</span>, <span class="author">Holden MT</span>, <span class="author">Parkhill J</span>, <span class="author">Peacock SJ</span>, <span class="author">Spratt BG</span>, <span class="author">Jacobs J</span>, <span class="author">Vandamme P</span> and <span class="author">Currie BJ</span></p>
<p class="affiliation">Institute of Tropical Medicine, Antwerp, Belgium.</p><p class="abstract">Burkholderia pseudomallei isolates with shared multilocus sequence types (STs) have not been isolated from different continents. We identified two STs shared between Australia and Cambodia. Whole-genome analysis revealed substantial diversity within STs, correctly identified the Asian or Australian origin, and confirmed that these shared STs were due to homoplasy.</p>
<p class="publication"><span class="title">Journal of clinical microbiology</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25392354">25392354</a>; DOI: <a href="http://dx.doi.org/10.1128%2FJCM.02574-14">10.1128/JCM.02574-14</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Knowing who to trust: exploring the role of &#39;ethical metadata&#39; in mediating risk of harm in collaborative genomics research in Africa.</h4>
<p class="authors"><span class="author">de Vries J</span>, <span class="author">Williams TN</span>, <span class="author">Bojang K</span>, <span class="author">Kwiatkowski DP</span>, <span class="author">Fitzpatrick R</span> and <span class="author">Parker M</span></p>
<p class="affiliation">Department of Medicine, University of Cape Town, Anzio Road Observatory, Cape Town 7925, South Africa. <a href="mailto:%4A%61%6E%74%69%6E%61.%64%65%76%72%69%65%73%40%75%63%74.%61%63.%7A%61">&#74;&#97;&#110;&#116;&#105;&#110;&#97;&#46;&#100;&#101;&#118;&#114;&#105;&#101;&#115;&#64;&#117;&#99;&#116;&#46;&#97;&#99;&#46;&#122;&#97;</a>.</p><p class="abstract"><strong>Background</strong>: The practice of making datasets publicly available for use by the wider scientific community has become firmly integrated in genomic science. One significant gap in literature around data sharing concerns how it impacts on scientists&#39; ability to preserve values and ethical standards that form an essential component of scientific collaborations. We conducted a qualitative sociological study examining the potential for harm to ethnic groups, and implications of such ethical concerns for data sharing. We focused our empirical work on the MalariaGEN Consortium, one of the first international collaborative genomics research projects in Africa.</p><p class="abstract"><strong>Methods</strong>: We conducted a study in three MalariaGEN project sites in Kenya, the Gambia, and the United Kingdom. The study entailed analysis of project documents and 49 semi-structured interviews with fieldworkers, researchers and ethics committee members.</p><p class="abstract"><strong>Results</strong>: Concerns about how best to address the potential for harm to ethnic groups in MalariaGEN crystallised in discussions about the development of a data sharing policy. Particularly concerning for researchers was how best to manage the sharing of genomic data outside of the original collaboration. Within MalariaGEN, genomic data is accompanied by information about the locations of sample collection, the limitations of consent and ethics approval, and the values and relations that accompanied sample collection. For interviewees, this information and context were of important ethical value in safeguarding against harmful uses of data, but is not customarily shared with secondary data users. This challenged the ability of primary researchers to protect against harmful uses of &#39;their&#39; data.</p><p class="abstract"><strong>Conclusion</strong>: We identified three protective mechanisms - trust, the existence of a shared morality, and detailed contextual understanding - which together might play an important role in preventing the use of genomic data in ways that could harm the ethnic groups included in the study. We suggest that the current practice of sharing of datasets as isolated objects rather than as embedded within a particular scientific culture, without regard for the normative context within which samples were collected, may cause ethical tensions to emerge that could have been prevented or addressed had the &#39;ethical metadata&#39; that accompanies genomic data also been shared.</p>
<p class="publication"><span class="title">BMC medical ethics</span>&nbsp;<span class="year">2014</span>;<span class="volume">15</span>;<span class="number">1</span>;<span class="pagerange">62</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25124199">25124199</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4146449">4146449</a>; DOI: <a href="http://dx.doi.org/10.1186%2F1472-6939-15-62">10.1186/1472-6939-15-62</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Genome-wide association meta-analysis of human longevity identifies a novel locus conferring survival beyond 90 years of age.</h4>
<p class="authors"><span class="author">Deelen J</span>, <span class="author">Beekman M</span>, <span class="author">Uh HW</span>, <span class="author">Broer L</span>, <span class="author">Ayers KL</span>, <span class="author">Tan Q</span>, <span class="author">Kamatani Y</span>, <span class="author">Bennet AM</span>, <span class="author">Tamm R</span>, <span class="author">Trompet S</span>, <span class="author">Gu&eth;bjartsson DF</span>, <span class="author">Flachsbart F</span>, <span class="author">Rose G</span>, <span class="author">Viktorin A</span>, <span class="author">Fischer K</span>, <span class="author">Nygaard M</span>, <span class="author">Cordell HJ</span>, <span class="author">Crocco P</span>, <span class="author">van den Akker EB</span>, <span class="author">B&ouml;hringer S</span>, <span class="author">Helmer Q</span>, <span class="author">Nelson CP</span>, <span class="author">Saunders GI</span>, <span class="author">Alver M</span>, <span class="author">Andersen-Ranberg K</span>, <span class="author">Breen ME</span>, <span class="author">van der Breggen R</span>, <span class="author">Caliebe A</span>, <span class="author">Capri M</span>, <span class="author">Cevenini E</span>, <span class="author">Collerton JC</span>, <span class="author">Dato S</span>, <span class="author">Davies K</span>, <span class="author">Ford I</span>, <span class="author">Gampe J</span>, <span class="author">Garagnani P</span>, <span class="author">de Geus EJ</span>, <span class="author">Harrow J</span>, <span class="author">van Heemst D</span>, <span class="author">Heijmans BT</span>, <span class="author">Heinsen FA</span>, <span class="author">Hottenga JJ</span>, <span class="author">Hofman A</span>, <span class="author">Jeune B</span>, <span class="author">Jonsson PV</span>, <span class="author">Lathrop M</span>, <span class="author">Lechner D</span>, <span class="author">Martin-Ruiz C</span>, <span class="author">Mcnerlan SE</span>, <span class="author">Mihailov E</span>, <span class="author">Montesanto A</span>, <span class="author">Mooijaart SP</span>, <span class="author">Murphy A</span>, <span class="author">Nohr EA</span>, <span class="author">Paternoster L</span>, <span class="author">Postmus I</span>, <span class="author">Rivadeneira F</span>, <span class="author">Ross OA</span>, <span class="author">Salvioli S</span>, <span class="author">Sattar N</span>, <span class="author">Schreiber S</span>, <span class="author">Stef&aacute;nsson H</span>, <span class="author">Stott DJ</span>, <span class="author">Tiemeier H</span>, <span class="author">Uitterlinden AG</span>, <span class="author">Westendorp RG</span>, <span class="author">Willemsen G</span>, <span class="author">Samani NJ</span>, <span class="author">Galan P</span>, <span class="author">S&oslash;rensen TI</span>, <span class="author">Boomsma DI</span>, <span class="author">Jukema JW</span>, <span class="author">Rea IM</span>, <span class="author">Passarino G</span>, <span class="author">de Craen AJ</span>, <span class="author">Christensen K</span>, <span class="author">Nebel A</span>, <span class="author">Stef&aacute;nsson K</span>, <span class="author">Metspalu A</span>, <span class="author">Magnusson P</span>, <span class="author">Blanch&eacute; H</span>, <span class="author">Christiansen L</span>, <span class="author">Kirkwood TB</span>, <span class="author">van Duijn CM</span>, <span class="author">Franceschi C</span>, <span class="author">Houwing-Duistermaat JJ</span> and <span class="author">Slagboom PE</span></p>
<p class="affiliation">Department of Molecular Epidemiology, Netherlands Consortium for Healthy Ageing.</p><p class="abstract">The genetic contribution to the variation in human lifespan is &sim;25%. Despite the large number of identified disease-susceptibility loci, it is not known which loci influence population mortality. We performed a genome-wide association meta-analysis of 7729 long-lived individuals of European descent (&ge;85 years) and 16 121 younger controls (&lt;65 years) followed by replication in an additional set of 13 060 long-lived individuals and 61 156 controls. In addition, we performed a subset analysis in cases aged &ge;90 years. We observed genome-wide significant association with longevity, as reflected by survival to ages beyond 90 years, at a novel locus, rs2149954, on chromosome 5q33.3 (OR = 1.10, P = 1.74 &times; 10(-8)). We also confirmed association of rs4420638 on chromosome 19q13.32 (OR = 0.72, P = 3.40 &times; 10(-36)), representing the TOMM40/APOE/APOC1 locus. In a prospective meta-analysis (n = 34 103), the minor allele of rs2149954 (T) on chromosome 5q33.3 associates with increased survival (HR = 0.95, P = 0.003). This allele has previously been reported to associate with low blood pressure in middle age. Interestingly, the minor allele (T) associates with decreased cardiovascular mortality risk, independent of blood pressure. We report on the first GWAS-identified longevity locus on chromosome 5q33.3 influencing survival in the general European population. The minor allele of this locus associates with low blood pressure in middle age, although the contribution of this allele to survival may be less dependent on blood pressure. Hence, the pleiotropic mechanisms by which this intragenic variation contributes to lifespan regulation have to be elucidated.</p>
<p class="grants">Funded by: NHGRI NIH HHS: <span class="grant">T32 HG002536</span></p>
<p class="publication"><span class="title">Human molecular genetics</span>&nbsp;<span class="year">2014</span>;<span class="volume">23</span>;<span class="number">16</span>;<span class="pagerange">4420-32</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24688116">24688116</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4103672">4103672</a>; DOI: <a href="http://dx.doi.org/10.1093%2Fhmg%2Fddu139">10.1093/hmg/ddu139</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Minimal morphological criteria for defining bone marrow dysplasia: a basis for clinical implementation of WHO classification of myelodysplastic syndromes.</h4>
<p class="authors"><span class="author">Della Porta MG</span>, <span class="author">Travaglino E</span>, <span class="author">Boveri E</span>, <span class="author">Ponzoni M</span>, <span class="author">Malcovati L</span>, <span class="author">Papaemmanuil E</span>, <span class="author">Rigolin GM</span>, <span class="author">Pascutto C</span>, <span class="author">Croci G</span>, <span class="author">Gianelli U</span>, <span class="author">Milani R</span>, <span class="author">Ambaglio I</span>, <span class="author">Elena C</span>, <span class="author">Ubezio M</span>, <span class="author">Da Via&#39; MC</span>, <span class="author">Bono E</span>, <span class="author">Pietra D</span>, <span class="author">Quaglia F</span>, <span class="author">Bastia R</span>, <span class="author">Ferretti V</span>, <span class="author">Cuneo A</span>, <span class="author">Morra E</span>, <span class="author">Campbell PJ</span>, <span class="author">Orazi A</span>, <span class="author">Invernizzi R</span> and <span class="author">Cazzola M</span></p>
<p class="affiliation">1] Department of Hematology Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy [2] Department of Internal Medicine, University of Pavia, Pavia, Italy.</p><p class="abstract">The World Health Organization classification of myelodysplastic syndromes (MDS) is based on morphological evaluation of marrow dysplasia. We performed a systematic review of cytological and histological data from 1150 patients with peripheral blood cytopenia. We analyzed the frequency and discriminant power of single morphological abnormalities. A score to define minimal morphological criteria associated to the presence of marrow dysplasia was developed. This score showed high sensitivity/specificity (&gt;90%), acceptable reproducibility and was independently validated. The severity of granulocytic and megakaryocytic dysplasia significantly affected survival. A close association was found between ring sideroblasts and SF3B1 mutations, and between severe granulocytic dysplasia and mutation of ASXL1, RUNX1, TP53 and SRSF2 genes. In myeloid neoplasms with fibrosis, multilineage dysplasia, hypolobulated/multinucleated megakaryocytes and increased CD34+ progenitors in the absence of JAK2, MPL and CALR gene mutations were significantly associated with a myelodysplastic phenotype. In myeloid disorders with marrow hypoplasia, granulocytic and/or megakaryocytic dysplasia, increased CD34+ progenitors and chromosomal abnormalities are consistent with a diagnosis of MDS. The proposed morphological score may be useful to evaluate the presence of dysplasia in cases without a clearly objective myelodysplastic phenotype. The integration of cytological and histological parameters improves the identification of MDS cases among myeloid disorders with fibrosis and hypocellularity.Leukemia advance online publication, 17 June 2014; doi:10.1038/leu.2014.161.</p>
<p class="publication"><span class="title">Leukemia</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24935723">24935723</a>; DOI: <a href="http://dx.doi.org/10.1038%2Fleu.2014.161">10.1038/leu.2014.161</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Phylogenetic studies of transmission dynamics in generalized HIV epidemics: An essential tool where the burden is greatest?</h4>
<p class="authors"><span class="author">Dennis AM</span>, <span class="author">Herbeck JT</span>, <span class="author">Brown AL</span>, <span class="author">Kellam P</span>, <span class="author">de Oliveira T</span>, <span class="author">Pillay D</span>, <span class="author">Fraser C</span> and <span class="author">Cohen MS</span></p>
<p class="affiliation">aDivision of Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, NC bDepartment of Microbiology, University of Washington, Seattle, WA cInstitute of Evolutionary Biology, University of Edinburgh, Edinburgh, UK dWellcome Trust Sanger Institute, Cambridge, UK eDivision of Infection and Immunity, University College London, London, UK fWellcome Trust-Africa Centre for Health and Population Studies, University of Kwazula-Natal, ZA gDepartment of Infectious Disease Epidemiology, Imperial College London, London, UK.</p><p class="abstract">Efficient and effective HIV prevention measures for generalized epidemics in sub-Saharan Africa have not yet been validated at the population-level. Design and impact evaluation of such measures requires fine-scale understanding of local HIV transmission dynamics. The novel tools of HIV phylogenetics and molecular epidemiology may elucidate these transmission dynamics. Such methods have been incorporated into studies of concentrated HIV epidemics to identify proximate and determinant traits associated with ongoing transmission. However, applying similar phylogenetic analyses to generalized epidemics, including the design and evaluation of prevention trials, presents additional challenges. Here we review the scope of these methods and present examples of their use in concentrated epidemics in the context of prevention. Next, we describe the current uses for phylogenetics in generalized epidemics, and discuss their promise for elucidating transmission patterns and informing prevention trials. Finally, we review logistic and technical challenges inherent to large-scale molecular epidemiological studies of generalized epidemics, and suggest potential solutions.</p>
<p class="publication"><span class="title">Journal of acquired immune deficiency syndromes (1999)</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24977473">24977473</a>; DOI: <a href="http://dx.doi.org/10.1097%2FQAI.0000000000000271">10.1097/QAI.0000000000000271</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Mitochondrial Genome Sequencing in Mesolithic North East Europe Unearths a New Sub-Clade within the Broadly Distributed Human Haplogroup C1.</h4>
<p class="authors"><span class="author">Der Sarkissian C</span>, <span class="author">Brotherton P</span>, <span class="author">Balanovsky O</span>, <span class="author">Templeton JE</span>, <span class="author">Llamas B</span>, <span class="author">Soubrier J</span>, <span class="author">Moiseyev V</span>, <span class="author">Khartanovich V</span>, <span class="author">Cooper A</span>, <span class="author">Haak W</span> and <span class="author">Genographic Consortium</span></p>
<p class="affiliation">Australian Centre for Ancient DNA, School of Earth and Environmental Sciences, University of Adelaide, Adelaide, South Australia, Australia.</p><p class="abstract">The human mitochondrial haplogroup C1 has a broad global distribution but is extremely rare in Europe today. Recent ancient DNA evidence has demonstrated its presence in European Mesolithic individuals. Three individuals from the 7,500 year old Mesolithic site of Yuzhnyy Oleni Ostrov, Western Russia, could be assigned to haplogroup C1 based on mitochondrial hypervariable region I sequences. However, hypervariable region I data alone could not provide enough resolution to establish the phylogenetic relationship of these Mesolithic haplotypes with haplogroup C1 mitochondrial DNA sequences found today in populations of Europe, Asia and the Americas. In order to obtain high-resolution data and shed light on the origin of this European Mesolithic C1 haplotype, we target-enriched and sequenced the complete mitochondrial genome of one Yuzhnyy Oleni Ostrov C1 individual. The updated phylogeny of C1 haplogroups indicated that the Yuzhnyy Oleni Ostrov haplotype represents a new distinct clade, provisionally coined &quot;C1f&quot;. We show that all three C1 carriers of Yuzhnyy Oleni Ostrov belong to this clade. No haplotype closely related to the C1f sequence could be found in the large current database of ancient and present-day mitochondrial genomes. Hence, we have discovered past human mitochondrial diversity that has not been observed in modern-day populations so far. The lack of positive matches in modern populations may be explained by under-sampling of rare modern C1 carriers or by demographic processes, population extinction or replacement, that may have impacted on populations of Northeast Europe since prehistoric times.</p>
<p class="publication"><span class="title">PloS one</span>&nbsp;<span class="year">2014</span>;<span class="volume">9</span>;<span class="number">2</span>;<span class="pagerange">e87612</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24503968">24503968</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC3913659">3913659</a>; DOI: <a href="http://dx.doi.org/10.1371%2Fjournal.pone.0087612">10.1371/journal.pone.0087612</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility.</h4>
<p class="authors"><span class="author">DIAbetes Genetics Replication And Meta-analysis (DIAGRAM) Consortium</span></p>
<p class="abstract">To further understanding of the genetic basis of type 2 diabetes (T2D) susceptibility, we aggregated published meta-analyses of genome-wide association studies (GWAS), including 26,488 cases and 83,964 controls of European, east Asian, south Asian and Mexican and Mexican American ancestry. We observed a significant excess in the directional consistency of T2D risk alleles across ancestry groups, even at SNPs demonstrating only weak evidence of association. By following up the strongest signals of association from the trans-ethnic meta-analysis in an additional 21,491 cases and 55,647 controls of European ancestry, we identified seven new T2D susceptibility loci. Furthermore, we observed considerable improvements in the fine-mapping resolution of common variant association signals at several T2D susceptibility loci. These observations highlight the benefits of trans-ethnic GWAS for the discovery and characterization of complex trait loci and emphasize an exciting opportunity to extend insight into the genetic architecture and pathogenesis of human diseases across populations of diverse ancestry.</p>
<p class="publication"><span class="title">Nature genetics</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24509480">24509480</a>; DOI: <a href="http://dx.doi.org/10.1038%2Fng.2897">10.1038/ng.2897</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">DNA methylation and body-mass index: a genome-wide analysis.</h4>
<p class="authors"><span class="author">Dick KJ</span>, <span class="author">Nelson CP</span>, <span class="author">Tsaprouni L</span>, <span class="author">Sandling JK</span>, <span class="author">A&iuml;ssi D</span>, <span class="author">Wahl S</span>, <span class="author">Meduri E</span>, <span class="author">Morange PE</span>, <span class="author">Gagnon F</span>, <span class="author">Grallert H</span>, <span class="author">Waldenberger M</span>, <span class="author">Peters A</span>, <span class="author">Erdmann J</span>, <span class="author">Hengstenberg C</span>, <span class="author">Cambien F</span>, <span class="author">Goodall AH</span>, <span class="author">Ouwehand WH</span>, <span class="author">Schunkert H</span>, <span class="author">Thompson JR</span>, <span class="author">Spector TD</span>, <span class="author">Gieger C</span>, <span class="author">Tr&eacute;gou&euml;t DA</span>, <span class="author">Deloukas P</span> and <span class="author">Samani NJ</span></p>
<p class="affiliation">Department of Cardiovascular Sciences, University of Leicester, Leicester, UK; National Institute for Health Research Leicester Cardiovascular Biomedical Research Unit, Glenfield Hospital, Leicester, UK.</p><p class="abstract"><strong>Background</strong>: Obesity is a major health problem that is determined by interactions between lifestyle and environmental and genetic factors. Although associations between several genetic variants and body-mass index (BMI) have been identified, little is known about epigenetic changes related to BMI. We undertook a genome-wide analysis of methylation at CpG sites in relation to BMI.</p><p class="abstract"><strong>Methods</strong>: 479 individuals of European origin recruited by the Cardiogenics Consortium formed our discovery cohort. We typed their whole-blood DNA with the Infinium HumanMethylation450 array. After quality control, methylation levels were tested for association with BMI. Methylation sites showing an association with BMI at a false discovery rate q value of 0&middot;05 or less were taken forward for replication in a cohort of 339 unrelated white patients of northern European origin from the MARTHA cohort. Sites that remained significant in this primary replication cohort were tested in a second replication cohort of 1789 white patients of European origin from the KORA cohort. We examined whether methylation levels at identified sites also showed an association with BMI in DNA from adipose tissue (n=635) and skin (n=395) obtained from white female individuals participating in the MuTHER study. Finally, we examined the association of methylation at BMI-associated sites with genetic variants and with gene expression.</p><p class="abstract"><strong>Findings</strong>: 20 individuals from the discovery cohort were excluded from analyses after quality-control checks, leaving 459 participants. After adjustment for covariates, we identified an association (q value &le;0&middot;05) between methylation at five probes across three different genes and BMI. The associations with three of these probes--cg22891070, cg27146050, and cg16672562, all of which are in intron 1 of HIF3A--were confirmed in both the primary and second replication cohorts. For every 0&middot;1 increase in methylation &beta; value at cg22891070, BMI was 3&middot;6% (95% CI 2&middot;4-4&middot;9) higher in the discovery cohort, 2&middot;7% (1&middot;2-4&middot;2) higher in the primary replication cohort, and 0&middot;8% (0&middot;2-1&middot;4) higher in the second replication cohort. For the MuTHER cohort, methylation at cg22891070 was associated with BMI in adipose tissue (p=1&middot;72&#x2008;&times;&#x2008;10(-5)) but not in skin (p=0&middot;882). We observed a significant inverse correlation (p=0&middot;005) between methylation at cg22891070 and expression of one HIF3A gene-expression probe in adipose tissue. Two single nucleotide polymorphisms--rs8102595 and rs3826795--had independent associations with methylation at cg22891070 in all cohorts. However, these single nucleotide polymorphisms were not significantly associated with BMI.</p><p class="abstract"><strong>Interpretation</strong>: Increased BMI in adults of European origin is associated with increased methylation at the HIF3A locus in blood cells and in adipose tissue. Our findings suggest that perturbation of hypoxia inducible transcription factor pathways could have an important role in the response to increased weight in people.</p><p class="abstract"><strong>Funding</strong>: The European Commission, National Institute for Health Research, British Heart Foundation, and Wellcome Trust.</p>
<p class="grants">Funded by: British Heart Foundation; Canadian Institutes of Health Research: <span class="grant">MOP 86466</span>; Department of Health: <span class="grant">NF-SI-0510-10214</span>; Wellcome Trust: <span class="grant">081917/Z/07/Z</span>, <span class="grant">098051</span></p>
<p class="publication"><span class="title">Lancet</span>&nbsp;<span class="year">2014</span>;<span class="volume">383</span>;<span class="number">9933</span>;<span class="pagerange">1990-8</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24630777">24630777</a>; DOI: <a href="http://dx.doi.org/10.1016%2FS0140-6736%2813%2962674-4">10.1016/S0140-6736(13)62674-4</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Open-source electronic data capture system offered increased accuracy and cost-effectiveness compared with paper methods in Africa.</h4>
<p class="authors"><span class="author">Dillon DG</span>, <span class="author">Pirie F</span>, <span class="author">Pomilla C</span>, <span class="author">Sandhu MS</span>, <span class="author">Motala AA</span>, <span class="author">Young EH</span> and <span class="author">African Partnership for Chronic Disease Research (APCDR)</span></p>
<p class="affiliation">International Health Research Group, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Wort&#39;s Causeway, Cambridge, CB1 8RN, United Kingdom; Genetic Epidemiology Group, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, CB10 1HH, United Kingdom.</p><p class="abstract"><strong>Objectives</strong>: Existing electronic data capture options are often financially unfeasible in resource-poor settings or difficult to support technically in the field. To help facilitate large-scale multicenter studies in sub-Saharan Africa, the African Partnership for Chronic Disease Research (APCDR) has developed an open-source electronic questionnaire (EQ).</p><p class="abstract">To assess its relative validity, we compared the EQ against traditional pen-and-paper methods using 200 randomized interviews conducted in an ongoing type 2 diabetes case-control study in South Africa.</p><p class="abstract"><strong>Results</strong>: During its 3-month validation, the EQ had a lower frequency of errors (EQ, 0.17 errors per 100 questions; paper, 0.73 errors per 100 questions; P-value &le;0.001), and a lower monetary cost per correctly entered question, compared with the pen-and-paper method. We found no marked difference in the average duration of the interview between methods (EQ, 5.4&nbsp;minutes; paper, 5.6&nbsp;minutes).</p><p class="abstract"><strong>Conclusion</strong>: This validation study suggests that the EQ may offer increased accuracy, similar interview duration, and increased cost-effectiveness compared with paper-based data collection methods. The APCDR EQ software is freely available (https://github.com/apcdr/questionnaire).</p>
<p class="publication"><span class="title">Journal of clinical epidemiology</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25135245">25135245</a>; DOI: <a href="http://dx.doi.org/10.1016%2Fj.jclinepi.2014.06.012">10.1016/j.jclinepi.2014.06.012</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Impact of type 2 diabetes susceptibility variants on quantitative glycemic traits reveals mechanistic heterogeneity.</h4>
<p class="authors"><span class="author">Dimas AS</span>, <span class="author">Lagou V</span>, <span class="author">Barker A</span>, <span class="author">Knowles JW</span>, <span class="author">M&auml;gi R</span>, <span class="author">Hivert MF</span>, <span class="author">Benazzo A</span>, <span class="author">Rybin D</span>, <span class="author">Jackson AU</span>, <span class="author">Stringham HM</span>, <span class="author">Song C</span>, <span class="author">Fischer-Rosinsky A</span>, <span class="author">Boesgaard TW</span>, <span class="author">Grarup N</span>, <span class="author">Abbasi FA</span>, <span class="author">Assimes TL</span>, <span class="author">Hao K</span>, <span class="author">Yang X</span>, <span class="author">Lecoeur C</span>, <span class="author">Barroso I</span>, <span class="author">Bonnycastle LL</span>, <span class="author">B&ouml;ttcher Y</span>, <span class="author">Bumpstead S</span>, <span class="author">Chines PS</span>, <span class="author">Erdos MR</span>, <span class="author">Graessler J</span>, <span class="author">Kovacs P</span>, <span class="author">Morken MA</span>, <span class="author">Narisu N</span>, <span class="author">Payne F</span>, <span class="author">Stancakova A</span>, <span class="author">Swift AJ</span>, <span class="author">T&ouml;njes A</span>, <span class="author">Bornstein SR</span>, <span class="author">Cauchi S</span>, <span class="author">Froguel P</span>, <span class="author">Meyre D</span>, <span class="author">Schwarz PE</span>, <span class="author">H&auml;ring HU</span>, <span class="author">Smith U</span>, <span class="author">Boehnke M</span>, <span class="author">Bergman RN</span>, <span class="author">Collins FS</span>, <span class="author">Mohlke KL</span>, <span class="author">Tuomilehto J</span>, <span class="author">Quertemous T</span>, <span class="author">Lind L</span>, <span class="author">Hansen T</span>, <span class="author">Pedersen O</span>, <span class="author">Walker M</span>, <span class="author">Pfeiffer AF</span>, <span class="author">Spranger J</span>, <span class="author">Stumvoll M</span>, <span class="author">Meigs JB</span>, <span class="author">Wareham NJ</span>, <span class="author">Kuusisto J</span>, <span class="author">Laakso M</span>, <span class="author">Langenberg C</span>, <span class="author">Dupuis J</span>, <span class="author">Watanabe RM</span>, <span class="author">Florez JC</span>, <span class="author">Ingelsson E</span>, <span class="author">McCarthy MI</span>, <span class="author">Prokopenko I</span> and <span class="author">MAGIC Investigators</span></p>
<p class="affiliation">Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, U.K.Alexander Fleming, Biomedical Sciences Research Center, Vari, Athens, Greece.</p><p class="abstract">Patients with established type 2 diabetes display both &beta;-cell dysfunction and insulin resistance. To define fundamental processes leading to the diabetic state, we examined the relationship between type 2 diabetes risk variants at 37 established susceptibility loci, and indices of proinsulin processing, insulin secretion, and insulin sensitivity. We included data from up to 58,614 nondiabetic subjects with basal measures and 17,327 with dynamic measures. We used additive genetic models with adjustment for sex, age, and BMI, followed by fixed-effects, inverse-variance meta-analyses. Cluster analyses grouped risk loci into five major categories based on their relationship to these continuous glycemic phenotypes. The first cluster (PPARG, KLF14, IRS1, GCKR) was characterized by primary effects on insulin sensitivity. The second cluster (MTNR1B, GCK) featured risk alleles associated with reduced insulin secretion and fasting hyperglycemia. ARAP1 constituted a third cluster characterized by defects in insulin processing. A fourth cluster (TCF7L2, SLC30A8, HHEX/IDE, CDKAL1, CDKN2A/2B) was defined by loci influencing insulin processing and secretion without a detectable change in fasting glucose levels. The final group contained 20 risk loci with no clear-cut associations to continuous glycemic traits. By assembling extensive data on continuous glycemic traits, we have exposed the diverse mechanisms whereby type 2 diabetes risk variants impact disease predisposition.</p>
<p class="grants">Funded by: Department of Health: <span class="grant">NF-SI-0512-10135</span>; Medical Research Council: <span class="grant">G0701863</span>, <span class="grant">MC_U106179471</span>, <span class="grant">MC_UU_12015/1</span>; NCRR NIH HHS: <span class="grant">2 M01 RR000070</span>, <span class="grant">RR01066</span>; NHGRI NIH HHS: <span class="grant">1 Z01 HG000024</span>; NHLBI NIH HHS: <span class="grant">N01-HC-25195</span>, <span class="grant">N02-HL-6-4278</span>; NIDA NIH HHS: <span class="grant">U54 DA021519</span>; NIDDK NIH HHS: <span class="grant">DK-062370</span>, <span class="grant">DK-069922</span>, <span class="grant">DK-072193</span>, <span class="grant">K24 DK-080140</span>, <span class="grant">K24 DK080140</span>, <span class="grant">R01 DK-078616</span>, <span class="grant">R01 DK062370</span>, <span class="grant">R01 DK069922</span>, <span class="grant">R01 DK072193</span>, <span class="grant">R01 DK078616</span>, <span class="grant">R01 DK093757</span>, <span class="grant">R56 DK062370</span>, <span class="grant">U01 DK062370</span>; Wellcome Trust: <span class="grant">090532</span>, <span class="grant">098381</span></p>
<p class="publication"><span class="title">Diabetes</span>&nbsp;<span class="year">2014</span>;<span class="volume">63</span>;<span class="number">6</span>;<span class="pagerange">2158-71</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24296717">24296717</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4030103">4030103</a>; DOI: <a href="http://dx.doi.org/10.2337%2Fdb13-0949">10.2337/db13-0949</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Estimating telomere length from whole genome sequence data.</h4>
<p class="authors"><span class="author">Ding Z</span>, <span class="author">Mangino M</span>, <span class="author">Aviv A</span>, <span class="author">UK10K Consortium</span>, <span class="author">Spector T</span> and <span class="author">Durbin R</span></p>
<p class="affiliation">Genome Informatics, Wellcome Trust Sanger Institute, Hinxton, CB10 1SA, UK.</p><p class="abstract">Telomeres play a key role in replicative ageing and undergo age-dependent attrition in vivo. Here, we report a novel method, TelSeq, to measure average telomere length from whole genome or exome shotgun sequence data. In 260 leukocyte samples, we show that TelSeq results correlate with Southern blot measurements of the mean length of terminal restriction fragments (mTRFs) and display age-dependent attrition comparably well as mTRFs.</p>
<p class="publication"><span class="title">Nucleic acids research</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24609383">24609383</a>; DOI: <a href="http://dx.doi.org/10.1093%2Fnar%2Fgku181">10.1093/nar/gku181</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Quantitative Genetics of CTCF Binding Reveal Local Sequence Effects and Different Modes of X-Chromosome Association.</h4>
<p class="authors"><span class="author">Ding Z</span>, <span class="author">Ni Y</span>, <span class="author">Timmer SW</span>, <span class="author">Lee BK</span>, <span class="author">Battenhouse A</span>, <span class="author">Louzada S</span>, <span class="author">Yang F</span>, <span class="author">Dunham I</span>, <span class="author">Crawford GE</span>, <span class="author">Lieb JD</span>, <span class="author">Durbin R</span>, <span class="author">Iyer VR</span> and <span class="author">Birney E</span></p>
<p class="affiliation">The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire, United Kingdom.</p><p class="abstract">Associating genetic variation with quantitative measures of gene regulation offers a way to bridge the gap between genotype and complex phenotypes. In order to identify quantitative trait loci (QTLs) that influence the binding of a transcription factor in humans, we measured binding of the multifunctional transcription and chromatin factor CTCF in 51 HapMap cell lines. We identified thousands of QTLs in which genotype differences were associated with differences in CTCF binding strength, hundreds of them confirmed by directly observable allele-specific binding bias. The majority of QTLs were either within 1 kb of the CTCF binding motif, or in linkage disequilibrium with a variant within 1 kb of the motif. On the X chromosome we observed three classes of binding sites: a minority class bound only to the active copy of the X chromosome, the majority class bound to both the active and inactive X, and a small set of female-specific CTCF sites associated with two non-coding RNA genes. In sum, our data reveal extensive genetic effects on CTCF binding, both direct and indirect, and identify a diversity of patterns of CTCF binding on the X chromosome.</p>
<p class="publication"><span class="title">PLoS genetics</span>&nbsp;<span class="year">2014</span>;<span class="volume">10</span>;<span class="number">11</span>;<span class="pagerange">e1004798</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25411781">25411781</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4238955">4238955</a>; DOI: <a href="http://dx.doi.org/10.1371%2Fjournal.pgen.1004798">10.1371/journal.pgen.1004798</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Identification of genes important for cutaneous function revealed by a large scale reverse genetic screen in the mouse.</h4>
<p class="authors"><span class="author">DiTommaso T</span>, <span class="author">Jones LK</span>, <span class="author">Cottle DL</span>, <span class="author">WTSI Mouse Genetics Program</span>, <span class="author">Gerdin AK</span>, <span class="author">Vancollie VE</span>, <span class="author">Watt FM</span>, <span class="author">Ramirez-Solis R</span>, <span class="author">Bradley A</span>, <span class="author">Steel KP</span>, <span class="author">Sundberg JP</span>, <span class="author">White JK</span> and <span class="author">Smyth IM</span></p>
<p class="affiliation">Department of Biochemistry and Molecular Biology, Monash University, Clayton, Melbourne, Australia.</p><p class="abstract">The skin is a highly regenerative organ which plays critical roles in protecting the body and sensing its environment. Consequently, morbidity and mortality associated with skin defects represent a significant health issue. To identify genes important in skin development and homeostasis, we have applied a high throughput, multi-parameter phenotype screen to the conditional targeted mutant mice generated by the Wellcome Trust Sanger Institute&#39;s Mouse Genetics Project (Sanger-MGP). A total of 562 different mouse lines were subjected to a variety of tests assessing cutaneous expression, macroscopic clinical disease, histological change, hair follicle cycling, and aberrant marker expression. Cutaneous lesions were associated with mutations in 23 different genes. Many of these were not previously associated with skin disease in the organ (Mysm1, Vangl1, Trpc4ap, Nom1, Sparc, Farp2, and Prkab1), while others were ascribed new cutaneous functions on the basis of the screening approach (Krt76, Lrig1, Myo5a, Nsun2, and Nf1). The integration of these skin specific screening protocols into the Sanger-MGP primary phenotyping pipelines marks the largest reported reverse genetic screen undertaken in any organ and defines approaches to maximise the productivity of future projects of this nature, while flagging genes for further characterisation.</p>
<p class="publication"><span class="title">PLoS genetics</span>&nbsp;<span class="year">2014</span>;<span class="volume">10</span>;<span class="number">10</span>;<span class="pagerange">e1004705</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25340873">25340873</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4207618">4207618</a>; DOI: <a href="http://dx.doi.org/10.1371%2Fjournal.pgen.1004705">10.1371/journal.pgen.1004705</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Disruption of SF3B1 results in deregulated expression and splicing of key genes and pathways in myelodysplastic syndrome hematopoietic stem and progenitor cells.</h4>
<p class="authors"><span class="author">Dolatshad H</span>, <span class="author">Pellagatti A</span>, <span class="author">Fernandez-Mercado M</span>, <span class="author">Yip BH</span>, <span class="author">Malcovati L</span>, <span class="author">Attwood M</span>, <span class="author">Przychodzen B</span>, <span class="author">Sahgal N</span>, <span class="author">Kanapin AA</span>, <span class="author">Lockstone H</span>, <span class="author">Scifo L</span>, <span class="author">Vandenberghe P</span>, <span class="author">Papaemmanuil E</span>, <span class="author">Smith CW</span>, <span class="author">Campbell PJ</span>, <span class="author">Ogawa S</span>, <span class="author">Maciejewski JP</span>, <span class="author">Cazzola M</span>, <span class="author">Savage KI</span> and <span class="author">Boultwood J</span></p>
<p class="affiliation">LLR Molecular Haematology Unit, NDCLS, RDM, University of Oxford, Oxford, UK.</p><p class="abstract">The splicing factor SF3B1 is the most commonly mutated gene in the myelodysplastic syndromes (MDS), particularly in patients with refractory anemia with ring sideroblasts (RARS). We investigated the functional effects of SF3B1 disruption in myeloid cell lines: SF3B1 knockdown resulted in growth inhibition, cell cycle arrest and impaired erythroid differentiation, and deregulation of many genes and pathways, including cell cycle regulation and RNA processing. MDS is a disorder of the hematopoietic stem cell and we thus studied the transcriptome of CD34(+) cells from MDS patients with SF3B1 mutations using RNA-sequencing. Genes significantly differentially expressed at the transcript and/or exon level in SF3B1 mutant compared to wildtype cases include genes involved in MDS pathogenesis (ASXL1, CBL), iron homeostasis and mitochondrial metabolism (ALAS2, ABCB7, SLC25A37) and RNA splicing/processing (PRPF8, HNRNPD). Many genes regulated by a DNA damage-induced BRCA1-BCLAF1-SF3B1 protein complex showed differential expression/splicing in SF3B1 mutant cases. This is the first study to determine the target genes of SF3B1 mutation in MDS CD34+ cells. Our data indicate that SF3B1 plays a critical role in MDS by affecting the expression and splicing of genes involved in specific cellular processes/pathways, many of which are relevant to the known RARS pathophysiology, suggesting a causal link.Leukemia accepted article preview online, 27 November 2014. doi:10.1038/leu.2014.331.</p>
<p class="publication"><span class="title">Leukemia</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25428262">25428262</a>; DOI: <a href="http://dx.doi.org/10.1038%2Fleu.2014.331">10.1038/leu.2014.331</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Epidermal Wnt/&beta;-catenin signaling regulates adipocyte differentiation via secretion of adipogenic factors.</h4>
<p class="authors"><span class="author">Donati G</span>, <span class="author">Proserpio V</span>, <span class="author">Lichtenberger BM</span>, <span class="author">Natsuga K</span>, <span class="author">Sinclair R</span>, <span class="author">Fujiwara H</span> and <span class="author">Watt FM</span></p>
<p class="affiliation">Centre for Stem Cells and Regenerative Medicine, Kings College London, London SE1 9RT, United Kingdom.</p><p class="abstract">It has long been recognized that the hair follicle growth cycle and oscillation in the thickness of the underlying adipocyte layer are synchronized. Although factors secreted by adipocytes are known to regulate the hair growth cycle, it is unclear whether the epidermis can regulate adipogenesis. We show that inhibition of epidermal Wnt/&beta;-catenin signaling reduced adipocyte differentiation in developing and adult mouse dermis. Conversely, ectopic activation of epidermal Wnt signaling promoted adipocyte differentiation and hair growth. When the Wnt pathway was activated in the embryonic epidermis, there was a dramatic and premature increase in adipocytes in the absence of hair follicle formation, demonstrating that Wnt activation, rather than mature hair follicles, is required for adipocyte generation. Epidermal and dermal gene expression profiling identified keratinocyte-derived adipogenic factors that are induced by &beta;-catenin activation. Wnt/&beta;-catenin signaling-dependent secreted factors from keratinocytes promoted adipocyte differentiation in vitro, and we identified ligands for the bone morphogenetic protein and insulin pathways as proadipogenic factors. Our results indicate epidermal Wnt/&beta;-catenin as a critical initiator of a signaling cascade that induces adipogenesis and highlight the role of epidermal Wnt signaling in synchronizing adipocyte differentiation with the hair growth cycle.</p>
<p class="publication"><span class="title">Proceedings of the National Academy of Sciences of the United States of America</span>&nbsp;<span class="year">2014</span>;<span class="volume">111</span>;<span class="number">15</span>;<span class="pagerange">E1501-9</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24706781">24706781</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC3992657">3992657</a>; DOI: <a href="http://dx.doi.org/10.1073%2Fpnas.1312880111">10.1073/pnas.1312880111</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Leucophore identity is more gold than silver.</h4>
<p class="authors"><span class="author">Dooley CM</span></p>
<p class="affiliation">Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, CB10 1SA, UK.</p><p class="abstract">The diversity of body color patterns seen throughout nature arises from neural crest derived chromatophores. Mammals and birds achieve a stunning variety of color with a single chromatophore, the melanocyte. Our cold blooded relatives, fish, amphibians and reptiles typically have a larger palette to choose from, presenting most commonly with melanocytes, xanthophores and iridophores. Medaka are one of the minority of fish species which also form a forth white reflective cell type called the leucophore. This article is protected by copyright. All rights reserved.</p>
<p class="publication"><span class="title">Pigment cell &amp; melanoma research</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25546351">25546351</a>; DOI: <a href="http://dx.doi.org/10.1111%2Fpcmr.12349">10.1111/pcmr.12349</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Novel determinants of antibiotic resistance: identification of mutated loci in highly methicillin-resistant subpopulations of methicillin-resistant Staphylococcus aureus.</h4>
<p class="authors"><span class="author">Dordel J</span>, <span class="author">Kim C</span>, <span class="author">Chung M</span>, <span class="author">Pardos de la G&aacute;ndara M</span>, <span class="author">Holden MT</span>, <span class="author">Parkhill J</span>, <span class="author">de Lencastre H</span>, <span class="author">Bentley SD</span> and <span class="author">Tomasz A</span></p><p class="abstract">We identified mutated genes in highly resistant subpopulations of methicillin-resistant Staphylococcus aureus (MRSA) that are most likely responsible for the historic failure of the &beta;-lactam family of antibiotics as therapeutic agents against these important pathogens. Such subpopulations are produced during growth of most clinical MRSA strains, including the four historically early MRSA isolates studied here. Chromosomal DNA was prepared from the highly resistant cells along with DNA from the majority of cells (poorly resistant cells) followed by full genome sequencing. In the highly resistant cells, mutations were identified in 3 intergenic sequences and 27 genes representing a wide range of functional categories. A common feature of these mutations appears to be their capacity to induce high-level &beta;-lactam resistance and increased amounts of the resistance protein PBP2A in the bacteria. The observations fit a recently described model in which the ultimate controlling factor of the phenotypic expression of &beta;-lactam resistance in MRSA is a RelA-mediated stringent response. IMPORTANCE It has been well established that the level of antibiotic resistance (i.e., minimum concentration of a &beta;-lactam antibiotic needed to inhibit growth) of a methicillin-resistant Staphylococcus aureus (MRSA) strain depends on the transcription and translation of the resistance protein PBP2A. Here we describe mutated loci in an additional novel set of genetic determinants that appear to be essential for the unusually high resistance levels typical of subpopulations of staphylococci that are produced with unique low frequency in most MRSA clinical isolates. We propose that mutations in these determinants can trigger induction of the stringent stress response which was recently shown to cause increased transcription/translation of the resistance protein PBP2A in parallel with the increased level of resistance.</p>
<p class="grants">Funded by: NCATS NIH HHS: <span class="grant">UL1 TR000043-07S1</span>; NIAID NIH HHS: <span class="grant">2 RO1 AI457838-14</span>; Wellcome Trust: <span class="grant">098051</span></p>
<p class="publication"><span class="title">mBio</span>&nbsp;<span class="year">2014</span>;<span class="volume">5</span>;<span class="number">2</span>;<span class="pagerange">e01000</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24713324">24713324</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC3993859">3993859</a>; DOI: <a href="http://dx.doi.org/10.1128%2FmBio.01000-13">10.1128/mBio.01000-13</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Salmonella enterica Serovar Typhi and the Pathogenesis of Typhoid Fever.</h4>
<p class="authors"><span class="author">Dougan G</span> and <span class="author">Baker S</span></p>
<p class="affiliation">The Wellcome Trust Sanger Institute, The Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1SA, United Kingdom; email: <a href="mailto:%67%64%31%40%73%61%6E%67%65%72.%61%63.%75%6B">&#103;&#100;&#49;&#64;&#115;&#97;&#110;&#103;&#101;&#114;&#46;&#97;&#99;&#46;&#117;&#107;</a>.</p><p class="abstract">Salmonella enterica serovar Typhi, the cause of typhoid, is host restricted to humans. S. Typhi has a monophyletic population structure, indicating that typhoid in humans is a relatively new disease. Antimicrobial usage is reshaping the current S. Typhi global population and may be driving the emergence of a specific haplotype, H58, that is well adapted to transmission in modern settings and is able to resist antimicrobial killing more efficiently than other S. Typhi. Evidence gathered through genomics and functional studies using the mouse and in vitro cell systems, together with clinical investigations, has provided insight into the mechanisms that underpin the pathogenesis of human typhoid and host restriction. Here we review the latest scientific advances in typhoid research and discuss how these novel approaches are changing our understanding of the disease.</p>
<p class="publication"><span class="title">Annual review of microbiology</span>&nbsp;<span class="year">2014</span>;<span class="volume">68</span>;<span class="pagerange">317-36</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25208300">25208300</a>; DOI: <a href="http://dx.doi.org/10.1146%2Fannurev-micro-091313-103739">10.1146/annurev-micro-091313-103739</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Neutralization of Plasmodium falciparum Merozoites by Antibodies against PfRH5.</h4>
<p class="authors"><span class="author">Douglas AD</span>, <span class="author">Williams AR</span>, <span class="author">Knuepfer E</span>, <span class="author">Illingworth JJ</span>, <span class="author">Furze JM</span>, <span class="author">Crosnier C</span>, <span class="author">Choudhary P</span>, <span class="author">Bustamante LY</span>, <span class="author">Zakutansky SE</span>, <span class="author">Awuah DK</span>, <span class="author">Alanine DG</span>, <span class="author">Theron M</span>, <span class="author">Worth A</span>, <span class="author">Shimkets R</span>, <span class="author">Rayner JC</span>, <span class="author">Holder AA</span>, <span class="author">Wright GJ</span> and <span class="author">Draper SJ</span></p>
<p class="affiliation">Jenner Institute, University of Oxford, Oxford OX3 7DQ, United Kingdom;</p>
<p class="abstract">There is intense interest in induction and characterization of strain-transcending neutralizing Ab against antigenically variable human pathogens. We have recently identified the human malaria parasite Plasmodium falciparum reticulocyte-binding protein homolog 5 (PfRH5) as a target of broadly neutralizing Abs, but there is little information regarding the functional mechanism(s) of Ab-mediated neutralization. In this study, we report that vaccine-induced polyclonal anti-PfRH5 Abs inhibit the tight attachment of merozoites to erythrocytes and are capable of blocking the interaction of PfRH5 with its receptor basigin. Furthermore, by developing anti-PfRH5 mAbs, we provide evidence of the following: 1) the ability to block the PfRH5-basigin interaction in vitro is predictive of functional activity, but absence of blockade does not predict absence of functional activity; 2) neutralizing mAbs bind spatially related epitopes on the folded protein, involving at least two defined regions of the PfRH5 primary sequence; 3) a brief exposure window of PfRH5 is likely to necessitate rapid binding of Ab to neutralize parasites; and 4) intact bivalent IgG contributes to but is not necessary for parasite neutralization. These data provide important insight into the mechanisms of broadly neutralizing anti-malaria Abs and further encourage anti-PfRH5-based malaria prevention efforts.</p>
<p class="publication"><span class="title">Journal of immunology (Baltimore, Md. : 1950)</span>&nbsp;<span class="year">2014</span>;<span class="volume">192</span>;<span class="number">1</span>;<span class="pagerange">245-58</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24293631">24293631</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC3872115">3872115</a>; DOI: <a href="http://dx.doi.org/10.4049%2Fjimmunol.1302045">10.4049/jimmunol.1302045</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">A strategy to identify dominant point mutant modifiers of a quantitative trait.</h4>
<p class="authors"><span class="author">Dove WF</span>, <span class="author">Shedlovsky A</span>, <span class="author">Clipson L</span>, <span class="author">Amos-Landgraf JM</span>, <span class="author">Halberg RB</span>, <span class="author">Krentz KJ</span>, <span class="author">Boehm FJ</span>, <span class="author">Newton MA</span>, <span class="author">Adams DJ</span> and <span class="author">Keane TM</span></p>
<p class="affiliation">McArdle Laboratory for Cancer Research, Department of Oncology, University of Wisconsin-Madison, Madison, Wisconsin 53706 Laboratory of Genetics, University of Wisconsin-Madison, Madison, Wisconsin 53706 <a href="mailto:%64%6F%76%65%40%6F%6E%63%6F%6C%6F%67%79.%77%69%73%63.%65%64%75">&#100;&#111;&#118;&#101;&#64;&#111;&#110;&#99;&#111;&#108;&#111;&#103;&#121;&#46;&#119;&#105;&#115;&#99;&#46;&#101;&#100;&#117;</a>.</p><p class="abstract">A central goal in the analysis of complex traits is to identify genes that modify a phenotype. Modifiers of a cancer phenotype may act either intrinsically or extrinsically on the salient cell lineage. Germline point mutagenesis by ethylnitrosourea can provide alleles for a gene of interest that include loss-, gain-, or alteration-of-function. Unlike strain polymorphisms, point mutations with heterozygous quantitative phenotypes are detectable in both essential and nonessential genes and are unlinked from other variants that might confound their identification and analysis. This report analyzes strategies seeking quantitative mutational modifiers of Apc(Min) in the mouse. To identify a quantitative modifier of a phenotype of interest, a cluster of test progeny is needed. The cluster size can be increased as necessary for statistical significance if the founder is a male whose sperm is cryopreserved. A second critical element in this identification is a mapping panel free of polymorphic modifiers of the phenotype, to enable low-resolution mapping followed by targeted resequencing to identify the causative mutation. Here, we describe the development of a panel of six &quot;isogenic mapping partner lines&quot; for C57BL/6J, carrying single-nucleotide markers introduced by mutagenesis. One such derivative, B6.SNVg, shown to be phenotypically neutral in combination with Apc(Min), is an appropriate mapping partner to locate induced mutant modifiers of the Apc(Min) phenotype. The evolved strategy can complement four current major initiatives in the genetic analysis of complex systems: the Genome-wide Association Study; the Collaborative Cross; the Knockout Mouse Project; and The Cancer Genome Atlas.</p>
<p class="publication"><span class="title">G3 (Bethesda, Md.)</span>&nbsp;<span class="year">2014</span>;<span class="volume">4</span>;<span class="number">6</span>;<span class="pagerange">1113-21</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24747760">24747760</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4065254">4065254</a>; DOI: <a href="http://dx.doi.org/10.1534%2Fg3.114.010595">10.1534/g3.114.010595</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Mosaic aneuploidy in Leishmania: the perspective of whole genome sequencing.</h4>
<p class="authors"><span class="author">Dujardin JC</span>, <span class="author">Mannaert A</span>, <span class="author">Durrant C</span> and <span class="author">Cotton JA</span></p>
<p class="affiliation">Unit of Molecular Parasitology, Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium; Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium. Electronic address: <a href="mailto:%6A%63%64%75%6A%61%72%64%69%6E%40%69%74%67.%62%65">&#106;&#99;&#100;&#117;&#106;&#97;&#114;&#100;&#105;&#110;&#64;&#105;&#116;&#103;&#46;&#98;&#101;</a>.</p>
<p class="publication"><span class="title">Trends in parasitology</span>&nbsp;<span class="year">2014</span>;<span class="volume">30</span>;<span class="number">12</span>;<span class="pagerange">554-555</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25458156">25458156</a>; DOI: <a href="http://dx.doi.org/10.1016%2Fj.pt.2014.09.004">10.1016/j.pt.2014.09.004</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Efficient haplotype matching and storage using the Positional Burrows-Wheeler Transform (PBWT).</h4>
<p class="authors"><span class="author">Durbin R</span></p>
<p class="affiliation">Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Cambridge CB10 1SA, UK.</p>
<p class="abstract">Motivation: Over the last few years, methods based on suffix arrays using the Burrows-Wheeler Transform have been widely used for DNA sequence read matching and assembly. These provide very fast search algorithms, linear in the search pattern size, on a highly compressible representation of the data set being searched. Meanwhile, algorithmic development for genotype data has concentrated on statistical methods for phasing and imputation, based on probabilistic matching to hidden Markov model representations of the reference data, which while powerful are much less computationally efficient. Here I develop a theory of haplotype matching using suffix array ideas, which should scale to much larger data sets than those currently handled by genotype algorithms.

Results: Given M sequences with N bi-allelic variable sites, I give an O(NM) algorithm to derive a representation of the data based on positional prefix arrays, which I term the Positional Burrows-Wheeler Transform (PBWT). On large data sets this compresses with run-length encoding by more than a factor of a hundred smaller than using gzip on the raw data. Using this representation I show how to find all maximal haplotype matches within the set in O(NM) time rather than O(NM(2)) as expected from naive pairwise comparison, and provide a fast algorithm, empirically independent of M given sufficient memory for indexes, to find maximal matches between a new sequence and the set. The discussion includes some proposals about how these approaches could be used for imputation and phasing.

Availability: http://github.com/richarddurbin/pbwt CONTACT: <a href="mailto:%72%69%63%68%61%72%64.%64%75%72%62%69%6E%40%73%61%6E%67%65%72.%61%63.%75%6B">&#114;&#105;&#99;&#104;&#97;&#114;&#100;&#46;&#100;&#117;&#114;&#98;&#105;&#110;&#64;&#115;&#97;&#110;&#103;&#101;&#114;&#46;&#97;&#99;&#46;&#117;&#107;</a>.</p>
<p class="publication"><span class="title">Bioinformatics (Oxford, England)</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24413527">24413527</a>; DOI: <a href="http://dx.doi.org/10.1093%2Fbioinformatics%2Fbtu014">10.1093/bioinformatics/btu014</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">The peculiar epidemiology of dracunculiasis in Chad.</h4>
<p class="authors"><span class="author">Eberhard ML</span>, <span class="author">Ruiz-Tiben E</span>, <span class="author">Hopkins DR</span>, <span class="author">Farrell C</span>, <span class="author">Toe F</span>, <span class="author">Weiss A</span>, <span class="author">Withers PC</span>, <span class="author">Jenks MH</span>, <span class="author">Thiele EA</span>, <span class="author">Cotton JA</span>, <span class="author">Hance Z</span>, <span class="author">Holroyd N</span>, <span class="author">Cama VA</span>, <span class="author">Tahir MA</span> and <span class="author">Mounda T</span></p>
<p class="affiliation">Division of Parasitic Diseases and Malaria, Centers for Disease Control and Prevention, Atlanta, Georgia; The Carter Center, Atlanta, Georgia; The Carter Center, N&#39;Djamena, Chad; LifeSource Biomedical, Centreville, Virginia; The Wellcome Trust Sanger Institute, Hinxton, United Kingdom; Ministry of Public Health, N&#39;Djamena, Chad.</p><p class="abstract">Dracunculiasis was rediscovered in Chad in 2010 after an apparent absence of 10 years. In April 2012 active village-based surveillance was initiated to determine where, when, and how transmission of the disease was occurring, and to implement interventions to interrupt it. The current epidemiologic pattern of the disease in Chad is unlike that seen previously in Chad or other endemic countries, i.e., no clustering of cases by village or association with a common water source, the average number of worms per person was small, and a large number of dogs were found to be infected. Molecular sequencing suggests these infections were all caused by Dracunculus medinensis. It appears that the infection in dogs is serving as the major driving force sustaining transmission in Chad, that an aberrant life cycle involving a paratenic host common to people and dogs is occurring, and that the cases in humans are sporadic and incidental.</p>
<p class="grants">Funded by: Wellcome Trust: <span class="grant">098051</span></p>
<p class="publication"><span class="title">The American journal of tropical medicine and hygiene</span>&nbsp;<span class="year">2014</span>;<span class="volume">90</span>;<span class="number">1</span>;<span class="pagerange">61-70</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24277785">24277785</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC3886430">3886430</a>; DOI: <a href="http://dx.doi.org/10.4269%2Fajtmh.13-0554">10.4269/ajtmh.13-0554</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">CYP6 P450 Enzymes and ACE-1 Duplication Produce Extreme and Multiple Insecticide Resistance in the Malaria Mosquito Anopheles gambiae.</h4>
<p class="authors"><span class="author">Edi CV</span>, <span class="author">Djogb&eacute;nou L</span>, <span class="author">Jenkins AM</span>, <span class="author">Regna K</span>, <span class="author">Muskavitch MA</span>, <span class="author">Poupardin R</span>, <span class="author">Jones CM</span>, <span class="author">Essandoh J</span>, <span class="author">K&eacute;toh GK</span>, <span class="author">Paine MJ</span>, <span class="author">Koudou BG</span>, <span class="author">Donnelly MJ</span>, <span class="author">Ranson H</span> and <span class="author">Weetman D</span></p>
<p class="affiliation">Vector Biology Department, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool, United Kingdom; Centre Suisse de Recherches Scientifiques en C&ocirc;te d&#39;Ivoire, Abidjan, Cote d&#39;Ivoire.</p><p class="abstract">Malaria control relies heavily on pyrethroid insecticides, to which susceptibility is declining in Anopheles mosquitoes. To combat pyrethroid resistance, application of alternative insecticides is advocated for indoor residual spraying (IRS), and carbamates are increasingly important. Emergence of a very strong carbamate resistance phenotype in Anopheles gambiae from Tiassal&eacute;, C&ocirc;te d&#39;Ivoire, West Africa, is therefore a potentially major operational challenge, particularly because these malaria vectors now exhibit resistance to multiple insecticide classes. We investigated the genetic basis of resistance to the most commonly-applied carbamate, bendiocarb, in An. gambiae from Tiassal&eacute;. Geographically-replicated whole genome microarray experiments identified elevated P450 enzyme expression as associated with bendiocarb resistance, most notably genes from the CYP6 subfamily. P450s were further implicated in resistance phenotypes by induction of significantly elevated mortality to bendiocarb by the synergist piperonyl butoxide (PBO), which also enhanced the action of pyrethroids and an organophosphate. CYP6P3 and especially CYP6M2 produced bendiocarb resistance via transgenic expression in Drosophila in addition to pyrethroid resistance for both genes, and DDT resistance for CYP6M2 expression. CYP6M2 can thus cause resistance to three distinct classes of insecticide although the biochemical mechanism for carbamates is unclear because, in contrast to CYP6P3, recombinant CYP6M2 did not metabolise bendiocarb in vitro. Strongly bendiocarb resistant mosquitoes also displayed elevated expression of the acetylcholinesterase ACE-1 gene, arising at least in part from gene duplication, which confers a survival advantage to carriers of additional copies of resistant ACE-1 G119S alleles. Our results are alarming for vector-based malaria control. Extreme carbamate resistance in Tiassal&eacute; An. gambiae results from coupling of over-expressed target site allelic variants with heightened CYP6 P450 expression, which also provides resistance across contrasting insecticides. Mosquito populations displaying such a diverse basis of extreme and cross-resistance are likely to be unresponsive to standard insecticide resistance management practices.</p>
<p class="publication"><span class="title">PLoS genetics</span>&nbsp;<span class="year">2014</span>;<span class="volume">10</span>;<span class="number">3</span>;<span class="pagerange">e1004236</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24651294">24651294</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC3961184">3961184</a>; DOI: <a href="http://dx.doi.org/10.1371%2Fjournal.pgen.1004236">10.1371/journal.pgen.1004236</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Accumulation of human-adapting mutations during circulation of A(H1N1)pdm09 influenza in humans in the UK.</h4>
<p class="authors"><span class="author">Elderfield RA</span>, <span class="author">Watson SJ</span>, <span class="author">Godlee A</span>, <span class="author">Adamson WE</span>, <span class="author">Thompson CI</span>, <span class="author">Dunning J</span>, <span class="author">Fernandez-Alonso M</span>, <span class="author">Blumenkrantz D</span>, <span class="author">Hussell T</span>, <span class="author">The MOSAIC investigators</span>, <span class="author">Zambon M</span>, <span class="author">Openshaw P</span>, <span class="author">Kellam P</span> and <span class="author">Barclay WS</span></p>
<p class="affiliation">Sections of Virology.</p><p class="abstract">The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the UK, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second and third wave viruses replicated more rapidly in human airway epithelial (HAE) cells than first wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave, and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second and third wave viruses induced less interferon-&alpha; in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second and third wave viruses. Recombinant viruses with third wave NS gene induced less interferon in human cells but this alone was did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third wave viruses caused increased binding to &alpha;-2,6 sialic acid, and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza during successive waves.</p><p class="abstract"><strong>Importance</strong>: Although most people infected with the 2009 pandemic influenza virus had mild or unapparent symptoms, some suffered severe and devastating disease. The reasons for this variability were unknown but the numbers of severe cases increased during successive waves of human infection in the UK. To determine the causes of this variation, we studied genetic changes in virus isolates from individual hospitalized patients. There were no consistent differences between these viruses and those circulating in the community, but we found multiple evolutionary changes that in combination over time increased the virus&#39;s ability to infect human cells. These adaptations may explain the remarkable ability of A(H1N1)pdm09 virus to continue to circulate despite widespread immunity, and the apparent increase in severity of influenza over successive waves of infection.</p>
<p class="publication"><span class="title">Journal of virology</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25210166">25210166</a>; DOI: <a href="http://dx.doi.org/10.1128%2FJVI.01636-14">10.1128/JVI.01636-14</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Geographic population structure analysis of worldwide human populations infers their biogeographical origins.</h4>
<p class="authors"><span class="author">Elhaik E</span>, <span class="author">Tatarinova T</span>, <span class="author">Chebotarev D</span>, <span class="author">Piras IS</span>, <span class="author">Maria Cal&ograve; C</span>, <span class="author">De Montis A</span>, <span class="author">Atzori M</span>, <span class="author">Marini M</span>, <span class="author">Tofanelli S</span>, <span class="author">Francalacci P</span>, <span class="author">Pagani L</span>, <span class="author">Tyler-Smith C</span>, <span class="author">Xue Y</span>, <span class="author">Cucca F</span>, <span class="author">Schurr TG</span>, <span class="author">Gaieski JB</span>, <span class="author">Melendez C</span>, <span class="author">Vilar MG</span>, <span class="author">Owings AC</span>, <span class="author">G&oacute;mez R</span>, <span class="author">Fujita R</span>, <span class="author">Santos FR</span>, <span class="author">Comas D</span>, <span class="author">Balanovsky O</span>, <span class="author">Balanovska E</span>, <span class="author">Zalloua P</span>, <span class="author">Soodyall H</span>, <span class="author">Pitchappan R</span>, <span class="author">Ganeshprasad A</span>, <span class="author">Hammer M</span>, <span class="author">Matisoo-Smith L</span>, <span class="author">Wells RS</span> and <span class="author">Genographic Consortium</span></p>
<p class="affiliation">1] Department of Animal and Plant Sciences, University of Sheffield, Western Bank, Sheffield, S10 2TN, UK [2] Department of Mental Health, Johns Hopkins University Bloomberg School of Public Health, 615 N. Wolfe Street, Baltimore, Maryland 21205, USA [3].</p><p class="abstract">The search for a method that utilizes biological information to predict humans&#39; place of origin has occupied scientists for millennia. Over the past four decades, scientists have employed genetic data in an effort to achieve this goal but with limited success. While biogeographical algorithms using next-generation sequencing data have achieved an accuracy of 700 km in Europe, they were inaccurate elsewhere. Here we describe the Geographic Population Structure (GPS) algorithm and demonstrate its accuracy with three data sets using 40,000-130,000 SNPs. GPS placed 83% of worldwide individuals in their country of origin. Applied to over 200 Sardinians villagers, GPS placed a quarter of them in their villages and most of the rest within 50 km of their villages. GPS&#39;s accuracy and power to infer the biogeography of worldwide individuals down to their country or, in some cases, village, of origin, underscores the promise of admixture-based methods for biogeography and has ramifications for genetic ancestry testing.</p>
<p class="grants">Funded by: NICHD NIH HHS: <span class="grant">HD070996</span>; NIGMS NIH HHS: <span class="grant">GM068968</span>, <span class="grant">R01 GM068968</span>; Wellcome Trust: <span class="grant">098051</span></p>
<p class="publication"><span class="title">Nature communications</span>&nbsp;<span class="year">2014</span>;<span class="volume">5</span>;<span class="pagerange">3513</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24781250">24781250</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4007635">4007635</a>; DOI: <a href="http://dx.doi.org/10.1038%2Fncomms4513">10.1038/ncomms4513</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Multiple evidence strands suggest that there may be as few as 19,000 human protein-coding genes.</h4>
<p class="authors"><span class="author">Ezkurdia I</span>, <span class="author">Juan D</span>, <span class="author">Rodriguez JM</span>, <span class="author">Frankish A</span>, <span class="author">Diekhans M</span>, <span class="author">Harrow J</span>, <span class="author">Vazquez J</span>, <span class="author">Valencia A</span> and <span class="author">Tress ML</span></p>
<p class="affiliation">Unidad de Prote&oacute;mica, Centro Nacional de Investigaciones Cardiovasculares, CNIC, Melchor Fern&aacute;ndez Almagro, 3, 28029, Madrid, Spain.</p><p class="abstract">Determining the full complement of protein-coding genes is a key goal of genome annotation. The most powerful approach for confirming protein coding potential is the detection of cellular protein expression through peptide mass spectrometry experiments. Here we mapped peptides detected in 7 large-scale proteomics studies to almost 60% of the protein coding genes in the GENCODE annotation of the human genome. We found a strong relationship between detection in proteomics experiments and both gene family age and cross-species conservation. Most of the genes for which we detected peptides were highly conserved. We found peptides for more than 96% of genes that evolved before bilateria. At the opposite end of the scale we identified almost no peptides for genes that have appeared since primates, for genes that did not have any protein-like features or for genes with poor cross-species conservation. These results motivated us to describe a set of 2,001 potentially non-coding genes based on features such as weak conservation, a lack of protein features, or ambiguous annotations from major databases, all of which correlated with low peptide detection across the seven experiments. We identified peptides for just 3% of these genes. We show that many of these genes behave more like non-coding genes than protein-coding genes, and suggest that most are unlikely to code for proteins under normal circumstances. We believe that their inclusion in the human protein coding gene catalogue should be revised as part of the ongoing human genome annotation effort.</p>
<p class="publication"><span class="title">Human molecular genetics</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24939910">24939910</a>; DOI: <a href="http://dx.doi.org/10.1093%2Fhmg%2Fddu309">10.1093/hmg/ddu309</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Innate immune activity conditions the effect of regulatory variants upon monocyte gene expression.</h4>
<p class="authors"><span class="author">Fairfax BP</span>, <span class="author">Humburg P</span>, <span class="author">Makino S</span>, <span class="author">Naranbhai V</span>, <span class="author">Wong D</span>, <span class="author">Lau E</span>, <span class="author">Jostins L</span>, <span class="author">Plant K</span>, <span class="author">Andrews R</span>, <span class="author">McGee C</span> and <span class="author">Knight JC</span></p>
<p class="affiliation">Wellcome Trust Centre for Human Genetics, University of Oxford, Roosevelt Drive, Oxford OX3 7BN, UK.</p><p class="abstract">To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon-&gamma; (IFN-&gamma;) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN-&beta; cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants.</p>
<p class="grants">Funded by: Medical Research Council: <span class="grant">98082</span>; Wellcome Trust: <span class="grant">074318</span>, <span class="grant">088891</span>, <span class="grant">090532/Z/09/Z</span></p>
<p class="publication"><span class="title">Science (New York, N.Y.)</span>&nbsp;<span class="year">2014</span>;<span class="volume">343</span>;<span class="number">6175</span>;<span class="pagerange">1246949</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24604202">24604202</a>; DOI: <a href="http://dx.doi.org/10.1126%2Fscience.1246949">10.1126/science.1246949</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Low copy number of the salivary amylase gene predisposes to obesity.</h4>
<p class="authors"><span class="author">Falchi M</span>, <span class="author">El-Sayed Moustafa JS</span>, <span class="author">Takousis P</span>, <span class="author">Pesce F</span>, <span class="author">Bonnefond A</span>, <span class="author">Andersson-Assarsson JC</span>, <span class="author">Sudmant PH</span>, <span class="author">Dorajoo R</span>, <span class="author">Al-Shafai MN</span>, <span class="author">Bottolo L</span>, <span class="author">Ozdemir E</span>, <span class="author">So HC</span>, <span class="author">Davies RW</span>, <span class="author">Patrice A</span>, <span class="author">Dent R</span>, <span class="author">Mangino M</span>, <span class="author">Hysi PG</span>, <span class="author">Dechaume A</span>, <span class="author">Huyvaert M</span>, <span class="author">Skinner J</span>, <span class="author">Pigeyre M</span>, <span class="author">Caiazzo R</span>, <span class="author">Raverdy V</span>, <span class="author">Vaillant E</span>, <span class="author">Field S</span>, <span class="author">Balkau B</span>, <span class="author">Marre M</span>, <span class="author">Visvikis-Siest S</span>, <span class="author">Weill J</span>, <span class="author">Poulain-Godefroy O</span>, <span class="author">Jacobson P</span>, <span class="author">Sjostrom L</span>, <span class="author">Hammond CJ</span>, <span class="author">Deloukas P</span>, <span class="author">Sham PC</span>, <span class="author">McPherson R</span>, <span class="author">Lee J</span>, <span class="author">Tai ES</span>, <span class="author">Sladek R</span>, <span class="author">Carlsson LM</span>, <span class="author">Walley A</span>, <span class="author">Eichler EE</span>, <span class="author">Pattou F</span>, <span class="author">Spector TD</span> and <span class="author">Froguel P</span></p>
<p class="affiliation">1] Department of Genomics of Common Disease, Imperial College London, London, UK. [2] [3] [4].</p><p class="abstract">Common multi-allelic copy number variants (CNVs) appear enriched for phenotypic associations compared to their biallelic counterparts. Here we investigated the influence of gene dosage effects on adiposity through a CNV association study of gene expression levels in adipose tissue. We identified significant association of a multi-allelic CNV encompassing the salivary amylase gene (AMY1) with body mass index (BMI) and obesity, and we replicated this finding in 6,200 subjects. Increased AMY1 copy number was positively associated with both amylase gene expression (P = 2.31 &times; 10(-14)) and serum enzyme levels (P &lt; 2.20 &times; 10(-16)), whereas reduced AMY1 copy number was associated with increased BMI (change in BMI per estimated copy = -0.15 (0.02) kg/m(2); P = 6.93 &times; 10(-10)) and obesity risk (odds ratio (OR) per estimated copy = 1.19, 95% confidence interval (CI) = 1.13-1.26; P = 1.46 &times; 10(-10)). The OR value of 1.19 per copy of AMY1 translates into about an eightfold difference in risk of obesity between subjects in the top (copy number &gt; 9) and bottom (copy number &lt; 4) 10% of the copy number distribution. Our study provides a first genetic link between carbohydrate metabolism and BMI and demonstrates the power of integrated genomic approaches beyond genome-wide association studies.</p>
<p class="grants">Funded by: Biotechnology and Biological Sciences Research Council: <span class="grant">G20234</span>; Medical Research Council: <span class="grant">G1002084/1</span>, <span class="grant">K2010-55X-11285-13</span>, <span class="grant">MR/K01353X/1</span>; NHGRI NIH HHS: <span class="grant">HG004221</span>; NIGMS NIH HHS: <span class="grant">GM081533</span>; Wellcome Trust: <span class="grant">077006/Z/05/Z</span>, <span class="grant">079534/z/06/z</span>, <span class="grant">085555</span></p>
<p class="publication"><span class="title">Nature genetics</span>&nbsp;<span class="year">2014</span>;<span class="volume">46</span>;<span class="number">5</span>;<span class="pagerange">492-7</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24686848">24686848</a>; DOI: <a href="http://dx.doi.org/10.1038%2Fng.2939">10.1038/ng.2939</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Current status and new features of the Consensus Coding Sequence database.</h4>
<p class="authors"><span class="author">Farrell CM</span>, <span class="author">O&#39;Leary NA</span>, <span class="author">Harte RA</span>, <span class="author">Loveland JE</span>, <span class="author">Wilming LG</span>, <span class="author">Wallin C</span>, <span class="author">Diekhans M</span>, <span class="author">Barrell D</span>, <span class="author">Searle SM</span>, <span class="author">Aken B</span>, <span class="author">Hiatt SM</span>, <span class="author">Frankish A</span>, <span class="author">Suner MM</span>, <span class="author">Rajput B</span>, <span class="author">Steward CA</span>, <span class="author">Brown GR</span>, <span class="author">Bennett R</span>, <span class="author">Murphy M</span>, <span class="author">Wu W</span>, <span class="author">Kay MP</span>, <span class="author">Hart J</span>, <span class="author">Rajan J</span>, <span class="author">Weber J</span>, <span class="author">Snow C</span>, <span class="author">Riddick LD</span>, <span class="author">Hunt T</span>, <span class="author">Webb D</span>, <span class="author">Thomas M</span>, <span class="author">Tamez P</span>, <span class="author">Rangwala SH</span>, <span class="author">McGarvey KM</span>, <span class="author">Pujar S</span>, <span class="author">Shkeda A</span>, <span class="author">Mudge JM</span>, <span class="author">Gonzalez JM</span>, <span class="author">Gilbert JG</span>, <span class="author">Trevanion SJ</span>, <span class="author">Baertsch R</span>, <span class="author">Harrow JL</span>, <span class="author">Hubbard T</span>, <span class="author">Ostell JM</span>, <span class="author">Haussler D</span> and <span class="author">Pruitt KD</span></p>
<p class="affiliation">National Center for Biotechnology Information, National Library of Medicine, National Institutes of Health, Building 38A, 8600 Rockville Pike, Bethesda, MD 20894, USA, Center for Biomolecular Science and Engineering, University of California Santa Cruz (UCSC), Santa Cruz, CA 95064, USA, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, CB10 1SA, UK and Howard Hughes Medical Institute, University of California Santa Cruz, Santa Cruz, CA 95064, USA.</p>
<p class="abstract">The Consensus Coding Sequence (CCDS) project (http://www.ncbi.nlm.nih.gov/CCDS/) is a collaborative effort to maintain a dataset of protein-coding regions that are identically annotated on the human and mouse reference genome assemblies by the National Center for Biotechnology Information (NCBI) and Ensembl genome annotation pipelines. Identical annotations that pass quality assurance tests are tracked with a stable identifier (CCDS ID). Members of the collaboration, who are from NCBI, the Wellcome Trust Sanger Institute and the University of California Santa Cruz, provide coordinated and continuous review of the dataset to ensure high-quality CCDS representations. We describe here the current status and recent growth in the CCDS dataset, as well as recent changes to the CCDS web and FTP sites. These changes include more explicit reporting about the NCBI and Ensembl annotation releases being compared, new search and display options, the addition of biologically descriptive information and our approach to representing genes for which support evidence is incomplete. We also present a summary of recent and future curation targets.</p>
<p class="publication"><span class="title">Nucleic acids research</span>&nbsp;<span class="year">2014</span>;<span class="volume">42</span>;<span class="number">1</span>;<span class="pagerange">D865-72</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24217909">24217909</a>; DOI: <a href="http://dx.doi.org/10.1093%2Fnar%2Fgkt1059">10.1093/nar/gkt1059</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Workshops: a great way to enhance and supplement a degree.</h4>
<p class="authors"><span class="author">Fatumo S</span>, <span class="author">Shome S</span> and <span class="author">Macintyre G</span></p>
<p class="affiliation">H3Africa Bioinformatics Network (H3ABioNet) Node, National Biotechnology Development Agency (NABDA), Federal Ministry of Science and Technology (FMST), Abuja, Nigeria ; International Health Research Group, Dept of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom ; Genetic Epidemiology Group, Wellcome Trust Sanger Institute, Hinxton, Cambridge, United Kingdom.</p><p class="abstract">As part of the International Society for Computational Biology Student Council (ISCB-SC), Regional Student Groups (RSGs) have helped organise workshops in the emerging fields of bioinformatics and computational biology. Workshops are a great way for students to gain hands-on experience and rapidly acquire knowledge in advanced research topics where curriculum-based education is yet to be developed. RSG workshops have improved dissemination of knowledge of the latest bioinformatics techniques and resources among student communities and young scientists, especially in developing nations. This article highlights some of the benefits and challenges encountered while running RSG workshops. Examples cover a variety of subjects, including introductory bioinformatics and advanced bioinformatics, as well as soft skills such as networking, career development, and socializing. The collective experience condensed in this article is a useful starting point for students wishing to organise their own tailor-made workshops.</p>
<p class="publication"><span class="title">PLoS computational biology</span>&nbsp;<span class="year">2014</span>;<span class="volume">10</span>;<span class="number">2</span>;<span class="pagerange">e1003497</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24586140">24586140</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC3937119">3937119</a>; DOI: <a href="http://dx.doi.org/10.1371%2Fjournal.pcbi.1003497">10.1371/journal.pcbi.1003497</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Computational biology and bioinformatics in Nigeria.</h4>
<p class="authors"><span class="author">Fatumo SA</span>, <span class="author">Adoga MP</span>, <span class="author">Ojo OO</span>, <span class="author">Oluwagbemi O</span>, <span class="author">Adeoye T</span>, <span class="author">Ewejobi I</span>, <span class="author">Adebiyi M</span>, <span class="author">Adebiyi E</span>, <span class="author">Bewaji C</span> and <span class="author">Nashiru O</span></p>
<p class="affiliation">H3Africa Bioinformatics Network (H3ABioNet) Node, National Biotechnology Development Agency (NABDA), Federal Ministry of Science and Technology (FMST), Abuja, Nigeria; Human Genetics Department, Wellcome Trust Sanger Institute, Cambridge, United Kingdom; International Health Research Group, Department of Public Health &amp; Primary Care, University of Cambridge, Cambridge, United Kingdom.</p><p class="abstract">Over the past few decades, major advances in the field of molecular biology, coupled with advances in genomic technologies, have led to an explosive growth in the biological data generated by the scientific community. The critical need to process and analyze such a deluge of data and turn it into useful knowledge has caused bioinformatics to gain prominence and importance. Bioinformatics is an interdisciplinary research area that applies techniques, methodologies, and tools in computer and information science to solve biological problems. In Nigeria, bioinformatics has recently played a vital role in the advancement of biological sciences. As a developing country, the importance of bioinformatics is rapidly gaining acceptance, and bioinformatics groups comprised of biologists, computer scientists, and computer engineers are being constituted at Nigerian universities and research institutes. In this article, we present an overview of bioinformatics education and research in Nigeria. We also discuss professional societies and academic and research institutions that play central roles in advancing the discipline in Nigeria. Finally, we propose strategies that can bolster bioinformatics education and support from policy makers in Nigeria, with potential positive implications for other developing countries.</p>
<p class="publication"><span class="title">PLoS computational biology</span>&nbsp;<span class="year">2014</span>;<span class="volume">10</span>;<span class="number">4</span>;<span class="pagerange">e1003516</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24763310">24763310</a>; DOI: <a href="http://dx.doi.org/10.1371%2Fjournal.pcbi.1003516">10.1371/journal.pcbi.1003516</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Drug Resistance in Salmonella enterica ser. Typhimurium Bloodstream Infection, Malawi.</h4>
<p class="authors"><span class="author">Feasey NA</span>, <span class="author">Cain AK</span>, <span class="author">Msefula CL</span>, <span class="author">Pickard D</span>, <span class="author">Alaerts M</span>, <span class="author">Aslett M</span>, <span class="author">Everett DB</span>, <span class="author">Allain TJ</span>, <span class="author">Dougan G</span>, <span class="author">Gordon MA</span>, <span class="author">Heyderman RS</span> and <span class="author">Kingsley RA</span></p>
<p class="publication"><span class="title">Emerging infectious diseases</span>&nbsp;<span class="year">2014</span>;<span class="volume">20</span>;<span class="number">11</span>;<span class="pagerange">1957-9</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25340988">25340988</a>; DOI: <a href="http://dx.doi.org/10.3201%2Feid2011.141175">10.3201/eid2011.141175</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Survival and differentiation of adenovirus-generated induced pluripotent stem cells transplanted into the rat striatum.</h4>
<p class="authors"><span class="author">Fink KD</span>, <span class="author">Rossignol J</span>, <span class="author">Lu M</span>, <span class="author">L&eacute;v&ecirc;que X</span>, <span class="author">Hulse TD</span>, <span class="author">Crane AT</span>, <span class="author">Nerriere-Daguin V</span>, <span class="author">Wyse RD</span>, <span class="author">Starski PA</span>, <span class="author">Schloop MT</span>, <span class="author">Dues DJ</span>, <span class="author">Witte SJ</span>, <span class="author">Song C</span>, <span class="author">Vallier L</span>, <span class="author">Nguyen TH</span>, <span class="author">Naveilhan P</span>, <span class="author">Anegon I</span>, <span class="author">Lescaudron L</span> and <span class="author">Dunbar GL</span></p>
<p class="affiliation">Program in Neuroscience, Field Neurosciences Laboratory for Restorative Neurology Brain Research and Integrative Neuroscience Center, Central Michigan University, Mount Pleasant, MI, USA.</p><p class="abstract">Induced pluripotent stem cells (iPSCs) offer certain advantages over embryonic stem cells in cell replacement therapy for a variety of neurological disorders. However, reliable procedures, whereby transplanted iPSCs can survive and differentiate into functional neurons, without forming tumors, have yet to be devised. Currently, retroviral or lentiviral reprogramming methods are often used to reprogram somatic cells. Although the use of these viruses has proven to be effective, formation of tumors often results following in vivo transplantation, possibly due to the integration of the reprogramming genes. The goal of the current study was to develop a new approach, using an adenovirus for reprogramming cells, characterize the iPSCs in vitro, and test their safety, survivability, and ability to differentiate into region-appropriate neurons following transplantation into the rat brain. To this end, iPSCs were derived from bone marrow-derived mesenchymal stem cells and tail-tip fibroblasts using a single cassette lentivirus or a combination of adenoviruses. The reprogramming efficiency and levels of pluripotency were compared using immunocytochemistry, flow cytometry, and real-time polymerase chain reaction. Our data indicate that adenovirus-generated iPSCs from tail-tip fibroblasts are as efficient as the method we used for lentiviral reprogramming. All generated iPSCs were also capable of differentiating into neuronal-like cells in vitro. To test the in vivo survivability and the ability to differentiate into region-specific neurons in the absence of tumor formation, 400,000 of the iPSCs derived from tail-tip fibroblasts that were transfected with the adenovirus pair were transplanted into the striatum of adult, immune-competent rats. We observed that these iPSCs produced region-specific neuronal phenotypes, in the absence of tumor formation, at 90 days posttransplantation. These results suggest that adenovirus-generated iPSCs may provide a safe and viable means for neuronal replacement therapies.</p>
<p class="grants">Funded by: Medical Research Council: <span class="grant">G0701448</span></p>
<p class="publication"><span class="title">Cell transplantation</span>&nbsp;<span class="year">2014</span>;<span class="volume">23</span>;<span class="number">11</span>;<span class="pagerange">1407-23</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/23879897">23879897</a>; DOI: <a href="http://dx.doi.org/10.3727%2F096368913X670958">10.3727/096368913X670958</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Pfam: the protein families database.</h4>
<p class="authors"><span class="author">Finn RD</span>, <span class="author">Bateman A</span>, <span class="author">Clements J</span>, <span class="author">Coggill P</span>, <span class="author">Eberhardt RY</span>, <span class="author">Eddy SR</span>, <span class="author">Heger A</span>, <span class="author">Hetherington K</span>, <span class="author">Holm L</span>, <span class="author">Mistry J</span>, <span class="author">Sonnhammer EL</span>, <span class="author">Tate J</span> and <span class="author">Punta M</span></p>
<p class="affiliation">HHMI Janelia Farm Research Campus, 19700 Helix Drive, Ashburn, VA 20147 USA, European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1SD, UK, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1SA, UK, MRC Functional Genomics Unit, Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford, OX1 3QX, UK, Institute of Biotechnology and Department of Biological and Environmental Sciences, University of Helsinki, PO Box 56 (Viikinkaari 5), 00014 Helsinki, Finland and Stockholm Bioinformatics Center, Swedish eScience Research Center, Department of Biochemistry and Biophysics, Science for Life Laboratory, Stockholm University, PO Box 1031, SE-17121 Solna, Sweden.</p>
<p class="abstract">Pfam, available via servers in the UK (http://pfam.sanger.ac.uk/) and the USA (http://pfam.janelia.org/), is a widely used database of protein families, containing 14 831 manually curated entries in the current release, version 27.0. Since the last update article 2 years ago, we have generated 1182 new families and maintained sequence coverage of the UniProt Knowledgebase (UniProtKB) at nearly 80%, despite a 50% increase in the size of the underlying sequence database. Since our 2012 article describing Pfam, we have also undertaken a comprehensive review of the features that are provided by Pfam over and above the basic family data. For each feature, we determined the relevance, computational burden, usage statistics and the functionality of the feature in a website context. As a consequence of this review, we have removed some features, enhanced others and developed new ones to meet the changing demands of computational biology. Here, we describe the changes to Pfam content. Notably, we now provide family alignments based on four different representative proteome sequence data sets and a new interactive DNA search interface. We also discuss the mapping between Pfam and known 3D structures.</p>
<p class="publication"><span class="title">Nucleic acids research</span>&nbsp;<span class="year">2014</span>;<span class="volume">42</span>;<span class="number">1</span>;<span class="pagerange">D222-30</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24288371">24288371</a>; DOI: <a href="http://dx.doi.org/10.1093%2Fnar%2Fgkt1223">10.1093/nar/gkt1223</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">High-definition reconstruction of clonal composition in cancer.</h4>
<p class="authors"><span class="author">Fischer A</span>, <span class="author">V&aacute;zquez-Garc&iacute;a I</span>, <span class="author">Illingworth CJ</span> and <span class="author">Mustonen V</span></p>
<p class="affiliation">Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1SA, UK. Electronic address: <a href="mailto:%61%66%37%40%73%61%6E%67%65%72.%61%63.%75%6B">&#97;&#102;&#55;&#64;&#115;&#97;&#110;&#103;&#101;&#114;&#46;&#97;&#99;&#46;&#117;&#107;</a>.</p><p class="abstract">The extensive genetic heterogeneity of cancers can greatly affect therapy success due to the existence of subclonal mutations conferring resistance. However, the characterization of subclones in mixed-cell populations is computationally challenging due to the short length of sequence reads that are generated by current sequencing technologies. Here, we report cloneHD, a probabilistic algorithm for the performance of subclone reconstruction from data generated by high-throughput DNA sequencing: read depth, B-allele counts at germline heterozygous loci, and somatic mutation counts. The algorithm can exploit the added information present in correlated longitudinal or multiregion samples and takes into account correlations along genomes caused by events such as copy-number changes. We apply cloneHD to two case studies: a breast cancer sample and time-resolved samples of chronic lymphocytic leukemia, where we demonstrate that monitoring the response of a patient to therapy regimens is feasible. Our work provides new opportunities for tracking cancer development.</p>
<p class="grants">Funded by: Wellcome Trust: <span class="grant">097678</span>, <span class="grant">098051</span>, <span class="grant">101239</span>, <span class="grant">101239/Z/13/Z</span></p>
<p class="publication"><span class="title">Cell reports</span>&nbsp;<span class="year">2014</span>;<span class="volume">7</span>;<span class="number">5</span>;<span class="pagerange">1740-52</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24882004">24882004</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4062932">4062932</a>; DOI: <a href="http://dx.doi.org/10.1016%2Fj.celrep.2014.04.055">10.1016/j.celrep.2014.04.055</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Biomarker profiling by nuclear magnetic resonance spectroscopy for the prediction of all-cause mortality: an observational study of 17,345 persons.</h4>
<p class="authors"><span class="author">Fischer K</span>, <span class="author">Kettunen J</span>, <span class="author">W&uuml;rtz P</span>, <span class="author">Haller T</span>, <span class="author">Havulinna AS</span>, <span class="author">Kangas AJ</span>, <span class="author">Soininen P</span>, <span class="author">Esko T</span>, <span class="author">Tammesoo ML</span>, <span class="author">M&auml;gi R</span>, <span class="author">Smit S</span>, <span class="author">Palotie A</span>, <span class="author">Ripatti S</span>, <span class="author">Salomaa V</span>, <span class="author">Ala-Korpela M</span>, <span class="author">Perola M</span> and <span class="author">Metspalu A</span></p>
<p class="affiliation">The Estonian Genome Center, University of Tartu, Tartu, Estonia.</p><p class="abstract"><strong>Background</strong>: Early identification of ambulatory persons at high short-term risk of death could benefit targeted prevention. To identify biomarkers for all-cause mortality and enhance risk prediction, we conducted high-throughput profiling of blood specimens in two large population-based cohorts.</p><p class="abstract">106 candidate biomarkers were quantified by nuclear magnetic resonance spectroscopy of non-fasting plasma samples from a random subset of the Estonian Biobank (n&#x200A;=&#x200A;9,842; age range 18-103 y; 508 deaths during a median of 5.4 y of follow-up). Biomarkers for all-cause mortality were examined using stepwise proportional hazards models. Significant biomarkers were validated and incremental predictive utility assessed in a population-based cohort from Finland (n&#x200A;=&#x200A;7,503; 176 deaths during 5 y of follow-up). Four circulating biomarkers predicted the risk of all-cause mortality among participants from the Estonian Biobank after adjusting for conventional risk factors: alpha-1-acid glycoprotein (hazard ratio [HR] 1.67 per 1-standard deviation increment, 95% CI 1.53-1.82, p&#x200A;=&#x200A;5&times;10(-31)), albumin (HR 0.70, 95% CI 0.65-0.76, p&#x200A;=&#x200A;2&times;10(-18)), very-low-density lipoprotein particle size (HR 0.69, 95% CI 0.62-0.77, p&#x200A;=&#x200A;3&times;10(-12)), and citrate (HR 1.33, 95% CI 1.21-1.45, p&#x200A;=&#x200A;5&times;10(-10)). All four biomarkers were predictive of cardiovascular mortality, as well as death from cancer and other nonvascular diseases. One in five participants in the Estonian Biobank cohort with a biomarker summary score within the highest percentile died during the first year of follow-up, indicating prominent systemic reflections of frailty. The biomarker associations all replicated in the Finnish validation cohort. Including the four biomarkers in a risk prediction score improved risk assessment for 5-y mortality (increase in C-statistics 0.031, p&#x200A;=&#x200A;0.01; continuous reclassification improvement 26.3%, p&#x200A;=&#x200A;0.001).</p><p class="abstract"><strong>Conclusions</strong>: Biomarker associations with cardiovascular, nonvascular, and cancer mortality suggest novel systemic connectivities across seemingly disparate morbidities. The biomarker profiling improved prediction of the short-term risk of death from all causes above established risk factors. Further investigations are needed to clarify the biological mechanisms and the utility of these biomarkers for guiding screening and prevention. Please see later in the article for the Editors&#39; Summary.</p>
<p class="publication"><span class="title">PLoS medicine</span>&nbsp;<span class="year">2014</span>;<span class="volume">11</span>;<span class="number">2</span>;<span class="pagerange">e1001606</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24586121">24586121</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC3934819">3934819</a>; DOI: <a href="http://dx.doi.org/10.1371%2Fjournal.pmed.1001606">10.1371/journal.pmed.1001606</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Xenopus mutant reveals necessity of rax for specifying the eye field which otherwise forms tissue with telencephalic and diencephalic character.</h4>
<p class="authors"><span class="author">Fish MB</span>, <span class="author">Nakayama T</span>, <span class="author">Fisher M</span>, <span class="author">Hirsch N</span>, <span class="author">Cox A</span>, <span class="author">Reeder R</span>, <span class="author">Carruthers S</span>, <span class="author">Hall A</span>, <span class="author">Stemple DL</span> and <span class="author">Grainger RM</span></p>
<p class="affiliation">Department of Biology, University of Virginia, Charlottesville, VA 22904, USA.</p><p class="abstract">The retinal anterior homeobox (rax) gene encodes a transcription factor necessary for vertebrate eye development. rax transcription is initiated at the end of gastrulation in Xenopus, and is a key part of the regulatory network specifying anterior neural plate and retina. We describe here a Xenopus tropicalis rax mutant, the first mutant analyzed in detail from a reverse genetic screen. As in other vertebrates, this nonsense mutation results in eyeless animals, and is lethal peri-metamorphosis. Tissue normally fated to form retina in these mutants instead forms tissue with characteristics of diencephalon and telencephalon. This implies that a key role of rax, in addition to defining the eye field, is in preventing alternative forebrain identities. Our data highlight that brain and retina regions are not determined by the mid-gastrula stage but are by the neural plate stage. An RNA-Seq analysis and in situ hybridization assays for early gene expression in the mutant revealed that several key eye field transcription factors (e.g. pax6, lhx2 and six6) are not dependent on rax activity through neurulation. However, these analyses identified other genes either up- or down-regulated in mutant presumptive retinal tissue. Two neural patterning genes of particular interest that appear up-regulated in the rax mutant RNA-seq analysis are hesx1 and fezf2. These genes were not previously known to be regulated by rax. The normal function of rax is to partially repress their expression by an indirect mechanism in the presumptive retina region in wildtype embryos, thus accounting for the apparent up-regulation in the rax mutant. Knock-down experiments using antisense morpholino oligonucleotides directed against hesx1 and fezf2 show that failure to repress these two genes contributes to transformation of presumptive retinal tissue into non-retinal forebrain identities in the rax mutant.</p>
<p class="publication"><span class="title">Developmental biology</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25224223">25224223</a>; DOI: <a href="http://dx.doi.org/10.1016%2Fj.ydbio.2014.09.004">10.1016/j.ydbio.2014.09.004</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Ensembl 2014.</h4>
<p class="authors"><span class="author">Flicek P</span>, <span class="author">Amode MR</span>, <span class="author">Barrell D</span>, <span class="author">Beal K</span>, <span class="author">Billis K</span>, <span class="author">Brent S</span>, <span class="author">Carvalho-Silva D</span>, <span class="author">Clapham P</span>, <span class="author">Coates G</span>, <span class="author">Fitzgerald S</span>, <span class="author">Gil L</span>, <span class="author">Gir&oacute;n CG</span>, <span class="author">Gordon L</span>, <span class="author">Hourlier T</span>, <span class="author">Hunt S</span>, <span class="author">Johnson N</span>, <span class="author">Juettemann T</span>, <span class="author">K&auml;h&auml;ri AK</span>, <span class="author">Keenan S</span>, <span class="author">Kulesha E</span>, <span class="author">Martin FJ</span>, <span class="author">Maurel T</span>, <span class="author">McLaren WM</span>, <span class="author">Murphy DN</span>, <span class="author">Nag R</span>, <span class="author">Overduin B</span>, <span class="author">Pignatelli M</span>, <span class="author">Pritchard B</span>, <span class="author">Pritchard E</span>, <span class="author">Riat HS</span>, <span class="author">Ruffier M</span>, <span class="author">Sheppard D</span>, <span class="author">Taylor K</span>, <span class="author">Thormann A</span>, <span class="author">Trevanion SJ</span>, <span class="author">Vullo A</span>, <span class="author">Wilder SP</span>, <span class="author">Wilson M</span>, <span class="author">Zadissa A</span>, <span class="author">Aken BL</span>, <span class="author">Birney E</span>, <span class="author">Cunningham F</span>, <span class="author">Harrow J</span>, <span class="author">Herrero J</span>, <span class="author">Hubbard TJ</span>, <span class="author">Kinsella R</span>, <span class="author">Muffato M</span>, <span class="author">Parker A</span>, <span class="author">Spudich G</span>, <span class="author">Yates A</span>, <span class="author">Zerbino DR</span> and <span class="author">Searle SM</span></p>
<p class="affiliation">European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, CB10 1SD and Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, CB10 1SA, UK.</p><p class="abstract">Ensembl (http://www.ensembl.org) creates tools and data resources to facilitate genomic analysis in chordate species with an emphasis on human, major vertebrate model organisms and farm animals. Over the past year we have increased the number of species that we support to 77 and expanded our genome browser with a new scrollable overview and improved variation and phenotype views. We also report updates to our core datasets and improvements to our gene homology relationships from the addition of new species. Our REST service has been extended with additional support for comparative genomics and ontology information. Finally, we provide updated information about our methods for data access and resources for user training.</p>
<p class="grants">Funded by: Biotechnology and Biological Sciences Research Council: <span class="grant">BB/I025360/1</span>, <span class="grant">BB/I025506/1</span>, <span class="grant">BB/K009524/1</span>; NCRR NIH HHS: <span class="grant">1R24RR032658</span>; NHGRI NIH HHS: <span class="grant">U41 HG007234</span>, <span class="grant">U41HG007234</span>, <span class="grant">U54 HG004555</span>; NICHD NIH HHS: <span class="grant">1R01HD074078</span>; Wellcome Trust: <span class="grant">095908</span>, <span class="grant">WT095908</span>, <span class="grant">WT098051</span></p>
<p class="publication"><span class="title">Nucleic acids research</span>&nbsp;<span class="year">2014</span>;<span class="volume">42</span>;<span class="number">Database issue</span>;<span class="pagerange">D749-55</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24316576">24316576</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC3964975">3964975</a>; DOI: <a href="http://dx.doi.org/10.1093%2Fnar%2Fgkt1196">10.1093/nar/gkt1196</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Chromosome instability induced by Mps1 and p53 mutation generates aggressive lymphomas exhibiting aneuploidy-induced stress.</h4>
<p class="authors"><span class="author">Foijer F</span>, <span class="author">Xie SZ</span>, <span class="author">Simon JE</span>, <span class="author">Bakker PL</span>, <span class="author">Conte N</span>, <span class="author">Davis SH</span>, <span class="author">Kregel E</span>, <span class="author">Jonkers J</span>, <span class="author">Bradley A</span> and <span class="author">Sorger PK</span></p>
<p class="affiliation">European Research Institute for the Biology of Ageing, University of Groningen, University Medical Center Groningen, NL-9713 AV, Groningen, The Netherlands; Department of Systems Biology, Harvard Medical School, Boston, MA 02115; Mouse Genomics, Wellcome Trust Sanger Institute, Hinxton CB10 1SA, United Kingdom; and <a href="mailto:%66.%66%6F%69%6A%65%72%40%75%6D%63%67.%6E%6C">&#102;&#46;&#102;&#111;&#105;&#106;&#101;&#114;&#64;&#117;&#109;&#99;&#103;&#46;&#110;&#108;</a> <a href="mailto:%70%65%74%65%72%5F%73%6F%72%67%65%72%40%68%6D%73.%68%61%72%76%61%72%64.%65%64%75">&#112;&#101;&#116;&#101;&#114;&#95;&#115;&#111;&#114;&#103;&#101;&#114;&#64;&#104;&#109;&#115;&#46;&#104;&#97;&#114;&#118;&#97;&#114;&#100;&#46;&#101;&#100;&#117;</a>.</p><p class="abstract">Aneuploidy is a hallmark of human solid cancers that arises from errors in mitosis and results in gain and loss of oncogenes and tumor suppressors. Aneuploidy poses a growth disadvantage for cells grown in vitro, suggesting that cancer cells adapt to this burden. To understand better the consequences of aneuploidy in a rapidly proliferating adult tissue, we engineered a mouse in which chromosome instability was selectively induced in T cells. A flanked by Lox mutation was introduced into the monopolar spindle 1 (Mps1) spindle-assembly checkpoint gene so that Cre-mediated recombination would create a truncated protein (Mps1(DK)) that retained the kinase domain but lacked the kinetochore-binding domain and thereby weakened the checkpoint. In a sensitized p53(+/-) background we observed that Mps1(DK/DK) mice suffered from rapid-onset acute lymphoblastic lymphoma. The tumors were highly aneuploid and exhibited a metabolic burden similar to that previously characterized in aneuploid yeast and cultured cells. The tumors nonetheless grew rapidly and were lethal within 3-4 mo after birth.</p>
<p class="publication"><span class="title">Proceedings of the National Academy of Sciences of the United States of America</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25197064">25197064</a>; DOI: <a href="http://dx.doi.org/10.1073%2Fpnas.1400892111">10.1073/pnas.1400892111</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Genetics in PSC: What Do the &quot;Risk Genes&quot; Teach Us?</h4>
<p class="authors"><span class="author">Folseraas T</span>, <span class="author">Liaskou E</span>, <span class="author">Anderson CA</span> and <span class="author">Karlsen TH</span></p>
<p class="affiliation">Norwegian PSC Research Center, Department of Transplantation Medicine, Division of Cancer Medicine, Surgery and Transplantation, Oslo University Hospital Rikshospitalet, 4950 Nydalen, 0424, Oslo, Norway.</p><p class="abstract">A role of genetics in primary sclerosing cholangitis (PSC) development is now firmly established. A total of 16 risk genes have been reported at highly robust (&quot;genome-wide&quot;) significance levels, and ongoing efforts suggest that the list will ultimately be considerably longer. Importantly, this genetic risk pool so far accounts for less than 10&nbsp;% of an estimated overall PSC susceptibility. The relative importance of genetic versus environmental factors (including gene-gene and gene-environment interactions) in remaining aspects of PSC pathogenesis is unknown, and other study designs than genome-wide association studies are needed to explore these aspects. For some of the loci, e.g. HLA and FUT2, distinct interacting environmental factors may exist, and working from the genetic associations may prove one valid path for determining the specific nature of environmental triggers. So far the biological implications for PSC risk genes are typically merely hypothesized based on previously published literature, and there is therefore a strong need for dedicated translational studies to determine their roles within the specific disease context of PSC. Apparently, most risk loci seem to involve in a subset of biological pathways for which genetic associations exist in a multitude of immune-mediated diseases, accounting for both inflammatory bowel disease as well as prototypical autoimmunity. In the present article, we will survey the current knowledge on PSC genetics with a particular emphasis on the pathophysiological insight potentially gained from genetic risk loci involving in this profound immunogenetic pleiotropy.</p>
<p class="publication"><span class="title">Clinical reviews in allergy &amp; immunology</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24736995">24736995</a>; DOI: <a href="http://dx.doi.org/10.1007%2Fs12016-014-8417-z">10.1007/s12016-014-8417-z</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">COSMIC: exploring the world&#39;s knowledge of somatic mutations in human cancer.</h4>
<p class="authors"><span class="author">Forbes SA</span>, <span class="author">Beare D</span>, <span class="author">Gunasekaran P</span>, <span class="author">Leung K</span>, <span class="author">Bindal N</span>, <span class="author">Boutselakis H</span>, <span class="author">Ding M</span>, <span class="author">Bamford S</span>, <span class="author">Cole C</span>, <span class="author">Ward S</span>, <span class="author">Kok CY</span>, <span class="author">Jia M</span>, <span class="author">De T</span>, <span class="author">Teague JW</span>, <span class="author">Stratton MR</span>, <span class="author">McDermott U</span> and <span class="author">Campbell PJ</span></p>
<p class="affiliation">Cancer Genome Project, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK, CB10 1SA. <a href="mailto:%73%61%66%40%73%61%6E%67%65%72.%61%63.%75%6B">&#115;&#97;&#102;&#64;&#115;&#97;&#110;&#103;&#101;&#114;&#46;&#97;&#99;&#46;&#117;&#107;</a>.</p><p class="abstract">COSMIC, the Catalogue Of Somatic Mutations In Cancer (http://cancer.sanger.ac.uk) is the world&#39;s largest and most comprehensive resource for exploring the impact of somatic mutations in human cancer. Our latest release (v70; Aug 2014) describes 2 002 811 coding point mutations in over one million tumor samples and across most human genes. To emphasize depth of knowledge on known cancer genes, mutation information is curated manually from the scientific literature, allowing very precise definitions of disease types and patient details. Combination of almost 20 000 published studies gives substantial resolution of how mutations and phenotypes relate in human cancer, providing insights into the stratification of mutations and biomarkers across cancer patient populations. Conversely, our curation of cancer genomes (over 12 000) emphasizes knowledge breadth, driving discovery of unrecognized cancer-driving hotspots and molecular targets. Our high-resolution curation approach is globally unique, giving substantial insight into molecular biomarkers in human oncology. In addition, COSMIC also details more than six million noncoding mutations, 10 534 gene fusions, 61 299 genome rearrangements, 695 504 abnormal copy number segments and 60 119 787 abnormal expression variants. All these types of somatic mutation are annotated to both the human genome and each affected coding gene, then correlated across disease and mutation types.</p>
<p class="publication"><span class="title">Nucleic acids research</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25355519">25355519</a>; DOI: <a href="http://dx.doi.org/10.1093%2Fnar%2Fgku1075">10.1093/nar/gku1075</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Genome-wide association study of intracranial aneurysm identifies a new association on chromosome 7.</h4>
<p class="authors"><span class="author">Foroud T</span>, <span class="author">Lai D</span>, <span class="author">Koller D</span>, <span class="author">Van&#39;t Hof F</span>, <span class="author">Kurki MI</span>, <span class="author">Anderson CS</span>, <span class="author">Brown RD</span>, <span class="author">Connolly ES</span>, <span class="author">Eriksson JG</span>, <span class="author">Flaherty M</span>, <span class="author">Fornage M</span>, <span class="author">von Und Zu Fraunberg M</span>, <span class="author">Ga&aacute;l EI</span>, <span class="author">Laakso A</span>, <span class="author">Hernesniemi J</span>, <span class="author">Huston J</span>, <span class="author">J&auml;&auml;skel&auml;inen JE</span>, <span class="author">Kiemeney LA</span>, <span class="author">Kivisaari R</span>, <span class="author">Kleindorfer D</span>, <span class="author">Ko N</span>, <span class="author">Lehto H</span>, <span class="author">Mackey J</span>, <span class="author">Meissner I</span>, <span class="author">Moomaw CJ</span>, <span class="author">Mosley TH</span>, <span class="author">Moskala M</span>, <span class="author">Niemel&auml; M</span>, <span class="author">Palotie A</span>, <span class="author">Pera J</span>, <span class="author">Rinkel G</span>, <span class="author">Ripke S</span>, <span class="author">Rouleau G</span>, <span class="author">Ruigrok Y</span>, <span class="author">Sauerbeck L</span>, <span class="author">S&#x142;owik A</span>, <span class="author">Vermeulen SH</span>, <span class="author">Woo D</span>, <span class="author">Worrall BB</span>, <span class="author">Broderick J</span> and <span class="author">Familial Intracranial Aneurysm Study Investigators</span></p>
<p class="affiliation">From the Indiana University School of Medicine, Indianapolis (T.F., D.L., D.K., J.M.); University Medical Center Utrecht, Utrecht, The Netherlands (F.v.H., G.R., Y.R.); Kuopio University Hospital, Kuopio, Finland (M.I.K., M.v.u.z.F., J.E.J.); University of Eastern Finland, Kuopio, Finland (M.I.K., M.v.u.z.F., J.E.J.); Massachusetts General Hospital and Harvard Medical School, Boston (M.I.K., A.P., S.R.); Broad Institute of Harvard and MIT, Cambridge, MA (M.I.K., A.P., S.R.); University of Sydney and Royal Prince Alfred Hospital, Sydney, Australia (C.S.A.); Mayo Clinic, Rochester, MN (R.D.B., J. Huston I.M.); Columbia University School of Medicine, New York, NY (E.S.C.); University of Helsinki, Helsinki, Finland (J.G.E., E.I.G.); Folkh&auml;lsan Research Center, Helsinki, Finland (J.G.E.); National Institute for Health and Welfare, Helsinki, Finland (J.G.E.); Vasa Central Hospital, Vasa, Finland (J.G.E.); Helsinki University Central Hospital, Helsinki, Finland (J.G.E., E.I.G., A.L., J. Hernesniemi, R.K., H.L., M.N.); University of Cincinnati, OH (M. Flaherty, D.K., C.J.M., L.S., D.W., J.B.); University of Texas Health Science Center at Houston (M. Fornage); Radboud University Medical Center, Nijmegen, The Netherlands (L.A.K., S.H.V.); University of California, San Francisco (N.K.); University of Mississippi Medical Center, Jackson (T.H.M.); Jagiellonian University Medical College, Krakow, Poland (M.M., J.P., A.S.); The Wellcome Trust Sanger Institute, Cambridge, United Kingdom (A.P.); University of Montreal, Montr&eacute;al, Qu&eacute;bec, Canada (G.R.); and University of Virginia School of Medicine, Charlottesville (B.B.W.). <a href="mailto:%74%66%6F%72%6F%75%64%40%69%75.%65%64%75">&#116;&#102;&#111;&#114;&#111;&#117;&#100;&#64;&#105;&#117;&#46;&#101;&#100;&#117;</a>.</p><p class="abstract">Common variants have been identified using genome-wide association studies which contribute to intracranial aneurysms (IA) susceptibility. However, it is clear that the variants identified to date do not account for the estimated genetic contribution to disease risk.</p><p class="abstract"><strong>Methods</strong>: Initial analysis was performed in a discovery sample of 2617 IA cases and 2548 controls of white ancestry. Novel chromosomal regions meeting genome-wide significance were further tested for association in 2 independent replication samples: Dutch (717 cases; 3004 controls) and Finnish (799 cases; 2317 controls). A meta-analysis was performed to combine the results from the 3 studies for key chromosomal regions of interest.</p><p class="abstract"><strong>Results</strong>: Genome-wide evidence of association was detected in the discovery sample on chromosome 9 (CDKN2BAS; rs10733376: P&lt;1.0&times;10(-11)), in a gene previously associated with IA. A novel region on chromosome 7, near HDAC9, was associated with IA (rs10230207; P=4.14&times;10(-8)). This association replicated in the Dutch sample (P=0.01) but failed to show association in the Finnish sample (P=0.25). Meta-analysis results of the 3 cohorts reached statistical significant (P=9.91&times;10(-10)).</p><p class="abstract"><strong>Conclusions</strong>: We detected a novel region associated with IA susceptibility that was replicated in an independent Dutch sample. This region on chromosome 7 has been previously associated with ischemic stroke and the large vessel stroke occlusive subtype (including HDAC9), suggesting a possible genetic link between this stroke subtype and IA.</p>
<p class="grants">Funded by: NINDS NIH HHS: <span class="grant">R01 NS039512</span></p>
<p class="publication"><span class="title">Stroke; a journal of cerebral circulation</span>&nbsp;<span class="year">2014</span>;<span class="volume">45</span>;<span class="number">11</span>;<span class="pagerange">3194-9</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25256182">25256182</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4213281">4213281</a>; DOI: <a href="http://dx.doi.org/10.1161%2FSTROKEAHA.114.006096">10.1161/STROKEAHA.114.006096</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Genomics illuminates parasite biology.</h4>
<p class="authors"><span class="author">Foth BJ</span> and <span class="author">Otto TD</span></p>
<p class="affiliation">Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1SA, UK.</p>
<p class="publication"><span class="title">Nature reviews. Microbiology</span>&nbsp;<span class="year">2014</span>;<span class="volume">12</span>;<span class="number">11</span>;<span class="pagerange">727</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25402362">25402362</a>; DOI: <a href="http://dx.doi.org/10.1038%2Fnrmicro3368">10.1038/nrmicro3368</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Whipworm genome and dual-species transcriptome analyses provide molecular insights into an intimate host-parasite interaction.</h4>
<p class="authors"><span class="author">Foth BJ</span>, <span class="author">Tsai IJ</span>, <span class="author">Reid AJ</span>, <span class="author">Bancroft AJ</span>, <span class="author">Nichol S</span>, <span class="author">Tracey A</span>, <span class="author">Holroyd N</span>, <span class="author">Cotton JA</span>, <span class="author">Stanley EJ</span>, <span class="author">Zarowiecki M</span>, <span class="author">Liu JZ</span>, <span class="author">Huckvale T</span>, <span class="author">Cooper PJ</span>, <span class="author">Grencis RK</span> and <span class="author">Berriman M</span></p>
<p class="affiliation">1] Parasite Genomics, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, UK. [2].</p><p class="abstract">Whipworms are common soil-transmitted helminths that cause debilitating chronic infections in man. These nematodes are only distantly related to Caenorhabditis elegans and have evolved to occupy an unusual niche, tunneling through epithelial cells of the large intestine. We report here the whole-genome sequences of the human-infective Trichuris trichiura and the mouse laboratory model Trichuris muris. On the basis of whole-transcriptome analyses, we identify many genes that are expressed in a sex- or life stage-specific manner and characterize the transcriptional landscape of a morphological region with unique biological adaptations, namely, bacillary band and stichosome, found only in whipworms and related parasites. Using RNA sequencing data from whipworm-infected mice, we describe the regulated T helper 1 (TH1)-like immune response of the chronically infected cecum in unprecedented detail. In silico screening identified numerous new potential drug targets against trichuriasis. Together, these genomes and associated functional data elucidate key aspects of the molecular host-parasite interactions that define chronic whipworm infection.</p>
<p class="grants">Funded by: Wellcome Trust: <span class="grant">088862/Z/09/Z</span>, <span class="grant">098051</span>, <span class="grant">WT083620MA</span>, <span class="grant">WT100290MA</span></p>
<p class="publication"><span class="title">Nature genetics</span>&nbsp;<span class="year">2014</span>;<span class="volume">46</span>;<span class="number">7</span>;<span class="pagerange">693-700</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24929830">24929830</a>; DOI: <a href="http://dx.doi.org/10.1038%2Fng.3010">10.1038/ng.3010</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">GENCODE Pseudogenes.</h4>
<p class="authors"><span class="author">Frankish A</span> and <span class="author">Harrow J</span></p>
<p class="affiliation">Human and Vertebrate Analysis and Annotation Group, Wellcome Trust Sanger Institute, Morgan Building, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire, CB10 1HH, UK, <a href="mailto:%61%64%61%6D.%66%72%61%6E%6B%69%73%68%40%73%61%6E%67%65%72.%61%63.%75%6B">&#97;&#100;&#97;&#109;&#46;&#102;&#114;&#97;&#110;&#107;&#105;&#115;&#104;&#64;&#115;&#97;&#110;&#103;&#101;&#114;&#46;&#97;&#99;&#46;&#117;&#107;</a>.</p><p class="abstract">Historically pseudogenes were believed to represent nonfunctional genomic fossils; however, there is emerging evidence that many of them could be biologically active. This possibility has ignited interest in pseudogene loci and made the need for their high-quality annotation more pressing as an accurate knowledge of all pseudogenes in the human reference genome sequence facilitates confident functional analysis. GENCODE have undertaken the first genome-wide pseudogene assignment for protein-coding genes combining both large-scale manual annotation and computational pseudogene prediction pipelines. Multiple computational predictions provide an unbiased set of hints for manual annotators to investigate, both during first-pass annotation and as part of QC to identify any potential missing pseudogene loci. Where a pseudogene is identified, the extent of its homology to the parent locus is fully investigated by a manual annotator; a pseudogene model is built and assigned to one of eight pseudogene biotypes depending on the mechanism of creation and on the presence of locus-specific transcriptional or proteomic data. The high-quality, information-rich set of pseudogenes created has been integrated with ENCODE functional genomics data, specifically expression level, transcription factor and RNA polymerase II binding, and chromatin marks. In this way we have been able to identify some pseudogenes that possess conventional characteristics of functionality as well as others with interesting patterns of partial activity, which might suggest that putatively inactive loci could be gaining a novel function, for example as long noncoding RNAs. The activity data associated with every pseudogene is stored in the psiDR resource.</p>
<p class="publication"><span class="title">Methods in molecular biology (Clifton, N.J.)</span>&nbsp;<span class="year">2014</span>;<span class="volume">1167</span>;<span class="pagerange">129-55</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24823776">24823776</a>; DOI: <a href="http://dx.doi.org/10.1007%2F978-1-4939-0835-6_10">10.1007/978-1-4939-0835-6_10</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Mutation, clonal fitness and field change in epithelial carcinogenesis.</h4>
<p class="authors"><span class="author">Frede J</span>, <span class="author">Adams DJ</span> and <span class="author">Jones PH</span></p>
<p class="affiliation">MRC Cancer Unit, University of Cambridge, Hutchison/MRC Research Centre, Box 197, Cambridge Biomedical Campus, Cambridge, CB2 0XZ, UK.</p><p class="abstract">Developments in lineage tracing in mouse models have revealed how stem cells maintain normal squamous and glandular epithelia. Here we review recent quantitative studies tracing the fate of individual mutant stem cells which have uncovered how common oncogenic mutations alter cell behaviour, creating clones with a growth advantage that may persist long term. In the intestine this occurs by a mutant clone colonizing an entire crypt, whilst in the squamous oesophagus blocking differentiation creates clones that expand to colonize large areas of epithelium, a phenomenon known as field change. We consider the implications of these findings for early cancer evolution and the cancer stem cell hypothesis, and the prospects of targeted cancer prevention by purging mutant clones from normal-appearing epithelia. &copy; 2014 The Authors. The Journal of Pathology published by John Wiley &amp; Sons Ltd on behalf of Pathological Society of Great Britain and Ireland.</p>
<p class="grants">Funded by: Cancer Research UK: <span class="grant">13031</span></p>
<p class="publication"><span class="title">The Journal of pathology</span>&nbsp;<span class="year">2014</span>;<span class="volume">234</span>;<span class="number">3</span>;<span class="pagerange">296-301</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25046364">25046364</a>; DOI: <a href="http://dx.doi.org/10.1002%2Fpath.4409">10.1002/path.4409</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">De novo mutations in schizophrenia implicate synaptic networks.</h4>
<p class="authors"><span class="author">Fromer M</span>, <span class="author">Pocklington AJ</span>, <span class="author">Kavanagh DH</span>, <span class="author">Williams HJ</span>, <span class="author">Dwyer S</span>, <span class="author">Gormley P</span>, <span class="author">Georgieva L</span>, <span class="author">Rees E</span>, <span class="author">Palta P</span>, <span class="author">Ruderfer DM</span>, <span class="author">Carrera N</span>, <span class="author">Humphreys I</span>, <span class="author">Johnson JS</span>, <span class="author">Roussos P</span>, <span class="author">Barker DD</span>, <span class="author">Banks E</span>, <span class="author">Milanova V</span>, <span class="author">Grant SG</span>, <span class="author">Hannon E</span>, <span class="author">Rose SA</span>, <span class="author">Chambert K</span>, <span class="author">Mahajan M</span>, <span class="author">Scolnick EM</span>, <span class="author">Moran JL</span>, <span class="author">Kirov G</span>, <span class="author">Palotie A</span>, <span class="author">McCarroll SA</span>, <span class="author">Holmans P</span>, <span class="author">Sklar P</span>, <span class="author">Owen MJ</span>, <span class="author">Purcell SM</span> and <span class="author">O&#39;Donovan MC</span></p>
<p class="affiliation">1] Division of Psychiatric Genomics in the Department of Psychiatry, and Institute for Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, New York, New York 10029, USA [2] Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, Massachusetts 02142, USA.</p><p class="abstract">Inherited alleles account for most of the genetic risk for schizophrenia. However, new (de novo) mutations, in the form of large chromosomal copy number changes, occur in a small fraction of cases and disproportionally disrupt genes encoding postsynaptic proteins. Here we show that small de novo mutations, affecting one or a few nucleotides, are overrepresented among glutamatergic postsynaptic proteins comprising activity-regulated cytoskeleton-associated protein (ARC) and N-methyl-d-aspartate receptor (NMDAR) complexes. Mutations are additionally enriched in proteins that interact with these complexes to modulate synaptic strength, namely proteins regulating actin filament dynamics and those whose messenger RNAs are targets of fragile X mental retardation protein (FMRP). Genes affected by mutations in schizophrenia overlap those mutated in autism and intellectual disability, as do mutation-enriched synaptic pathways. Aligning our findings with a parallel case-control study, we demonstrate reproducible insights into aetiological mechanisms for schizophrenia and reveal pathophysiology shared with other neurodevelopmental disorders.</p>
<p class="grants">Funded by: Medical Research Council: <span class="grant">G0800509</span>, <span class="grant">G0801418</span>; NHGRI NIH HHS: <span class="grant">R01HG005827</span>; NIMH NIH HHS: <span class="grant">2 P50MH066392-05A1</span>, <span class="grant">R01MH071681</span>, <span class="grant">R01MH099126</span>; Wellcome Trust: <span class="grant">WT089062</span>, <span class="grant">WT098051</span></p>
<p class="publication"><span class="title">Nature</span>&nbsp;<span class="year">2014</span>;<span class="volume">506</span>;<span class="number">7487</span>;<span class="pagerange">179-84</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24463507">24463507</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4237002">4237002</a>; DOI: <a href="http://dx.doi.org/10.1038%2Fnature12929">10.1038/nature12929</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Complete Genome Sequence of the WHO International Standard for HIV-1 RNA Determined by Deep Sequencing.</h4>
<p class="authors"><span class="author">Gall A</span>, <span class="author">Morris C</span>, <span class="author">Kellam P</span> and <span class="author">Berry N</span></p>
<p class="affiliation">Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, United Kingdom.</p><p class="abstract">The World Health Organization (WHO) International Standard for HIV-1 RNA nucleic acid assays was characterized by complete genome deep sequencing analysis. The entire coding sequence and flanking long terminal repeats (LTRs), including minority species, were assigned subtype B. This information will aid the design, development, and evaluation of HIV-1 RNA amplification assays.</p>
<p class="publication"><span class="title">Genome announcements</span>&nbsp;<span class="year">2014</span>;<span class="volume">2</span>;<span class="number">1</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24503998">24503998</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC3916492">3916492</a>; DOI: <a href="http://dx.doi.org/10.1128%2FgenomeA.01254-13">10.1128/genomeA.01254-13</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">27th International Mammalian Genome Conference meeting report.</h4>
<p class="authors"><span class="author">Gamache B</span>, <span class="author">Leist SR</span>, <span class="author">Bard AD</span>, <span class="author">Logan DW</span> and <span class="author">Carpanini SM</span></p>
<p class="affiliation">National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, US.</p>
<p class="publication"><span class="title">Mammalian genome : official journal of the International Mammalian Genome Society</span>&nbsp;<span class="year">2014</span>;<span class="volume">25</span>;<span class="number">5-6</span>;<span class="pagerange">195-201</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24752582">24752582</a>; DOI: <a href="http://dx.doi.org/10.1007%2Fs00335-014-9513-3">10.1007/s00335-014-9513-3</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Recurrent ETNK1 mutations in atypical chronic myeloid leukemia.</h4>
<p class="authors"><span class="author">Gambacorti-Passerini CB</span>, <span class="author">Donadoni C</span>, <span class="author">Parmiani A</span>, <span class="author">Pirola A</span>, <span class="author">Redaelli S</span>, <span class="author">Signore G</span>, <span class="author">Piazza V</span>, <span class="author">Malcovati L</span>, <span class="author">Fontana D</span>, <span class="author">Spinelli R</span>, <span class="author">Magistroni V</span>, <span class="author">Gaipa G</span>, <span class="author">Peronaci M</span>, <span class="author">Morotti A</span>, <span class="author">Panuzzo C</span>, <span class="author">Saglio G</span>, <span class="author">Usala E</span>, <span class="author">Kim DW</span>, <span class="author">Rea D</span>, <span class="author">Zervakis K</span>, <span class="author">Viniou N</span>, <span class="author">Symeonidis A</span>, <span class="author">Becker H</span>, <span class="author">Boultwood J</span>, <span class="author">Campiotti L</span>, <span class="author">Carrabba M</span>, <span class="author">Elli E</span>, <span class="author">Bignell GR</span>, <span class="author">Papaemmanuil E</span>, <span class="author">Campbell PJ</span>, <span class="author">Cazzola M</span> and <span class="author">Piazza R</span></p>
<p class="affiliation">Department of Health Sciences, University of Milano-Bicocca, Monza, Italy;</p><p class="abstract">Despite the recent identification of recurrent SETBP1 mutations in Atypical Chronic Myeloid Leukemia (aCML), a complete description of the somatic lesions responsible for the onset of this disorder is still lacking. To find additional somatic abnormalities in aCML, we performed whole-exome sequencing on 15 aCML cases. In 2 cases (13.3%) we identified somatic missense mutations in the ETNK1 gene. Targeted resequencing on 515 hematological clonal disorders revealed the presence of ETNK1 variants in 6/68 aCML (9%) and 2/77 chronic myelomonocytic leukemia samples (3%). These mutations clustered in a small region of the kinase domain, encoding for H243Y and N244S (1/8 H243Y; 7/8 N244S), they were all heterozygous and present in the dominant clone. Intracellular phosphoethanolamine/phosphocholine ratio was, on average, 5.2-fold lower in ETNK1-mutated samples (p-value &lt; 0.05). Similar results were obtained using myeloid TF1 cells transduced with ETNK1 Wild-Type, ETNK1-N244S and ETNK1-H243Y, where the intracellular phosphoethanolamine/phosphocholine ratio was significantly lower in ETNK1-N244S (0.76&plusmn;0.07) and ETNK1-H243Y (0.37&plusmn;0.02) than in ETNK1-WT (1.37&plusmn;0.32; p=0.01 and p=0.0008, respectively), suggesting that ETNK1 mutations may inhibit the catalytic activity of the enzyme. In summary, our study shows for the first time the evidence of recurrent somatic ETNK1 mutations in the context of MDS/MPN disorders.</p>
<p class="publication"><span class="title">Blood</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25343957">25343957</a>; DOI: <a href="http://dx.doi.org/10.1182%2Fblood-2014-06-579466">10.1182/blood-2014-06-579466</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Comparison of TALE designer transcription factors and the CRISPR/dCas9 in regulation of gene expression by targeting enhancers.</h4>
<p class="authors"><span class="author">Gao X</span>, <span class="author">Tsang JC</span>, <span class="author">Gaba F</span>, <span class="author">Wu D</span>, <span class="author">Lu L</span> and <span class="author">Liu P</span></p>
<p class="affiliation">Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1HH, UK.</p><p class="abstract">The transcription activator-like effectors (TALEs) and the RNA-guided clustered regularly interspaced short palindromic repeat (CRISPR) associated protein (Cas9) utlilize distinct molecular mechanisms in targeting site recognition. The two proteins can be modified to carry additional functional domains to regulate expression of genomic loci in mammalian cells. In this study, we have compared the two systems in activation and suppression of the Oct4 and Nanog loci by targeting their enhancers. Although both are able to efficiently activate the luciferase reporters, the CRISPR/dCas9 system is much less potent in activating the endogenous loci and in the application of reprogramming somatic cells to iPS cells. Nevertheless, repression by CRISPR/dCas9 is comparable to or even better than TALE repressors. We demonstrated that dCas9 protein binding results in significant physical interference to binding of native transcription factors at enhancer, less efficient active histone markers induction or recruitment of activating complexes in gene activation. This study thus highlighted the merits and drawbacks of transcription regulation by each system. A combined approach of TALEs and CRISPR/dCas9 should provide an optimized solution to regulate genomic loci and to study genetic elements such as enhancers in biological processes including somatic cell reprogramming and guided differentiation.</p>
<p class="publication"><span class="title">Nucleic acids research</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25223790">25223790</a>; DOI: <a href="http://dx.doi.org/10.1093%2Fnar%2Fgku836">10.1093/nar/gku836</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">The evolving role of cancer cell line-based screens to define the impact of cancer genomes on drug response.</h4>
<p class="authors"><span class="author">Garnett MJ</span> and <span class="author">McDermott U</span></p>
<p class="affiliation">Cancer Genome Project, Wellcome Trust Sanger Institute Hinxton, Cambridge, United Kingdom.</p><p class="abstract">Over the last decade we have witnessed the convergence of two powerful experimental designs toward a common goal of defining the molecular subtypes that underpin the likelihood of a cancer patient responding to treatment in the clinic. The first of these &#39;experiments&#39; has been the systematic sequencing of large numbers of cancer genomes through the International Cancer Genome Consortium and The Cancer Genome Atlas. This endeavour is beginning to yield a complete catalogue of the cancer genes that are critical for tumourigenesis and amongst which we will find tomorrow&#39;s biomarkers and drug targets. The second &#39;experiment&#39; has been the use of large-scale biological models such as cancer cell lines to correlate mutations in cancer genes with drug sensitivity, such that one could begin to develop rationale clinical trials to begin to test these hypotheses. It is at this intersection of cancer genome sequencing and biological models that there exists the opportunity to completely transform how we stratify cancer patients in the clinic for treatment.</p>
<p class="grants">Funded by: Cancer Research UK; Wellcome Trust</p>
<p class="publication"><span class="title">Current opinion in genetics &amp; development</span>&nbsp;<span class="year">2014</span>;<span class="volume">24</span>;<span class="pagerange">114-9</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24607840">24607840</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4003351">4003351</a>; DOI: <a href="http://dx.doi.org/10.1016%2Fj.gde.2013.12.002">10.1016/j.gde.2013.12.002</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Identification of new SNPs in native South American populations by resequencing the Y chromosome.</h4>
<p class="authors"><span class="author">Geppert M</span>, <span class="author">Ayub Q</span>, <span class="author">Xue Y</span>, <span class="author">Santos S</span>, <span class="author">Ribeiro-Dos-Santos A</span>, <span class="author">Baeta M</span>, <span class="author">N&uacute;&ntilde;ez C</span>, <span class="author">Mart&iacute;nez-Jarreta B</span>, <span class="author">Tyler-Smith C</span> and <span class="author">Roewer L</span></p>
<p class="affiliation">Institute of Legal Medicine and Forensic Sciences, Department of Forensic Genetics, Charit&eacute; - Universit&auml;tsmedizin Berlin, Germany. Electronic address: <a href="mailto:%6D%61%72%69%61.%67%65%70%70%65%72%74%40%63%68%61%72%69%74%65.%64%65">&#109;&#97;&#114;&#105;&#97;&#46;&#103;&#101;&#112;&#112;&#101;&#114;&#116;&#64;&#99;&#104;&#97;&#114;&#105;&#116;&#101;&#46;&#100;&#101;</a>.</p><p class="abstract">The Y-chromosomal genetic landscape of South America is relatively homogenous. The majority of native Amerindian people are assigned to haplogroup Q and only a small percentage belongs to haplogroup C. With the aim of further differentiating the major Q lineages and thus obtaining new insights into the population history of South America, two individuals, both belonging to the sub-haplogroup Q-M3, were analyzed with next-generation sequencing. Several new candidate SNPs were evaluated and four were confirmed to be new, haplogroup Q-specific, and variable. One of the new SNPs, named MG2, identifies a new sub-haplogroup downstream of Q-M3; the other three (MG11, MG13, MG15) are upstream of Q-M3 but downstream of M242, and describe branches at the same phylogenetic positions as previously known SNPs in the samples tested. These four SNPs were typed in 100 individuals belonging to haplogroup Q.</p>
<p class="publication"><span class="title">Forensic science international. Genetics</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25303787">25303787</a>; DOI: <a href="http://dx.doi.org/10.1016%2Fj.fsigen.2014.09.014">10.1016/j.fsigen.2014.09.014</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Subclonal variant calling with multiple samples and prior knowledge.</h4>
<p class="authors"><span class="author">Gerstung M</span>, <span class="author">Papaemmanuil E</span> and <span class="author">Campbell PJ</span></p>
<p class="affiliation">Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton, CB10 1SA, UK; Department of Haematology, Addenbrooke's Hospital, Cambridge CB2 0QQ, UK; Department of Haematology, University of Cambridge, Cambridge CB22XY, UK.</p>
<p class="abstract">Motivation: Targeted resequencing of cancer genes in large cohorts of patients is important to understand the biological and clinical consequences of mutations. Cancers are often clonally heterogeneous and the detection of subclonal mutations is important from a diagnostic point of view, but presents strong statistical challenges.

Results: Here we present a novel statistical approach for calling mutations from large cohorts of deeply resequenced cancer genes. These data allow for precisely estimating local error profiles and enable detecting mutations with high sensitivity and specificity. Our probabilistic method incorporates knowledge about the distribution of variants in terms of a prior probability. We show that our algorithm has a high accuracy of calling cancer mutations and demonstrate that the detected clonal and subclonal variants have important prognostic consequences.

Availability: Code is available as part of the Bioconductor package deepSNV.

Contact: <a href="mailto:%6D%67%31%34%40%73%61%6E%67%65%72.%61%63.%75%6B">&#109;&#103;&#49;&#52;&#64;&#115;&#97;&#110;&#103;&#101;&#114;&#46;&#97;&#99;&#46;&#117;&#107;</a>, <a href="mailto:%70%63%38%40%73%61%6E%67%65%72.%61%63.%75%6B">&#112;&#99;&#56;&#64;&#115;&#97;&#110;&#103;&#101;&#114;&#46;&#97;&#99;&#46;&#117;&#107;</a>.</p>
<p class="publication"><span class="title">Bioinformatics (Oxford, England)</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24443148">24443148</a>; DOI: <a href="http://dx.doi.org/10.1093%2Fbioinformatics%2Fbtt750">10.1093/bioinformatics/btt750</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Monitoring parasite diversity for malaria elimination in sub-Saharan Africa.</h4>
<p class="authors"><span class="author">Ghansah A</span>, <span class="author">Amenga-Etego L</span>, <span class="author">Amambua-Ngwa A</span>, <span class="author">Andagalu B</span>, <span class="author">Apinjoh T</span>, <span class="author">Bouyou-Akotet M</span>, <span class="author">Cornelius V</span>, <span class="author">Golassa L</span>, <span class="author">Andrianaranjaka VH</span>, <span class="author">Ishengoma D</span>, <span class="author">Johnson K</span>, <span class="author">Kamau E</span>, <span class="author">Ma&iuml;ga-Ascofar&eacute; O</span>, <span class="author">Mumba D</span>, <span class="author">Tindana P</span>, <span class="author">Tshefu-Kitoto A</span>, <span class="author">Randrianarivelojosia M</span>, <span class="author">William Y</span>, <span class="author">Kwiatkowski DP</span> and <span class="author">Djimde AA</span></p>
<p class="affiliation">Noguchi Memorial Institute for Medical Research, Accra, Ghana.</p><p class="abstract">The African continent continues to bear the greatest burden of malaria and the greatest diversity of parasites, mosquito vectors, and human victims. The evolutionary plasticity of malaria parasites and their vectors is a major obstacle to eliminating the disease. Of current concern is the recently reported emergence of resistance to the front-line drug, artemisinin, in South-East Asia in Plasmodium falciparum, which calls for preemptive surveillance of the African parasite population for genetic markers of emerging drug resistance. Here we describe the Plasmodium Diversity Network Africa (PDNA), which has been established across 11 countries in sub-Saharan Africa to ensure that African scientists are enabled to work together and to play a key role in the global effort for tracking and responding to this public health threat.</p>
<p class="grants">Funded by: Medical Research Council: <span class="grant">G0600718</span></p>
<p class="publication"><span class="title">Science (New York, N.Y.)</span>&nbsp;<span class="year">2014</span>;<span class="volume">345</span>;<span class="number">6202</span>;<span class="pagerange">1297-8</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25214619">25214619</a>; DOI: <a href="http://dx.doi.org/10.1126%2Fscience.1259423">10.1126/science.1259423</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Maturation of Induced Pluripotent Stem Cell Derived Hepatocytes by 3D-Culture.</h4>
<p class="authors"><span class="author">Gieseck Iii RL</span>, <span class="author">Hannan NR</span>, <span class="author">Bort R</span>, <span class="author">Hanley NA</span>, <span class="author">Drake RA</span>, <span class="author">Cameron GW</span>, <span class="author">Wynn TA</span> and <span class="author">Vallier L</span></p>
<p class="affiliation">Wellcome Trust-Medical Research Council Stem Cell Institute, Anne McLaren Laboratory for Regenerative Medicine, Department of Surgery, University of Cambridge, Cambridge, United Kingdom ; Immunopathogenesis Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.</p>
<p class="abstract">Induced pluripotent stem cell derived hepatocytes (IPSC-Heps) have the potential to reduce the demand for a dwindling number of primary cells used in applications ranging from therapeutic cell infusions to in vitro toxicology studies. However, current differentiation protocols and culture methods produce cells with reduced functionality and fetal-like properties compared to adult hepatocytes. We report a culture method for the maturation of IPSC-Heps using 3-Dimensional (3D) collagen matrices compatible with high throughput screening. This culture method significantly increases functional maturation of IPSC-Heps towards an adult phenotype when compared to conventional 2D systems. Additionally, this approach spontaneously results in the presence of polarized structures necessary for drug metabolism and improves functional longevity to over 75 days. Overall, this research reveals a method to shift the phenotype of existing IPSC-Heps towards primary adult hepatocytes allowing such cells to be a more relevant replacement for the current primary standard.</p>
<p class="publication"><span class="title">PloS one</span>&nbsp;<span class="year">2014</span>;<span class="volume">9</span>;<span class="number">1</span>;<span class="pagerange">e86372</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24466060">24466060</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC3899231">3899231</a>; DOI: <a href="http://dx.doi.org/10.1371%2Fjournal.pone.0086372">10.1371/journal.pone.0086372</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Genomic investigations unmask Mycoplasma amphoriforme, a new respiratory pathogen.</h4>
<p class="authors"><span class="author">Gillespie SH</span>, <span class="author">Ling CL</span>, <span class="author">Oravcova K</span>, <span class="author">Pinheiro M</span>, <span class="author">Wells L</span>, <span class="author">Bryant JM</span>, <span class="author">McHugh TD</span>, <span class="author">B&eacute;b&eacute;ar C</span>, <span class="author">Webster D</span>, <span class="author">Harris SR</span>, <span class="author">Seth-Smith HM</span> and <span class="author">Thomson NR</span></p>
<p class="affiliation">School of Medicine, University of St Andrews, North Haugh, St Andrews, KY16 9TF.</p><p class="abstract"><strong>Background</strong>: &emsp;Mycoplasma amphoriforme has been associated with infection in patients with Primary Antibody Deficiency (PAD). Little is known about the natural history of infection with this organism and its ability to be transmitted in the community.</p><p class="abstract"><strong>Methods</strong>: &emsp;The bacterial load was estimated in sequential sputum samples from nine patients by qPCR. The genomes of all available isolates, originating from patients in the UK, France and Tunisia, were sequenced along with the type strain. Genomic data was assembled, annotated and a high-resolution phylogenetic tree constructed.</p><p class="abstract"><strong>Results</strong>: &emsp;By using high-resolution whole genome sequence data we show that patients can be chronically infected with M. amphoriforme manifesting as a relapsing remitting bacterial load interspersed by periods when the organism is undetectable. Importantly we demonstrate transmission of strains within a clinical environment. Antibiotic resistance mutations accumulate in isolates taken from patients who received multiple courses of antibiotics.</p><p class="abstract"><strong>Conclusions</strong>: &emsp;Mycoplasma amphoriforme isolates form a closely related species responsible for a chronic relapsing and remitting infection in PAD patients in the UK and from immunocompetent patients in other countries. We provide strong evidence of transmission between patients attending the same clinic suggesting that screening and isolation may be necessary for susceptible patients. This work demonstrates the critical role that whole genome sequencing can play in unravelling the biology of a novel pathogen rapidly.</p>
<p class="publication"><span class="title">Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25344534">25344534</a>; DOI: <a href="http://dx.doi.org/10.1093%2Fcid%2Fciu820">10.1093/cid/ciu820</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Expression and replication studies to identify new candidate genes involved in normal hearing function.</h4>
<p class="authors"><span class="author">Girotto G</span>, <span class="author">Vuckovic D</span>, <span class="author">Buniello A</span>, <span class="author">Lorente-C&aacute;novas B</span>, <span class="author">Lewis M</span>, <span class="author">Gasparini P</span> and <span class="author">Steel KP</span></p>
<p class="affiliation">Department of Medical Sciences, University of Trieste, Trieste, Italy.</p>
<p class="abstract">Considerable progress has been made in identifying deafness genes, but still little is known about the genetic basis of normal variation in hearing function. We recently carried out a Genome Wide Association Study (GWAS) of quantitative hearing traits in southern European populations and found several SNPs with suggestive but none with significant association. In the current study, we followed up these SNPs to investigate which of them might show a genuine association with auditory function using alternative approaches. Firstly, we generated a shortlist of 19 genes from the published GWAS results. Secondly, we carried out immunocytochemistry to examine expression of these 19 genes in the mouse inner ear. Twelve of them showed distinctive cochlear expression patterns. Four showed expression restricted to sensory hair cells (Csmd1, Arsg, Slc16a6 and Gabrg3), one only in marginal cells of the stria vascularis (Dclk1) while the others (Ptprd, Grm8, GlyBP, Evi5, Rimbp2, Ank2, Cdh13) in multiple cochlear cell types. In the third step, we tested these 12 genes for replication of association in an independent set of samples from the Caucasus and Central Asia. Nine out of them showed nominally significant association (p<0.05). In particular, 4 were replicated at the same SNP and with the same effect direction while the remaining 5 showed a significant association in a gene-based test. Finally, to look for genotype-phenotype relationship, the audiometric profiles of the three genotypes of the most strongly associated gene variants were analyzed. Seven out of the 9 replicated genes (CDH13, GRM8, ANK2, SLC16A6, ARSG, RIMBP2 and DCLK1) showed an audiometric pattern with differences between different genotypes further supporting their role in hearing function. These data demonstrate the usefulness of this multistep approach in providing new insights into the molecular basis of hearing and may suggest new targets for treatment and prevention of hearing impairment.</p>
<p class="publication"><span class="title">PloS one</span>&nbsp;<span class="year">2014</span>;<span class="volume">9</span>;<span class="number">1</span>;<span class="pagerange">e85352</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24454846">24454846</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC3891868">3891868</a>; DOI: <a href="http://dx.doi.org/10.1371%2Fjournal.pone.0085352">10.1371/journal.pone.0085352</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Fast randomization of large genomic datasets while preserving alteration counts.</h4>
<p class="authors"><span class="author">Gobbi A</span>, <span class="author">Iorio F</span>, <span class="author">Dawson KJ</span>, <span class="author">Wedge DC</span>, <span class="author">Tamborero D</span>, <span class="author">Alexandrov LB</span>, <span class="author">Lopez-Bigas N</span>, <span class="author">Garnett MJ</span>, <span class="author">Jurman G</span> and <span class="author">Saez-Rodriguez J</span></p>
<p class="affiliation">Fondazione Bruno Kessler, I-38100 Povo (Trento), Italy, European Molecular Biology Laboratory, European Bioinformatics Institute, Cambridge CB10 1SD, UK, Wellcome Trust Sanger Institute, Cambridge CB10 1SD, UK and Universitat Pompeu Fabra, Barcelona 08003, Spain.</p><p class="abstract"><strong>Motivation</strong>: Studying combinatorial patterns in cancer genomic datasets has recently emerged as a tool for identifying novel cancer driver networks. Approaches have been devised to quantify, for example, the tendency of a set of genes to be mutated in a &#39;mutually exclusive&#39; manner. The significance of the proposed metrics is usually evaluated by computing P-values under appropriate null models. To this end, a Monte Carlo method (the switching-algorithm) is used to sample simulated datasets under a null model that preserves patient- and gene-wise mutation rates. In this method, a genomic dataset is represented as a bipartite network, to which Markov chain updates (switching-steps) are applied. These steps modify the network topology, and a minimal number of them must be executed to draw simulated datasets independently under the null model. This number has previously been deducted empirically to be a linear function of the total number of variants, making this process computationally expensive.</p><p class="abstract"><strong>Results</strong>: We present a novel approximate lower bound for the number of switching-steps, derived analytically. Additionally, we have developed the R package BiRewire, including new efficient implementations of the switching-algorithm. We illustrate the performances of BiRewire by applying it to large real cancer genomics datasets. We report vast reductions in time requirement, with respect to existing implementations/bounds and equivalent P-value computations. Thus, we propose BiRewire to study statistical properties in genomic datasets, and other data that can be modeled as bipartite networks. Availability and implementation: BiRewire is available on BioConductor at http://www.bioconductor.org/packages/2.13/bioc/html/BiRewire.html CONTACT: <a href="mailto:%69%6F%72%69%6F%40%65%62%69.%61%63.%75%6B">&#105;&#111;&#114;&#105;&#111;&#64;&#101;&#98;&#105;&#46;&#97;&#99;&#46;&#117;&#107;</a> Supplementary information: Supplementary data are available at Bioinformatics online.</p>
<p class="publication"><span class="title">Bioinformatics (Oxford, England)</span>&nbsp;<span class="year">2014</span>;<span class="volume">30</span>;<span class="number">17</span>;<span class="pagerange">i617-i623</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25161255">25161255</a>; DOI: <a href="http://dx.doi.org/10.1093%2Fbioinformatics%2Fbtu474">10.1093/bioinformatics/btu474</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Nongenetic stochastic expansion of JAK2V617F-homozygous subclones in polycythemia vera?</h4>
<p class="authors"><span class="author">Godfrey AL</span>, <span class="author">Nangalia J</span>, <span class="author">Baxter EJ</span>, <span class="author">Massie CE</span>, <span class="author">Kent DG</span>, <span class="author">Papaemmanuil E</span>, <span class="author">Campbell PJ</span> and <span class="author">Green AR</span></p>
<p class="affiliation">Cambridge Institute for Medical Research and Wellcome Trust/Medical Research Council, Stem Cell Institute and Department of Haematology, University of Cambridge, Cambridge, United Kingdom Department of Haematology, Addenbrooke&#39;s Hospital, Cambridge, United Kingdom.</p>
<p class="publication"><span class="title">Blood</span>&nbsp;<span class="year">2014</span>;<span class="volume">124</span>;<span class="number">22</span>;<span class="pagerange">3332-4</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25414437">25414437</a>; DOI: <a href="http://dx.doi.org/10.1182%2Fblood-2014-09-603043">10.1182/blood-2014-09-603043</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Novel loci associated with usual sleep duration: the CHARGE Consortium Genome-Wide Association Study.</h4>
<p class="authors"><span class="author">Gottlieb DJ</span>, <span class="author">Hek K</span>, <span class="author">Chen TH</span>, <span class="author">Watson NF</span>, <span class="author">Eiriksdottir G</span>, <span class="author">Byrne EM</span>, <span class="author">Cornelis M</span>, <span class="author">Warby SC</span>, <span class="author">Bandinelli S</span>, <span class="author">Cherkas L</span>, <span class="author">Evans DS</span>, <span class="author">Grabe HJ</span>, <span class="author">Lahti J</span>, <span class="author">Li M</span>, <span class="author">Lehtim&auml;ki T</span>, <span class="author">Lumley T</span>, <span class="author">Marciante KD</span>, <span class="author">P&eacute;russe L</span>, <span class="author">Psaty BM</span>, <span class="author">Robbins J</span>, <span class="author">Tranah GJ</span>, <span class="author">Vink JM</span>, <span class="author">Wilk JB</span>, <span class="author">Stafford JM</span>, <span class="author">Bellis C</span>, <span class="author">Biffar R</span>, <span class="author">Bouchard C</span>, <span class="author">Cade B</span>, <span class="author">Curhan GC</span>, <span class="author">Eriksson JG</span>, <span class="author">Ewert R</span>, <span class="author">Ferrucci L</span>, <span class="author">F&uuml;l&ouml;p T</span>, <span class="author">Gehrman PR</span>, <span class="author">Goodloe R</span>, <span class="author">Harris TB</span>, <span class="author">Heath AC</span>, <span class="author">Hernandez D</span>, <span class="author">Hofman A</span>, <span class="author">Hottenga JJ</span>, <span class="author">Hunter DJ</span>, <span class="author">Jensen MK</span>, <span class="author">Johnson AD</span>, <span class="author">K&auml;h&ouml;nen M</span>, <span class="author">Kao L</span>, <span class="author">Kraft P</span>, <span class="author">Larkin EK</span>, <span class="author">Lauderdale DS</span>, <span class="author">Luik AI</span>, <span class="author">Medici M</span>, <span class="author">Montgomery GW</span>, <span class="author">Palotie A</span>, <span class="author">Patel SR</span>, <span class="author">Pistis G</span>, <span class="author">Porcu E</span>, <span class="author">Quaye L</span>, <span class="author">Raitakari O</span>, <span class="author">Redline S</span>, <span class="author">Rimm EB</span>, <span class="author">Rotter JI</span>, <span class="author">Smith AV</span>, <span class="author">Spector TD</span>, <span class="author">Teumer A</span>, <span class="author">Uitterlinden AG</span>, <span class="author">Vohl MC</span>, <span class="author">Widen E</span>, <span class="author">Willemsen G</span>, <span class="author">Young T</span>, <span class="author">Zhang X</span>, <span class="author">Liu Y</span>, <span class="author">Blangero J</span>, <span class="author">Boomsma DI</span>, <span class="author">Gudnason V</span>, <span class="author">Hu F</span>, <span class="author">Mangino M</span>, <span class="author">Martin NG</span>, <span class="author">O&#39;Connor GT</span>, <span class="author">Stone KL</span>, <span class="author">Tanaka T</span>, <span class="author">Viikari J</span>, <span class="author">Gharib SA</span>, <span class="author">Punjabi NM</span>, <span class="author">R&auml;ikk&ouml;nen K</span>, <span class="author">V&ouml;lzke H</span>, <span class="author">Mignot E</span> and <span class="author">Tiemeier H</span></p>
<p class="affiliation">1] VA Boston Healthcare System, Boston, MA, USA [2] Division of Sleep and Circadian Disorders, Department of Medicine, Brigham and Women&#39;s Hospital, Boston, MA, USA [3] Department of Medicine, Boston University School of Medicine, Boston, MA, USA [4] The NHLBI&#39;s Framingham Heart Study, Framingham, MA, USA.</p><p class="abstract">Usual sleep duration is a heritable trait correlated with psychiatric morbidity, cardiometabolic disease and mortality, although little is known about the genetic variants influencing this trait. A genome-wide association study (GWAS) of usual sleep duration was conducted using 18 population-based cohorts totaling 47&thinsp;180 individuals of European ancestry. Genome-wide significant association was identified at two loci. The strongest is located on chromosome 2, in an intergenic region 35- to 80-kb upstream from the thyroid-specific transcription factor PAX8 (lowest P=1.1 &times; 10(-9)). This finding was replicated in an African-American sample of 4771 individuals (lowest P=9.3 &times; 10(-4)). The strongest combined association was at rs1823125 (P=1.5 &times; 10(-10), minor allele frequency 0.26 in the discovery sample, 0.12 in the replication sample), with each copy of the minor allele associated with a sleep duration 3.1&thinsp;min longer per night. The alleles associated with longer sleep duration were associated in previous GWAS with a more favorable metabolic profile and a lower risk of attention deficit hyperactivity disorder. Understanding the mechanisms underlying these associations may help elucidate biological mechanisms influencing sleep duration and its association with psychiatric, metabolic and cardiovascular disease.Molecular Psychiatry advance online publication, 2 December 2014; doi:10.1038/mp.2014.133.</p>
<p class="publication"><span class="title">Molecular psychiatry</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25469926">25469926</a>; DOI: <a href="http://dx.doi.org/10.1038%2Fmp.2014.133">10.1038/mp.2014.133</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Genomic epidemiology of Neisseria gonorrhoeae with reduced susceptibility to cefixime in the USA: a retrospective observational study.</h4>
<p class="authors"><span class="author">Grad YH</span>, <span class="author">Kirkcaldy RD</span>, <span class="author">Trees D</span>, <span class="author">Dordel J</span>, <span class="author">Harris SR</span>, <span class="author">Goldstein E</span>, <span class="author">Weinstock H</span>, <span class="author">Parkhill J</span>, <span class="author">Hanage WP</span>, <span class="author">Bentley S</span> and <span class="author">Lipsitch M</span></p>
<p class="affiliation">Center for Communicable Disease Dynamics, Department of Epidemiology, Harvard School of Public Health, Boston, MA, USA; Division of Infectious Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. Electronic address: <a href="mailto:%79%67%72%61%64%40%68%73%70%68.%68%61%72%76%61%72%64.%65%64%75">&#121;&#103;&#114;&#97;&#100;&#64;&#104;&#115;&#112;&#104;&#46;&#104;&#97;&#114;&#118;&#97;&#114;&#100;&#46;&#101;&#100;&#117;</a>.</p>
<p class="abstract">Background: The emergence of Neisseria gonorrhoeae with decreased susceptibility to extended spectrum cephalosporins raises the prospect of untreatable gonorrhoea. In the absence of new treatments, efforts to slow the increasing incidence of resistant gonococcus require insight into the factors that contribute to its emergence and spread. We assessed the relatedness between isolates in the USA and reconstructed likely spread of lineages through different sexual networks.

Methods: We sequenced the genomes of 236 isolates of N gonorrhoeae collected by the Centers for Disease Control and Prevention's Gonococcal Isolate Surveillance Project (GISP) from sentinel public sexually transmitted disease clinics in the USA, including 118 (97%) of the isolates from 2009-10 in GISP with reduced susceptibility to cefixime (cef(RS)) and 118 cefixime-susceptible isolates from GISP matched as closely as possible by location, collection date, and sexual orientation. We assessed the association between antimicrobial resistance genotype and phenotype and correlated phylogenetic clustering with location and sexual orientation.

Findings: Mosaic penA XXXIV had a high positive predictive value for cef(RS). We found that two of the 118 cef(RS) isolates lacked a mosaic penA allele, and rechecking showed that these two were susceptible to cefixime. Of the 116 remaining cef(RS) isolates, 114 (98%) fell into two distinct lineages that have independently acquired mosaic penA allele XXXIV. A major lineage of cef(RS) strains spread eastward, predominantly through a sexual network of men who have sex with men. Eight of nine inferred transitions between sexual networks were introductions from men who have sex with men into the heterosexual population.

Interpretation: Genomic methods might aid efforts to slow the spread of antibiotic-resistant N gonorrhoeae through augmentation of gonococcal outbreak surveillance and identification of populations that could benefit from increased screening for aymptomatic infections.

Funding: American Sexually Transmitted Disease Association, Wellcome Trust, National Institute of General Medical Sciences, and National Institute of Allergy and Infectious Diseases, National Institutes of Health.</p>
<p class="grants">Funded by: NIGMS NIH HHS: <span class="grant">U54 GM088558</span></p>
<p class="publication"><span class="title">The Lancet infectious diseases</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24462211">24462211</a>; DOI: <a href="http://dx.doi.org/10.1016%2FS1473-3099%2813%2970693-5">10.1016/S1473-3099(13)70693-5</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Acute myeloid leukaemia: a paradigm for the clonal evolution of cancer?</h4>
<p class="authors"><span class="author">Grove CS</span> and <span class="author">Vassiliou GS</span></p>
<p class="affiliation">Haematological Cancer Genetics, The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1SA, UK.</p><p class="abstract">Acute myeloid leukaemia (AML) is an uncontrolled clonal proliferation of abnormal myeloid progenitor cells in the bone marrow and blood. Advances in cancer genomics have revealed the spectrum of somatic mutations that give rise to human AML and drawn our attention to its molecular evolution and clonal architecture. It is now evident that most AML genomes harbour small numbers of mutations, which are acquired in a stepwise manner. This characteristic, combined with our ability to identify mutations in individual leukaemic cells and our detailed understanding of normal human and murine haematopoiesis, makes AML an excellent model for understanding the principles of cancer evolution. Furthermore, a better understanding of how AML evolves can help us devise strategies to improve the therapy and prognosis of AML patients. Here, we draw from recent advances in genomics, clinical studies and experimental models to describe the current knowledge of the clonal evolution of AML and its implications for the biology and treatment of leukaemias and other cancers.</p>
<p class="grants">Funded by: Wellcome Trust</p>
<p class="publication"><span class="title">Disease models &amp; mechanisms</span>&nbsp;<span class="year">2014</span>;<span class="volume">7</span>;<span class="number">8</span>;<span class="pagerange">941-51</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25056697">25056697</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4107323">4107323</a>; DOI: <a href="http://dx.doi.org/10.1242%2Fdmm.015974">10.1242/dmm.015974</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">De Novo Loss-of-Function Mutations in SETD5, Encoding a Methyltransferase in a 3p25 Microdeletion Syndrome Critical Region, Cause Intellectual Disability.</h4>
<p class="authors"><span class="author">Grozeva D</span>, <span class="author">Carss K</span>, <span class="author">Spasic-Boskovic O</span>, <span class="author">Parker MJ</span>, <span class="author">Archer H</span>, <span class="author">Firth HV</span>, <span class="author">Park SM</span>, <span class="author">Canham N</span>, <span class="author">Holder SE</span>, <span class="author">Wilson M</span>, <span class="author">Hackett A</span>, <span class="author">Field M</span>, <span class="author">Floyd JA</span>, <span class="author">UK10K Consortium</span>, <span class="author">Hurles M</span> and <span class="author">Raymond FL</span></p>
<p class="affiliation">Department of Medical Genetics, Cambridge Institute for Medical Research, University of Cambridge, Cambridge CB2 0XY, UK.</p><p class="abstract">To identify further Mendelian causes of intellectual disability (ID), we screened a cohort of 996 individuals with ID for variants in 565 known or candidate genes by using a targeted next-generation sequencing approach. Seven loss-of-function (LoF) mutations-four nonsense (c.1195A&gt;T [p.Lys399(&lowast;)], c.1333C&gt;T [p.Arg445(&lowast;)], c.1866C&gt;G [p.Tyr622(&lowast;)], and c.3001C&gt;T [p.Arg1001(&lowast;)]) and three frameshift (c.2177_2178del [p.Thr726Asnfs(&lowast;)39], c.3771dup [p.Ser1258Glufs(&lowast;)65], and c.3856del [p.Ser1286Leufs(&lowast;)84])-were identified in SETD5, a gene predicted to encode a methyltransferase. All mutations were compatible with de novo dominant inheritance. The affected individuals had moderate to severe ID with additional variable features of brachycephaly; a prominent high forehead with synophrys or striking full and broad eyebrows; a long, thin, and tubular nose; long, narrow upslanting palpebral fissures; and large, fleshy low-set ears. Skeletal anomalies, including significant leg-length discrepancy, were a frequent finding in two individuals. Congenital heart defects, inguinal hernia, or hypospadias were also reported. Behavioral problems, including obsessive-compulsive disorder, hand flapping with ritualized behavior, and autism, were prominent features. SETD5 lies within the critical interval for 3p25 microdeletion syndrome. The individuals with SETD5 mutations showed phenotypic similarity to those previously reported with a deletion in 3p25, and thus loss of SETD5 might be sufficient to account for many of the clinical features observed in this condition. Our findings add to the growing evidence that mutations in genes encoding methyltransferases regulating histone modification are important causes of ID. This analysis provides sufficient evidence that rare de novo LoF mutations in SETD5 are a relatively frequent (0.7%) cause of ID.</p>
<p class="publication"><span class="title">American journal of human genetics</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24680889">24680889</a>; DOI: <a href="http://dx.doi.org/10.1016%2Fj.ajhg.2014.03.006">10.1016/j.ajhg.2014.03.006</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Relapse or reinfection with tuberculosis: a whole genome sequencing approach in a large population-based cohort with high HIV prevalence and active follow-up.</h4>
<p class="authors"><span class="author">Guerra-Assun&ccedil;&atilde;o JA</span>, <span class="author">Houben RM</span>, <span class="author">Crampin AC</span>, <span class="author">Mzembe T</span>, <span class="author">Mallard K</span>, <span class="author">Coll F</span>, <span class="author">Khan P</span>, <span class="author">Banda L</span>, <span class="author">Chiwaya A</span>, <span class="author">Pereira RP</span>, <span class="author">McNerney R</span>, <span class="author">Harris D</span>, <span class="author">Parkhill J</span>, <span class="author">Clark TG</span> and <span class="author">Glynn JR</span></p>
<p class="affiliation">Faculty of Epidemiology and Population Health, London School of Hygiene &amp; Tropical Medicine, London UK.</p><p class="abstract"><strong>Background</strong>: &emsp;Recurrent tuberculosis is a major health burden and may be due to relapse with the original strain or reinfection with a new strain.</p><p class="abstract"><strong>Methods</strong>: &emsp;In a population-based study in northern Malawi, tuberculosis patients diagnosed from 1996-2010 were actively followed after the end of treatment. Whole genome sequencing with approximately 100X coverage was carried out on all available cultures. IS6110 RFLP was available on cultures up to 2008.</p><p class="abstract"><strong>Results</strong>: &emsp;Based on our data, a single nucleotide polymorphism (SNP) difference of &le;10 SNPs was used to define relapse, and &gt;100 SNPs for reinfection. There was no evidence of mixed infections among those classified as reinfections. Of 1471 patients, 139 had laboratory-confirmed recurrences: 55 relapse, 20 reinfection, unclassified for 64. Almost all relapses occurred in the first two years. HIV was associated with reinfection but not relapse. Relapses were associated with isoniazid resistance, treatment before 2007, and lineage-3 strains. We identified several gene variants associated with relapse. Lineage-2 (Beijing) was over-represented and lineage-1 under-represented among the reinfecting strains (p=0.004).</p><p class="abstract"><strong>Conclusions</strong>: &emsp;While some of the factors determining recurrence depend on the patient and their treatment, differences in the M.tuberculosis genome appear to have a role in both relapse and reinfection.</p>
<p class="publication"><span class="title">The Journal of infectious diseases</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25336729">25336729</a>; DOI: <a href="http://dx.doi.org/10.1093%2Finfdis%2Fjiu574">10.1093/infdis/jiu574</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Gray platelet syndrome: proinflammatory megakaryocytes and &alpha;-granule loss cause myelofibrosis and confer metastasis resistance in mice.</h4>
<p class="authors"><span class="author">Guerrero JA</span>, <span class="author">Bennett C</span>, <span class="author">van der Weyden L</span>, <span class="author">McKinney H</span>, <span class="author">Chin M</span>, <span class="author">Nurden P</span>, <span class="author">McIntyre Z</span>, <span class="author">Cambridge EL</span>, <span class="author">Estabel J</span>, <span class="author">Wardle-Jones H</span>, <span class="author">Speak AO</span>, <span class="author">Erber WN</span>, <span class="author">Rendon A</span>, <span class="author">Ouwehand WH</span> and <span class="author">Ghevaert C</span></p>
<p class="affiliation">Department of Haematology, University of Cambridge, and National Health Service Blood and Transplant, Cambridge Biomedical Campus, Cambridge, United Kingdom;</p><p class="abstract">NBEAL2 encodes a multidomain scaffolding protein with a putative role in granule ontogeny in human platelets. Mutations in NBEAL2 underlie gray platelet syndrome (GPS), a rare inherited bleeding disorder characterized by a lack of &alpha;-granules within blood platelets and progressive bone marrow fibrosis. We present here a novel Nbeal2(-/-) murine model of GPS and demonstrate that the lack of &alpha;-granules is due to their loss from platelets/mature megakaryocytes (MKs), and not by initial impaired formation. We show that the lack of Nbeal2 confers a proinflammatory phenotype to the bone marrow MKs, which in combination with the loss of proteins from &alpha;-granules drives the development of bone marrow fibrosis. In addition, we demonstrate that &alpha;-granule deficiency impairs platelet function beyond their purely hemostatic role and that Nbeal2 deficiency has a protective effect against cancer metastasis.</p>
<p class="publication"><span class="title">Blood</span>&nbsp;<span class="year">2014</span>;<span class="volume">124</span>;<span class="number">24</span>;<span class="pagerange">3624-35</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25258341">25258341</a>; DOI: <a href="http://dx.doi.org/10.1182%2Fblood-2014-04-566760">10.1182/blood-2014-04-566760</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">The African Genome Variation Project shapes medical genetics in Africa.</h4>
<p class="authors"><span class="author">Gurdasani D</span>, <span class="author">Carstensen T</span>, <span class="author">Tekola-Ayele F</span>, <span class="author">Pagani L</span>, <span class="author">Tachmazidou I</span>, <span class="author">Hatzikotoulas K</span>, <span class="author">Karthikeyan S</span>, <span class="author">Iles L</span>, <span class="author">Pollard MO</span>, <span class="author">Choudhury A</span>, <span class="author">Ritchie GR</span>, <span class="author">Xue Y</span>, <span class="author">Asimit J</span>, <span class="author">Nsubuga RN</span>, <span class="author">Young EH</span>, <span class="author">Pomilla C</span>, <span class="author">Kivinen K</span>, <span class="author">Rockett K</span>, <span class="author">Kamali A</span>, <span class="author">Doumatey AP</span>, <span class="author">Asiki G</span>, <span class="author">Seeley J</span>, <span class="author">Sisay-Joof F</span>, <span class="author">Jallow M</span>, <span class="author">Tollman S</span>, <span class="author">Mekonnen E</span>, <span class="author">Ekong R</span>, <span class="author">Oljira T</span>, <span class="author">Bradman N</span>, <span class="author">Bojang K</span>, <span class="author">Ramsay M</span>, <span class="author">Adeyemo A</span>, <span class="author">Bekele E</span>, <span class="author">Motala A</span>, <span class="author">Norris SA</span>, <span class="author">Pirie F</span>, <span class="author">Kaleebu P</span>, <span class="author">Kwiatkowski D</span>, <span class="author">Tyler-Smith C</span>, <span class="author">Rotimi C</span>, <span class="author">Zeggini E</span> and <span class="author">Sandhu MS</span></p>
<p class="affiliation">1] Wellcome Trust Sanger Institute, Genome Campus, Hinxton, Cambridge CB10 1SA, UK [2] Department of Public Health and Primary Care, University of Cambridge, 2 Wort&#39;s Causeway, Cambridge, CB1 8RN, UK.</p><p class="abstract">Given the importance of Africa to studies of human origins and disease susceptibility, detailed characterization of African genetic diversity is needed. The African Genome Variation Project provides a resource with which to design, implement and interpret genomic studies in sub-Saharan Africa and worldwide. The African Genome Variation Project represents dense genotypes from 1,481 individuals and whole-genome sequences from 320 individuals across sub-Saharan Africa. Using this resource, we find novel evidence of complex, regionally distinct hunter-gatherer and Eurasian admixture across sub-Saharan Africa. We identify new loci under selection, including loci related to malaria susceptibility and hypertension. We show that modern imputation panels (sets of reference genotypes from which unobserved or missing genotypes in study sets can be inferred) can identify association signals at highly differentiated loci across populations in sub-Saharan Africa. Using whole-genome sequencing, we demonstrate further improvements in imputation accuracy, strengthening the case for large-scale sequencing efforts of diverse African haplotypes. Finally, we present an efficient genotype array design capturing common genetic variation in Africa.</p>
<p class="publication"><span class="title">Nature</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25470054">25470054</a>; DOI: <a href="http://dx.doi.org/10.1038%2Fnature13997">10.1038/nature13997</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">A systematic review of definitions of extreme phenotypes of HIV control and progression.</h4>
<p class="authors"><span class="author">Gurdasani D</span>, <span class="author">Iles L</span>, <span class="author">Dillon DG</span>, <span class="author">Young EH</span>, <span class="author">Olson AD</span>, <span class="author">Naranbhai V</span>, <span class="author">Fidler S</span>, <span class="author">Gkrania-Klotsas E</span>, <span class="author">Post FA</span>, <span class="author">Kellam P</span>, <span class="author">Porter K</span> and <span class="author">Sandhu MS</span></p>
<p class="affiliation">aWellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton bStrangeways Research Laboratory, Department of Public Health and Primary Care, University of Cambridge, Wort&#39;s Causeway, Cambridge cMedical Research Council, Clinical Trials Unit, Aviation House, London, UK dCentre for the AIDS Programme of Research in South Africa (CAPRISA), Doris Duke Medical Research Institute, Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa eWellcome Trust Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford fImperial College Healthcare NHS Trust, London gCambridge University Hospitals NHS Foundation Trust, Department of Infectious Diseases, Addenbrooke&#39;s Hospital, Cambridge hKing&#39;s College London, Weston Education Centre iDivision of Infection and Immunity, University College London, London, UK.</p><p class="abstract">The study of individuals at opposite ends of the HIV clinical spectrum can provide invaluable insights into HIV biology. Heterogeneity in criteria used to define these individuals can introduce inconsistencies in results from research and make it difficult to identify biological mechanisms underlying these phenotypes. In this systematic review, we formally quantified the heterogeneity in definitions used for terms referring to extreme phenotypes in the literature, and identified common definitions and components used to describe these phenotypes. We assessed 714 definitions of HIV extreme phenotypes in 501 eligible studies published between 1 January 2000 and 15 March 2012, and identified substantial variation among these. This heterogeneity in definitions may represent important differences in biological endophenotypes and clinical progression profiles of individuals selected by these, suggesting the need for harmonized definitions. In this context, we were able to identify common components in existing definitions that may provide a framework for developing consensus definitions for these phenotypes in HIV infection.</p>
<p class="grants">Funded by: Medical Research Council: <span class="grant">G0901213</span>; Wellcome Trust</p>
<p class="publication"><span class="title">AIDS (London, England)</span>&nbsp;<span class="year">2014</span>;<span class="volume">28</span>;<span class="number">2</span>;<span class="pagerange">149-62</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24149086">24149086</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC3882304">3882304</a>; DOI: <a href="http://dx.doi.org/10.1097%2FQAD.0000000000000049">10.1097/QAD.0000000000000049</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Use of whole genus genome sequence data to develop a Multi-Locus Sequencing Type tool that accurately speciates and sub-speciates within the Yersinia genus.</h4>
<p class="authors"><span class="author">Hall M</span>, <span class="author">Chattaway MA</span>, <span class="author">Reuter S</span>, <span class="author">Savin C</span>, <span class="author">Strauch E</span>, <span class="author">Carniel E</span>, <span class="author">Connor T</span>, <span class="author">Van Damme I</span>, <span class="author">Rajakaruna L</span>, <span class="author">Rajendram D</span>, <span class="author">Jenkins C</span>, <span class="author">Thomson NR</span> and <span class="author">McNally A</span></p>
<p class="affiliation">Pathogen research group, Nottingham Trent University, Clifton Lane, Nottingham NG11 8NS.</p><p class="abstract">The genus Yersinia is a large and diverse bacterial genus consisting of human pathogenic species, a fish pathogenic species, and a large number of environmental species. Recently the phylogenetic and population structure of the entire genus was elucidated through genome sequence data of 241 strains encompassing every known species in the genus. Here we report the mining of this enormous data set to create a multi-locus sequence typing-based scheme that can speciate Yersinia strains to a level of resolution equal to whole genome sequencing. Our assay is designed so that it is able to accurately sub-type the important human pathogenic species Y. enterocolitica to whole genome resolution levels. We also report the validation of the scheme on 386 strains from reference laboratory collections across Europe. We propose the scheme to be an important molecular typing system to allow accurate and reproducible speciation of Yersinia isolates, a process often inconsistent in non-specialist laboratories. Additionally our assay is the most phylogenetically informative typing scheme available for Y. enterocolitica.</p>
<p class="publication"><span class="title">Journal of clinical microbiology</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25339391">25339391</a>; DOI: <a href="http://dx.doi.org/10.1128%2FJCM.02395-14">10.1128/JCM.02395-14</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">The Y-Chromosome Tree Bursts into Leaf: 13,000 High-Confidence SNPs Covering the Majority of Known Clades.</h4>
<p class="authors"><span class="author">Hallast P</span>, <span class="author">Batini C</span>, <span class="author">Zadik D</span>, <span class="author">Maisano Delser P</span>, <span class="author">Wetton JH</span>, <span class="author">Arroyo-Pardo E</span>, <span class="author">Cavalleri GL</span>, <span class="author">de Knijff P</span>, <span class="author">Destro Bisol G</span>, <span class="author">Dupuy BM</span>, <span class="author">Eriksen HA</span>, <span class="author">Jorde LB</span>, <span class="author">King TE</span>, <span class="author">Larmuseau MH</span>, <span class="author">L&oacute;pez de Munain A</span>, <span class="author">L&oacute;pez-Parra AM</span>, <span class="author">Loutradis A</span>, <span class="author">Milasin J</span>, <span class="author">Novelletto A</span>, <span class="author">Pamjav H</span>, <span class="author">Sajantila A</span>, <span class="author">Schempp W</span>, <span class="author">Sears M</span>, <span class="author">Tolun A</span>, <span class="author">Tyler-Smith C</span>, <span class="author">Van Geystelen A</span>, <span class="author">Watkins S</span>, <span class="author">Winney B</span> and <span class="author">Jobling MA</span></p>
<p class="affiliation">Department of Genetics, University of Leicester, Leicester, United Kingdom.</p><p class="abstract">Many studies of human populations have used the male-specific region of the Y chromosome (MSY) as a marker, but MSY sequence variants have traditionally been subject to ascertainment bias. Also, dating of haplogroups has relied on Y-specific short tandem repeats (STRs), involving problems of mutation rate choice, and possible long-term mutation saturation. Next-generation sequencing can ascertain single nucleotide polymorphisms (SNPs) in an unbiased way, leading to phylogenies in which branch-lengths are proportional to time, and allowing the times-to-most-recent-common-ancestor (TMRCAs) of nodes to be estimated directly. Here we describe the sequencing of 3.7 Mb of MSY in each of 448 human males at a mean coverage of 51&times;, yielding 13,261 high-confidence SNPs, 65.9% of which are previously unreported. The resulting phylogeny covers the majority of the known clades, provides date estimates of nodes, and constitutes a robust evolutionary framework for analyzing the history of other classes of mutation. Different clades within the tree show subtle but significant differences in branch lengths to the root. We also apply a set of 23 Y-STRs to the same samples, allowing SNP- and STR-based diversity and TMRCA estimates to be systematically compared. Ongoing purifying selection is suggested by our analysis of the phylogenetic distribution of nonsynonymous variants in 15 MSY single-copy genes.</p>
<p class="publication"><span class="title">Molecular biology and evolution</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25468874">25468874</a>; DOI: <a href="http://dx.doi.org/10.1093%2Fmolbev%2Fmsu327">10.1093/molbev/msu327</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">A GC1 Acinetobacter baumannii isolate carrying AbaR3 and the aminoglycoside resistance transposon TnaphA6 in a conjugative plasmid.</h4>
<p class="authors"><span class="author">Hamidian M</span>, <span class="author">Holt KE</span>, <span class="author">Pickard D</span>, <span class="author">Dougan G</span> and <span class="author">Hall RM</span></p>
<p class="affiliation">School of Molecular Bioscience, The University of Sydney, NSW 2006, Australia.</p><p class="abstract"><strong>Objectives</strong>: To locate the acquired antibiotic resistance genes, including the amikacin resistance transposon TnaphA6, in the genome of an Australian isolate belonging to Acinetobacter baumannii global clone 1 (GC1).</p><p class="abstract"><strong>Methods</strong>: A multiply antibiotic-resistant GC1 isolate harbouring TnaphA6 was sequenced using Illumina HiSeq, and reads were used to generate a de novo assembly and determine multilocus sequence types (STs). PCR was used to assemble the AbaR chromosomal resistance island and a large plasmid carrying TnaphA6. Plasmid DNA sequences were compared with ones available in GenBank. Conjugation experiments were conducted.</p><p class="abstract"><strong>Results</strong>: The A. baumannii GC1 isolate G7 was shown to include the AbaR3 antibiotic resistance island. It also contains an 8.7 kb cryptic plasmid, pAb-G7-1, and a 70&#x200A;100 bp plasmid, pAb-G7-2, carrying TnaphA6. pAb-G7-2 belongs to the Aci6 Acinetobacter plasmid family. It encodes transfer functions and was shown to conjugate. Plasmids related to pAb-G7-2 were detected in further amikacin-resistant GC1 isolates using PCR. From the genome sequence, isolate G7 was ST1 (Institut Pasteur scheme) and ST231 (Oxford scheme). Using Oxford scheme PCR-based methods, the isolate was ST109 and this difference was traced to a single base difference resulting from the inclusion of the original primers in the gpi segment analysed.</p><p class="abstract"><strong>Conclusions</strong>: The multiply antibiotic-resistant GC1 isolate G7 carries most of its resistance genes in AbaR3 located in the chromosome. However, TnaphA6 is on a conjugative plasmid, pAb-G7-2. Primers developed to locate TnaphA6 in pAb-G7-2 will simplify the detection of plasmids related to pAb-G7-2 in A. baumannii isolates.</p>
<p class="publication"><span class="title">The Journal of antimicrobial chemotherapy</span>&nbsp;<span class="year">2014</span>;<span class="volume">69</span>;<span class="number">4</span>;<span class="pagerange">955-8</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24235096">24235096</a>; DOI: <a href="http://dx.doi.org/10.1093%2Fjac%2Fdkt454">10.1093/jac/dkt454</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">A conjugative plasmid carrying the carbapenem resistance gene blaOXA-23 in AbaR4 in an extensively resistant GC1 Acinetobacter baumannii isolate.</h4>
<p class="authors"><span class="author">Hamidian M</span>, <span class="author">Kenyon JJ</span>, <span class="author">Holt KE</span>, <span class="author">Pickard D</span> and <span class="author">Hall RM</span></p>
<p class="affiliation">School of Molecular Bioscience, The University of Sydney, NSW 2006, Australia.</p><p class="abstract"><strong>Objectives</strong>: To locate the acquired blaOXA-23 carbapenem resistance gene in an Australian A. baumannii global clone 1 (GC1) isolate.</p><p class="abstract"><strong>Methods</strong>: The genome of the extensively antibiotic-resistant GC1 isolate A85 harbouring blaOXA-23 in Tn2006 was sequenced using Illumina HiSeq, and the reads were used to generate a de novo assembly. PCR was used to assemble relevant contigs. Sequences were compared with ones in GenBank. Conjugation experiments were conducted.</p><p class="abstract"><strong>Results</strong>: The sporadic GC1 isolate A85, recovered in 2003, was extensively resistant, exhibiting resistance to imipenem, meropenem and ticarcillin/clavulanate, to cephalosporins and fluoroquinolones and to the older antibiotics gentamicin, kanamycin and neomycin, sulfamethoxazole, trimethoprim and tetracycline. Genes for resistance to older antibiotics are in the chromosome, in an AbaR3 resistance island. A second copy of the ampC gene in Tn6168 confers cephalosporin resistance and the gyrA and parC genes have mutations leading to fluoroquinolone resistance. An 86&#x200A;335 bp repAci6 plasmid, pA85-3, carrying blaOXA-23 in Tn2006 in AbaR4, was shown to transfer imipenem, meropenem and ticarcillin/clavulanate resistance into a susceptible recipient. A85 also contains two small cryptic plasmids of 2.7 and 8.7 kb. A85 is sequence type ST126 (Oxford scheme) and carries a novel KL15 capsule locus and the OCL3 outer core locus.</p><p class="abstract"><strong>Conclusions</strong>: A85 represents a new GC1 lineage identified by the novel capsule locus but retains AbaR3 carrying genes for resistance to older antibiotics. Resistance to imipenem, meropenem and ticarcillin/clavulanate has been introduced into A85 by pA85-3, a repAci6 conjugative plasmid carrying Tn2006 in AbaR4.</p>
<p class="publication"><span class="title">The Journal of antimicrobial chemotherapy</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24907141">24907141</a>; DOI: <a href="http://dx.doi.org/10.1093%2Fjac%2Fdku188">10.1093/jac/dku188</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Identification of a marker for two lineages within the GC1 clone of Acinetobacter baumannii.</h4>
<p class="authors"><span class="author">Hamidian M</span>, <span class="author">Wynn M</span>, <span class="author">Holt KE</span>, <span class="author">Pickard D</span>, <span class="author">Dougan G</span> and <span class="author">Hall RM</span></p>
<p class="affiliation">School of Molecular Bioscience, The University of Sydney, NSW 2006, Australia.</p>
<p class="publication"><span class="title">The Journal of antimicrobial chemotherapy</span>&nbsp;<span class="year">2014</span>;<span class="volume">69</span>;<span class="number">2</span>;<span class="pagerange">557-8</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24080502">24080502</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC3886933">3886933</a>; DOI: <a href="http://dx.doi.org/10.1093%2Fjac%2Fdkt379">10.1093/jac/dkt379</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Efficient in vivo deletion of a large imprinted lncRNA by CRISPR/Cas9.</h4>
<p class="authors"><span class="author">Han J</span>, <span class="author">Zhang J</span>, <span class="author">Chen L</span>, <span class="author">Shen B</span>, <span class="author">Zhou J</span>, <span class="author">Hu B</span>, <span class="author">Du Y</span>, <span class="author">Tate PH</span>, <span class="author">Huang X</span> and <span class="author">Zhang W</span></p>
<p class="affiliation">MOE Key Laboratory of Model Animal for Disease Study; Model Animal Research Center of Nanjing University; Nanjing, Jiangsu Province, PR China.</p><p class="abstract">Recent genome-wide studies have revealed that the majority of the mouse genome is transcribed as non-coding RNAs (ncRNAs) and growing evidence supports the importance of ncRNAs in regulating gene expression and epigenetic processes. However, the low efficiency of conventional gene targeting strategies has hindered the functional study of ncRNAs in vivo, particularly in generating large fragment deletions of long non-coding RNAs (lncRNAs) with multiple expression variants. The bacterial clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated 9 (Cas9) system has recently been applied as an efficient tool for engineering site-specific mutations of protein-coding genes in the genome. In this study, we explored the potential of using the CRISPR/Cas9 system to generate large genomic deletions of lncRNAs in mice. We developed an efficient one-step strategy to target the maternally expressed lncRNA, Rian, on chromosome 12 in mice. We showed that paired sgRNAs can precisely generate large deletions up to 23kb and the deletion efficiency can be further improved up to 33% by combining multiple sgRNAs. The deletion successfully abolished the expression of Rian from the maternally inherited allele, validating the biological relevance of the mutations in studying an imprinted locus. Mutation of Rian has differential effects on expression of nearby genes in different somatic tissues. Taken together, we have established a robust one-step method to engineer large deletions to knockout lncRNA genes with the CRISPR/Cas9 system. Our work will facilitate future functional studies of other lncRNAs in vivo.</p>
<p class="publication"><span class="title">RNA biology</span>&nbsp;<span class="year">2014</span>;<span class="volume">11</span>;<span class="number">7</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25137067">25137067</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Collateral damage.</h4>
<p class="authors"><span class="author">Hancock RE</span></p>
<p class="affiliation">Centre for Microbial Diseases and Immunity Research, University of British Columbia, Vancouver, British Columbia, Canada, and the Wellcome Trust Sanger Institute, Hinxton, UK.</p>
<p class="publication"><span class="title">Nature biotechnology</span>&nbsp;<span class="year">2014</span>;<span class="volume">32</span>;<span class="number">1</span>;<span class="pagerange">66-8</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24406933">24406933</a>; DOI: <a href="http://dx.doi.org/10.1038%2Fnbt.2779">10.1038/nbt.2779</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Haptoglobin (HP) and Haptoglobin-related protein (HPR) copy number variation, natural selection, and trypanosomiasis.</h4>
<p class="authors"><span class="author">Hardwick RJ</span>, <span class="author">M&eacute;nard A</span>, <span class="author">Sironi M</span>, <span class="author">Milet J</span>, <span class="author">Garcia A</span>, <span class="author">Sese C</span>, <span class="author">Yang F</span>, <span class="author">Fu B</span>, <span class="author">Courtin D</span> and <span class="author">Hollox EJ</span></p>
<p class="affiliation">Department of Genetics, University of Leicester, Leicester, UK.</p><p class="abstract">Haptoglobin, coded by the HP gene, is a plasma protein that acts as a scavenger for free heme, and haptoglobin-related protein (coded by the HPR gene) forms part of the trypanolytic factor TLF-1, together with apolipoprotein L1 (ApoL1). We analyse the polymorphic small intragenic duplication of the HP gene, with alleles Hp1 and Hp2, in 52 populations, and find no evidence for natural selection either from extended haplotype analysis or from correlation with pathogen richness matrices. Using fiber-FISH, the paralog ratio test, and array-CGH data, we also confirm that the HPR gene is copy number variable, with duplication of the whole HPR gene at polymorphic frequencies in west and central Africa, up to an allele frequency of 15&nbsp;%. The geographical distribution of the HPR duplication allele overlaps the region where the pathogen causing chronic human African trypanosomiasis, Trypanosoma brucei gambiense, is endemic. The HPR duplication has occurred on one SNP haplotype, but there is no strong evidence of extended homozygosity, a characteristic of recent natural selection. The HPR duplication shows a slight, non-significant undertransmission to human African trypanosomiasis-affected children of unaffected parents in the Democratic Republic of Congo. However, taken together with alleles of APOL1, there is an overall significant undertransmission of putative protective alleles to human African trypanosomiasis-affected children.</p>
<p class="publication"><span class="title">Human genetics</span>&nbsp;<span class="year">2014</span>;<span class="volume">133</span>;<span class="number">1</span>;<span class="pagerange">69-83</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24005574">24005574</a>; DOI: <a href="http://dx.doi.org/10.1007%2Fs00439-013-1352-x">10.1007/s00439-013-1352-x</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Restriction and recruitment - gene duplication and the origin and evolution of snake venom toxins.</h4>
<p class="authors"><span class="author">Hargreaves AD</span>, <span class="author">Swain MT</span>, <span class="author">Hegarty MJ</span>, <span class="author">Logan DW</span> and <span class="author">Mulley JF</span></p>
<p class="affiliation">1. School of Biological Sciences, Bangor University, Brambell Building, Deiniol Road, Bangor, Gwynedd, LL57 2UW, United Kingdom.</p><p class="abstract">Snake venom has been hypothesised to have originated and diversified via a process that involves duplication of genes encoding body proteins with subsequent recruitment of the copy to the venom gland, where natural selection acts to develop or increase toxicity. However, gene duplication is known to be a rare event in vertebrate genomes and the recruitment of duplicated genes to a novel expression domain (neofunctionalisation) is an even rarer process that requires the evolution of novel combinations of transcription factor binding sites in upstream regulatory regions. Therefore, whilst this hypothesis concerning the evolution of snake venom is therefore very unlikely and should be regarded with caution, it is nonetheless often assumed to be established fact, hindering research into the true origins of snake venom toxins. To critically evaluate this hypothesis we have generated transcriptomic data for body tissues and salivary and venom glands from five species of venomous and non-venomous reptiles. Our comparative transcriptomic analysis of these data reveals that snake venom does not evolve via the hypothesised process of duplication and recruitment of genes encoding body proteins. Indeed, our results show that many proposed venom toxins are in fact expressed in a wide variety of body tissues, including the salivary gland of non-venomous reptiles and that these genes have therefore been restricted to the venom gland following duplication, not recruited. Thus snake venom evolves via the duplication and subfunctionalisation of genes encoding existing salivary proteins. These results highlight the danger of the elegant and intuitive &quot;just-so story&quot; in evolutionary biology.</p>
<p class="publication"><span class="title">Genome biology and evolution</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25079342">25079342</a>; DOI: <a href="http://dx.doi.org/10.1093%2Fgbe%2Fevu166">10.1093/gbe/evu166</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Abundant and Diverse Clustered Regularly Interspaced Short Palindromic Repeat Spacers in Clostridium difficile Strains and Prophages Target Multiple Phage Types within This Pathogen.</h4>
<p class="authors"><span class="author">Hargreaves KR</span>, <span class="author">Flores CO</span>, <span class="author">Lawley TD</span> and <span class="author">Clokie MR</span></p>
<p class="affiliation">Department of Infection, Inflammation and Immunity, University of Leicester, Leicester, United Kingdom.</p><p class="abstract">Clostridium difficile is an important human-pathogenic bacterium causing antibiotic-associated nosocomial infections worldwide. Mobile genetic elements and bacteriophages have helped shape C.&nbsp;difficile genome evolution. In many bacteria, phage infection may be controlled by a form of bacterial immunity called the clustered regularly interspaced short palindromic repeats/CRISPR-associated (CRISPR/Cas) system. This uses acquired short nucleotide sequences (spacers) to target homologous sequences (protospacers) in phage genomes. C.&nbsp;difficile carries multiple CRISPR arrays, and in this paper we examine the relationships between the host- and phage-carried elements of the system. We detected multiple matches between spacers and regions in 31 C.&nbsp;difficile phage and prophage genomes. A subset of the spacers was located in prophage-carried CRISPR arrays. The CRISPR spacer profiles generated suggest that related phages would have similar host ranges. Furthermore, we show that C.&nbsp;difficile strains of the same ribotype could either have similar or divergent CRISPR contents. Both synonymous and nonsynonymous mutations in the protospacer sequences were identified, as well as differences in the protospacer adjacent motif (PAM), which could explain how phages escape this system. This paper illustrates how the distribution and diversity of CRISPR spacers in C.&nbsp;difficile, and its prophages, could modulate phage predation for this pathogen and impact upon its evolution and pathogenicity.</p><p class="abstract"><strong>Importance</strong>: Clostridium difficile is a significant bacterial human pathogen which undergoes continual genome evolution, resulting in the emergence of new virulent strains. Phages are major facilitators of genome evolution in other bacterial species, and we use sequence analysis-based approaches in order to examine whether the CRISPR/Cas system could control these interactions across divergent C.&nbsp;difficile strains. The presence of spacer sequences in prophages that are homologous to phage genomes raises an extra level of complexity in this predator-prey microbial system. Our results demonstrate that the impact of phage infection in this system is widespread and that the CRISPR/Cas system is likely to be an important aspect of the evolutionary dynamics in C.&nbsp;difficile.</p>
<p class="publication"><span class="title">mBio</span>&nbsp;<span class="year">2014</span>;<span class="volume">5</span>;<span class="number">5</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25161187">25161187</a>; DOI: <a href="http://dx.doi.org/10.1128%2FmBio.01045-13">10.1128/mBio.01045-13</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">WormBase 2014: new views of curated biology.</h4>
<p class="authors"><span class="author">Harris TW</span>, <span class="author">Baran J</span>, <span class="author">Bieri T</span>, <span class="author">Cabunoc A</span>, <span class="author">Chan J</span>, <span class="author">Chen WJ</span>, <span class="author">Davis P</span>, <span class="author">Done J</span>, <span class="author">Grove C</span>, <span class="author">Howe K</span>, <span class="author">Kishore R</span>, <span class="author">Lee R</span>, <span class="author">Li Y</span>, <span class="author">Muller HM</span>, <span class="author">Nakamura C</span>, <span class="author">Ozersky P</span>, <span class="author">Paulini M</span>, <span class="author">Raciti D</span>, <span class="author">Schindelman G</span>, <span class="author">Tuli MA</span>, <span class="author">Van Auken K</span>, <span class="author">Wang D</span>, <span class="author">Wang X</span>, <span class="author">Williams G</span>, <span class="author">Wong JD</span>, <span class="author">Yook K</span>, <span class="author">Schedl T</span>, <span class="author">Hodgkin J</span>, <span class="author">Berriman M</span>, <span class="author">Kersey P</span>, <span class="author">Spieth J</span>, <span class="author">Stein L</span> and <span class="author">Sternberg PW</span></p>
<p class="affiliation">Informatics and Bio-computing Platform, Ontario Institute for Cancer Research, Toronto, ON M5G0A3, Canada, Genome Sequencing Center, Washington University, School of Medicine, St Louis, MO 63108, USA, Division of Biology and Biological Engineering 156-29, California Institute of Technology, Pasadena, CA 91125, USA, European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1SD, UK, Department of Genetics Campus, Washington University School of Medicine, St. Louis, MO 63110, USA, Genetics Unit, Department of Biochemistry, University of Oxford, Oxford OX1 3QU, UK, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1SA, UK and Howard Hughes Medical Institute, California Institute of Technology, Pasadena, CA 91125, USA.</p><p class="abstract">WormBase (http://www.wormbase.org/) is a highly curated resource dedicated to supporting research using the model organism Caenorhabditis elegans. With an electronic history predating the World Wide Web, WormBase contains information ranging from the sequence and phenotype of individual alleles to genome-wide studies generated using next-generation sequencing technologies. In recent years, we have expanded the contents to include data on additional nematodes of agricultural and medical significance, bringing the knowledge of C. elegans to bear on these systems and providing support for underserved research communities. Manual curation of the primary literature remains a central focus of the WormBase project, providing users with reliable, up-to-date and highly cross-linked information. In this update, we describe efforts to organize the original atomized and highly contextualized curated data into integrated syntheses of discrete biological topics. Next, we discuss our experiences coping with the vast increase in available genome sequences made possible through next-generation sequencing platforms. Finally, we describe some of the features and tools of the new WormBase Web site that help users better find and explore data of interest.</p>
<p class="grants">Funded by: Howard Hughes Medical Institute; Medical Research Council: <span class="grant">G070119</span>, <span class="grant">MR/L001020/1</span>; NHGRI NIH HHS: <span class="grant">P41 HG002223</span>, <span class="grant">U41-HG002223</span></p>
<p class="publication"><span class="title">Nucleic acids research</span>&nbsp;<span class="year">2014</span>;<span class="volume">42</span>;<span class="number">Database issue</span>;<span class="pagerange">D789-93</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24194605">24194605</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC3965043">3965043</a>; DOI: <a href="http://dx.doi.org/10.1093%2Fnar%2Fgkt1063">10.1093/nar/gkt1063</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Modification of British Committee for Standards in Haematology diagnostic criteria for essential thrombocythaemia.</h4>
<p class="authors"><span class="author">Harrison CN</span>, <span class="author">Butt N</span>, <span class="author">Campbell P</span>, <span class="author">Conneally E</span>, <span class="author">Drummond M</span>, <span class="author">Green AR</span>, <span class="author">Murrin R</span>, <span class="author">Radia DH</span>, <span class="author">Mead A</span>, <span class="author">Reilly JT</span>, <span class="author">Cross NC</span> and <span class="author">McMullin MF</span></p>
<p class="affiliation">Department of Haematology, Guy&#39;s and St Thomas, Hospitals&#39; NHS Foundation Trust, London, UK. <a href="mailto:%43%6C%61%69%72%65.%48%61%72%72%69%73%6F%6E%40%67%73%74%74.%6E%68%73.%75%6B">&#67;&#108;&#97;&#105;&#114;&#101;&#46;&#72;&#97;&#114;&#114;&#105;&#115;&#111;&#110;&#64;&#103;&#115;&#116;&#116;&#46;&#110;&#104;&#115;&#46;&#117;&#107;</a>.</p>
<p class="publication"><span class="title">British journal of haematology</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24935860">24935860</a>; DOI: <a href="http://dx.doi.org/10.1111%2Fbjh.12986">10.1111/bjh.12986</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">A novel hybrid SCCmec-mecC region in Staphylococcus sciuri.</h4>
<p class="authors"><span class="author">Harrison EM</span>, <span class="author">Paterson GK</span>, <span class="author">Holden MT</span>, <span class="author">Ba X</span>, <span class="author">Rolo J</span>, <span class="author">Morgan FJ</span>, <span class="author">Pichon B</span>, <span class="author">Kearns A</span>, <span class="author">Zadoks RN</span>, <span class="author">Peacock SJ</span>, <span class="author">Parkhill J</span> and <span class="author">Holmes MA</span></p>
<p class="affiliation">Department of Veterinary Medicine, University of Cambridge, Cambridge, UK.</p><p class="abstract"><strong>Objectives</strong>: Methicillin resistance in Staphylococcus spp. results from the expression of an alternative penicillin-binding protein 2a (encoded by mecA) with a low affinity for &beta;-lactam antibiotics. Recently, a novel variant of mecA known as mecC (formerly mecALGA251) was identified in Staphylococcus aureus isolates from both humans and animals. In this study, we identified two Staphylococcus sciuri subsp. carnaticus isolates from bovine infections that harbour three different mecA homologues: mecA, mecA1 and mecC.</p><p class="abstract"><strong>Methods</strong>: We subjected the two isolates to whole-genome sequencing to further understand the genetic context of the mec-containing region. We also used PCR and RT-PCR to investigate the excision and expression of the SCCmec element and mec genes, respectively.</p><p class="abstract"><strong>Results</strong>: Whole-genome sequencing revealed a novel hybrid SCCmec region at the orfX locus consisting of a class E mec complex (mecI-mecR1-mecC1-blaZ) located immediately downstream of a staphylococcal cassette chromosome mec (SCCmec) type VII element. A second SCCmec attL site (attL2), which was imperfect, was present downstream of the mecC region. PCR analysis of stationary-phase cultures showed that both the SCCmec type VII element and a hybrid SCCmec-mecC element were capable of excision from the genome and forming a circular intermediate. Transcriptional analysis showed that mecC and mecA, but not mecA1, were both expressed in liquid culture supplemented with oxacillin.</p><p class="abstract"><strong>Conclusions</strong>: Overall, this study further highlights that a range of staphylococcal species harbour the mecC gene and furthers the view that coagulase-negative staphylococci associated with animals may act as reservoirs of antibiotic resistance genes for more pathogenic staphylococcal species.</p>
<p class="publication"><span class="title">The Journal of antimicrobial chemotherapy</span>&nbsp;<span class="year">2014</span>;<span class="volume">69</span>;<span class="number">4</span>;<span class="pagerange">911-8</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24302651">24302651</a>; DOI: <a href="http://dx.doi.org/10.1093%2Fjac%2Fdkt452">10.1093/jac/dkt452</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">A shared population of epidemic methicillin-resistant Staphylococcus aureus 15 circulates in humans and companion animals.</h4>
<p class="authors"><span class="author">Harrison EM</span>, <span class="author">Weinert LA</span>, <span class="author">Holden MT</span>, <span class="author">Welch JJ</span>, <span class="author">Wilson K</span>, <span class="author">Morgan FJ</span>, <span class="author">Harris SR</span>, <span class="author">Loeffler A</span>, <span class="author">Boag AK</span>, <span class="author">Peacock SJ</span>, <span class="author">Paterson GK</span>, <span class="author">Waller AS</span>, <span class="author">Parkhill J</span> and <span class="author">Holmes MA</span></p>
<p class="affiliation">Department of Veterinary Medicine, University of Cambridge, Cambridge, United Kingdom.</p><p class="abstract"><strong>Unlabelled</strong>: Methicillin-resistant Staphylococcus aureus (MRSA) is a global human health problem causing infections in both hospitals and the community. Companion animals, such as cats, dogs, and horses, are also frequently colonized by MRSA and can become infected. We sequenced the genomes of 46 multilocus sequence type (ST) 22 MRSA isolates from cats and dogs in the United Kingdom and compared these to an extensive population framework of human isolates from the same lineage. Phylogenomic analyses showed that all companion animal isolates were interspersed throughout the epidemic MRSA-15 (EMRSA-15) pandemic clade and clustered with human isolates from the United Kingdom, with human isolates basal to those from companion animals, suggesting a human source for isolates infecting companion animals. A number of isolates from the same veterinary hospital clustered together, suggesting that as in human hospitals, EMRSA-15 isolates are readily transmitted in the veterinary hospital setting. Genome-wide association analysis did not identify any host-specific single nucleotide polymorphisms (SNPs) or virulence factors. However, isolates from companion animals were significantly less likely to harbor a plasmid encoding erythromycin resistance. When this plasmid was present in animal-associated isolates, it was more likely to contain mutations mediating resistance to clindamycin. This finding is consistent with the low levels of erythromycin and high levels of clindamycin used in veterinary medicine in the United Kingdom. This study furthers the &quot;one health&quot; view of infectious diseases that the pathogen pool of human and animal populations are intrinsically linked and provides evidence that antibiotic usage in animal medicine is shaping the population of a major human pathogen.</p><p class="abstract"><strong>Importance</strong>: Methicillin-resistant Staphylococcus aureus (MRSA) is major problem in human medicine. Companion animals, such as cats, dogs, and horses, can also become colonized and infected by MRSA. Here, we demonstrate that a shared population of an important and globally disseminated lineage of MRSA can infect both humans and companion animals without undergoing host adaptation. This suggests that companion animals might act as a reservoir for human infections. We also show that the isolates from companion animals have differences in the presence of certain antibiotic resistance genes. This study furthers the &quot;one health&quot; view of infectious diseases by demonstrating that the pool of MRSA isolates in the human and animal populations are shared and highlights how different antibiotic usage patterns between human and veterinary medicine can shape the population of bacterial pathogens.</p>
<p class="grants">Funded by: Medical Research Council: <span class="grant">G1001787</span>, <span class="grant">G1001787/1</span>; Wellcome Trust: <span class="grant">098051</span></p>
<p class="publication"><span class="title">mBio</span>&nbsp;<span class="year">2014</span>;<span class="volume">5</span>;<span class="number">3</span>;<span class="pagerange">e00985-13</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24825010">24825010</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4030480">4030480</a>; DOI: <a href="http://dx.doi.org/10.1128%2FmBio.00985-13">10.1128/mBio.00985-13</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">The Vertebrate Genome Annotation browser 10 years on.</h4>
<p class="authors"><span class="author">Harrow JL</span>, <span class="author">Steward CA</span>, <span class="author">Frankish A</span>, <span class="author">Gilbert JG</span>, <span class="author">Gonzalez JM</span>, <span class="author">Loveland JE</span>, <span class="author">Mudge J</span>, <span class="author">Sheppard D</span>, <span class="author">Thomas M</span>, <span class="author">Trevanion S</span> and <span class="author">Wilming LG</span></p>
<p class="affiliation">Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire CB10 1HH, UK.</p><p class="abstract">The Vertebrate Genome Annotation (VEGA) database (http://vega.sanger.ac.uk), initially designed as a community resource for browsing manual annotation of the human genome project, now contains five reference genomes (human, mouse, zebrafish, pig and rat). Its introduction pages have been redesigned to enable the user to easily navigate between whole genomes and smaller multi-species haplotypic regions of interest such as the major histocompatibility complex. The VEGA browser is unique in that annotation is updated via the Human And Vertebrate Analysis aNd Annotation (HAVANA) update track every 2 weeks, allowing single gene updates to be made publicly available to the research community quickly. The user can now access different haplotypic subregions more easily, such as those from the non-obese diabetic mouse, and display them in a more intuitive way using the comparative tools. We also highlight how the user can browse manually annotated updated patches from the Genome Reference Consortium (GRC).</p>
<p class="grants">Funded by: Biotechnology and Biological Sciences Research Council: <span class="grant">BB/K009524/1</span>; NHGRI NIH HHS: <span class="grant">5U54HG004555</span>, <span class="grant">U41 HG007234</span>, <span class="grant">U54 HG004555</span>; Wellcome Trust: <span class="grant">WT098051</span></p>
<p class="publication"><span class="title">Nucleic acids research</span>&nbsp;<span class="year">2014</span>;<span class="volume">42</span>;<span class="number">Database issue</span>;<span class="pagerange">D771-9</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24316575">24316575</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC3964964">3964964</a>; DOI: <a href="http://dx.doi.org/10.1093%2Fnar%2Fgkt1241">10.1093/nar/gkt1241</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Using population isolates in genetic association studies.</h4>
<p class="authors"><span class="author">Hatzikotoulas K</span>, <span class="author">Gilly A</span> and <span class="author">Zeggini E</span></p><p class="abstract">The use of genetically isolated populations can empower next-generation association studies. In this review, we discuss the advantages of this approach and review study design and analytical considerations of genetic association studies focusing on isolates. We cite successful examples of using population isolates in association studies and outline potential ways forward.</p>
<p class="grants">Funded by: Wellcome Trust: <span class="grant">098051</span></p>
<p class="publication"><span class="title">Briefings in functional genomics</span>&nbsp;<span class="year">2014</span>;<span class="volume">13</span>;<span class="number">5</span>;<span class="pagerange">371-7</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25009120">25009120</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4168662">4168662</a>; DOI: <a href="http://dx.doi.org/10.1093%2Fbfgp%2Felu022">10.1093/bfgp/elu022</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Bayesian latent variable collapsing model for detecting rare variant interaction effect in twin study.</h4>
<p class="authors"><span class="author">He L</span>, <span class="author">Sillanp&auml;&auml; MJ</span>, <span class="author">Ripatti S</span> and <span class="author">Pitk&auml;niemi J</span></p>
<p class="affiliation">Department of Public Health, Hjelt Institute, University of Helsinki, Finland.</p><p class="abstract">By analyzing more next-generation sequencing data, researchers have affirmed that rare genetic variants are widespread among populations and likely play an important role in complex phenotypes. Recently, a handful of statistical models have been developed to analyze rare variant (RV) association in different study designs. However, due to the scarce occurrence of minor alleles in data, appropriate statistical methods for detecting RV interaction effects are still difficult to develop. We propose a hierarchical Bayesian latent variable collapsing method (BLVCM), which circumvents the obstacles by parameterizing the signals of RVs with latent variables in a Bayesian framework and is parameterized for twin data. The BLVCM can tackle nonassociated variants, allow both protective and deleterious effects, capture SNP-SNP synergistic effect, provide estimates for the gene level and individual SNP contributions, and can be applied to both independent and various twin designs. We assessed the statistical properties of the BLVCM using simulated data, and found that it achieved better performance in terms of power for interaction effect detection compared to the Granvil and the SKAT. As proof of practical application, the BLVCM was then applied to a twin study analysis of more than 20,000 gene regions to identify significant RVs associated with low-density lipoprotein cholesterol level. The results show that some of the findings are consistent with previous studies, and we identified some novel gene regions with significant SNP-SNP synergistic effects.</p>
<p class="grants">Funded by: NIAAA NIH HHS: <span class="grant">AA-00145</span>, <span class="grant">AA-09203</span>, <span class="grant">AA-12502</span>, <span class="grant">AA15416</span>, <span class="grant">K02AA018755</span></p>
<p class="publication"><span class="title">Genetic epidemiology</span>&nbsp;<span class="year">2014</span>;<span class="volume">38</span>;<span class="number">4</span>;<span class="pagerange">310-24</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24719390">24719390</a>; DOI: <a href="http://dx.doi.org/10.1002%2Fgepi.21804">10.1002/gepi.21804</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Mechanisms underlying mutational signatures in human cancers.</h4>
<p class="authors"><span class="author">Helleday T</span>, <span class="author">Eshtad S</span> and <span class="author">Nik-Zainal S</span></p>
<p class="affiliation">Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, S-171 21 Stockholm, Sweden.</p><p class="abstract">The collective somatic mutations observed in a cancer are the outcome of multiple mutagenic processes that have been operative over the lifetime of a patient. Each process leaves a characteristic imprint - a mutational signature - on the cancer genome, which is defined by the type of DNA damage and DNA repair processes that result in base substitutions, insertions and deletions or structural variations. With the advent of whole-genome sequencing, researchers are identifying an increasing array of these signatures. Mutational signatures can be used as a physiological readout of the biological history of a cancer and also have potential use for discerning ongoing mutational processes from historical ones, thus possibly revealing new targets for anticancer therapies.</p>
<p class="publication"><span class="title">Nature reviews. Genetics</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24981601">24981601</a>; DOI: <a href="http://dx.doi.org/10.1038%2Fnrg3729">10.1038/nrg3729</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Innate immunity. A Spaetzle-like role for nerve growth factor &beta; in vertebrate immunity to Staphylococcus aureus.</h4>
<p class="authors"><span class="author">Hepburn L</span>, <span class="author">Prajsnar TK</span>, <span class="author">Klapholz C</span>, <span class="author">Moreno P</span>, <span class="author">Loynes CA</span>, <span class="author">Ogryzko NV</span>, <span class="author">Brown K</span>, <span class="author">Schiebler M</span>, <span class="author">Hegyi K</span>, <span class="author">Antrobus R</span>, <span class="author">Hammond KL</span>, <span class="author">Connolly J</span>, <span class="author">Ochoa B</span>, <span class="author">Bryant C</span>, <span class="author">Otto M</span>, <span class="author">Surewaard B</span>, <span class="author">Seneviratne SL</span>, <span class="author">Grogono DM</span>, <span class="author">Cachat J</span>, <span class="author">Ny T</span>, <span class="author">Kaser A</span>, <span class="author">T&ouml;r&ouml;k ME</span>, <span class="author">Peacock SJ</span>, <span class="author">Holden M</span>, <span class="author">Blundell T</span>, <span class="author">Wang L</span>, <span class="author">Ligoxygakis P</span>, <span class="author">Minichiello L</span>, <span class="author">Woods CG</span>, <span class="author">Foster SJ</span>, <span class="author">Renshaw SA</span> and <span class="author">Floto RA</span></p>
<p class="affiliation">Cambridge Institute for Medical Research, University of Cambridge, UK. Department of Medicine, University of Cambridge, UK.</p><p class="abstract">Many key components of innate immunity to infection are shared between Drosophila and humans. However, the fly Toll ligand Spaetzle is not thought to have a vertebrate equivalent. We have found that the structurally related cystine-knot protein, nerve growth factor &beta; (NGF&beta;), plays an unexpected Spaetzle-like role in immunity to Staphylococcus aureus infection in chordates. Deleterious mutations of either human NGF&beta; or its high-affinity receptor tropomyosin-related kinase receptor A (TRKA) were associated with severe S. aureus infections. NGF&beta; was released by macrophages in response to S. aureus exoproteins through activation of the NOD-like receptors NLRP3 and NLRP4 and enhanced phagocytosis and superoxide-dependent killing, stimulated proinflammatory cytokine production, and promoted calcium-dependent neutrophil recruitment. TrkA knockdown in zebrafish increased susceptibility to S. aureus infection, confirming an evolutionarily conserved role for NGF&beta;-TRKA signaling in pathogen-specific host immunity.</p>
<p class="grants">Funded by: Department of Health; Medical Research Council: <span class="grant">G0700091</span>, <span class="grant">G0701932</span>; Wellcome Trust: <span class="grant">084953</span>, <span class="grant">089981</span></p>
<p class="publication"><span class="title">Science (New York, N.Y.)</span>&nbsp;<span class="year">2014</span>;<span class="volume">346</span>;<span class="number">6209</span>;<span class="pagerange">641-6</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25359976">25359976</a>; DOI: <a href="http://dx.doi.org/10.1126%2Fscience.1258705">10.1126/science.1258705</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Optoactivation of locus ceruleus neurons evokes bidirectional changes in thermal nociception in rats.</h4>
<p class="authors"><span class="author">Hickey L</span>, <span class="author">Li Y</span>, <span class="author">Fyson SJ</span>, <span class="author">Watson TC</span>, <span class="author">Perrins R</span>, <span class="author">Hewinson J</span>, <span class="author">Teschemacher AG</span>, <span class="author">Furue H</span>, <span class="author">Lumb BM</span> and <span class="author">Pickering AE</span></p>
<p class="affiliation">School of Physiology and Pharmacology, University of Bristol, Bristol BS8 1TD, United Kingdom, Department of Anesthesia, University Hospitals Bristol, Bristol BS2 8HW, United Kingdom, Department of Information Physiology, National Institute for Physiological Sciences, Myodaiji, Okazaki 444-8787, Japan, Wellcome Trust Sanger Institute, Cambridge CB10 1SA, United Kingdom, and Sorbonne Universit&eacute;s, Universit&eacute; Pierre et Marie Curie Paris 6, Unit&eacute; Mixte de Recherche-Scientifique 8246, Neuroscience Paris Seine, Navigation Memory and Aging team, F-75005 Paris, France.</p><p class="abstract">Pontospinal noradrenergic neurons are thought to form part of a descending endogenous analgesic system that exerts inhibitory influences on spinal nociception. Using optogenetic targeting, we tested the hypothesis that excitation of the locus ceruleus (LC) is antinociceptive. We transduced rat LC neurons by direct injection of a lentiviral vector expressing channelrhodopsin2 under the control of the PRS promoter. Subsequent optoactivation of the LC evoked repeatable, robust, antinociceptive (+4.7&deg;C &plusmn; 1.0, p &lt; 0.0001) or pronociceptive (-4.4&deg;C &plusmn; 0.7, p &lt; 0.0001) changes in hindpaw thermal withdrawal thresholds. Post hoc anatomical characterization of the distribution of transduced somata referenced against the position of the optical fiber and subsequent further functional analysis showed that antinociceptive actions were evoked from a distinct, ventral subpopulation of LC neurons. Therefore, the LC is capable of exerting potent, discrete, bidirectional influences on thermal nociception that are produced by specific subpopulations of noradrenergic neurons. This reflects an underlying functional heterogeneity of the influence of the LC on the processing of nociceptive information.</p>
<p class="publication"><span class="title">The Journal of neuroscience : the official journal of the Society for Neuroscience</span>&nbsp;<span class="year">2014</span>;<span class="volume">34</span>;<span class="number">12</span>;<span class="pagerange">4148-60</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24647936">24647936</a>; DOI: <a href="http://dx.doi.org/10.1523%2FJNEUROSCI.4835-13.2014">10.1523/JNEUROSCI.4835-13.2014</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Global phylogenomic analysis of nonencapsulated Streptococcus pneumoniae reveals a deep-branching classic lineage that is distinct from multiple sporadic lineages.</h4>
<p class="authors"><span class="author">Hilty M</span>, <span class="author">W&uuml;thrich D</span>, <span class="author">Salter SJ</span>, <span class="author">Engel H</span>, <span class="author">Campbell S</span>, <span class="author">S&aacute;-Le&atilde;o R</span>, <span class="author">de Lencastre H</span>, <span class="author">Hermans P</span>, <span class="author">Sadowy E</span>, <span class="author">Turner P</span>, <span class="author">Chewapreecha C</span>, <span class="author">Diggle M</span>, <span class="author">Pluschke G</span>, <span class="author">McGee L</span>, <span class="author">Eser OK</span>, <span class="author">Low DE</span>, <span class="author">Smith-Vaughan H</span>, <span class="author">Endimiani A</span>, <span class="author">K&uuml;ffer M</span>, <span class="author">Dupasquier M</span>, <span class="author">Beaudoing E</span>, <span class="author">Weber J</span>, <span class="author">Bruggmann R</span>, <span class="author">Hanage WP</span>, <span class="author">Parkhill J</span>, <span class="author">Hathaway LJ</span>, <span class="author">M&uuml;hlemann K</span> and <span class="author">Bentley SD</span></p>
<p class="affiliation">1. Institute for Infectious Diseases, University of Bern, Switzerland 2. Department of Infectious Diseases, Inselspital, Bern University Hospital and University of Bern, Switzerland <a href="mailto:%4D%61%72%6B%75%73.%48%69%6C%74%79%40%69%66%69%6B.%75%6E%69%62%65.%63%68">&#77;&#97;&#114;&#107;&#117;&#115;&#46;&#72;&#105;&#108;&#116;&#121;&#64;&#105;&#102;&#105;&#107;&#46;&#117;&#110;&#105;&#98;&#101;&#46;&#99;&#104;</a>.</p><p class="abstract">The surrounding capsule of Streptococcus pneumoniae has been identified as a major virulence factor and is targeted by pneumococcal conjugate vaccines (PCV). However, nonencapsulated Streptococcus pneumoniae (Non-Ec-Sp) have also been isolated globally, mainly in carriage studies. It is unknown if Non-Ec-Sp evolve sporadically, if they have high antibiotic non-susceptiblity rates and a unique, specific gene content. Here, whole genome sequencing of 131 Non-Ec-Sp isolates sourced from 17 different locations around the world was performed. Results revealed a deep-branching classic lineage that is distinct from multiple sporadic lineages. The sporadic lineages clustered with a previously sequenced, global collection of encapsulated S. pneumoniae (Ec-Sp) isolates while the classic lineage is comprised mainly of the frequently identified multi-locus sequences types ST344 (n=39) and ST448 (n=40). All ST344 and nine ST448 isolates had high non-susceptiblity rates to &beta;-lactams and other antimicrobials. Analysis of the accessory genome reveals that the classic Non-Ec-Sp contained an increased number of mobile elements, than Ec-Sp and sporadic Non-Ec-Sp. Performing adherence assays to human epithelial cells for selected classic and sporadic Non-Ec-Sp revealed that the presence of a integrative conjugative element (ICE) results in increased adherence to human epithelial cells (P=0.005). In contrast, sporadic Non-Ec-Sp lacking the ICE had greater growth in vitro possibly resulting in improved fitness. In conclusion, Non-Ec-Sp isolates from the classic lineage have evolved separately. They have spread globally, are well adapted to nasopharyngeal carriage and are able to coexist with Ec-Sp. Due to continued use of pneumococcal conjugate vaccines, Non-Ec-Sp may become more prevalent.</p>
<p class="publication"><span class="title">Genome biology and evolution</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25480686">25480686</a>; DOI: <a href="http://dx.doi.org/10.1093%2Fgbe%2Fevu263">10.1093/gbe/evu263</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Medicine. Halting harmful helminths.</h4>
<p class="authors"><span class="author">Hoffmann KF</span>, <span class="author">Brindley PJ</span> and <span class="author">Berriman M</span></p>
<p class="affiliation">Institute of Biological, Environmental and Rural Sciences (IBERS), Aberystwyth University, Aberystwyth SY23 3DA, UK. <a href="mailto:%6B%72%68%40%61%62%65%72.%61%63.%75%6B">&#107;&#114;&#104;&#64;&#97;&#98;&#101;&#114;&#46;&#97;&#99;&#46;&#117;&#107;</a>.</p>
<p class="publication"><span class="title">Science (New York, N.Y.)</span>&nbsp;<span class="year">2014</span>;<span class="volume">346</span>;<span class="number">6206</span>;<span class="pagerange">168-9</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25301604">25301604</a>; DOI: <a href="http://dx.doi.org/10.1126%2Fscience.1261139">10.1126/science.1261139</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Trypsin- and Chymotrypsin-Like Serine Proteases in Schistosoma mansoni - &#39;The Undiscovered Country&#39;.</h4>
<p class="authors"><span class="author">Horn M</span>, <span class="author">Fajtov&aacute; P</span>, <span class="author">Rojo Arreola L</span>, <span class="author">Ulrychov&aacute; L</span>, <span class="author">Barto&scaron;ov&aacute;-Sojkov&aacute; P</span>, <span class="author">Franta Z</span>, <span class="author">Protasio AV</span>, <span class="author">Opavsk&yacute; D</span>, <span class="author">Vondr&aacute;&scaron;ek J</span>, <span class="author">McKerrow JH</span>, <span class="author">Mare&scaron; M</span>, <span class="author">Caffrey CR</span> and <span class="author">Dvo&#x159;&aacute;k J</span></p>
<p class="affiliation">Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, Prague, Czech Republic.</p><p class="abstract"><strong>Background</strong>: Blood flukes (Schistosoma spp.) are parasites that can survive for years or decades in the vasculature of permissive mammalian hosts, including humans. Proteolytic enzymes (proteases) are crucial for successful parasitism, including aspects of invasion, maturation and reproduction. Most attention has focused on the &#39;cercarial elastase&#39; serine proteases that facilitate skin invasion by infective schistosome larvae, and the cysteine and aspartic proteases that worms use to digest the blood meal. Apart from the cercarial elastases, information regarding other S. mansoni serine proteases (SmSPs) is limited. To address this, we investigated SmSPs using genomic, transcriptomic, phylogenetic and functional proteomic approaches.</p><p class="abstract">Genes encoding five distinct SmSPs, termed SmSP1 - SmSP5, some of which comprise disparate protein domains, were retrieved from the S. mansoni genome database and annotated. Reverse transcription quantitative PCR (RT- qPCR) in various schistosome developmental stages indicated complex expression patterns for SmSPs, including their constituent protein domains. SmSP2 stood apart as being massively expressed in schistosomula and adult stages. Phylogenetic analysis segregated SmSPs into diverse clusters of family S1 proteases. SmSP1 to SmSP4 are trypsin-like proteases, whereas SmSP5 is chymotrypsin-like. In agreement, trypsin-like activities were shown to predominate in eggs, schistosomula and adults using peptidyl fluorogenic substrates. SmSP5 is particularly novel in the phylogenetics of family S1 schistosome proteases, as it is part of a cluster of sequences that fill a gap between the highly divergent cercarial elastases and other family S1 proteases.</p><p class="abstract">Our series of post-genomics analyses clarifies the complexity of schistosome family S1 serine proteases and highlights their interrelationships, including the cercarial elastases and, not least, the identification of a &#39;missing-link&#39; protease cluster, represented by SmSP5. A framework is now in place to guide the characterization of individual proteases, their stage-specific expression and their contributions to parasitism, in particular, their possible modulation of host physiology.</p>
<p class="publication"><span class="title">PLoS neglected tropical diseases</span>&nbsp;<span class="year">2014</span>;<span class="volume">8</span>;<span class="number">3</span>;<span class="pagerange">e2766</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24676141">24676141</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC3967958">3967958</a>; DOI: <a href="http://dx.doi.org/10.1371%2Fjournal.pntd.0002766">10.1371/journal.pntd.0002766</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Obesity accelerates epigenetic aging of human liver.</h4>
<p class="authors"><span class="author">Horvath S</span>, <span class="author">Erhart W</span>, <span class="author">Brosch M</span>, <span class="author">Ammerpohl O</span>, <span class="author">von Sch&ouml;nfels W</span>, <span class="author">Ahrens M</span>, <span class="author">Heits N</span>, <span class="author">Bell JT</span>, <span class="author">Tsai PC</span>, <span class="author">Spector TD</span>, <span class="author">Deloukas P</span>, <span class="author">Siebert R</span>, <span class="author">Sipos B</span>, <span class="author">Becker T</span>, <span class="author">R&ouml;cken C</span>, <span class="author">Schafmayer C</span> and <span class="author">Hampe J</span></p>
<p class="affiliation">Departments of Human Genetics, David Geffen School of Medicine, and Biostatistics, School of Public Health, University of California Los Angeles, CA 90095; <a href="mailto:%73%68%6F%72%76%61%74%68%40%6D%65%64%6E%65%74.%75%63%6C%61.%65%64%75">&#115;&#104;&#111;&#114;&#118;&#97;&#116;&#104;&#64;&#109;&#101;&#100;&#110;&#101;&#116;&#46;&#117;&#99;&#108;&#97;&#46;&#101;&#100;&#117;</a>.</p><p class="abstract">Because of the dearth of biomarkers of aging, it has been difficult to test the hypothesis that obesity increases tissue age. Here we use a novel epigenetic biomarker of aging (referred to as an &quot;epigenetic clock&quot;) to study the relationship between high body mass index (BMI) and the DNA methylation ages of human blood, liver, muscle, and adipose tissue. A significant correlation between BMI and epigenetic age acceleration could only be observed for liver (r = 0.42, P = 6.8 &times; 10(-4) in dataset 1 and r = 0.42, P = 1.2 &times; 10(-4) in dataset 2). On average, epigenetic age increased by 3.3 y for each 10 BMI units. The detected age acceleration in liver is not associated with the Nonalcoholic Fatty Liver Disease Activity Score or any of its component traits after adjustment for BMI. The 279 genes that are underexpressed in older liver samples are highly enriched (1.2 &times; 10(-9)) with nuclear mitochondrial genes that play a role in oxidative phosphorylation and electron transport. The epigenetic age acceleration, which is not reversible in the short term after rapid weight loss induced by bariatric surgery, may play a role in liver-related comorbidities of obesity, such as insulin resistance and liver cancer.</p>
<p class="publication"><span class="title">Proceedings of the National Academy of Sciences of the United States of America</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25313081">25313081</a>; DOI: <a href="http://dx.doi.org/10.1073%2Fpnas.1412759111">10.1073/pnas.1412759111</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Host genetics of Epstein-Barr virus infection, latency and disease.</h4>
<p class="authors"><span class="author">Houldcroft CJ</span> and <span class="author">Kellam P</span></p>
<p class="affiliation">Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Cambridge, UK; Division of Biological Anthropology, Department of Archaeology and Anthropology, University of Cambridge, Cambridge, UK.</p><p class="abstract">Epstein-Barr virus (EBV) infects 95% of the adult population and is the cause of infectious mononucleosis. It is also associated with 1% of cancers worldwide, such as nasopharyngeal carcinoma, Hodgkin&#39;s lymphoma and Burkitt&#39;s lymphoma. Human and cancer genetic studies are now major forces determining gene variants associated with many cancers, including nasopharyngeal carcinoma and Hodgkin&#39;s lymphoma. Host genetics is also important in infectious disease; however, there have been no large-scale efforts towards understanding the contribution that human genetic variation plays in primary EBV infection and latency. This review covers 25&thinsp;years of studies into host genetic susceptibility to EBV infection and disease, from candidate gene studies, to the first genome-wide association study of EBV antibody response, and an EBV-status stratified genome-wide association study of Hodgkin&#39;s lymphoma. Although many genes are implicated in EBV-related disease, studies are often small, not replicated or followed up in a different disease. Larger, appropriately powered genomic studies to understand the host response to EBV will be needed to move our understanding of the biology of EBV infection beyond the handful of genes currently identified. Fifty years since the discovery of EBV and its identification as a human oncogenic virus, a glimpse of the future is shown by the first whole-genome and whole-exome studies, revealing new human genes at the heart of the host-EBV interaction. &copy; 2014 The Authors. Reviews in Medical Virology published by John Wiley &amp; Sons Ltd.</p>
<p class="publication"><span class="title">Reviews in medical virology</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25430668">25430668</a>; DOI: <a href="http://dx.doi.org/10.1002%2Frmv.1816">10.1002/rmv.1816</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Host genetic variants and gene expression patterns associated with epstein-barr virus copy number in lymphoblastoid cell lines.</h4>
<p class="authors"><span class="author">Houldcroft CJ</span>, <span class="author">Petrova V</span>, <span class="author">Liu JZ</span>, <span class="author">Frampton D</span>, <span class="author">Anderson CA</span>, <span class="author">Gall A</span> and <span class="author">Kellam P</span></p>
<p class="affiliation">Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, United Kingdom; Division of Biological Anthropology, Department of Archaeology and Anthropology, University of Cambridge, Cambridge, United Kingdom.</p><p class="abstract">Lymphoblastoid cell lines (LCLs) are commonly used in molecular genetics, supplying DNA for the HapMap and 1000 Genomes Projects, used to test chemotherapeutic agents, and informing the basis of a number of population genetics studies of gene expression. The process of transforming human B cells into LCLs requires the presence of Epstein-Barr virus (EBV), a double-stranded DNA virus which through B-cell immortalisation maintains an episomal virus genome in every cell of an LCL at variable copy numbers. Previous studies have reported that EBV alters host-gene expression and EBV copy number may be under host genetic control. We performed a genome-wide association study of EBV genome copy number in LCLs and found the phenotype to be highly heritable, although no individual SNPs achieved a significant association with EBV copy number. The expression of two host genes (CXCL16 and AGL) was positively correlated and expression of ADARB2 was negatively correlated with EBV copy number in a genotype-independent manner. This study shows an association between EBV copy number and the gene expression profile of LCLs, and suggests that EBV copy number should be considered as a covariate in future studies of host gene expression in LCLs.</p>
<p class="publication"><span class="title">PloS one</span>&nbsp;<span class="year">2014</span>;<span class="volume">9</span>;<span class="number">10</span>;<span class="pagerange">e108384</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25290448">25290448</a>; DOI: <a href="http://dx.doi.org/10.1371%2Fjournal.pone.0108384">10.1371/journal.pone.0108384</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Using population data for assessing next generation sequencing performance.</h4>
<p class="authors"><span class="author">Houniet DT</span>, <span class="author">Rahman TJ</span>, <span class="author">Al Turki S</span>, <span class="author">Hurles ME</span>, <span class="author">Xu Y</span>, <span class="author">Goodship J</span>, <span class="author">Keavney B</span> and <span class="author">Santibanez Koref M</span></p>
<p class="affiliation">Oxford Gene Technology, Begbroke Science Park, Oxford, Oxfordshire, OX5 1PF, UK. <a href="mailto:%44%61%72%72%65%6E.%48%6F%75%6E%69%65%74%40%6F%67%74.%63%6F%6D">&#68;&#97;&#114;&#114;&#101;&#110;&#46;&#72;&#111;&#117;&#110;&#105;&#101;&#116;&#64;&#111;&#103;&#116;&#46;&#99;&#111;&#109;</a>.</p><p class="abstract"><strong>Motivation</strong>: During the past four years whole exome sequencing has become a standard tool for finding rare variants causing Mendelian disorders. In that time there has also been a proliferation of both sequencing platforms and approaches to analyse their output. This requires approaches to assess the performance of different methods. Traditionally criteria such as comparison with microarray data or a number of known polymorphic sites have been used. Here we expand such approaches, developing a maximum likelihood framework and using it to estimate the sensitivity and specificity of whole exome sequencing data.</p><p class="abstract"><strong>Results</strong>: Using whole exome sequencing data for a panel of 19 individuals, we show that estimated sensitivity and specificity are similar to those calculated using microarray data as a reference. We explore the effect of frequency misspecification arising from using an inappropriately selected population and find that, although the estimates are affected, the rankings across procedures remain the same. Availability: An implementation using Perl and R can be found at busso.ncl.ac.uk (Username: igm101; Password : Z1z1nts).</p><p class="abstract"><strong>Contact</strong>: <a href="mailto:%44%61%72%72%65%6E.%48%6F%75%6E%69%65%74%40%6F%67%74.%63%6F%6D">&#68;&#97;&#114;&#114;&#101;&#110;&#46;&#72;&#111;&#117;&#110;&#105;&#101;&#116;&#64;&#111;&#103;&#116;&#46;&#99;&#111;&#109;</a>.</p>
<p class="publication"><span class="title">Bioinformatics (Oxford, England)</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25236458">25236458</a>; DOI: <a href="http://dx.doi.org/10.1093%2Fbioinformatics%2Fbtu606">10.1093/bioinformatics/btu606</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Different waves and directions of Neolithic migrations in the Armenian Highland.</h4>
<p class="authors"><span class="author">Hovhannisyan A</span>, <span class="author">Khachatryan Z</span>, <span class="author">Haber M</span>, <span class="author">Hrechdakian P</span>, <span class="author">Karafet T</span>, <span class="author">Zalloua P</span> and <span class="author">Yepiskoposyan L</span></p>
<p class="affiliation">Laboratory of Ethnogenomics, Institute of Molecular Biology NAS RA, 7 Hasratyan Str., Yerevan, Armenia.</p><p class="abstract"><strong>Background</strong>: The peopling of Europe and the nature of the Neolithic agricultural migration as a primary issue in the modern human colonization of the globe is still widely debated. At present, much uncertainty is associated with the reconstruction of the routes of migration for the first farmers from the Near East. In this context, hospitable climatic conditions and the key geographic position of the Armenian Highland suggest that it may have served as a conduit for several waves of expansion of the first agriculturalists from the Near East to Europe and the North Caucasus.</p><p class="abstract"><strong>Results</strong>: Here, we assess Y-chromosomal distribution in six geographically distinct populations of Armenians that roughly represent the extent of historical Armenia. Using the general haplogroup structure and the specific lineages representing putative genetic markers of the Neolithic Revolution, haplogroups R1b1a2, J2, and G, we identify distinct patterns of genetic affinity between the populations of the Armenian Highland and the neighboring ones north and west from this area.</p><p class="abstract"><strong>Conclusions</strong>: Based on the results obtained, we suggest a new insight on the different routes and waves of Neolithic expansion of the first farmers through the Armenian Highland. We detected at least two principle migratory directions: (1) westward alongside the coastline of the Mediterranean Sea and (2) northward to the North Caucasus.</p>
<p class="publication"><span class="title">Investigative genetics</span>&nbsp;<span class="year">2014</span>;<span class="volume">5</span>;<span class="number">1</span>;<span class="pagerange">15</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25452838">25452838</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4249771">4249771</a>; DOI: <a href="http://dx.doi.org/10.1186%2Fs13323-014-0015-6">10.1186/s13323-014-0015-6</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Genome-Wide Association Study for Circulating Tissue Plasminogen Activator Levels and Functional Follow-Up Implicates Endothelial STXBP5 and STX2.</h4>
<p class="authors"><span class="author">Huang J</span>, <span class="author">Huffman JE</span>, <span class="author">Yamkauchi M</span>, <span class="author">Trompet S</span>, <span class="author">Asselbergs FW</span>, <span class="author">Sabater-Lleal M</span>, <span class="author">Tr&eacute;gou&euml;t DA</span>, <span class="author">Chen WM</span>, <span class="author">Smith NL</span>, <span class="author">Kleber ME</span>, <span class="author">Shin SY</span>, <span class="author">Becker DM</span>, <span class="author">Tang W</span>, <span class="author">Dehghan A</span>, <span class="author">Johnson AD</span>, <span class="author">Truong V</span>, <span class="author">Folkersen L</span>, <span class="author">Yang Q</span>, <span class="author">Oudot-Mellkah T</span>, <span class="author">Buckley BM</span>, <span class="author">Moore JH</span>, <span class="author">Williams FM</span>, <span class="author">Campbell H</span>, <span class="author">Silbernagel G</span>, <span class="author">Vitart V</span>, <span class="author">Rudan I</span>, <span class="author">Tofler GH</span>, <span class="author">Navis GJ</span>, <span class="author">Destefano A</span>, <span class="author">Wright AF</span>, <span class="author">Chen MH</span>, <span class="author">de Craen AJ</span>, <span class="author">Worrall BB</span>, <span class="author">Rudnicka AR</span>, <span class="author">Rumley A</span>, <span class="author">Bookman EB</span>, <span class="author">Psaty BM</span>, <span class="author">Chen F</span>, <span class="author">Keene KL</span>, <span class="author">Franco OH</span>, <span class="author">B&ouml;hm BO</span>, <span class="author">Uitterlinden AG</span>, <span class="author">Carter AM</span>, <span class="author">Jukema JW</span>, <span class="author">Sattar N</span>, <span class="author">Bis JC</span>, <span class="author">Ikram MA</span>, <span class="author">the Cohorts for Heart and Aging Research in Genome Epidemiology (CHARGE) Consortium Neurology Working Group</span>, <span class="author">Sale MM</span>, <span class="author">McKnight B</span>, <span class="author">Fornage M</span>, <span class="author">Ford I</span>, <span class="author">Taylor K</span>, <span class="author">Slagboom PE</span>, <span class="author">McArdle WL</span>, <span class="author">Hsu FC</span>, <span class="author">Franco-Cereceda A</span>, <span class="author">Goodall AH</span>, <span class="author">Yanek LR</span>, <span class="author">Furie KL</span>, <span class="author">Cushman M</span>, <span class="author">Hofman A</span>, <span class="author">Witteman JC</span>, <span class="author">Folsom AR</span>, <span class="author">Basu S</span>, <span class="author">Matijevic N</span>, <span class="author">van Gilst WH</span>, <span class="author">Wilson JF</span>, <span class="author">Westendorp RG</span>, <span class="author">Kathiresan S</span>, <span class="author">Reilly MP</span>, <span class="author">the CARDIoGRAM Consortium</span>, <span class="author">Tracy RP</span>, <span class="author">Polasek O</span>, <span class="author">Winkelmann BR</span>, <span class="author">Grant PJ</span>, <span class="author">Hillege HL</span>, <span class="author">Cambien F</span>, <span class="author">Stott DJ</span>, <span class="author">Lowe GD</span>, <span class="author">Spector TD</span>, <span class="author">Meigs JB</span>, <span class="author">Marz W</span>, <span class="author">Eriksson P</span>, <span class="author">Becker LC</span>, <span class="author">Morange PE</span>, <span class="author">Soranzo N</span>, <span class="author">Williams SM</span>, <span class="author">Hayward C</span>, <span class="author">van der Harst P</span>, <span class="author">Hamsten A</span>, <span class="author">Lowenstein CJ</span>, <span class="author">Strachan DP</span>, <span class="author">O&#39;Donnell CJ</span> and <span class="author">the CHARGE Consortium Hemostatic Factor Working Group</span></p>
<p class="affiliation">From National Heart, Lung, and Blood Institute&#39;s Framingham Heart Study, Framingham, MA (J.H., A.D.J., C.J.O.); Division of Intramural Research, National Heart, Lung, and Blood Institute, Bethesda, MD (J.H., A.D.J., C.J.O.); MRC Human Genetics Unit, Institute of Genetics and Molecular Medicine, Western General Hospital, Edinburgh, Scotland, United Kingdom (J.E.H., V.V., A.F.W., C.H.); The Aab Cardiovascular Research Institute, Department of Medicine, University of Rochester School of Medicine and Dentistry, Rochester, NY (M.Y., C.J.L.); Departments of Cardiology (S.T., J.W.J.), Gerontology and Geriatrics (S.T., A.J.M.d.C., R.G.J.W.), and Molecular Epidemiology (P.E.S.), Leiden University Medical Center, the Netherlands; Department of Cardiology, Division of Heart and Lungs, University Medical Center Utrecht, Utrecht, the Netherlands (F.W.A.); Durrer Center for Cardiogenetic Research, ICIN-Netherlands Heart Institute, Utrecht, the Netherlands (F.W.A.); Institute of Cardiovascular Science, Faculty of Population Health Sciences, University College London, London, United Kingdom (F.W.A.); Cardiovascular Genetics and Genomics Group, Atherosclerosis Research Unit, Department of Medicine (M.S.-L., L.F., P.E., A.H.), Karolinska Institutet, Karolinska University Hospital, Solna, Stockholm, Sweden; INSERM UMRS 937, Pierre et Marie Curie University, Paris, France (D.-A.T., V.T., T.O.M., F.C.); ICAN Institute for Cardiometabolism and Nutrion, Paris, France (D.-A.T., V.T., F.C.); Departments of Public Health Sciences (W.M.C., B.B.W., F.C.) and Biochemistry and Molecular Genetics (M.M.S.), Center for Public Health Genomics, University of Virginia, Charlottesville, VA; Departments of Epidemiology (N.L.S., B.M.P., B.M.), Medicine (B.M.P., J.C.B.), and Health Services (B.M.P.), University of Washington, Seattle, WA; Group Health Research Institute, Group Health Cooperative, Seattle, WA (N.L.S., B.M.P.); Seattle Epidemiologic Research and Information Center, VA Office of Research and Development, Seattle, WA (N.L.S.); Departments of Internal Medicine II-Cardiology (M.E.K.) and Internal Medicine I (B.O.B.), University of Ulm Medical Centre, Ulm, Germany; Mannheim Institute of Public Health, Medical Faculty of Mannheim, University of Heidelberg, Mannheim, Germany (M.E.K., W.M.); Wellcome Trust Sanger Institute, Hinxton, United Kingdom (S.-Y.S., N.S.); MRC Centre for CAiTE, School of Social and Community Medicine (S.-Y.S.), and ALSPAC Laboratory, Department of Social Medicine (W.L.M.), University of Bristol, Bristol, United Kingdom; Division of Internal Medicine, Johns Hopkins School of Medicine, Baltimore, MD (D.M.B., L.R.Y., L.C.B.); Divisions of Epidemiology and Community Health (W.T., A.R.F.) and Biostatistics (S.B.), University of Minnesota, Minneapolis, MN; Departments of Epidemiology (A.D., O.H.F., M.A.I., A.H., J.C.M.W.), Internal Medicine (A.G.U., P.J.G.), Radiology (M.A.I.), and Neurology (M.A.I.), Erasmus Medical Center, Rotterdam, the Netherlands; Netherlands Consortium of Healthy Aging sponsored by Netherlands Genomics Initiative, Leiden, the Netherlands (A.D., O.H.F., A.G.U., P.E.S., A.H., J.C.M.W., R.G.J.W.); Department of Biostatistics, Boston University, Boston, MA (Q.Y., A.D., M.-H.C.); Department of Pharmacology and Therapeutics, University College Cork, Ireland (B.M.B.); Departments of Genetics (J.H.M., S.M.W.) and Community and Family Medicine (J.H.M.), Gesiel School of Medicine at Dartmouth, Lebanon, NH; Department of Twin Research and Genetic Epidemiology, King&#39;s College London, United Kingdom (F.M.K.W., T.D.S., N.S.); Centre for Population Health Sciences, University of Edinburgh, Scotland, United Kingdom (H.C., I.R., J.F.W.); Department of Angiology, Swiss Cardiovascular Center, Bern, Switzerland (G.S.); Royal North Shore Hospital, University of Sydney, Australia (G.H.T.); Departments of Internal Medicine (G.J.N.) and Cardiology (W.H.v.G., H.L.H., P.v.d.H.), University Medical Center Groningen, University of Groningen, Groningen, the Netherlands; Division of Population Health Sciences and Education, St George&#39;s University of London, London, United Kingdom (A.R.R., D.P.S.); Institute of Cardiovascular and Medical Sciences (A.R., D.J.S., G.D.L.), and Robertson Center for Biostatistics (I.F.), University of Glasgow, Glasgow, United Kingdom; Division of Genomic Medicine, National Human Genome Research Institute, Bethesda, MD (E.B.B.); Department of Biology and Center for Health Disparities Research, East Carolina University, Greenville, NC (K.L.K.); LKC School of Medicine, Nanyang Technological University, Singapore (B.O.B.); Division of Cardiovascular and Diabetes Research, Leeds University, Leeds, United Kingdom (A.M.C.); Durrer Center for Cardiogenetic Research, Amsterdam, the Netherlands (J.W.J.); Interuniversity Cardiology Institute of the Netherlands, Utrecht, the Netherlands (J.W.J.); BHF Glasgow Cardiovascular Research Centre, Faculty of Medicine, Glasgow, United Kingdom (N.S.); Brown Foundation Institute of Molecular Medicine and Human Genetics Center, Division of Epidemiology, School of Public Health (M.F.), and Hemostasis Laboratory (N.M.), University of Texas Health Science Center at Houston, Houston, TX; Medical Genetics Institute, Cedars-Sinai Medical Center, Los Angeles, CA (K.T.); Department of Biostatistical Sciences, Wake Forest School of Medicine, Winston-Salem, NC (F.-C.H.); Cardiothoracic Surgery Unit, Department of Molecular Medicine and Surgery (A.-F.C.), Karolinska Institutet, Stockholm, Sweden; Department of Cardiovascular Sciences, University of Leicester, Leicester, United Kingdom (A.H.G.); The Warren Alpert Medical School of Brown University, Providence, RI (K.L.F.); Departments of Medicine (M.C.) and Pathology (M.C., R.P.T.), University of Vermont, Burlington, VT; Cardiology Division (S.K., C.J.O.), Cardiovascular Research Center (S.K.), Center for Human Genetic Research (S.K.), and General Medicine Division (J.B.M.), Massachusetts General Hospital, Boston, MA; Program in Medical and Population Genetics, Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, MA (S.K.); The Cardiovascular Institute, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (M.R.P.); Department of Public Health, Faculty of Medicine, University of Split, Split, Croatia (O.P.); Cardiology Team Sachsenhausen, Frankfurt am Main, Germany (B.R.W.); Department of Medicine, Harvard Medical School, Boston, MA (J.B.M.); Synlab Academy, Mannheim, Germany (W.M.); Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Graz, Graz, Austria (W.M.); and INSERM UMRS 1062, Aix-Marseille Universit&eacute;, Marseille, France (P.-E.M.).</p><p class="abstract"><strong>Objective</strong>: Tissue plasminogen activator (tPA), a serine protease, catalyzes the conversion of plasminogen to plasmin, the major enzyme responsible for endogenous fibrinolysis. In some populations, elevated plasma levels of tPA have been associated with myocardial infarction and other cardiovascular diseases. We conducted a meta-analysis of genome-wide association studies to identify novel correlates of circulating levels of tPA.</p><p class="abstract">Fourteen cohort studies with tPA measures (N=26&nbsp;929) contributed to the meta-analysis. Three loci were significantly associated with circulating tPA levels (P&lt;5.0&times;10(-8)). The first locus is on 6q24.3, with the lead single nucleotide polymorphism (SNP; rs9399599; P=2.9&times;10(-14)) within STXBP5. The second locus is on 8p11.21. The lead SNP (rs3136739; P=1.3&times;10(-9)) is intronic to POLB and &lt;200 kb away from the tPA encoding the gene PLAT. We identified a nonsynonymous SNP (rs2020921) in modest linkage disequilibrium with rs3136739 (r(2)=0.50) within exon 5 of PLAT (P=2.0&times;10(-8)). The third locus is on 12q24.33, with the lead SNP (rs7301826; P=1.0&times;10(-9)) within intron 7 of STX2. We further found evidence for the association of lead SNPs in STXBP5 and STX2 with expression levels of the respective transcripts. In in vitro cell studies, silencing STXBP5 decreased the release of tPA from vascular endothelial cells, whereas silencing STX2 increased the tPA release. Through an in silico lookup, we found no associations of the 3 lead SNPs with coronary artery disease or stroke.</p><p class="abstract"><strong>Conclusions</strong>: We identified 3 loci associated with circulating tPA levels, the PLAT region, STXBP5, and STX2. Our functional studies implicate a novel role for STXBP5 and STX2 in regulating tPA release.</p>
<p class="publication"><span class="title">Arteriosclerosis, thrombosis, and vascular biology</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24578379">24578379</a>; DOI: <a href="http://dx.doi.org/10.1161%2FATVBAHA.113.302088">10.1161/ATVBAHA.113.302088</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Whole exome sequencing in family trios reveals de novo mutations in PURA as a cause of severe neurodevelopmental delay and learning disability.</h4>
<p class="authors"><span class="author">Hunt D</span>, <span class="author">Leventer RJ</span>, <span class="author">Simons C</span>, <span class="author">Taft R</span>, <span class="author">Swoboda KJ</span>, <span class="author">Gawne-Cain M</span>, <span class="author">DDD study</span>, <span class="author">Magee AC</span>, <span class="author">Turnpenny PD</span> and <span class="author">Baralle D</span></p>
<p class="affiliation">Wessex Clinical Genetics Service, Princess Anne Hospital, Southampton, UK.</p><p class="abstract"><strong>Background</strong>: De novo mutations are emerging as an important cause of neurocognitive impairment, and whole exome sequencing of case-parent trios is a powerful way of detecting them. Here, we report the findings in four such trios.</p><p class="abstract"><strong>Methods</strong>: The Deciphering Developmental Disorders study is using whole exome sequencing in family trios to investigate children with severe, sporadic, undiagnosed developmental delay. Three of our patients were ascertained from the first 1133 children to have been investigated through this large-scale study. Case 4 was a phenotypically isolated case recruited into an undiagnosed rare disorders sequencing study.</p><p class="abstract"><strong>Results</strong>: Protein-altering de novo mutations in PURA were identified in four subjects. They include two different frameshifts, one inframe deletion and one missense mutation. PURA encodes Pur-&alpha;, a highly conserved multifunctional protein that has an important role in normal postnatal brain development in animal models. The associated human phenotype of de novo heterozygous mutations in this gene is variable, but moderate to severe neurodevelopmental delay and learning disability are common to all. Neonatal hypotonia, early feeding difficulties and seizures, or &#39;seizure-like&#39; movements, were also common. Additionally, it is suspected that anterior pituitary dysregulation may be within the spectrum of this disorder. Psychomotor developmental outcomes appear variable between patients, and we propose a possible genotype-phenotype correlation, with disruption of Pur repeat III resulting in a more severe phenotype.</p><p class="abstract"><strong>Conclusions</strong>: These findings provide definitive evidence for the role of PURA in causing a variable syndrome of neurodevelopmental delay, learning disability, neonatal hypotonia, feeding difficulties, abnormal movements and epilepsy in humans, and help clarify the role of PURA in the previously described 5q31.3 microdeletion phenotype.</p>
<p class="publication"><span class="title">Journal of medical genetics</span>&nbsp;<span class="year">2014</span>;<span class="volume">51</span>;<span class="number">12</span>;<span class="pagerange">806-13</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25342064">25342064</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4251168">4251168</a>; DOI: <a href="http://dx.doi.org/10.1136%2Fjmedgenet-2014-102798">10.1136/jmedgenet-2014-102798</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">A comprehensive evaluation of assembly scaffolding tools.</h4>
<p class="authors"><span class="author">Hunt M</span>, <span class="author">Newbold C</span>, <span class="author">Berriman M</span> and <span class="author">Otto TD</span></p><p class="abstract"><strong>Background</strong>: Genome assembly is typically a two-stage process: contig assembly followed by the use of paired sequencing reads to join contigs into scaffolds. Scaffolds are usually the focus of reported assembly statistics; longer scaffolds greatly facilitate the use of genome sequences in downstream analyses, and it is appealing to present larger numbers as metrics of assembly performance. However, scaffolds are highly prone to errors, especially when generated using short reads, which can directly result in inflated assembly statistics.</p><p class="abstract"><strong>Results</strong>: Here we provide the first independent evaluation of scaffolding tools for second-generation sequencing data. We find large variations in the quality of results depending on the tool and dataset used. Even extremely simple test cases of perfect input, constructed to elucidate the behaviour of each algorithm, produced some surprising results. We further dissect the performance of the scaffolders using real and simulated sequencing data derived from the genomes of Staphylococcus aureus, Rhodobacter sphaeroides, Plasmodium falciparum and Homo sapiens. The results from simulated data are of high quality, with several of the tools producing perfect output. However, at least 10% of joins remains unidentified when using real data.</p><p class="abstract"><strong>Conclusions</strong>: The scaffolders vary in their usability, speed and number of correct and missed joins made between contigs. Results from real data highlight opportunities for further improvements of the tools. Overall, SGA, SOPRA and SSPACE generally outperform the other tools on our datasets. However, the quality of the results is highly dependent on the read mapper and genome complexity.</p>
<p class="grants">Funded by: Wellcome Trust: <span class="grant">082130/Z/07/Z</span>, <span class="grant">098051</span></p>
<p class="publication"><span class="title">Genome biology</span>&nbsp;<span class="year">2014</span>;<span class="volume">15</span>;<span class="number">3</span>;<span class="pagerange">R42</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24581555">24581555</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4053845">4053845</a>; DOI: <a href="http://dx.doi.org/10.1186%2Fgb-2014-15-3-r42">10.1186/gb-2014-15-3-r42</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Insertional Mutagenesis and Deep Profiling Reveals Gene Hierarchies and a Myc/p53-Dependent Bottleneck in Lymphomagenesis.</h4>
<p class="authors"><span class="author">Huser CA</span>, <span class="author">Gilroy KL</span>, <span class="author">de Ridder J</span>, <span class="author">Kilbey A</span>, <span class="author">Borland G</span>, <span class="author">Mackay N</span>, <span class="author">Jenkins A</span>, <span class="author">Bell M</span>, <span class="author">Herzyk P</span>, <span class="author">van der Weyden L</span>, <span class="author">Adams DJ</span>, <span class="author">Rust AG</span>, <span class="author">Cameron E</span> and <span class="author">Neil JC</span></p>
<p class="affiliation">Centre for Virus Research, Institute of Infection, Immunity and Inflammation, College of Medicine, Veterinary Medicine and Life Sciences, University of Glasgow, Glasgow, United Kingdom.</p><p class="abstract">Retroviral insertional mutagenesis (RIM) is a powerful tool for cancer genomics that was combined in this study with deep sequencing (RIM/DS) to facilitate a comprehensive analysis of lymphoma progression. Transgenic mice expressing two potent collaborating oncogenes in the germ line (CD2-MYC, -Runx2) develop rapid onset tumours that can be accelerated and rendered polyclonal by neonatal Moloney murine leukaemia virus (MoMLV) infection. RIM/DS analysis of 28 polyclonal lymphomas identified 771 common insertion sites (CISs) defining a &#39;progression network&#39; that encompassed a remarkably large fraction of known MoMLV target genes, with further strong indications of oncogenic selection above the background of MoMLV integration preference. Progression driven by RIM was characterised as a Darwinian process of clonal competition engaging proliferation control networks downstream of cytokine and T-cell receptor signalling. Enhancer mode activation accounted for the most efficiently selected CIS target genes, including Ccr7 as the most prominent of a set of chemokine receptors driving paracrine growth stimulation and lymphoma dissemination. Another large target gene subset including candidate tumour suppressors was disrupted by intragenic insertions. A second RIM/DS screen comparing lymphomas of wild-type and parental transgenics showed that CD2-MYC tumours are virtually dependent on activation of Runx family genes in strong preference to other potent Myc collaborating genes (Gfi1, Notch1). Ikzf1 was identified as a novel collaborating gene for Runx2 and illustrated the interface between integration preference and oncogenic selection. Lymphoma target genes for MoMLV can be classified into (a) a small set of master regulators that confer self-renewal; overcoming p53 and other failsafe pathways and (b) a large group of progression genes that control autonomous proliferation in transformed cells. These findings provide insights into retroviral biology, human cancer genetics and the safety of vector-mediated gene therapy.</p>
<p class="publication"><span class="title">PLoS genetics</span>&nbsp;<span class="year">2014</span>;<span class="volume">10</span>;<span class="number">2</span>;<span class="pagerange">e1004167</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24586197">24586197</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC3937229">3937229</a>; DOI: <a href="http://dx.doi.org/10.1371%2Fjournal.pgen.1004167">10.1371/journal.pgen.1004167</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Who watches the watchmen? An appraisal of benchmarks for multiple sequence alignment.</h4>
<p class="authors"><span class="author">Iantorno S</span>, <span class="author">Gori K</span>, <span class="author">Goldman N</span>, <span class="author">Gil M</span> and <span class="author">Dessimoz C</span></p>
<p class="affiliation">Wellcome Trust Sanger Institute, Cambridge, UK.</p>
<p class="abstract">Multiple sequence alignment (MSA) is a fundamental and ubiquitous technique in bioinformatics used to infer related residues among biological sequences. Thus alignment accuracy is crucial to a vast range of analyses, often in ways difficult to assess in those analyses. To compare the performance of different aligners and help detect systematic errors in alignments, a number of benchmarking strategies have been pursued. Here we present an overview of the main strategies-based on simulation, consistency, protein structure, and phylogeny-and discuss their different advantages and associated risks. We outline a set of desirable characteristics for effective benchmarking, and evaluate each strategy in light of them. We conclude that there is currently no universally applicable means of benchmarking MSA, and that developers and users of alignment tools should base their choice of benchmark depending on the context of application-with a keen awareness of the assumptions underlying each benchmarking strategy.</p>
<p class="publication"><span class="title">Methods in molecular biology (Clifton, N.J.)</span>&nbsp;<span class="year">2014</span>;<span class="volume">1079</span>;<span class="pagerange">59-73</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24170395">24170395</a>; DOI: <a href="http://dx.doi.org/10.1007%2F978-1-62703-646-7_4">10.1007/978-1-62703-646-7_4</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">The genomic basis of vomeronasal-mediated behaviour.</h4>
<p class="authors"><span class="author">Ibarra-Soria X</span>, <span class="author">Levitin MO</span> and <span class="author">Logan DW</span></p>
<p class="affiliation">Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, CB10 1SA, UK.</p><p class="abstract">The vomeronasal organ (VNO) is a chemosensory subsystem found in the nose of most mammals. It is principally tasked with detecting pheromones and other chemical signals that initiate innate behavioural responses. The VNO expresses subfamilies of vomeronasal receptors (VRs) in a cell-specific manner: each sensory neuron expresses just one or two receptors and silences all the other receptor genes. VR genes vary greatly in number within mammalian genomes, from no functional genes in some primates to many hundreds in rodents. They bind semiochemicals, some of which are also encoded in gene families that are coexpanded in species with correspondingly large VR repertoires. Protein and peptide cues that activate the VNO tend to be expressed in exocrine tissues in sexually dimorphic, and sometimes individually variable, patterns. Few chemical ligand-VR-behaviour relationships have been fully elucidated to date, largely due to technical difficulties in working with large, homologous gene families with high sequence identity. However, analysis of mouse lines with mutations in genes involved in ligand-VR signal transduction has revealed that the VNO mediates a range of social behaviours, including male-male and maternal aggression, sexual attraction, lordosis, and selective pregnancy termination, as well as interspecific responses such as avoidance and defensive behaviours. The unusual logic of VR expression now offers an opportunity to map the specific neural circuits that drive these behaviours.</p>
<p class="publication"><span class="title">Mammalian genome : official journal of the International Mammalian Genome Society</span>&nbsp;<span class="year">2014</span>;<span class="volume">25</span>;<span class="number">1-2</span>;<span class="pagerange">75-86</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/23884334">23884334</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC3916702">3916702</a>; DOI: <a href="http://dx.doi.org/10.1007%2Fs00335-013-9463-1">10.1007/s00335-013-9463-1</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">The olfactory transcriptomes of mice.</h4>
<p class="authors"><span class="author">Ibarra-Soria X</span>, <span class="author">Levitin MO</span>, <span class="author">Saraiva LR</span> and <span class="author">Logan DW</span></p>
<p class="affiliation">Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, United Kingdom.</p><p class="abstract">The olfactory (OR) and vomeronasal receptor (VR) repertoires are collectively encoded by 1700 genes and pseudogenes in the mouse genome. Most OR and VR genes were identified by comparative genomic techniques and therefore, in many of those cases, only their protein coding sequences are defined. Some also lack experimental support, due in part to the similarity between them and their monogenic, cell-specific expression in olfactory tissues. Here we use deep RNA sequencing, expression microarray and quantitative RT-PCR in both the vomeronasal organ and whole olfactory mucosa to quantify their full transcriptomes in multiple male and female mice. We find evidence of expression for all VR, and almost all OR genes that are annotated as functional in the reference genome, and use the data to generate over 1100 new, multi-exonic, significantly extended receptor gene annotations. We find that OR and VR genes are neither equally nor randomly expressed, but have reproducible distributions of abundance in both tissues. The olfactory transcriptomes are only minimally different between males and females, suggesting altered gene expression at the periphery is unlikely to underpin the striking sexual dimorphism in olfactory-mediated behavior. Finally, we present evidence that hundreds of novel, putatively protein-coding genes are expressed in these highly specialized olfactory tissues, and carry out a proof-of-principle validation. Taken together, these data provide a comprehensive, quantitative catalog of the genes that mediate olfactory perception and pheromone-evoked behavior at the periphery.</p>
<p class="grants">Funded by: Wellcome Trust: <span class="grant">098051</span></p>
<p class="publication"><span class="title">PLoS genetics</span>&nbsp;<span class="year">2014</span>;<span class="volume">10</span>;<span class="number">9</span>;<span class="pagerange">e1004593</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25187969">25187969</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4154679">4154679</a>; DOI: <a href="http://dx.doi.org/10.1371%2Fjournal.pgen.1004593">10.1371/journal.pgen.1004593</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Removal of Reprogramming Transgenes Improves the Tissue Reconstitution Potential of Keratinocytes Generated From Human Induced Pluripotent Stem Cells.</h4>
<p class="authors"><span class="author">Igawa K</span>, <span class="author">Kokubu C</span>, <span class="author">Yusa K</span>, <span class="author">Horie K</span>, <span class="author">Yoshimura Y</span>, <span class="author">Yamauchi K</span>, <span class="author">Suemori H</span>, <span class="author">Yokozeki H</span>, <span class="author">Toyoda M</span>, <span class="author">Kiyokawa N</span>, <span class="author">Okita H</span>, <span class="author">Miyagawa Y</span>, <span class="author">Akutsu H</span>, <span class="author">Umezawa A</span>, <span class="author">Katayama I</span> and <span class="author">Takeda J</span></p>
<p class="affiliation">Department of Dermatology and Department of Social and Environmental Medicine, Graduate School of Medicine, Osaka University, Osaka, Japan; Department of Dermatology, Graduate School of Medicine, Tokyo Medical and Dental University, Tokyo, Japan; Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, United Kingdom; Department of Embryonic Stem Cell Research, Institute for Frontier Medical Sciences, Kyoto University, Kyoto, Japan; Department of Reproductive Biology, Center for Regenerative Medicine, National Center for Child Health and Development, Tokyo, Japan <a href="mailto:%6B.%69%67%61%77%61.%64%65%72%6D%40%74%6D%64.%61%63.%6A%70">&#107;&#46;&#105;&#103;&#97;&#119;&#97;&#46;&#100;&#101;&#114;&#109;&#64;&#116;&#109;&#100;&#46;&#97;&#99;&#46;&#106;&#112;</a> <a href="mailto:%74%61%6B%65%64%61%40%6D%72-%65%6E%76%69.%6D%65%64.%6F%73%61%6B%61-%75.%61%63.%6A%70">&#116;&#97;&#107;&#101;&#100;&#97;&#64;&#109;&#114;&#45;&#101;&#110;&#118;&#105;&#46;&#109;&#101;&#100;&#46;&#111;&#115;&#97;&#107;&#97;&#45;&#117;&#46;&#97;&#99;&#46;&#106;&#112;</a>.</p><p class="abstract">Human induced pluripotent stem cell (hiPSC) lines have a great potential for therapeutics because customized cells and organs can be induced from such cells. Assessment of the residual reprogramming factors after the generation of hiPSC lines is required, but an ideal system has been lacking. Here, we generated hiPSC lines from normal human dermal fibroblasts with piggyBac transposon bearing reprogramming transgenes followed by removal of the transposon by the transposase. Under this condition, we compared the phenotypes of transgene-residual and -free hiPSCs of the same genetic background. The transgene-residual hiPSCs, in which the transcription levels of the reprogramming transgenes were eventually suppressed, were quite similar to the transgene-free hiPSCs in a pluripotent state. However, after differentiation into keratinocytes, clear differences were observed. Morphological, functional, and molecular analyses including single-cell gene expression profiling revealed that keratinocytes from transgene-free hiPSC lines were more similar to normal human keratinocytes than those from transgene-residual hiPSC lines, which may be partly explained by reactivation of residual transgenes upon induction of keratinocyte differentiation. These results suggest that transgene-free hiPSC lines should be chosen for therapeutic purposes.</p>
<p class="publication"><span class="title">Stem cells translational medicine</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25024429">25024429</a>; DOI: <a href="http://dx.doi.org/10.5966%2Fsctm.2013-0179">10.5966/sctm.2013-0179</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">A complete view of the genetic diversity of the Escherichia coli O-antigen biosynthesis gene cluster.</h4>
<p class="authors"><span class="author">Iguchi A</span>, <span class="author">Iyoda S</span>, <span class="author">Kikuchi T</span>, <span class="author">Ogura Y</span>, <span class="author">Katsura K</span>, <span class="author">Ohnishi M</span>, <span class="author">Hayashi T</span> and <span class="author">Thomson NR</span></p>
<p class="affiliation">Department of Animal and Grassland Sciences, Faculty of Agriculture, University of Miyazaki, Miyazaki 889-2192, Japan <a href="mailto:%69%67%75%63%68%69%40%6D%65%64.%6D%69%79%61%7A%61%6B%69-%75.%61%63.%6A%70">&#105;&#103;&#117;&#99;&#104;&#105;&#64;&#109;&#101;&#100;&#46;&#109;&#105;&#121;&#97;&#122;&#97;&#107;&#105;&#45;&#117;&#46;&#97;&#99;&#46;&#106;&#112;</a>.</p><p class="abstract">The O antigen constitutes the outermost part of the lipopolysaccharide layer in Gram-negative bacteria. The chemical composition and structure of the O antigen show high levels of variation even within a single species revealing itself as serological diversity. Here, we present a complete sequence set for the O-antigen biosynthesis gene clusters (O-AGCs) from all 184 recognized Escherichia coli O serogroups. By comparing these sequences, we identified 161 well-defined O-AGCs. Based on the wzx/wzy or wzm/wzt gene sequences, in addition to 145 singletons, 37 serogroups were placed into 16 groups. Furthermore, phylogenetic analysis of all the E. coli O-serogroup reference strains revealed that the nearly one-quarter of the 184 serogroups were found in the ST10 lineage, which may have a unique genetic background allowing a more successful exchange of O-AGCs. Our data provide a complete view of the genetic diversity of O-AGCs in E. coli showing a stronger association between host phylogenetic lineage and O-serogroup diversification than previously recognized. These data will be a valuable basis for developing a systematic molecular O-typing scheme that will allow traditional typing approaches to be linked to genomic exploration of E. coli diversity.</p>
<p class="publication"><span class="title">DNA research : an international journal for rapid publication of reports on genes and genomes</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25428893">25428893</a>; DOI: <a href="http://dx.doi.org/10.1093%2Fdnares%2Fdsu043">10.1093/dnares/dsu043</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Genome evolution and plasticity of Serratia marcescens, an important multidrug resistant nosocomial pathogen.</h4>
<p class="authors"><span class="author">Iguchi A</span>, <span class="author">Nagaya Y</span>, <span class="author">Pradel E</span>, <span class="author">Ooka T</span>, <span class="author">Ogura Y</span>, <span class="author">Katsura K</span>, <span class="author">Kurokawa K</span>, <span class="author">Oshima K</span>, <span class="author">Hattori M</span>, <span class="author">Parkhill J</span>, <span class="author">Sebaihia M</span>, <span class="author">Coulthurst S</span>, <span class="author">Gotoh N</span>, <span class="author">Thomson NR</span>, <span class="author">Ewbank JJ</span> and <span class="author">Hayashi T</span></p>
<p class="affiliation">Interdisciplinary Research Organization, University of Miyazaki, Miyazaki, Japan; Department of Microbiology and Infection Control Science, Kyoto Pharmaceutical University, Kyoto, Japan; Centre d&#39;Immunologie de Marseille-Luminy, UM2 Aix-Marseille Universit&eacute;, Marseille, France; INSERM, U1104, Marseille, France; CNRS, UMR7280, Marseille, France; Department of Infectious Diseases, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan; Department of Genomics and Bioenvironmental Science, Frontier Science Research Center, University of Miyazaki, Miyazaki, Japan; Earth-Life Science Institute, Tokyo Institute of Technology, Kanagawa, Japan; Graduate School of Frontier Sciences, University of Tokyo, Chiba, Japan; Pathogen Genomics, The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Cambridge, UK; Division of Molecular Microbiology, College of Life Sciences, University of Dundee, Dundee, UK. Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK.</p><p class="abstract">Serratia marcescens is an important nosocomial pathogen that can cause an array of infections, most notably of the urinary tract and bloodstream. Naturally, it is found in many environmental niches, and is capable of infecting plants and animals. The emergence and spread of multidrug-resistant strains producing extended-spectrum or metallo beta-lactamases now pose a threat to public health worldwide. Here we report the complete genome sequences of two carefully selected S. marcescens strains, a multidrug-resistant clinical isolate (strain SM39) and an insect isolate (strain Db11). Our comparative analyses reveal the core genome of S. marcescens and define the potential metabolic capacity, virulence, and multi-drug resistance of this species. We show a remarkable intra-species genetic diversity, both at the sequence level and with regards genome flexibility, which may reflect the diversity of niches inhabited by members of this species. A broader analysis with other Serratia species identifies a set of ca. 3,000 genes that characterize the genus. Within this apparent genetic diversity, we identified many genes implicated in the high virulence potential and antibiotic resistance of SM39, including the metallo beta-lactamase and multiple other drug resistance determinants carried on plasmid pSMC1. We further show that pSMC1 is most closely related to plasmids circulating in Pseudomonas species. Our data will provide a valuable basis for future studies on S. marcescens and new insights into the genetic mechanisms that underlie the emergence of pathogens highly resistant to multiple antimicrobial agents.</p>
<p class="publication"><span class="title">Genome biology and evolution</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25070509">25070509</a>; DOI: <a href="http://dx.doi.org/10.1093%2Fgbe%2Fevu160">10.1093/gbe/evu160</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Identifying selection in the within-host evolution of influenza using viral sequence data.</h4>
<p class="authors"><span class="author">Illingworth CJ</span>, <span class="author">Fischer A</span> and <span class="author">Mustonen V</span></p>
<p class="affiliation">Department of Genetics, University of Cambridge, Cambridge, United Kingdom.</p><p class="abstract">The within-host evolution of influenza is a vital component of its epidemiology. A question of particular interest is the role that selection plays in shaping the viral population over the course of a single infection. We here describe a method to measure selection acting upon the influenza virus within an individual host, based upon time-resolved genome sequence data from an infection. Analysing sequence data from a transmission study conducted in pigs, describing part of the haemagglutinin gene (HA1) of an influenza virus, we find signatures of non-neutrality in six of a total of sixteen infections. We find evidence for both positive and negative selection acting upon specific alleles, while in three cases, the data suggest the presence of time-dependent selection. In one infection we observe what is potentially a specific immune response against the virus; a non-synonymous mutation in an epitope region of the virus is found to be under initially positive, then strongly negative selection. Crucially, given the lack of homologous recombination in influenza, our method accounts for linkage disequilibrium between nucleotides at different positions in the haemagglutinin gene, allowing for the analysis of populations in which multiple mutations are present at any given time. Our approach offers a new insight into the dynamics of influenza infection, providing a detailed characterisation of the forces that underlie viral evolution.</p>
<p class="grants">Funded by: Wellcome Trust: <span class="grant">098051</span>, <span class="grant">101239</span>, <span class="grant">101239/Z/13/Z</span></p>
<p class="publication"><span class="title">PLoS computational biology</span>&nbsp;<span class="year">2014</span>;<span class="volume">10</span>;<span class="number">7</span>;<span class="pagerange">e1003755</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25080215">25080215</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4117419">4117419</a>; DOI: <a href="http://dx.doi.org/10.1371%2Fjournal.pcbi.1003755">10.1371/journal.pcbi.1003755</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Genome sequence of the tsetse fly (Glossina morsitans): vector of African trypanosomiasis.</h4>
<p class="authors"><span class="author">International Glossina Genome Initiative</span></p><p class="abstract">Tsetse flies are the sole vectors of human African trypanosomiasis throughout sub-Saharan Africa. Both sexes of adult tsetse feed exclusively on blood and contribute to disease transmission. Notable differences between tsetse and other disease vectors include obligate microbial symbioses, viviparous reproduction, and lactation. Here, we describe the sequence and annotation of the 366-megabase Glossina morsitans morsitans genome. Analysis of the genome and the 12,308 predicted protein-encoding genes led to multiple discoveries, including chromosomal integrations of bacterial (Wolbachia) genome sequences, a family of lactation-specific proteins, reduced complement of host pathogen recognition proteins, and reduced olfaction/chemosensory associated genes. These genome data provide a foundation for research into trypanosomiasis prevention and yield important insights with broad implications for multiple aspects of tsetse biology.</p>
<p class="grants">Funded by: Biotechnology and Biological Sciences Research Council: <span class="grant">BBS/E/C/00005193</span>, <span class="grant">BBS/E/C/00005194</span>; FIC NIH HHS: <span class="grant">D43 TW007391</span>, <span class="grant">R03 TW009444</span>; NHGRI NIH HHS: <span class="grant">U54 HG003079</span>; NIAID NIH HHS: <span class="grant">R01 AI051584</span>, <span class="grant">R01 AI081774</span>; Wellcome Trust: <span class="grant">085775/Z/08/Z</span>, <span class="grant">098051</span></p>
<p class="publication"><span class="title">Science (New York, N.Y.)</span>&nbsp;<span class="year">2014</span>;<span class="volume">344</span>;<span class="number">6182</span>;<span class="pagerange">380-6</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24763584">24763584</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4077534">4077534</a>; DOI: <a href="http://dx.doi.org/10.1126%2Fscience.1249656">10.1126/science.1249656</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Jannovar: a java library for exome annotation.</h4>
<p class="authors"><span class="author">J&auml;ger M</span>, <span class="author">Wang K</span>, <span class="author">Bauer S</span>, <span class="author">Smedley D</span>, <span class="author">Krawitz P</span> and <span class="author">Robinson PN</span></p>
<p class="affiliation">Institute for Medical and Human Genetics, Charit&eacute;-Universit&auml;tsmedizin Berlin, Berlin, Germany; Berlin Brandenburg Center for Regenerative Therapies (BCRT), Charit&eacute;-Universit&auml;tsmedizin Berlin, Berlin, Germany.</p><p class="abstract">Transcript-based annotation and pedigree analysis are two basic steps in the computational analysis of whole-exome sequencing experiments in genetic diagnostics and disease-gene discovery projects. Here, we present Jannovar, a stand-alone Java application as well as a Java library designed to be used in larger software frameworks for exome and genome analysis. Jannovar uses an interval tree to identify all transcripts affected by a given variant, and provides Human Genome Variation Society-compliant annotations both for variants affecting coding sequences and splice junctions as well as untranslated regions and noncoding RNA transcripts. Jannovar can also perform family-based pedigree analysis with Variant Call Format (VCF) files with data from members of a family segregating a Mendelian disorder. Using a desktop computer, Jannovar requires a few seconds to annotate a typical VCF file with exome data. Jannovar is freely available under the BSD2 license. Source code as well as the Java application and library file can be downloaded from http://compbio.charite.de (with tutorial) and https://github.com/charite/jannovar.</p>
<p class="publication"><span class="title">Human mutation</span>&nbsp;<span class="year">2014</span>;<span class="volume">35</span>;<span class="number">5</span>;<span class="pagerange">548-55</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24677618">24677618</a>; DOI: <a href="http://dx.doi.org/10.1002%2Fhumu.22531">10.1002/humu.22531</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">The evolutionary dynamics of variant antigen genes in Babesia reveal a history of genomic innovation underlying host-parasite interaction.</h4>
<p class="authors"><span class="author">Jackson AP</span>, <span class="author">Otto TD</span>, <span class="author">Darby A</span>, <span class="author">Ramaprasad A</span>, <span class="author">Xia D</span>, <span class="author">Echaide IE</span>, <span class="author">Farber M</span>, <span class="author">Gahlot S</span>, <span class="author">Gamble J</span>, <span class="author">Gupta D</span>, <span class="author">Gupta Y</span>, <span class="author">Jackson L</span>, <span class="author">Malandrin L</span>, <span class="author">Malas TB</span>, <span class="author">Moussa E</span>, <span class="author">Nair M</span>, <span class="author">Reid AJ</span>, <span class="author">Sanders M</span>, <span class="author">Sharma J</span>, <span class="author">Tracey A</span>, <span class="author">Quail MA</span>, <span class="author">Weir W</span>, <span class="author">Wastling JM</span>, <span class="author">Hall N</span>, <span class="author">Willadsen P</span>, <span class="author">Lingelbach K</span>, <span class="author">Shiels B</span>, <span class="author">Tait A</span>, <span class="author">Berriman M</span>, <span class="author">Allred DR</span> and <span class="author">Pain A</span></p>
<p class="affiliation">Department of Infection Biology, Institute of Infection and Global Health, University of Liverpool, Liverpool Science Park Ic2, 146 Brownlow Hill, Liverpool L3 5RF, UK <a href="mailto:%61.%70.%6A%61%63%6B%73%6F%6E%40%6C%69%76.%61%63.%75%6B">&#97;&#46;&#112;&#46;&#106;&#97;&#99;&#107;&#115;&#111;&#110;&#64;&#108;&#105;&#118;&#46;&#97;&#99;&#46;&#117;&#107;</a>.</p><p class="abstract">Babesia spp. are tick-borne, intraerythrocytic hemoparasites that use antigenic variation to resist host immunity, through sequential modification of the parasite-derived variant erythrocyte surface antigen (VESA) expressed on the infected red blood cell surface. We identified the genomic processes driving antigenic diversity in genes encoding VESA (ves1) through comparative analysis within and between three Babesia species, (B. bigemina, B. divergens and B. bovis). Ves1 structure diverges rapidly after speciation, notably through the evolution of shortened forms (ves2) from 5&#39; ends of canonical ves1 genes. Phylogenetic analyses show that ves1 genes are transposed between loci routinely, whereas ves2 genes are not. Similarly, analysis of sequence mosaicism shows that recombination drives variation in ves1 sequences, but less so for ves2, indicating the adoption of different mechanisms for variation of the two families. Proteomic analysis of the B. bigemina PR isolate shows that two dominant VESA1 proteins are expressed in the population, whereas numerous VESA2 proteins are co-expressed, consistent with differential transcriptional regulation of each family. Hence, VESA2 proteins are abundant and previously unrecognized elements of Babesia biology, with evolutionary dynamics consistently different to those of VESA1, suggesting that their functions are distinct.</p>
<p class="grants">Funded by: NIAID NIH HHS: <span class="grant">R01 AI055864</span>; Wellcome Trust: <span class="grant">097826/Z/11/A</span>, <span class="grant">098051</span></p>
<p class="publication"><span class="title">Nucleic acids research</span>&nbsp;<span class="year">2014</span>;<span class="volume">42</span>;<span class="number">11</span>;<span class="pagerange">7113-31</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24799432">24799432</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4066756">4066756</a>; DOI: <a href="http://dx.doi.org/10.1093%2Fnar%2Fgku322">10.1093/nar/gku322</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Human stem cells for craniomaxillofacial reconstruction.</h4>
<p class="authors"><span class="author">Jalali M</span>, <span class="author">Kirkpatrick WN</span>, <span class="author">Cameron MG</span>, <span class="author">Pauklin S</span> and <span class="author">Vallier L</span></p>
<p class="affiliation">1 Anne McLaren Laboratory for Regenerative Medicine, Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute, University of Cambridge , Cambridge, United Kingdom .</p><p class="abstract">Human stem cell research represents an exceptional opportunity for regenerative medicine and the surgical reconstruction of the craniomaxillofacial complex. The correct architecture and function of the vastly diverse tissues of this important anatomical region are critical for life supportive processes, the delivery of senses, social interaction, and aesthetics. Craniomaxillofacial tissue loss is commonly associated with inflammatory responses of the surrounding tissue, significant scarring, disfigurement, and psychological sequelae as an inevitable consequence. The in vitro production of fully functional cells for skin, muscle, cartilage, bone, and neurovascular tissue formation from human stem cells, may one day provide novel materials for the reconstructive surgeon operating on patients with both hard and soft tissue deficit due to cancer, congenital disease, or trauma. However, the clinical translation of human stem cell technology, including the application of human pluripotent stem cells (hPSCs) in novel regenerative therapies, faces several hurdles that must be solved to permit safe and effective use in patients. The basic biology of hPSCs remains to be fully elucidated and concerns of tumorigenicity need to be addressed, prior to the development of cell transplantation treatments. Furthermore, functional comparison of in vitro generated tissue to their in vivo counterparts will be necessary for confirmation of maturity and suitability for application in reconstructive surgery. Here, we provide an overview of human stem cells in disease modeling, drug screening, and therapeutics, while also discussing the application of regenerative medicine for craniomaxillofacial tissue deficit and surgical reconstruction.</p>
<p class="grants">Funded by: Medical Research Council: <span class="grant">G0701448</span></p>
<p class="publication"><span class="title">Stem cells and development</span>&nbsp;<span class="year">2014</span>;<span class="volume">23</span>;<span class="number">13</span>;<span class="pagerange">1437-51</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24564584">24564584</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4066224">4066224</a>; DOI: <a href="http://dx.doi.org/10.1089%2Fscd.2013.0576">10.1089/scd.2013.0576</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Histone deacetylase (HDAC) 1 and 2 are essential for accurate cell division and the pluripotency of embryonic stem cells.</h4>
<p class="authors"><span class="author">Jamaladdin S</span>, <span class="author">Kelly RD</span>, <span class="author">O&#39;Regan L</span>, <span class="author">Dovey OM</span>, <span class="author">Hodson GE</span>, <span class="author">Millard CJ</span>, <span class="author">Portolano N</span>, <span class="author">Fry AM</span>, <span class="author">Schwabe JW</span> and <span class="author">Cowley SM</span></p>
<p class="affiliation">Department of Biochemistry, University of Leicester, Leicester LE1 9HN, United Kingdom; and.</p><p class="abstract">Histone deacetylases 1 and 2 (HDAC1/2) form the core catalytic components of corepressor complexes that modulate gene expression. In most cell types, deletion of both Hdac1 and Hdac2 is required to generate a discernible phenotype, suggesting their activity is largely redundant. We have therefore generated an ES cell line in which Hdac1 and Hdac2 can be inactivated simultaneously. Loss of HDAC1/2 resulted in a 60% reduction in total HDAC activity and a loss of cell viability. Cell death is dependent upon cell cycle progression, because differentiated, nonproliferating cells retain their viability. Furthermore, we observe increased mitotic defects, chromatin bridges, and micronuclei, suggesting HDAC1/2 are necessary for accurate chromosome segregation. Consistent with a critical role in the regulation of gene expression, microarray analysis of Hdac1/2-deleted cells reveals 1,708 differentially expressed genes. Significantly for the maintenance of stem cell self-renewal, we detected a reduction in the expression of the pluripotent transcription factors, Oct4, Nanog, Esrrb, and Rex1. HDAC1/2 activity is regulated through binding of an inositol tetraphosphate molecule (IP4) sandwiched between the HDAC and its cognate corepressor. This raises the important question of whether IP4 regulates the activity of the complex in cells. By rescuing the viability of double-knockout cells, we demonstrate for the first time (to our knowledge) that mutations that abolish IP4 binding reduce the activity of HDAC1/2 in vivo. Our data indicate that HDAC1/2 have essential and pleiotropic roles in cellular proliferation and regulate stem cell self-renewal by maintaining expression of key pluripotent transcription factors.</p>
<p class="publication"><span class="title">Proceedings of the National Academy of Sciences of the United States of America</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24958871">24958871</a>; DOI: <a href="http://dx.doi.org/10.1073%2Fpnas.1321330111">10.1073/pnas.1321330111</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">A novel RCE1 isoform is required for H-Ras plasma membrane localization and is regulated by USP17.</h4>
<p class="authors"><span class="author">Jaworski J</span>, <span class="author">Govender U</span>, <span class="author">McFarlane C</span>, <span class="author">de la Vega M</span>, <span class="author">Greene MK</span>, <span class="author">Rawlings ND</span>, <span class="author">Johnston JA</span>, <span class="author">Scott CJ</span> and <span class="author">Burrows JF</span></p>
<p class="affiliation">*School of Pharmacy, Queen&#39;s University Belfast, McClay Research Building, 97 Lisburn Road, Belfast BT9 7BL, U.K.</p><p class="abstract">Processing of the &#39;CaaX&#39; motif found on the C-termini of many proteins, including the proto-oncogene Ras, requires the ER (endoplasmic reticulum)-resident protease RCE1 (Ras-converting enzyme 1) and is necessary for the proper localization and function of many of these &#39;CaaX&#39; proteins. In the present paper, we report that several mammalian species have a novel isoform (isoform 2) of RCE1 resulting from an alternate splice site and producing an N-terminally truncated protein. We demonstrate that both RCE1 isoform 1 and the newly identified isoform 2 are required to reinstate proper H-Ras processing and thus plasma membrane localization in RCE1-null cells. In addition, we show that the deubiquitinating enzyme USP17 (ubiquitin-specific protease 17), previously shown to modulate RCE1 activity, can regulate the abundance and localization of isoform 2. Furthermore, we show that isoform 2 is ubiquitinated on Lys43 and deubiquitinated by USP17. Collectively, the findings of the present study indicate that RCE1 isoform 2 is required for proper &#39;CaaX&#39; processing and that USP17 can regulate this via its modulation of RCE1 isoform 2 ubiquitination.</p>
<p class="grants">Funded by: Biotechnology and Biological Sciences Research Council: <span class="grant">BB/F013647/1</span></p>
<p class="publication"><span class="title">The Biochemical journal</span>&nbsp;<span class="year">2014</span>;<span class="volume">457</span>;<span class="number">2</span>;<span class="pagerange">289-300</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24134311">24134311</a>; DOI: <a href="http://dx.doi.org/10.1042%2FBJ20131213">10.1042/BJ20131213</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">The sheep genome illuminates biology of the rumen and lipid metabolism.</h4>
<p class="authors"><span class="author">Jiang Y</span>, <span class="author">Xie M</span>, <span class="author">Chen W</span>, <span class="author">Talbot R</span>, <span class="author">Maddox JF</span>, <span class="author">Faraut T</span>, <span class="author">Wu C</span>, <span class="author">Muzny DM</span>, <span class="author">Li Y</span>, <span class="author">Zhang W</span>, <span class="author">Stanton JA</span>, <span class="author">Brauning R</span>, <span class="author">Barris WC</span>, <span class="author">Hourlier T</span>, <span class="author">Aken BL</span>, <span class="author">Searle SM</span>, <span class="author">Adelson DL</span>, <span class="author">Bian C</span>, <span class="author">Cam GR</span>, <span class="author">Chen Y</span>, <span class="author">Cheng S</span>, <span class="author">DeSilva U</span>, <span class="author">Dixen K</span>, <span class="author">Dong Y</span>, <span class="author">Fan G</span>, <span class="author">Franklin IR</span>, <span class="author">Fu S</span>, <span class="author">Fuentes-Utrilla P</span>, <span class="author">Guan R</span>, <span class="author">Highland MA</span>, <span class="author">Holder ME</span>, <span class="author">Huang G</span>, <span class="author">Ingham AB</span>, <span class="author">Jhangiani SN</span>, <span class="author">Kalra D</span>, <span class="author">Kovar CL</span>, <span class="author">Lee SL</span>, <span class="author">Liu W</span>, <span class="author">Liu X</span>, <span class="author">Lu C</span>, <span class="author">Lv T</span>, <span class="author">Mathew T</span>, <span class="author">McWilliam S</span>, <span class="author">Menzies M</span>, <span class="author">Pan S</span>, <span class="author">Robelin D</span>, <span class="author">Servin B</span>, <span class="author">Townley D</span>, <span class="author">Wang W</span>, <span class="author">Wei B</span>, <span class="author">White SN</span>, <span class="author">Yang X</span>, <span class="author">Ye C</span>, <span class="author">Yue Y</span>, <span class="author">Zeng P</span>, <span class="author">Zhou Q</span>, <span class="author">Hansen JB</span>, <span class="author">Kristiansen K</span>, <span class="author">Gibbs RA</span>, <span class="author">Flicek P</span>, <span class="author">Warkup CC</span>, <span class="author">Jones HE</span>, <span class="author">Oddy VH</span>, <span class="author">Nicholas FW</span>, <span class="author">McEwan JC</span>, <span class="author">Kijas JW</span>, <span class="author">Wang J</span>, <span class="author">Worley KC</span>, <span class="author">Archibald AL</span>, <span class="author">Cockett N</span>, <span class="author">Xu X</span>, <span class="author">Wang W</span> and <span class="author">Dalrymple BP</span></p>
<p class="affiliation">State Key Laboratory of Genetic Resources and Evolution, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming 650223, China. Commonwealth Scientific and Industrial Research Organisation Animal Food and Health Sciences, St Lucia, QLD 4067, Australia. College of Animal Science and Technology, Northwest A&amp;F University, Yangling 712100, China.</p><p class="abstract">Sheep (Ovis aries) are a major source of meat, milk, and fiber in the form of wool and represent a distinct class of animals that have a specialized digestive organ, the rumen, that carries out the initial digestion of plant material. We have developed and analyzed a high-quality reference sheep genome and transcriptomes from 40 different tissues. We identified highly expressed genes encoding keratin cross-linking proteins associated with rumen evolution. We also identified genes involved in lipid metabolism that had been amplified and/or had altered tissue expression patterns. This may be in response to changes in the barrier lipids of the skin, an interaction between lipid metabolism and wool synthesis, and an increased role of volatile fatty acids in ruminants compared with nonruminant animals.</p>
<p class="grants">Funded by: Biotechnology and Biological Sciences Research Council: <span class="grant">BB/1025360/1</span>, <span class="grant">BB/I025328/1</span>, <span class="grant">BB/I025360/1</span>, <span class="grant">BB/I025506/1</span>; Wellcome Trust: <span class="grant">WT095908</span>, <span class="grant">WT098051</span></p>
<p class="publication"><span class="title">Science (New York, N.Y.)</span>&nbsp;<span class="year">2014</span>;<span class="volume">344</span>;<span class="number">6188</span>;<span class="pagerange">1168-73</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24904168">24904168</a>; DOI: <a href="http://dx.doi.org/10.1126%2Fscience.1252806">10.1126/science.1252806</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Allele variants of enterotoxigenic Escherichia coli heat labile toxin are globally transmitted and associated with colonization factors.</h4>
<p class="authors"><span class="author">Joffr&eacute; E</span>, <span class="author">von Mentzer A</span>, <span class="author">Abd El Ghany M</span>, <span class="author">Oezguen N</span>, <span class="author">Savidge T</span>, <span class="author">Dougan G</span>, <span class="author">Svennerholm AM</span> and <span class="author">Sj&ouml;ling A</span></p>
<p class="affiliation">Department of Microbiology and Immunology, Sahlgrenska Academy, University of Gothenburg, G&ouml;teborg, Sweden Institute of Molecular Biology and Biotechnology, Universidad Mayor de San Andr&eacute;s, La Paz, Bolivia.</p><p class="abstract">Enterotoxigenic Escherichia coli (ETEC) is a significant cause of morbidity and mortality in the developing world. ETEC-mediated diarrhea is orchestrated by heat-labile (LT) and heat-stable (STp and STh) toxins, acting in concert with a repertoire of more than 25 colonization factors (CFs). LT, the major virulence factor, induce fluid-secretion after delivery of a monomeric ADP-ribosylase (LTA) and its pentameric carrier B subunit (LTB). A study of Brazilian-derived ETEC isolates reported the existence of natural LT variants. Here, the analysis of predicted amino acid sequences showed that the LT amino acid polymorphisms is associated with a geographically and temporally diverse set of 192 clinical ETEC strains, identifying 12 novel LT variants. Twenty distinct LT amino acid variants were classified in the globally distributed strains and phylogenetic analysis showed these to be associated with different CF profiles. Notably, the most prevalent LT1 and LT2 allele variants were correlated with major ETEC lineages expressing CS1+CS3, CS2+CS3, and CS5+CS6, CFA/I, respectively. LTB allele variants generally exhibited more stringent amino acid sequence conservation (2 substitutions identified) than LTA (22 substitutions identified). The functional impact of LT1 and LT2 polymorphisms on virulence was investigated by measuring total toxin production, secretion and stability using GM1-ELISA and in silico protein modeling. Our data show that LT2 strains produce 5-fold more toxin than LT1 strains (P&lt;0.001), which may suggest a greater virulence potential for this genetic variant. Our data suggests that functionally distinct LT - CF variants with increased fitness have persisted during evolution of ETEC and spread globally.</p>
<p class="publication"><span class="title">Journal of bacteriology</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25404692">25404692</a>; DOI: <a href="http://dx.doi.org/10.1128%2FJB.02050-14">10.1128/JB.02050-14</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Characterisation of plasmids in extensively drug-resistant (XDR) Acinetobacter species from India and Pakistan.</h4>
<p class="authors"><span class="author">Jones LS</span>, <span class="author">Carvalho MJ</span>, <span class="author">Toleman MA</span>, <span class="author">White PL</span>, <span class="author">Connor TR</span>, <span class="author">Mushtaq A</span>, <span class="author">Weeks JL</span>, <span class="author">Kumarasamy KK</span>, <span class="author">Raven KE</span>, <span class="author">T&ouml;r&ouml;k ME</span>, <span class="author">Peacock SJ</span>, <span class="author">Howe RA</span> and <span class="author">Walsh TR</span></p>
<p class="affiliation">Cardiff University, Cardiff School of Medicine, University Hospital of Wales Main Building, Heath Park, Cardiff CF14 4XN, United Kingdom Public Health Wales Microbiology Cardiff, University Hospital of Wales, Heath Park, Cardiff, CF14 4XW, United Kingdom <a href="mailto:%4A%6F%6E%65%73%4C%53%35%40%63%61%72%64%69%66%66.%61%63.%75%6B">&#74;&#111;&#110;&#101;&#115;&#76;&#83;&#53;&#64;&#99;&#97;&#114;&#100;&#105;&#102;&#102;&#46;&#97;&#99;&#46;&#117;&#107;</a>.</p><p class="abstract">The blaNDM-1 gene is associated with extensive-drug resistance in Gram-negative bacteria. This probably spread to Enterobacteriaceae from Acinetobacter spp., and we characterised plasmids associated with blaNDM-1 in Acinetobacter spp. to gain insight into their role in this dissemination. Four clinical NDM-1 producing Acinetobacter spp. strains from India and Pakistan were investigated. A plasmid harbouring blaNDM-1, pNDM-40-1, was characterised by whole genome sequencing of Acinetobacter bereziniae CHI-40-1 and comparison with related plasmids. The presence of similar plasmids in strains from Pakistan was sought by PCR and sequencing of amplicons. Conjugation frequency was tested and stability of pNDM-40-1 investigated by real-time PCR of isolates passaged with and without antimicrobial selection pressure. A. bereziniae and Acinetobacter haemolyticus strains contained plasmids similar to the pNDM-BJ01-like plasmids identified in Acinetobacter spp. in China. The backbone of pNDM-40-1 was almost identical to that of pNDM-BJ01-like plasmids but the transposon harbouring blaNDM-1, Tn125, contained two short deletions. Escherichia coli and Acinetobacter pittii transconjugants were readily obtained. Transconjugants retained pNDM-40-1 after a 14 day passage experiment, although stability was greater with meropenem selection. Fragments of pNDM-BJ01-like plasmid backbones are found near to blaNDM-1 in some genetic contexts from Enterobacteriaceae, suggesting cross-genus transfer has occurred. pNDM-BJ01-like plasmids have been described in isolates originating from a wide geographical region, in southern Asia. In vitro data on plasmid transfer and stability suggest that these plasmids could have contributed to the spread of blaNDM-1 into Enterobacteriaceae.</p>
<p class="publication"><span class="title">Antimicrobial agents and chemotherapy</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25421466">25421466</a>; DOI: <a href="http://dx.doi.org/10.1128%2FAAC.03242-14">10.1128/AAC.03242-14</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">RNA-seq Analysis of Host and Viral Gene Expression Highlights Interaction between Varicella Zoster Virus and Keratinocyte Differentiation.</h4>
<p class="authors"><span class="author">Jones M</span>, <span class="author">Dry IR</span>, <span class="author">Frampton D</span>, <span class="author">Singh M</span>, <span class="author">Kanda RK</span>, <span class="author">Yee MB</span>, <span class="author">Kellam P</span>, <span class="author">Hollinshead M</span>, <span class="author">Kinchington PR</span>, <span class="author">O&#39;Toole EA</span> and <span class="author">Breuer J</span></p>
<p class="affiliation">Division of Infection and Immunity, University College London, London, United Kingdom.</p>
<p class="abstract">Varicella zoster virus (VZV) is the etiological agent of chickenpox and shingles, diseases characterized by epidermal skin blistering. Using a calcium-induced keratinocyte differentiation model we investigated the interaction between epidermal differentiation and VZV infection. RNA-seq analysis showed that VZV infection has a profound effect on differentiating keratinocytes, altering the normal process of epidermal gene expression to generate a signature that resembles patterns of gene expression seen in both heritable and acquired skin-blistering disorders. Further investigation by real-time PCR, protein analysis and electron microscopy revealed that VZV specifically reduced expression of specific suprabasal cytokeratins and desmosomal proteins, leading to disruption of epidermal structure and function. These changes were accompanied by an upregulation of kallikreins and serine proteases. Taken together VZV infection promotes blistering and desquamation of the epidermis, both of which are necessary to the viral spread and pathogenesis. At the same time, analysis of the viral transcriptome provided evidence that VZV gene expression was significantly increased following calcium treatment of keratinocytes. Using reporter viruses and immunohistochemistry we confirmed that VZV gene and protein expression in skin is linked with cellular differentiation. These studies highlight the intimate host-pathogen interaction following VZV infection of skin and provide insight into the mechanisms by which VZV remodels the epidermal environment to promote its own replication and spread.</p>
<p class="publication"><span class="title">PLoS pathogens</span>&nbsp;<span class="year">2014</span>;<span class="volume">10</span>;<span class="number">1</span>;<span class="pagerange">e1003896</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24497829">24497829</a>; DOI: <a href="http://dx.doi.org/10.1371%2Fjournal.ppat.1003896">10.1371/journal.ppat.1003896</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Origins and functional consequences of somatic mitochondrial DNA mutations in human cancer.</h4>
<p class="authors"><span class="author">Ju YS</span>, <span class="author">Alexandrov LB</span>, <span class="author">Gerstung M</span>, <span class="author">Martincorena I</span>, <span class="author">Nik-Zainal S</span>, <span class="author">Ramakrishna M</span>, <span class="author">Davies HR</span>, <span class="author">Papaemmanuil E</span>, <span class="author">Gundem G</span>, <span class="author">Shlien A</span>, <span class="author">Bolli N</span>, <span class="author">Behjati S</span>, <span class="author">Tarpey PS</span>, <span class="author">Nangalia J</span>, <span class="author">Massie CE</span>, <span class="author">Butler AP</span>, <span class="author">Teague JW</span>, <span class="author">Vassiliou GS</span>, <span class="author">Green AR</span>, <span class="author">Du MQ</span>, <span class="author">Unnikrishnan A</span>, <span class="author">Pimanda JE</span>, <span class="author">Teh BT</span>, <span class="author">Munshi N</span>, <span class="author">Greaves M</span>, <span class="author">Vyas P</span>, <span class="author">El-Naggar AK</span>, <span class="author">Santarius T</span>, <span class="author">Collins VP</span>, <span class="author">Grundy R</span>, <span class="author">Taylor JA</span>, <span class="author">Hayes DN</span>, <span class="author">Malkin D</span>, <span class="author">ICGC Breast Cancer Group</span>, <span class="author">ICGC Chronic Myeloid Disorders Group</span>, <span class="author">ICGC Prostate Cancer Group</span>, <span class="author">Foster CS</span>, <span class="author">Warren AY</span>, <span class="author">Whitaker HC</span>, <span class="author">Brewer D</span>, <span class="author">Eeles R</span>, <span class="author">Cooper C</span>, <span class="author">Neal D</span>, <span class="author">Visakorpi T</span>, <span class="author">Isaacs WB</span>, <span class="author">Bova GS</span>, <span class="author">Flanagan AM</span>, <span class="author">Futreal PA</span>, <span class="author">Lynch AG</span>, <span class="author">Chinnery PF</span>, <span class="author">McDermott U</span>, <span class="author">Stratton MR</span> and <span class="author">Campbell PJ</span></p>
<p class="affiliation">Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton, United Kingdom.</p><p class="abstract">Recent sequencing studies have extensively explored the somatic alterations present in the nuclear genomes of cancers. Although mitochondria control energy metabolism and apoptosis, the origins and impact of cancer-associated mutations in mtDNA are unclear. In this study, we analyzed somatic alterations in mtDNA from 1675 tumors. We identified 1907 somatic substitutions, which exhibited dramatic replicative strand bias, predominantly C &gt; T and A &gt; G on the mitochondrial heavy strand. This strand-asymmetric signature differs from those found in nuclear cancer genomes but matches the inferred germline process shaping primate mtDNA sequence content. A number of mtDNA mutations showed considerable heterogeneity across tumor types. Missense mutations were selectively neutral and often gradually drifted towards homoplasmy over time. In contrast, mutations resulting in protein truncation undergo negative selection and were almost exclusively heteroplasmic. Our findings indicate that the endogenous mutational mechanism has far greater impact than any other external mutagens in mitochondria and is fundamentally linked to mtDNA replication.</p>
<p class="grants">Funded by: Cancer Research UK: <span class="grant">19556</span>; Medical Research Council: <span class="grant">G1000729</span>, <span class="grant">MR/K000608/1</span>; Wellcome Trust: <span class="grant">101876</span></p>
<p class="publication"><span class="title">eLife</span>&nbsp;<span class="year">2014</span>;<span class="volume">3</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25271376">25271376</a>; DOI: <a href="http://dx.doi.org/10.7554%2FeLife.02935">10.7554/eLife.02935</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">The Human Phenotype Ontology project: linking molecular biology and disease through phenotype data.</h4>
<p class="authors"><span class="author">K&ouml;hler S</span>, <span class="author">Doelken SC</span>, <span class="author">Mungall CJ</span>, <span class="author">Bauer S</span>, <span class="author">Firth HV</span>, <span class="author">Bailleul-Forestier I</span>, <span class="author">Black GC</span>, <span class="author">Brown DL</span>, <span class="author">Brudno M</span>, <span class="author">Campbell J</span>, <span class="author">Fitzpatrick DR</span>, <span class="author">Eppig JT</span>, <span class="author">Jackson AP</span>, <span class="author">Freson K</span>, <span class="author">Girdea M</span>, <span class="author">Helbig I</span>, <span class="author">Hurst JA</span>, <span class="author">J&auml;hn J</span>, <span class="author">Jackson LG</span>, <span class="author">Kelly AM</span>, <span class="author">Ledbetter DH</span>, <span class="author">Mansour S</span>, <span class="author">Martin CL</span>, <span class="author">Moss C</span>, <span class="author">Mumford A</span>, <span class="author">Ouwehand WH</span>, <span class="author">Park SM</span>, <span class="author">Riggs ER</span>, <span class="author">Scott RH</span>, <span class="author">Sisodiya S</span>, <span class="author">Vooren SV</span>, <span class="author">Wapner RJ</span>, <span class="author">Wilkie AO</span>, <span class="author">Wright CF</span>, <span class="author">Vulto-van Silfhout AT</span>, <span class="author">Leeuw Nd</span>, <span class="author">de Vries BB</span>, <span class="author">Washingthon NL</span>, <span class="author">Smith CL</span>, <span class="author">Westerfield M</span>, <span class="author">Schofield P</span>, <span class="author">Ruef BJ</span>, <span class="author">Gkoutos GV</span>, <span class="author">Haendel M</span>, <span class="author">Smedley D</span>, <span class="author">Lewis SE</span> and <span class="author">Robinson PN</span></p>
<p class="affiliation">Institute for Medical Genetics and Human Genetics, Charit&eacute;-Universit&auml;tsmedizin Berlin, Augustenburger Platz 1, 13353 Berlin, Germany, Berlin-Brandenburg Center for Regenerative Therapies, Charit&eacute;-Universit&auml;tsmedizin Berlin, Augustenburger Platz 1, 13353 Berlin, Germany, Lawrence Berkeley National Laboratory, Mail Stop 84R0171, Berkeley, CA 94720, USA, The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK, Department of Medical Genetics, Cambridge University Addenbrooke&#39;s Hospital, Cambridge CB2 2QQ, UK, Universit&eacute; Paul Sabatier, Facult&eacute; de Chirurgie Dentaire, CHU Toulouse, France, Centre for Genomic Medicine, Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Sciences Centre (MAHSC), Manchester, UK, Centre for Genomic Medicine, Institute of Human Development, Faculty of Medical and Human Sciences, University of Manchester, MAHSC, Manchester M13 9WL, UK, Institute of Genetic Medicine. Newcastle University, Central Parkway, Newcastle upon Tyne, NE1 3BZ, UK, Department of Computer Science, University of Toronto, Ontario, Canada, Centre for Computational Medicine, Hospital for Sick Children, Toronto, Ontario, Canada, Department of Clinical Genetics, Leeds Teaching Hospitals NHS Trust, Leeds LS2 9NS, UK, MRC Human Genetics Unit, MRC Institute of Genetic and Molecular Medicine, University of Edinburgh, Edinburgh EH4 2XU, UK, The Jackson Laboratory, Bar Harbor, ME 04609, USA, Center for Molecular and Vascular Biology, University of Leuven, Belgium, Department of Neuropediatrics, University Medical Center Schleswig-Holstein, Kiel Campus, 24105 Kiel, Germany, NE Thames Genetics Service, Great Ormond Street Hospital, London WC1N 3JH, UK, Drexel University College of Medicine, Philadelphia, PA 19102, USA, Department of Haematology, University of Cambridge and NHS Blood and Transplant Cambridge, CB2 0PT Cambridge, UK, Autism and Developmental Medicine Institute, Geisinger Health System</p><p class="abstract">The Human Phenotype Ontology (HPO) project, available at http://www.human-phenotype-ontology.org, provides a structured, comprehensive and well-defined set of 10,088 classes (terms) describing human phenotypic abnormalities and 13,326 subclass relations between the HPO classes. In addition we have developed logical definitions for 46% of all HPO classes using terms from ontologies for anatomy, cell types, function, embryology, pathology and other domains. This allows interoperability with several resources, especially those containing phenotype information on model organisms such as mouse and zebrafish. Here we describe the updated HPO database, which provides annotations of 7,278 human hereditary syndromes listed in OMIM, Orphanet and DECIPHER to classes of the HPO. Various meta-attributes such as frequency, references and negations are associated with each annotation. Several large-scale projects worldwide utilize the HPO for describing phenotype information in their datasets. We have therefore generated equivalence mappings to other phenotype vocabularies such as LDDB, Orphanet, MedDRA, UMLS and phenoDB, allowing integration of existing datasets and interoperability with multiple biomedical resources. We have created various ways to access the HPO database content using flat files, a MySQL database, and Web-based tools. All data and documentation on the HPO project can be found online.</p>
<p class="grants">Funded by: NIH HHS: <span class="grant">R24 OD011883</span></p>
<p class="publication"><span class="title">Nucleic acids research</span>&nbsp;<span class="year">2014</span>;<span class="volume">42</span>;<span class="number">1</span>;<span class="pagerange">D966-74</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24217912">24217912</a>; DOI: <a href="http://dx.doi.org/10.1093%2Fnar%2Fgkt1026">10.1093/nar/gkt1026</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Clinical interpretation of CNVs with cross-species phenotype data.</h4>
<p class="authors"><span class="author">K&ouml;hler S</span>, <span class="author">Schoeneberg U</span>, <span class="author">Czeschik JC</span>, <span class="author">Doelken SC</span>, <span class="author">Hehir-Kwa JY</span>, <span class="author">Ibn-Salem J</span>, <span class="author">Mungall CJ</span>, <span class="author">Smedley D</span>, <span class="author">Haendel MA</span> and <span class="author">Robinson PN</span></p>
<p class="affiliation">Institute for Medical Genetics and Human Genetics, Charit&eacute;-Universit&auml;tsmedizin Berlin, Berlin, Germany Berlin-Brandenburg Center for Regenerative Therapies (BCRT), Berlin, Germany.</p><p class="abstract"><strong>Background</strong>: Clinical evaluation of CNVs identified via techniques such as array comparative genome hybridisation (aCGH) involves the inspection of lists of known and unknown duplications and deletions with the goal of distinguishing pathogenic from benign CNVs. A key step in this process is the comparison of the individual&#39;s phenotypic abnormalities with those associated with Mendelian disorders of the genes affected by the CNV. However, because often there is not much known about these human genes, an additional source of data that could be used is model organism phenotype data. Currently, almost 6000 genes in mouse and zebrafish are, when knocked out, associated with a phenotype in the model organism, but no disease is known to be caused by mutations in the human ortholog. Yet, searching model organism databases and comparing model organism phenotypes with patient phenotypes for identifying novel disease genes and medical evaluation of CNVs is hindered by the difficulty in integrating phenotype information across species and the lack of appropriate software tools.</p><p class="abstract"><strong>Methods</strong>: Here, we present an integrated ranking scheme based on phenotypic matching, degree of overlap with known benign or pathogenic CNVs and the haploinsufficiency score for the prioritisation of CNVs responsible for a patient&#39;s clinical findings.</p><p class="abstract"><strong>Results</strong>: We show that this scheme leads to significant improvements compared with rankings that do not exploit phenotypic information. We provide a software tool called PhenogramViz, which supports phenotype-driven interpretation of aCGH findings based on multiple data sources, including the integrated cross-species phenotype ontology Uberpheno, in order to visualise gene-to-phenotype relations.</p><p class="abstract"><strong>Conclusions</strong>: Integrating and visualising cross-species phenotype information on the affected genes may help in routine diagnostics of CNVs.</p>
<p class="publication"><span class="title">Journal of medical genetics</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25280750">25280750</a>; DOI: <a href="http://dx.doi.org/10.1136%2Fjmedgenet-2014-102633">10.1136/jmedgenet-2014-102633</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Comment on: characterization of the embB gene in Mycobacterium tuberculosis isolates from Barcelona and rapid detection of main mutations related to ethambutol resistance using a low-density DNA array.</h4>
<p class="authors"><span class="author">K&ouml;ser CU</span>, <span class="author">Bryant JM</span>, <span class="author">Comas I</span>, <span class="author">Feuerriegel S</span>, <span class="author">Niemann S</span>, <span class="author">Gagneux S</span>, <span class="author">Parkhill J</span> and <span class="author">Peacock SJ</span></p>
<p class="affiliation">Department of Medicine, University of Cambridge, Cambridge, UK <a href="mailto:%63%75%6B%32%31%40%63%61%6D.%61%63.%75%6B">&#99;&#117;&#107;&#50;&#49;&#64;&#99;&#97;&#109;&#46;&#97;&#99;&#46;&#117;&#107;</a>.</p>
<p class="publication"><span class="title">The Journal of antimicrobial chemotherapy</span>&nbsp;<span class="year">2014</span>;<span class="volume">69</span>;<span class="number">8</span>;<span class="pagerange">2298-9</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24752956">24752956</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4100706">4100706</a>; DOI: <a href="http://dx.doi.org/10.1093%2Fjac%2Fdku101">10.1093/jac/dku101</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Genetic diversity within Mycobacterium tuberculosis complex impacts on the accuracy of genotypic pyrazinamide drug-susceptibility assay.</h4>
<p class="authors"><span class="author">K&ouml;ser CU</span>, <span class="author">Comas I</span>, <span class="author">Feuerriegel S</span>, <span class="author">Niemann S</span>, <span class="author">Gagneux S</span> and <span class="author">Peacock SJ</span></p>
<p class="affiliation">Department of Medicine, University of Cambridge, Cambridge, United Kingdom. Electronic address: <a href="mailto:%63%75%6B%32%31%40%63%61%6D.%61%63.%75%6B">&#99;&#117;&#107;&#50;&#49;&#64;&#99;&#97;&#109;&#46;&#97;&#99;&#46;&#117;&#107;</a>.</p>
<p class="publication"><span class="title">Tuberculosis (Edinburgh, Scotland)</span>&nbsp;<span class="year">2014</span>;<span class="volume">94</span>;<span class="number">4</span>;<span class="pagerange">451-3</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24870943">24870943</a>; DOI: <a href="http://dx.doi.org/10.1016%2Fj.tube.2014.04.002">10.1016/j.tube.2014.04.002</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Whole-genome sequencing to control antimicrobial resistance.</h4>
<p class="authors"><span class="author">K&ouml;ser CU</span>, <span class="author">Ellington MJ</span> and <span class="author">Peacock SJ</span></p>
<p class="affiliation">Department of Medicine, University of Cambridge, Cambridge, UK. Electronic address: <a href="mailto:%63%75%6B%32%31%40%63%61%6D.%61%63.%75%6B">&#99;&#117;&#107;&#50;&#49;&#64;&#99;&#97;&#109;&#46;&#97;&#99;&#46;&#117;&#107;</a>.</p><p class="abstract">Following recent improvements in sequencing technologies, whole-genome sequencing (WGS) is positioned to become an essential tool in the control of antibiotic resistance, a major threat in modern healthcare. WGS has already found numerous applications in this area, ranging from the development of novel antibiotics and diagnostic tests through to antibiotic stewardship of currently available drugs via surveillance and the elucidation of the factors that allow the emergence and persistence of resistance. Numerous proof-of-principle studies have also highlighted the value of WGS as a tool for day-to-day infection control and, for some pathogens, as a primary diagnostic tool to detect antibiotic resistance. However, appropriate data analysis platforms will need to be developed before routine WGS can be introduced on a large scale.</p>
<p class="publication"><span class="title">Trends in genetics : TIG</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25096945">25096945</a>; DOI: <a href="http://dx.doi.org/10.1016%2Fj.tig.2014.07.003">10.1016/j.tig.2014.07.003</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Rapid single-colony whole-genome sequencing of bacterial pathogens.</h4>
<p class="authors"><span class="author">K&ouml;ser CU</span>, <span class="author">Fraser LJ</span>, <span class="author">Ioannou A</span>, <span class="author">Becq J</span>, <span class="author">Ellington MJ</span>, <span class="author">Holden MT</span>, <span class="author">Reuter S</span>, <span class="author">T&ouml;r&ouml;k ME</span>, <span class="author">Bentley SD</span>, <span class="author">Parkhill J</span>, <span class="author">Gormley NA</span>, <span class="author">Smith GP</span> and <span class="author">Peacock SJ</span></p>
<p class="affiliation">Department of Medicine, University of Cambridge, Cambridge, UK.</p><p class="abstract"><strong>Objectives</strong>: As a result of the introduction of rapid benchtop sequencers, the time required to subculture a bacterial pathogen to extract sufficient DNA for library preparation can now exceed the time to sequence said DNA. We have eliminated this rate-limiting step by developing a protocol to generate DNA libraries for whole-genome sequencing directly from single bacterial colonies grown on primary culture plates.</p><p class="abstract"><strong>Methods</strong>: We developed our protocol using single colonies of 17 bacterial pathogens responsible for severe human infection that were grown using standard diagnostic media and incubation conditions. We then applied this method to four clinical scenarios that currently require time-consuming reference laboratory tests: full identification and genotyping of salmonellae; identification of blaNDM-1, a highly transmissible carbapenemase resistance gene, in Klebsiella pneumoniae; detection of genes encoding staphylococcal toxins associated with specific disease syndromes; and monitoring of vaccine targets to detect vaccine escape in Neisseria meningitidis.</p><p class="abstract"><strong>Results</strong>: We validated our single-colony whole-genome sequencing protocol for all 40 combinations of pathogen and selective, non-selective or indicator media tested in this study. Moreover, we demonstrated the clinical value of this method compared with current reference laboratory tests.</p><p class="abstract"><strong>Conclusions</strong>: This advance will facilitate the implementation of whole-genome sequencing into diagnostic and public health microbiology.</p>
<p class="publication"><span class="title">The Journal of antimicrobial chemotherapy</span>&nbsp;<span class="year">2014</span>;<span class="volume">69</span>;<span class="number">5</span>;<span class="pagerange">1275-81</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24370932">24370932</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC3977605">3977605</a>; DOI: <a href="http://dx.doi.org/10.1093%2Fjac%2Fdkt494">10.1093/jac/dkt494</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">A transcriptional switch underlies commitment to sexual development in malaria parasites.</h4>
<p class="authors"><span class="author">Kafsack BF</span>, <span class="author">Rovira-Graells N</span>, <span class="author">Clark TG</span>, <span class="author">Bancells C</span>, <span class="author">Crowley VM</span>, <span class="author">Campino SG</span>, <span class="author">Williams AE</span>, <span class="author">Drought LG</span>, <span class="author">Kwiatkowski DP</span>, <span class="author">Baker DA</span>, <span class="author">Cort&eacute;s A</span> and <span class="author">Llin&aacute;s M</span></p>
<p class="affiliation">1] Lewis-Sigler Institute for Integrative Genomics, Princeton University, Princeton, New Jersey 08544, USA [2] Division of Basic Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA (B.F.C.K.); Department of Molecular Biology and Center for Infectious Disease Dynamics, The Pennsylvania State University, State College, Pennsylvania 16802, USA (V.M.C., M.L.).</p><p class="abstract">The life cycles of many parasites involve transitions between disparate host species, requiring these parasites to go through multiple developmental stages adapted to each of these specialized niches. Transmission of malaria parasites (Plasmodium spp.) from humans to the mosquito vector requires differentiation from asexual stages replicating within red blood cells into non-dividing male and female gametocytes. Although gametocytes were first described in 1880, our understanding of the molecular mechanisms involved in commitment to gametocyte formation is extremely limited, and disrupting this critical developmental transition remains a long-standing goal. Here we show that expression levels of the DNA-binding protein PfAP2-G correlate strongly with levels of gametocyte formation. Using independent forward and reverse genetics approaches, we demonstrate that PfAP2-G function is essential for parasite sexual differentiation. By combining genome-wide PfAP2-G cognate motif occurrence with global transcriptional changes resulting from PfAP2-G ablation, we identify early gametocyte genes as probable targets of PfAP2-G and show that their regulation by PfAP2-G is critical for their wild-type level expression. In the asexual blood-stage parasites pfap2-g appears to be among a set of epigenetically silenced loci prone to spontaneous activation. Stochastic activation presents a simple mechanism for a low baseline of gametocyte production. Overall, these findings identify PfAP2-G as a master regulator of sexual-stage development in malaria parasites and mark the first discovery of a transcriptional switch controlling a differentiation decision in protozoan parasites.</p>
<p class="grants">Funded by: Biotechnology and Biological Sciences Research Council; Howard Hughes Medical Institute; Medical Research Council: <span class="grant">G0600230</span>, <span class="grant">G0600718</span>, <span class="grant">J005398</span>; NIAID NIH HHS: <span class="grant">R01 AI076276</span>; NIGMS NIH HHS: <span class="grant">P50GM071508</span>, <span class="grant">T32 GM007388</span>; Wellcome Trust: <span class="grant">090532</span>, <span class="grant">090532/Z/09/Z</span>, <span class="grant">094752</span>, <span class="grant">098051</span></p>
<p class="publication"><span class="title">Nature</span>&nbsp;<span class="year">2014</span>;<span class="volume">507</span>;<span class="number">7491</span>;<span class="pagerange">248-52</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24572369">24572369</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4040541">4040541</a>; DOI: <a href="http://dx.doi.org/10.1038%2Fnature12920">10.1038/nature12920</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Antibacterial resistance in sub-Saharan Africa: an underestimated emergency.</h4>
<p class="authors"><span class="author">Kariuki S</span> and <span class="author">Dougan G</span></p>
<p class="affiliation">Centre for Microbiology Research, Kenya Medical Research Institute, Nairobi, Kenya; Wellcome Trust Sanger Institute, Hinxton, Cambridge, United Kingdom.</p><p class="abstract">Antibacterial resistance-associated infections are known to increase morbidity, mortality, and cost of treatment, and to potentially put others in the community at higher risk of infections. In high-income countries, where the burden of infectious diseases is relatively modest, resistance to first-line antibacterial agents is usually overcome by use of second- and third-line agents. However, in developing countries where the burden of infectious diseases is high, patients with antibacterial-resistant infections may be unable to obtain or afford effective second-line treatments. In sub-Saharan Africa (SSA), the situation is aggravated by poor hygiene, unreliable water supplies, civil conflicts, and increasing numbers of immunocompromised people, such as those with HIV, which facilitate both the evolution of resistant pathogens and their rapid spread in the community. Because of limited capacity for disease detection and surveillance, the burden of illnesses due to treatable bacterial infections, their specific etiologies, and the awareness of antibacterial resistance are less well established in most of SSA, and therefore the ability to mitigate their consequences is significantly limited.</p>
<p class="publication"><span class="title">Annals of the New York Academy of Sciences</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24628272">24628272</a>; DOI: <a href="http://dx.doi.org/10.1111%2Fnyas.12380">10.1111/nyas.12380</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Natural selection and infectious disease in human populations.</h4>
<p class="authors"><span class="author">Karlsson EK</span>, <span class="author">Kwiatkowski DP</span> and <span class="author">Sabeti PC</span></p>
<p class="affiliation">1] Center for Systems Biology, Department of Organismic and Evolutionary Biology, Harvard University, Cambridge, Massachusetts 02138, USA. [2] Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, Massachusetts 02142, USA.</p><p class="abstract">The ancient biological &#39;arms race&#39; between microbial pathogens and humans has shaped genetic variation in modern populations, and this has important implications for the growing field of medical genomics. As humans migrated throughout the world, populations encountered distinct pathogens, and natural selection increased the prevalence of alleles that are advantageous in the new ecosystems in both host and pathogens. This ancient history now influences human infectious disease susceptibility and microbiome homeostasis, and contributes to common diseases that show geographical disparities, such as autoimmune and metabolic disorders. Using new high-throughput technologies, analytical methods and expanding public data resources, the investigation of natural selection is leading to new insights into the function and dysfunction of human biology.</p>
<p class="publication"><span class="title">Nature reviews. Genetics</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24776769">24776769</a>; DOI: <a href="http://dx.doi.org/10.1038%2Fnrg3734">10.1038/nrg3734</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Impact of temporal variation on design and analysis of mouse knockout phenotyping studies.</h4>
<p class="authors"><span class="author">Karp NA</span>, <span class="author">Speak AO</span>, <span class="author">White JK</span>, <span class="author">Adams DJ</span>, <span class="author">Hrab&eacute; de Angelis M</span>, <span class="author">H&eacute;rault Y</span> and <span class="author">Mott RF</span></p>
<p class="affiliation">Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, United Kingdom.</p><p class="abstract">A significant challenge facing high-throughput phenotyping of in-vivo knockout mice is ensuring phenotype calls are robust and reliable. Central to this problem is selecting an appropriate statistical analysis that models both the experimental design (the workflow and the way control mice are selected for comparison with knockout animals) and the sources of variation. Recently we proposed a mixed model suitable for small batch-oriented studies, where controls are not phenotyped concurrently with mutants. Here we evaluate this method both for its sensitivity to detect phenotypic effects and to control false positives, across a range of workflows used at mouse phenotyping centers. We found the sensitivity and control of false positives depend on the workflow. We show that the phenotypes in control mice fluctuate unexpectedly between batches and this can cause the false positive rate of phenotype calls to be inflated when only a small number of batches are tested, when the effect of knockout becomes confounded with temporal fluctuations in control mice. This effect was observed in both behavioural and physiological assays. Based on this analysis, we recommend two approaches (workflow and accompanying control strategy) and associated analyses, which would be robust, for use in high-throughput phenotyping pipelines. Our results show the importance in modelling all sources of variability in high-throughput phenotyping studies.</p>
<p class="publication"><span class="title">PloS one</span>&nbsp;<span class="year">2014</span>;<span class="volume">9</span>;<span class="number">10</span>;<span class="pagerange">e111239</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25343444">25343444</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4208881">4208881</a>; DOI: <a href="http://dx.doi.org/10.1371%2Fjournal.pone.0111239">10.1371/journal.pone.0111239</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Kdm3a lysine demethylase is an Hsp90 client required for cytoskeletal rearrangements during spermatogenesis.</h4>
<p class="authors"><span class="author">Kasioulis I</span>, <span class="author">Syred HM</span>, <span class="author">Tate P</span>, <span class="author">Finch A</span>, <span class="author">Shaw J</span>, <span class="author">Seawright A</span>, <span class="author">Fuszard M</span>, <span class="author">Botting CH</span>, <span class="author">Shirran S</span>, <span class="author">Adams IR</span>, <span class="author">Jackson IJ</span>, <span class="author">van Heyningen V</span> and <span class="author">Yeyati PL</span></p>
<p class="affiliation">MRC Human Genetics Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Edinburgh, EH4 2XU, UK Edinburgh Cancer Research UK Centre, Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Edinburgh, EH4 2XU, UK Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Cambridge, CB10 1HH, UK Biomedical Sciences Research Complex Mass Spectrometry and Proteomics Facility, BMS Annexe, North Haugh, University of St Andrews, St Andrews, Fife, KY16 9ST, UK.</p>
<p class="abstract">The lysine demethylase Kdm3a (Jhdm2a, Jmjd1a) is required for male fertility, sex determination and metabolic homeostasis through its nuclear role in chromatin remodeling. Many histone-modifying enzymes have additional non-histone substrates, as well as non-enzymatic functions, contributing to the full spectrum of events underlying their biological roles. Here, we present two Kdm3a mouse models that exhibit cytoplasmic defects that may account in part for the globozoospermia phenotype reported previously. Electron microscopy revealed abnormal acrosome, manchette and the absence of implantation fossa at the caudal end of the nucleus in mice without Kdm3a demethylase activity, thus affecting cytoplasmic structures required to elongate the sperm head. We describe an enzymatically active new Kdm3a isoform and show that subcellular distribution, protein levels and lysine demethylation activity of Kdm3a depended on Hsp90. We show that Kdm3a localizes to cytoplasmic structures of maturing spermatids affected in Kdm3a mutant mice which in turn display altered fractionation of -actin and -tubulin. Kdm3a is therefore a multi-functional Hsp90 client protein that participates directly in the regulation of cytoskeletal components.</p>
<p class="publication"><span class="title">Molecular biology of the cell</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24554764">24554764</a>; DOI: <a href="http://dx.doi.org/10.1091%2Fmbc.E13-08-0471">10.1091/mbc.E13-08-0471</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Managing clinically significant findings in research: the UK10K example.</h4>
<p class="authors"><span class="author">Kaye J</span>, <span class="author">Hurles M</span>, <span class="author">Griffin H</span>, <span class="author">Grewal J</span>, <span class="author">Bobrow M</span>, <span class="author">Timpson N</span>, <span class="author">Smee C</span>, <span class="author">Bolton P</span>, <span class="author">Durbin R</span>, <span class="author">Dyke S</span>, <span class="author">Fitzpatrick D</span>, <span class="author">Kennedy K</span>, <span class="author">Kent A</span>, <span class="author">Muddyman D</span>, <span class="author">Muntoni F</span>, <span class="author">Raymond LF</span>, <span class="author">Semple R</span>, <span class="author">Spector T</span> and <span class="author">UK 10K</span></p>
<p class="affiliation">Nuffield Department of Population Health, HeLEX - Centre for Health, Law and Emerging Technologies, University of Oxford, Oxford, UK.</p><p class="abstract">Recent advances in sequencing technology allow data on the human genome to be generated more quickly and in greater detail than ever before. Such detail includes findings that may be of significance to the health of the research participant involved. Although research studies generally do not feed back information on clinically significant findings (CSFs) to participants, this stance is increasingly being questioned. There may be difficulties and risks in feeding clinically significant information back to research participants, however, the UK10K consortium sought to address these by creating a detailed management pathway. This was not intended to create any obligation upon the researchers to feed back any CSFs they discovered. Instead, it provides a mechanism to ensure that any such findings can be passed on to the participant where appropriate. This paper describes this mechanism and the specific criteria, which must be fulfilled in order for a finding and participant to qualify for feedback. This mechanism could be used by future research consortia, and may also assist in the development of sound principles for dealing with CSFs.</p>
<p class="grants">Funded by: Medical Research Council: <span class="grant">MC_UU_12012/5/B</span>, <span class="grant">MC_UU_12013/3</span>; Wellcome Trust: <span class="grant">091310</span>, <span class="grant">092731</span>, <span class="grant">096599</span>, <span class="grant">098498</span>, <span class="grant">WT091310</span>, <span class="grant">WT096599/2/11/Z</span></p>
<p class="publication"><span class="title">European journal of human genetics : EJHG</span>&nbsp;<span class="year">2014</span>;<span class="volume">22</span>;<span class="number">9</span>;<span class="pagerange">1100-4</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24424120">24424120</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4026295">4026295</a>; DOI: <a href="http://dx.doi.org/10.1038%2Fejhg.2013.290">10.1038/ejhg.2013.290</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Identification of structural variation in mouse genomes.</h4>
<p class="authors"><span class="author">Keane TM</span>, <span class="author">Wong K</span>, <span class="author">Adams DJ</span>, <span class="author">Flint J</span>, <span class="author">Reymond A</span> and <span class="author">Yalcin B</span></p>
<p class="affiliation">Wellcome Trust Sanger Institute Hinxton, Cambridge, UK.</p><p class="abstract">Structural variation is variation in structure of DNA regions affecting DNA sequence length and/or orientation. It generally includes deletions, insertions, copy-number gains, inversions, and transposable elements. Traditionally, the identification of structural variation in genomes has been challenging. However, with the recent advances in high-throughput DNA sequencing and paired-end mapping (PEM) methods, the ability to identify structural variation and their respective association to human diseases has improved considerably. In this review, we describe our current knowledge of structural variation in the mouse, one of the prime model systems for studying human diseases and mammalian biology. We further present the evolutionary implications of structural variation on transposable elements. We conclude with future directions on the study of structural variation in mouse genomes that will increase our understanding of molecular architecture and functional consequences of structural variation.</p>
<p class="publication"><span class="title">Frontiers in genetics</span>&nbsp;<span class="year">2014</span>;<span class="volume">5</span>;<span class="pagerange">192</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25071822">25071822</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4079067">4079067</a>; DOI: <a href="http://dx.doi.org/10.3389%2Ffgene.2014.00192">10.3389/fgene.2014.00192</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">The origins of malaria: there are more things in heaven and earth &hellip;</h4>
<p class="authors"><span class="author">Keeling PJ</span> and <span class="author">Rayner JC</span></p>
<p class="affiliation">Department of Botany, Canadian Institute for Advanced Research, Evolutionary Biology Program,University of British Columbia,Vancouver, BC V6T 1Z4,Canada.</p><p class="abstract">SUMMARY Malaria remains one of the most significant global public health burdens, with nearly half of the world&#39;s population at risk of infection. Malaria is not however a monolithic disease - it can be caused by multiple different parasite species of the Plasmodium genus, each of which can induce different symptoms and pathology, and which pose quite different challenges for control. Furthermore, malaria is in no way restricted to humans. There are Plasmodium species that have adapted to infect most warm-blooded vertebrate species, and the genus as a whole is both highly successful and highly diverse. How, where and when human malaria parasites originated from within this diversity has long been a subject of fascination and sometimes also controversy. The past decade has seen the publication of a number of important discoveries about malaria parasite origins, all based on the application of molecular diagnostic tools to new sources of samples. This review summarizes some of those recent discoveries and discusses their implication for our current understanding of the origin and evolution of the Plasmodium genus. The nature of these discoveries and the manner in which they are made are then used to lay out a series of opportunities and challenges for the next wave of parasite hunters.</p>
<p class="publication"><span class="title">Parasitology</span>&nbsp;<span class="year">2014</span>;<span class="pagerange">1-10</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24963725">24963725</a>; DOI: <a href="http://dx.doi.org/10.1017%2FS0031182014000766">10.1017/S0031182014000766</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Expression of phosphofructokinase in skeletal muscle is influenced by genetic variation and associated with insulin sensitivity.</h4>
<p class="authors"><span class="author">Keildson S</span>, <span class="author">Fadista J</span>, <span class="author">Ladenvall C</span>, <span class="author">Hedman AK</span>, <span class="author">Elgzyri T</span>, <span class="author">Small KS</span>, <span class="author">Grundberg E</span>, <span class="author">Nica AC</span>, <span class="author">Glass D</span>, <span class="author">Richards JB</span>, <span class="author">Barrett A</span>, <span class="author">Nisbet J</span>, <span class="author">Zheng HF</span>, <span class="author">R&ouml;nn T</span>, <span class="author">Str&ouml;m K</span>, <span class="author">Eriksson KF</span>, <span class="author">Prokopenko I</span>, <span class="author">MAGIC Consortium</span>, <span class="author">DIAGRAM Consortium</span>, <span class="author">MuTHER Consortium</span>, <span class="author">Spector TD</span>, <span class="author">Dermitzakis ET</span>, <span class="author">Deloukas P</span>, <span class="author">McCarthy MI</span>, <span class="author">Rung J</span>, <span class="author">Groop L</span>, <span class="author">Franks PW</span>, <span class="author">Lindgren CM</span> and <span class="author">Hansson O</span></p>
<p class="affiliation">Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, U.K.</p><p class="abstract">Using an integrative approach in which genetic variation, gene expression, and clinical phenotypes are assessed in relevant tissues may help functionally characterize the contribution of genetics to disease susceptibility. We sought to identify genetic variation influencing skeletal muscle gene expression (expression quantitative trait loci [eQTLs]) as well as expression associated with measures of insulin sensitivity. We investigated associations of 3,799,401 genetic variants in expression of &gt;7,000 genes from three cohorts (n = 104). We identified 287 genes with cis-acting eQTLs (false discovery rate [FDR] &lt;5%; P &lt; 1.96 &times; 10(-5)) and 49 expression-insulin sensitivity phenotype associations (i.e., fasting insulin, homeostasis model assessment-insulin resistance, and BMI) (FDR &lt;5%; P = 1.34 &times; 10(-4)). One of these associations, fasting insulin/phosphofructokinase (PFKM), overlaps with an eQTL. Furthermore, the expression of PFKM, a rate-limiting enzyme in glycolysis, was nominally associated with glucose uptake in skeletal muscle (P = 0.026; n = 42) and overexpressed (Bonferroni-corrected P = 0.03) in skeletal muscle of patients with T2D (n = 102) compared with normoglycemic controls (n = 87). The PFKM eQTL (rs4547172; P = 7.69 &times; 10(-6)) was nominally associated with glucose uptake, glucose oxidation rate, intramuscular triglyceride content, and metabolic flexibility (P = 0.016-0.048; n = 178). We explored eQTL results using published data from genome-wide association studies (DIAGRAM and MAGIC), and a proxy for the PFKM eQTL (rs11168327; r(2) = 0.75) was nominally associated with T2D (DIAGRAM P = 2.7 &times; 10(-3)). Taken together, our analysis highlights PFKM as a potential regulator of skeletal muscle insulin sensitivity.</p>
<p class="publication"><span class="title">Diabetes</span>&nbsp;<span class="year">2014</span>;<span class="volume">63</span>;<span class="number">3</span>;<span class="pagerange">1154-65</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24306210">24306210</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC3931395">3931395</a>; DOI: <a href="http://dx.doi.org/10.2337%2Fdb13-1301">10.2337/db13-1301</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">The Impact of Different DNA Extraction Kits and Laboratories upon the Assessment of Human Gut Microbiota Composition by 16S rRNA Gene Sequencing.</h4>
<p class="authors"><span class="author">Kennedy NA</span>, <span class="author">Walker AW</span>, <span class="author">Berry SH</span>, <span class="author">Duncan SH</span>, <span class="author">Farquarson FM</span>, <span class="author">Louis P</span>, <span class="author">Thomson JM</span>, <span class="author">Other members not named within the manuscript author list (alphabetical by surname):</span>, <span class="author">Satsangi J</span>, <span class="author">Flint HJ</span>, <span class="author">Parkhill J</span>, <span class="author">Lees CW</span> and <span class="author">Hold GL</span></p>
<p class="affiliation">Gastrointestinal Unit, Centre for Genomic and Experimental Medicine, University of Edinburgh, Western General Hospital, Edinburgh, United Kingdom.</p><p class="abstract"><strong>Introduction</strong>: Determining bacterial community structure in fecal samples through DNA sequencing is an important facet of intestinal health research. The impact of different commercially available DNA extraction kits upon bacterial community structures has received relatively little attention. The aim of this study was to analyze bacterial communities in volunteer and inflammatory bowel disease (IBD) patient fecal samples extracted using widely used DNA extraction kits in established gastrointestinal research laboratories.</p><p class="abstract"><strong>Methods</strong>: Fecal samples from two healthy volunteers (H3 and H4) and two relapsing IBD patients (I1 and I2) were investigated. DNA extraction was undertaken using MoBio Powersoil and MP Biomedicals FastDNA SPIN Kit for Soil DNA extraction kits. PCR amplification for pyrosequencing of bacterial 16S rRNA genes was performed in both laboratories on all samples. Hierarchical clustering of sequencing data was done using the Yue and Clayton similarity coefficient.</p><p class="abstract"><strong>Results</strong>: DNA extracted using the FastDNA kit and the MoBio kit gave median DNA concentrations of 475 (interquartile range 228-561) and 22 (IQR 9-36) ng/&micro;L respectively (p&lt;0.0001). Hierarchical clustering of sequence data by Yue and Clayton coefficient revealed four clusters. Samples from individuals H3 and I2 clustered by patient; however, samples from patient I1 extracted with the MoBio kit clustered with samples from patient H4 rather than the other I1 samples. Linear modelling on relative abundance of common bacterial families revealed significant differences between kits; samples extracted with MoBio Powersoil showed significantly increased Bacteroidaceae, Ruminococcaceae and Porphyromonadaceae, and lower Enterobacteriaceae, Lachnospiraceae, Clostridiaceae, and Erysipelotrichaceae (p&lt;0.05).</p><p class="abstract"><strong>Conclusion</strong>: This study demonstrates significant differences in DNA yield and bacterial DNA composition when comparing DNA extracted from the same fecal sample with different extraction kits. This highlights the importance of ensuring that samples in a study are prepared with the same method, and the need for caution when cross-comparing studies that use different methods.</p>
<p class="publication"><span class="title">PloS one</span>&nbsp;<span class="year">2014</span>;<span class="volume">9</span>;<span class="number">2</span>;<span class="pagerange">e88982</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24586470">24586470</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC3933346">3933346</a>; DOI: <a href="http://dx.doi.org/10.1371%2Fjournal.pone.0088982">10.1371/journal.pone.0088982</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Zebrafish Rab5 proteins and a role for Rab5ab in nodal signalling.</h4>
<p class="authors"><span class="author">Kenyon EJ</span>, <span class="author">Campos I</span>, <span class="author">Bull JC</span>, <span class="author">Williams PH</span>, <span class="author">Stemple DL</span> and <span class="author">Clark MD</span></p>
<p class="affiliation">Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1SA, United Kingdom.</p><p class="abstract">The RAB5 gene family is the best characterised of all human RAB families and is essential for in vitro homotypic fusion of early endosomes. In recent years, the disruption or activation of Rab5 family proteins has been used as a tool to understand growth factor signal transduction in whole animal systems such as Drosophila melanogaster and zebrafish. In this study we have examined the functions for four rab5 genes in zebrafish. Disruption of rab5ab expression by antisense morpholino oligonucleotide (MO) knockdown abolishes nodal signalling in early zebrafish embryos, whereas overexpression of rab5ab mRNA leads to ectopic expression of markers that are normally downstream of nodal signalling. By contrast MO disruption of other zebrafish rab5 genes shows little or no effect on expression of markers of dorsal organiser development. We conclude that rab5ab is essential for nodal signalling and organizer specification in the developing zebrafish embryo.</p>
<p class="publication"><span class="title">Developmental biology</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25478908">25478908</a>; DOI: <a href="http://dx.doi.org/10.1016%2Fj.ydbio.2014.11.007">10.1016/j.ydbio.2014.11.007</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Insertions in the OCL1 locus of Acinetobacter baumannii lead to shortened lipooligosaccharides.</h4>
<p class="authors"><span class="author">Kenyon JJ</span>, <span class="author">Holt KE</span>, <span class="author">Pickard D</span>, <span class="author">Dougan G</span> and <span class="author">Hall RM</span></p>
<p class="affiliation">School of Molecular Bioscience, The University of Sydney, New South Wales, Australia. Electronic address: <a href="mailto:%6A%6F%68%61%6E%6E%61.%6B%65%6E%79%6F%6E%40%73%79%64%6E%65%79.%65%64%75.%61%75">&#106;&#111;&#104;&#97;&#110;&#110;&#97;&#46;&#107;&#101;&#110;&#121;&#111;&#110;&#64;&#115;&#121;&#100;&#110;&#101;&#121;&#46;&#101;&#100;&#117;&#46;&#97;&#117;</a>.</p><p class="abstract">Genomes of 82 Acinetobacter baumannii global clones 1 (GC1) and 2 (GC2) isolates were sequenced and different forms of the locus predicted to direct synthesis of the outer core (OC) of the lipooligosaccharide were identified. OCL1 was in all GC2 genomes, whereas GC1 isolates carried OCL1, OCL3 or a new locus, OCL5. Three mutants in which an insertion sequence (ISAba1 or ISAba23) interrupted OCL1 were identified. Isolates with OCL1 intact produced only lipooligosaccharide, while the mutants produced lipooligosaccharide of reduced molecular weight. Thus, the assignment of the OC locus as that responsible for the synthesis of the OC is correct.</p>
<p class="publication"><span class="title">Research in microbiology</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24861001">24861001</a>; DOI: <a href="http://dx.doi.org/10.1016%2Fj.resmic.2014.05.034">10.1016/j.resmic.2014.05.034</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Ensembl Genomes 2013: scaling up access to genome-wide data.</h4>
<p class="authors"><span class="author">Kersey PJ</span>, <span class="author">Allen JE</span>, <span class="author">Christensen M</span>, <span class="author">Davis P</span>, <span class="author">Falin LJ</span>, <span class="author">Grabmueller C</span>, <span class="author">Hughes DS</span>, <span class="author">Humphrey J</span>, <span class="author">Kerhornou A</span>, <span class="author">Khobova J</span>, <span class="author">Langridge N</span>, <span class="author">McDowall MD</span>, <span class="author">Maheswari U</span>, <span class="author">Maslen G</span>, <span class="author">Nuhn M</span>, <span class="author">Ong CK</span>, <span class="author">Paulini M</span>, <span class="author">Pedro H</span>, <span class="author">Toneva I</span>, <span class="author">Tuli MA</span>, <span class="author">Walts B</span>, <span class="author">Williams G</span>, <span class="author">Wilson D</span>, <span class="author">Youens-Clark K</span>, <span class="author">Monaco MK</span>, <span class="author">Stein J</span>, <span class="author">Wei X</span>, <span class="author">Ware D</span>, <span class="author">Bolser DM</span>, <span class="author">Howe KL</span>, <span class="author">Kulesha E</span>, <span class="author">Lawson D</span> and <span class="author">Staines DM</span></p>
<p class="affiliation">The European Molecular Biology Laboratory, The European Bioinformatics Institute, The Wellcome Trust Genome Campus, Hinxton, Cambridgeshire, CB10 1SD, UK, Wellcome Trust Sanger Centre, The Wellcome Trust Genome Campus, Hinxton, Cambridgeshire, CB10 1SA, UK, Cold Spring Harbor Laboratory, 1 Bungtown Rd, Cold Spring Harbor, NY 11724, USA and USDA-ARS, Cornell University, Ithaca, NY, 14853, USA.</p>
<p class="abstract">Ensembl Genomes (http://www.ensemblgenomes.org) is an integrating resource for genome-scale data from non-vertebrate species. The project exploits and extends technologies for genome annotation, analysis and dissemination, developed in the context of the vertebrate-focused Ensembl project, and provides a complementary set of resources for non-vertebrate species through a consistent set of programmatic and interactive interfaces. These provide access to data including reference sequence, gene models, transcriptional data, polymorphisms and comparative analysis. This article provides an update to the previous publications about the resource, with a focus on recent developments. These include the addition of important new genomes (and related data sets) including crop plants, vectors of human disease and eukaryotic pathogens. In addition, the resource has scaled up its representation of bacterial genomes, and now includes the genomes of over 9000 bacteria. Specific extensions to the web and programmatic interfaces have been developed to support users in navigating these large data sets. Looking forward, analytic tools to allow targeted selection of data for visualization and download are likely to become increasingly important in future as the number of available genomes increases within all domains of life, and some of the challenges faced in representing bacterial data are likely to become commonplace for eukaryotes in future.</p>
<p class="publication"><span class="title">Nucleic acids research</span>&nbsp;<span class="year">2014</span>;<span class="volume">42</span>;<span class="number">1</span>;<span class="pagerange">D546-52</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24163254">24163254</a>; DOI: <a href="http://dx.doi.org/10.1093%2Fnar%2Fgkt979">10.1093/nar/gkt979</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Cancer mouse models: Past, present and future.</h4>
<p class="authors"><span class="author">Khaled WT</span> and <span class="author">Liu P</span></p>
<p class="affiliation">Department of Pharmacology, University of Cambridge, Cambridge CB2 1PD, UK. Electronic address: <a href="mailto:%77%74%6B%32%32%40%63%61%6D.%61%63.%75%6B">&#119;&#116;&#107;&#50;&#50;&#64;&#99;&#97;&#109;&#46;&#97;&#99;&#46;&#117;&#107;</a>.</p><p class="abstract">The development and advances in gene targeting technology over the past three decades has facilitated the generation of cancer mouse models that recapitulate features of human malignancies. These models have been and still remain instrumental in revealing the complexities of human cancer biology. However, they will need to evolve in the post-genomic era of cancer research. In this review we will highlight some of the key developments over the past decades and will discuss the new possibilities of cancer mouse models in the light of emerging powerful gene manipulating tools.</p>
<p class="publication"><span class="title">Seminars in cell &amp; developmental biology</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24718321">24718321</a>; DOI: <a href="http://dx.doi.org/10.1016%2Fj.semcdb.2014.04.003">10.1016/j.semcdb.2014.04.003</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">A novel method for detecting uniparental disomy from trio genotypes identifies a significant excess in children with developmental disorders.</h4>
<p class="authors"><span class="author">King DA</span>, <span class="author">Fitzgerald TW</span>, <span class="author">Miller R</span>, <span class="author">Canham N</span>, <span class="author">Clayton-Smith J</span>, <span class="author">Johnson D</span>, <span class="author">Mansour S</span>, <span class="author">Stewart F</span>, <span class="author">Vasudevan P</span>, <span class="author">Hurles ME</span> and <span class="author">DDD Study</span></p>
<p class="affiliation">Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1HH, United Kingdom;</p><p class="abstract">Exome sequencing of parent-offspring trios is a popular strategy for identifying causative genetic variants in children with rare diseases. This method owes its strength to the leveraging of inheritance information, which facilitates de novo variant calling, inference of compound heterozygosity, and the identification of inheritance anomalies. Uniparental disomy describes the inheritance of a homologous chromosome pair from only one parent. This aberration is important to detect in genetic disease studies because it can result in imprinting disorders and recessive diseases. We have developed a software tool to detect uniparental disomy from child-mother-father genotype data that uses a binomial test to identify chromosomes with a significant burden of uniparentally inherited genotypes. This tool is the first to read VCF-formatted genotypes, to perform integrated copy number filtering, and to use a statistical test inherently robust for use in platforms of varying genotyping density and noise characteristics. Simulations demonstrated superior accuracy compared with previously developed approaches. We implemented the method on 1057 trios from the Deciphering Developmental Disorders project, a trio-based rare disease study, and detected six validated events, a significant enrichment compared with the population prevalence of UPD (1 in 3500), suggesting that most of these events are pathogenic. One of these events represents a known imprinting disorder, and exome analyses have identified rare homozygous candidate variants, mainly in the isodisomic regions of UPD chromosomes, which, among other variants, provide targets for further genetic and functional evaluation.</p>
<p class="grants">Funded by: Wellcome Trust: <span class="grant">076113</span>, <span class="grant">WT098051</span></p>
<p class="publication"><span class="title">Genome research</span>&nbsp;<span class="year">2014</span>;<span class="volume">24</span>;<span class="number">4</span>;<span class="pagerange">673-87</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24356988">24356988</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC3975066">3975066</a>; DOI: <a href="http://dx.doi.org/10.1101%2Fgr.160465.113">10.1101/gr.160465.113</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Determinants of invasiveness beneath the capsule of the pneumococcus.</h4>
<p class="authors"><span class="author">Klugman KP</span>, <span class="author">Bentley SD</span> and <span class="author">McGee L</span></p>
<p class="affiliation">Department of Global Health, Emory University.</p>
<p class="publication"><span class="title">The Journal of infectious diseases</span>&nbsp;<span class="year">2014</span>;<span class="volume">209</span>;<span class="number">3</span>;<span class="pagerange">321-2</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24009157">24009157</a>; DOI: <a href="http://dx.doi.org/10.1093%2Finfdis%2Fjit483">10.1093/infdis/jit483</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Population distribution and ancestry of the cancer protective MDM2 SNP285 (rs117039649).</h4>
<p class="authors"><span class="author">Knappskog S</span>, <span class="author">Gansmo LB</span>, <span class="author">Dibirova K</span>, <span class="author">Metspalu A</span>, <span class="author">Cybulski C</span>, <span class="author">Peterlongo P</span>, <span class="author">Aaltonen L</span>, <span class="author">Vatten L</span>, <span class="author">Romundstad P</span>, <span class="author">Hveem K</span>, <span class="author">Devilee P</span>, <span class="author">Evans GD</span>, <span class="author">Lin D</span>, <span class="author">Van Camp G</span>, <span class="author">Manolopoulos VG</span>, <span class="author">Osorio A</span>, <span class="author">Milani L</span>, <span class="author">Ozcelik T</span>, <span class="author">Zalloua P</span>, <span class="author">Mouzaya F</span>, <span class="author">Bliznetz E</span>, <span class="author">Balanovska E</span>, <span class="author">Pocheshkova E</span>, <span class="author">Ku&#x10D;inskas V</span>, <span class="author">Atramentova L</span>, <span class="author">Nymadawa P</span>, <span class="author">Titov K</span>, <span class="author">Lavryashina M</span>, <span class="author">Yusupov Y</span>, <span class="author">Bogdanova N</span>, <span class="author">Koshel S</span>, <span class="author">Zamora J</span>, <span class="author">Wedge DC</span>, <span class="author">Charlesworth D</span>, <span class="author">D&ouml;rk T</span>, <span class="author">Balanovsky O</span> and <span class="author">L&oslash;nning PE</span></p>
<p class="affiliation">Section of Oncology, Department of Clinical Science, University of Bergen, 5020 Bergen, Norway. Department of Oncology, Haukeland University Hospital, 5021 Bergen, Norway.</p><p class="abstract">The MDM2 promoter SNP285C is located on the SNP309G allele. While SNP309G enhances Sp1 transcription factor binding and MDM2 transcription, SNP285C antagonizes Sp1 binding and reduces the risk of breast-, ovary- and endometrial cancer. Assessing SNP285 and 309 genotypes across 25 different ethnic populations (&gt;10.000 individuals), the incidence of SNP285C was 6-8% across European populations except for Finns (1.2%) and Saami (0.3%). The incidence decreased towards the Middle-East and Eastern Russia, and SNP285C was absent among Han Chinese, Mongolians and African Americans. Interhaplotype variation analyses estimated SNP285C to have originated about 14,700 years ago (95% CI: 8,300 - 33,300). Both this estimate and the geographical distribution suggest SNP285C to have arisen after the separation between Caucasians and modern day East Asians (17,000 - 40,000 years ago). We observed a strong inverse correlation (r = -0.805; p &lt; 0.001) between the percentage of SNP309G alleles harboring SNP285C and the MAF for SNP309G itself across different populations suggesting selection and environmental adaptation with respect to MDM2 expression in recent human evolution. In conclusion, we found SNP285C to be a pan-Caucasian variant. Ethnic variation regarding distribution of SNP285C needs to be taken into account when assessing the impact of MDM2 SNPs on cancer risk.</p>
<p class="publication"><span class="title">Oncotarget</span>&nbsp;<span class="year">2014</span>;<span class="volume">5</span>;<span class="number">18</span>;<span class="pagerange">8223-34</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25327560">25327560</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Whole genome sequencing reveals potential spread of Clostridium difficile between humans and farm animals in the Netherlands, 2002 to 2011.</h4>
<p class="authors"><span class="author">Knetsch C</span>, <span class="author">Connor T</span>, <span class="author">Mutreja A</span>, <span class="author">van Dorp S</span>, <span class="author">Sanders I</span>, <span class="author">Browne H</span>, <span class="author">Harris D</span>, <span class="author">Lipman L</span>, <span class="author">Keessen E</span>, <span class="author">Corver J</span>, <span class="author">Kuijper E</span> and <span class="author">Lawley T</span></p>
<p class="affiliation">Section Experimental Bacteriology, Department of Medical Microbiology, Leiden University Medical Center, Leiden, the Netherlands.</p>
<p class="publication"><span class="title">Euro surveillance : bulletin Europ&eacute;en sur les maladies transmissibles = European communicable disease bulletin</span>&nbsp;<span class="year">2014</span>;<span class="volume">19</span>;<span class="number">45</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25411691">25411691</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">USP28 Is Recruited to Sites of DNA Damage by the Tandem BRCT Domains of 53BP1 but Plays a Minor Role in Double-Strand Break Metabolism.</h4>
<p class="authors"><span class="author">Knobel PA</span>, <span class="author">Belotserkovskaya R</span>, <span class="author">Galanty Y</span>, <span class="author">Schmidt CK</span>, <span class="author">Jackson SP</span> and <span class="author">Stracker TH</span></p>
<p class="affiliation">Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain.</p><p class="abstract">The DNA damage response (DDR) is critical for genome stability and the suppression of a wide variety of human malignancies, including neurodevelopmental disorders, immunodeficiency, and cancer. In addition, the efficacy of many chemotherapeutic strategies is dictated by the status of the DDR. Ubiquitin-specific protease 28 (USP28) was reported to govern the stability of multiple factors that are critical for diverse aspects of the DDR. Here, we examined the effects of USP28 depletion on the DDR in cells and in vivo. We found that USP28 is recruited to double-strand breaks in a manner that requires the tandem BRCT domains of the DDR protein 53BP1. However, we observed only minor DDR defects in USP28-depleted cells, and mice lacking USP28 showed normal longevity, immunological development, and radiation responses. Our results thus indicate that USP28 is not a critical factor in double-strand break metabolism and is unlikely to be an attractive target for therapeutic intervention aimed at chemotherapy sensitization.</p>
<p class="publication"><span class="title">Molecular and cellular biology</span>&nbsp;<span class="year">2014</span>;<span class="volume">34</span>;<span class="number">11</span>;<span class="pagerange">2062-74</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24687851">24687851</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4019063">4019063</a>; DOI: <a href="http://dx.doi.org/10.1128%2FMCB.00197-14">10.1128/MCB.00197-14</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Confinement and Deformation of Single Cells and Their Nuclei Inside Size-Adapted Microtubes.</h4>
<p class="authors"><span class="author">Koch B</span>, <span class="author">Sanchez S</span>, <span class="author">Schmidt CK</span>, <span class="author">Swiersy A</span>, <span class="author">Jackson SP</span> and <span class="author">Schmidt OG</span></p>
<p class="affiliation">Institute for Integrative Nanosciences, IFW Dresden, Helmholtzstra&szlig;e 20, Dresden, D-01069, Germany.</p><p class="abstract">Rolled-up transparent microtubes are shown to serve as cell culture scaffolds that exactly define the space available for single cell growth. Human U2OS osteosarcoma cells are confined within microtubes of different diameters and the effects of the cell deformation on the integrity of the DNA and cell survival are studied.</p>
<p class="publication"><span class="title">Advanced healthcare materials</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24764273">24764273</a>; DOI: <a href="http://dx.doi.org/10.1002%2Fadhm.201300678">10.1002/adhm.201300678</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Genome-wide recessive genetic screening in mammalian cells with a lentiviral CRISPR-guide RNA library.</h4>
<p class="authors"><span class="author">Koike-Yusa H</span>, <span class="author">Li Y</span>, <span class="author">Tan EP</span>, <span class="author">Velasco-Herrera Mdel C</span> and <span class="author">Yusa K</span></p>
<p class="affiliation">1] Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK. [2].</p><p class="abstract">Identification of genes influencing a phenotype of interest is frequently achieved through genetic screening by RNA interference (RNAi) or knockouts. However, RNAi may only achieve partial depletion of gene activity, and knockout-based screens are difficult in diploid mammalian cells. Here we took advantage of the efficiency and high throughput of genome editing based on type II, clustered, regularly interspaced, short palindromic repeats (CRISPR)-CRISPR-associated (Cas) systems to introduce genome-wide targeted mutations in mouse embryonic stem cells (ESCs). We designed 87,897 guide RNAs (gRNAs) targeting 19,150 mouse protein-coding genes and used a lentiviral vector to express these gRNAs in ESCs that constitutively express Cas9. Screening the resulting ESC mutant libraries for resistance to either Clostridium septicum alpha-toxin or 6-thioguanine identified 27 known and 4 previously unknown genes implicated in these phenotypes. Our results demonstrate the potential for efficient loss-of-function screening using the CRISPR-Cas9 system.</p>
<p class="grants">Funded by: Cancer Research UK; Wellcome Trust: <span class="grant">WT077187</span></p>
<p class="publication"><span class="title">Nature biotechnology</span>&nbsp;<span class="year">2014</span>;<span class="volume">32</span>;<span class="number">3</span>;<span class="pagerange">267-73</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24535568">24535568</a>; DOI: <a href="http://dx.doi.org/10.1038%2Fnbt.2800">10.1038/nbt.2800</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">MARIMO cells harbor a CALR mutation but are not dependent on JAK2/STAT5 signaling.</h4>
<p class="authors"><span class="author">Kollmann K</span>, <span class="author">Nangalia J</span>, <span class="author">Warsch W</span>, <span class="author">Quentmeier H</span>, <span class="author">Bench A</span>, <span class="author">Boyd E</span>, <span class="author">Scott M</span>, <span class="author">Drexler HG</span> and <span class="author">Green AR</span></p>
<p class="affiliation">Cambridge Institute for Medical Research, Wellcome Trust/MRC Stem Cell Institute and Department of Haematology, University of Cambridge, Cambridge, UK.</p>
<p class="publication"><span class="title">Leukemia</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25249012">25249012</a>; DOI: <a href="http://dx.doi.org/10.1038%2Fleu.2014.285">10.1038/leu.2014.285</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">A Comparison of Peak Callers Used for DNase-Seq Data.</h4>
<p class="authors"><span class="author">Koohy H</span>, <span class="author">Down TA</span>, <span class="author">Spivakov M</span> and <span class="author">Hubbard T</span></p>
<p class="affiliation">The Babraham Institute, Babraham Research Campus, Cambridge, United Kingdom; Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Cambridge, United Kingdom.</p><p class="abstract">Genome-wide profiling of open chromatin regions using DNase I and high-throughput sequencing (DNase-seq) is an increasingly popular approach for finding and studying regulatory elements. A variety of algorithms have been developed to identify regions of open chromatin from raw sequence-tag data, which has motivated us to assess and compare their performance. In this study, four published, publicly available peak calling algorithms used for DNase-seq data analysis (F-seq, Hotspot, MACS and ZINBA) are assessed at a range of signal thresholds on two published DNase-seq datasets for three cell types. The results were benchmarked against an independent dataset of regulatory regions derived from ENCODE in vivo transcription factor binding data for each particular cell type. The level of overlap between peak regions reported by each algorithm and this ENCODE-derived reference set was used to assess sensitivity and specificity of the algorithms. Our study suggests that F-seq has a slightly higher sensitivity than the next best algorithms. Hotspot and the ChIP-seq oriented method, MACS, both perform competitively when used with their default parameters. However the generic peak finder ZINBA appears to be less sensitive than the other three. We also assess accuracy of each algorithm over a range of signal thresholds. In particular, we show that the accuracy of F-Seq can be considerably improved by using a threshold setting that is different from the default value.</p>
<p class="publication"><span class="title">PloS one</span>&nbsp;<span class="year">2014</span>;<span class="volume">9</span>;<span class="number">5</span>;<span class="pagerange">e96303</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24810143">24810143</a>; DOI: <a href="http://dx.doi.org/10.1371%2Fjournal.pone.0096303">10.1371/journal.pone.0096303</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">The International Mouse Phenotyping Consortium Web Portal, a unified point of access for knockout mice and related phenotyping data.</h4>
<p class="authors"><span class="author">Koscielny G</span>, <span class="author">Yaikhom G</span>, <span class="author">Iyer V</span>, <span class="author">Meehan TF</span>, <span class="author">Morgan H</span>, <span class="author">Atienza-Herrero J</span>, <span class="author">Blake A</span>, <span class="author">Chen CK</span>, <span class="author">Easty R</span>, <span class="author">Di Fenza A</span>, <span class="author">Fiegel T</span>, <span class="author">Grifiths M</span>, <span class="author">Horne A</span>, <span class="author">Karp NA</span>, <span class="author">Kurbatova N</span>, <span class="author">Mason JC</span>, <span class="author">Matthews P</span>, <span class="author">Oakley DJ</span>, <span class="author">Qazi A</span>, <span class="author">Regnart J</span>, <span class="author">Retha A</span>, <span class="author">Santos LA</span>, <span class="author">Sneddon DJ</span>, <span class="author">Warren J</span>, <span class="author">Westerberg H</span>, <span class="author">Wilson RJ</span>, <span class="author">Melvin DG</span>, <span class="author">Smedley D</span>, <span class="author">Brown SD</span>, <span class="author">Flicek P</span>, <span class="author">Skarnes WC</span>, <span class="author">Mallon AM</span> and <span class="author">Parkinson H</span></p>
<p class="affiliation">European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1SD, UK, Medical Research Council Harwell (Mammalian Genetics Unit and Mary Lyon Centre), Harwell, Oxfordshire OX11 0RD, UK and Mouse Informatics Group, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1SA, UK.</p><p class="abstract">The International Mouse Phenotyping Consortium (IMPC) web portal (http://www.mousephenotype.org) provides the biomedical community with a unified point of access to mutant mice and rich collection of related emerging and existing mouse phenotype data. IMPC mouse clinics worldwide follow rigorous highly structured and standardized protocols for the experimentation, collection and dissemination of data. Dedicated &#39;data wranglers&#39; work with each phenotyping center to collate data and perform quality control of data. An automated statistical analysis pipeline has been developed to identify knockout strains with a significant change in the phenotype parameters. Annotation with biomedical ontologies allows biologists and clinicians to easily find mouse strains with phenotypic traits relevant to their research. Data integration with other resources will provide insights into mammalian gene function and human disease. As phenotype data become available for every gene in the mouse, the IMPC web portal will become an invaluable tool for researchers studying the genetic contributions of genes to human diseases.</p>
<p class="grants">Funded by: Medical Research Council: <span class="grant">MC_U142684171</span>, <span class="grant">MC_U142684172</span>, <span class="grant">MC_U142684175</span>; NHGRI NIH HHS: <span class="grant">1 U54 HG006370-01</span>, <span class="grant">U54 HG006370</span>; Wellcome Trust</p>
<p class="publication"><span class="title">Nucleic acids research</span>&nbsp;<span class="year">2014</span>;<span class="volume">42</span>;<span class="number">Database issue</span>;<span class="pagerange">D802-9</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24194600">24194600</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC3964955">3964955</a>; DOI: <a href="http://dx.doi.org/10.1093%2Fnar%2Fgkt977">10.1093/nar/gkt977</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Dysfunction of phospholipase C&gamma; in immune disorders and cancer.</h4>
<p class="authors"><span class="author">Koss H</span>, <span class="author">Bunney TD</span>, <span class="author">Behjati S</span> and <span class="author">Katan M</span></p>
<p class="affiliation">Institute of Structural and Molecular Biology, Division of Biosciences, University College London, London, UK; Division of Molecular Structure, Medical Research Council (MRC) National Institute for Medical Research, London, UK.</p><p class="abstract">The surge in genetic and genomic investigations over the past 5 years has resulted in many discoveries of causative variants relevant to disease pathophysiology. Although phospholipase C (PLC) enzymes have long been recognized as important components in intracellular signal transmission, it is only recently that this approach highlighted their role in disease development through gain-of-function mutations. In this review we describe the new findings that link the PLC&gamma; family to immune disorders and cancer, and illustrate further efforts to elucidate the molecular mechanisms that underpin their dysfunction.</p>
<p class="publication"><span class="title">Trends in biochemical sciences</span>&nbsp;<span class="year">2014</span>;<span class="volume">39</span>;<span class="number">12</span>;<span class="pagerange">603-611</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25456276">25456276</a>; DOI: <a href="http://dx.doi.org/10.1016%2Fj.tibs.2014.09.004">10.1016/j.tibs.2014.09.004</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Clinical and molecular characterization of a novel PLIN1 frameshift mutation identified in patients with familial partial lipodystrophy.</h4>
<p class="authors"><span class="author">Kozusko K</span>, <span class="author">Tsang V</span>, <span class="author">Bottomley W</span>, <span class="author">Cho Y</span>, <span class="author">Gandotra S</span>, <span class="author">Mimmack M</span>, <span class="author">Lim K</span>, <span class="author">Isaac I</span>, <span class="author">Patel S</span>, <span class="author">Saudek V</span>, <span class="author">O&#39;Rahilly S</span>, <span class="author">Srinivasan S</span>, <span class="author">Greenfield J</span>, <span class="author">Barroso I</span>, <span class="author">Campbell L</span> and <span class="author">Savage D</span></p>
<p class="affiliation">University of Cambridge Metabolic Research Laboratories, Wellcome Trust-Medical Research Council Institute of Metabolic Science, University of Cambridge, UK.</p><p class="abstract">Perilipin-1 is a lipid droplet coat protein predominantly expressed in adipocytes, where it inhibits basal and facilitates stimulated lipolysis. Loss-of-function mutations in PLIN1 were recently reported in patients with a novel subtype of familial partial lipodystrophy, designated as FPLD4. We now report the identification and characterization of a novel heterozygous frameshift mutation affecting the carboxy-terminus (439fs) of perilipin-1 in two unrelated families. The mutation co-segregated with a similar phenotype including partial lipodystrophy, severe insulin resistance and type 2 diabetes, extreme hypertriglyceridaemia and non-alcoholic fatty liver disease in both families. Poor metabolic control despite maximal medical therapy prompted two patients to undergo bariatric surgery, with remarkably beneficial consequences. Functional studies indicated that expression levels of the mutant protein were lower than wild type protein and in stably tranfected pre-adipocytes the mutant protein was associated with smaller lipid droplets. Interestingly, unlike the previously reported 398 and 404 frameshift mutants, this variant binds and stabilizes ABHD5 expression, but still fails to inhibit basal lipolysis as effectively as wild type perilipin-1. Collectively, these findings highlight the physiological need for exquisite regulation of neutral lipid storage within adipocyte lipid droplets, as well as the possible metabolic benefits of bariatric surgery in this serious disease.</p>
<p class="publication"><span class="title">Diabetes</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25114292">25114292</a>; DOI: <a href="http://dx.doi.org/10.2337%2Fdb14-0104">10.2337/db14-0104</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">A linguistically informed autosomal STR survey of human populations residing in the greater Himalayan region.</h4>
<p class="authors"><span class="author">Kraaijenbrink T</span>, <span class="author">van der Gaag KJ</span>, <span class="author">Zuniga SB</span>, <span class="author">Xue Y</span>, <span class="author">Carvalho-Silva DR</span>, <span class="author">Tyler-Smith C</span>, <span class="author">Jobling MA</span>, <span class="author">Parkin EJ</span>, <span class="author">Su B</span>, <span class="author">Shi H</span>, <span class="author">Xiao CJ</span>, <span class="author">Tang WR</span>, <span class="author">Kashyap VK</span>, <span class="author">Trivedi R</span>, <span class="author">Sitalaximi T</span>, <span class="author">Banerjee J</span>, <span class="author">Karma Tshering of Gasel&ocirc;</span>, <span class="author">Tuladhar NM</span>, <span class="author">Opgenort JR</span>, <span class="author">van Driem GL</span>, <span class="author">Barbujani G</span> and <span class="author">de Knijff P</span></p>
<p class="affiliation">MGC Department of Human and Clinical Genetics, Leiden University Medical Centre, Leiden, the Netherlands.</p><p class="abstract">The greater Himalayan region demarcates two of the most prominent linguistic phyla in Asia: Tibeto-Burman and Indo-European. Previous genetic surveys, mainly using Y-chromosome polymorphisms and/or mitochondrial DNA polymorphisms suggested a substantially reduced geneflow between populations belonging to these two phyla. These studies, however, have mainly focussed on populations residing far to the north and/or south of this mountain range, and have not been able to study geneflow patterns within the greater Himalayan region itself. We now report a detailed, linguistically informed, genetic survey of Tibeto-Burman and Indo-European speakers from the Himalayan countries Nepal and Bhutan based on autosomal microsatellite markers and compare these populations with surrounding regions. The genetic differentiation between populations within the Himalayas seems to be much higher than between populations in the neighbouring countries. We also observe a remarkable genetic differentiation between the Tibeto-Burman speaking populations on the one hand and Indo-European speaking populations on the other, suggesting that language and geography have played an equally large role in defining the genetic composition of present-day populations within the Himalayas.</p>
<p class="grants">Funded by: Wellcome Trust: <span class="grant">087576</span>, <span class="grant">WT 087576</span>, <span class="grant">WT 098051</span></p>
<p class="publication"><span class="title">PloS one</span>&nbsp;<span class="year">2014</span>;<span class="volume">9</span>;<span class="number">3</span>;<span class="pagerange">e91534</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24614536">24614536</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC3948894">3948894</a>; DOI: <a href="http://dx.doi.org/10.1371%2Fjournal.pone.0091534">10.1371/journal.pone.0091534</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Crystal structures of three representatives of a new Pfam family PF14869 (DUF4488) suggest they function in sugar binding/uptake.</h4>
<p class="authors"><span class="author">Kumar A</span>, <span class="author">Punta M</span>, <span class="author">Axelrod HL</span>, <span class="author">Das D</span>, <span class="author">Farr CL</span>, <span class="author">Grant JC</span>, <span class="author">Chiu HJ</span>, <span class="author">Miller MD</span>, <span class="author">Coggill PC</span>, <span class="author">Klock HE</span>, <span class="author">Elsliger MA</span>, <span class="author">Deacon AM</span>, <span class="author">Godzik A</span>, <span class="author">Lesley SA</span> and <span class="author">Wilson IA</span></p>
<p class="affiliation">Joint Center for Structural Genomics, http://www.jcsg.org; Stanford Synchrotron Radiation Lightsource, SLAC National Accelerator Laboratory, Menlo Park, California, 94025.</p><p class="abstract">Crystal structures of three members (BACOVA_00364 from Bacteroides ovatus, BACUNI_03039 from Bacteroides uniformis and BACEGG_00036 from Bacteroides eggerthii) of the Pfam domain of unknown function (DUF4488) were determined to 1.95, 1.66, and 1.81 &Aring; resolutions, respectively. The protein structures adopt an eight-stranded, calycin-like, &beta;-barrel fold and bind an endogenous unknown ligand at one end of the &beta;-barrel. The amino acids interacting with the ligand are not conserved in any other protein of known structure with this particular fold. The size and chemical environment of the bound ligand suggest binding or transport of a small polar molecule(s) as a potential function for these proteins. These are the first structural representatives of a newly defined PF14869 (DUF4488) Pfam family.</p>
<p class="publication"><span class="title">Protein science : a publication of the Protein Society</span>&nbsp;<span class="year">2014</span>;<span class="volume">23</span>;<span class="number">10</span>;<span class="pagerange">1380-91</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25044324">25044324</a>; DOI: <a href="http://dx.doi.org/10.1002%2Fpro.2522">10.1002/pro.2522</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Gene-Lifestyle Interactions in Complex Diseases: Design and Description of the GLACIER and VIKING Studies.</h4>
<p class="authors"><span class="author">Kurbasic A</span>, <span class="author">Poveda A</span>, <span class="author">Chen Y</span>, <span class="author">Agren A</span>, <span class="author">Engberg E</span>, <span class="author">Hu FB</span>, <span class="author">Johansson I</span>, <span class="author">Barroso I</span>, <span class="author">Br&auml;ndstr&ouml;m A</span>, <span class="author">Hallmans G</span>, <span class="author">Renstr&ouml;m F</span> and <span class="author">Franks PW</span></p>
<p class="affiliation">Department of Clinical Sciences, Genetic and Molecular Epidemiology Unit, Lund University, Sk&aring;ne University Hospital Malm&ouml;, CRC, Building 91, Level 10, Jan Waldenstr&ouml;ms gata 35, SE-205 02 Malm&ouml;, Sweden.</p><p class="abstract">Most complex diseases have well-established genetic and non-genetic risk factors. In some instances, these risk factors are likely to interact, whereby their joint effects convey a level of risk that is either significantly more or less than the sum of these risks. Characterizing these gene-environment interactions may help elucidate the biology of complex diseases, as well as to guide strategies for their targeted prevention. In most cases, the detection of gene-environment interactions will require sample sizes in excess of those needed to detect the marginal effects of the genetic and environmental risk factors. Although many consortia have been formed, comprising multiple diverse cohorts to detect gene-environment interactions, few robust examples of such interactions have been discovered. This may be because combining data across studies, usually through meta-analysis of summary data from the contributing cohorts, is often a statistically inefficient approach for the detection of gene-environment interactions. Ideally, single, very large and well-genotyped prospective cohorts, with validated measures of environmental risk factor and disease outcomes should be used to study interactions. The presence of strong founder effects within those cohorts might further strengthen the capacity to detect novel genetic effects and gene-environment interactions. Access to accurate genealogical data would also aid in studying the diploid nature of the human genome, such as genomic imprinting (parent-of-origin effects). Here we describe two studies from northern Sweden (the GLACIER and VIKING studies) that fulfill these characteristics.</p>
<p class="grants">Funded by: NHGRI NIH HHS: <span class="grant">U01 HG004399</span></p>
<p class="publication"><span class="title">Current nutrition reports</span>&nbsp;<span class="year">2014</span>;<span class="volume">3</span>;<span class="number">4</span>;<span class="pagerange">400-411</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25396097">25396097</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4225623">4225623</a>; DOI: <a href="http://dx.doi.org/10.1007%2Fs13668-014-0100-8">10.1007/s13668-014-0100-8</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">High risk population isolate reveals low frequency variants predisposing to intracranial aneurysms.</h4>
<p class="authors"><span class="author">Kurki MI</span>, <span class="author">Ga&aacute;l EI</span>, <span class="author">Kettunen J</span>, <span class="author">Lappalainen T</span>, <span class="author">Menelaou A</span>, <span class="author">Anttila V</span>, <span class="author">van &#39;t Hof FN</span>, <span class="author">von Und Zu Fraunberg M</span>, <span class="author">Helisalmi S</span>, <span class="author">Hiltunen M</span>, <span class="author">Lehto H</span>, <span class="author">Laakso A</span>, <span class="author">Kivisaari R</span>, <span class="author">Koivisto T</span>, <span class="author">Ronkainen A</span>, <span class="author">Rinne J</span>, <span class="author">Kiemeney LA</span>, <span class="author">Vermeulen SH</span>, <span class="author">Kaunisto MA</span>, <span class="author">Eriksson JG</span>, <span class="author">Aromaa A</span>, <span class="author">Perola M</span>, <span class="author">Lehtim&auml;ki T</span>, <span class="author">Raitakari OT</span>, <span class="author">Salomaa V</span>, <span class="author">Gunel M</span>, <span class="author">Dermitzakis ET</span>, <span class="author">Ruigrok YM</span>, <span class="author">Rinkel GJ</span>, <span class="author">Niemel&auml; M</span>, <span class="author">Hernesniemi J</span>, <span class="author">Ripatti S</span>, <span class="author">de Bakker PI</span>, <span class="author">Palotie A</span> and <span class="author">J&auml;&auml;skel&auml;inen JE</span></p>
<p class="affiliation">Neurosurgery, NeuroCenter, Kuopio University Hospital, Kuopio, Finland ; Neurosurgery, Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland ; Department of Neurobiology, A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland.</p><p class="abstract">3% of the population develops saccular intracranial aneurysms (sIAs), a complex trait, with a sporadic and a familial form. Subarachnoid hemorrhage from sIA (sIA-SAH) is a devastating form of stroke. Certain rare genetic variants are enriched in the Finns, a population isolate with a small founder population and bottleneck events. As the sIA-SAH incidence in Finland is &gt;2&times; increased, such variants may associate with sIA in the Finnish population. We tested 9.4 million variants for association in 760 Finnish sIA patients (enriched for familial sIA), and in 2,513 matched controls with case-control status and with the number of sIAs. The most promising loci (p&lt;5E-6) were replicated in 858 Finnish sIA patients and 4,048 controls. The frequencies and effect sizes of the replicated variants were compared to a continental European population using 717 Dutch cases and 3,004 controls. We discovered four new high-risk loci with low frequency lead variants. Three were associated with the case-control status: 2q23.3 (MAF 2.1%, OR 1.89, p 1.42&times;10-9); 5q31.3 (MAF 2.7%, OR 1.66, p 3.17&times;10-8); 6q24.2 (MAF 2.6%, OR 1.87, p 1.87&times;10-11) and one with the number of sIAs: 7p22.1 (MAF 3.3%, RR 1.59, p 6.08&times;-9). Two of the associations (5q31.3, 6q24.2) replicated in the Dutch sample. The 7p22.1 locus was strongly differentiated; the lead variant was more frequent in Finland (4.6%) than in the Netherlands (0.3%). Additionally, we replicated a previously inconclusive locus on 2q33.1 in all samples tested (OR 1.27, p 1.87&times;10-12). The five loci explain 2.1% of the sIA heritability in Finland, and may relate to, but not explain, the increased incidence of sIA-SAH in Finland. This study illustrates the utility of population isolates, familial enrichment, dense genotype imputation and alternate phenotyping in search for variants associated with complex diseases.</p>
<p class="publication"><span class="title">PLoS genetics</span>&nbsp;<span class="year">2014</span>;<span class="volume">10</span>;<span class="number">1</span>;<span class="pagerange">e1004134</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24497844">24497844</a>; DOI: <a href="http://dx.doi.org/10.1371%2Fjournal.pgen.1004134">10.1371/journal.pgen.1004134</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Genomic diversity of Epstein-Barr virus genomes isolated from primary nasopharyngeal carcinoma biopsy samples.</h4>
<p class="authors"><span class="author">Kwok H</span>, <span class="author">Wu CW</span>, <span class="author">Palser AL</span>, <span class="author">Kellam P</span>, <span class="author">Sham PC</span>, <span class="author">Kwong DL</span> and <span class="author">Chiang AK</span></p>
<p class="affiliation">Department of Paediatrics and Adolescent Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China.</p><p class="abstract"><strong>Unlabelled</strong>: Undifferentiated nasopharyngeal carcinoma (NPC) has a 100% association with Epstein-Barr virus (EBV). However, only three EBV genomes isolated from NPC patients have been sequenced to date, and the role of EBV genomic variations in the pathogenesis of NPC is unclear. We sought to obtain the sequences of EBV genomes in multiple NPC biopsy specimens in the same geographic location in order to reveal their sequence diversity. Three published EBV (B95-8, C666-1, and HKNPC1) genomes were first resequenced using the sequencing workflow of target enrichment of EBV DNA by hybridization, followed by next-generation sequencing, de novo assembly, and joining of contigs by Sanger sequencing. The sequences of eight NPC biopsy specimen-derived EBV (NPC-EBV) genomes, designated HKNPC2 to HKNPC9, were then determined. They harbored 1,736 variations in total, including 1,601 substitutions, 64 insertions, and 71 deletions, compared to the reference EBV. Furthermore, genes encoding latent, early lytic, and tegument proteins and glycoproteins were found to contain nonsynonymous mutations of potential biological significance. Phylogenetic analysis showed that the HKNPC6 and -7 genomes, which were isolated from tumor biopsy specimens of advanced metastatic NPC cases, were distinct from the other six NPC-EBV genomes, suggesting the presence of at least two parental lineages of EBV among the NPC-EBV genomes. In conclusion, much greater sequence diversity among EBV isolates derived from NPC biopsy specimens is demonstrated on a whole-genome level through a complete sequencing workflow. Large-scale sequencing and comparison of EBV genomes isolated from NPC and normal subjects should be performed to assess whether EBV genomic variations contribute to NPC pathogenesis.</p><p class="abstract"><strong>Importance</strong>: This study established a sequencing workflow from EBV DNA capture and sequencing to de novo assembly and contig joining. We reported eight newly sequenced EBV genomes isolated from primary NPC biopsy specimens and revealed the sequence diversity on a whole-genome level among these EBV isolates. At least two lineages of EBV strains are observed, and recombination among these lineages is inferred. Our study has demonstrated the value of, and provided a platform for, genome sequencing of EBV.</p>
<p class="publication"><span class="title">Journal of virology</span>&nbsp;<span class="year">2014</span>;<span class="volume">88</span>;<span class="number">18</span>;<span class="pagerange">10662-72</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24991008">24991008</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4178900">4178900</a>; DOI: <a href="http://dx.doi.org/10.1128%2FJVI.01665-14">10.1128/JVI.01665-14</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Genomic encyclopedia of bacteria and archaea: sequencing a myriad of type strains.</h4>
<p class="authors"><span class="author">Kyrpides NC</span>, <span class="author">Hugenholtz P</span>, <span class="author">Eisen JA</span>, <span class="author">Woyke T</span>, <span class="author">G&ouml;ker M</span>, <span class="author">Parker CT</span>, <span class="author">Amann R</span>, <span class="author">Beck BJ</span>, <span class="author">Chain PS</span>, <span class="author">Chun J</span>, <span class="author">Colwell RR</span>, <span class="author">Danchin A</span>, <span class="author">Dawyndt P</span>, <span class="author">Dedeurwaerdere T</span>, <span class="author">DeLong EF</span>, <span class="author">Detter JC</span>, <span class="author">De Vos P</span>, <span class="author">Donohue TJ</span>, <span class="author">Dong XZ</span>, <span class="author">Ehrlich DS</span>, <span class="author">Fraser C</span>, <span class="author">Gibbs R</span>, <span class="author">Gilbert J</span>, <span class="author">Gilna P</span>, <span class="author">Gl&ouml;ckner FO</span>, <span class="author">Jansson JK</span>, <span class="author">Keasling JD</span>, <span class="author">Knight R</span>, <span class="author">Labeda D</span>, <span class="author">Lapidus A</span>, <span class="author">Lee JS</span>, <span class="author">Li WJ</span>, <span class="author">Ma J</span>, <span class="author">Markowitz V</span>, <span class="author">Moore ER</span>, <span class="author">Morrison M</span>, <span class="author">Meyer F</span>, <span class="author">Nelson KE</span>, <span class="author">Ohkuma M</span>, <span class="author">Ouzounis CA</span>, <span class="author">Pace N</span>, <span class="author">Parkhill J</span>, <span class="author">Qin N</span>, <span class="author">Rossello-Mora R</span>, <span class="author">Sikorski J</span>, <span class="author">Smith D</span>, <span class="author">Sogin M</span>, <span class="author">Stevens R</span>, <span class="author">Stingl U</span>, <span class="author">Suzuki K</span>, <span class="author">Taylor D</span>, <span class="author">Tiedje JM</span>, <span class="author">Tindall B</span>, <span class="author">Wagner M</span>, <span class="author">Weinstock G</span>, <span class="author">Weissenbach J</span>, <span class="author">White O</span>, <span class="author">Wang J</span>, <span class="author">Zhang L</span>, <span class="author">Zhou YG</span>, <span class="author">Field D</span>, <span class="author">Whitman WB</span>, <span class="author">Garrity GM</span> and <span class="author">Klenk HP</span></p>
<p class="affiliation">DOE-Joint Genome Institute, Walnut Creek, California, United States of America; Department of Biological Sciences, Faculty of Science, King Abdulaziz University, Jeddah, Saudi Arabia.</p><p class="abstract">Microbes hold the key to life. They hold the secrets to our past (as the descendants of the earliest forms of life) and the prospects for our future (as we mine their genes for solutions to some of the planet&#39;s most pressing problems, from global warming to antibiotic resistance). However, the piecemeal approach that has defined efforts to study microbial genetic diversity for over 20 years and in over 30,000 genome projects risks squandering that promise. These efforts have covered less than 20% of the diversity of the cultured archaeal and bacterial species, which represent just 15% of the overall known prokaryotic diversity. Here we call for the funding of a systematic effort to produce a comprehensive genomic catalog of all cultured Bacteria and Archaea by sequencing, where available, the type strain of each species with a validly published name (currently&sim;11,000). This effort will provide an unprecedented level of coverage of our planet&#39;s genetic diversity, allow for the large-scale discovery of novel genes and functions, and lead to an improved understanding of microbial evolution and function in the environment.</p>
<p class="publication"><span class="title">PLoS biology</span>&nbsp;<span class="year">2014</span>;<span class="volume">12</span>;<span class="number">8</span>;<span class="pagerange">e1001920</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25093819">25093819</a>; DOI: <a href="http://dx.doi.org/10.1371%2Fjournal.pbio.1001920">10.1371/journal.pbio.1001920</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Design of clone-specific probes from genome sequences for rapid PCR-typing of outbreak pathogens.</h4>
<p class="authors"><span class="author">L&oacute;pez-Camacho E</span>, <span class="author">Rentero Z</span>, <span class="author">Ruiz-Carrascoso G</span>, <span class="author">Wesselink JJ</span>, <span class="author">P&eacute;rez-V&aacute;zquez M</span>, <span class="author">Lusa-Bernal S</span>, <span class="author">G&oacute;mez-Puertas P</span>, <span class="author">Kingsley RA</span>, <span class="author">G&oacute;mez-S&aacute;nchez P</span>, <span class="author">Campos J</span>, <span class="author">Oteo J</span> and <span class="author">Mingorance J</span></p>
<p class="affiliation">Servicio de Microbiolog&iacute;a, Hospital Universitario La Paz, IdiPAZ, Madrid, Spain.</p><p class="abstract">The genome sequence of one OXA-48-producing Klebsiella pneumoniae belonging to sequence type (ST) 405, and three belonging to ST11, were used to design and test ST-specific PCR assays for typing OXA-48-producing K.&nbsp;pneumoniae. The approach proved to be useful for in-house development of rapid PCR typing assays for local outbreak surveillance.</p>
<p class="publication"><span class="title">Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24606530">24606530</a>; DOI: <a href="http://dx.doi.org/10.1111%2F1469-0691.12616">10.1111/1469-0691.12616</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Predicting the virulence of MRSA from its genome sequence.</h4>
<p class="authors"><span class="author">Laabei M</span>, <span class="author">Recker M</span>, <span class="author">Rudkin JK</span>, <span class="author">Aldeljawi M</span>, <span class="author">Gulay Z</span>, <span class="author">Sloan TJ</span>, <span class="author">Williams P</span>, <span class="author">Endres JL</span>, <span class="author">Bayles KW</span>, <span class="author">Fey PD</span>, <span class="author">Yajjala VK</span>, <span class="author">Widhelm T</span>, <span class="author">Hawkins E</span>, <span class="author">Lewis K</span>, <span class="author">Parfett S</span>, <span class="author">Scowen L</span>, <span class="author">Peacock SJ</span>, <span class="author">Holden M</span>, <span class="author">Wilson D</span>, <span class="author">Read TD</span>, <span class="author">van den Elsen J</span>, <span class="author">Priest NK</span>, <span class="author">Feil EJ</span>, <span class="author">Hurst LD</span>, <span class="author">Josefsson E</span> and <span class="author">Massey RC</span></p>
<p class="affiliation">Department of Biology and Biochemistry, University of Bath, Bath BA2 7AY, United Kingdom;</p><p class="abstract">Microbial virulence is a complex and often multifactorial phenotype, intricately linked to a pathogen&#39;s evolutionary trajectory. Toxicity, the ability to destroy host cell membranes, and adhesion, the ability to adhere to human tissues, are the major virulence factors of many bacterial pathogens, including Staphylococcus aureus. Here, we assayed the toxicity and adhesiveness of 90 MRSA (methicillin resistant S. aureus) isolates and found that while there was remarkably little variation in adhesion, toxicity varied by over an order of magnitude between isolates, suggesting different evolutionary selection pressures acting on these two traits. We performed a genome-wide association study (GWAS) and identified a large number of loci, as well as a putative network of epistatically interacting loci, that significantly associated with toxicity. Despite this apparent complexity in toxicity regulation, a predictive model based on a set of significant single nucleotide polymorphisms (SNPs) and insertion and deletions events (indels) showed a high degree of accuracy in predicting an isolate&#39;s toxicity solely from the genetic signature at these sites. Our results thus highlight the potential of using sequence data to determine clinically relevant parameters and have further implications for understanding the microbial virulence of this opportunistic pathogen.</p>
<p class="publication"><span class="title">Genome research</span>&nbsp;<span class="year">2014</span>;<span class="volume">24</span>;<span class="number">5</span>;<span class="pagerange">839-49</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24717264">24717264</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4009613">4009613</a>; DOI: <a href="http://dx.doi.org/10.1101%2Fgr.165415.113">10.1101/gr.165415.113</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Emergence of a new epidemic Neisseria meningitidis serogroup A Clone in the African meningitis belt: high-resolution picture of genomic changes that mediate immune evasion.</h4>
<p class="authors"><span class="author">Lamelas A</span>, <span class="author">Harris SR</span>, <span class="author">R&ouml;ltgen K</span>, <span class="author">Dangy JP</span>, <span class="author">Hauser J</span>, <span class="author">Kingsley RA</span>, <span class="author">Connor TR</span>, <span class="author">Sie A</span>, <span class="author">Hodgson A</span>, <span class="author">Dougan G</span>, <span class="author">Parkhill J</span>, <span class="author">Bentley SD</span> and <span class="author">Pluschke G</span></p>
<p class="affiliation">Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, United Kingdom.</p><p class="abstract">In the African &quot;meningitis belt,&quot; outbreaks of meningococcal meningitis occur in cycles, representing a model for the role of host-pathogen interactions in epidemic processes. The periodicity of the epidemics is not well understood, nor is it currently possible to predict them. In our longitudinal colonization and disease surveys, we have observed waves of clonal replacement with the same serogroup, suggesting that immunity to noncapsular antigens plays a significant role in natural herd immunity. Here, through comparative genomic analysis of 100 meningococcal isolates, we provide a high-resolution view of the evolutionary changes that occurred during clonal replacement of a hypervirulent meningococcal clone (ST-7) by a descendant clone (ST-2859). We show that the majority of genetic changes are due to homologous recombination of laterally acquired DNA, with more than 20% of these events involving acquisition of DNA from other species. Signals of adaptation to evade herd immunity were indicated by genomic hot spots of recombination. Most striking is the high frequency of changes involving the pgl locus, which determines the glycosylation patterns of major protein antigens. High-frequency changes were also observed for genes involved in the regulation of pilus expression and the synthesis of Maf3 adhesins, highlighting the importance of these surface features in host-pathogen interaction and immune evasion. Importance: While established meningococcal capsule polysaccharide vaccines are protective through the induction of anticapsular antibodies, findings of our longitudinal studies in the African meningitis belt have indicated that immunity to noncapsular antigens plays a significant role in natural herd immunity. Our results show that meningococci evade herd immunity through the rapid homologous replacement of just a few key genomic loci that affect noncapsular cell surface components. Identification of recombination hot spots thus represents an eminent approach to gain insight into targets of protective natural immune responses. Moreover, our results highlight the role of the dynamics of the protein glycosylation repertoire in immune evasion by Neisseria meningitidis. These results have major implications for the design of next-generation protein-based subunit vaccines.</p>
<p class="grants">Funded by: Wellcome Trust</p>
<p class="publication"><span class="title">mBio</span>&nbsp;<span class="year">2014</span>;<span class="volume">5</span>;<span class="number">5</span>;<span class="pagerange">e01974-14</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25336458">25336458</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4212839">4212839</a>; DOI: <a href="http://dx.doi.org/10.1128%2FmBio.01974-14">10.1128/mBio.01974-14</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Gene-lifestyle interaction and type 2 diabetes: the EPIC interact case-cohort study.</h4>
<p class="authors"><span class="author">Langenberg C</span>, <span class="author">Sharp SJ</span>, <span class="author">Franks PW</span>, <span class="author">Scott RA</span>, <span class="author">Deloukas P</span>, <span class="author">Forouhi NG</span>, <span class="author">Froguel P</span>, <span class="author">Groop LC</span>, <span class="author">Hansen T</span>, <span class="author">Palla L</span>, <span class="author">Pedersen O</span>, <span class="author">Schulze MB</span>, <span class="author">Tormo MJ</span>, <span class="author">Wheeler E</span>, <span class="author">Agnoli C</span>, <span class="author">Arriola L</span>, <span class="author">Barricarte A</span>, <span class="author">Boeing H</span>, <span class="author">Clarke GM</span>, <span class="author">Clavel-Chapelon F</span>, <span class="author">Duell EJ</span>, <span class="author">Fagherazzi G</span>, <span class="author">Kaaks R</span>, <span class="author">Kerrison ND</span>, <span class="author">Key TJ</span>, <span class="author">Khaw KT</span>, <span class="author">Kr&ouml;ger J</span>, <span class="author">Lajous M</span>, <span class="author">Morris AP</span>, <span class="author">Navarro C</span>, <span class="author">Nilsson PM</span>, <span class="author">Overvad K</span>, <span class="author">Palli D</span>, <span class="author">Panico S</span>, <span class="author">Quir&oacute;s JR</span>, <span class="author">Rolandsson O</span>, <span class="author">Sacerdote C</span>, <span class="author">S&aacute;nchez MJ</span>, <span class="author">Slimani N</span>, <span class="author">Spijkerman AM</span>, <span class="author">Tumino R</span>, <span class="author">van der A DL</span>, <span class="author">van der Schouw YT</span>, <span class="author">Barroso I</span>, <span class="author">McCarthy MI</span>, <span class="author">Riboli E</span> and <span class="author">Wareham NJ</span></p>
<p class="affiliation">Medical Research Council Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom.</p><p class="abstract"><strong>Background</strong>: Understanding of the genetic basis of type 2 diabetes (T2D) has progressed rapidly, but the interactions between common genetic variants and lifestyle risk factors have not been systematically investigated in studies with adequate statistical power. Therefore, we aimed to quantify the combined effects of genetic and lifestyle factors on risk of T2D in order to inform strategies for prevention.</p><p class="abstract">The InterAct study includes 12,403 incident T2D cases and a representative sub-cohort of 16,154 individuals from a cohort of 340,234 European participants with 3.99 million person-years of follow-up. We studied the combined effects of an additive genetic T2D risk score and modifiable and non-modifiable risk factors using Prentice-weighted Cox regression and random effects meta-analysis methods. The effect of the genetic score was significantly greater in younger individuals (p for interaction &#x200A;=&#x200A;1.20&times;10-4). Relative genetic risk (per standard deviation [4.4 risk alleles]) was also larger in participants who were leaner, both in terms of body mass index (p for interaction &#x200A;=&#x200A;1.50&times;10-3) and waist circumference (p for interaction &#x200A;=&#x200A;7.49&times;10-9). Examination of absolute risks by strata showed the importance of obesity for T2D risk. The 10-y cumulative incidence of T2D rose from 0.25% to 0.89% across extreme quartiles of the genetic score in normal weight individuals, compared to 4.22% to 7.99% in obese individuals. We detected no significant interactions between the genetic score and sex, diabetes family history, physical activity, or dietary habits assessed by a Mediterranean diet score.</p><p class="abstract"><strong>Conclusions</strong>: The relative effect of a T2D genetic risk score is greater in younger and leaner participants. However, this sub-group is at low absolute risk and would not be a logical target for preventive interventions. The high absolute risk associated with obesity at any level of genetic risk highlights the importance of universal rather than targeted approaches to lifestyle intervention.</p>
<p class="grants">Funded by: Cancer Research UK: <span class="grant">14136</span>, <span class="grant">16491</span>; Department of Health: <span class="grant">NF-SI-0512-10114</span>, <span class="grant">NF-SI-0512-10135</span>, <span class="grant">NF-SI-0611-10099</span>; Medical Research Council: <span class="grant">G0601261</span>, <span class="grant">G1000143</span>, <span class="grant">MC_U106179471</span>, <span class="grant">MC_UP_A100_1003</span>, <span class="grant">MC_UU_12015/1</span>, <span class="grant">MC_UU_12015/5</span>; Wellcome Trust: <span class="grant">083270/Z/07/Z</span>, <span class="grant">090532</span>, <span class="grant">098017</span>, <span class="grant">WT090532</span>, <span class="grant">WT098017</span></p>
<p class="publication"><span class="title">PLoS medicine</span>&nbsp;<span class="year">2014</span>;<span class="volume">11</span>;<span class="number">5</span>;<span class="pagerange">e1001647</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24845081">24845081</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4028183">4028183</a>; DOI: <a href="http://dx.doi.org/10.1371%2Fjournal.pmed.1001647">10.1371/journal.pmed.1001647</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">New insights into the maternal to zygotic transition.</h4>
<p class="authors"><span class="author">Langley AR</span>, <span class="author">Smith JC</span>, <span class="author">Stemple DL</span> and <span class="author">Harvey SA</span></p>
<p class="affiliation">MRC National Institute for Medical Research, The Ridgeway, Mill Hill, London NW7 1AA, UK.</p><p class="abstract">The initial phases of embryonic development occur in the absence of de novo transcription and are instead controlled by maternally inherited mRNAs and proteins. During this initial period, cell cycles are synchronous and lack gap phases. Following this period of transcriptional silence, zygotic transcription begins, the maternal influence on development starts to decrease, and dramatic changes to the cell cycle take place. Here, we discuss recent work that is shedding light on the maternal to zygotic transition and the interrelated but distinct mechanisms regulating the onset of zygotic transcription and changes to the cell cycle during early embryonic development.</p>
<p class="publication"><span class="title">Development (Cambridge, England)</span>&nbsp;<span class="year">2014</span>;<span class="volume">141</span>;<span class="number">20</span>;<span class="pagerange">3834-3841</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25294937">25294937</a>; DOI: <a href="http://dx.doi.org/10.1242%2Fdev.102368">10.1242/dev.102368</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Buzz off, that&#39;s my bee!</h4>
<p class="authors"><span class="author">Langridge G</span></p>
<p class="affiliation">Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1SA, UK.</p>
<p class="publication"><span class="title">Nature reviews. Microbiology</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25198139">25198139</a>; DOI: <a href="http://dx.doi.org/10.1038%2Fnrmicro3353">10.1038/nrmicro3353</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Patterns of genome evolution that have accompanied host adaptation in Salmonella.</h4>
<p class="authors"><span class="author">Langridge GC</span>, <span class="author">Fookes M</span>, <span class="author">Connor TR</span>, <span class="author">Feltwell T</span>, <span class="author">Feasey N</span>, <span class="author">Parsons BN</span>, <span class="author">Seth-Smith HM</span>, <span class="author">Barquist L</span>, <span class="author">Stedman A</span>, <span class="author">Humphrey T</span>, <span class="author">Wigley P</span>, <span class="author">Peters SE</span>, <span class="author">Maskell DJ</span>, <span class="author">Corander J</span>, <span class="author">Chabalgoity JA</span>, <span class="author">Barrow P</span>, <span class="author">Parkhill J</span>, <span class="author">Dougan G</span> and <span class="author">Thomson NR</span></p>
<p class="affiliation">Pathogen Genomics, The Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, United Kingdom; <a href="mailto:%67%62%34%40%73%61%6E%67%65%72.%61%63.%75%6B">&#103;&#98;&#52;&#64;&#115;&#97;&#110;&#103;&#101;&#114;&#46;&#97;&#99;&#46;&#117;&#107;</a>.</p><p class="abstract">Many bacterial pathogens are specialized, infecting one or few hosts, and this is often associated with more acute disease presentation. Specific genomes show markers of this specialization, which often reflect a balance between gene acquisition and functional gene loss. Within Salmonella enterica subspecies enterica, a single lineage exists that includes human and animal pathogens adapted to cause infection in different hosts, including S. enterica serovar Enteritidis (multiple hosts), S. Gallinarum (birds), and S. Dublin (cattle). This provides an excellent evolutionary context in which differences between these pathogen genomes can be related to host range. Genome sequences were obtained from &sim;60 isolates selected to represent the known diversity of this lineage. Examination and comparison of the clades within the phylogeny of this lineage revealed signs of host restriction as well as evolutionary events that mark a path to host generalism. We have identified the nature and order of events for both evolutionary trajectories. The impact of functional gene loss was predicted based upon position within metabolic pathways and confirmed with phenotyping assays. The structure of S. Enteritidis is more complex than previously known, as a second clade of S. Enteritidis was revealed that is distinct from those commonly seen to cause disease in humans or animals, and that is more closely related to S. Gallinarum. Isolates from this second clade were tested in a chick model of infection and exhibited a reduced colonization phenotype, which we postulate represents an intermediate stage in pathogen-host adaptation.</p>
<p class="publication"><span class="title">Proceedings of the National Academy of Sciences of the United States of America</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25535353">25535353</a>; DOI: <a href="http://dx.doi.org/10.1073%2Fpnas.1416707112">10.1073/pnas.1416707112</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Chemical inhibition of NAT10 corrects defects of laminopathic cells.</h4>
<p class="authors"><span class="author">Larrieu D</span>, <span class="author">Britton S</span>, <span class="author">Demir M</span>, <span class="author">Rodriguez R</span> and <span class="author">Jackson SP</span></p>
<p class="affiliation">The Wellcome Trust/Cancer Research UK (CRUK) Gurdon Institute and Department of Biochemistry, University of Cambridge, CB2 1QN Cambridge, UK.</p><p class="abstract">Down-regulation and mutations of the nuclear-architecture proteins lamin A and C cause misshapen nuclei and altered chromatin organization associated with cancer and laminopathies, including the premature-aging disease Hutchinson-Gilford progeria syndrome (HGPS). Here, we identified the small molecule &quot;Remodelin&quot; that improved nuclear architecture, chromatin organization, and fitness of both human lamin A/C-depleted cells and HGPS-derived patient cells and decreased markers of DNA damage in these cells. Using a combination of chemical, cellular, and genetic approaches, we identified the acetyl-transferase protein NAT10 as the target of Remodelin that mediated nuclear shape rescue in laminopathic cells via microtubule reorganization. These findings provide insights into how NAT10 affects nuclear architecture and suggest alternative strategies for treating laminopathies and aging.</p>
<p class="grants">Funded by: Cancer Research UK: <span class="grant">11224</span>, <span class="grant">C6/A11224</span>, <span class="grant">C6946/A14492</span>; Medical Research Council: <span class="grant">MR/L019116/1</span>; Wellcome Trust: <span class="grant">WT092096</span></p>
<p class="publication"><span class="title">Science (New York, N.Y.)</span>&nbsp;<span class="year">2014</span>;<span class="volume">344</span>;<span class="number">6183</span>;<span class="pagerange">527-32</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24786082">24786082</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4246063">4246063</a>; DOI: <a href="http://dx.doi.org/10.1126%2Fscience.1252651">10.1126/science.1252651</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Complete humanization of the mouse immunoglobulin loci enables efficient therapeutic antibody discovery.</h4>
<p class="authors"><span class="author">Lee EC</span>, <span class="author">Liang Q</span>, <span class="author">Ali H</span>, <span class="author">Bayliss L</span>, <span class="author">Beasley A</span>, <span class="author">Bloomfield-Gerdes T</span>, <span class="author">Bonoli L</span>, <span class="author">Brown R</span>, <span class="author">Campbell J</span>, <span class="author">Carpenter A</span>, <span class="author">Chalk S</span>, <span class="author">Davis A</span>, <span class="author">England N</span>, <span class="author">Fane-Dremucheva A</span>, <span class="author">Franz B</span>, <span class="author">Germaschewski V</span>, <span class="author">Holmes H</span>, <span class="author">Holmes S</span>, <span class="author">Kirby I</span>, <span class="author">Kosmac M</span>, <span class="author">Legent A</span>, <span class="author">Lui H</span>, <span class="author">Manin A</span>, <span class="author">O&#39;Leary S</span>, <span class="author">Paterson J</span>, <span class="author">Sciarrillo R</span>, <span class="author">Speak A</span>, <span class="author">Spensberger D</span>, <span class="author">Tuffery L</span>, <span class="author">Waddell N</span>, <span class="author">Wang W</span>, <span class="author">Wells S</span>, <span class="author">Wong V</span>, <span class="author">Wood A</span>, <span class="author">Owen MJ</span>, <span class="author">Friedrich GA</span> and <span class="author">Bradley A</span></p>
<p class="affiliation">Kymab Ltd., Babraham Research Campus, Cambridge, UK.</p><p class="abstract">If immunized with an antigen of interest, transgenic mice with large portions of unrearranged human immunoglobulin loci can produce fully human antigen-specific antibodies; several such antibodies are in clinical use. However, technical limitations inherent to conventional transgenic technology and sequence divergence between the human and mouse immunoglobulin constant regions limit the utility of these mice. Here, using repetitive cycles of genome engineering in embryonic stem cells, we have inserted the entire human immunoglobulin variable-gene repertoire (2.7 Mb) into the mouse genome, leaving the mouse constant regions intact. These transgenic mice are viable and fertile, with an immune system resembling that of wild-type mice. Antigen immunization results in production of high-affinity antibodies with long human-like complementarity-determining region 3 (CDR3H), broad epitope coverage and strong signatures of somatic hypermutation. These mice provide a robust system for the discovery of therapeutic human monoclonal antibodies; as a surrogate readout of the human antibody response, they may also aid vaccine design efforts.</p>
<p class="grants">Funded by: Wellcome Trust</p>
<p class="publication"><span class="title">Nature biotechnology</span>&nbsp;<span class="year">2014</span>;<span class="volume">32</span>;<span class="number">4</span>;<span class="pagerange">356-63</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24633243">24633243</a>; DOI: <a href="http://dx.doi.org/10.1038%2Fnbt.2825">10.1038/nbt.2825</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Reprogramming the methylome: erasing memory and creating diversity.</h4>
<p class="authors"><span class="author">Lee HJ</span>, <span class="author">Hore TA</span> and <span class="author">Reik W</span></p>
<p class="affiliation">Epigenetics Programme, The Babraham Institute, Cambridge, CB22 3AT, UK; Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK.</p><p class="abstract">The inheritance of epigenetic marks, in particular DNA methylation, provides a molecular memory that ensures faithful commitment to transcriptional programs during mammalian development. Epigenetic reprogramming results in global hypomethylation of the genome together with a profound loss of memory, which underlies naive pluripotency. Such global reprogramming occurs in primordial germ cells, early embryos, and embryonic stem cells where reciprocal molecular links connect the methylation machinery to pluripotency. Priming for differentiation is initiated upon exit from pluripotency, and we propose that epigenetic mechanisms create diversity of transcriptional states, which help with symmetry breaking during cell fate decisions and lineage commitment.</p>
<p class="grants">Funded by: Biotechnology and Biological Sciences Research Council; Wellcome Trust: <span class="grant">095645</span></p>
<p class="publication"><span class="title">Cell stem cell</span>&nbsp;<span class="year">2014</span>;<span class="volume">14</span>;<span class="number">6</span>;<span class="pagerange">710-9</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24905162">24905162</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4051243">4051243</a>; DOI: <a href="http://dx.doi.org/10.1016%2Fj.stem.2014.05.008">10.1016/j.stem.2014.05.008</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Molecular genetic evidence for overlap between general cognitive ability and risk for schizophrenia: a report from the Cognitive Genomics consorTium (COGENT).</h4>
<p class="authors"><span class="author">Lencz T</span>, <span class="author">Knowles E</span>, <span class="author">Davies G</span>, <span class="author">Guha S</span>, <span class="author">Liewald DC</span>, <span class="author">Starr JM</span>, <span class="author">Djurovic S</span>, <span class="author">Melle I</span>, <span class="author">Sundet K</span>, <span class="author">Christoforou A</span>, <span class="author">Reinvang I</span>, <span class="author">Mukherjee S</span>, <span class="author">Derosse P</span>, <span class="author">Lundervold A</span>, <span class="author">Steen VM</span>, <span class="author">John M</span>, <span class="author">Espeseth T</span>, <span class="author">R&auml;ikk&ouml;nen K</span>, <span class="author">Widen E</span>, <span class="author">Palotie A</span>, <span class="author">Eriksson JG</span>, <span class="author">Giegling I</span>, <span class="author">Konte B</span>, <span class="author">Ikeda M</span>, <span class="author">Roussos P</span>, <span class="author">Giakoumaki S</span>, <span class="author">Burdick KE</span>, <span class="author">Payton A</span>, <span class="author">Ollier W</span>, <span class="author">Horan M</span>, <span class="author">Donohoe G</span>, <span class="author">Morris D</span>, <span class="author">Corvin A</span>, <span class="author">Gill M</span>, <span class="author">Pendleton N</span>, <span class="author">Iwata N</span>, <span class="author">Darvasi A</span>, <span class="author">Bitsios P</span>, <span class="author">Rujescu D</span>, <span class="author">Lahti J</span>, <span class="author">Hellard SL</span>, <span class="author">Keller MC</span>, <span class="author">Andreassen OA</span>, <span class="author">Deary IJ</span>, <span class="author">Glahn DC</span> and <span class="author">Malhotra AK</span></p>
<p class="affiliation">1] Division of Psychiatry Research, Zucker Hillside Hospital, Glen Oaks, NY, USA [2] Center for Psychiatric Neuroscience, Feinstein Institute for Medical Research, Manhasset, NY, USA [3] Hofstra North Shore-LIJ School of Medicine, Departments of Psychiatry and Molecular Medicine, Hempstead, NY, USA.</p>
<p class="abstract">It has long been recognized that generalized deficits in cognitive ability represent a core component of schizophrenia (SCZ), evident before full illness onset and independent of medication. The possibility of genetic overlap between risk for SCZ and cognitive phenotypes has been suggested by the presence of cognitive deficits in first-degree relatives of patients with SCZ; however, until recently, molecular genetic approaches to test this overlap have been lacking. Within the last few years, large-scale genome-wide association studies (GWAS) of SCZ have demonstrated that a substantial proportion of the heritability of the disorder is explained by a polygenic component consisting of many common single-nucleotide polymorphisms (SNPs) of extremely small effect. Similar results have been reported in GWAS of general cognitive ability. The primary aim of the present study is to provide the first molecular genetic test of the classic endophenotype hypothesis, which states that alleles associated with reduced cognitive ability should also serve to increase risk for SCZ. We tested the endophenotype hypothesis by applying polygenic SNP scores derived from a large-scale cognitive GWAS meta-analysis (~5000 individuals from nine nonclinical cohorts comprising the Cognitive Genomics consorTium (COGENT)) to four SCZ case-control cohorts. As predicted, cases had significantly lower cognitive polygenic scores compared to controls. In parallel, polygenic risk scores for SCZ were associated with lower general cognitive ability. In addition, using our large cognitive meta-analytic data set, we identified nominally significant cognitive associations for several SNPs that have previously been robustly associated with SCZ susceptibility. Results provide molecular confirmation of the genetic overlap between SCZ and general cognitive ability, and may provide additional insight into pathophysiology of the disorder.</p>
<p class="publication"><span class="title">Molecular psychiatry</span>&nbsp;<span class="year">2014</span>;<span class="volume">19</span>;<span class="number">2</span>;<span class="pagerange">168-74</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24342994">24342994</a>; DOI: <a href="http://dx.doi.org/10.1038%2Fmp.2013.166">10.1038/mp.2013.166</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">JAK2V617F homozygosity drives a phenotypic switch in myeloproliferative neoplasms, but is insufficient to sustain disease.</h4>
<p class="authors"><span class="author">Li J</span>, <span class="author">Kent DG</span>, <span class="author">Godfrey AL</span>, <span class="author">Manning H</span>, <span class="author">Nangalia J</span>, <span class="author">Aziz A</span>, <span class="author">Chen E</span>, <span class="author">Saeb-Parsy K</span>, <span class="author">Fink J</span>, <span class="author">Sneade R</span>, <span class="author">Hamilton TL</span>, <span class="author">Pask DC</span>, <span class="author">Silber Y</span>, <span class="author">Zhao X</span>, <span class="author">Ghevaert C</span>, <span class="author">Liu P</span> and <span class="author">Green AR</span></p>
<p class="affiliation">Cambridge Institute for Medical Research and Wellcome Trust/Medical Research Council Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom; Department of Haematology, University of Cambridge, United Kingdom;</p><p class="abstract">Genomic regions of acquired uniparental disomy (UPD) are common in malignancy and frequently harbor mutated oncogenes. Homozygosity for such gain-of-function mutations is thought to modulate tumor phenotype, but direct evidence has been elusive. Polycythemia vera (PV) and essential thrombocythemia (ET), 2 subtypes of myeloproliferative neoplasms, are associated with an identical acquired JAK2V617F mutation but the mechanisms responsible for distinct clinical phenotypes remain unclear. We provide direct genetic evidence and demonstrate that homozygosity for human JAK2V617F in knock-in mice results in a striking phenotypic switch from an ET-like to PV-like phenotype. The resultant erythrocytosis is driven by increased numbers of early erythroid progenitors and enhanced erythroblast proliferation, whereas reduced platelet numbers are associated with impaired platelet survival. JAK2V617F-homozygous mice developed a severe hematopoietic stem cell defect, suggesting that additional lesions are needed to sustain clonal expansion. Together, our results indicate that UPD for 9p plays a causal role in the PV phenotype in patients as a consequence of JAK2V617F homozygosity. The generation of a JAK2V617F allelic series of mice with a dose-dependent effect on hematopoiesis provides a powerful model for studying the consequences of mutant JAK2 homozygosity.</p>
<p class="grants">Funded by: Canadian Institutes of Health Research; Cancer Research UK: <span class="grant">12765</span>; Department of Health: <span class="grant">NF-SI-0512-10079</span></p>
<p class="publication"><span class="title">Blood</span>&nbsp;<span class="year">2014</span>;<span class="volume">123</span>;<span class="number">20</span>;<span class="pagerange">3139-51</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24692758">24692758</a>; DOI: <a href="http://dx.doi.org/10.1182%2Fblood-2013-06-510222">10.1182/blood-2013-06-510222</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Constitutional and somatic rearrangement of chromosome 21 in acute lymphoblastic leukaemia.</h4>
<p class="authors"><span class="author">Li Y</span>, <span class="author">Schwab C</span>, <span class="author">Ryan SL</span>, <span class="author">Papaemmanuil E</span>, <span class="author">Robinson HM</span>, <span class="author">Jacobs P</span>, <span class="author">Moorman AV</span>, <span class="author">Dyer S</span>, <span class="author">Borrow J</span>, <span class="author">Griffiths M</span>, <span class="author">Heerema NA</span>, <span class="author">Carroll AJ</span>, <span class="author">Talley P</span>, <span class="author">Bown N</span>, <span class="author">Telford N</span>, <span class="author">Ross FM</span>, <span class="author">Gaunt L</span>, <span class="author">McNally RJ</span>, <span class="author">Young BD</span>, <span class="author">Sinclair P</span>, <span class="author">Rand V</span>, <span class="author">Teixeira MR</span>, <span class="author">Joseph O</span>, <span class="author">Robinson B</span>, <span class="author">Maddison M</span>, <span class="author">Dastugue N</span>, <span class="author">Vandenberghe P</span>, <span class="author">Haferlach C</span>, <span class="author">Stephens PJ</span>, <span class="author">Cheng J</span>, <span class="author">Van Loo P</span>, <span class="author">Stratton MR</span>, <span class="author">Campbell PJ</span> and <span class="author">Harrison CJ</span></p>
<p class="affiliation">1] Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK [2].</p><p class="abstract">Changes in gene dosage are a major driver of cancer, known to be caused by a finite, but increasingly well annotated, repertoire of mutational mechanisms. This can potentially generate correlated copy-number alterations across hundreds of linked genes, as exemplified by the 2% of childhood acute lymphoblastic leukaemia (ALL) with recurrent amplification of megabase regions of chromosome 21 (iAMP21). We used genomic, cytogenetic and transcriptional analysis, coupled with novel bioinformatic approaches, to reconstruct the evolution of iAMP21 ALL. Here we show that individuals born with the rare constitutional Robertsonian translocation between chromosomes 15 and 21, rob(15;21)(q10;q10)c, have approximately 2,700-fold increased risk of developing iAMP21 ALL compared to the general population. In such cases, amplification is initiated by a chromothripsis event involving both sister chromatids of the Robertsonian chromosome, a novel mechanism for cancer predisposition. In sporadic iAMP21, breakage-fusion-bridge cycles are typically the initiating event, often followed by chromothripsis. In both sporadic and rob(15;21)c-associated iAMP21, the final stages frequently involve duplications of the entire abnormal chromosome. The end-product is a derivative of chromosome 21 or the rob(15;21)c chromosome with gene dosage optimized for leukaemic potential, showing constrained copy-number levels over multiple linked genes. Thus, dicentric chromosomes may be an important precipitant of chromothripsis, as we show rob(15;21)c to be constitutionally dicentric and breakage-fusion-bridge cycles generate dicentric chromosomes somatically. Furthermore, our data illustrate that several cancer-specific mutational processes, applied sequentially, can coordinate to fashion copy-number profiles over large genomic scales, incrementally refining the fitness benefits of aggregated gene dosage changes.</p>
<p class="publication"><span class="title">Nature</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24670643">24670643</a>; DOI: <a href="http://dx.doi.org/10.1038%2Fnature13115">10.1038/nature13115</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Novel skin phenotypes revealed by a genome-wide mouse reverse genetic screen.</h4>
<p class="authors"><span class="author">Liakath-Ali K</span>, <span class="author">Vancollie VE</span>, <span class="author">Heath E</span>, <span class="author">Smedley DP</span>, <span class="author">Estabel J</span>, <span class="author">Sunter D</span>, <span class="author">Ditommaso T</span>, <span class="author">White JK</span>, <span class="author">Ramirez-Solis R</span>, <span class="author">Smyth I</span>, <span class="author">Steel KP</span> and <span class="author">Watt FM</span></p>
<p class="affiliation">1] Centre for Stem Cells and Regenerative Medicine, King&#39;s College London, Guy&#39;s Hospital, London SE1 9RT, UK [2] Department of Biochemistry, University of Cambridge, Tennis Court Road, Cambridge CB2 1QW, UK [3] Wellcome Trust-Medical Research Council Stem Cell Institute, University of Cambridge, Tennis Court Road, Cambridge CB2 1QR, UK.</p><p class="abstract">Permanent stop-and-shop large-scale mouse mutant resources provide an excellent platform to decipher tissue phenogenomics. Here we analyse skin from 538 knockout mouse mutants generated by the Sanger Institute Mouse Genetics Project. We optimize immunolabelling of tail epidermal wholemounts to allow systematic annotation of hair follicle, sebaceous gland and interfollicular epidermal abnormalities using ontology terms from the Mammalian Phenotype Ontology. Of the 50 mutants with an epidermal phenotype, 9 map to human genetic conditions with skin abnormalities. Some mutant genes are expressed in the skin, whereas others are not, indicating systemic effects. One phenotype is affected by diet and several are incompletely penetrant. In-depth analysis of three mutants, Krt76, Myo5a (a model of human Griscelli syndrome) and Mysm1, provides validation of the screen. Our study is the first large-scale genome-wide tissue phenotype screen from the International Knockout Mouse Consortium and provides an open access resource for the scientific community.</p>
<p class="grants">Funded by: Medical Research Council: <span class="grant">G0300212</span>, <span class="grant">MC_QA137918</span>; Wellcome Trust: <span class="grant">096540</span>, <span class="grant">098051</span></p>
<p class="publication"><span class="title">Nature communications</span>&nbsp;<span class="year">2014</span>;<span class="volume">5</span>;<span class="pagerange">3540</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24721909">24721909</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC3996542">3996542</a>; DOI: <a href="http://dx.doi.org/10.1038%2Fncomms4540">10.1038/ncomms4540</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Distribution and Medical Impact of Loss-of-Function Variants in the Finnish Founder Population.</h4>
<p class="authors"><span class="author">Lim ET</span>, <span class="author">W&uuml;rtz P</span>, <span class="author">Havulinna AS</span>, <span class="author">Palta P</span>, <span class="author">Tukiainen T</span>, <span class="author">Rehnstr&ouml;m K</span>, <span class="author">Esko T</span>, <span class="author">M&auml;gi R</span>, <span class="author">Inouye M</span>, <span class="author">Lappalainen T</span>, <span class="author">Chan Y</span>, <span class="author">Salem RM</span>, <span class="author">Lek M</span>, <span class="author">Flannick J</span>, <span class="author">Sim X</span>, <span class="author">Manning A</span>, <span class="author">Ladenvall C</span>, <span class="author">Bumpstead S</span>, <span class="author">H&auml;m&auml;l&auml;inen E</span>, <span class="author">Aalto K</span>, <span class="author">Maksimow M</span>, <span class="author">Salmi M</span>, <span class="author">Blankenberg S</span>, <span class="author">Ardissino D</span>, <span class="author">Shah S</span>, <span class="author">Horne B</span>, <span class="author">McPherson R</span>, <span class="author">Hovingh GK</span>, <span class="author">Reilly MP</span>, <span class="author">Watkins H</span>, <span class="author">Goel A</span>, <span class="author">Farrall M</span>, <span class="author">Girelli D</span>, <span class="author">Reiner AP</span>, <span class="author">Stitziel NO</span>, <span class="author">Kathiresan S</span>, <span class="author">Gabriel S</span>, <span class="author">Barrett JC</span>, <span class="author">Lehtim&auml;ki T</span>, <span class="author">Laakso M</span>, <span class="author">Groop L</span>, <span class="author">Kaprio J</span>, <span class="author">Perola M</span>, <span class="author">McCarthy MI</span>, <span class="author">Boehnke M</span>, <span class="author">Altshuler DM</span>, <span class="author">Lindgren CM</span>, <span class="author">Hirschhorn JN</span>, <span class="author">Metspalu A</span>, <span class="author">Freimer NB</span>, <span class="author">Zeller T</span>, <span class="author">Jalkanen S</span>, <span class="author">Koskinen S</span>, <span class="author">Raitakari O</span>, <span class="author">Durbin R</span>, <span class="author">MacArthur DG</span>, <span class="author">Salomaa V</span>, <span class="author">Ripatti S</span>, <span class="author">Daly MJ</span>, <span class="author">Palotie A</span> and <span class="author">Sequencing Initiative Suomi (SISu) Project</span></p>
<p class="affiliation">Analytic and Translational Genetics Unit, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, United States of America; Program in Medical and Population Genetics, Broad Institute, Cambridge, Massachusetts, United States of America; Department of Genetics, Harvard Medical School, Boston, Massachusetts, United States of America; Program in Biological and Biomedical Sciences, Harvard Medical School, Boston, Massachusetts, United States of America.</p><p class="abstract">Exome sequencing studies in complex diseases are challenged by the allelic heterogeneity, large number and modest effect sizes of associated variants on disease risk and the presence of large numbers of neutral variants, even in phenotypically relevant genes. Isolated populations with recent bottlenecks offer advantages for studying rare variants in complex diseases as they have deleterious variants that are present at higher frequencies as well as a substantial reduction in rare neutral variation. To explore the potential of the Finnish founder population for studying low-frequency (0.5-5%) variants in complex diseases, we compared exome sequence data on 3,000 Finns to the same number of non-Finnish Europeans and discovered that, despite having fewer variable sites overall, the average Finn has more low-frequency loss-of-function variants and complete gene knockouts. We then used several well-characterized Finnish population cohorts to study the phenotypic effects of 83 enriched loss-of-function variants across 60 phenotypes in 36,262 Finns. Using a deep set of quantitative traits collected on these cohorts, we show 5 associations (p&lt;5&times;10-8) including splice variants in LPA that lowered plasma lipoprotein(a) levels (P&#x200A;=&#x200A;1.5&times;10-117). Through accessing the national medical records of these participants, we evaluate the LPA finding via Mendelian randomization and confirm that these splice variants confer protection from cardiovascular disease (OR&#x200A;=&#x200A;0.84, P&#x200A;=&#x200A;3&times;10-4), demonstrating for the first time the correlation between very low levels of LPA in humans with potential therapeutic implications for cardiovascular diseases. More generally, this study articulates substantial advantages for studying the role of rare variation in complex phenotypes in founder populations like the Finns and by combining a unique population genetic history with data from large population cohorts and centralized research access to National Health Registers.</p>
<p class="publication"><span class="title">PLoS genetics</span>&nbsp;<span class="year">2014</span>;<span class="volume">10</span>;<span class="number">7</span>;<span class="pagerange">e1004494</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25078778">25078778</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4117444">4117444</a>; DOI: <a href="http://dx.doi.org/10.1371%2Fjournal.pgen.1004494">10.1371/journal.pgen.1004494</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Robust identification of noncoding RNA from transcriptomes requires phylogenetically-informed sampling.</h4>
<p class="authors"><span class="author">Lindgreen S</span>, <span class="author">Umu SU</span>, <span class="author">Lai AS</span>, <span class="author">Eldai H</span>, <span class="author">Liu W</span>, <span class="author">McGimpsey S</span>, <span class="author">Wheeler NE</span>, <span class="author">Biggs PJ</span>, <span class="author">Thomson NR</span>, <span class="author">Barquist L</span>, <span class="author">Poole AM</span> and <span class="author">Gardner PP</span></p>
<p class="affiliation">Department of Biology, University of Copenhagen, Copenhagen, Denmark; School of Biological Sciences, University of Canterbury, Christchurch, New Zealand.</p><p class="abstract">Noncoding RNAs are integral to a wide range of biological processes, including translation, gene regulation, host-pathogen interactions and environmental sensing. While genomics is now a mature field, our capacity to identify noncoding RNA elements in bacterial and archaeal genomes is hampered by the difficulty of de novo identification. The emergence of new technologies for characterizing transcriptome outputs, notably RNA-seq, are improving noncoding RNA identification and expression quantification. However, a major challenge is to robustly distinguish functional outputs from transcriptional noise. To establish whether annotation of existing transcriptome data has effectively captured all functional outputs, we analysed over 400 publicly available RNA-seq datasets spanning 37 different Archaea and Bacteria. Using comparative tools, we identify close to a thousand highly-expressed candidate noncoding RNAs. However, our analyses reveal that capacity to identify noncoding RNA outputs is strongly dependent on phylogenetic sampling. Surprisingly, and in stark contrast to protein-coding genes, the phylogenetic window for effective use of comparative methods is perversely narrow: aggregating public datasets only produced one phylogenetic cluster where these tools could be used to robustly separate unannotated noncoding RNAs from a null hypothesis of transcriptional noise. Our results show that for the full potential of transcriptomics data to be realized, a change in experimental design is paramount: effective transcriptomics requires phylogeny-aware sampling.</p>
<p class="publication"><span class="title">PLoS computational biology</span>&nbsp;<span class="year">2014</span>;<span class="volume">10</span>;<span class="number">10</span>;<span class="pagerange">e1003907</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25357249">25357249</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4214555">4214555</a>; DOI: <a href="http://dx.doi.org/10.1371%2Fjournal.pcbi.1003907">10.1371/journal.pcbi.1003907</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">High-throughput epitope discovery reveals frequent recognition of neo-antigens by CD4+ T cells in human melanoma.</h4>
<p class="authors"><span class="author">Linnemann C</span>, <span class="author">van Buuren MM</span>, <span class="author">Bies L</span>, <span class="author">Verdegaal EM</span>, <span class="author">Schotte R</span>, <span class="author">Calis JJ</span>, <span class="author">Behjati S</span>, <span class="author">Velds A</span>, <span class="author">Hilkmann H</span>, <span class="author">Atmioui DE</span>, <span class="author">Visser M</span>, <span class="author">Stratton MR</span>, <span class="author">Haanen JB</span>, <span class="author">Spits H</span>, <span class="author">van der Burg SH</span> and <span class="author">Schumacher TN</span></p>
<p class="affiliation">Division of Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.</p><p class="abstract">Tumor-specific neo-antigens that arise as a consequence of mutations are thought to be important for the therapeutic efficacy of cancer immunotherapies. Accumulating evidence suggests that neo-antigens may be commonly recognized by intratumoral CD8+ T cells, but it is unclear whether neo-antigen-specific CD4+ T cells also frequently reside within human tumors. In view of the accepted role of tumor-specific CD4+ T-cell responses in tumor control, we addressed whether neo-antigen-specific CD4+ T-cell reactivity is a common property in human melanoma.</p>
<p class="publication"><span class="title">Nature medicine</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25531942">25531942</a>; DOI: <a href="http://dx.doi.org/10.1038%2Fnm.3773">10.1038/nm.3773</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">CD28 expression is required after T cell priming for helper T cell responses and protective immunity to infection.</h4>
<p class="authors"><span class="author">Linterman MA</span>, <span class="author">Denton AE</span>, <span class="author">Divekar DP</span>, <span class="author">Zvetkova I</span>, <span class="author">Kane L</span>, <span class="author">Ferreira C</span>, <span class="author">Veldhoen M</span>, <span class="author">Clare S</span>, <span class="author">Dougan G</span>, <span class="author">Esp&eacute;li M</span> and <span class="author">Smith KG</span></p>
<p class="affiliation">Lymphocyte Signalling and Development, Babraham Institute, Cambridge, United Kingdom.</p><p class="abstract">The costimulatory molecule CD28 is essential for activation of helper T cells. Despite this critical role, it is not known whether CD28 has functions in maintaining T cell responses following activation. To determine the role for CD28 after T cell priming we generated a strain of mice where CD28 is removed from CD4(+) T cells after priming. We show that continued CD28 expression is important for effector CD4(+) T cells following infection; maintained CD28 is required for the expansion of T helper type 1 cells, and for the differentiation and maintenance of T follicular helper cells during viral infection. Persistent CD28 is also required for clearance of the bacterium Citrobacter rodentium from the gastrointestinal tract. Together, this study demonstrates that CD28 persistence is required for helper T cell polarization in response to infection, describing a novel function for CD28 that is distinct from its role in T cell priming.</p>
<p class="publication"><span class="title">eLife</span>&nbsp;<span class="year">2014</span>;<span class="volume">3</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25347065">25347065</a>; DOI: <a href="http://dx.doi.org/10.7554%2FeLife.03180">10.7554/eLife.03180</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Multi-stage genome wide association study identifies new susceptibility locus for testicular germ cell tumour on chromosome 3q25.</h4>
<p class="authors"><span class="author">Litchfield K</span>, <span class="author">Sultana R</span>, <span class="author">Renwick A</span>, <span class="author">Dudakia D</span>, <span class="author">Seal S</span>, <span class="author">Ramsay E</span>, <span class="author">Powell S</span>, <span class="author">Elliott A</span>, <span class="author">Warren-Perry M</span>, <span class="author">Eeles R</span>, <span class="author">Peto J</span>, <span class="author">Kote-Jarai Z</span>, <span class="author">Muir K</span>, <span class="author">Nsengimana J</span>, <span class="author">UKTCC</span>, <span class="author">Stratton MR</span>, <span class="author">Easton DF</span>, <span class="author">Bishop DT</span>, <span class="author">Huddart RA</span>, <span class="author">Rahman N</span> and <span class="author">Turnbull C</span></p>
<p class="affiliation">Division of Genetics and Epidemiology, Institute of Cancer Research, London, UK.</p><p class="abstract">Recent genome wide association studies (GWAS) and subsequent meta-analyses have identified over 25 SNPs at 18 loci, together accounting for &gt;15% of the genetic susceptibility to testicular germ cell tumour (TGCT). To identify further common SNPs associated with TGCT here we report a three-stage experiment, involving 4,098 cases and 18,972 controls. Stage 1 comprised previously published GWAS analysis of 307,291 SNPs in 986 cases and 4,946 controls. In stage 2 we used previously published customised Illumina iSelect genotyping array (iCOGs) data across 694 SNPs in 1,064 cases and 10,082 controls. Here we report new genotyping of eight SNPs showing some evidence of association in combined analysis of stage 1 and stage 2 in an additional 2,048 cases of TGCT and 3,944 controls (stage 3). Through fixed effects meta-analysis across 3 stages, we identified a novel locus at 3q25.31 (rs1510272) demonstrating association with TGCT (per-allele odds ratio (OR)=1.16, 95% confidence interval (CI)=1.06-1.27; P=1.2 x 10(-9)).</p>
<p class="publication"><span class="title">Human molecular genetics</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25281660">25281660</a>; DOI: <a href="http://dx.doi.org/10.1093%2Fhmg%2Fddu511">10.1093/hmg/ddu511</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Genetic studies of Crohn&#39;s disease: past, present and future.</h4>
<p class="authors"><span class="author">Liu JZ</span> and <span class="author">Anderson CA</span></p>
<p class="affiliation">The Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK.</p><p class="abstract">The exact aetiology of Crohn&#39;s disease is unknown, though it is clear from early epidemiological studies that a combination of genetic and environmental risk factors contributes to an individual&#39;s disease susceptibility. Here, we review the history of gene-mapping studies of Crohn&#39;s disease, from the linkage-based studies that first implicated the NOD2 locus, through to modern-day genome-wide association studies that have discovered over 140 loci associated with Crohn&#39;s disease and yielded novel insights into the biological pathways underlying pathogenesis. We describe on-going and future gene-mapping studies that utilise next generation sequencing technology to pinpoint causal variants and identify rare genetic variation underlying Crohn&#39;s disease risk. We comment on the utility of genetic markers for predicting an individual&#39;s disease risk and discuss their potential for identifying novel drug targets and influencing disease management. Finally, we describe how these studies have shaped and continue to shape our understanding of the genetic architecture of Crohn&#39;s disease.</p>
<p class="grants">Funded by: Wellcome Trust: <span class="grant">098051</span></p>
<p class="publication"><span class="title">Best practice &amp; research. Clinical gastroenterology</span>&nbsp;<span class="year">2014</span>;<span class="volume">28</span>;<span class="number">3</span>;<span class="pagerange">373-86</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24913378">24913378</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4075408">4075408</a>; DOI: <a href="http://dx.doi.org/10.1016%2Fj.bpg.2014.04.009">10.1016/j.bpg.2014.04.009</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">African origin of the malaria parasite Plasmodium vivax.</h4>
<p class="authors"><span class="author">Liu W</span>, <span class="author">Li Y</span>, <span class="author">Shaw KS</span>, <span class="author">Learn GH</span>, <span class="author">Plenderleith LJ</span>, <span class="author">Malenke JA</span>, <span class="author">Sundararaman SA</span>, <span class="author">Ramirez MA</span>, <span class="author">Crystal PA</span>, <span class="author">Smith AG</span>, <span class="author">Bibollet-Ruche F</span>, <span class="author">Ayouba A</span>, <span class="author">Locatelli S</span>, <span class="author">Esteban A</span>, <span class="author">Mouacha F</span>, <span class="author">Guichet E</span>, <span class="author">Butel C</span>, <span class="author">Ahuka-Mundeke S</span>, <span class="author">Inogwabini BI</span>, <span class="author">Ndjango JB</span>, <span class="author">Speede S</span>, <span class="author">Sanz CM</span>, <span class="author">Morgan DB</span>, <span class="author">Gonder MK</span>, <span class="author">Kranzusch PJ</span>, <span class="author">Walsh PD</span>, <span class="author">Georgiev AV</span>, <span class="author">Muller MN</span>, <span class="author">Piel AK</span>, <span class="author">Stewart FA</span>, <span class="author">Wilson ML</span>, <span class="author">Pusey AE</span>, <span class="author">Cui L</span>, <span class="author">Wang Z</span>, <span class="author">F&auml;rnert A</span>, <span class="author">Sutherland CJ</span>, <span class="author">Nolder D</span>, <span class="author">Hart JA</span>, <span class="author">Hart TB</span>, <span class="author">Bertolani P</span>, <span class="author">Gillis A</span>, <span class="author">LeBreton M</span>, <span class="author">Tafon B</span>, <span class="author">Kiyang J</span>, <span class="author">Djoko CF</span>, <span class="author">Schneider BS</span>, <span class="author">Wolfe ND</span>, <span class="author">Mpoudi-Ngole E</span>, <span class="author">Delaporte E</span>, <span class="author">Carter R</span>, <span class="author">Culleton RL</span>, <span class="author">Shaw GM</span>, <span class="author">Rayner JC</span>, <span class="author">Peeters M</span>, <span class="author">Hahn BH</span> and <span class="author">Sharp PM</span></p>
<p class="affiliation">Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.</p><p class="abstract">Plasmodium vivax is the leading cause of human malaria in Asia and Latin America but is absent from most of central Africa due to the near fixation of a mutation that inhibits the expression of its receptor, the Duffy antigen, on human erythrocytes. The emergence of this protective allele is not understood because P. vivax is believed to have originated in Asia. Here we show, using a non-invasive approach, that wild chimpanzees and gorillas throughout central Africa are endemically infected with parasites that are closely related to human P. vivax. Sequence analyses reveal that ape parasites lack host specificity and are much more diverse than human parasites, which form a monophyletic lineage within the ape parasite radiation. These findings indicate that human P. vivax is of African origin and likely selected for the Duffy-negative mutation. All extant human P. vivax parasites are derived from a single ancestor that escaped out of Africa.</p>
<p class="grants">Funded by: Medical Research Council: <span class="grant">MR/L008661/1</span>; NIAID NIH HHS: <span class="grant">P30 AI045008</span>, <span class="grant">R01 AI058715</span>, <span class="grant">R01 AI091595</span>, <span class="grant">R01 AI58715</span>, <span class="grant">R37 AI050529</span>, <span class="grant">T32 AI007532</span>; Wellcome Trust: <span class="grant">098051</span></p>
<p class="publication"><span class="title">Nature communications</span>&nbsp;<span class="year">2014</span>;<span class="volume">5</span>;<span class="pagerange">3346</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24557500">24557500</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4089193">4089193</a>; DOI: <a href="http://dx.doi.org/10.1038%2Fncomms4346">10.1038/ncomms4346</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Loss-of-function mutations in MICU1 cause a brain and muscle disorder linked to primary alterations in mitochondrial calcium signaling.</h4>
<p class="authors"><span class="author">Logan CV</span>, <span class="author">Szabadkai G</span>, <span class="author">Sharpe JA</span>, <span class="author">Parry DA</span>, <span class="author">Torelli S</span>, <span class="author">Childs AM</span>, <span class="author">Kriek M</span>, <span class="author">Phadke R</span>, <span class="author">Johnson CA</span>, <span class="author">Roberts NY</span>, <span class="author">Bonthron DT</span>, <span class="author">Pysden KA</span>, <span class="author">Whyte T</span>, <span class="author">Munteanu I</span>, <span class="author">Foley AR</span>, <span class="author">Wheway G</span>, <span class="author">Szymanska K</span>, <span class="author">Natarajan S</span>, <span class="author">Abdelhamed ZA</span>, <span class="author">Morgan JE</span>, <span class="author">Roper H</span>, <span class="author">Santen GW</span>, <span class="author">Niks EH</span>, <span class="author">van der Pol WL</span>, <span class="author">Lindhout D</span>, <span class="author">Raffaello A</span>, <span class="author">De Stefani D</span>, <span class="author">den Dunnen JT</span>, <span class="author">Sun Y</span>, <span class="author">Ginjaar I</span>, <span class="author">Sewry CA</span>, <span class="author">Hurles M</span>, <span class="author">Rizzuto R</span>, <span class="author">UK10K Consortium</span>, <span class="author">Duchen MR</span>, <span class="author">Muntoni F</span> and <span class="author">Sheridan E</span></p><p class="abstract">Mitochondrial Ca(2+) uptake has key roles in cell life and death. Physiological Ca(2+) signaling regulates aerobic metabolism, whereas pathological Ca(2+) overload triggers cell death. Mitochondrial Ca(2+) uptake is mediated by the Ca(2+) uniporter complex in the inner mitochondrial membrane, which comprises MCU, a Ca(2+)-selective ion channel, and its regulator, MICU1. Here we report mutations of MICU1 in individuals with a disease phenotype characterized by proximal myopathy, learning difficulties and a progressive extrapyramidal movement disorder. In fibroblasts from subjects with MICU1 mutations, agonist-induced mitochondrial Ca(2+) uptake at low cytosolic Ca(2+) concentrations was increased, and cytosolic Ca(2+) signals were reduced. Although resting mitochondrial membrane potential was unchanged in MICU1-deficient cells, the mitochondrial network was severely fragmented. Whereas the pathophysiology of muscular dystrophy and the core myopathies involves abnormal mitochondrial Ca(2+) handling, the phenotype associated with MICU1 deficiency is caused by a primary defect in mitochondrial Ca(2+) signaling, demonstrating the crucial role of mitochondrial Ca(2+) uptake in humans.</p>
<p class="grants">Funded by: British Heart Foundation; Medical Research Council: <span class="grant">MC_UU_12012/5/B</span>, <span class="grant">MR/K000608/1</span>, <span class="grant">MR/K011154/1</span>; NIA NIH HHS: <span class="grant">1P01AG025532-01A1</span>; Parkinson&#39;s UK: <span class="grant">G-0905</span>; Telethon: <span class="grant">GEP12066</span>, <span class="grant">GGP11082</span>, <span class="grant">GPP10005</span>; Wellcome Trust: <span class="grant">090532</span>, <span class="grant">WT091310</span></p>
<p class="publication"><span class="title">Nature genetics</span>&nbsp;<span class="year">2014</span>;<span class="volume">46</span>;<span class="number">2</span>;<span class="pagerange">188-93</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24336167">24336167</a>; DOI: <a href="http://dx.doi.org/10.1038%2Fng.2851">10.1038/ng.2851</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Do you smell what I smell? Genetic variation in olfactory perception.</h4>
<p class="authors"><span class="author">Logan DW</span></p>
<p class="affiliation">*Welcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1SA, U.K.</p><p class="abstract">The sense of smell is mediated by the detection of chemical odours by ORs (olfactory receptors) in the nose. This initiates a neural percept of the odour in the brain, which may provoke an emotional or behavioural response. Analogous to colour-blindness in the visual system, some individuals report a very different percept of specific odours to others, in terms of intensity, valence or detection threshold. A significant proportion of variance in odour perception is heritable, and recent advances in genome sequencing and genotyping technologies have permitted studies into the genes that underpin these phenotypic differences. In the present article, I review the evidence that OR genes are extremely variable between individuals. I argue that this contributes to a unique receptor repertoire in our noses that provides us each with a personalized perception of our environment. I highlight specific examples where known OR variants influence odour detection and discuss the wider implications of this for both humans and other mammals that use chemical communication for social interaction.</p>
<p class="publication"><span class="title">Biochemical Society transactions</span>&nbsp;<span class="year">2014</span>;<span class="volume">42</span>;<span class="number">4</span>;<span class="pagerange">861-5</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25109969">25109969</a>; DOI: <a href="http://dx.doi.org/10.1042%2FBST20140052">10.1042/BST20140052</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">A DERL3-associated defect in the degradation of SLC2A1 mediates the Warburg effect.</h4>
<p class="authors"><span class="author">Lopez-Serra P</span>, <span class="author">Marcilla M</span>, <span class="author">Villanueva A</span>, <span class="author">Ramos-Fernandez A</span>, <span class="author">Palau A</span>, <span class="author">Leal L</span>, <span class="author">Wahi JE</span>, <span class="author">Setien-Baranda F</span>, <span class="author">Szczesna K</span>, <span class="author">Moutinho C</span>, <span class="author">Martinez-Cardus A</span>, <span class="author">Heyn H</span>, <span class="author">Sandoval J</span>, <span class="author">Puertas S</span>, <span class="author">Vidal A</span>, <span class="author">Sanjuan X</span>, <span class="author">Martinez-Balibrea E</span>, <span class="author">Vi&ntilde;als F</span>, <span class="author">Perales JC</span>, <span class="author">Bramsem JB</span>, <span class="author">&Oslash;rntoft TF</span>, <span class="author">Andersen CL</span>, <span class="author">Tabernero J</span>, <span class="author">McDermott U</span>, <span class="author">Boxer MB</span>, <span class="author">Heiden MG</span>, <span class="author">Albar JP</span> and <span class="author">Esteller M</span></p>
<p class="affiliation">Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), L&#39;Hospitalet, Barcelona, 08908 Catalonia, Spain.</p><p class="abstract">Cancer cells possess aberrant proteomes that can arise by the disruption of genes involved in physiological protein degradation. Here we demonstrate the presence of promoter CpG island hypermethylation-linked inactivation of DERL3 (Derlin-3), a key gene in the endoplasmic reticulum-associated protein degradation pathway, in human tumours. The restoration of in vitro and in vivo DERL3 activity highlights the tumour suppressor features of the gene. Using the stable isotopic labelling of amino acids in cell culture workflow for differential proteome analysis, we identify SLC2A1 (glucose transporter 1, GLUT1) as a downstream target of DERL3. Most importantly, SLC2A1 overexpression mediated by DERL3 epigenetic loss contributes to the Warburg effect in the studied cells and pinpoints a subset of human tumours with greater vulnerability to drugs targeting glycolysis.</p>
<p class="publication"><span class="title">Nature communications</span>&nbsp;<span class="year">2014</span>;<span class="volume">5</span>;<span class="pagerange">3608</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24699711">24699711</a>; DOI: <a href="http://dx.doi.org/10.1038%2Fncomms4608">10.1038/ncomms4608</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Genome-wide association analysis identifies six new loci associated with forced vital capacity.</h4>
<p class="authors"><span class="author">Loth DW</span>, <span class="author">Artigas MS</span>, <span class="author">Gharib SA</span>, <span class="author">Wain LV</span>, <span class="author">Franceschini N</span>, <span class="author">Koch B</span>, <span class="author">Pottinger TD</span>, <span class="author">Smith AV</span>, <span class="author">Duan Q</span>, <span class="author">Oldmeadow C</span>, <span class="author">Lee MK</span>, <span class="author">Strachan DP</span>, <span class="author">James AL</span>, <span class="author">Huffman JE</span>, <span class="author">Vitart V</span>, <span class="author">Ramasamy A</span>, <span class="author">Wareham NJ</span>, <span class="author">Kaprio J</span>, <span class="author">Wang XQ</span>, <span class="author">Trochet H</span>, <span class="author">K&auml;h&ouml;nen M</span>, <span class="author">Flexeder C</span>, <span class="author">Albrecht E</span>, <span class="author">Lopez LM</span>, <span class="author">de Jong K</span>, <span class="author">Thyagarajan B</span>, <span class="author">Alves AC</span>, <span class="author">Enroth S</span>, <span class="author">Omenaas E</span>, <span class="author">Joshi PK</span>, <span class="author">Fall T</span>, <span class="author">Vi&ntilde;uela A</span>, <span class="author">Launer LJ</span>, <span class="author">Loehr LR</span>, <span class="author">Fornage M</span>, <span class="author">Li G</span>, <span class="author">Wilk JB</span>, <span class="author">Tang W</span>, <span class="author">Manichaikul A</span>, <span class="author">Lahousse L</span>, <span class="author">Harris TB</span>, <span class="author">North KE</span>, <span class="author">Rudnicka AR</span>, <span class="author">Hui J</span>, <span class="author">Gu X</span>, <span class="author">Lumley T</span>, <span class="author">Wright AF</span>, <span class="author">Hastie ND</span>, <span class="author">Campbell S</span>, <span class="author">Kumar R</span>, <span class="author">Pin I</span>, <span class="author">Scott RA</span>, <span class="author">Pietil&auml;inen KH</span>, <span class="author">Surakka I</span>, <span class="author">Liu Y</span>, <span class="author">Holliday EG</span>, <span class="author">Schulz H</span>, <span class="author">Heinrich J</span>, <span class="author">Davies G</span>, <span class="author">Vonk JM</span>, <span class="author">Wojczynski M</span>, <span class="author">Pouta A</span>, <span class="author">Johansson A</span>, <span class="author">Wild SH</span>, <span class="author">Ingelsson E</span>, <span class="author">Rivadeneira F</span>, <span class="author">V&ouml;lzke H</span>, <span class="author">Hysi PG</span>, <span class="author">Eiriksdottir G</span>, <span class="author">Morrison AC</span>, <span class="author">Rotter JI</span>, <span class="author">Gao W</span>, <span class="author">Postma DS</span>, <span class="author">White WB</span>, <span class="author">Rich SS</span>, <span class="author">Hofman A</span>, <span class="author">Aspelund T</span>, <span class="author">Couper D</span>, <span class="author">Smith LJ</span>, <span class="author">Psaty BM</span>, <span class="author">Lohman K</span>, <span class="author">Burchard EG</span>, <span class="author">Uitterlinden AG</span>, <span class="author">Garcia M</span>, <span class="author">Joubert BR</span>, <span class="author">McArdle WL</span>, <span class="author">Musk AB</span>, <span class="author">Hansel N</span>, <span class="author">Heckbert SR</span>, <span class="author">Zgaga L</span>, <span class="author">van Meurs JB</span>, <span class="author">Navarro P</span>, <span class="author">Rudan I</span>, <span class="author">Oh YM</span>, <span class="author">Redline S</span>, <span class="author">Jarvis DL</span>, <span class="author">Zhao JH</span>, <span class="author">Rantanen T</span>, <span class="author">O&#39;Connor GT</span>, <span class="author">Ripatti S</span>, <span class="author">Scott RJ</span>, <span class="author">Karrasch S</span>, <span class="author">Grallert H</span>, <span class="author">Gaddis NC</span>, <span class="author">Starr JM</span>, <span class="author">Wijmenga C</span>, <span class="author">Minster RL</span>, <span class="author">Lederer DJ</span>, <span class="author">Pekkanen J</span>, <span class="author">Gyllensten U</span>, <span class="author">Campbell H</span>, <span class="author">Morris AP</span>, <span class="author">Gl&auml;ser S</span>, <span class="author">Hammond CJ</span>, <span class="author">Burkart KM</span>, <span class="author">Beilby J</span>, <span class="author">Kritchevsky SB</span>, <span class="author">Gudnason V</span>, <span class="author">Hancock DB</span>, <span class="author">Williams OD</span>, <span class="author">Polasek O</span>, <span class="author">Zemunik T</span>, <span class="author">Kolcic I</span>, <span class="author">Petrini MF</span>, <span class="author">Wjst M</span>, <span class="author">Kim WJ</span>, <span class="author">Porteous DJ</span>, <span class="author">Scotland G</span>, <span class="author">Smith BH</span>, <span class="author">Viljanen A</span>, <span class="author">Heli&ouml;vaara M</span>, <span class="author">Attia JR</span>, <span class="author">Sayers I</span>, <span class="author">Hampel R</span>, <span class="author">Gieger C</span>, <span class="author">Deary IJ</span>, <span class="author">Boezen HM</span>, <span class="author">Newman A</span>, <span class="author">Jarvelin MR</span>, <span class="author">Wilson JF</span>, <span class="author">Lind L</span>, <span class="author">Stricker BH</span>, <span class="author">Teumer A</span>, <span class="author">Spector TD</span>, <span class="author">Mel&eacute;n E</span>, <span class="author">Peters MJ</span>, <span class="author">Lange LA</span>, <span class="author">Barr RG</span>, <span class="author">Bracke KR</span>, <span class="author">Verhamme FM</span>, <span class="author">Sung J</span>, <span class="author">Hiemstra PS</span>, <span class="author">Cassano PA</span>, <span class="author">Sood A</span>, <span class="author">Hayward C</span>, <span class="author">Dupuis J</span>, <span class="author">Hall IP</span>, <span class="author">Brusselle GG</span>, <span class="author">Tobin MD</span> and <span class="author">London SJ</span></p>
<p class="affiliation">1] Department of Epidemiology, Erasmus MC, Rotterdam, the Netherlands. [2] Netherlands Health Care Inspectorate, The Hague, the Netherlands. [3].</p><p class="abstract">Forced vital capacity (FVC), a spirometric measure of pulmonary function, reflects lung volume and is used to diagnose and monitor lung diseases. We performed genome-wide association study meta-analysis of FVC in 52,253 individuals from 26 studies and followed up the top associations in 32,917 additional individuals of European ancestry. We found six new regions associated at genome-wide significance (P &lt; 5 &times; 10(-8)) with FVC in or near EFEMP1, BMP6, MIR129-2-HSD17B12, PRDM11, WWOX and KCNJ2. Two loci previously associated with spirometric measures (GSTCD and PTCH1) were related to FVC. Newly implicated regions were followed up in samples from African-American, Korean, Chinese and Hispanic individuals. We detected transcripts for all six newly implicated genes in human lung tissue. The new loci may inform mechanisms involved in lung development and the pathogenesis of restrictive lung disease.</p>
<p class="publication"><span class="title">Nature genetics</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24929828">24929828</a>; DOI: <a href="http://dx.doi.org/10.1038%2Fng.3011">10.1038/ng.3011</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Candidate-gene association study searching for genetic factors involved in migraine chronification.</h4>
<p class="authors"><span class="author">Louter M</span>, <span class="author">Fernandez-Morales J</span>, <span class="author">de Vries B</span>, <span class="author">Winsvold B</span>, <span class="author">Anttila V</span>, <span class="author">Fernandez-Cadenas I</span>, <span class="author">Vila-Pueyo M</span>, <span class="author">Sintas C</span>, <span class="author">van Duijn C</span>, <span class="author">Cormand B</span>, <span class="author">Alvarez-Sabin J</span>, <span class="author">Montaner J</span>, <span class="author">Ferrari M</span>, <span class="author">van den Maagdenberg A</span>, <span class="author">Palotie A</span>, <span class="author">Zwart J</span>, <span class="author">Macaya A</span>, <span class="author">Terwindt G</span> and <span class="author">Pozo-Rosich P</span></p>
<p class="affiliation">Department of Neurology, Leiden University Medical Center (LUMC), the Netherlands Department of Psychiatry, Leiden University Medical Center (LUMC), the Netherlands.</p><p class="abstract"><strong>Introduction</strong>: Chronic migraine (CM) is at the severe end of the clinical migraine spectrum, but its genetic background is unknown. Our study searched for evidence that genetic factors are involved in the chronification process.</p><p class="abstract"><strong>Methods</strong>: We initially selected 144 single-nucleotide polymorphisms (SNPs) from 48 candidate genes, which we tested for association in two stages: The first stage encompassed 262 CM patients, the second investigated 226 patients with high-frequency migraine (HFM). Subsequently, SNPs with p values&thinsp;&lt;&thinsp;0.05 were forwarded to the replication stage containing 531 patients with CM or HFM.</p><p class="abstract"><strong>Results</strong>: Eight SNPs were significantly associated with CM and HFM in the two-stage phase. None survived replication in the third stage.</p><p class="abstract"><strong>Discussion</strong>: We present the first comprehensive genetic association study for migraine chronification. There were no significant findings. Future studies may benefit from larger, genome-wide data sets or should use other genetic approaches to identify genetic factors involved in migraine chronification.</p>
<p class="publication"><span class="title">Cephalalgia : an international journal of headache</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25169732">25169732</a>; DOI: <a href="http://dx.doi.org/10.1177%2F0333102414547141">10.1177/0333102414547141</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">A proteomic chronology of gene expression through the cell cycle in human myeloid leukemia cells.</h4>
<p class="authors"><span class="author">Ly T</span>, <span class="author">Ahmad Y</span>, <span class="author">Shlien A</span>, <span class="author">Soroka D</span>, <span class="author">Mills A</span>, <span class="author">Emanuele MJ</span>, <span class="author">Stratton MR</span> and <span class="author">Lamond AI</span></p>
<p class="affiliation">Centre for Gene Regulation and Expression, College of Life Sciences, University of Dundee, Dundee, United Kingdom.</p><p class="abstract">Technological advances have enabled the analysis of cellular protein and RNA levels with unprecedented depth and sensitivity, allowing for an unbiased re-evaluation of gene regulation during fundamental biological processes. Here, we have chronicled the dynamics of protein and mRNA expression levels across a minimally perturbed cell cycle in human myeloid leukemia cells using centrifugal elutriation combined with mass spectrometry-based proteomics and RNA-Seq, avoiding artificial synchronization procedures. We identify myeloid-specific gene expression and variations in protein abundance, isoform expression and phosphorylation at different cell cycle stages. We dissect the relationship between protein and mRNA levels for both bulk gene expression and for over &sim;6000 genes individually across the cell cycle, revealing complex, gene-specific patterns. This data set, one of the deepest surveys to date of gene expression in human cells, is presented in an online, searchable database, the Encyclopedia of Proteome Dynamics (http://www.peptracker.com/epd/). DOI: http://dx.doi.org/10.7554/eLife.01630.001.</p>
<p class="publication"><span class="title">eLife</span>&nbsp;<span class="year">2014</span>;<span class="volume">3</span>;<span class="pagerange">e01630</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24596151">24596151</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC3936288">3936288</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Barriers to the effective treatment of sepsis: antimicrobial agents, sepsis definitions, and host-directed therapies.</h4>
<p class="authors"><span class="author">Lyle NH</span>, <span class="author">Pena OM</span>, <span class="author">Boyd JH</span> and <span class="author">Hancock RE</span></p>
<p class="affiliation">Centre for Microbial Diseases and Immunity Research, University of British Columbia, Vancouver, British Columbia, Canada.</p><p class="abstract">Sepsis is a complex clinical syndrome involving both infection and a deleterious host immune response. Antimicrobial agents are key elements of sepsis treatment, yet despite great strides in antimicrobial development in the last decades, sepsis continues to be associated with unacceptably high mortality (&sim;30%). This is the result, on one hand, of the rise of antimicrobial resistant organisms and, on the other hand, of the dearth of effective host-directed immune therapies. A major obstacle to the development of good host-directed therapies is the lack of understanding of the host immune response. The problem is exacerbated by poor nonspecific clinical definitions of disease. Poor definitions have had a profound impact on sepsis research, from epidemiologic studies to the failed clinical trials of host-directed therapies. Therefore, better definitions must be developed to enable advancement in the field.</p>
<p class="publication"><span class="title">Annals of the New York Academy of Sciences</span>&nbsp;<span class="year">2014</span>;<span class="volume">1323</span>;<span class="number">1</span>;<span class="pagerange">101-14</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24797961">24797961</a>; DOI: <a href="http://dx.doi.org/10.1111%2Fnyas.12444">10.1111/nyas.12444</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma.</h4>
<p class="authors"><span class="author">M&uuml;ller J</span>, <span class="author">Krijgsman O</span>, <span class="author">Tsoi J</span>, <span class="author">Robert L</span>, <span class="author">Hugo W</span>, <span class="author">Song C</span>, <span class="author">Kong X</span>, <span class="author">Possik PA</span>, <span class="author">Cornelissen-Steijger PD</span>, <span class="author">Foppen MH</span>, <span class="author">Kemper K</span>, <span class="author">Goding CR</span>, <span class="author">McDermott U</span>, <span class="author">Blank C</span>, <span class="author">Haanen J</span>, <span class="author">Graeber TG</span>, <span class="author">Ribas A</span>, <span class="author">Lo RS</span> and <span class="author">Peeper DS</span></p>
<p class="affiliation">Division of Molecular Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066CX Amsterdam, The Netherlands.</p><p class="abstract">Increased expression of the Microphthalmia-associated transcription factor (MITF) contributes to melanoma progression and resistance to BRAF pathway inhibition. Here we show that the lack of MITF is associated with more severe resistance to a range of inhibitors, while its presence is required for robust drug responses. Both in primary and acquired resistance, MITF levels inversely correlate with the expression of several activated receptor tyrosine kinases, most frequently AXL. The MITF-low/AXL-high/drug-resistance phenotype is common among mutant BRAF and NRAS melanoma cell lines. The dichotomous behaviour of MITF in drug response is corroborated in vemurafenib-resistant biopsies, including MITF-high and -low clones in a relapsed patient. Furthermore, drug cocktails containing AXL inhibitor enhance melanoma cell elimination by BRAF or ERK inhibition. Our results demonstrate that a low MITF/AXL ratio predicts early resistance to multiple targeted drugs, and warrant clinical validation of AXL inhibitors to combat resistance of BRAF and NRAS mutant MITF-low melanomas.</p>
<p class="publication"><span class="title">Nature communications</span>&nbsp;<span class="year">2014</span>;<span class="volume">5</span>;<span class="pagerange">5712</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25502142">25502142</a>; DOI: <a href="http://dx.doi.org/10.1038%2Fncomms6712">10.1038/ncomms6712</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Cloning of recombinant monoclonal antibodies from hybridomas in a single mammalian expression plasmid.</h4>
<p class="authors"><span class="author">M&uuml;ller-Sienerth N</span>, <span class="author">Crosnier C</span>, <span class="author">Wright GJ</span> and <span class="author">Staudt N</span></p>
<p class="affiliation">Cell Surface Signalling Laboratory, Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK.</p><p class="abstract">Antibodies are an integral part of biological and medical research. In addition, immunoglobulins are used in many diagnostic tests and are becoming increasingly important in the therapy of diseases. To express antibodies recombinantly, the immunoglobulin heavy and light chains are usually cloned into two different expression plasmids. Here, we describe a method for recombinant antibody expression from a single plasmid.</p>
<p class="publication"><span class="title">Methods in molecular biology (Clifton, N.J.)</span>&nbsp;<span class="year">2014</span>;<span class="volume">1131</span>;<span class="pagerange">229-40</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24515469">24515469</a>; DOI: <a href="http://dx.doi.org/10.1007%2F978-1-62703-992-5_14">10.1007/978-1-62703-992-5_14</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Guidelines for investigating causality of sequence variants in human disease.</h4>
<p class="authors"><span class="author">MacArthur DG</span>, <span class="author">Manolio TA</span>, <span class="author">Dimmock DP</span>, <span class="author">Rehm HL</span>, <span class="author">Shendure J</span>, <span class="author">Abecasis GR</span>, <span class="author">Adams DR</span>, <span class="author">Altman RB</span>, <span class="author">Antonarakis SE</span>, <span class="author">Ashley EA</span>, <span class="author">Barrett JC</span>, <span class="author">Biesecker LG</span>, <span class="author">Conrad DF</span>, <span class="author">Cooper GM</span>, <span class="author">Cox NJ</span>, <span class="author">Daly MJ</span>, <span class="author">Gerstein MB</span>, <span class="author">Goldstein DB</span>, <span class="author">Hirschhorn JN</span>, <span class="author">Leal SM</span>, <span class="author">Pennacchio LA</span>, <span class="author">Stamatoyannopoulos JA</span>, <span class="author">Sunyaev SR</span>, <span class="author">Valle D</span>, <span class="author">Voight BF</span>, <span class="author">Winckler W</span> and <span class="author">Gunter C</span></p>
<p class="affiliation">1] Analytic and Translational Genetics Unit, Massachusetts General Hospital, Boston, Massachusetts 02114, USA [2] Program in Medical and Population Genetics, Broad Institute of Harvard and MIT, Cambridge, Massachusetts 02142, USA.</p><p class="abstract">The discovery of rare genetic variants is accelerating, and clear guidelines for distinguishing disease-causing sequence variants from the many potentially functional variants present in any human genome are urgently needed. Without rigorous standards we risk an acceleration of false-positive reports of causality, which would impede the translation of genomic research findings into the clinical diagnostic setting and hinder biological understanding of disease. Here we discuss the key challenges of assessing sequence variants in human disease, integrating both gene-level and variant-level support for causality. We propose guidelines for summarizing confidence in variant pathogenicity and highlight several areas that require further resource development.</p>
<p class="publication"><span class="title">Nature</span>&nbsp;<span class="year">2014</span>;<span class="volume">508</span>;<span class="number">7497</span>;<span class="pagerange">469-76</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24759409">24759409</a>; DOI: <a href="http://dx.doi.org/10.1038%2Fnature13127">10.1038/nature13127</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">The rate of nonallelic homologous recombination in males is highly variable, correlated between monozygotic twins and independent of age.</h4>
<p class="authors"><span class="author">MacArthur JA</span>, <span class="author">Spector TD</span>, <span class="author">Lindsay SJ</span>, <span class="author">Mangino M</span>, <span class="author">Gill R</span>, <span class="author">Small KS</span> and <span class="author">Hurles ME</span></p>
<p class="affiliation">Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, United Kingdom.</p><p class="abstract">Nonallelic homologous recombination (NAHR) between highly similar duplicated sequences generates chromosomal deletions, duplications and inversions, which can cause diverse genetic disorders. Little is known about interindividual variation in NAHR rates and the factors that influence this. We estimated the rate of deletion at the CMT1A-REP NAHR hotspot in sperm DNA from 34 male donors, including 16 monozygotic (MZ) co-twins (8 twin pairs) aged 24 to 67 years old. The average NAHR rate was 3.5 &times; 10(-5) with a seven-fold variation across individuals. Despite good statistical power to detect even a subtle correlation, we observed no relationship between age of unrelated individuals and the rate of NAHR in their sperm, likely reflecting the meiotic-specific origin of these events. We then estimated the heritability of deletion rate by calculating the intraclass correlation (ICC) within MZ co-twins, revealing a significant correlation between MZ co-twins (ICC = 0.784, p = 0.0039), with MZ co-twins being significantly more correlated than unrelated pairs. We showed that this heritability cannot be explained by variation in PRDM9, a known regulator of NAHR, or variation within the NAHR hotspot itself. We also did not detect any correlation between Body Mass Index (BMI), smoking status or alcohol intake and rate of NAHR. Our results suggest that other, as yet unidentified, genetic or environmental factors play a significant role in the regulation of NAHR and are responsible for the extensive variation in the population for the probability of fathering a child with a genomic disorder resulting from a pathogenic deletion.</p>
<p class="grants">Funded by: Wellcome Trust: <span class="grant">077014/Z/05/Z</span></p>
<p class="publication"><span class="title">PLoS genetics</span>&nbsp;<span class="year">2014</span>;<span class="volume">10</span>;<span class="number">3</span>;<span class="pagerange">e1004195</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24603440">24603440</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC3945173">3945173</a>; DOI: <a href="http://dx.doi.org/10.1371%2Fjournal.pgen.1004195">10.1371/journal.pgen.1004195</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Single cell genomics: advances and future perspectives.</h4>
<p class="authors"><span class="author">Macaulay IC</span> and <span class="author">Voet T</span></p>
<p class="affiliation">Single Cell Genomics Centre, Wellcome Trust Sanger Institute, Hinxton, Cambridge, United Kingdom.</p>
<p class="abstract">Advances in whole-genome and whole-transcriptome amplification have permitted the sequencing of the minute amounts of DNA and RNA present in a single cell, offering a window into the extent and nature of genomic and transcriptomic heterogeneity which occurs in both normal development and disease. Single-cell approaches stand poised to revolutionise our capacity to understand the scale of genomic, epigenomic, and transcriptomic diversity that occurs during the lifetime of an individual organism. Here, we review the major technological and biological breakthroughs achieved, describe the remaining challenges to overcome, and provide a glimpse into the promise of recent and future developments.</p>
<p class="publication"><span class="title">PLoS genetics</span>&nbsp;<span class="year">2014</span>;<span class="volume">10</span>;<span class="number">1</span>;<span class="pagerange">e1004126</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24497842">24497842</a>; DOI: <a href="http://dx.doi.org/10.1371%2Fjournal.pgen.1004126">10.1371/journal.pgen.1004126</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Evidence for camel-to-human transmission of MERS coronavirus.</h4>
<p class="authors"><span class="author">Madani TA</span>, <span class="author">Azhar EI</span> and <span class="author">Hashem AM</span></p>
<p class="publication"><span class="title">The New England journal of medicine</span>&nbsp;<span class="year">2014</span>;<span class="volume">371</span>;<span class="number">14</span>;<span class="pagerange">1360</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25271614">25271614</a>; DOI: <a href="http://dx.doi.org/10.1056%2FNEJMc1409847">10.1056/NEJMc1409847</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Targeting of Slc25a21 Is Associated with Orofacial Defects and Otitis Media Due to Disrupted Expression of a Neighbouring Gene.</h4>
<p class="authors"><span class="author">Maguire S</span>, <span class="author">Estabel J</span>, <span class="author">Ingham N</span>, <span class="author">Pearson S</span>, <span class="author">Ryder E</span>, <span class="author">Carragher DM</span>, <span class="author">Walker N</span>, <span class="author">Sanger MGP Slc25a21 Project Team</span>, <span class="author">Bussell J</span>, <span class="author">Chan WI</span>, <span class="author">Keane TM</span>, <span class="author">Adams DJ</span>, <span class="author">Scudamore CL</span>, <span class="author">Lelliott CJ</span>, <span class="author">Ram&iacute;rez-Solis R</span>, <span class="author">Karp NA</span>, <span class="author">Steel KP</span>, <span class="author">White JK</span> and <span class="author">Gerdin AK</span></p>
<p class="affiliation">Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire, United Kingdom.</p><p class="abstract">Homozygosity for Slc25a21tm1a(KOMP)Wtsi results in mice exhibiting orofacial abnormalities, alterations in carpal and rugae structures, hearing impairment and inflammation in the middle ear. In humans it has been hypothesised that the 2-oxoadipate mitochondrial carrier coded by SLC25A21 may be involved in the disease 2-oxoadipate acidaemia. Unexpectedly, no 2-oxoadipate acidaemia-like symptoms were observed in animals homozygous for Slc25a21tm1a(KOMP)Wtsi despite confirmation that this allele reduces Slc25a21 expression by 71.3%. To study the complete knockout, an allelic series was generated using the loxP and FRT sites typical of a Knockout Mouse Project allele. After removal of the critical exon and neomycin selection cassette, Slc25a21 knockout mice homozygous for the Slc25a21tm1b(KOMP)Wtsi and Slc25a21tm1d(KOMP)Wtsi alleles were phenotypically indistinguishable from wild-type. This led us to explore the genomic environment of Slc25a21 and to discover that expression of Pax9, located 3&#39; of the target gene, was reduced in homozygous Slc25a21tm1a(KOMP)Wtsi mice. We hypothesize that the presence of the selection cassette is the cause of the down regulation of Pax9 observed. The phenotypes we observed in homozygous Slc25a21tm1a(KOMP)Wtsi mice were broadly consistent with a hypomorphic Pax9 allele with the exception of otitis media and hearing impairment which may be a novel consequence of Pax9 down regulation. We explore the ramifications associated with this particular targeted mutation and emphasise the need to interpret phenotypes taking into consideration all potential underlying genetic mechanisms.</p>
<p class="publication"><span class="title">PloS one</span>&nbsp;<span class="year">2014</span>;<span class="volume">9</span>;<span class="number">3</span>;<span class="pagerange">e91807</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24642684">24642684</a>; DOI: <a href="http://dx.doi.org/10.1371%2Fjournal.pone.0091807">10.1371/journal.pone.0091807</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Single-cell RNA sequencing reveals T helper cells synthesizing steroids de novo to contribute to immune homeostasis.</h4>
<p class="authors"><span class="author">Mahata B</span>, <span class="author">Zhang X</span>, <span class="author">Kolodziejczyk AA</span>, <span class="author">Proserpio V</span>, <span class="author">Haim-Vilmovsky L</span>, <span class="author">Taylor AE</span>, <span class="author">Hebenstreit D</span>, <span class="author">Dingler FA</span>, <span class="author">Moignard V</span>, <span class="author">G&ouml;ttgens B</span>, <span class="author">Arlt W</span>, <span class="author">McKenzie AN</span> and <span class="author">Teichmann SA</span></p>
<p class="affiliation">EMBL-European Bioinformatics Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1SD, UK; MRC Laboratory of Molecular Biology, Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 OQH, UK; Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1SA, UK. Electronic address: <a href="mailto:%62%6D%31%31%40%73%61%6E%67%65%72.%61%63.%75%6B">&#98;&#109;&#49;&#49;&#64;&#115;&#97;&#110;&#103;&#101;&#114;&#46;&#97;&#99;&#46;&#117;&#107;</a>.</p><p class="abstract">T helper 2 (Th2) cells regulate helminth infections, allergic disorders, tumor immunity, and pregnancy by secreting various cytokines. It is likely that there are undiscovered Th2 signaling molecules. Although steroids are known to be immunoregulators, de novo steroid production from immune cells has not been previously characterized. Here, we demonstrate production of the steroid pregnenolone by Th2 cells in vitro and in vivo in a helminth infection model. Single-cell RNA sequencing and quantitative PCR analysis suggest that pregnenolone synthesis in Th2 cells is related to immunosuppression. In support of this, we show that pregnenolone inhibits Th cell proliferation and B cell immunoglobulin class switching. We also show that steroidogenic Th2 cells inhibit Th cell proliferation in a Cyp11a1 enzyme-dependent manner. We propose pregnenolone as a &quot;lymphosteroid,&quot; a steroid produced by lymphocytes. We speculate that this de novo steroid production may be an intrinsic phenomenon of Th2-mediated immune responses to actively restore immune homeostasis.</p>
<p class="grants">Funded by: Biotechnology and Biological Sciences Research Council: <span class="grant">BB/L006340/1</span>; Medical Research Council: <span class="grant">G0801473</span>, <span class="grant">MC_U105161047</span>, <span class="grant">MC_U105178805</span>; Wellcome Trust</p>
<p class="publication"><span class="title">Cell reports</span>&nbsp;<span class="year">2014</span>;<span class="volume">7</span>;<span class="number">4</span>;<span class="pagerange">1130-42</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24813893">24813893</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4039991">4039991</a>; DOI: <a href="http://dx.doi.org/10.1016%2Fj.celrep.2014.04.011">10.1016/j.celrep.2014.04.011</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">A 2.5 kb deletion contaning a cluster of nine microRNAs in the LAT locus of the pseudorabies virus affects the host response of porcine trigeminal ganglia during established latency.</h4>
<p class="authors"><span class="author">Mahjoub N</span>, <span class="author">Dhorne-Pollet S</span>, <span class="author">Fuchs W</span>, <span class="author">Endale Ahanda ML</span>, <span class="author">Lange E</span>, <span class="author">Klupp B</span>, <span class="author">Arya A</span>, <span class="author">Loveland JE</span>, <span class="author">Lefevre F</span>, <span class="author">Mettenleiter TC</span> and <span class="author">Giuffra E</span></p>
<p class="affiliation">INRA, AgroParisTech, UMR1313 Animal Genetics and Integrative Biology, Jouy-en-Josas, France CEA, DSV, IRCM, SREIT, LREG, INRA Jouy-en-Josas, France.</p><p class="abstract">The alphaherpesvirus Pseudorabies virus (PrV) establishes latency primarily in neurons of trigeminal ganglia when only transcription of the latency-associated transcript (LAT) locus is detected. Eleven microRNAs (miRNAs) cluster within LAT, suggesting a role in establishment and/or maintenance of latency. We generated a mutant PrV (M) deleted of nine miRNA genes which displayed almost identical properties with the parental PrV (WT) during propagation in vitro. Fifteen pigs were experimentally infected with either WT, M or mock infected. Similar levels of virus excretion and host antibody response were observed in all infected animals. At 62 days post infection trigeminal ganglia were excised and profiled by deep sequencing and RT-qPCR. Latency was established in all infected animals without evidence of viral reactivation demonstrating that miRNAs are not mandatory for this process. Lower levels of Large Latency Transcript (LLT) were found in ganglia infected by M compared to WT PrV. All PrV miRNAs were expressed, with highest expression found for prv-miR-LLT1, prv-miR-LLT2 (in WT-ganglia) and prv-miR-LLT10 (in both WT and M-ganglia). No evidence of differentially expressed porcine miRNAs was found. Fifty-four porcine genes were differentially expressed between WT, M and control ganglia. Both viruses triggered a strong host immune response, but in M- ganglia gene upregulation was prevalent. Pathway analyses indicated that several biofunctions, including those related to cell-mediated immune response and migration of dendritic cells, were impaired in M- ganglia. These findings are consistent with a function of the LAT locus in the modulation of host response for maintaining a latent state.</p><p class="abstract"><strong>Importance</strong>: This study provides a thorough reference on the establishment of latency by PrV in its natural host, the pig. Our results corroborate the evidence obtained from the study of several LAT mutants of other alphaherpesviruses encoding miRNAs from their LAT regions. Neither PrV miRNA expression nor high LLT expression levels are essential to achieve latency in trigeminal ganglia. Once latency is established by PrV the only remarkable differences are found in the pattern of host response. This indicates that, LAT functions as an immune evasion locus.</p>
<p class="publication"><span class="title">Journal of virology</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25320324">25320324</a>; DOI: <a href="http://dx.doi.org/10.1128%2FJVI.02181-14">10.1128/JVI.02181-14</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Glucose-6-phosphate dehydrogenase polymorphisms and susceptibility to mild malaria in Dogon and Fulani, Mali.</h4>
<p class="authors"><span class="author">Maiga B</span>, <span class="author">Dolo A</span>, <span class="author">Campino S</span>, <span class="author">Sepulveda N</span>, <span class="author">Corran P</span>, <span class="author">Rockett KA</span>, <span class="author">Troye-Blomberg M</span>, <span class="author">Doumbo OK</span> and <span class="author">Clark TG</span></p>
<p class="affiliation">Malaria Research and Training Centre, Department of Epidemiology of Parasitic Diseases, Faculty of Medicine, Pharmacy and Odonto - Stomatology, USTTB, BP 1805 Bamako, Mali. <a href="mailto:%62%6D%61%69%67%61%40%69%63%65%72%6D%61%6C%69.%6F%72%67">&#98;&#109;&#97;&#105;&#103;&#97;&#64;&#105;&#99;&#101;&#114;&#109;&#97;&#108;&#105;&#46;&#111;&#114;&#103;</a>.</p><p class="abstract"><strong>Background</strong>: Glucose-6-phosphate dehydrogenase (G6PD) deficiency is associated with protection from severe malaria, and potentially uncomplicated malaria phenotypes. It has been documented that G6PD deficiency in sub-Saharan Africa is due to the 202A/376G G6PD A-allele, and association studies have used genotyping as a convenient technique for epidemiological studies. However, recent studies have shown discrepancies in G6PD202/376 associations with severe malaria. There is evidence to suggest that other G6PD deficiency alleles may be common in some regions of West Africa, and that allelic heterogeneity could explain these discrepancies.</p><p class="abstract"><strong>Methods</strong>: A cross-sectional epidemiological study of malaria susceptibility was conducted during 2006 and 2007 in the Sahel meso-endemic malaria zone of Mali. The study included Dogon (n&thinsp;=&thinsp;375) and Fulani (n&thinsp;=&thinsp;337) sympatric ethnic groups, where the latter group is characterized by lower susceptibility to Plasmodium falciparum malaria. Fifty-three G6PD polymorphisms, including 202/376, were genotyped across the 712 samples. Evidence of association of these G6PD polymorphisms and mild malaria was assessed in both ethnic groups using genotypic and haplotypic statistical tests.</p><p class="abstract"><strong>Results</strong>: It was confirmed that the Fulani are less susceptible to malaria, and the 202A mutation is rare in this group (&lt;&thinsp;1% versus Dogon 7.9%). The Betica-Selma 968C/376G (~11% enzymatic activity) was more common in Fulani (6.1% vs Dogon 0.0%). There are differences in haplotype frequencies between Dogon and Fulani, and association analysis did not reveal strong evidence of protective G6PD genetic effects against uncomplicated malaria in both ethnic groups and gender. However, there was some evidence of increased risk of mild malaria in Dogon with the 202A mutation, attaining borderline statistical significance in females. The rs915942 polymorphism was found to be associated with asymptomatic malaria in Dogon females, and the rs61042368 polymorphism was associated with clinical malaria in Fulani males.</p><p class="abstract"><strong>Conclusions</strong>: The results highlight the need to consider markers in addition to G6PD202 in studies of deficiency. Further, large genetic epidemiological studies of multi-ethnic groups in West Africa across a spectrum of malaria severity phenotypes are required to establish who receives protection from G6PD deficiency.</p>
<p class="publication"><span class="title">Malaria journal</span>&nbsp;<span class="year">2014</span>;<span class="volume">13</span>;<span class="number">1</span>;<span class="pagerange">270</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25015414">25015414</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4110528">4110528</a>; DOI: <a href="http://dx.doi.org/10.1186%2F1475-2875-13-270">10.1186/1475-2875-13-270</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Fc gamma Receptor IIa-H131R Polymorphism and Malaria Susceptibility in Sympatric Ethnic Groups, Fulani and Dogon of Mali.</h4>
<p class="authors"><span class="author">Maiga B</span>, <span class="author">Dolo A</span>, <span class="author">Tour&eacute; O</span>, <span class="author">Dara V</span>, <span class="author">Tapily A</span>, <span class="author">Campino S</span>, <span class="author">Sepulveda N</span>, <span class="author">Corran P</span>, <span class="author">Rockett K</span>, <span class="author">Clark TG</span>, <span class="author">Troye Blomberg M</span> and <span class="author">Doumbo OK</span></p>
<p class="affiliation">Malaria Research and Training Center/Department of Epidemiology of Parasitic Diseases/Faculty of Medicine, Pharmacy and Odonto - Stomatology, Bamako/USTTB, Mali; Department of Molecular Biosciences, The Wenner-Gren Institute, Stockholm University, Stockholm, Sweden.</p>
<p class="abstract">It has been previously shown that there are some interethnic differences in susceptibility to malaria between two sympatric ethnic groups of Mali, the Fulani and the Dogon. The lower susceptibility to Plasmodium falciparum malaria seen in the Fulani has not been fully explained by genetic polymorphisms previously known to be associated with malaria resistance, including haemoglobin S (HbS), haemoglobin C (HbC), alpha-thalassaemia and glucose-6-phosphate dehydrogenase (G6PD) deficiency. Given the observed differences in the distribution of FcRIIa allotypes among different ethnic groups and with malaria susceptibility that have been reported, we analysed the rs1801274-R131H polymorphism in the FcRIIa gene in a study of Dogon and Fulani in Mali (n=939). We confirm that the Fulani have less parasite densities, less parasite prevalence, more spleen enlargement and higher levels of total IgG antibodies (anti-CSP, anti-AMA1, anti-MSP1 and anti-MSP2) and more total IgE (P<0.05) compared with the Dogon ethnic group. Furthermore, the Fulani exhibit higher frequencies of the blood group O (56.5%) compared with the Dogon (43.5%) (P<0.001). With regard to the FcRIIa polymorphism and allele frequency, the Fulani group have a higher frequency of the H allele (Fulani 0.474, Dogon 0.341, P<0.0001), which was associated with greater total IgE production (P=0.004). Our findings show that the FcRIIa polymorphism might have an implication in the relative protection seen in the Fulani tribe, with confirmatory studies required in other malaria endemic settings.</p>
<p class="publication"><span class="title">Scandinavian journal of immunology</span>&nbsp;<span class="year">2014</span>;<span class="volume">79</span>;<span class="number">1</span>;<span class="pagerange">43-50</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24117665">24117665</a>; DOI: <a href="http://dx.doi.org/10.1111%2Fsji.12122">10.1111/sji.12122</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Characterization of Vibrio cholerae bacteriophages isolated from the environmental waters of the Lake Victoria region of Kenya.</h4>
<p class="authors"><span class="author">Maina AN</span>, <span class="author">Mwaura FB</span>, <span class="author">Oyugi J</span>, <span class="author">Goulding D</span>, <span class="author">Toribio AL</span> and <span class="author">Kariuki S</span></p>
<p class="affiliation">School of Biological Sciences, University of Nairobi, Nairobi, Kenya, <a href="mailto:%6E%79%61%6D%62%75%72%61%67%69%63%68%75%68%69%40%67%6D%61%69%6C.%63%6F%6D">&#110;&#121;&#97;&#109;&#98;&#117;&#114;&#97;&#103;&#105;&#99;&#104;&#117;&#104;&#105;&#64;&#103;&#109;&#97;&#105;&#108;&#46;&#99;&#111;&#109;</a>.</p><p class="abstract">Over the last decade, cholera outbreaks have become common in some parts of Kenya. The most recent cholera outbreak occurred in Coastal and Lake Victoria region during January 2009 and May 2010, where a total of 11,769 cases and 274 deaths were reported by the Ministry of Public Health and Sanitation. The objective of this study is to isolate Vibrio cholerae bacteriophages from the environmental waters of the Lake Victoria region of Kenya with potential for use as a biocontrol for cholera outbreaks. Water samples from wells, ponds, sewage effluent, boreholes, rivers, and lakes of the Lake Victoria region of Kenya were enriched for 48&nbsp;h at 37&nbsp;&deg;C in broth containing a an environmental strain of V. cholerae. Bacteriophages were isolated from 5 out of the 42 environmental water samples taken. Isolated phages produced tiny, round, and clear plaques suggesting that these phages were lytic to V. cholerae. Transmission electron microscope examination revealed that all the nine phages belonged to the family Myoviridae, with typical icosahedral heads, long contractile tails, and fibers. Head had an average diameter of 88.3&nbsp;nm and tail of length and width 84.9 and 16.1&nbsp;nm, respectively. Vibriophages isolated from the Lake Victoria region of Kenya have been characterized and the isolated phages may have a potential to be used as antibacterial agents to control pathogenic V. cholerae bacteria in water reservoirs.</p>
<p class="publication"><span class="title">Current microbiology</span>&nbsp;<span class="year">2014</span>;<span class="volume">68</span>;<span class="number">1</span>;<span class="pagerange">64-70</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/23982202">23982202</a>; DOI: <a href="http://dx.doi.org/10.1007%2Fs00284-013-0447-x">10.1007/s00284-013-0447-x</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Mutation in KERA Identified by Linkage Analysis and Targeted Resequencing in a Pedigree with Premature Atherosclerosis.</h4>
<p class="authors"><span class="author">Maiwald S</span>, <span class="author">Sivapalaratnam S</span>, <span class="author">Motazacker MM</span>, <span class="author">van Capelleveen JC</span>, <span class="author">Bot I</span>, <span class="author">de Jager SC</span>, <span class="author">van Eck M</span>, <span class="author">Jolley J</span>, <span class="author">Kuiper J</span>, <span class="author">Stephens J</span>, <span class="author">Albers CA</span>, <span class="author">Vosmeer CR</span>, <span class="author">Kruize H</span>, <span class="author">Geerke DP</span>, <span class="author">van der Wal AC</span>, <span class="author">van der Loos CM</span>, <span class="author">Kastelein JJ</span>, <span class="author">Trip MD</span>, <span class="author">Ouwehand WH</span>, <span class="author">Dallinga-Thie GM</span> and <span class="author">Hovingh GK</span></p>
<p class="affiliation">Department of Vascular Medicine, Academic Medical Centre, Amsterdam, the Netherlands; Department of Experimental Vascular Medicine, Academic Medical Centre, Amsterdam, the Netherlands.</p><p class="abstract"><strong>Aims</strong>: Genetic factors explain a proportion of the inter-individual variation in the risk for atherosclerotic events, but the genetic basis of atherosclerosis and atherothrombosis in families with Mendelian forms of premature atherosclerosis is incompletely understood. We set out to unravel the molecular pathology in a large kindred with an autosomal dominant inherited form of premature atherosclerosis.</p><p class="abstract">Parametric linkage analysis was performed in a pedigree comprising 4 generations, of which a total of 11 members suffered from premature vascular events. A parametric LOD-score of 3.31 was observed for a 4.4 Mb interval on chromosome 12. Upon sequencing, a non-synonymous variant in KERA (c.920C&gt;G; p.Ser307Cys) was identified. The variant was absent from nearly 28,000 individuals, including 2,571 patients with premature atherosclerosis. KERA, a proteoglycan protein, was expressed in lipid-rich areas of human atherosclerotic lesions, but not in healthy arterial specimens. Moreover, KERA expression in plaques was significantly associated with plaque size in a carotid-collar Apoe-/- mice (r2&#x200A;=&#x200A;0.69; p&lt;0.0001).</p><p class="abstract"><strong>Conclusion</strong>: A rare variant in KERA was identified in a large kindred with premature atherosclerosis. The identification of KERA in atherosclerotic plaque specimen in humans and mice lends support to its potential role in atherosclerosis.</p>
<p class="publication"><span class="title">PloS one</span>&nbsp;<span class="year">2014</span>;<span class="volume">9</span>;<span class="number">5</span>;<span class="pagerange">e98289</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24879339">24879339</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4039470">4039470</a>; DOI: <a href="http://dx.doi.org/10.1371%2Fjournal.pone.0098289">10.1371/journal.pone.0098289</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Reappraisal of known malaria resistance loci in a large multicenter study.</h4>
<p class="authors"><span class="author">Malaria Genomic Epidemiology Network</span> and <span class="author">Malaria Genomic Epidemiology Network</span></p><p class="abstract">Many human genetic associations with resistance to malaria have been reported, but few have been reliably replicated. We collected data on 11,890 cases of severe malaria due to Plasmodium falciparum and 17,441 controls from 12 locations in Africa, Asia and Oceania. We tested 55 SNPs in 27 loci previously reported to associate with severe malaria. There was evidence of association at P &lt; 1 &times; 10(-4) with the HBB, ABO, ATP2B4, G6PD and CD40LG loci, but previously reported associations at 22 other loci did not replicate in the multicenter analysis. The large sample size made it possible to identify authentic genetic effects that are heterogeneous across populations or phenotypes, with a striking example being the main African form of G6PD deficiency, which reduced the risk of cerebral malaria but increased the risk of severe malarial anemia. The finding that G6PD deficiency has opposing effects on different fatal complications of P. falciparum infection indicates that the evolutionary origins of this common human genetic disorder are more complex than previously supposed.</p>
<p class="publication"><span class="title">Nature genetics</span>&nbsp;<span class="year">2014</span>;<span class="volume">46</span>;<span class="number">11</span>;<span class="pagerange">1197-204</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25261933">25261933</a>; DOI: <a href="http://dx.doi.org/10.1038%2Fng.3107">10.1038/ng.3107</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Driver somatic mutations identify distinct disease entities within myeloid neoplasms with myelodysplasia.</h4>
<p class="authors"><span class="author">Malcovati L</span>, <span class="author">Papaemmanuil E</span>, <span class="author">Ambaglio I</span>, <span class="author">Elena C</span>, <span class="author">Gall&igrave; A</span>, <span class="author">Della Porta MG</span>, <span class="author">Travaglino E</span>, <span class="author">Pietra D</span>, <span class="author">Pascutto C</span>, <span class="author">Ubezio M</span>, <span class="author">Bono E</span>, <span class="author">Da Vi&agrave; MC</span>, <span class="author">Brisci A</span>, <span class="author">Bruno F</span>, <span class="author">Cremonesi L</span>, <span class="author">Ferrari M</span>, <span class="author">Boveri E</span>, <span class="author">Invernizzi R</span>, <span class="author">Campbell PJ</span> and <span class="author">Cazzola M</span></p>
<p class="affiliation">Department of Molecular Medicine, University of Pavia, Pavia, Italy; <a href="mailto:%6C%75%63%61.%6D%61%6C%63%6F%76%61%74%69%40%75%6E%69%70%76.%69%74">&#108;&#117;&#99;&#97;&#46;&#109;&#97;&#108;&#99;&#111;&#118;&#97;&#116;&#105;&#64;&#117;&#110;&#105;&#112;&#118;&#46;&#105;&#116;</a>.</p><p class="abstract">Our knowledge of the genetic basis of myelodysplastic syndromes (MDS) and myelodysplastic/myeloproliferative neoplasms (MDS/MPN) has considerably improved. To define genotype/phenotype relationships of clinical relevance, we studied 308 patients with MDS, MDS/MPN or acute myeloid leukemia evolving from MDS. Unsupervised statistical analysis, including the World Health Organization (WHO) classification criteria and somatic mutations, showed that MDS associated with SF3B1-mutation (51/245 patients, 20.8%) is a distinct nosologic entity irrespective of current morphological classification criteria. Conversely, MDS with ring sideroblasts with nonmutated SF3B1 segregated in different clusters with other MDS subtypes. Mutations of genes involved DNA methylation, splicing factors other than SF3B1, and genes of the RAS pathway and cohesin complex were independently associated with multilineage dysplasia and identify a distinct subset (51/245 patients, 20.8%). No recurrent mutation pattern correlated with unilineage dysplasia without ring sideroblasts. Irrespective of driver somatic mutations, a threshold of 5% bone marrow blasts retained a significant discriminant value for identifying cases with clonal evolution. Co-mutation of TET2 and SRSF2 was highly predictive of a myeloid neoplasm characterized by myelodysplasia and monocytosis, including but not limited to chronic myelomonocytic leukemia. These results serve as a proof of concept that a molecular classification of myeloid neoplasms is feasible.</p>
<p class="publication"><span class="title">Blood</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24970933">24970933</a>; DOI: <a href="http://dx.doi.org/10.1182%2Fblood-2014-03-560227">10.1182/blood-2014-03-560227</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Absence of Appl2 sensitizes endotoxin shock through activation of PI3K/Akt pathway.</h4>
<p class="authors"><span class="author">Mao L</span>, <span class="author">Lin W</span>, <span class="author">Nie T</span>, <span class="author">Hui X</span>, <span class="author">Gao X</span>, <span class="author">Li K</span>, <span class="author">Ding M</span>, <span class="author">Tang X</span>, <span class="author">Li P</span>, <span class="author">Wang Y</span>, <span class="author">Xu A</span>, <span class="author">Liu P</span> and <span class="author">Wu D</span></p>
<p class="affiliation">Key Laboratory of Regenerative Biology, Guangzhou Institute of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, 510530 China.</p><p class="abstract"><strong>Background</strong>: The adapter proteins Appl1 (adaptor protein containing pleckstrin homology domain, phosphotyrosine domain, and leucine zipper motif 1) and Appl2 are highly homologous and involved in several signaling pathways. While previous studies have shown that Appl1 plays a pivotal role in adiponectin signaling and insulin secretion, the physiological functions of Appl2 are largely unknown.</p><p class="abstract"><strong>Results</strong>: In the present study, the role of Appl2 in sepsis shock was investigated by using Appl2 knockout (KO) mice. When challenged with lipopolysaccharides (LPS), Appl2 KO mice exhibited more severe symptoms of endotoxin shock, accompanied by increased production of proinflammatory cytokines. In comparison with the wild-type control, deletion of Appl2 led to higher levels of TNF-&alpha; and IL-1&beta; in primary macrophages. In addition, phosphorylation of Akt and its downstream effector NF-&kappa;B was significantly enhanced. By co-immunoprecipitation, we found that Appl2 and Appl1 interacted with each other and formed a complex with PI3K regulatory subunit p85&alpha;, which is an upstream regulator of Akt. Consistent with these results, deletion of Appl1 in macrophages exhibited characteristics of reduced Akt activation and decreased the production of TNF&alpha; and IL-1&beta; when challenged by LPS.</p><p class="abstract"><strong>Conclusions</strong>: Results of the present study demonstrated that Appl2 is a critical negative regulator of innate immune response via inhibition of PI3K/Akt/NF-&kappa;B signaling pathway by forming a complex with Appl1 and PI3K.</p>
<p class="publication"><span class="title">Cell &amp; bioscience</span>&nbsp;<span class="year">2014</span>;<span class="volume">4</span>;<span class="number">1</span>;<span class="pagerange">60</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25328665">25328665</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4201708">4201708</a>; DOI: <a href="http://dx.doi.org/10.1186%2F2045-3701-4-60">10.1186/2045-3701-4-60</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">The common marmoset genome provides insight into primate biology and evolution.</h4>
<p class="authors"><span class="author">Marmoset Genome Sequencing and Analysis Consortium</span></p><p class="abstract">We report the whole-genome sequence of the common marmoset (Callithrix jacchus). The 2.26-Gb genome of a female marmoset was assembled using Sanger read data (6&times;) and a whole-genome shotgun strategy. A first analysis has permitted comparison with the genomes of apes and Old World monkeys and the identification of specific features that might contribute to the unique biology of this diminutive primate, including genetic changes that may influence body size, frequent twinning and chimerism. We observed positive selection in growth hormone/insulin-like growth factor genes (growth pathways), respiratory complex I genes (metabolic pathways), and genes encoding immunobiological factors and proteases (reproductive and immunity pathways). In addition, both protein-coding and microRNA genes related to reproduction exhibited evidence of rapid sequence evolution. This genome sequence for a New World monkey enables increased power for comparative analyses among available primate genomes and facilitates biomedical research application.</p>
<p class="grants">Funded by: Howard Hughes Medical Institute; NHGRI NIH HHS: <span class="grant">K99 HG005846</span>, <span class="grant">R01 HG002385</span>, <span class="grant">U54 HG003079</span>, <span class="grant">U54 HG003273</span>; NIDDK NIH HHS: <span class="grant">R01 DK077639</span>; NIGMS NIH HHS: <span class="grant">R01 GM059290</span>; NIH HHS: <span class="grant">P51 OD011133</span></p>
<p class="publication"><span class="title">Nature genetics</span>&nbsp;<span class="year">2014</span>;<span class="volume">46</span>;<span class="number">8</span>;<span class="pagerange">850-7</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25038751">25038751</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4138798">4138798</a>; DOI: <a href="http://dx.doi.org/10.1038%2Fng.3042">10.1038/ng.3042</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Parallel dynamics and evolution: Protein conformational fluctuations and assembly reflect evolutionary changes in sequence and structure.</h4>
<p class="authors"><span class="author">Marsh JA</span> and <span class="author">Teichmann SA</span></p>
<p class="affiliation">European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK.</p>
<p class="abstract">Protein structure is dynamic: the intrinsic flexibility of polypeptides facilitates a range of conformational fluctuations, and individual protein chains can assemble into complexes. Proteins are also dynamic in evolution: significant variations in secondary, tertiary and quaternary structure can be observed among divergent members of a protein family. Recent work has highlighted intriguing similarities between these structural and evolutionary dynamics occurring at various levels. Here we review evidence showing how evolutionary changes in protein sequence and structure are often closely related to local protein flexibility and disorder, large-scale motions and quaternary structure assembly. We suggest that these correspondences can be largely explained by neutral evolution, while deviations between structural and evolutionary dynamics can provide valuable functional insights. Finally, we address future prospects for the field and practical applications that arise from a deeper understanding of the intimate relationship between protein structure, dynamics, function and evolution.</p>
<p class="publication"><span class="title">BioEssays : news and reviews in molecular, cellular and developmental biology</span>&nbsp;<span class="year">2014</span>;<span class="volume">36</span>;<span class="number">2</span>;<span class="pagerange">209-18</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24272815">24272815</a>; DOI: <a href="http://dx.doi.org/10.1002%2Fbies.201300134">10.1002/bies.201300134</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Mutations in PLK4, encoding a master regulator of centriole biogenesis, cause microcephaly, growth failure and retinopathy.</h4>
<p class="authors"><span class="author">Martin CA</span>, <span class="author">Ahmad I</span>, <span class="author">Klingseisen A</span>, <span class="author">Hussain MS</span>, <span class="author">Bicknell LS</span>, <span class="author">Leitch A</span>, <span class="author">N&uuml;rnberg G</span>, <span class="author">Toliat MR</span>, <span class="author">Murray JE</span>, <span class="author">Hunt D</span>, <span class="author">Khan F</span>, <span class="author">Ali Z</span>, <span class="author">Tinschert S</span>, <span class="author">Ding J</span>, <span class="author">Keith C</span>, <span class="author">Harley ME</span>, <span class="author">Heyn P</span>, <span class="author">M&uuml;ller R</span>, <span class="author">Hoffmann I</span>, <span class="author">Daire VC</span>, <span class="author">Dollfus H</span>, <span class="author">Dupuis L</span>, <span class="author">Bashamboo A</span>, <span class="author">McElreavey K</span>, <span class="author">Kariminejad A</span>, <span class="author">Mendoza-Londono R</span>, <span class="author">Moore AT</span>, <span class="author">Saggar A</span>, <span class="author">Schlechter C</span>, <span class="author">Weleber R</span>, <span class="author">Thiele H</span>, <span class="author">Altm&uuml;ller J</span>, <span class="author">H&ouml;hne W</span>, <span class="author">Hurles ME</span>, <span class="author">Noegel AA</span>, <span class="author">Baig SM</span>, <span class="author">N&uuml;rnberg P</span> and <span class="author">Jackson AP</span></p>
<p class="affiliation">Medical Research Council (MRC) Human Genetics Unit, Institute of Genetics and Molecular Medicine (IGMM), University of Edinburgh, Edinburgh, UK.</p><p class="abstract">Centrioles are essential for ciliogenesis. However, mutations in centriole biogenesis genes have been reported in primary microcephaly and Seckel syndrome, disorders without the hallmark clinical features of ciliopathies. Here we identify mutations in the genes encoding PLK4 kinase, a master regulator of centriole duplication, and its substrate TUBGCP6 in individuals with microcephalic primordial dwarfism and additional congenital anomalies, including retinopathy, thereby extending the human phenotypic spectrum associated with centriole dysfunction. Furthermore, we establish that different levels of impaired PLK4 activity result in growth and cilia phenotypes, providing a mechanism by which microcephaly disorders can occur with or without ciliopathic features.</p>
<p class="publication"><span class="title">Nature genetics</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25344692">25344692</a>; DOI: <a href="http://dx.doi.org/10.1038%2Fng.3122">10.1038/ng.3122</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Assessing multivariate gene-metabolome associations with rare variants using Bayesian reduced rank regression.</h4>
<p class="authors"><span class="author">Marttinen P</span>, <span class="author">Pirinen M</span>, <span class="author">Sarin AP</span>, <span class="author">Gillberg J</span>, <span class="author">Kettunen J</span>, <span class="author">Surakka I</span>, <span class="author">Kangas AJ</span>, <span class="author">Soininen P</span>, <span class="author">O&#39;Reilly PF</span>, <span class="author">Kaakinen M</span>, <span class="author">K&auml;h&ouml;nen M</span>, <span class="author">Lehtim&auml;ki T</span>, <span class="author">Ala-Korpela M</span>, <span class="author">Raitakari OT</span>, <span class="author">Salomaa V</span>, <span class="author">J&auml;rvelin MR</span>, <span class="author">Ripatti S</span> and <span class="author">Kaski S</span></p>
<p class="affiliation">Helsinki Institute for Information Technology HIIT, Department of Information and Computer Science, Aalto University, Finland, Center for Communicable Disease Dynamics, Harvard School of Public Health, Boston, MA, Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Finland, Unit of Public Health Genomics, National Institute for Health and Welfare, Helsinki, Finland, Computational Medicine, Institute of Health Sciences, University of Oulu and Oulu University Hospital, Oulu, Finland, NMR Metabolomics Laboratory, School of Pharmacy, University of Eastern Finland, Kuopio, Finland, Department of Epidemiology and Biostatistics, MRC Health Protection, Agency (HPA) Centre for Environment and Health, School of Public Health, Imperial College, London, UK, Institute of Health Sciences, University of Oulu, Finland, Biocenter Oulu, University of Oulu, Finland, Department of Clinical Physiology, Tampere University Hospital and University of Tampere, Department of Clinical Chemistry, Fimlab Laboratories, University of Tampere School of Medicine, Tampere, Finland, Computational Medicine, School of Social and Community Medicine and the Medical Research Council Integrative Epidemiology Unit, University of Bristol, Bristol, UK, Department of Clinical Physiology and Nuclear Medicine, University of Turku and Turku University Hospital, Turku, Finland, Research Centre of Applied and Preventive Cardiovascular Medicine, University of Turku and Turku University Hospital, Turku, Finland, Department of Chronic Disease Prevention, National Institute for Health and Welfare, Helsinki, Finland, Unit of Primary Care, Oulu University Hospital, Finland, Department of Children and Young People and Families, National Institute for Health and Welfare, Oulu, Finland, Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK, Hjelt Institute, University of Helsinki, Helsinki, Finland, Helsinki Institute for Information Technology HIIT, Department of Computer Science, University of Helsinki, Finland.</p><p class="abstract"><strong>Motivation</strong>: A typical genome-wide association study searches for associations between single nucleotide polymorphisms (SNPs) and a univariate phenotype. However, there is a growing interest to investigate associations between genomics data and multivariate phenotypes, for example in gene expression or metabolomics studies. A common approach is to perform a univariate test between each genotype-phenotype pair, and then to apply a stringent significance cutoff to account for the large number of tests performed. However, this approach has limited ability to uncover dependencies involving multiple variables. Another trend in the current genetics is the investigation of the impact of rare variants on the phenotype, where the standard methods often fail due to lack of power when the minor allele is present in only a limited number of individuals.</p><p class="abstract"><strong>Results</strong>: We propose a new statistical approach based on Bayesian reduced rank regression to assess the impact of multiple SNPs on a high-dimensional phenotype. Due to the method&#39;s ability to combine information over multiple SNPs and phenotypes, it is particularly suitable for detecting associations involving rare variants. We demonstrate the potential of our method and compare it with alternatives using the Northern Finland Birth Cohort with 4,702 individuals, for whom genome-wide SNP data along with lipoprotein profiles comprising 74 traits are available. We discovered two genes (XRCC4 and MTHFD2L) without previously reported associations, which replicated in a combined analysis of two additional cohorts: 2,390 individuals from the Cardiovascular Risk in Young Finns study and 3,659 individuals from the FINRISK Study.</p><p class="abstract">R-code freely available for download at http://users.ics.aalto.fi/pemartti/gene_metabolome/.</p><p class="abstract"><strong>Contact</strong>: <a href="mailto:%73%61%6D%75%6C%69.%72%69%70%61%74%74%69%40%68%65%6C%73%69%6E%6B%69.%66%69">&#115;&#97;&#109;&#117;&#108;&#105;&#46;&#114;&#105;&#112;&#97;&#116;&#116;&#105;&#64;&#104;&#101;&#108;&#115;&#105;&#110;&#107;&#105;&#46;&#102;&#105;</a>, <a href="mailto:%73%61%6D%75%65%6C.%6B%61%73%6B%69%40%61%61%6C%74%6F.%66%69">&#115;&#97;&#109;&#117;&#101;&#108;&#46;&#107;&#97;&#115;&#107;&#105;&#64;&#97;&#97;&#108;&#116;&#111;&#46;&#102;&#105;</a>.</p>
<p class="publication"><span class="title">Bioinformatics (Oxford, England)</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24665129">24665129</a>; DOI: <a href="http://dx.doi.org/10.1093%2Fbioinformatics%2Fbtu140">10.1093/bioinformatics/btu140</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Characterization of the neural stem cell gene regulatory network identifies OLIG2 as a multi-functional regulator of self-renewal.</h4>
<p class="authors"><span class="author">Mateo JL</span>, <span class="author">van den Berg DL</span>, <span class="author">Haeussler M</span>, <span class="author">Drechsel D</span>, <span class="author">Gaber ZB</span>, <span class="author">Castro DS</span>, <span class="author">Robson P</span>, <span class="author">Crawford GE</span>, <span class="author">Flicek P</span>, <span class="author">Ettwiller L</span>, <span class="author">Wittbrodt J</span>, <span class="author">Guillemot F</span> and <span class="author">Martynoga B</span></p>
<p class="affiliation">University of Heidelberg;</p><p class="abstract">The gene regulatory network (GRN) that supports neural stem cell (NS cell) self-renewal has so far been poorly characterised. Knowledge of the central transcription factors (TFs), the non-coding gene regulatory regions that they bind to and the genes whose expression they modulate will be crucial in unlocking the full therapeutic potential of these cells. Here, we use DNase-seq in combination with analysis of histone modifications to identify multiple classes of epigenetically and functionally distinct cis-regulatory elements (CREs). Through motif analysis and ChIP-seq we identify several of the crucial TF regulators of NS cells. At the core of the network are TFs of the basic helix-loop-helix (bHLH), nuclear factor I (NFI), SOX and FOX families, with CREs often densely bound by several of these different TFs. We use machine learning to highlight several crucial regulatory features of the network that underpin NS cell self-renewal and multipotency. We validate our predictions by functional analysis of the bHLH TF OLIG2. This TF makes an important contribution to NS cell self-renewal by concurrently activating pro-proliferation genes and preventing the untimely activation of genes promoting neuronal differentiation and stem cell quiescence.</p>
<p class="publication"><span class="title">Genome research</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25294244">25294244</a>; DOI: <a href="http://dx.doi.org/10.1101%2Fgr.173435.114">10.1101/gr.173435.114</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Bacillary dysentery from World War 1 and NCTC1, the first bacterial isolate in the National Collection.</h4>
<p class="authors"><span class="author">Mather AE</span>, <span class="author">Baker KS</span>, <span class="author">McGregor H</span>, <span class="author">Coupland P</span>, <span class="author">Mather PL</span>, <span class="author">Deheer-Graham A</span>, <span class="author">Parkhill J</span>, <span class="author">Bracegirdle P</span>, <span class="author">Russell JE</span> and <span class="author">Thomson NR</span></p>
<p class="affiliation">Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, UK.</p>
<p class="publication"><span class="title">Lancet</span>&nbsp;<span class="year">2014</span>;<span class="volume">384</span>;<span class="number">9955</span>;<span class="pagerange">1720</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25441203">25441203</a>; DOI: <a href="http://dx.doi.org/10.1016%2FS0140-6736%2814%2961790-6">10.1016/S0140-6736(14)61790-6</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Antibiotics and Collateral Damage</h4>
<p class="authors"><span class="author">MATHER,A. E.;</span></p>
<p class="abstract">Book review of :
Missing Microbes How the Overuse of Antibiotics Is Fueling Our Modern Plagues by Martin J. Blaser</p>
<p class="publication"><span class="title">Science</span>&nbsp;<span class="year">2014</span>;<span class="volume">344</span>;<span class="number">6183</span>;<span class="pagerange">472-3</span></p>
<p class="links">DOI: <a href="http://dx.doi.org/10.1126%2Fscience.1252914">10.1126/science.1252914</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">The genome sequence of ectromelia virus Naval and Cornell isolates from outbreaks in North America.</h4>
<p class="authors"><span class="author">Mavian C</span>, <span class="author">L&oacute;pez-Bueno A</span>, <span class="author">Bryant NA</span>, <span class="author">Seeger K</span>, <span class="author">Quail MA</span>, <span class="author">Harris D</span>, <span class="author">Barrell B</span> and <span class="author">Alcami A</span></p>
<p class="affiliation">Centro de Biolog&iacute;a Molecular Severo Ochoa (Consejo Superior de Investigaciones Cient&iacute;ficas-Universidad Aut&oacute;noma de Madrid), Nicolas Cabrera 1, Campus de Cantoblanco, Madrid, Spain.</p><p class="abstract">Ectromelia virus (ECTV) is the causative agent of mousepox, a disease of laboratory mouse colonies and an excellent model for human smallpox. We report the genome sequence of two isolates from outbreaks in laboratory mouse colonies in the USA in 1995 and 1999: ECTV-Naval and ECTV-Cornell, respectively. The genome of ECTV-Naval and ECTV-Cornell was sequenced by the 454-Roche technology. The ECTV-Naval genome was also sequenced by the Sanger and Illumina technologies in order to evaluate these technologies for poxvirus genome sequencing. Genomic comparisons revealed that ECTV-Naval and ECTV-Cornell correspond to the same virus isolated from independent outbreaks. Both ECTV-Naval and ECTV-Cornell are extremely virulent in susceptible BALB/c mice, similar to ECTV-Moscow. This is consistent with the ECTV-Naval genome sharing 98.2% DNA sequence identity with that of ECTV-Moscow, and indicates that the genetic differences with ECTV-Moscow do not affect the virulence of ECTV-Naval in the mousepox model of footpad infection.</p>
<p class="publication"><span class="title">Virology</span>&nbsp;<span class="year">2014</span>;<span class="volume">462-463C</span>;<span class="pagerange">218-226</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24999046">24999046</a>; DOI: <a href="http://dx.doi.org/10.1016%2Fj.virol.2014.06.010">10.1016/j.virol.2014.06.010</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">The cavefish genome reveals candidate genes for eye loss.</h4>
<p class="authors"><span class="author">McGaugh SE</span>, <span class="author">Gross JB</span>, <span class="author">Aken B</span>, <span class="author">Blin M</span>, <span class="author">Borowsky R</span>, <span class="author">Chalopin D</span>, <span class="author">Hinaux H</span>, <span class="author">Jeffery WR</span>, <span class="author">Keene A</span>, <span class="author">Ma L</span>, <span class="author">Minx P</span>, <span class="author">Murphy D</span>, <span class="author">O&#39;Quin KE</span>, <span class="author">R&eacute;taux S</span>, <span class="author">Rohner N</span>, <span class="author">Searle SM</span>, <span class="author">Stahl BA</span>, <span class="author">Tabin C</span>, <span class="author">Volff JN</span>, <span class="author">Yoshizawa M</span> and <span class="author">Warren WC</span></p>
<p class="affiliation">The Genome Institute, Washington University, Campus Box 8501, St Louis, Missouri 63108, USA.</p><p class="abstract">Natural populations subjected to strong environmental selection pressures offer a window into the genetic underpinnings of evolutionary change. Cavefish populations, Astyanax mexicanus (Teleostei: Characiphysi), exhibit repeated, independent evolution for a variety of traits including eye degeneration, pigment loss, increased size and number of taste buds and mechanosensory organs, and shifts in many behavioural traits. Surface and cave forms are interfertile making this system amenable to genetic interrogation; however, lack of a reference genome has hampered efforts to identify genes responsible for changes in cave forms of A. mexicanus. Here we present the first de novo genome assembly for Astyanax mexicanus cavefish, contrast repeat elements to other teleost genomes, identify candidate genes underlying quantitative trait loci (QTL), and assay these candidate genes for potential functional and expression differences. We expect the cavefish genome to advance understanding of the evolutionary process, as well as, analogous human disease including retinal dysfunction.</p>
<p class="publication"><span class="title">Nature communications</span>&nbsp;<span class="year">2014</span>;<span class="volume">5</span>;<span class="pagerange">5307</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25329095">25329095</a>; DOI: <a href="http://dx.doi.org/10.1038%2Fncomms6307">10.1038/ncomms6307</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Identification of novel genetic Loci associated with thyroid peroxidase antibodies and clinical thyroid disease.</h4>
<p class="authors"><span class="author">Medici M</span>, <span class="author">Porcu E</span>, <span class="author">Pistis G</span>, <span class="author">Teumer A</span>, <span class="author">Brown SJ</span>, <span class="author">Jensen RA</span>, <span class="author">Rawal R</span>, <span class="author">Roef GL</span>, <span class="author">Plantinga TS</span>, <span class="author">Vermeulen SH</span>, <span class="author">Lahti J</span>, <span class="author">Simmonds MJ</span>, <span class="author">Husemoen LL</span>, <span class="author">Freathy RM</span>, <span class="author">Shields BM</span>, <span class="author">Pietzner D</span>, <span class="author">Nagy R</span>, <span class="author">Broer L</span>, <span class="author">Chaker L</span>, <span class="author">Korevaar TI</span>, <span class="author">Plia MG</span>, <span class="author">Sala C</span>, <span class="author">V&ouml;lker U</span>, <span class="author">Richards JB</span>, <span class="author">Sweep FC</span>, <span class="author">Gieger C</span>, <span class="author">Corre T</span>, <span class="author">Kajantie E</span>, <span class="author">Thuesen B</span>, <span class="author">Taes YE</span>, <span class="author">Visser WE</span>, <span class="author">Hattersley AT</span>, <span class="author">Kratzsch J</span>, <span class="author">Hamilton A</span>, <span class="author">Li W</span>, <span class="author">Homuth G</span>, <span class="author">Lobina M</span>, <span class="author">Mariotti S</span>, <span class="author">Soranzo N</span>, <span class="author">Cocca M</span>, <span class="author">Nauck M</span>, <span class="author">Spielhagen C</span>, <span class="author">Ross A</span>, <span class="author">Arnold A</span>, <span class="author">van de Bunt M</span>, <span class="author">Liyanarachchi S</span>, <span class="author">Heier M</span>, <span class="author">Grabe HJ</span>, <span class="author">Masciullo C</span>, <span class="author">Galesloot TE</span>, <span class="author">Lim EM</span>, <span class="author">Reischl E</span>, <span class="author">Leedman PJ</span>, <span class="author">Lai S</span>, <span class="author">Delitala A</span>, <span class="author">Bremner AP</span>, <span class="author">Philips DI</span>, <span class="author">Beilby JP</span>, <span class="author">Mulas A</span>, <span class="author">Vocale M</span>, <span class="author">Abecasis G</span>, <span class="author">Forsen T</span>, <span class="author">James A</span>, <span class="author">Widen E</span>, <span class="author">Hui J</span>, <span class="author">Prokisch H</span>, <span class="author">Rietzschel EE</span>, <span class="author">Palotie A</span>, <span class="author">Feddema P</span>, <span class="author">Fletcher SJ</span>, <span class="author">Schramm K</span>, <span class="author">Rotter JI</span>, <span class="author">Kluttig A</span>, <span class="author">Radke D</span>, <span class="author">Traglia M</span>, <span class="author">Surdulescu GL</span>, <span class="author">He H</span>, <span class="author">Franklyn JA</span>, <span class="author">Tiller D</span>, <span class="author">Vaidya B</span>, <span class="author">de Meyer T</span>, <span class="author">J&oslash;rgensen T</span>, <span class="author">Eriksson JG</span>, <span class="author">O&#39;Leary PC</span>, <span class="author">Wichmann E</span>, <span class="author">Hermus AR</span>, <span class="author">Psaty BM</span>, <span class="author">Ittermann T</span>, <span class="author">Hofman A</span>, <span class="author">Bosi E</span>, <span class="author">Schlessinger D</span>, <span class="author">Wallaschofski H</span>, <span class="author">Pirastu N</span>, <span class="author">Aulchenko YS</span>, <span class="author">de la Chapelle A</span>, <span class="author">Netea-Maier RT</span>, <span class="author">Gough SC</span>, <span class="author">Meyer Zu Schwabedissen H</span>, <span class="author">Frayling TM</span>, <span class="author">Kaufman JM</span>, <span class="author">Linneberg A</span>, <span class="author">R&auml;ikk&ouml;nen K</span>, <span class="author">Smit JW</span>, <span class="author">Kiemeney LA</span>, <span class="author">Rivadeneira F</span>, <span class="author">Uitterlinden AG</span>, <span class="author">Walsh JP</span>, <span class="author">Meisinger C</span>, <span class="author">den Heijer M</span>, <span class="author">Visser TJ</span>, <span class="author">Spector TD</span>, <span class="author">Wilson SG</span>, <span class="author">V&ouml;lzke H</span>, <span class="author">Cappola A</span>, <span class="author">Toniolo D</span>, <span class="author">Sanna S</span>, <span class="author">Naitza S</span> and <span class="author">Peeters RP</span></p>
<p class="affiliation">Department of Internal Medicine, Erasmus Medical Center Rotterdam, Rotterdam, The Netherlands.</p>
<p class="abstract">Autoimmune thyroid diseases (AITD) are common, affecting 2-5% of the general population. Individuals with positive thyroid peroxidase antibodies (TPOAbs) have an increased risk of autoimmune hypothyroidism (Hashimoto's thyroiditis), as well as autoimmune hyperthyroidism (Graves' disease). As the possible causative genes of TPOAbs and AITD remain largely unknown, we performed GWAS meta-analyses in 18,297 individuals for TPOAb-positivity (1769 TPOAb-positives and 16,528 TPOAb-negatives) and in 12,353 individuals for TPOAb serum levels, with replication in 8,990 individuals. Significant associations (P<510(-8)) were detected at TPO-rs11675434, ATXN2-rs653178, and BACH2-rs10944479 for TPOAb-positivity, and at TPO-rs11675434, MAGI3-rs1230666, and KALRN-rs2010099 for TPOAb levels. Individual and combined effects (genetic risk scores) of these variants on (subclinical) hypo- and hyperthyroidism, goiter and thyroid cancer were studied. Individuals with a high genetic risk score had, besides an increased risk of TPOAb-positivity (OR: 2.18, 95% CI 1.68-2.81, P=8.110(-8)), a higher risk of increased thyroid-stimulating hormone levels (OR: 1.51, 95% CI 1.26-1.82, P=2.910(-6)), as well as a decreased risk of goiter (OR: 0.77, 95% CI 0.66-0.89, P=6.510(-4)). The MAGI3 and BACH2 variants were associated with an increased risk of hyperthyroidism, which was replicated in an independent cohort of patients with Graves' disease (OR: 1.37, 95% CI 1.22-1.54, P=1.210(-7) and OR: 1.25, 95% CI 1.12-1.39, P=6.210(-5)). The MAGI3 variant was also associated with an increased risk of hypothyroidism (OR: 1.57, 95% CI 1.18-2.10, P=1.910(-3)). This first GWAS meta-analysis for TPOAbs identified five newly associated loci, three of which were also associated with clinical thyroid disease. With these markers we identified a large subgroup in the general population with a substantially increased risk of TPOAbs. The results provide insight into why individuals with thyroid autoimmunity do or do not eventually develop thyroid disease, and these markers may therefore predict which TPOAb-positives are particularly at risk of developing clinical thyroid dysfunction.</p>
<p class="publication"><span class="title">PLoS genetics</span>&nbsp;<span class="year">2014</span>;<span class="volume">10</span>;<span class="number">2</span>;<span class="pagerange">e1004123</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24586183">24586183</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC3937134">3937134</a>; DOI: <a href="http://dx.doi.org/10.1371%2Fjournal.pgen.1004123">10.1371/journal.pgen.1004123</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">The sex-specific associations of the aromatase gene with Alzheimer&#39;s disease and its interaction with IL10 in the Epistasis Project.</h4>
<p class="authors"><span class="author">Medway C</span>, <span class="author">Combarros O</span>, <span class="author">Cortina-Borja M</span>, <span class="author">Butler HT</span>, <span class="author">Ibrahim-Verbaas CA</span>, <span class="author">de Bruijn RF</span>, <span class="author">Koudstaal PJ</span>, <span class="author">van Duijn CM</span>, <span class="author">Ikram MA</span>, <span class="author">Mateo I</span>, <span class="author">S&aacute;nchez-Juan P</span>, <span class="author">Lehmann MG</span>, <span class="author">Heun R</span>, <span class="author">K&ouml;lsch H</span>, <span class="author">Deloukas P</span>, <span class="author">Hammond N</span>, <span class="author">Coto E</span>, <span class="author">Alvarez V</span>, <span class="author">Kehoe PG</span>, <span class="author">Barber R</span>, <span class="author">Wilcock GK</span>, <span class="author">Brown K</span>, <span class="author">Belbin O</span>, <span class="author">Warden DR</span>, <span class="author">Smith AD</span>, <span class="author">Morgan K</span> and <span class="author">Lehmann DJ</span></p>
<p class="affiliation">Human Genetics Research, Queens Medical Centre, School of Molecular Medical Sciences, University of Nottingham, Nottingham, UK.</p><p class="abstract">Epistasis between interleukin-10 (IL10) and aromatase gene polymorphisms has previously been reported to modify the risk of Alzheimer&#39;s disease (AD). However, although the main effects of aromatase variants suggest a sex-specific effect in AD, there has been insufficient power to detect sex-specific epistasis between these genes to date. Here we used the cohort of 1757 AD patients and 6294 controls in the Epistasis Project. We replicated the previously reported main effects of aromatase polymorphisms in AD risk in women, for example, adjusted odds ratio of disease for rs1065778 GG=1.22 (95% confidence interval: 1.01-1.48, P=0.03). We also confirmed a reported epistatic interaction between IL10 rs1800896 and aromatase (CYP19A1) rs1062033, again only in women: adjusted synergy factor=1.94 (1.16-3.25, 0.01). Aromatase, a rate-limiting enzyme in the synthesis of estrogens, is expressed in AD-relevant brain regions ,and is downregulated during the disease. IL-10 is an anti-inflammatory cytokine. Given that estrogens have neuroprotective and anti-inflammatory activities and regulate microglial cytokine production, epistasis is biologically plausible. Diminishing serum estrogen in postmenopausal women, coupled with suboptimal brain estrogen synthesis, may contribute to the inflammatory state, that is a pathological hallmark of AD.</p>
<p class="publication"><span class="title">European journal of human genetics : EJHG</span>&nbsp;<span class="year">2014</span>;<span class="volume">22</span>;<span class="number">2</span>;<span class="pagerange">216-20</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/23736221">23736221</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC3895636">3895636</a>; DOI: <a href="http://dx.doi.org/10.1038%2Fejhg.2013.116">10.1038/ejhg.2013.116</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">C. elegans whole genome sequencing reveals mutational signatures related to carcinogens and DNA repair deficiency.</h4>
<p class="authors"><span class="author">Meier B</span>, <span class="author">Cooke SL</span>, <span class="author">Weiss J</span>, <span class="author">Bailly AP</span>, <span class="author">Alexandrov LB</span>, <span class="author">Marshall J</span>, <span class="author">Raine K</span>, <span class="author">Maddison M</span>, <span class="author">Anderson E</span>, <span class="author">Stratton MR</span>, <span class="author">Gartner A</span> and <span class="author">Campbell PJ</span></p>
<p class="affiliation">University of Dundee;</p><p class="abstract">Mutation is associated with developmental and hereditary disorders, aging and cancer. While we understand some mutational processes operative in human disease, most remain mysterious. We used C. elegans whole genome sequencing to model mutational signatures, analyzing 183 worm populations across 17 DNA repair-deficient backgrounds, propagated for 20 generations or exposed to carcinogens. The baseline mutation rate in C. elegans was ~1/genome/generation, not overtly altered across several DNA repair deficiencies over 20 generations. Telomere erosion led to complex chromosomal rearrangements initiated by breakage-fusion-bridge cycles and completed by simultaneously acquired, localized clusters of breakpoints. Aflatoxin-B1 induced substitutions of guanines in GpC context, as observed in aflatoxin-induced liver cancers. Mutational burden increased with impaired nucleotide excision repair. Cisplatin and mechlorethamine, DNA crosslinking agents, caused dose- and genotype-dependent signatures among indels, substitutions and rearrangements. Strikingly, both agents induced clustered rearrangements resembling &#39;chromoanasynthesis,&#39; a replication-based mutational signature seen in constitutional genomic disorders, suggesting interstrand crosslinks may play a pathogenic role in such events. Cisplatin mutagenicity was most pronounced in xpf-1 mutants, suggesting this gene critically protects cells against platinum chemotherapy. Thus, experimental model systems combined with genome sequencing can recapture and mechanistically explain mutational signatures associated with human disease.</p>
<p class="publication"><span class="title">Genome research</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25030888">25030888</a>; DOI: <a href="http://dx.doi.org/10.1101%2Fgr.175547.114">10.1101/gr.175547.114</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Respiratory Tract Samples, Viral Load and Genome Fraction Yield in patients with Middle East Respiratory Syndrome.</h4>
<p class="authors"><span class="author">Memish ZA</span>, <span class="author">Al-Tawfiq JA</span>, <span class="author">Makhdoom HQ</span>, <span class="author">Assiri A</span>, <span class="author">Alhakeem RF</span>, <span class="author">Albarrak A</span>, <span class="author">Alsubaie S</span>, <span class="author">Al-Rabeeah AA</span>, <span class="author">Hajomar WH</span>, <span class="author">Hussain R</span>, <span class="author">Kheyami AM</span>, <span class="author">Almutairi A</span>, <span class="author">Azhar EI</span>, <span class="author">Drosten C</span>, <span class="author">Watson SJ</span>, <span class="author">Kellam P</span>, <span class="author">Cotten M</span> and <span class="author">Zumla A</span></p>
<p class="affiliation">Global Centre for Mass Gatherings Medicine (GCMGM), Ministry of Health, Riyadh, Kingdom of Saudi Arabia (KSA).</p><p class="abstract"><strong>Background</strong>: &emsp;Analysis of clinical samples of patients with new viral infections is critical to confirm the diagnosis, provide viral load and sequence data necessary for characterizing viral kinetics, transmission and evolution of the virus. We analysed samples from 112 patients infected with the recently discovered Middle East Respiratory Syndrome Coronavirus (MERS-CoV) METHODS: &emsp;Respiratory tract samples from MERS-CoV PCR-confirmed cases were analysed for yields of MERS-CoV viral load and fraction of MERS-CoV genome. These values were analyzed to determine associations with clinical sample type.</p><p class="abstract"><strong>Results</strong>: &emsp;Samples from 112 MERS-CoV PCR-positive individuals were analysed: 13 Sputum samples, 64 Nasopharyngeal swabs, 30 Tracheal aspirates, 3 Broncho-alveolar lavages and 2 were of unknown origin. Tracheal aspirates yielded significantly higher MERS-CoV high viral load when compared with Nasopharyngeal swabs (p=0.005) and to Sputum (p=0.0001). Tracheal aspirates had similar viral load compared to Broncho-alveolar lavage (p=0.3079). Broncho-alveolar lavage samples and tracheal aspirates had significantly higher vital load values than nasopharyngeal swabs (p=0.0095 and p=0.0002) and Sputum samples (p=0.0009 and p=0.0001). The genome yield from tracheal aspirates and bronchoalveolar lavage samples were similar (p=0.1174).</p><p class="abstract"><strong>Conclusions</strong>: &emsp;Lower respiratory tract samples yield significantly higher MERS-CoV viral load, and genome fractions than upper respiratory tract samples.</p>
<p class="publication"><span class="title">The Journal of infectious diseases</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24837403">24837403</a>; DOI: <a href="http://dx.doi.org/10.1093%2Finfdis%2Fjiu292">10.1093/infdis/jiu292</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Community case clusters of Middle East respiratory syndrome coronavirus in Hafr Al-Batin, Kingdom of Saudi Arabia: a descriptive genomic study.</h4>
<p class="authors"><span class="author">Memish ZA</span>, <span class="author">Cotten M</span>, <span class="author">Watson SJ</span>, <span class="author">Kellam P</span>, <span class="author">Zumla A</span>, <span class="author">Alhakeem RF</span>, <span class="author">Assiri A</span>, <span class="author">Rabeeah AA</span> and <span class="author">Al-Tawfiq JA</span></p>
<p class="affiliation">Global Centre for Mass Gatherings Medicine (GCMGM), Ministry of Health, Riyadh, Kingdom of Saudi Arabia (KSA); College of Medicine, Alfaisal University, Riyadh, Kingdom of Saudi Arabia. Electronic address: <a href="mailto:%7A%6D%65%6D%69%73%68%40%79%61%68%6F%6F.%63%6F%6D">&#122;&#109;&#101;&#109;&#105;&#115;&#104;&#64;&#121;&#97;&#104;&#111;&#111;&#46;&#99;&#111;&#109;</a>.</p><p class="abstract">The Middle East respiratory syndrome coronavirus (MERS-CoV) was first described in September 2012 and to date 86 deaths from a total of 206 cases of MERS-CoV infection have been reported to the WHO. Camels have been implicated as the reservoir of MERS-CoV, but the exact source and mode of transmission for most patients remain unknown. During a 3 month period, June to August 2013, there were 12 positive MERS-CoV cases reported from the Hafr Al-Batin region district in the north east region of the Kingdom of Saudi Arabia. In addition to the different regional camel festivals in neighboring countries, Hafr Al-Batin has the biggest camel market in the entire Kingdom and hosts an annual camel festival. Thus, we conducted a detailed epidemiological, clinical and genomic study to ascertain common exposure and transmission patterns of all cases of MERS-CoV reported from Hafr Al-Batin. Analysis of previously reported genetic data indicated that at least two of the infected contacts could not have been directly infected from the index patient and alternate source should be considered. While camels appear as the likely source, other sources have not been ruled out. More detailed case control studies with detailed case histories, epidemiological information and genomic analysis are being conducted to delineate the missing pieces in the transmission dynamics of MERS-CoV outbreak.</p>
<p class="publication"><span class="title">International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases</span>&nbsp;<span class="year">2014</span>;<span class="volume">23</span>;<span class="pagerange">63-8</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24699184">24699184</a>; DOI: <a href="http://dx.doi.org/10.1016%2Fj.ijid.2014.03.1372">10.1016/j.ijid.2014.03.1372</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Molecular characterization of choroid plexus tumors reveals novel clinically relevant subgroups.</h4>
<p class="authors"><span class="author">Merino DM</span>, <span class="author">Shlien A</span>, <span class="author">Villani A</span>, <span class="author">Pienkowska M</span>, <span class="author">Mack SC</span>, <span class="author">Ramaswamy V</span>, <span class="author">Shih DJ</span>, <span class="author">Tatevossian R</span>, <span class="author">Novokmet A</span>, <span class="author">Choufani S</span>, <span class="author">Dvir R</span>, <span class="author">Ben-Arush M</span>, <span class="author">Harris BT</span>, <span class="author">Hwang EI</span>, <span class="author">Lulla RR</span>, <span class="author">Pfister SM</span>, <span class="author">Achatz MI</span>, <span class="author">Jabado N</span>, <span class="author">Finlay JL</span>, <span class="author">Weksberg R</span>, <span class="author">Hawkins C</span>, <span class="author">Taylor MD</span>, <span class="author">Tabori U</span>, <span class="author">Ellison DW</span>, <span class="author">Gilbertson RJ</span> and <span class="author">Malkin D</span></p>
<p class="affiliation">Genetics and Genome Biology Program, The Hospital for Sick Children.</p><p class="abstract">Purpose: To investigate molecular alterations in choroid plexus tumors (CPTs) using a genome-wide high-throughput approach, in order to identify diagnostic and prognostic signatures that will refine tumor stratification and guide therapeutic options. Experimental Design: One hundred CPTs were obtained from a multi-institutional database. Copy number (CN), DNA methylation and gene expression signatures were assessed for 74, 36 and 40 samples, respectively. Molecular subgroups were correlated with clinical parameters and outcomes. Results: Unique molecular signatures distinguished choroid plexus carcinomas (CPCs) from choroid plexus papillomas (CPPs) and atypical choroid plexus papillomas (aCPPs). No significantly distinct molecular alterations between CPPs and aCPPs were observed. Allele-specific CN analysis revealed two novel subgroups: hypodiploid and hyperdiploid CPCs. Hyperdiploid CPCs exhibited recurrent acquired uniparental disomy (aUPD) events. We observed 60% of CPCs harbored TP53 mutations, and we identified a high-risk group of CPC patients carrying 2 mutant copies. These patients exhibited worse 5-year event-free (EFS) and overall survival (OS) compared to patients with CPC carrying 1 mutant copy (OS: 14.3%, 95% CI 0.71%-46.5% versus 66.7%, 28.2%-87.8%, respectively, p=0.04; EFS: 0% versus 44.4%, 13.6%-71.9%, respectively, p=0.03). CPPs and aCPPs exhibited favorable survival. Discussion: Our data demonstrates that distinct molecular signatures distinguish CPCs from CPPs and aCPPs; however molecular similarities among the papillomas suggest these two histological subgroups are indeed a single entity. A greater number of copies of mutated TP53 was significantly associated to increased tumor aggressiveness and a worse survival outcome in CPCs. Collectively, these findings will facilitate stratified approaches to the clinical management of CPTs.</p>
<p class="publication"><span class="title">Clinical cancer research : an official journal of the American Association for Cancer Research</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25336695">25336695</a>; DOI: <a href="http://dx.doi.org/10.1158%2F1078-0432.CCR-14-1324">10.1158/1078-0432.CCR-14-1324</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Insights into the origin of rare haplogroup C3* Y chromosomes in South America from high-density autosomal SNP genotyping.</h4>
<p class="authors"><span class="author">Mezzavilla M</span>, <span class="author">Geppert M</span>, <span class="author">Tyler-Smith C</span>, <span class="author">Roewer L</span> and <span class="author">Xue Y</span></p>
<p class="affiliation">The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK; Medical Genetics, Department of Reproductive Sciences and Development, IRCCS-Burlo Garofolo, University of Trieste, Trieste, Italy.</p><p class="abstract">The colonization of Americas is thought to have occurred 15-20 thousand years ago (Kya), with little or no subsequent migration into South America until the European expansions beginning 0.5Kya. Recently, however, haplogroup C3* Y chromosomes were discovered in two nearby Native American populations from Ecuador. Since this haplogroup is otherwise nearly absent from the Americas but is common in East Asia, and an archaeological link between Ecuador and Japan is known from 6Kya, an additional migration 6Kya was suggested. Here, we have generated high-density autosomal SNP genotypes from the Ecuadorian populations and compared them with genotypes from East Asia and elsewhere to evaluate three hypotheses: a recent migration from Japan, a single pulse of migration from Japan 6Kya, and no migration after the First Americans. First, using forward-time simulations and an appropriate demographic model, we investigated our power to detect both ancient and recent gene flow at different levels. Second, we analyzed 207,321 single nucleotide polymorphisms from 16 Ecuadorian individuals, comparing them with populations from the HGDP panel using descriptive and formal tests for admixture. Our simulations revealed good power to detect recent admixture, and that &ge;5% admixture 6Kya ago could be detected. However, in the experimental data we saw no evidence of gene flow from Japan to Ecuador. In summary, we can exclude recent migration and probably admixture 6Kya as the source of the C3* Y chromosomes in Ecuador, and thus suggest that they represent a rare founding lineage lost by drift elsewhere.</p>
<p class="publication"><span class="title">Forensic science international. Genetics</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25435155">25435155</a>; DOI: <a href="http://dx.doi.org/10.1016%2Fj.fsigen.2014.11.005">10.1016/j.fsigen.2014.11.005</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Online questionnaire development: using film to engage participants and then gather attitudes towards the sharing of genomic data.</h4>
<p class="authors"><span class="author">Middleton A</span>, <span class="author">Bragin E</span>, <span class="author">Morley KI</span>, <span class="author">Parker M</span> and <span class="author">DDD Study</span></p>
<p class="affiliation">Wellcome Trust Sanger Institute, Cambridge, UK. Electronic address: <a href="mailto:%61%6D%33%33%40%73%61%6E%67%65%72.%61%63.%75%6B">&#97;&#109;&#51;&#51;&#64;&#115;&#97;&#110;&#103;&#101;&#114;&#46;&#97;&#99;&#46;&#117;&#107;</a>.</p><p class="abstract">How can a researcher engage a participant in a survey, when the subject matter may be perceived as &#39;challenging&#39; or even be totally unfamiliar to the participant? The Genomethics study addressed this via the creation and delivery of a novel online questionnaire containing 10 integrated films. The films documented various ethical dilemmas raised by genomic technologies and the survey ascertained attitudes towards these. Participants were recruited into the research using social media, traditional media and email invitation. The film-survey strategy was successful: 11,336 initial hits on the survey website led to 6944 completed surveys. Participants included from those who knew nothing of the subject matter through to experts in the field of genomics (61% compliance rate), 72% of participants answered every single question. This paper summarises the survey design process and validation methods applied. The recruitment strategy and results from the survey are presented elsewhere.</p>
<p class="grants">Funded by: Department of Health; Wellcome Trust</p>
<p class="publication"><span class="title">Social science research</span>&nbsp;<span class="year">2014</span>;<span class="volume">44</span>;<span class="pagerange">211-23</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24468445">24468445</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC3969308">3969308</a>; DOI: <a href="http://dx.doi.org/10.1016%2Fj.ssresearch.2013.12.004">10.1016/j.ssresearch.2013.12.004</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Finding people who will tell you their thoughts on genomics-recruitment strategies for social sciences research.</h4>
<p class="authors"><span class="author">Middleton A</span>, <span class="author">Bragin E</span>, <span class="author">Parker M</span> and <span class="author">DDD Study</span></p>
<p class="affiliation">Wellcome Trust Sanger Institute, Cambridge, CB10 1SA, UK, <a href="mailto:%41%6D%33%33%40%73%61%6E%67%65%72.%61%63.%75%6B">&#65;&#109;&#51;&#51;&#64;&#115;&#97;&#110;&#103;&#101;&#114;&#46;&#97;&#99;&#46;&#117;&#107;</a>.</p><p class="abstract">This paper offers a description of how social media, traditional media and direct invitation were used as tools for the recruitment of 6,944 research participants for a social sciences study on genomics. The remit was to gather the views of various stakeholders towards sharing incidental findings from whole genome studies. This involved recruiting members of the public, genetic health professionals, genomic researchers and non-genetic health professionals. A novel survey was designed that contained ten integrated films; this was made available online and open for completion by anyone worldwide. The recruitment methods are described together with the convenience and snowballing sampling framework. The most successful strategy involved the utilisation of social media; Facebook, Blogging, Twitter, LinkedIn and Google Ads led to the ascertainment of over 75&nbsp;% of the final sample. We conclude that the strategies used were successful in recruiting in eclectic mix of appropriate participants. Design of the survey and results from the study are presented separately.</p>
<p class="publication"><span class="title">Journal of community genetics</span>&nbsp;<span class="year">2014</span>;<span class="volume">5</span>;<span class="number">4</span>;<span class="pagerange">291-302</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24535681">24535681</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4159472">4159472</a>; DOI: <a href="http://dx.doi.org/10.1007%2Fs12687-014-0184-2">10.1007/s12687-014-0184-2</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">No expectation to share incidental findings in genomic research.</h4>
<p class="authors"><span class="author">Middleton A</span>, <span class="author">Morley KI</span>, <span class="author">Bragin E</span>, <span class="author">Firth HV</span>, <span class="author">Hurles ME</span>, <span class="author">Wright CF</span>, <span class="author">Parker M</span> and <span class="author">on behalf of the Deciphering Developmental Disorders Study</span></p>
<p class="affiliation">Human Genetics, Wellcome Trust Sanger Institute, Cambridge CB10 1SA, UK. Electronic address: <a href="mailto:%61%6D%33%33%40%73%61%6E%67%65%72.%61%63.%75%6B">&#97;&#109;&#51;&#51;&#64;&#115;&#97;&#110;&#103;&#101;&#114;&#46;&#97;&#99;&#46;&#117;&#107;</a>.</p>
<p class="publication"><span class="title">Lancet</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25529584">25529584</a>; DOI: <a href="http://dx.doi.org/10.1016%2FS0140-6736%2814%2962119-X">10.1016/S0140-6736(14)62119-X</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Position statement on opportunistic genomic screening from the Association of Genetic Nurses and Counsellors (UK and Ireland).</h4>
<p class="authors"><span class="author">Middleton A</span>, <span class="author">Patch C</span>, <span class="author">Wiggins J</span>, <span class="author">Barnes K</span>, <span class="author">Crawford G</span>, <span class="author">Benjamin C</span> and <span class="author">Bruce A</span></p>
<p class="affiliation">Human Genetics, Wellcome Trust Sanger Institute, Cambridge, UK.</p>
<p class="abstract">The American College of Medical Genetics and Genomics released recommendations for reporting incidental findings (IFs) in clinical exome and genome sequencing. These suggest 'opportunistic genomic screening' should be available to both adults and children each time a sequence is done and would be undertaken without seeking preferences from the patient first. Should opportunistic genomic screening be implemented in the United Kingdom, the Association of Genetic Nurses and Counsellors (AGNC), which represents British and Irish genetic counsellors and nurses, feels strongly that the following must be considered (see article for complete list): (1) Following appropriate genetic counselling, patients should be allowed to consent to or opt out of opportunistic genomic screening. (2) If true IFs are discovered the AGNC are guided by the report from the Joint Committee on Medical Genetics about the sharing of genetic testing results. (3) Children should not be routinely tested for adult-onset conditions. (4) The formation of a list of variants should involve a representative from the AGNC as well as a patient support group. (5) The variants should be for serious or life-threatening conditions for which there are treatments or preventative strategies available. (6) There needs to be robust evidence that the benefits of opportunistic screening outweigh the potential harms. (7) The clinical validity and utility of variants should be known. (8) There must be a quality assurance framework that operates to International standards for laboratory testing. (9) Psychosocial research is urgently needed in this area to understand the impact on patients.European Journal of Human Genetics advance online publication, 8 January 2014; doi:10.1038/ejhg.2013.301.</p>
<p class="publication"><span class="title">European journal of human genetics : EJHG</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24398792">24398792</a>; DOI: <a href="http://dx.doi.org/10.1038%2Fejhg.2013.301">10.1038/ejhg.2013.301</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">The International Cancer Genome Consortium&#39;s evolving data-protection policies.</h4>
<p class="authors"><span class="author">Milius D</span>, <span class="author">Dove ES</span>, <span class="author">Chalmers D</span>, <span class="author">Dyke SO</span>, <span class="author">Kato K</span>, <span class="author">Nicol&aacute;s P</span>, <span class="author">Ouellette BF</span>, <span class="author">Ozenberger B</span>, <span class="author">Rodriguez LL</span>, <span class="author">Zeps N</span> and <span class="author">Joly Y</span></p>
<p class="affiliation">Centre of Genomics and Policy, McGill University, Montreal, Quebec, Canada.</p>
<p class="publication"><span class="title">Nature biotechnology</span>&nbsp;<span class="year">2014</span>;<span class="volume">32</span>;<span class="number">6</span>;<span class="pagerange">519-23</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24911490">24911490</a>; DOI: <a href="http://dx.doi.org/10.1038%2Fnbt.2926">10.1038/nbt.2926</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Metabolic and Target-Site Mechanisms Combine to Confer Strong DDT Resistance in Anopheles gambiae.</h4>
<p class="authors"><span class="author">Mitchell SN</span>, <span class="author">Rigden DJ</span>, <span class="author">Dowd AJ</span>, <span class="author">Lu F</span>, <span class="author">Wilding CS</span>, <span class="author">Weetman D</span>, <span class="author">Dadzie S</span>, <span class="author">Jenkins AM</span>, <span class="author">Regna K</span>, <span class="author">Boko P</span>, <span class="author">Djogbenou L</span>, <span class="author">Muskavitch MA</span>, <span class="author">Ranson H</span>, <span class="author">Paine MJ</span>, <span class="author">Mayans O</span> and <span class="author">Donnelly MJ</span></p>
<p class="affiliation">Department of Vector Biology, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.</p><p class="abstract">The development of resistance to insecticides has become a classic exemplar of evolution occurring within human time scales. In this study we demonstrate how resistance to DDT in the major African malaria vector Anopheles gambiae is a result of both target-site resistance mechanisms that have introgressed between incipient species (the M- and S-molecular forms) and allelic variants in a DDT-detoxifying enzyme. Sequencing of the detoxification enzyme, Gste2, from DDT resistant and susceptible strains of An. gambiae, revealed a non-synonymous polymorphism (I114T), proximal to the DDT binding domain, which segregated with strain phenotype. Recombinant protein expression and DDT metabolism analysis revealed that the proteins from the susceptible strain lost activity at higher DDT concentrations, characteristic of substrate inhibition. The effect of I114T on GSTE2 protein structure was explored through X-ray crystallography. The amino acid exchange in the DDT-resistant strain introduced a hydroxyl group nearby the hydrophobic DDT-binding region. The exchange does not result in structural alterations but is predicted to facilitate local dynamics and enzyme activity. Expression of both wild-type and 114T alleles the allele in Drosophila conferred an increase in DDT tolerance. The 114T mutation was significantly associated with DDT resistance in wild caught M-form populations and acts in concert with target-site mutations in the voltage gated sodium channel (Vgsc-1575Y and Vgsc-1014F) to confer extreme levels of DDT resistance in wild caught An. gambiae.</p>
<p class="publication"><span class="title">PloS one</span>&nbsp;<span class="year">2014</span>;<span class="volume">9</span>;<span class="number">3</span>;<span class="pagerange">e92662</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24675797">24675797</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC3968025">3968025</a>; DOI: <a href="http://dx.doi.org/10.1371%2Fjournal.pone.0092662">10.1371/journal.pone.0092662</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Genome-wide analysis of selection on the malaria parasite Plasmodium falciparum in West African populations of differing infection endemicity.</h4>
<p class="authors"><span class="author">Mobegi VA</span>, <span class="author">Duffy CW</span>, <span class="author">Amambua-Ngwa A</span>, <span class="author">Loua KM</span>, <span class="author">Laman E</span>, <span class="author">Nwakanma DC</span>, <span class="author">Macinnis B</span>, <span class="author">Aspeling-Jones H</span>, <span class="author">Murray L</span>, <span class="author">Clark TG</span>, <span class="author">Kwiatkowski DP</span> and <span class="author">Conway DJ</span></p>
<p class="affiliation">Pathogen Molecular Biology Department, London School of Hygiene and Tropical Medicine, London, UK; Medical Research Council Unit, Fajara, Banjul, The Gambia; National Institute of Public Health, Conakry, Republic of Guinea; The Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK; Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK.</p><p class="abstract">Locally varying selection on pathogens may be due to differences in drug pressure, host immunity, transmission opportunities between hosts, or the intensity of between-genotype competition within hosts. Highly recombining populations of the human malaria parasite Plasmodium falciparum throughout West Africa are closely related, as gene flow is relatively unrestricted in this endemic region, but markedly varying ecology and transmission intensity should cause distinct local selective pressures. Genome-wide analysis of sequence variation was undertaken on a sample of 100 P. falciparum clinical isolates from a highly endemic region of the Republic of Guinea where transmission occurs for most of each year, and compared with data from 52 clinical isolates from a previously sampled population from The Gambia where there is relatively limited seasonal malaria transmission. Paired-end short read sequences were mapped against the 3D7 P. falciparum reference genome sequence, and data on 136144 SNPs were obtained. Within-population analyses identifying loci showing evidence of recent positive directional selection and balancing selection confirm that antimalarial drugs and host immunity have been major selective agents. Many of the signatures of recent directional selection reflected by standardised integrated haplotype scores (|iHS|) were population-specific, including differences at drug resistance loci due to historically different antimalarial use between the countries. In contrast, both populations showed a similar set of loci likely to be under balancing selection as indicated by very high Tajima&#39;s D values, including a significant over-representation of genes expressed at the merozoite stage that invades erythrocytes, and several previously validated targets of acquired immunity. Between-population FST analysis identified exceptional differentiation of allele frequencies at a small number of loci, most markedly for five SNPs covering a 15kb region within and flanking the gdv1 gene that regulates the early stages of gametocyte development, which is likely related to the extreme differences in mosquito vector abundance and seasonality which determine the transmission opportunities for the sexual stage of the parasite.</p>
<p class="publication"><span class="title">Molecular biology and evolution</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24644299">24644299</a>; DOI: <a href="http://dx.doi.org/10.1093%2Fmolbev%2Fmsu106">10.1093/molbev/msu106</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Population transcriptomics of human malaria parasites reveals the mechanism of artemisinin resistance.</h4>
<p class="authors"><span class="author">Mok S</span>, <span class="author">Ashley EA</span>, <span class="author">Ferreira PE</span>, <span class="author">Zhu L</span>, <span class="author">Lin Z</span>, <span class="author">Yeo T</span>, <span class="author">Chotivanich K</span>, <span class="author">Imwong M</span>, <span class="author">Pukrittayakamee S</span>, <span class="author">Dhorda M</span>, <span class="author">Nguon C</span>, <span class="author">Lim P</span>, <span class="author">Amaratunga C</span>, <span class="author">Suon S</span>, <span class="author">Hien TT</span>, <span class="author">Htut Y</span>, <span class="author">Faiz MA</span>, <span class="author">Onyamboko MA</span>, <span class="author">Mayxay M</span>, <span class="author">Newton PN</span>, <span class="author">Tripura R</span>, <span class="author">Woodrow CJ</span>, <span class="author">Miotto O</span>, <span class="author">Kwiatkowski DP</span>, <span class="author">Nosten F</span>, <span class="author">Day NP</span>, <span class="author">Preiser PR</span>, <span class="author">White NJ</span>, <span class="author">Dondorp AM</span>, <span class="author">Fairhurst RM</span> and <span class="author">Bozdech Z</span></p>
<p class="affiliation">School of Biological Sciences, Nanyang Technological University, Singapore.</p><p class="abstract">Artemisinin resistance in Plasmodium falciparum threatens global efforts to control and eliminate malaria. Polymorphisms in the kelch domain-carrying protein K13 are associated with artemisinin resistance, but the underlying molecular mechanisms are unknown. Here we analyze the in-vivo transcriptomes of 1,043 P. falciparum isolates from patients with acute malaria, and show that artemisinin resistance is associated with increased expression of unfolded protein response (UPR) pathways involving the major PROSC and TRiC chaperone complexes. Artemisinin resistant parasites also exhibit decelerated progression through the first part of the asexual intraerythrocytic development cycle. These findings suggest that artemisinin resistant parasites remain in a state of decelerated development at the young ring stage while their upregulated UPR pathways mitigate protein damage caused by artemisinin. The expression profiles of UPR-related genes also associate with the geographical origin of parasite isolates, further suggesting their role in emerging artemisinin resistance in the Greater Mekong Subregion.</p>
<p class="publication"><span class="title">Science (New York, N.Y.)</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25502316">25502316</a>; DOI: <a href="http://dx.doi.org/10.1126%2Fscience.1260403">10.1126/science.1260403</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Comparative analysis of the domestic cat genome reveals genetic signatures underlying feline biology and domestication.</h4>
<p class="authors"><span class="author">Montague MJ</span>, <span class="author">Li G</span>, <span class="author">Gandolfi B</span>, <span class="author">Khan R</span>, <span class="author">Aken BL</span>, <span class="author">Searle SM</span>, <span class="author">Minx P</span>, <span class="author">Hillier LW</span>, <span class="author">Koboldt DC</span>, <span class="author">Davis BW</span>, <span class="author">Driscoll CA</span>, <span class="author">Barr CS</span>, <span class="author">Blackistone K</span>, <span class="author">Quilez J</span>, <span class="author">Lorente-Galdos B</span>, <span class="author">Marques-Bonet T</span>, <span class="author">Alkan C</span>, <span class="author">Thomas GW</span>, <span class="author">Hahn MW</span>, <span class="author">Menotti-Raymond M</span>, <span class="author">O&#39;Brien SJ</span>, <span class="author">Wilson RK</span>, <span class="author">Lyons LA</span>, <span class="author">Murphy WJ</span> and <span class="author">Warren WC</span></p>
<p class="affiliation">The Genome Institute, Washington University School of Medicine, St. Louis, MO 63108;</p><p class="abstract">Little is known about the genetic changes that distinguish domestic cat populations from their wild progenitors. Here we describe a high-quality domestic cat reference genome assembly and comparative inferences made with other cat breeds, wildcats, and other mammals. Based upon these comparisons, we identified positively selected genes enriched for genes involved in lipid metabolism that underpin adaptations to a hypercarnivorous diet. We also found positive selection signals within genes underlying sensory processes, especially those affecting vision and hearing in the carnivore lineage. We observed an evolutionary tradeoff between functional olfactory and vomeronasal receptor gene repertoires in the cat and dog genomes, with an expansion of the feline chemosensory system for detecting pheromones at the expense of odorant detection. Genomic regions harboring signatures of natural selection that distinguish domestic cats from their wild congeners are enriched in neural crest-related genes associated with behavior and reward in mouse models, as predicted by the domestication syndrome hypothesis. Our description of a previously unidentified allele for the gloving pigmentation pattern found in the Birman breed supports the hypothesis that cat breeds experienced strong selection on specific mutations drawn from random bred populations. Collectively, these findings provide insight into how the process of domestication altered the ancestral wildcat genome and build a resource for future disease mapping and phylogenomic studies across all members of the Felidae.</p>
<p class="publication"><span class="title">Proceedings of the National Academy of Sciences of the United States of America</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25385592">25385592</a>; DOI: <a href="http://dx.doi.org/10.1073%2Fpnas.1410083111">10.1073/pnas.1410083111</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Widespread epidemic cholera caused by a restricted subset of Vibrio cholerae clones.</h4>
<p class="authors"><span class="author">Moore S</span>, <span class="author">Thomson N</span>, <span class="author">Mutreja A</span> and <span class="author">Piarroux R</span></p>
<p class="affiliation">Aix-Marseille University, UMR MD3, Marseilles, France.</p><p class="abstract">Since 1817, seven cholera pandemics have plagued humankind. As the causative agent, Vibrio cholerae, is autochthonous in the aquatic ecosystem and some studies have revealed links between outbreaks and fluctuations in climatic and aquatic conditions, it has been widely assumed that cholera epidemics are triggered by environmental factors that promote the growth of local bacterial reservoirs. However, mounting epidemiological findings and genome sequence analysis of clinical isolates have indicated that epidemics are largely unassociated with most of the V.&nbsp;cholerae strains in aquatic ecosystems. Instead, only a specific subset of V.&nbsp;cholerae El Tor &#39;types&#39; appears to be responsible for current epidemics. A recent report examining the evolution of a variety of V.&nbsp;cholerae strains indicates that the current pandemic is monophyletic and originated from a single ancestral clone that has spread globally in successive waves. In this review, we examine the clonal nature of the disease, with the example of the recent history of cholera in the Americas. Epidemiological data and genome sequence-based analysis of V.&nbsp;cholerae isolates demonstrate that the cholera epidemics of the 1990s in South America were triggered by the importation of a pathogenic V.&nbsp;cholerae strain that gradually spread throughout the region until local outbreaks ceased in 2001. Latin America remained almost unaffected by the disease until a new toxigenic V.&nbsp;cholerae clone was imported into Haiti in 2010. Overall, cholera appears to be largely caused by a subset of specific V.&nbsp;cholerae clones rather than by the vast diversity of V.&nbsp;cholerae strains in the environment.</p>
<p class="publication"><span class="title">Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24575898">24575898</a>; DOI: <a href="http://dx.doi.org/10.1111%2F1469-0691.12610">10.1111/1469-0691.12610</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Heterogeneity in the frequency and characteristics of homologous recombination in pneumococcal evolution.</h4>
<p class="authors"><span class="author">Mostowy R</span>, <span class="author">Croucher NJ</span>, <span class="author">Hanage WP</span>, <span class="author">Harris SR</span>, <span class="author">Bentley S</span> and <span class="author">Fraser C</span></p>
<p class="affiliation">Department of Infectious Disease Epidemiology, Imperial College London, St Mary&#39;s Campus, London, United Kingdom.</p><p class="abstract">The bacterium Streptococcus pneumoniae (pneumococcus) is one of the most important human bacterial pathogens, and a leading cause of morbidity and mortality worldwide. The pneumococcus is also known for undergoing extensive homologous recombination via transformation with exogenous DNA. It has been shown that recombination has a major impact on the evolution of the pathogen, including acquisition of antibiotic resistance and serotype-switching. Nevertheless, the mechanism and the rates of recombination in an epidemiological context remain poorly understood. Here, we proposed several mathematical models to describe the rate and size of recombination in the evolutionary history of two very distinct pneumococcal lineages, PMEN1 and CC180. We found that, in both lineages, the process of homologous recombination was best described by a heterogeneous model of recombination with single, short, frequent replacements, which we call micro-recombinations, and rarer, multi-fragment, saltational replacements, which we call macro-recombinations. Macro-recombination was associated with major phenotypic changes, including serotype-switching events, and thus was a major driver of the diversification of the pathogen. We critically evaluate biological and epidemiological processes that could give rise to the micro-recombination and macro-recombination processes.</p>
<p class="publication"><span class="title">PLoS genetics</span>&nbsp;<span class="year">2014</span>;<span class="volume">10</span>;<span class="number">5</span>;<span class="pagerange">e1004300</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24786281">24786281</a>; DOI: <a href="http://dx.doi.org/10.1371%2Fjournal.pgen.1004300">10.1371/journal.pgen.1004300</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">A New Method To Determine In Vivo Interactomes Reveals Binding of the Legionella pneumophila Effector PieE to Multiple Rab GTPases.</h4>
<p class="authors"><span class="author">Mousnier A</span>, <span class="author">Schroeder GN</span>, <span class="author">Stoneham CA</span>, <span class="author">So EC</span>, <span class="author">Garnett JA</span>, <span class="author">Yu L</span>, <span class="author">Matthews SJ</span>, <span class="author">Choudhary JS</span>, <span class="author">Hartland EL</span> and <span class="author">Frankel G</span></p>
<p class="affiliation">MRC Centre for Molecular Bacteriology and Infection, Department of Life Sciences, Imperial College London, London, United Kingdom.</p><p class="abstract"><strong>Unlabelled</strong>: Legionella pneumophila, the causative agent of Legionnaires&#39; disease, uses the Dot/Icm type IV secretion system (T4SS) to translocate more than 300 effectors into host cells, where they subvert host cell signaling. The function and host cell targets of most effectors remain unknown. PieE is a 69-kDa Dot/Icm effector containing three coiled-coil (CC) regions and 2 transmembrane (TM) helices followed by a fourth CC region. Here, we report that PieE dimerized by an interaction between CC3 and CC4. We found that ectopically expressed PieE localized to the endoplasmic reticulum (ER) and induced the formation of organized smooth ER, while following infection PieE localized to the Legionella-containing vacuole (LCV). To identify the physiological targets of PieE during infection, we established a new purification method for which we created an A549 cell line stably expressing the Escherichia coli biotin ligase BirA and infected the cells with L.&nbsp;pneumophila expressing PieE fused to a BirA-specific biotinylation site and a hexahistidine tag. Following tandem Ni(2+) nitrilotriacetic acid (NTA) and streptavidin affinity chromatography, the effector-target complexes were analyzed by mass spectrometry. This revealed interactions of PieE with multiple host cell proteins, including the Rab GTPases 1a, 1b, 2a, 5c, 6a, 7, and 10. Binding of the Rab GTPases, which was validated by yeast two-hybrid binding assays, was mediated by the PieE CC1 and CC2. In summary, using a novel, highly specific strategy to purify effector complexes from infected cells, which is widely applicable to other pathogens, we identified PieE as a multidomain LCV protein with promiscuous Rab GTPase-binding capacity.</p><p class="abstract"><strong>Importance</strong>: The respiratory pathogen Legionella pneumophila uses the Dot/Icm type IV secretion system to translocate more than 300 effector proteins into host cells. The function of most effectors in infection remains unknown. One of the bottlenecks for their characterization is the identification of target proteins. Frequently used in vitro approaches are not applicable to all effectors and suffer from high rates of false positives or missed interactions, as they are not performed in the context of an infection. Here, we determine key functional domains of the effector PieE and describe a new method to identify host cell targets under physiological infection conditions. Our approach, which is applicable to other pathogens, uncovered the interaction of PieE with several proteins involved in membrane trafficking, in particular Rab GTPases, revealing new details of the Legionella infection strategy and demonstrating the potential of this method to greatly advance our understanding of the molecular basis of infection.</p>
<p class="publication"><span class="title">mBio</span>&nbsp;<span class="year">2014</span>;<span class="volume">5</span>;<span class="number">4</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25118235">25118235</a>; DOI: <a href="http://dx.doi.org/10.1128%2FmBio.01148-14">10.1128/mBio.01148-14</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Genome wide association study of fetal hemoglobin in sickle cell anemia in Tanzania.</h4>
<p class="authors"><span class="author">Mtatiro SN</span>, <span class="author">Singh T</span>, <span class="author">Rooks H</span>, <span class="author">Mgaya J</span>, <span class="author">Mariki H</span>, <span class="author">Soka D</span>, <span class="author">Mmbando B</span>, <span class="author">Msaki E</span>, <span class="author">Kolder I</span>, <span class="author">Thein SL</span>, <span class="author">Menzel S</span>, <span class="author">Cox SE</span>, <span class="author">Makani J</span> and <span class="author">Barrett JC</span></p>
<p class="affiliation">Muhimbili Wellcome Programme, Department of Haematology and Blood Transfusion, Muhimbili University of Health and Allied Science, Dar-es-salaam, Tanzania; Department of Biological Sciences, Dar es Salaam University College of Education, Dar-es-salaam, Tanzania.</p><p class="abstract"><strong>Background</strong>: Fetal hemoglobin (HbF) is an important modulator of sickle cell disease (SCD). HbF has previously been shown to be affected by variants at three loci on chromosomes 2, 6 and 11, but it is likely that additional loci remain to be discovered.</p><p class="abstract">We conducted a genome-wide association study (GWAS) in 1,213 SCA (HbSS/HbS&beta;0) patients in Tanzania. Genotyping was done with Illumina Omni2.5 array and imputation using 1000 Genomes Phase I release data. Association with HbF was analysed using a linear mixed model to control for complex population structure within our study. We successfully replicated known associations for HbF near BCL11A and the HBS1L-MYB intergenic polymorphisms (HMIP), including multiple independent effects near BCL11A, consistent with previous reports. We observed eight additional associations with P&lt;10-6. These associations could not be replicated in a SCA population in the UK.</p><p class="abstract"><strong>Conclusions</strong>: This is the largest GWAS study in SCA in Africa. We have confirmed known associations and identified new genetic associations with HbF that require further replication in SCA populations in Africa.</p>
<p class="publication"><span class="title">PloS one</span>&nbsp;<span class="year">2014</span>;<span class="volume">9</span>;<span class="number">11</span>;<span class="pagerange">e111464</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25372704">25372704</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4221031">4221031</a>; DOI: <a href="http://dx.doi.org/10.1371%2Fjournal.pone.0111464">10.1371/journal.pone.0111464</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Reciprocal duplication of the williams-beuren syndrome deletion on chromosome 7q11.23 is associated with schizophrenia.</h4>
<p class="authors"><span class="author">Mulle JG</span>, <span class="author">Pulver AE</span>, <span class="author">McGrath JA</span>, <span class="author">Wolyniec PS</span>, <span class="author">Dodd AF</span>, <span class="author">Cutler DJ</span>, <span class="author">Sebat J</span>, <span class="author">Malhotra D</span>, <span class="author">Nestadt G</span>, <span class="author">Conrad DF</span>, <span class="author">Hurles M</span>, <span class="author">Barnes CP</span>, <span class="author">Ikeda M</span>, <span class="author">Iwata N</span>, <span class="author">Levinson DF</span>, <span class="author">Gejman PV</span>, <span class="author">Sanders AR</span>, <span class="author">Duan J</span>, <span class="author">Mitchell AA</span>, <span class="author">Peter I</span>, <span class="author">Sklar P</span>, <span class="author">O&#39;Dushlaine CT</span>, <span class="author">Grozeva D</span>, <span class="author">O&#39;Donovan MC</span>, <span class="author">Owen MJ</span>, <span class="author">Hultman CM</span>, <span class="author">K&auml;hler AK</span>, <span class="author">Sullivan PF</span>, <span class="author">Molecular Genetics of Schizophrenia Consortium</span>, <span class="author">Kirov G</span> and <span class="author">Warren ST</span></p>
<p class="affiliation">Department of Epidemiology, Rollins School of Public Health, Emory University; Department of Human Genetics, Emory University School of Medicine, Atlanta, Georgia. Electronic address: <a href="mailto:%6A%6D%75%6C%6C%65%40%65%6D%6F%72%79.%65%64%75">&#106;&#109;&#117;&#108;&#108;&#101;&#64;&#101;&#109;&#111;&#114;&#121;&#46;&#101;&#100;&#117;</a>.</p><p class="abstract"><strong>Background</strong>: Several copy number variants (CNVs) have been implicated as susceptibility factors for schizophrenia (SZ). Some of these same CNVs also increase risk for autism spectrum disorders, suggesting an etiologic overlap between these conditions. Recently, de novo duplications of a region on chromosome 7q11.23 were associated with autism spectrum disorders. The reciprocal deletion of this region causes Williams-Beuren syndrome.</p><p class="abstract"><strong>Methods</strong>: We assayed an Ashkenazi Jewish cohort of 554 SZ cases and 1014 controls for genome-wide CNV. An excess of large rare and de novo CNVs were observed, including a 1.4 Mb duplication on chromosome 7q11.23 identified in two unrelated patients. To test whether this 7q11.23 duplication is also associated with SZ, we obtained data for 14,387 SZ cases and 28,139 controls from seven additional studies with high-resolution genome-wide CNV detection. We performed a meta-analysis, correcting for study population of origin, to assess whether the duplication is associated with SZ.</p><p class="abstract"><strong>Results</strong>: We found duplications at 7q11.23 in 11 of 14,387 SZ cases with only 1 in 28,139 control subjects (unadjusted odds ratio 21.52, 95% confidence interval: 3.13-922.6, p value 5.5 &times; 10(-5); adjusted odds ratio 10.8, 95% confidence interval: 1.46-79.62, p value .007). Of three SZ duplication carriers with detailed retrospective data, all showed social anxiety and language delay premorbid to SZ onset, consistent with both human studies and animal models of the 7q11.23 duplication.</p><p class="abstract"><strong>Conclusions</strong>: We have identified a new CNV associated with SZ. Reciprocal duplication of the Williams-Beuren syndrome deletion at chromosome 7q11.23 confers an approximately tenfold increase in risk for SZ.</p>
<p class="grants">Funded by: Medical Research Council: <span class="grant">G0800509</span>; NIMH NIH HHS: <span class="grant">R01 MH080129</span>, <span class="grant">U01 MH094411</span></p>
<p class="publication"><span class="title">Biological psychiatry</span>&nbsp;<span class="year">2014</span>;<span class="volume">75</span>;<span class="number">5</span>;<span class="pagerange">371-7</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/23871472">23871472</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC3838485">3838485</a>; DOI: <a href="http://dx.doi.org/10.1016%2Fj.biopsych.2013.05.040">10.1016/j.biopsych.2013.05.040</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">A recurrent de novo mutation in KCNC1 causes progressive myoclonus epilepsy.</h4>
<p class="authors"><span class="author">Muona M</span>, <span class="author">Berkovic SF</span>, <span class="author">Dibbens LM</span>, <span class="author">Oliver KL</span>, <span class="author">Maljevic S</span>, <span class="author">Bayly MA</span>, <span class="author">Joensuu T</span>, <span class="author">Canafoglia L</span>, <span class="author">Franceschetti S</span>, <span class="author">Michelucci R</span>, <span class="author">Markkinen S</span>, <span class="author">Heron SE</span>, <span class="author">Hildebrand MS</span>, <span class="author">Andermann E</span>, <span class="author">Andermann F</span>, <span class="author">Gambardella A</span>, <span class="author">Tinuper P</span>, <span class="author">Licchetta L</span>, <span class="author">Scheffer IE</span>, <span class="author">Criscuolo C</span>, <span class="author">Filla A</span>, <span class="author">Ferlazzo E</span>, <span class="author">Ahmad J</span>, <span class="author">Ahmad A</span>, <span class="author">Baykan B</span>, <span class="author">Said E</span>, <span class="author">Topcu M</span>, <span class="author">Riguzzi P</span>, <span class="author">King MD</span>, <span class="author">Ozkara C</span>, <span class="author">Andrade DM</span>, <span class="author">Engelsen BA</span>, <span class="author">Crespel A</span>, <span class="author">Lindenau M</span>, <span class="author">Lohmann E</span>, <span class="author">Saletti V</span>, <span class="author">Massano J</span>, <span class="author">Privitera M</span>, <span class="author">Espay AJ</span>, <span class="author">Kauffmann B</span>, <span class="author">Duchowny M</span>, <span class="author">M&oslash;ller RS</span>, <span class="author">Straussberg R</span>, <span class="author">Afawi Z</span>, <span class="author">Ben-Zeev B</span>, <span class="author">Samocha KE</span>, <span class="author">Daly MJ</span>, <span class="author">Petrou S</span>, <span class="author">Lerche H</span>, <span class="author">Palotie A</span> and <span class="author">Lehesjoki AE</span></p>
<p class="affiliation">1] Institute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland. [2] Folkh&auml;lsan Institute of Genetics, Helsinki, Finland. [3] Neuroscience Center, University of Helsinki, Helsinki, Finland. [4] Research Programs Unit, Molecular Neurology, University of Helsinki, Helsinki, Finland.</p><p class="abstract">Progressive myoclonus epilepsies (PMEs) are a group of rare, inherited disorders manifesting with action myoclonus, tonic-clonic seizures and ataxia. We sequenced the exomes of 84 unrelated individuals with PME of unknown cause and molecularly solved 26 cases (31%). Remarkably, a recurrent de novo mutation, c.959G&gt;A (p.Arg320His), in KCNC1 was identified as a new major cause for PME. Eleven unrelated exome-sequenced (13%) and two affected individuals in a secondary cohort (7%) had this mutation. KCNC1 encodes KV3.1, a subunit of the KV3 voltage-gated potassium ion channels, which are major determinants of high-frequency neuronal firing. Functional analysis of the Arg320His mutant channel showed a dominant-negative loss-of-function effect. Ten cases had pathogenic mutations in known PME-associated genes (NEU1, NHLRC1, AFG3L2, EPM2A, CLN6 and SERPINI1). Identification of mutations in PRNP, SACS and TBC1D24 expand their phenotypic spectra to PME. These findings provide insights into the molecular genetic basis of PME and show the role of de novo mutations in this disease entity.</p>
<p class="publication"><span class="title">Nature genetics</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25401298">25401298</a>; DOI: <a href="http://dx.doi.org/10.1038%2Fng.3144">10.1038/ng.3144</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Transmissible [corrected] dog cancer genome reveals the origin and history of an ancient cell lineage.</h4>
<p class="authors"><span class="author">Murchison EP</span>, <span class="author">Wedge DC</span>, <span class="author">Alexandrov LB</span>, <span class="author">Fu B</span>, <span class="author">Martincorena I</span>, <span class="author">Ning Z</span>, <span class="author">Tubio JM</span>, <span class="author">Werner EI</span>, <span class="author">Allen J</span>, <span class="author">De Nardi AB</span>, <span class="author">Donelan EM</span>, <span class="author">Marino G</span>, <span class="author">Fassati A</span>, <span class="author">Campbell PJ</span>, <span class="author">Yang F</span>, <span class="author">Burt A</span>, <span class="author">Weiss RA</span> and <span class="author">Stratton MR</span></p>
<p class="affiliation">Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK.</p><p class="abstract">Canine transmissible venereal tumor (CTVT) is the oldest known somatic cell lineage. It is a transmissible cancer that propagates naturally in dogs. We sequenced the genomes of two CTVT tumors and found that CTVT has acquired 1.9 million somatic substitution mutations and bears evidence of exposure to ultraviolet light. CTVT is remarkably stable and lacks subclonal heterogeneity despite thousands of rearrangements, copy-number changes, and retrotransposon insertions. More than 10,000 genes carry nonsynonymous variants, and 646 genes have been lost. CTVT first arose in a dog with low genomic heterozygosity that may have lived about 11,000 years ago. The cancer spawned by this individual dispersed across continents about 500 years ago. Our results provide a genetic identikit of an ancient dog and demonstrate the robustness of mammalian somatic cells to survive for millennia despite a massive mutation burden.</p>
<p class="grants">Funded by: Wellcome Trust: <span class="grant">098051</span></p>
<p class="publication"><span class="title">Science (New York, N.Y.)</span>&nbsp;<span class="year">2014</span>;<span class="volume">343</span>;<span class="number">6169</span>;<span class="pagerange">437-40</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24458646">24458646</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC3918581">3918581</a>; DOI: <a href="http://dx.doi.org/10.1126%2Fscience.1247167">10.1126/science.1247167</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">The use of anthropometric measures for cardiometabolic risk identification in a rural African population.</h4>
<p class="authors"><span class="author">Murphy GA</span>, <span class="author">Asiki G</span>, <span class="author">Nsubuga RN</span>, <span class="author">Young EH</span>, <span class="author">Seeley J</span>, <span class="author">Sandhu MS</span> and <span class="author">Kamali A</span></p>
<p class="affiliation">Corresponding author: Georgina A.V. Murphy, <a href="mailto:%67%6D%37%40%73%61%6E%67%65%72.%61%63.%75%6B">&#103;&#109;&#55;&#64;&#115;&#97;&#110;&#103;&#101;&#114;&#46;&#97;&#99;&#46;&#117;&#107;</a>.</p>
<p class="grants">Funded by: Medical Research Council: <span class="grant">G0801566</span>, <span class="grant">G0901213</span>, <span class="grant">G0901213-92157</span>, <span class="grant">MR/K013491/1</span></p>
<p class="publication"><span class="title">Diabetes care</span>&nbsp;<span class="year">2014</span>;<span class="volume">37</span>;<span class="number">4</span>;<span class="pagerange">e64-5</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24652731">24652731</a>; DOI: <a href="http://dx.doi.org/10.2337%2Fdc13-2096">10.2337/dc13-2096</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Extreme Growth Failure is a Common Presentation of Ligase IV Deficiency.</h4>
<p class="authors"><span class="author">Murray JE</span>, <span class="author">Bicknell LS</span>, <span class="author">Yigit G</span>, <span class="author">Duker AL</span>, <span class="author">van Kogelenberg M</span>, <span class="author">Haghayegh S</span>, <span class="author">Wieczorek D</span>, <span class="author">Kayserili H</span>, <span class="author">Albert MH</span>, <span class="author">Wise CA</span>, <span class="author">Brandon J</span>, <span class="author">Kleefstra T</span>, <span class="author">Warris A</span>, <span class="author">van der Flier M</span>, <span class="author">Bamforth JS</span>, <span class="author">Doonanco K</span>, <span class="author">Ad&egrave;s L</span>, <span class="author">Ma A</span>, <span class="author">Field M</span>, <span class="author">Johnson D</span>, <span class="author">Shackley F</span>, <span class="author">Firth H</span>, <span class="author">Woods CG</span>, <span class="author">N&uuml;rnberg P</span>, <span class="author">Gatti RA</span>, <span class="author">Hurles M</span>, <span class="author">Bober MB</span>, <span class="author">Wollnik B</span> and <span class="author">Jackson AP</span></p>
<p class="affiliation">MRC Human Genetics Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK.</p>
<p class="abstract">Ligase IV syndrome is a rare differential diagnosis for Nijmegen breakage syndrome owing to a shared predisposition to lympho-reticular malignancies, significant microcephaly, and radiation hypersensitivity. Only 16 cases with mutations in LIG4 have been described to date with phenotypes varying from malignancy in developmentally normal individuals, to severe combined immunodeficiency and early mortality. Here, we report the identification of biallelic truncating LIG4 mutations in 11 patients with microcephalic primordial dwarfism presenting with restricted prenatal growth and extreme postnatal global growth failure (average OFC -10.1 s.d., height -5.1 s.d.). Subsequently, most patients developed thrombocytopenia and leucopenia later in childhood and many were found to have previously unrecognized immunodeficiency following molecular diagnosis. None have yet developed malignancy, though all patients tested had cellular radiosensitivity. A genotype-phenotype correlation was also noted with position of truncating mutations corresponding to disease severity. This work extends the phenotypic spectrum associated with LIG4 mutations, establishing that extreme growth retardation with microcephaly is a common presentation of bilallelic truncating mutations. Such growth failure is therefore sufficient to consider a diagnosis of LIG4 deficiency and early recognition of such cases is important as bone marrow failure, immunodeficiency, and sometimes malignancy are long term sequelae of this disorder.</p>
<p class="publication"><span class="title">Human mutation</span>&nbsp;<span class="year">2014</span>;<span class="volume">35</span>;<span class="number">1</span>;<span class="pagerange">76-85</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24123394">24123394</a>; DOI: <a href="http://dx.doi.org/10.1002%2Fhumu.22461">10.1002/humu.22461</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Differential methylation of the TRPA1 promoter in pain sensitivity.</h4>
<p class="authors"><span class="author">MuTHER Consortium</span></p><p class="abstract">Chronic pain is a global public health problem, but the underlying molecular mechanisms are not fully understood. Here we examine genome-wide DNA methylation, first in 50 identical twins discordant for heat pain sensitivity and then in 50 further unrelated individuals. Whole-blood DNA methylation was characterized at 5.2 million loci by MeDIP sequencing and assessed longitudinally to identify differentially methylated regions associated with high or low pain sensitivity (pain DMRs). Nine meta-analysis pain DMRs show robust evidence for association (false discovery rate 5%) with the strongest signal in the pain gene TRPA1 (P=1.2 &times; 10(-13)). Several pain DMRs show longitudinal stability consistent with susceptibility effects, have similar methylation levels in the brain and altered expression in the skin. Our approach identifies epigenetic changes in both novel and established candidate genes that provide molecular insights into pain and may generalize to other complex traits.</p>
<p class="publication"><span class="title">Nature communications</span>&nbsp;<span class="year">2014</span>;<span class="volume">5</span>;<span class="pagerange">2978</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24496475">24496475</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC3926001">3926001</a>; DOI: <a href="http://dx.doi.org/10.1038%2Fncomms3978">10.1038/ncomms3978</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Structural genomic variation as risk factor for idiopathic recurrent miscarriage.</h4>
<p class="authors"><span class="author">Nagirnaja L</span>, <span class="author">Palta P</span>, <span class="author">Kasak L</span>, <span class="author">Rull K</span>, <span class="author">Christiansen OB</span>, <span class="author">Nielsen HS</span>, <span class="author">Steffensen R</span>, <span class="author">Esko T</span>, <span class="author">Remm M</span> and <span class="author">Laan M</span></p>
<p class="affiliation">Human Molecular Genetics Research Group, Institute of Molecular and Cell Biology, University of Tartu, Tartu, Estonia.</p><p class="abstract">Recurrent miscarriage (RM) is a multifactorial disorder with acknowledged genetic heritability that affects &sim;3% of couples aiming at childbirth. As copy number variants (CNVs) have been shown to contribute to reproductive disease susceptibility, we aimed to describe genome-wide profile of CNVs and identify common rearrangements modulating risk to RM. Genome-wide screening of Estonian RM patients and fertile controls identified excessive cumulative burden of CNVs (5.4 and 6.1 Mb per genome) in two RM cases possibly increasing their individual disease risk. Functional profiling of all rearranged genes within RM study group revealed significant enrichment of loci related to innate immunity and immunoregulatory pathways essential for immune tolerance at fetomaternal interface. As a major finding, we report a multicopy duplication (61.6&nbsp;kb) at 5p13.3 conferring increased maternal risk to RM in Estonia and Denmark (meta-analysis, n = 309/205, odds ratio = 4.82, P = 0.012). Comparison to Estonian population-based cohort (total, n = 1000) confirmed the risk for Estonian female cases (P = 7.9 &times; 10(-4) ). Datasets of four cohorts from the Database of Genomic Variants (total, n = 5,846 subjects) exhibited similar low duplication prevalence worldwide (0.7%-1.2%) compared to RM cases of this study (6.6%-7.5%). The CNV disrupts PDZD2 and GOLPH3 genes predominantly expressed in placenta and it may represent a novel risk factor for pregnancy complications.</p>
<p class="publication"><span class="title">Human mutation</span>&nbsp;<span class="year">2014</span>;<span class="volume">35</span>;<span class="number">8</span>;<span class="pagerange">972-82</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24827138">24827138</a>; DOI: <a href="http://dx.doi.org/10.1002%2Fhumu.22589">10.1002/humu.22589</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Burkholderia pseudomallei sequencing identifies genomic clades with distinct recombination, accessory and epigenetic profiles.</h4>
<p class="authors"><span class="author">Nandi T</span>, <span class="author">Holden M</span>, <span class="author">Didelot X</span>, <span class="author">Mehershahi K</span>, <span class="author">Boddey JA</span>, <span class="author">Beacham I</span>, <span class="author">Peak I</span>, <span class="author">Harting J</span>, <span class="author">Baybayan P</span>, <span class="author">Guo Y</span>, <span class="author">Wang S</span>, <span class="author">Lee CH</span>, <span class="author">Sim B</span>, <span class="author">Essex-Lopresti A</span>, <span class="author">Sarkar-Tyson M</span>, <span class="author">Nelson M</span>, <span class="author">Smither S</span>, <span class="author">Ong C</span>, <span class="author">Aw LT</span>, <span class="author">Chua HH</span>, <span class="author">Michell S</span>, <span class="author">Studholme DJ</span>, <span class="author">Titball RW</span>, <span class="author">Chen SL</span>, <span class="author">Parkhill J</span> and <span class="author">Tan P</span></p>
<p class="affiliation">Genome Institute of Singapore;</p><p class="abstract">Burkholderia pseudomallei (Bp) is the causative agent of melioidosis, a serious infectious disease of human and animals. To investigate population diversity, recombination, and horizontal gene transfer in closely-related Bp isolates, we performed whole-genome sequencing (WGS) on 106 clinical, animal, and environmental strains from a restricted Asian locale. Whole-genome phylogeny resolved multiple genomic clades of Bp largely congruent with multi-locus sequence typing (MLST). We discovered widespread recombination in the Bp core genome, involving hundreds of regions associated with multiple haplotypes. Highly recombinant regions exhibited functional enrichments which may contribute to virulence. We observed striking clade-specific patterns of recombination and accessory gene exchange, and provide evidence that this is likely due to ongoing recombination between clade members. Reciprocally, inter-clade exchanges were rarely observed, suggesting mechanisms restricting gene flow between clades. Interrogation of accessory elements revealed that each clade harbored a distinct complement of restriction-modification (RM) systems, predicted to cause clade-specific patterns of DNA methylation. Using whole-genome methylome sequencing, we confirmed that representative strains from separate clades indeed exhibit distinct methylation profiles. Finally, using an E. coli experimental system, we demonstrate that Bp RM systems can inhibit uptake of non-self DNA. Our data suggests that RM systems on mobile elements, besides preventing invasion of foreign DNA, may also contribute to limit the exchange of genes and gene variants between individuals of the same species. Genomic clades may thus represent functional units of genetic isolation in Bp, modulating intra-species genetic diversity.</p>
<p class="publication"><span class="title">Genome research</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25236617">25236617</a>; DOI: <a href="http://dx.doi.org/10.1101%2Fgr.177543.114">10.1101/gr.177543.114</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">De novo mutations in HCN1 cause early infantile epileptic encephalopathy.</h4>
<p class="authors"><span class="author">Nava C</span>, <span class="author">Dalle C</span>, <span class="author">Rastetter A</span>, <span class="author">Striano P</span>, <span class="author">de Kovel CG</span>, <span class="author">Nabbout R</span>, <span class="author">Canc&egrave;s C</span>, <span class="author">Ville D</span>, <span class="author">Brilstra EH</span>, <span class="author">Gobbi G</span>, <span class="author">Raffo E</span>, <span class="author">Bouteiller D</span>, <span class="author">Marie Y</span>, <span class="author">Trouillard O</span>, <span class="author">Robbiano A</span>, <span class="author">Keren B</span>, <span class="author">Agher D</span>, <span class="author">Roze E</span>, <span class="author">Lesage S</span>, <span class="author">Nicolas A</span>, <span class="author">Brice A</span>, <span class="author">Baulac M</span>, <span class="author">Vogt C</span>, <span class="author">El Hajj N</span>, <span class="author">Schneider E</span>, <span class="author">Suls A</span>, <span class="author">Weckhuysen S</span>, <span class="author">Gormley P</span>, <span class="author">Lehesjoki AE</span>, <span class="author">De Jonghe P</span>, <span class="author">Helbig I</span>, <span class="author">Baulac S</span>, <span class="author">Zara F</span>, <span class="author">Koeleman BP</span>, <span class="author">EuroEPINOMICS RES Consortium</span>, <span class="author">Haaf T</span>, <span class="author">LeGuern E</span> and <span class="author">Depienne C</span></p>
<p class="affiliation">1] INSERM UMR 975, Institut du Cerveau et de la Moelle Epini&egrave;re, H&ocirc;pital Piti&eacute;-Salp&ecirc;tri&egrave;re, Paris, France. [2] CNRS 7225, H&ocirc;pital Piti&eacute;-Salp&ecirc;tri&egrave;re, Paris, France. [3] Universit&eacute; Pierre et Marie Curie-Paris 6 (UPMC), UMRS 975, Paris, France. [4] Assistance Publique-H&ocirc;pitaux de Paris (AP-HP), H&ocirc;pital Piti&eacute;-Salp&ecirc;tri&egrave;re, D&eacute;partement de G&eacute;n&eacute;tique et de Cytog&eacute;n&eacute;tique, Unit&eacute; Fonctionnelle de Neurog&eacute;n&eacute;tique Mol&eacute;culaire et Cellulaire, Paris, France. [5].</p><p class="abstract">Hyperpolarization-activated, cyclic nucleotide-gated (HCN) channels contribute to cationic Ih current in neurons and regulate the excitability of neuronal networks. Studies in rat models have shown that the Hcn1 gene has a key role in epilepsy, but clinical evidence implicating HCN1 mutations in human epilepsy is lacking. We carried out exome sequencing for parent-offspring trios with fever-sensitive, intractable epileptic encephalopathy, leading to the discovery of two de novo missense HCN1 mutations. Screening of follow-up cohorts comprising 157 cases in total identified 4 additional amino acid substitutions. Patch-clamp recordings of Ih currents in cells expressing wild-type or mutant human HCN1 channels showed that the mutations had striking but divergent effects on homomeric channels. Individuals with mutations had clinical features resembling those of Dravet syndrome with progression toward atypical absences, intellectual disability and autistic traits. These findings provide clear evidence that de novo HCN1 point mutations cause a recognizable early-onset epileptic encephalopathy in humans.</p>
<p class="publication"><span class="title">Nature genetics</span>&nbsp;<span class="year">2014</span>;<span class="volume">46</span>;<span class="number">6</span>;<span class="pagerange">640-5</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24747641">24747641</a>; DOI: <a href="http://dx.doi.org/10.1038%2Fng.2952">10.1038/ng.2952</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Global identification of Smad2 and Eomesodermin targets in zebrafish identifies a conserved transcriptional network in mesendoderm and a novel role for Eomesodermin in repression of ectodermal gene expression.</h4>
<p class="authors"><span class="author">Nelson AC</span>, <span class="author">Cutty SJ</span>, <span class="author">Niini M</span>, <span class="author">Stemple DL</span>, <span class="author">Flicek P</span>, <span class="author">Houart C</span>, <span class="author">Bruce AE</span> and <span class="author">Wardle FC</span></p><p class="abstract"><strong>Background</strong>: Nodal signalling is an absolute requirement for normal mesoderm and endoderm formation in vertebrate embryos, yet the transcriptional networks acting directly downstream of Nodal and the extent to which they are conserved is largely unexplored, particularly in vivo. Eomesodermin also plays a role in patterning mesoderm and endoderm in vertebrates, but its mechanisms of action, and how it interacts with the Nodal signalling pathway are still unclear.</p><p class="abstract"><strong>Results</strong>: Using a combination of ChIP-seq and expression analysis we identify direct targets of Smad2, the effector of Nodal signalling in blastula stage zebrafish embryos, including many novel target genes. Through comparison of these data with published ChIP-seq data in human, mouse and Xenopus we show that the transcriptional network driven by Smad2 in mesoderm and endoderm is conserved in these vertebrate species. We also show that Smad2 and zebrafish Eomesodermin a (Eomesa) bind common genomic regions proximal to genes involved in mesoderm and endoderm formation, suggesting Eomesa forms a general component of the Smad2 signalling complex in zebrafish. Combinatorial perturbation of Eomesa and Smad2-interacting factor Foxh1 results in loss of both mesoderm and endoderm markers, confirming the role of Eomesa in endoderm formation and its functional interaction with Foxh1 for correct Nodal signalling. Finally, we uncover a novel, role for Eomesa in repressing ectodermal genes in the early blastula.</p><p class="abstract"><strong>Conclusion</strong>: Our data demonstrate that evolutionarily conserved developmental functions of Nodal signalling occur through maintenance of the transcriptional network directed by Smad2. This network is modulated by Eomesa in zebrafish which acts to promote mesoderm and endoderm formation in combination with Nodal signalling, whilst Eomesa also opposes ectoderm gene expression. Eomesa therefore regulates the formation of all three germ layers in the early zebrafish embryo.</p>
<p class="grants">Funded by: Medical Research Council: <span class="grant">G0700213</span></p>
<p class="publication"><span class="title">BMC biology</span>&nbsp;<span class="year">2014</span>;<span class="volume">12</span>;<span class="pagerange">81</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25277163">25277163</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4206766">4206766</a>; DOI: <a href="http://dx.doi.org/10.1186%2Fs12915-014-0081-5">10.1186/s12915-014-0081-5</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Olfactory bulb encoding during learning under anesthesia.</h4>
<p class="authors"><span class="author">Nicol AU</span>, <span class="author">Sanchez-Andrade G</span>, <span class="author">Collado P</span>, <span class="author">Segonds-Pichon A</span> and <span class="author">Kendrick KM</span></p>
<p class="affiliation">Sub-department of Animal Behaviour, University of Cambridge Cambridge, UK.</p><p class="abstract">Neural plasticity changes within the olfactory bulb are important for olfactory learning, although how neural encoding changes support new associations with specific odors and whether they can be investigated under anesthesia, remain unclear. Using the social transmission of food preference olfactory learning paradigm in mice in conjunction with in vivo microdialysis sampling we have shown firstly that a learned preference for a scented food odor smelled on the breath of a demonstrator animal occurs under isofluorane anesthesia. Furthermore, subsequent exposure to this cued odor under anesthesia promotes the same pattern of increased release of glutamate and gamma-aminobutyric acid (GABA) in the olfactory bulb as previously found in conscious animals following olfactory learning, and evoked GABA release was positively correlated with the amount of scented food eaten. In a second experiment, multiarray (24 electrodes) electrophysiological recordings were made from olfactory bulb mitral cells under isofluorane anesthesia before, during and after a novel scented food odor was paired with carbon disulfide. Results showed significant increases in overall firing frequency to the cued-odor during and after learning and decreases in response to an uncued odor. Analysis of patterns of changes in individual neurons revealed that a substantial proportion (&gt;50%) of them significantly changed their response profiles during and after learning with most of those previously inhibited becoming excited. A large number of cells exhibiting no response to the odors prior to learning were either excited or inhibited afterwards. With the uncued odor many previously responsive cells became unresponsive or inhibited. Learning associated changes only occurred in the posterior part of the olfactory bulb. Thus olfactory learning under anesthesia promotes extensive, but spatially distinct, changes in mitral cell networks to both cued and uncued odors as well as in evoked glutamate and GABA release.</p>
<p class="publication"><span class="title">Frontiers in behavioral neuroscience</span>&nbsp;<span class="year">2014</span>;<span class="volume">8</span>;<span class="pagerange">193</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24926241">24926241</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4046573">4046573</a>; DOI: <a href="http://dx.doi.org/10.3389%2Ffnbeh.2014.00193">10.3389/fnbeh.2014.00193</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Carbapenem and amikacin resistance on a large conjugative Acinetobacter baumannii plasmid.</h4>
<p class="authors"><span class="author">Nigro SJ</span>, <span class="author">Holt KE</span>, <span class="author">Pickard D</span> and <span class="author">Hall RM</span></p>
<p class="affiliation">School of Molecular Bioscience, The University of Sydney, Sydney, New South Wales, Australia <a href="mailto:%73%74%65%76%65%6E.%6E%69%67%72%6F%40%73%79%64%6E%65%79.%65%64%75.%61%75">&#115;&#116;&#101;&#118;&#101;&#110;&#46;&#110;&#105;&#103;&#114;&#111;&#64;&#115;&#121;&#100;&#110;&#101;&#121;&#46;&#101;&#100;&#117;&#46;&#97;&#117;</a>.</p>
<p class="publication"><span class="title">The Journal of antimicrobial chemotherapy</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25433005">25433005</a>; DOI: <a href="http://dx.doi.org/10.1093%2Fjac%2Fdku486">10.1093/jac/dku486</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Insights into cancer biology through next-generation sequencing.</h4>
<p class="authors"><span class="author">Nik-Zainal S</span></p>
<p class="affiliation">Wellcome Trust Sanger Institute, Cambridge, UK, and Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK <a href="mailto:%73%6E%7A%40%73%61%6E%67%65%72.%61%63.%75%6B">&#115;&#110;&#122;&#64;&#115;&#97;&#110;&#103;&#101;&#114;&#46;&#97;&#99;&#46;&#117;&#107;</a>.</p><p class="abstract">Cancer is the ultimate disorder of the genome, characterised not by just one or two mutations, but by hundreds to thousands of acquired mutations that have been accrued through the development of a tumour. Thanks to the recent increase in the speed of sequencing offered by modern sequencing technologies, we are no longer restricted to exploring tiny fragments of protein-coding portions of the human genome. We can now read all the genetic material in human cells. Here, the framework of a next-generation sequencing experiment is explained, giving insight into the advances and difficulties posed by processing the enormous datasets generated through these methods. Some of the recent insights into tumour biology, that exploit the extraordinary surge in scale and the digital nature of next-generation sequencing, are highlighted, including cancer gene discovery, the detection of mutation signatures and cancer evolution. Technological and intellectual developments are starting to shape the personalized cancer genomic profiles of tomorrow. Let&#39;s train the next-generation of clinicians to be able to read them from today.</p>
<p class="publication"><span class="title">Clinical medicine (London, England)</span>&nbsp;<span class="year">2014</span>;<span class="volume">14 Suppl 6</span>;<span class="pagerange">s71-7</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25468925">25468925</a>; DOI: <a href="http://dx.doi.org/10.7861%2Fclinmedicine.14-6-s71">10.7861/clinmedicine.14-6-s71</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Association of a germline copy number polymorphism of APOBEC3A and APOBEC3B with burden of putative APOBEC-dependent mutations in breast cancer.</h4>
<p class="authors"><span class="author">Nik-Zainal S</span>, <span class="author">Wedge DC</span>, <span class="author">Alexandrov LB</span>, <span class="author">Petljak M</span>, <span class="author">Butler AP</span>, <span class="author">Bolli N</span>, <span class="author">Davies HR</span>, <span class="author">Knappskog S</span>, <span class="author">Martin S</span>, <span class="author">Papaemmanuil E</span>, <span class="author">Ramakrishna M</span>, <span class="author">Shlien A</span>, <span class="author">Simonic I</span>, <span class="author">Xue Y</span>, <span class="author">Tyler-Smith C</span>, <span class="author">Campbell PJ</span> and <span class="author">Stratton MR</span></p>
<p class="affiliation">1] Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, UK. [2] Department of Medical Genetics, Addenbrooke&#39;s Hospital National Health Service (NHS) Trust, Cambridge, UK.</p><p class="abstract">The somatic mutations in a cancer genome are the aggregate outcome of one or more mutational processes operative through the lifetime of the individual with cancer. Each mutational process leaves a characteristic mutational signature determined by the mechanisms of DNA damage and repair that constitute it. A role was recently proposed for the APOBEC family of cytidine deaminases in generating particular genome-wide mutational signatures and a signature of localized hypermutation called kataegis. A germline copy number polymorphism involving APOBEC3A and APOBEC3B, which effectively deletes APOBEC3B, has been associated with modestly increased risk of breast cancer. Here we show that breast cancers in carriers of the deletion show more mutations of the putative APOBEC-dependent genome-wide signatures than cancers in non-carriers. The results suggest that the APOBEC3A-APOBEC3B germline deletion allele confers cancer susceptibility through increased activity of APOBEC-dependent mutational processes, although the mechanism by which this increase in activity occurs remains unknown.</p>
<p class="grants">Funded by: Wellcome Trust: <span class="grant">100183</span>, <span class="grant">101126STRATTON</span>, <span class="grant">WT088340MA</span></p>
<p class="publication"><span class="title">Nature genetics</span>&nbsp;<span class="year">2014</span>;<span class="volume">46</span>;<span class="number">5</span>;<span class="pagerange">487-91</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24728294">24728294</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4137149">4137149</a>; DOI: <a href="http://dx.doi.org/10.1038%2Fng.2955">10.1038/ng.2955</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Systematic characterization of deubiquitylating enzymes for roles in maintaining genome integrity.</h4>
<p class="authors"><span class="author">Nishi R</span>, <span class="author">Wijnhoven P</span>, <span class="author">le Sage C</span>, <span class="author">Tjeertes J</span>, <span class="author">Galanty Y</span>, <span class="author">Forment JV</span>, <span class="author">Clague MJ</span>, <span class="author">Urb&eacute; S</span> and <span class="author">Jackson SP</span></p>
<p class="affiliation">The Wellcome Trust/Cancer Research UK Gurdon Institute and Department of Biochemistry, University of Cambridge, Cambridge, CB2 1QN, UK.</p><p class="abstract">DNA double-strand breaks (DSBs) are perhaps the most toxic of all DNA lesions, with defects in the DNA-damage response to DSBs being associated with various human diseases. Although it is known that DSB repair pathways are tightly regulated by ubiquitylation, we do not yet have a comprehensive understanding of how deubiquitylating enzymes (DUBs) function in DSB responses. Here, by carrying out a multidimensional screening strategy for human DUBs, we identify several with hitherto unknown links to DSB repair, the G2/M DNA-damage checkpoint and genome-integrity maintenance. Phylogenetic analyses reveal functional clustering within certain DUB subgroups, suggesting evolutionally conserved functions and/or related modes of action. Furthermore, we establish that the DUB UCHL5 regulates DSB resection and repair by homologous recombination through protecting its interactor, NFRKB, from degradation. Collectively, our findings extend the list of DUBs promoting the maintenance of genome integrity, and highlight their potential as therapeutic targets for cancer.</p>
<p class="grants">Funded by: Cancer Research UK: <span class="grant">11224</span>, <span class="grant">14831</span>, <span class="grant">C6/A11224</span>, <span class="grant">C6/A14831</span>, <span class="grant">C6946/A14492</span>; Wellcome Trust: <span class="grant">WT092096</span></p>
<p class="publication"><span class="title">Nature cell biology</span>&nbsp;<span class="year">2014</span>;<span class="volume">16</span>;<span class="number">10</span>;<span class="pagerange">1016-26, 1-8</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25194926">25194926</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4183562">4183562</a>; DOI: <a href="http://dx.doi.org/10.1038%2Fncb3028">10.1038/ncb3028</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Genomic catastrophes frequently arise in esophageal adenocarcinoma and drive tumorigenesis.</h4>
<p class="authors"><span class="author">Nones K</span>, <span class="author">Waddell N</span>, <span class="author">Wayte N</span>, <span class="author">Patch AM</span>, <span class="author">Bailey P</span>, <span class="author">Newell F</span>, <span class="author">Holmes O</span>, <span class="author">Fink JL</span>, <span class="author">Quinn MC</span>, <span class="author">Tang YH</span>, <span class="author">Lampe G</span>, <span class="author">Quek K</span>, <span class="author">Loffler KA</span>, <span class="author">Manning S</span>, <span class="author">Idrisoglu S</span>, <span class="author">Miller D</span>, <span class="author">Xu Q</span>, <span class="author">Waddell N</span>, <span class="author">Wilson PJ</span>, <span class="author">Bruxner TJ</span>, <span class="author">Christ AN</span>, <span class="author">Harliwong I</span>, <span class="author">Nourse C</span>, <span class="author">Nourbakhsh E</span>, <span class="author">Anderson M</span>, <span class="author">Kazakoff S</span>, <span class="author">Leonard C</span>, <span class="author">Wood S</span>, <span class="author">Simpson PT</span>, <span class="author">Reid LE</span>, <span class="author">Krause L</span>, <span class="author">Hussey DJ</span>, <span class="author">Watson DI</span>, <span class="author">Lord RV</span>, <span class="author">Nancarrow D</span>, <span class="author">Phillips WA</span>, <span class="author">Gotley D</span>, <span class="author">Smithers BM</span>, <span class="author">Whiteman DC</span>, <span class="author">Hayward NK</span>, <span class="author">Campbell PJ</span>, <span class="author">Pearson JV</span>, <span class="author">Grimmond SM</span> and <span class="author">Barbour AP</span></p>
<p class="affiliation">1] Queensland Centre for Medical Genomics, Institute for Molecular Bioscience, The University of Queensland, St Lucia, Brisbane, Queensland 4072, Australia [2] QIMR Berghofer Medical Research Institute, Herston, Brisbane, Queensland 4006, Australia.</p><p class="abstract">Oesophageal adenocarcinoma (EAC) incidence is rapidly increasing in Western countries. A better understanding of EAC underpins efforts to improve early detection and treatment outcomes. While large EAC exome sequencing efforts to date have found recurrent loss-of-function mutations, oncogenic driving events have been underrepresented. Here we use a combination of whole-genome sequencing (WGS) and single-nucleotide polymorphism-array profiling to show that genomic catastrophes are frequent in EAC, with almost a third (32%, n=40/123) undergoing chromothriptic events. WGS of 22 EAC cases show that catastrophes may lead to oncogene amplification through chromothripsis-derived double-minute chromosome formation (MYC and MDM2) or breakage-fusion-bridge (KRAS, MDM2 and RFC3). Telomere shortening is more prominent in EACs bearing localized complex rearrangements. Mutational signature analysis also confirms that extreme genomic instability in EAC can be driven by somatic BRCA2 mutations. These findings suggest that genomic catastrophes have a significant role in the malignant transformation of EAC.</p>
<p class="publication"><span class="title">Nature communications</span>&nbsp;<span class="year">2014</span>;<span class="volume">5</span>;<span class="pagerange">5224</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25351503">25351503</a>; DOI: <a href="http://dx.doi.org/10.1038%2Fncomms6224">10.1038/ncomms6224</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Changes in malaria parasite drug resistance in an endemic population over a 25-year period with resulting genomic evidence of selection.</h4>
<p class="authors"><span class="author">Nwakanma DC</span>, <span class="author">Duffy CW</span>, <span class="author">Amambua-Ngwa A</span>, <span class="author">Oriero EC</span>, <span class="author">Bojang KA</span>, <span class="author">Pinder M</span>, <span class="author">Drakeley CJ</span>, <span class="author">Sutherland CJ</span>, <span class="author">Milligan PJ</span>, <span class="author">Macinnis B</span>, <span class="author">Kwiatkowski DP</span>, <span class="author">Clark TG</span>, <span class="author">Greenwood BM</span> and <span class="author">Conway DJ</span></p>
<p class="affiliation">Medical Research Council Unit, Fajara, The Gambia.</p><p class="abstract">Background.&emsp;Analysis of genome-wide polymorphism in many organisms has potential to identify genes under recent selection. However, data on historical allele frequency changes are rarely available for direct confirmation. Methods.&emsp;We genotyped single nucleotide polymorphisms (SNPs) in 4 Plasmodium falciparum drug resistance genes in 668 archived parasite-positive blood samples of a Gambian population between 1984 and 2008. This covered a period before antimalarial resistance was detected locally, through subsequent failure of multiple drugs until introduction of artemisinin combination therapy. We separately performed genome-wide sequence analysis of 52 clinical isolates from 2008 to prospect for loci under recent directional selection. Results.&emsp;Resistance alleles increased from very low frequencies, peaking in 2000 for chloroquine resistance-associated crt and mdr1 genes and at the end of the survey period for dhfr and dhps genes respectively associated with pyrimethamine and sulfadoxine resistance. Temporal changes fit a model incorporating likely selection coefficients over the period. Three of the drug resistance loci were in the top 4 regions under strong selection implicated by the genome-wide analysis. Conclusions.&emsp;Genome-wide polymorphism analysis of an endemic population sample robustly identifies loci with detailed documentation of recent selection, demonstrating power to prospectively detect emerging drug resistance genes.</p>
<p class="grants">Funded by: Medical Research Council: <span class="grant">G1100123</span>, <span class="grant">MC_U190081987</span>, <span class="grant">MC_U190092708</span></p>
<p class="publication"><span class="title">The Journal of infectious diseases</span>&nbsp;<span class="year">2014</span>;<span class="volume">209</span>;<span class="number">7</span>;<span class="pagerange">1126-35</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24265439">24265439</a>; DOI: <a href="http://dx.doi.org/10.1093%2Finfdis%2Fjit618">10.1093/infdis/jit618</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">A General Approach for Haplotype Phasing across the Full Spectrum of Relatedness.</h4>
<p class="authors"><span class="author">O&#39;Connell J</span>, <span class="author">Gurdasani D</span>, <span class="author">Delaneau O</span>, <span class="author">Pirastu N</span>, <span class="author">Ulivi S</span>, <span class="author">Cocca M</span>, <span class="author">Traglia M</span>, <span class="author">Huang J</span>, <span class="author">Huffman JE</span>, <span class="author">Rudan I</span>, <span class="author">McQuillan R</span>, <span class="author">Fraser RM</span>, <span class="author">Campbell H</span>, <span class="author">Polasek O</span>, <span class="author">Asiki G</span>, <span class="author">Ekoru K</span>, <span class="author">Hayward C</span>, <span class="author">Wright AF</span>, <span class="author">Vitart V</span>, <span class="author">Navarro P</span>, <span class="author">Zagury JF</span>, <span class="author">Wilson JF</span>, <span class="author">Toniolo D</span>, <span class="author">Gasparini P</span>, <span class="author">Soranzo N</span>, <span class="author">Sandhu MS</span> and <span class="author">Marchini J</span></p>
<p class="affiliation">Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United Kingdom; Department of Statistics, University of Oxford, Oxford, United Kingdom.</p><p class="abstract">Many existing cohorts contain a range of relatedness between genotyped individuals, either by design or by chance. Haplotype estimation in such cohorts is a central step in many downstream analyses. Using genotypes from six cohorts from isolated populations and two cohorts from non-isolated populations, we have investigated the performance of different phasing methods designed for nominally &#39;unrelated&#39; individuals. We find that SHAPEIT2 produces much lower switch error rates in all cohorts compared to other methods, including those designed specifically for isolated populations. In particular, when large amounts of IBD sharing is present, SHAPEIT2 infers close to perfect haplotypes. Based on these results we have developed a general strategy for phasing cohorts with any level of implicit or explicit relatedness between individuals. First SHAPEIT2 is run ignoring all explicit family information. We then apply a novel HMM method (duoHMM) to combine the SHAPEIT2 haplotypes with any family information to infer the inheritance pattern of each meiosis at all sites across each chromosome. This allows the correction of switch errors, detection of recombination events and genotyping errors. We show that the method detects numbers of recombination events that align very well with expectations based on genetic maps, and that it infers far fewer spurious recombination events than Merlin. The method can also detect genotyping errors and infer recombination events in otherwise uninformative families, such as trios and duos. The detected recombination events can be used in association scans for recombination phenotypes. The method provides a simple and unified approach to haplotype estimation, that will be of interest to researchers in the fields of human, animal and plant genetics.</p>
<p class="publication"><span class="title">PLoS genetics</span>&nbsp;<span class="year">2014</span>;<span class="volume">10</span>;<span class="number">4</span>;<span class="pagerange">e1004234</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24743097">24743097</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC3990520">3990520</a>; DOI: <a href="http://dx.doi.org/10.1371%2Fjournal.pgen.1004234">10.1371/journal.pgen.1004234</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">RNA-seq reveals the pan-transcriptomic impact of attenuating the gliotoxin self-protection mechanism in Aspergillus fumigatus.</h4>
<p class="authors"><span class="author">O&#39;Keeffe G</span>, <span class="author">Hammel S</span>, <span class="author">Owens RA</span>, <span class="author">Keane TM</span>, <span class="author">Fitzpatrick DA</span>, <span class="author">Jones GW</span> and <span class="author">Doyle S</span></p>
<p class="affiliation">Department of Biology, National University of Ireland Maynooth, Maynooth, Co, Kildare, Ireland. <a href="mailto:%73%65%61%6E.%64%6F%79%6C%65%40%6E%75%69%6D.%69%65">&#115;&#101;&#97;&#110;&#46;&#100;&#111;&#121;&#108;&#101;&#64;&#110;&#117;&#105;&#109;&#46;&#105;&#101;</a>.</p><p class="abstract"><strong>Background</strong>: Aspergillus fumigatus produces a number of secondary metabolites, one of which, gliotoxin, has been shown to exhibit anti-fungal activity. Thus, A. fumigatus must be able to protect itself against gliotoxin. Indeed one of the genes in the gliotoxin biosynthetic gene cluster in A. fumigatus, gliT, is required for self-protection against the toxin- however the global self-protection mechanism deployed is unclear. RNA-seq was employed to identify genes differentially regulated upon exposure to gliotoxin in A. fumigatus wild-type and A. fumigatus &#x2206;gliT, a strain that is hypersensitive to gliotoxin.</p><p class="abstract"><strong>Results</strong>: Deletion of A. fumigatus gliT resulted in altered expression of 208 genes (log2 fold change of 1.5) when compared to A. fumigatus wild-type, of which 175 genes were up-regulated and 33 genes were down-regulated. Expression of 164 genes was differentially regulated (log2 fold change of 1.5) in A. fumigatus wild-type when exposed to gliotoxin, consisting of 101 genes with up-regulated expression and 63 genes with down-regulated expression. Interestingly, a much larger number of genes, 1700, were found to be differentially regulated (log2 fold change of 1.5) in A. fumigatus &#x2206;gliT when challenged with gliotoxin. These consisted of 508 genes with up-regulated expression, and 1192 genes with down-regulated expression. Functional Catalogue (FunCat) classification of differentially regulated genes revealed an enrichment of genes involved in both primary metabolic functions and secondary metabolism. Specifically, genes involved in gliotoxin biosynthesis, helvolic acid biosynthesis, siderophore-iron transport genes and also nitrogen metabolism genes and ribosome biogenesis genes underwent altered expression. It was confirmed that gliotoxin biosynthesis is induced upon exposure to exogenous gliotoxin, production of unrelated secondary metabolites is attenuated in A. fumigatus &#x2206;gliT, while quantitative proteomic analysis confirmed disrupted translation in A. fumigatus &#x2206;gliT challenged with exogenous gliotoxin.</p><p class="abstract"><strong>Conclusions</strong>: This study presents the first global investigation of the transcriptional response to exogenous gliotoxin in A. fumigatus wild-type and the hyper-sensitive strain, &#x2206;gliT. Our data highlight the global and extensive affects of exogenous gliotoxin on a sensitive strain devoid of a self-protection mechanism and infer that GliT functionality is required for the optimal biosynthesis of selected secondary metabolites in A. fumigatus.</p>
<p class="publication"><span class="title">BMC genomics</span>&nbsp;<span class="year">2014</span>;<span class="volume">15</span>;<span class="pagerange">894</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25311525">25311525</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4209032">4209032</a>; DOI: <a href="http://dx.doi.org/10.1186%2F1471-2164-15-894">10.1186/1471-2164-15-894</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Single nucleotide variants in the protein C pathway and mortality in dialysis patients.</h4>
<p class="authors"><span class="author">Ocak G</span>, <span class="author">Drechsler C</span>, <span class="author">Vossen CY</span>, <span class="author">Vos HL</span>, <span class="author">Rosendaal FR</span>, <span class="author">Reitsma PH</span>, <span class="author">Hoffmann MM</span>, <span class="author">M&auml;rz W</span>, <span class="author">Ouwehand WH</span>, <span class="author">Krediet RT</span>, <span class="author">Boeschoten EW</span>, <span class="author">Dekker FW</span>, <span class="author">Wanner C</span> and <span class="author">Verduijn M</span></p>
<p class="affiliation">Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands.</p><p class="abstract"><strong>Background</strong>: The protein C pathway plays an important role in the maintenance of endothelial barrier function and in the inflammatory and coagulant processes that are characteristic of patients on dialysis. We investigated whether common single nucleotide variants (SNV) in genes encoding protein C pathway components were associated with all-cause 5 years mortality risk in dialysis patients.</p><p class="abstract"><strong>Methods</strong>: Single nucleotides variants in the factor V gene (F5 rs6025; factor V Leiden), the thrombomodulin gene (THBD rs1042580), the protein C gene (PROC rs1799808 and 1799809) and the endothelial protein C receptor gene (PROCR rs867186, rs2069951, and rs2069952) were genotyped in 1070 dialysis patients from the NEtherlands COoperative Study on the Adequacy of Dialysis (NECOSAD) cohort) and in 1243 dialysis patients from the German 4D cohort.</p><p class="abstract"><strong>Results</strong>: Factor V Leiden was associated with a 1.5-fold (95% CI 1.1-1.9) increased 5-year all-cause mortality risk and carriers of the AG/GG genotypes of the PROC rs1799809 had a 1.2-fold (95% CI 1.0-1.4) increased 5-year all-cause mortality risk. The other SNVs in THBD, PROC, and PROCR were not associated with 5-years mortality.</p><p class="abstract"><strong>Conclusion</strong>: Our study suggests that factor V Leiden and PROC rs1799809 contributes to an increased mortality risk in dialysis patients.</p>
<p class="publication"><span class="title">PloS one</span>&nbsp;<span class="year">2014</span>;<span class="volume">9</span>;<span class="number">5</span>;<span class="pagerange">e97251</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24816905">24816905</a>; DOI: <a href="http://dx.doi.org/10.1371%2Fjournal.pone.0097251">10.1371/journal.pone.0097251</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Whole-Genome Scans Provide Evidence of Adaptive Evolution in Malawian Plasmodium falciparum Isolates.</h4>
<p class="authors"><span class="author">Ocholla H</span>, <span class="author">Preston MD</span>, <span class="author">Mipando M</span>, <span class="author">Jensen AT</span>, <span class="author">Campino S</span>, <span class="author">MacInnis B</span>, <span class="author">Alcock D</span>, <span class="author">Terlouw A</span>, <span class="author">Zongo I</span>, <span class="author">Oudraogo JB</span>, <span class="author">Djimde AA</span>, <span class="author">Assefa S</span>, <span class="author">Doumbo OK</span>, <span class="author">Borrmann S</span>, <span class="author">Nzila A</span>, <span class="author">Marsh K</span>, <span class="author">Fairhurst RM</span>, <span class="author">Nosten F</span>, <span class="author">Anderson TJ</span>, <span class="author">Kwiatkowski DP</span>, <span class="author">Craig A</span>, <span class="author">Clark TG</span> and <span class="author">Montgomery J</span></p>
<p class="affiliation">Malawi-Liverpool-Wellcome Trust Clinical Research Programme Liverpool School of Tropical Medicine, Pembroke Place, Liverpool.</p><p class="abstract"><strong>Background</strong>: Selection by host immunity and antimalarial drugs has driven extensive adaptive evolution in Plasmodium falciparum and continues to produce ever-changing landscapes of genetic variation.</p><p class="abstract"><strong>Methods</strong>: We performed whole-genome sequencing of 69 P. falciparum isolates from Malawi and used population genetics approaches to investigate genetic diversity and population structure and identify loci under selection.</p><p class="abstract"><strong>Results</strong>: High genetic diversity (&pi; = 2.4 &times; 10(-4)), moderately high multiplicity of infection (2.7), and low linkage disequilibrium (500-bp) were observed in Chikhwawa District, Malawi, an area of high malaria transmission. Allele frequency-based tests provided evidence of recent population growth in Malawi and detected potential targets of host immunity and candidate vaccine antigens. Comparison of the sequence variation between isolates from Malawi and those from 5 geographically dispersed countries (Kenya, Burkina Faso, Mali, Cambodia, and Thailand) detected population genetic differences between Africa and Asia, within Southeast Asia, and within Africa. Haplotype-based tests of selection to sequence data from all 6 populations identified signals of directional selection at known drug-resistance loci, including pfcrt, pfdhps, pfmdr1, and pfgch1.</p><p class="abstract"><strong>Conclusions</strong>: The sequence variations observed at drug-resistance loci reflect differences in each country&#39;s historical use of antimalarial drugs and may be useful in formulating local malaria treatment guidelines.</p>
<p class="grants">Funded by: NIAID NIH HHS: <span class="grant">R37 AI048071</span>; Wellcome Trust: <span class="grant">095507</span></p>
<p class="publication"><span class="title">The Journal of infectious diseases</span>&nbsp;<span class="year">2014</span>;<span class="volume">210</span>;<span class="number">12</span>;<span class="pagerange">1991-2000</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24948693">24948693</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4241944">4241944</a>; DOI: <a href="http://dx.doi.org/10.1093%2Finfdis%2Fjiu349">10.1093/infdis/jiu349</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Using association rule mining to determine promising secondary phenotyping hypotheses.</h4>
<p class="authors"><span class="author">Oellrich A</span>, <span class="author">Jacobsen J</span>, <span class="author">Papatheodorou I</span>, <span class="author">Sanger Mouse Genetics Project</span> and <span class="author">Smedley D</span></p>
<p class="affiliation">Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton CB1 10SA, UK.</p><p class="abstract"><strong>Motivation</strong>: Large-scale phenotyping projects such as the Sanger Mouse Genetics project are ongoing efforts to help identify the influences of genes and their modification on phenotypes. Gene-phenotype relations are crucial to the improvement of our understanding of human heritable diseases as well as the development of drugs. However, given that there are &sim;: 20 000 genes in higher vertebrate genomes and the experimental verification of gene-phenotype relations requires a lot of resources, methods are needed that determine good candidates for testing.</p><p class="abstract"><strong>Results</strong>: In this study, we applied an association rule mining approach to the identification of promising secondary phenotype candidates. The predictions rely on a large gene-phenotype annotation set that is used to find occurrence patterns of phenotypes. Applying an association rule mining approach, we could identify 1967 secondary phenotype hypotheses that cover 244 genes and 136 phenotypes. Using two automated and one manual evaluation strategies, we demonstrate that the secondary phenotype candidates possess biological relevance to the genes they are predicted for. From the results we conclude that the predicted secondary phenotypes constitute good candidates to be experimentally tested and confirmed.</p><p class="abstract"><strong>Availability</strong>: The secondary phenotype candidates can be browsed through at http://www.sanger.ac.uk/resources/databases/phenodigm/gene/secondaryphenotype/list.</p><p class="abstract"><strong>Contact</strong>: <a href="mailto:%61%6F%35%40%73%61%6E%67%65%72.%61%63.%75%6B">&#97;&#111;&#53;&#64;&#115;&#97;&#110;&#103;&#101;&#114;&#46;&#97;&#99;&#46;&#117;&#107;</a> or <a href="mailto:%64%73%35%40%73%61%6E%67%65%72.%61%63.%75%6B">&#100;&#115;&#53;&#64;&#115;&#97;&#110;&#103;&#101;&#114;&#46;&#97;&#99;&#46;&#117;&#107;</a></p><p class="abstract">Supplementary data are available at Bioinformatics online.</p>
<p class="grants">Funded by: NHGRI NIH HHS: <span class="grant">1 U54 HG006370-01</span>; Wellcome Trust: <span class="grant">098051</span></p>
<p class="publication"><span class="title">Bioinformatics (Oxford, England)</span>&nbsp;<span class="year">2014</span>;<span class="volume">30</span>;<span class="number">12</span>;<span class="pagerange">i52-59</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24932005">24932005</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4059059">4059059</a>; DOI: <a href="http://dx.doi.org/10.1093%2Fbioinformatics%2Fbtu260">10.1093/bioinformatics/btu260</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">The influence of disease categories on gene candidate predictions from model organism phenotypes.</h4>
<p class="authors"><span class="author">Oellrich A</span>, <span class="author">Koehler S</span>, <span class="author">Washington N</span>, <span class="author">Sanger Mouse Genetic Project</span>, <span class="author">Mungall C</span>, <span class="author">Lewis S</span>, <span class="author">Haendel M</span>, <span class="author">Robinson PN</span> and <span class="author">Smedley D</span></p>
<p class="affiliation">Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, CB10 1SA Hinxton, UK.</p><p class="abstract"><strong>Background</strong>: The molecular etiology is still to be identified for about half of the currently described Mendelian diseases in humans, thereby hindering efforts to find treatments or preventive measures. Advances, such as new sequencing technologies, have led to increasing amounts of data becoming available with which to address the problem of identifying disease genes. Therefore, automated methods are needed that reliably predict disease gene candidates based on available data. We have recently developed Exomiser as a tool for identifying causative variants from exome analysis results by filtering and prioritising using a number of criteria including the phenotype similarity between the disease and mouse mutants involving the gene candidates. Initial investigations revealed a variation in performance for different medical categories of disease, due in part to a varying contribution of the phenotype scoring component.</p><p class="abstract"><strong>Results</strong>: In this study, we further analyse the performance of our cross-species phenotype matching algorithm, and examine in more detail the reasons why disease gene filtering based on phenotype data works better for certain disease categories than others. We found that in addition to misleading phenotype alignments between species, some disease categories are still more amenable to automated predictions than others, and that this often ties in with community perceptions on how well the organism works as model.</p><p class="abstract"><strong>Conclusions</strong>: In conclusion, our automated disease gene candidate predictions are highly dependent on the organism used for the predictions and the disease category being studied. Future work on computational disease gene prediction using phenotype data would benefit from methods that take into account the disease category and the source of model organism data.</p>
<p class="publication"><span class="title">Journal of biomedical semantics</span>&nbsp;<span class="year">2014</span>;<span class="volume">5</span>;<span class="number">Suppl 1 Proceedings of the Bio-Ontologies Spec Interest G</span>;<span class="pagerange">S4</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25093073">25093073</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4108905">4108905</a>; DOI: <a href="http://dx.doi.org/10.1186%2F2041-1480-5-S1-S4">10.1186/2041-1480-5-S1-S4</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Linking tissues to phenotypes using gene expression profiles.</h4>
<p class="authors"><span class="author">Oellrich A</span>, <span class="author">Sanger Mouse Genetics Project</span> and <span class="author">Smedley D</span></p>
<p class="affiliation">Mouse Informatics Group, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, CB10 1SA, UK.</p><p class="abstract">Despite great biological and computational efforts to determine the genetic causes underlying human heritable diseases, approximately half (3500) of these diseases are still without an identified genetic cause. Model organism studies allow the targeted modification of the genome and can help with the identification of genetic causes for human diseases. Targeted modifications have led to a vast amount of model organism data. However, these data are scattered across different databases, preventing an integrated view and missing out on contextual information. Once we are able to combine all the existing resources, will we be able to fully understand the causes underlying a disease and how species differ. Here, we present an integrated data resource combining tissue expression with phenotypes in mouse lines and bringing us one step closer to consequence chains from a molecular level to a resulting phenotype. Mutations in genes often manifest in phenotypes in the same tissue that the gene is expressed in. However, in other cases, a systems level approach is required to understand how perturbations to gene-networks connecting multiple tissues lead to a phenotype. Automated evaluation of the predicted tissue-phenotype associations reveals that 72-76% of the phenotypes are associated with disruption of genes expressed in the affected tissue. However, 55-64% of the individual phenotype-tissue associations show spatially separated gene expression and phenotype manifestation. For example, we see a correlation between &#39;total body fat&#39; abnormalities and genes expressed in the &#39;brain&#39;, which fits recent discoveries linking genes expressed in the hypothalamus to obesity. Finally, we demonstrate that the use of our predicted tissue-phenotype associations can improve the detection of a known disease-gene association when combined with a disease gene candidate prediction tool. For example, JAK2, the known gene associated with Familial Erythrocytosis 1, rises from the seventh best candidate to the top hit when the associated tissues are taken into consideration. Database URL: http://www.sanger.ac.uk/resources/databases/phenodigm/phenotype/list.</p>
<p class="grants">Funded by: NHGRI NIH HHS: <span class="grant">1 U54 HG006370-01</span>; Wellcome Trust: <span class="grant">098051</span></p>
<p class="publication"><span class="title">Database : the journal of biological databases and curation</span>&nbsp;<span class="year">2014</span>;<span class="volume">2014</span>;<span class="pagerange">bau017</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24634472">24634472</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC3982582">3982582</a>; DOI: <a href="http://dx.doi.org/10.1093%2Fdatabase%2Fbau017">10.1093/database/bau017</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Regularized Machine Learning in the Genetic Prediction of Complex Traits.</h4>
<p class="authors"><span class="author">Okser S</span>, <span class="author">Pahikkala T</span>, <span class="author">Airola A</span>, <span class="author">Salakoski T</span>, <span class="author">Ripatti S</span> and <span class="author">Aittokallio T</span></p>
<p class="affiliation">Department of Information Technology, University of Turku, Turku, Finland; Turku Centre for Computer Science (TUCS), University of Turku and &Aring;bo Akademi University, Turku, Finland.</p>
<p class="publication"><span class="title">PLoS genetics</span>&nbsp;<span class="year">2014</span>;<span class="volume">10</span>;<span class="number">11</span>;<span class="pagerange">e1004754</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25393026">25393026</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4230844">4230844</a>; DOI: <a href="http://dx.doi.org/10.1371%2Fjournal.pgen.1004754">10.1371/journal.pgen.1004754</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Genome-wide association study of sleep duration in the Finnish population.</h4>
<p class="authors"><span class="author">Ollila HM</span>, <span class="author">Kettunen J</span>, <span class="author">Pietil&auml;inen O</span>, <span class="author">Aho V</span>, <span class="author">Silander K</span>, <span class="author">Kronholm E</span>, <span class="author">Perola M</span>, <span class="author">Lahti J</span>, <span class="author">R&auml;ikk&ouml;nen K</span>, <span class="author">Widen E</span>, <span class="author">Palotie A</span>, <span class="author">Eriksson JG</span>, <span class="author">Partonen T</span>, <span class="author">Kaprio J</span>, <span class="author">Salomaa V</span>, <span class="author">Raitakari O</span>, <span class="author">Lehtim&auml;ki T</span>, <span class="author">Sallinen M</span>, <span class="author">H&auml;rm&auml; M</span>, <span class="author">Porkka-Heiskanen T</span> and <span class="author">Paunio T</span></p>
<p class="affiliation">Public Health Genomics Unit and Institute for Molecular Medicine FIMM, National Institute for Health and Welfare, Helsinki, Finland; Institute of Biomedicine, Physiology, University of Helsinki, Helsinki, Finland; Department of Psychiatry, University of Helsinki, Helsinki, Finland.</p><p class="abstract">Sleep duration is genetically regulated, but the genetic variants are largely unknown. We aimed to identify such genes using a genome-wide association study (GWAS) combined with RNA expression at the population level, and with experimental verification. A GWAS was performed in a Finnish sample (n&nbsp;=&nbsp;1941), and variants with suggestive association (P&nbsp;&lt;&nbsp;5&nbsp;&times;&nbsp;10(-5) ) were tested in a follow-up sample from the same population with sleep duration (n&nbsp;=&nbsp;6834) and time in bed (n&nbsp;=&nbsp;1720). Variants with pointwise association of P&nbsp;&lt;&nbsp;0.05 in the follow-up sample were analysed further. First, we correlated genotypes with transcript expression levels with sleep duration (n&nbsp;=&nbsp;207). The expression levels of significant transcripts were further studied in experimental sleep restriction. Of the 31 variants with P&nbsp;&lt;&nbsp;5&nbsp;&times;&nbsp;10(-5) in the discovery sample, three variants showed nominal allelic association (P&nbsp;&lt;&nbsp;0.05) in the follow-up sample: rs10914351, near PTPRU (P&nbsp;= 0.049), rs1037079 in PCDH7-CENTD1 (P&nbsp;=&nbsp;0.011) and rs2031573 near KLF6 (P&nbsp;=&nbsp;0.044). The risk alleles for shorter sleep (rs2031573 and rs1037079) were also associated with higher KLF6 and PCDH7 expression levels (P&nbsp;&lt;&nbsp;0.05). Experimental sleep restriction increased the expression of KLF6 (P&nbsp;&lt;&nbsp;0.01). These data suggest that rs2031573 near KLF6 or related loci and rs1037079 between PCDH7-CENTD1 or related loci may contribute to the regulation of sleep duration via gene expression. These results illustrate the utility of combining different analytical approaches to identify genetic determinants for traits related to sleep physiology. However, additional studies are needed in order to understand the roles of KLF6 and PCDH7 in sleep regulation.</p>
<p class="publication"><span class="title">Journal of sleep research</span>&nbsp;<span class="year">2014</span>;<span class="volume">23</span>;<span class="number">6</span>;<span class="pagerange">609-18</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25109461">25109461</a>; DOI: <a href="http://dx.doi.org/10.1111%2Fjsr.12175">10.1111/jsr.12175</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">An Evaluation of HIV Elite Controller Definitions within a Large Seroconverter Cohort Collaboration.</h4>
<p class="authors"><span class="author">Olson AD</span>, <span class="author">Meyer L</span>, <span class="author">Prins M</span>, <span class="author">Thiebaut R</span>, <span class="author">Gurdasani D</span>, <span class="author">Guiguet M</span>, <span class="author">Chaix ML</span>, <span class="author">Amornkul P</span>, <span class="author">Babiker A</span>, <span class="author">Sandhu MS</span>, <span class="author">Porter K</span> and <span class="author">for C. A. S. C. A. D. E. Collaboration in EuroCoord</span></p>
<p class="affiliation">Medical Research Council Clinical Trials Unit at University College London, London, United Kingdom.</p>
<p class="abstract">Background: Understanding the mechanisms underlying viral control is highly relevant to vaccine studies and elite control (EC) of HIV infection. Although numerous definitions of EC exist, it is not clear which, if any, best identify this rare phenotype.

Methods: We assessed a number of EC definitions used in the literature using CASCADE data of 25,692 HIV seroconverters. We estimated proportions maintaining EC of total ART-nave follow-up time, and disease progression, comparing to non-EC. We also examined HIV-RNA and CD4 values and CD4 slope during EC and beyond (while ART nave).

Results: Most definitions classify 1% as ECs with median HIV-RNA 43-903 copies/ml and median CD4>500 cells/mm(3). Beyond EC status, median HIV-RNA levels remained low, although often detectable, and CD4 values high but with strong evidence of decline for all definitions. Median % ART-nave time as EC was 92% although overlap between definitions was low. EC definitions with consecutive HIV-RNA measurements <75 copies/ml with follow-up six months, or with 90% of measurements <400 copies/ml over 10 year follow-up preformed best overall. Individuals thus defined were less likely to progress to endpoint (hazard ratios ranged from 12.5-19.0 for non-ECs compared to ECs).

Conclusions: ECs are rare, less likely to progress to clinical disease, but may eventually lose control. We suggest definitions requiring individuals to have consecutive undetectable HIV-RNA measurements for  six months or otherwise with >90% of measurements <400 copies/ml over 10 years be used to define this phenotype.</p>
<p class="publication"><span class="title">PloS one</span>&nbsp;<span class="year">2014</span>;<span class="volume">9</span>;<span class="number">1</span>;<span class="pagerange">e86719</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24489776">24489776</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC3904947">3904947</a>; DOI: <a href="http://dx.doi.org/10.1371%2Fjournal.pone.0086719">10.1371/journal.pone.0086719</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Paving the way towards a successful and fulfilling career in computational biology.</h4>
<p class="authors"><span class="author">Oluwagbemi O</span>, <span class="author">Adebiyi M</span>, <span class="author">Fatumo S</span> and <span class="author">Macintyre G</span></p>
<p class="affiliation">Department of Computer and Information Sciences, College of Science and Technology, Bioinformatics Unit, Covenant University, Ota, Ogun State, Nigeria.</p>
<p class="publication"><span class="title">PLoS computational biology</span>&nbsp;<span class="year">2014</span>;<span class="volume">10</span>;<span class="number">5</span>;<span class="pagerange">e1003593</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24784875">24784875</a>; DOI: <a href="http://dx.doi.org/10.1371%2Fjournal.pcbi.1003593">10.1371/journal.pcbi.1003593</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">BCKDH: the missing link in apicomplexan mitochondrial metabolism is required for full virulence of Toxoplasma gondii and Plasmodium berghei.</h4>
<p class="authors"><span class="author">Oppenheim RD</span>, <span class="author">Creek DJ</span>, <span class="author">Macrae JI</span>, <span class="author">Modrzynska KK</span>, <span class="author">Pino P</span>, <span class="author">Limenitakis J</span>, <span class="author">Polonais V</span>, <span class="author">Seeber F</span>, <span class="author">Barrett MP</span>, <span class="author">Billker O</span>, <span class="author">McConville MJ</span> and <span class="author">Soldati-Favre D</span></p>
<p class="affiliation">Department of Microbiology and Molecular Medicine, Faculty of Medicine, University of Geneva, Geneva, Switzerland.</p><p class="abstract">While the apicomplexan parasites Plasmodium falciparum and Toxoplasma gondii are thought to primarily depend on glycolysis for ATP synthesis, recent studies have shown that they can fully catabolize glucose in a canonical TCA cycle. However, these parasites lack a mitochondrial isoform of pyruvate dehydrogenase and the identity of the enzyme that catalyses the conversion of pyruvate to acetyl-CoA remains enigmatic. Here we demonstrate that the mitochondrial branched chain ketoacid dehydrogenase (BCKDH) complex is the missing link, functionally replacing mitochondrial PDH in both T. gondii and P. berghei. Deletion of the E1a subunit of T. gondii and P. berghei BCKDH significantly impacted on intracellular growth and virulence of both parasites. Interestingly, disruption of the P. berghei E1a restricted parasite development to reticulocytes only and completely prevented maturation of oocysts during mosquito transmission. Overall this study highlights the importance of the molecular adaptation of BCKDH in this important class of pathogens.</p>
<p class="grants">Funded by: Howard Hughes Medical Institute; Medical Research Council: <span class="grant">G0501670</span>; Wellcome Trust: <span class="grant">098051</span></p>
<p class="publication"><span class="title">PLoS pathogens</span>&nbsp;<span class="year">2014</span>;<span class="volume">10</span>;<span class="number">7</span>;<span class="pagerange">e1004263</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25032958">25032958</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4102578">4102578</a>; DOI: <a href="http://dx.doi.org/10.1371%2Fjournal.ppat.1004263">10.1371/journal.ppat.1004263</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Loss of FTO antagonises Wnt signaling and leads to developmental defects associated with ciliopathies.</h4>
<p class="authors"><span class="author">Osborn DP</span>, <span class="author">Roccasecca RM</span>, <span class="author">McMurray F</span>, <span class="author">Hernandez-Hernandez V</span>, <span class="author">Mukherjee S</span>, <span class="author">Barroso I</span>, <span class="author">Stemple D</span>, <span class="author">Cox R</span>, <span class="author">Beales PL</span> and <span class="author">Christou-Savina S</span></p>
<p class="affiliation">Biomedical Sciences, St George&#39;s University of London, London, United Kingdom.</p><p class="abstract">Common intronic variants in the Human fat mass and obesity-associated gene (FTO) are found to be associated with an increased risk of obesity. Overexpression of FTO correlates with increased food intake and obesity, whilst loss-of-function results in lethality and severe developmental defects. Despite intense scientific discussions around the role of FTO in energy metabolism, the function of FTO during development remains undefined. Here, we show that loss of Fto leads to developmental defects such as growth retardation, craniofacial dysmorphism and aberrant neural crest cells migration in Zebrafish. We find that the important developmental pathway, Wnt, is compromised in the absence of FTO, both in vivo (zebrafish) and in vitro (Fto(-/-) MEFs and HEK293T). Canonical Wnt signalling is down regulated by abrogated &beta;-Catenin translocation to the nucleus whilst non-canonical Wnt/Ca(2+) pathway is activated via its key signal mediators CaMKII and PKC&delta;. Moreover, we demonstrate that loss of Fto results in short, absent or disorganised cilia leading to situs inversus, renal cystogenesis, neural crest cell defects and microcephaly in Zebrafish. Congruently, Fto knockout mice display aberrant tissue specific cilia. These data identify FTO as a protein-regulator of the balanced activation between canonical and non-canonical branches of the Wnt pathway. Furthermore, we present the first evidence that FTO plays a role in development and cilia formation/function.</p>
<p class="grants">Funded by: Medical Research Council: <span class="grant">G0801843</span>, <span class="grant">MC_U142661184</span></p>
<p class="publication"><span class="title">PloS one</span>&nbsp;<span class="year">2014</span>;<span class="volume">9</span>;<span class="number">2</span>;<span class="pagerange">e87662</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24503721">24503721</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC3913654">3913654</a>; DOI: <a href="http://dx.doi.org/10.1371%2Fjournal.pone.0087662">10.1371/journal.pone.0087662</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">New antigens for a multicomponent blood-stage malaria vaccine.</h4>
<p class="authors"><span class="author">Osier FH</span>, <span class="author">Mackinnon MJ</span>, <span class="author">Crosnier C</span>, <span class="author">Fegan G</span>, <span class="author">Kamuyu G</span>, <span class="author">Wanaguru M</span>, <span class="author">Ogada E</span>, <span class="author">McDade B</span>, <span class="author">Rayner JC</span>, <span class="author">Wright GJ</span> and <span class="author">Marsh K</span></p>
<p class="affiliation">Pathogen Vector and Human Biology Department, Kenya Medical Research Institute Centre for Geographical Medicine Research, Coast, P. O. Box 230, 80108 Kilifi, Kenya.</p><p class="abstract">An effective blood-stage vaccine against Plasmodium falciparum remains a research priority, but the number of antigens that have been translated into multicomponent vaccines for testing in clinical trials remains limited. Investigating the large number of potential targets found in the parasite proteome has been constrained by an inability to produce natively folded recombinant antigens for immunological studies. We overcame these constraints by generating a large library of biochemically active merozoite surface and secreted full-length ectodomain proteins. We then systematically examined the antibody reactivity against these proteins in a cohort of Kenyan children (n = 286) who were sampled at the start of a malaria transmission season and prospectively monitored for clinical episodes of malaria over the ensuing 6 months. We found that antibodies to previously untested or little-studied proteins had superior or equivalent potential protective efficacy to the handful of current leading malaria vaccine candidates. Moreover, cumulative responses to combinations comprising 5 of the 10 top-ranked antigens, including PF3D7_1136200, MSP2, RhopH3, P41, MSP11, MSP3, PF3D7_0606800, AMA1, Pf113, and MSRP1, were associated with 100% protection against clinical episodes of malaria. These data suggest not only that there are many more potential antigen candidates for the malaria vaccine development pipeline but also that effective vaccination may be achieved by combining a selection of these antigens.</p>
<p class="grants">Funded by: Medical Research Council: <span class="grant">MR/J002283/1</span>; Wellcome Trust: <span class="grant">077092</span>, <span class="grant">077176</span>, <span class="grant">088634</span>, <span class="grant">089833</span>, <span class="grant">092654</span>, <span class="grant">092741</span>, <span class="grant">098051</span></p>
<p class="publication"><span class="title">Science translational medicine</span>&nbsp;<span class="year">2014</span>;<span class="volume">6</span>;<span class="number">247</span>;<span class="pagerange">247ra102</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25080477">25080477</a>; DOI: <a href="http://dx.doi.org/10.1126%2Fscitranslmed.3008705">10.1126/scitranslmed.3008705</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">A comprehensive evaluation of rodent malaria parasite genomes and gene expression.</h4>
<p class="authors"><span class="author">Otto TD</span>, <span class="author">B&ouml;hme U</span>, <span class="author">Jackson AP</span>, <span class="author">Hunt M</span>, <span class="author">Franke-Fayard B</span>, <span class="author">Hoeijmakers WA</span>, <span class="author">Religa AA</span>, <span class="author">Robertson L</span>, <span class="author">Sanders M</span>, <span class="author">Ogun SA</span>, <span class="author">Cunningham D</span>, <span class="author">Erhart A</span>, <span class="author">Billker O</span>, <span class="author">Khan SM</span>, <span class="author">Stunnenberg HG</span>, <span class="author">Langhorne J</span>, <span class="author">Holder AA</span>, <span class="author">Waters AP</span>, <span class="author">Newbold CI</span>, <span class="author">Pain A</span>, <span class="author">Berriman M</span> and <span class="author">Janse CJ</span></p><p class="abstract">BackgroundRodent malaria parasites (RMP) are used extensively as models of human malaria. Draft RMP genomes have been published for Plasmodium yoelii, P. berghei ANKA (PbA) and P. chabaudi AS (PcAS). Although availability of these genomes made a significant impact on recent malaria research, these genomes were highly fragmented and were annotated with little manual curation. The fragmented nature of the genomes has hampered genome wide analysis of Plasmodium gene regulation and function.ResultsWe have greatly improved the genome assemblies of PbA and PcAS, newly sequenced the virulent parasite P. yoelii YM genome, sequenced additional RMP isolates/lines and have characterized genotypic diversity within RMP species. We have produced RNA-seq data and utilized it to improve gene-model prediction and to provide quantitative, genome-wide, data on gene expression. Comparison of the RMP genomes with the genome of the human malaria parasite P. falciparum and RNA-seq mapping permitted gene annotation at base-pair resolution. Full-length chromosomal annotation permitted a comprehensive classification of all subtelomeric multigene families including the `Plasmodium interspersed repeat genes&iquest; (pir). Phylogenetic classification of the pir family, combined with pir expression patterns, indicates functional diversification within this family.ConclusionsComplete RMP genomes, RNA-seq and genotypic diversity data are excellent and important resources for gene-function and post-genomic analyses and to better interrogate Plasmodium biology. Genotypic diversity between P. chabaudi isolates makes this species an excellent parasite to study genotype-phenotype relationships. The improved classification of multigene families will enhance studies on the role of (variant) exported proteins in virulence and immune evasion/modulation.</p>
<p class="grants">Funded by: Medical Research Council: <span class="grant">G0501670</span>, <span class="grant">MC_EX_G0901345</span>, <span class="grant">MC_U117532067</span></p>
<p class="publication"><span class="title">BMC biology</span>&nbsp;<span class="year">2014</span>;<span class="volume">12</span>;<span class="number">1</span>;<span class="pagerange">86</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25359557">25359557</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4242472">4242472</a>; DOI: <a href="http://dx.doi.org/10.1186%2FPREACCEPT-1233682211145405">10.1186/PREACCEPT-1233682211145405</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Genome sequencing of chimpanzee malaria parasites reveals possible pathways of adaptation to human hosts.</h4>
<p class="authors"><span class="author">Otto TD</span>, <span class="author">Rayner JC</span>, <span class="author">B&ouml;hme U</span>, <span class="author">Pain A</span>, <span class="author">Spottiswoode N</span>, <span class="author">Sanders M</span>, <span class="author">Quail M</span>, <span class="author">Ollomo B</span>, <span class="author">Renaud F</span>, <span class="author">Thomas AW</span>, <span class="author">Prugnolle F</span>, <span class="author">Conway DJ</span>, <span class="author">Newbold C</span> and <span class="author">Berriman M</span></p>
<p class="affiliation">Parasite Genomics, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Cambridge CB10 1SA, UK.</p><p class="abstract">Plasmodium falciparum causes most human malaria deaths, having prehistorically evolved from parasites of African Great Apes. Here we explore the genomic basis of P. falciparum adaptation to human hosts by fully sequencing the genome of the closely related chimpanzee parasite species P. reichenowi, and obtaining partial sequence data from a more distantly related chimpanzee parasite (P. gaboni). The close relationship between P. reichenowi and P. falciparum is emphasized by almost complete conservation of genomic synteny, but against this strikingly conserved background we observe major differences at loci involved in erythrocyte invasion. The organization of most virulence-associated multigene families, including the hypervariable var genes, is broadly conserved, but P. falciparum has a smaller subset of rif and stevor genes whose products are expressed on the infected erythrocyte surface. Genome-wide analysis identifies other loci under recent positive selection, but a limited number of changes at the host-parasite interface may have mediated host switching.</p>
<p class="grants">Funded by: NIAID NIH HHS: <span class="grant">R01 AI091595</span>; Wellcome Trust: <span class="grant">082130/Z/07/Z</span>, <span class="grant">098051</span></p>
<p class="publication"><span class="title">Nature communications</span>&nbsp;<span class="year">2014</span>;<span class="volume">5</span>;<span class="pagerange">4754</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25203297">25203297</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4166903">4166903</a>; DOI: <a href="http://dx.doi.org/10.1038%2Fncomms5754">10.1038/ncomms5754</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Unexplained diarrhoea in HIV-1 infected individuals.</h4>
<p class="authors"><span class="author">Oude Munnink BB</span>, <span class="author">Canuti M</span>, <span class="author">Deijs M</span>, <span class="author">de Vries M</span>, <span class="author">Jebbink MF</span>, <span class="author">Rebers S</span>, <span class="author">Molenkamp R</span>, <span class="author">van Hemert FJ</span>, <span class="author">Chung K</span>, <span class="author">Cotten M</span>, <span class="author">Snijders F</span>, <span class="author">Sol CJ</span> and <span class="author">van der Hoek L</span></p>
<p class="affiliation">Laboratory of Experimental Virology, Department of Medical Microbiology, Center for Infection and Immunity Amsterdam (CINIMA), Academic Medical Center of the University of Amsterdam, Amsterdam, The Netherlands. <a href="mailto:%63.%6D.%76%61%6E%64%65%72%68%6F%65%6B%40%61%6D%63.%75%76%61.%6E%6C">&#99;&#46;&#109;&#46;&#118;&#97;&#110;&#100;&#101;&#114;&#104;&#111;&#101;&#107;&#64;&#97;&#109;&#99;&#46;&#117;&#118;&#97;&#46;&#110;&#108;</a>.</p><p class="abstract"><strong>Background</strong>: Gastrointestinal symptoms, in particular diarrhoea, are common in non-treated HIV-1 infected individuals. Although various enteric pathogens have been implicated, the aetiology of diarrhoea remains unexplained in a large proportion of HIV-1 infected patients. Our aim is to identify the cause of diarrhoea for patients that remain negative in routine diagnostics.</p><p class="abstract"><strong>Methods</strong>: In this study stool samples of 196 HIV-1 infected persons, including 29 persons with diarrhoea, were examined for enteropathogens and HIV-1. A search for unknown and unexpected viruses was performed using virus discovery cDNA-AFLP combined with Roche-454 sequencing (VIDISCA-454).</p><p class="abstract"><strong>Results</strong>: HIV-1 RNA was detected in stool of 19 patients with diarrhoea (66%) compared to 75 patients (45%) without diarrhoea. In 19 of the 29 diarrhoea cases a known enteropathogen could be identified (66%). Next to these known causative agents, a range of recently identified viruses was identified via VIDISCA-454: cosavirus, Aichi virus, human gyrovirus, and non-A non-B hepatitis virus. Moreover, a novel virus was detected which was named immunodeficiency-associated stool virus (IASvirus). However, PCR based screening for these viruses showed that none of these novel viruses was associated with diarrhoea. Notably, among the 34% enteropathogen-negative cases, HIV-1 RNA shedding in stool was more frequently observed (80%) compared to enteropathogen-positive cases (47%), indicating that HIV-1 itself is the most likely candidate to be involved in diarrhoea.</p><p class="abstract"><strong>Conclusion</strong>: Unexplained diarrhoea in HIV-1 infected patients is probably not caused by recently described or previously unknown pathogens, but it is more likely that HIV-1 itself plays a role in intestinal mucosal abnormalities which leads to diarrhoea.</p>
<p class="publication"><span class="title">BMC infectious diseases</span>&nbsp;<span class="year">2014</span>;<span class="volume">14</span>;<span class="number">1</span>;<span class="pagerange">22</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24410947">24410947</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC3925291">3925291</a>; DOI: <a href="http://dx.doi.org/10.1186%2F1471-2334-14-22">10.1186/1471-2334-14-22</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Optimized Whole-Genome Amplification Strategy for Extremely AT-Biased Template.</h4>
<p class="authors"><span class="author">Oyola SO</span>, <span class="author">Manske M</span>, <span class="author">Campino S</span>, <span class="author">Claessens A</span>, <span class="author">Hamilton WL</span>, <span class="author">Kekre M</span>, <span class="author">Drury E</span>, <span class="author">Mead D</span>, <span class="author">Gu Y</span>, <span class="author">Miles A</span>, <span class="author">MacInnis B</span>, <span class="author">Newbold C</span>, <span class="author">Berriman M</span> and <span class="author">Kwiatkowski DP</span></p>
<p class="affiliation">Wellcome Trust Sanger Institute, Hinxton, UK <a href="mailto:%73%6F%31%40%73%61%6E%67%65%72.%61%63.%75%6B">&#115;&#111;&#49;&#64;&#115;&#97;&#110;&#103;&#101;&#114;&#46;&#97;&#99;&#46;&#117;&#107;</a>.</p><p class="abstract">Pathogen genome sequencing directly from clinical samples is quickly gaining importance in genetic and medical research studies. However, low DNA yield from blood-borne pathogens is often a limiting factor. The problem worsens in extremely base-biased genomes such as the AT-rich Plasmodium falciparum. We present a strategy for whole-genome amplification (WGA) of low-yield samples from P. falciparum prior to short-read sequencing. We have developed WGA conditions that incorporate tetramethylammonium chloride for improved amplification and coverage of AT-rich regions of the genome. We show that this method reduces amplification bias and chimera formation. Our data show that this method is suitable for as low as 10 pg input DNA, and offers the possibility of sequencing the parasite genome from small blood samples.</p>
<p class="publication"><span class="title">DNA research : an international journal for rapid publication of reports on genes and genomes</span>&nbsp;<span class="year">2014</span>;<span class="volume">21</span>;<span class="number">6</span>;<span class="pagerange">661-671</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25240466">25240466</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4263299">4263299</a>; DOI: <a href="http://dx.doi.org/10.1093%2Fdnares%2Fdsu028">10.1093/dnares/dsu028</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">SDF-1 chemokine signalling modulates the apoptotic responses to iron deprivation of clathrin-depleted DT40 cells.</h4>
<p class="authors"><span class="author">Pance A</span>, <span class="author">Morrissey-Wettey FR</span>, <span class="author">Craig H</span>, <span class="author">Downing A</span>, <span class="author">Talbot R</span> and <span class="author">Jackson AP</span></p>
<p class="affiliation">The Wellcome Trust Sanger Institute, Hinxton, Cambridge, United Kingdom.</p><p class="abstract">We have previously deleted both endogenous copies of the clathrin heavy-chain gene in the chicken pre B-cell-line DT40 and replaced them with clathrin under the control of a tetracycline-regulatable promoter (Tet-Off). The originally derived cell-line DKO-S underwent apoptosis when clathrin expression was repressed. We have also described a cell-line DKO-R derived from DKO-S cells that was less sensitive to clathrin-depletion. Here we show that the restriction of transferrin uptake, resulting in iron deprivation, is responsible for the lethal consequence of clathrin-depletion. We further show that the DKO-R cells have up-regulated an anti-apoptotic survival pathway based on the chemokine SDF-1 and its receptor CXCR4. Our work clarifies several puzzling features of clathrin-depleted DT40 cells and reveals an example of how SDF-1/CXCR4 signalling can abrogate pro-apoptotic pathways and increase cell survival. We propose that the phenomenon described here has implications for the therapeutic approach to a variety of cancers.</p>
<p class="grants">Funded by: Biotechnology and Biological Sciences Research Council</p>
<p class="publication"><span class="title">PloS one</span>&nbsp;<span class="year">2014</span>;<span class="volume">9</span>;<span class="number">8</span>;<span class="pagerange">e106278</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25162584">25162584</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4146602">4146602</a>; DOI: <a href="http://dx.doi.org/10.1371%2Fjournal.pone.0106278">10.1371/journal.pone.0106278</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Genetic characterization of Greek population isolates reveals strong genetic drift at missense and trait-associated variants.</h4>
<p class="authors"><span class="author">Panoutsopoulou K</span>, <span class="author">Hatzikotoulas K</span>, <span class="author">Xifara DK</span>, <span class="author">Colonna V</span>, <span class="author">Farmaki AE</span>, <span class="author">Ritchie GR</span>, <span class="author">Southam L</span>, <span class="author">Gilly A</span>, <span class="author">Tachmazidou I</span>, <span class="author">Fatumo S</span>, <span class="author">Matchan A</span>, <span class="author">Rayner NW</span>, <span class="author">Ntalla I</span>, <span class="author">Mezzavilla M</span>, <span class="author">Chen Y</span>, <span class="author">Kiagiadaki C</span>, <span class="author">Zengini E</span>, <span class="author">Mamakou V</span>, <span class="author">Athanasiadis A</span>, <span class="author">Giannakopoulou M</span>, <span class="author">Kariakli VE</span>, <span class="author">Nsubuga RN</span>, <span class="author">Karabarinde A</span>, <span class="author">Sandhu M</span>, <span class="author">McVean G</span>, <span class="author">Tyler-Smith C</span>, <span class="author">Tsafantakis E</span>, <span class="author">Karaleftheri M</span>, <span class="author">Xue Y</span>, <span class="author">Dedoussis G</span> and <span class="author">Zeggini E</span></p>
<p class="affiliation">Department of Human Genetics, Wellcome Trust Sanger Institute, Hinxton CB10 1HH, UK.</p><p class="abstract">Isolated populations are emerging as a powerful study design in the search for low-frequency and rare variant associations with complex phenotypes. Here we genotype 2,296 samples from two isolated Greek populations, the Pomak villages (HELIC-Pomak) in the North of Greece and the Mylopotamos villages (HELIC-MANOLIS) in Crete. We compare their genomic characteristics to the general Greek population and establish them as genetic isolates. In the MANOLIS cohort, we observe an enrichment of missense variants among the variants that have drifted up in frequency by more than fivefold. In the Pomak cohort, we find novel associations at variants on chr11p15.4 showing large allele frequency increases (from 0.2% in the general Greek population to 4.6% in the isolate) with haematological traits, for example, with mean corpuscular volume (rs7116019, P=2.3 &times; 10(-26)). We replicate this association in a second set of Pomak samples (combined P=2.0 &times; 10(-36)). We demonstrate significant power gains in detecting medical trait associations.</p>
<p class="grants">Funded by: European Research Council: <span class="grant">280559</span>; Wellcome Trust: <span class="grant">098051</span></p>
<p class="publication"><span class="title">Nature communications</span>&nbsp;<span class="year">2014</span>;<span class="volume">5</span>;<span class="pagerange">5345</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25373335">25373335</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4242463">4242463</a>; DOI: <a href="http://dx.doi.org/10.1038%2Fncomms6345">10.1038/ncomms6345</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">The effect of FTO variation on increased osteoarthritis risk is mediated through body mass index: a mendelian randomisation study.</h4>
<p class="authors"><span class="author">Panoutsopoulou K</span>, <span class="author">Metrustry S</span>, <span class="author">Doherty SA</span>, <span class="author">Laslett LL</span>, <span class="author">Maciewicz RA</span>, <span class="author">Hart DJ</span>, <span class="author">Zhang W</span>, <span class="author">Muir KR</span>, <span class="author">Wheeler M</span>, <span class="author">Cooper C</span>, <span class="author">Spector TD</span>, <span class="author">Cicuttini FM</span>, <span class="author">Jones G</span>, <span class="author">Arden NK</span>, <span class="author">Doherty M</span>, <span class="author">Zeggini E</span>, <span class="author">Valdes AM</span> and <span class="author">arcOGEN Consortium</span></p>
<p class="affiliation">Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, UK.</p><p class="abstract"><strong>Objective</strong>: Variation in the fat mass and obesity-associated (FTO) gene influences susceptibility to obesity. A variant in the FTO gene has been implicated in genetic risk to osteoarthritis (OA). We examined the role of the FTO polymorphism rs8044769 in risk of knee and hip OA in cases and controls incorporating body mass index (BMI) information.</p><p class="abstract"><strong>Methods</strong>: 5409 knee OA patients, 4355 hip OA patients and up to 5362 healthy controls from 7 independent cohorts from the UK and Australia were genotyped for rs8044769. The association of the FTO variant with OA was investigated in case/control analyses with and without BMI adjustment and in analyses matched for BMI category. A mendelian randomisation approach was employed using the FTO variant as the instrumental variable to evaluate the role of overweight on OA.</p><p class="abstract"><strong>Results</strong>: In the meta-analysis of all overweight (BMI&ge;25) samples versus normal-weight controls irrespective of OA status the association of rs8044769 with overweight is highly significant (OR[CIs] for allele G=1.14 [01.08 to 1.19], p=7.5&times;10(-7)). A significant association with knee OA is present in the analysis without BMI adjustment (OR[CIs]=1.08[1.02 to 1.14], p=0.009) but the signal fully attenuates after BMI adjustment (OR[CIs]=0.99[0.93 to 1.05], p=0.666). We observe no evidence for association in the BMI-matched meta-analyses. Using mendelian randomisation approaches we confirm the causal role of overweight on OA.</p><p class="abstract"><strong>Conclusions</strong>: Our data highlight the contribution of genetic risk to overweight in defining risk to OA but the association is exclusively mediated by the effect on BMI. This is consistent with what is known of the biology of the FTO gene and supports the causative role of high BMI in OA.</p>
<p class="grants">Funded by: Medical Research Council: <span class="grant">MC_UP_A620_1014</span></p>
<p class="publication"><span class="title">Annals of the rheumatic diseases</span>&nbsp;<span class="year">2014</span>;<span class="volume">73</span>;<span class="number">12</span>;<span class="pagerange">2082-6</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/23921993">23921993</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4251538">4251538</a>; DOI: <a href="http://dx.doi.org/10.1136%2Fannrheumdis-2013-203772">10.1136/annrheumdis-2013-203772</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">RAG-mediated recombination is the predominant driver of oncogenic rearrangement in ETV6-RUNX1 acute lymphoblastic leukemia.</h4>
<p class="authors"><span class="author">Papaemmanuil E</span>, <span class="author">Rapado I</span>, <span class="author">Li Y</span>, <span class="author">Potter NE</span>, <span class="author">Wedge DC</span>, <span class="author">Tubio J</span>, <span class="author">Alexandrov LB</span>, <span class="author">Van Loo P</span>, <span class="author">Cooke SL</span>, <span class="author">Marshall J</span>, <span class="author">Martincorena I</span>, <span class="author">Hinton J</span>, <span class="author">Gundem G</span>, <span class="author">van Delft FW</span>, <span class="author">Nik-Zainal S</span>, <span class="author">Jones DR</span>, <span class="author">Ramakrishna M</span>, <span class="author">Titley I</span>, <span class="author">Stebbings L</span>, <span class="author">Leroy C</span>, <span class="author">Menzies A</span>, <span class="author">Gamble J</span>, <span class="author">Robinson B</span>, <span class="author">Mudie L</span>, <span class="author">Raine K</span>, <span class="author">O&#39;Meara S</span>, <span class="author">Teague JW</span>, <span class="author">Butler AP</span>, <span class="author">Cazzaniga G</span>, <span class="author">Biondi A</span>, <span class="author">Zuna J</span>, <span class="author">Kempski H</span>, <span class="author">Muschen M</span>, <span class="author">Ford AM</span>, <span class="author">Stratton MR</span>, <span class="author">Greaves M</span> and <span class="author">Campbell PJ</span></p>
<p class="affiliation">Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton, UK.</p><p class="abstract">The ETV6-RUNX1 fusion gene, found in 25% of childhood acute lymphoblastic leukemia (ALL) cases, is acquired in utero but requires additional somatic mutations for overt leukemia. We used exome and low-coverage whole-genome sequencing to characterize secondary events associated with leukemic transformation. RAG-mediated deletions emerge as the dominant mutational process, characterized by recombination signal sequence motifs near breakpoints, incorporation of non-templated sequence at junctions, &sim;30-fold enrichment at promoters and enhancers of genes actively transcribed in B cell development and an unexpectedly high ratio of recurrent to non-recurrent structural variants. Single-cell tracking shows that this mechanism is active throughout leukemic evolution, with evidence of localized clustering and reiterated deletions. Integration of data on point mutations and rearrangements identifies ATF7IP and MGA as two new tumor-suppressor genes in ALL. Thus, a remarkably parsimonious mutational process transforms ETV6-RUNX1-positive lymphoblasts, targeting the promoters, enhancers and first exons of genes that normally regulate B cell differentiation.</p>
<p class="grants">Funded by: NCI NIH HHS: <span class="grant">R01 CA137060</span>, <span class="grant">R01 CA139032</span>, <span class="grant">R01 CA157644</span>, <span class="grant">R01 CA169458</span>, <span class="grant">R01 CA172558</span>; Wellcome Trust: <span class="grant">077012/05/Z</span>, <span class="grant">093867</span>, <span class="grant">WT088340MA</span>, <span class="grant">WT100183MA</span></p>
<p class="publication"><span class="title">Nature genetics</span>&nbsp;<span class="year">2014</span>;<span class="volume">46</span>;<span class="number">2</span>;<span class="pagerange">116-25</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24413735">24413735</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC3960636">3960636</a>; DOI: <a href="http://dx.doi.org/10.1038%2Fng.2874">10.1038/ng.2874</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Prevalence and properties of mecC methicillin-resistant Staphylococcus aureus (MRSA) in bovine bulk tank milk in Great Britain.</h4>
<p class="authors"><span class="author">Paterson GK</span>, <span class="author">Morgan FJ</span>, <span class="author">Harrison EM</span>, <span class="author">Peacock SJ</span>, <span class="author">Parkhill J</span>, <span class="author">Zadoks RN</span> and <span class="author">Holmes MA</span></p>
<p class="affiliation">Department of Veterinary Medicine, University of Cambridge, Madingley Road, Cambridge CB3 0ES, UK.</p>
<p class="abstract">Objectives: mecC methicillin-resistant Staphylococcus aureus (MRSA) represent a newly recognized form of MRSA, distinguished by the possession of a divergent mecA homologue, mecC. The first isolate to be identified came from bovine milk, but there are few data on the prevalence of mecC MRSA among dairy cattle. The aim of this study was to conduct a prevalence study of mecC MRSA among dairy farms in Great Britain.

Methods: Test farms were randomly selected by random order generation and bulk tank samples were tested for the presence of mecC MRSA by broth enrichment and plating onto chromogenic agar. All MRSA isolated were screened by PCR for mecA and mecC, and mecC MRSA were further characterized by multilocus sequence typing, spa typing and antimicrobial susceptibility testing.

Results: mecC MRSA were detected on 10 of 465 dairy farms sampled in England and Wales (prevalence 2.15%, 95% CI 1.17%-3.91%), but not from 625 farms sampled in Scotland (95% CI of prevalence 0%-0.61%). Seven isolates belonged to sequence type (ST) 425, while the other three belonged to clonal complex 130. Resistance to non--lactam antibiotics was uncommon. All 10 isolates produced a negative result by slide agglutination for penicillin-binding protein 2a. mecA MRSA ST398 was detected on one farm in England.

Conclusions: mecC MRSA is widely distributed among dairy farms in Great Britain, but this distribution is not uniform across the whole country. These results provide an important baseline dataset to monitor the epidemiology of this emerging form of MRSA.</p>
<p class="grants">Funded by: Medical Research Council: <span class="grant">G1001787</span></p>
<p class="publication"><span class="title">The Journal of antimicrobial chemotherapy</span>&nbsp;<span class="year">2014</span>;<span class="volume">69</span>;<span class="number">3</span>;<span class="pagerange">598-602</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24155057">24155057</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC3922150">3922150</a>; DOI: <a href="http://dx.doi.org/10.1093%2Fjac%2Fdkt417">10.1093/jac/dkt417</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Functional interpretation of non-coding sequence variation: Concepts and challenges.</h4>
<p class="authors"><span class="author">Paul DS</span>, <span class="author">Soranzo N</span> and <span class="author">Beck S</span></p>
<p class="affiliation">UCL Cancer Institute, University College London, London, United Kingdom.</p>
<p class="abstract">Understanding the functional mechanisms underlying genetic signals associated with complex traits and common diseases, such as cancer, diabetes and Alzheimer's disease, is a formidable challenge. Many genetic signals discovered through genome-wide association studies map to non-protein coding sequences, where their molecular consequences are difficult to evaluate. This article summarizes concepts for the systematic interpretation of non-coding genetic signals using genome annotation data sets in different cellular systems. We outline strategies for the global analysis of multiple association intervals and the in-depth molecular investigation of individual intervals. We highlight experimental techniques to validate candidate (potential causal) regulatory variants, with a focus on novel genome-editing techniques including CRISPR/Cas9. These approaches are also applicable to low-frequency and rare variants, which have become increasingly important in genomic studies of complex traits and diseases. There is a pressing need to translate genetic signals into biological mechanisms, leading to prognostic, diagnostic and therapeutic advances.</p>
<p class="publication"><span class="title">BioEssays : news and reviews in molecular, cellular and developmental biology</span>&nbsp;<span class="year">2014</span>;<span class="volume">36</span>;<span class="number">2</span>;<span class="pagerange">191-9</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24311363">24311363</a>; DOI: <a href="http://dx.doi.org/10.1002%2Fbies.201300126">10.1002/bies.201300126</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Hypomorphism in human NSMCE2 linked to primordial dwarfism and insulin resistance.</h4>
<p class="authors"><span class="author">Payne F</span>, <span class="author">Colnaghi R</span>, <span class="author">Rocha N</span>, <span class="author">Seth A</span>, <span class="author">Harris J</span>, <span class="author">Carpenter G</span>, <span class="author">Bottomley WE</span>, <span class="author">Wheeler E</span>, <span class="author">Wong S</span>, <span class="author">Saudek V</span>, <span class="author">Savage D</span>, <span class="author">O&#39;Rahilly S</span>, <span class="author">Carel JC</span>, <span class="author">Barroso I</span>, <span class="author">O&#39;Driscoll M</span> and <span class="author">Semple R</span></p><p class="abstract">Structural maintenance of chromosomes (SMC) complexes are essential for maintaining chromatin structure and regulating gene expression. Two the three known SMC complexes, cohesin and condensin, are important for sister chromatid cohesion and condensation, respectively; however, the function of the third complex, SMC5-6, which includes the E3 SUMO-ligase NSMCE2 (also widely known as MMS21) is less clear. Here, we characterized 2 patients with primordial dwarfism, extreme insulin resistance, and gonadal failure and identified compound heterozygous frameshift mutations in NSMCE2. Both mutations reduced NSMCE2 expression in patient cells. Primary cells from one patient showed increased micronucleus and nucleoplasmic bridge formation, delayed recovery of DNA synthesis, and reduced formation of foci containing Bloom syndrome helicase (BLM) after hydroxyurea-induced replication fork stalling. These nuclear abnormalities in patient dermal fibroblast were restored by expression of WT NSMCE2, but not a mutant form lacking SUMO-ligase activity. Furthermore, in zebrafish, knockdown of the NSMCE2 ortholog produced dwarfism, which was ameliorated by reexpression of WT, but not SUMO-ligase-deficient NSMCE. Collectively, these findings support a role for NSMCE2 in recovery from DNA damage and raise the possibility that loss of its function produces dwarfism through reduced tolerance of replicative stress.</p>
<p class="grants">Funded by: Cancer Research UK: <span class="grant">15394</span>; Department of Health; Medical Research Council: <span class="grant">MC_UU_12012/5/B</span>; NHLBI NIH HHS: <span class="grant">HL-102923</span>, <span class="grant">HL-102924</span>, <span class="grant">HL-102925</span>, <span class="grant">HL-102926</span>, <span class="grant">HL-103010</span>; Wellcome Trust: <span class="grant">WT091310</span>, <span class="grant">WT091551</span>, <span class="grant">WT095515</span>, <span class="grant">WT098051</span>, <span class="grant">WT098498</span></p>
<p class="publication"><span class="title">The Journal of clinical investigation</span>&nbsp;<span class="year">2014</span>;<span class="volume">124</span>;<span class="number">9</span>;<span class="pagerange">4028-38</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25105364">25105364</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4151221">4151221</a>; DOI: <a href="http://dx.doi.org/10.1172%2FJCI73264">10.1172/JCI73264</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Mutations disrupting the Kennedy phosphatidylcholine pathway in humans with congenital lipodystrophy and fatty liver disease.</h4>
<p class="authors"><span class="author">Payne F</span>, <span class="author">Lim K</span>, <span class="author">Girousse A</span>, <span class="author">Brown RJ</span>, <span class="author">Kory N</span>, <span class="author">Robbins A</span>, <span class="author">Xue Y</span>, <span class="author">Sleigh A</span>, <span class="author">Cochran E</span>, <span class="author">Adams C</span>, <span class="author">Dev Borman A</span>, <span class="author">Russel-Jones D</span>, <span class="author">Gorden P</span>, <span class="author">Semple RK</span>, <span class="author">Saudek V</span>, <span class="author">O&#39;Rahilly S</span>, <span class="author">Walther TC</span>, <span class="author">Barroso I</span> and <span class="author">Savage DB</span></p>
<p class="affiliation">Metabolic Disease Group, The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Cambridge CB10 1SA, United Kingdom;</p><p class="abstract">Phosphatidylcholine (PC) is the major glycerophospholipid in eukaryotic cells and is an essential component in all cellular membranes. The biochemistry of de novo PC synthesis by the Kennedy pathway is well established, but less is known about the physiological functions of PC. We identified two unrelated patients with defects in the Kennedy pathway due to biallellic loss-of-function mutations in phosphate cytidylyltransferase 1 alpha (PCYT1A), the rate-limiting enzyme in this pathway. The mutations lead to a marked reduction in PCYT1A expression and PC synthesis. The phenotypic consequences include some features, such as severe fatty liver and low HDL cholesterol levels, that are predicted by the results of previously reported liver-specific deletion of murine Pcyt1a. Both patients also had lipodystrophy, severe insulin resistance, and diabetes, providing evidence for an additional and essential role for PCYT1A-generated PC in the normal function of white adipose tissue and insulin action.</p>
<p class="grants">Funded by: Medical Research Council; NHLBI NIH HHS: <span class="grant">HL-102923</span>, <span class="grant">HL-102926</span>, <span class="grant">HL-103010</span>; NIGMS NIH HHS: <span class="grant">R01 GM09719</span>; Wellcome Trust: <span class="grant">091551</span>, <span class="grant">098498</span>, <span class="grant">WT091310</span>, <span class="grant">WT091551</span>, <span class="grant">WT095515</span>, <span class="grant">WT098051</span>, <span class="grant">WT098498</span></p>
<p class="publication"><span class="title">Proceedings of the National Academy of Sciences of the United States of America</span>&nbsp;<span class="year">2014</span>;<span class="volume">111</span>;<span class="number">24</span>;<span class="pagerange">8901-6</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24889630">24889630</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4066527">4066527</a>; DOI: <a href="http://dx.doi.org/10.1073%2Fpnas.1408523111">10.1073/pnas.1408523111</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Microbial sequencing to improve individual and population health.</h4>
<p class="authors"><span class="author">Peacock SJ</span> and <span class="author">Weinstock GM</span></p>
<p class="affiliation">Department of Medicine, University of Cambridge, Box 157 Addenbrooke&#39;s Hospital, Hills Road, Cambridge, CB2 0QQ UK ; The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1SA UK.</p><p class="abstract">Recent advances in sequencing technologies are changing the face of infectious disease investigation and control. Personalized anti-infective therapies and surveillance of emergent pathogen outbreaks are just two examples of the potential benefits of merging the fields of genomics and infectious diseases.</p>
<p class="publication"><span class="title">Genome medicine</span>&nbsp;<span class="year">2014</span>;<span class="volume">6</span>;<span class="number">11</span>;<span class="pagerange">103</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25505493">25505493</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4262389">4262389</a>; DOI: <a href="http://dx.doi.org/10.1186%2Fs13073-014-0103-5">10.1186/s13073-014-0103-5</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Functional Characterization of Obesity-Associated Variants Involving the &alpha; and &beta; Isoforms of Human SH2B1.</h4>
<p class="authors"><span class="author">Pearce LR</span>, <span class="author">Joe R</span>, <span class="author">Doche ME</span>, <span class="author">Su HW</span>, <span class="author">Keogh JM</span>, <span class="author">Henning E</span>, <span class="author">Argetsinger LS</span>, <span class="author">Bochukova EG</span>, <span class="author">Cline JM</span>, <span class="author">Garg S</span>, <span class="author">Saeed S</span>, <span class="author">Shoelson S</span>, <span class="author">O&#39;Rahilly S</span>, <span class="author">Barroso I</span>, <span class="author">Rui L</span>, <span class="author">Farooqi IS</span> and <span class="author">Carter-Su C</span></p>
<p class="affiliation">University of Cambridge Metabolic Research Laboratories and National Institute for Health Research Cambridge Biomedical Research Centre (L.R.P., J.M.K., E.H., E.G.B., S.G., S.Sa., S.O., I.B., I.S.F.), Wellcome Trust-Medical Research Council Institute of Metabolic Science, Addenbrooke&#39;s Hospital, Cambridge, CB2 0QQ United Kingdom; Graduate Program in Cellular and Molecular Biology (R.J., C.C.-S.), Department of Molecular and Integrative Physiology (M.E.D., H.-W.S., L.S.A., J.M.C., L.R., C.C.-S.), and Division of Metabolism, Endocrinology, and Diabetes (C.C.-S.), Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan 48109-5622; Joslin Diabetes Center and Department of Medicine (S.Sh.), Harvard University, Boston, Massachusetts 02115; and Wellcome Trust Sanger Institute (I.B.), Hinxton, CB10 1SA United Kingdom.</p><p class="abstract">We have previously reported rare variants in sarcoma (Src) homology 2 (SH2) B adaptor protein 1 (SH2B1) in individuals with obesity, insulin resistance, and maladaptive behavior. Here, we identify 4 additional SH2B1 variants by sequencing 500 individuals with severe early-onset obesity. SH2B1 has 4 alternatively spliced isoforms. One variant (T546A) lies within the N-terminal region common to all isoforms. As shown for past variants in this region, T546A impairs SH2B1&beta; enhancement of nerve growth factor-induced neurite outgrowth, and the individual with the T546A variant exhibits mild developmental delay. The other 3 variants (A663V, V695M, and A723V) lie in the C-terminal tail of SH2B1&alpha;. SH2B1&alpha; variant carriers were hyperinsulinemic but did not exhibit the behavioral phenotype observed in individuals with SH2B1 variants that disrupt all isoforms. In in vitro assays, SH2B1&alpha;, like SH2B1&beta;, enhances insulin- and leptin-induced insulin receptor substrate 2 (IRS2) phosphorylation and GH-induced cell motility. None of the variants affect SH2B1&alpha; enhancement of insulin- and leptin-induced IRS2 phosphorylation. However, T546A, A663V, and A723V all impair the ability of SH2B1&alpha; to enhance GH-induced cell motility. In contrast to SH2B1&beta;, SH2B1&alpha; does not enhance nerve growth factor-induced neurite outgrowth. These studies suggest that genetic variants that disrupt isoforms other than SH2B1&beta; may be functionally significant. Further studies are needed to understand the mechanism by which the individual isoforms regulate energy homeostasis and behavior.</p>
<p class="publication"><span class="title">Endocrinology</span>&nbsp;<span class="year">2014</span>;<span class="volume">155</span>;<span class="number">9</span>;<span class="pagerange">3219-26</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24971614">24971614</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4138566">4138566</a>; DOI: <a href="http://dx.doi.org/10.1210%2Fen.2014-1264">10.1210/en.2014-1264</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Genome-wide Bisulfite Sequencing in Zygotes Identifies Demethylation Targets and Maps the Contribution of TET3 Oxidation.</h4>
<p class="authors"><span class="author">Peat JR</span>, <span class="author">Dean W</span>, <span class="author">Clark SJ</span>, <span class="author">Krueger F</span>, <span class="author">Smallwood SA</span>, <span class="author">Ficz G</span>, <span class="author">Kim JK</span>, <span class="author">Marioni JC</span>, <span class="author">Hore TA</span> and <span class="author">Reik W</span></p>
<p class="affiliation">Epigenetics Programme, The Babraham Institute, Cambridge CB22 3AT, UK. Electronic address: <a href="mailto:%6A%75%6C%69%61%6E.%70%65%61%74%40%62%61%62%72%61%68%61%6D.%61%63.%75%6B">&#106;&#117;&#108;&#105;&#97;&#110;&#46;&#112;&#101;&#97;&#116;&#64;&#98;&#97;&#98;&#114;&#97;&#104;&#97;&#109;&#46;&#97;&#99;&#46;&#117;&#107;</a>.</p><p class="abstract">Fertilization triggers global erasure of paternal 5-methylcytosine as part of epigenetic reprogramming during the transition from gametic specialization to&nbsp;totipotency. This involves oxidation by TET3, but&nbsp;our understanding of its targets and the wider context of demethylation is limited to a small fraction of the genome. We employed an optimized bisulfite strategy to generate genome-wide methylation profiles of control and TET3-deficient zygotes, using SNPs to access paternal alleles. This revealed that in addition to pervasive removal from intergenic sequences and most retrotransposons, gene bodies constitute a major target of zygotic demethylation. Methylation loss is associated with zygotic genome activation and at gene bodies is also linked to increased transcriptional noise in early development. Our data map the primary contribution of oxidative demethylation to a subset of gene bodies and intergenic sequences and implicate redundant pathways at many loci. Unexpectedly, we demonstrate that TET3 activity also protects certain CpG islands against methylation buildup.</p>
<p class="publication"><span class="title">Cell reports</span>&nbsp;<span class="year">2014</span>;<span class="volume">9</span>;<span class="number">6</span>;<span class="pagerange">1990-2000</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25497087">25497087</a>; DOI: <a href="http://dx.doi.org/10.1016%2Fj.celrep.2014.11.034">10.1016/j.celrep.2014.11.034</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">RASSF1A-LATS1 signalling stabilizes replication forks by restricting CDK2-mediated phosphorylation of&nbsp;BRCA2.</h4>
<p class="authors"><span class="author">Pefani DE</span>, <span class="author">Latusek R</span>, <span class="author">Pires I</span>, <span class="author">Grawenda AM</span>, <span class="author">Yee KS</span>, <span class="author">Hamilton G</span>, <span class="author">van der Weyden L</span>, <span class="author">Esashi F</span>, <span class="author">Hammond EM</span> and <span class="author">O&#39;Neill E</span></p>
<p class="affiliation">CRUK/MRC Oxford Institute, Department of Oncology, University of Oxford, Oxford OX3 7DQ, UK.</p><p class="abstract">Genomic instability is a key hallmark of cancer leading to tumour heterogeneity and therapeutic resistance. BRCA2 has a fundamental role in error-free DNA repair but also sustains genome integrity by promoting RAD51 nucleofilament formation at stalled replication forks. CDK2 phosphorylates BRCA2 (pS3291-BRCA2) to limit stabilizing contacts with polymerized RAD51; however, how replication stress modulates CDK2 activity and whether loss of pS3291-BRCA2 regulation results in genomic instability of tumours are not known. Here we demonstrate that the Hippo pathway kinase LATS1 interacts with CDK2 in response to genotoxic stress to constrain pS3291-BRCA2 and support RAD51 nucleofilaments, thereby maintaining genomic fidelity during replication stalling. We also show that LATS1 forms part of an ATR-mediated response to replication stress that requires the tumour suppressor RASSF1A. Importantly, perturbation of the ATR-RASSF1A-LATS1 signalling axis leads to genomic defects associated with loss of BRCA2 function and contributes to genomic instability and &#39;BRCA-ness&#39; in lung cancers.</p>
<p class="publication"><span class="title">Nature cell biology</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25218637">25218637</a>; DOI: <a href="http://dx.doi.org/10.1038%2Fncb3035">10.1038/ncb3035</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">The different shades of fat.</h4>
<p class="authors"><span class="author">Peirce V</span>, <span class="author">Carobbio S</span> and <span class="author">Vidal-Puig A</span></p>
<p class="affiliation">University of Cambridge Metabolic Research Laboratories, Level 4, Wellcome Trust-MRC Institute of Metabolic Science, Box 289, Addenbrooke&#39;s Hospital, Cambridge CB2 OQQ, UK.</p><p class="abstract">Our understanding of adipose tissue biology has progressed rapidly since the turn of the century. White adipose tissue has emerged as a key determinant of healthy metabolism and metabolic dysfunction. This realization is paralleled only by the confirmation that adult humans have heat-dissipating brown adipose tissue, an important contributor to energy balance and a possible therapeutic target for the treatment of metabolic disease. We propose that the development of successful strategies to target brown and white adipose tissues will depend on investigations that elucidate their developmental origins and cell-type-specific functional regulators.</p>
<p class="grants">Funded by: Biotechnology and Biological Sciences Research Council; Medical Research Council; Wellcome Trust</p>
<p class="publication"><span class="title">Nature</span>&nbsp;<span class="year">2014</span>;<span class="volume">510</span>;<span class="number">7503</span>;<span class="pagerange">76-83</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24899307">24899307</a>; DOI: <a href="http://dx.doi.org/10.1038%2Fnature13477">10.1038/nature13477</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">The draft genome sequence of the ferret (Mustela putorius furo) facilitates study of human respiratory disease.</h4>
<p class="authors"><span class="author">Peng X</span>, <span class="author">Alf&ouml;ldi J</span>, <span class="author">Gori K</span>, <span class="author">Eisfeld AJ</span>, <span class="author">Tyler SR</span>, <span class="author">Tisoncik-Go J</span>, <span class="author">Brawand D</span>, <span class="author">Law GL</span>, <span class="author">Skunca N</span>, <span class="author">Hatta M</span>, <span class="author">Gasper DJ</span>, <span class="author">Kelly SM</span>, <span class="author">Chang J</span>, <span class="author">Thomas MJ</span>, <span class="author">Johnson J</span>, <span class="author">Berlin AM</span>, <span class="author">Lara M</span>, <span class="author">Russell P</span>, <span class="author">Swofford R</span>, <span class="author">Turner-Maier J</span>, <span class="author">Young S</span>, <span class="author">Hourlier T</span>, <span class="author">Aken B</span>, <span class="author">Searle S</span>, <span class="author">Sun X</span>, <span class="author">Yi Y</span>, <span class="author">Suresh M</span>, <span class="author">Tumpey TM</span>, <span class="author">Siepel A</span>, <span class="author">Wisely SM</span>, <span class="author">Dessimoz C</span>, <span class="author">Kawaoka Y</span>, <span class="author">Birren BW</span>, <span class="author">Lindblad-Toh K</span>, <span class="author">Di Palma F</span>, <span class="author">Engelhardt JF</span>, <span class="author">Palermo RE</span> and <span class="author">Katze MG</span></p>
<p class="affiliation">Department of Microbiology, University of Washington, Seattle, Washington, USA.</p><p class="abstract">The domestic ferret (Mustela putorius furo) is an important animal model for multiple human respiratory diseases. It is considered the &#39;gold standard&#39; for modeling human influenza virus infection and transmission. Here we describe the 2.41 Gb draft genome assembly of the domestic ferret, constituting 2.28 Gb of sequence plus gaps. We annotated 19,910 protein-coding genes on this assembly using RNA-seq data from 21 ferret tissues. We characterized the ferret host response to two influenza virus infections by RNA-seq analysis of 42 ferret samples from influenza time-course data and showed distinct signatures in ferret trachea and lung tissues specific to 1918 or 2009 human pandemic influenza virus infections. Using microarray data from 16 ferret samples reflecting cystic fibrosis disease progression, we showed that transcriptional changes in the CFTR-knockout ferret lung reflect pathways of early disease that cannot be readily studied in human infants with cystic fibrosis disease.</p>
<p class="grants">Funded by: NCRR NIH HHS: <span class="grant">T32 RR023916</span>; NHLBI NIH HHS: <span class="grant">R01 HL108902</span>; NIDDK NIH HHS: <span class="grant">P30 DK054759</span>, <span class="grant">R24 DK096518</span>, <span class="grant">R37 DK047967</span>; NIGMS NIH HHS: <span class="grant">R01 GM102192</span>; NIH HHS: <span class="grant">T32 OD010423</span></p>
<p class="publication"><span class="title">Nature biotechnology</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25402615">25402615</a>; DOI: <a href="http://dx.doi.org/10.1038%2Fnbt.3079">10.1038/nbt.3079</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Functional genomics reveals that Clostridium difficile Spo0A coordinates sporulation, virulence and metabolism.</h4>
<p class="authors"><span class="author">Pettit LJ</span>, <span class="author">Browne HP</span>, <span class="author">Yu L</span>, <span class="author">Smits WK</span>, <span class="author">Fagan RP</span>, <span class="author">Barquist L</span>, <span class="author">Martin MJ</span>, <span class="author">Goulding D</span>, <span class="author">Duncan SH</span>, <span class="author">Flint HJ</span>, <span class="author">Dougan G</span>, <span class="author">Choudhary JS</span> and <span class="author">Lawley TD</span></p>
<p class="affiliation">Wellcome Trust Sanger Institute, Hinxton, UK. <a href="mailto:%74%6C%32%40%73%61%6E%67%65%72.%61%63.%75%6B">&#116;&#108;&#50;&#64;&#115;&#97;&#110;&#103;&#101;&#114;&#46;&#97;&#99;&#46;&#117;&#107;</a>.</p><p class="abstract"><strong>Background</strong>: Clostridium difficile is an anaerobic, Gram-positive bacterium that can reside as a commensal within the intestinal microbiota of healthy individuals or cause life-threatening antibiotic-associated diarrhea in immunocompromised hosts. C. difficile can also form highly resistant spores that are excreted facilitating host-to-host transmission. The C. difficile spo0A gene encodes a highly conserved transcriptional regulator of sporulation that is required for relapsing disease and transmission in mice.</p><p class="abstract"><strong>Results</strong>: Here we describe a genome-wide approach using a combined transcriptomic and proteomic analysis to identify Spo0A regulated genes. Our results validate Spo0A as a positive regulator of putative and novel sporulation genes as well as components of the mature spore proteome. We also show that Spo0A regulates a number of virulence-associated factors such as flagella and metabolic pathways including glucose fermentation leading to butyrate production.</p><p class="abstract"><strong>Conclusions</strong>: The C. difficile spo0A gene is a global transcriptional regulator that controls diverse sporulation, virulence and metabolic phenotypes coordinating pathogen adaptation to a wide range of host interactions. Additionally, the rich breadth of functional data allowed us to significantly update the annotation of the C. difficile 630 reference genome which will facilitate basic and applied research on this emerging pathogen.</p>
<p class="grants">Funded by: Wellcome Trust: <span class="grant">086418</span>, <span class="grant">098051</span></p>
<p class="publication"><span class="title">BMC genomics</span>&nbsp;<span class="year">2014</span>;<span class="volume">15</span>;<span class="pagerange">160</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24568651">24568651</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4028888">4028888</a>; DOI: <a href="http://dx.doi.org/10.1186%2F1471-2164-15-160">10.1186/1471-2164-15-160</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Global dissemination of a multidrug resistant Escherichia coli clone.</h4>
<p class="authors"><span class="author">Petty NK</span>, <span class="author">Ben Zakour NL</span>, <span class="author">Stanton-Cook M</span>, <span class="author">Skippington E</span>, <span class="author">Totsika M</span>, <span class="author">Forde BM</span>, <span class="author">Phan MD</span>, <span class="author">Gomes Moriel D</span>, <span class="author">Peters KM</span>, <span class="author">Davies M</span>, <span class="author">Rogers BA</span>, <span class="author">Dougan G</span>, <span class="author">Rodriguez-Ba&ntilde;o J</span>, <span class="author">Pascual A</span>, <span class="author">Pitout JD</span>, <span class="author">Upton M</span>, <span class="author">Paterson DL</span>, <span class="author">Walsh TR</span>, <span class="author">Schembri MA</span> and <span class="author">Beatson SA</span></p>
<p class="affiliation">Australian Infectious Diseases Research Centre, and School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, QLD 4072, Australia.</p><p class="abstract">Escherichia coli sequence type 131 (ST131) is a globally disseminated, multidrug resistant (MDR) clone responsible for a high proportion of urinary tract and bloodstream infections. The rapid emergence and successful spread of E. coli ST131 is strongly associated with several factors, including resistance to fluoroquinolones, high virulence gene content, the possession of the type 1 fimbriae FimH30 allele, and the production of the CTX-M-15 extended spectrum &beta;-lactamase (ESBL). Here, we used genome sequencing to examine the molecular epidemiology of a collection of E. coli ST131 strains isolated from six distinct geographical locations across the world spanning 2000-2011. The global phylogeny of E. coli ST131, determined from whole-genome sequence data, revealed a single lineage of E. coli ST131 distinct from other extraintestinal E. coli strains within the B2 phylogroup. Three closely related E. coli ST131 sublineages were identified, with little association to geographic origin. The majority of single-nucleotide variants associated with each of the sublineages were due to recombination in regions adjacent to mobile genetic elements (MGEs). The most prevalent sublineage of ST131 strains was characterized by fluoroquinolone resistance, and a distinct virulence factor and MGE profile. Four different variants of the CTX-M ESBL-resistance gene were identified in our ST131 strains, with acquisition of CTX-M-15 representing a defining feature of a discrete but geographically dispersed ST131 sublineage. This study confirms the global dispersal of a single E. coli ST131 clone and demonstrates the role of MGEs and recombination in the evolution of this important MDR pathogen.</p>
<p class="publication"><span class="title">Proceedings of the National Academy of Sciences of the United States of America</span>&nbsp;<span class="year">2014</span>;<span class="volume">111</span>;<span class="number">15</span>;<span class="pagerange">5694-9</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24706808">24706808</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC3992628">3992628</a>; DOI: <a href="http://dx.doi.org/10.1073%2Fpnas.1322678111">10.1073/pnas.1322678111</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Vying over spilt oil.</h4>
<p class="authors"><span class="author">Pham N TA</span> and <span class="author">Anonye BO</span></p>
<p class="affiliation">Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1SA, UK.</p>
<p class="publication"><span class="title">Nature reviews. Microbiology</span>&nbsp;<span class="year">2014</span>;<span class="volume">12</span>;<span class="number">3</span>;<span class="pagerange">156</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24509784">24509784</a>; DOI: <a href="http://dx.doi.org/10.1038%2Fnrmicro3224">10.1038/nrmicro3224</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Pathogens&#39; exploitation of the intestinal food web.</h4>
<p class="authors"><span class="author">Pham N TA</span> and <span class="author">Lawley TD</span></p>
<p class="affiliation">Host-Microbiota Interactions Laboratory, Wellcome Trust Sanger Institute, Cambridge, UK.</p><p class="abstract">Competition for nutrients is a key factor controlling pathogen colonization within the gastrointestinal tract. In this issue, Ferreyra et&nbsp;al. (2014) and Curtis et&nbsp;al. (2014) show that diverse enteric pathogens can exploit a metabolic byproduct from the commensal microbiota, succinate, to enhance their own virulence expression and proliferation.</p>
<p class="publication"><span class="title">Cell host &amp; microbe</span>&nbsp;<span class="year">2014</span>;<span class="volume">16</span>;<span class="number">6</span>;<span class="pagerange">703-5</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25498340">25498340</a>; DOI: <a href="http://dx.doi.org/10.1016%2Fj.chom.2014.11.012">10.1016/j.chom.2014.11.012</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Emerging insights on intestinal dysbiosis during bacterial infections.</h4>
<p class="authors"><span class="author">Pham TA</span> and <span class="author">Lawley TD</span></p>
<p class="affiliation">Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton CB10 1SA, United Kingdom.</p><p class="abstract">Infection of the gastrointestinal tract is commonly linked to pathological imbalances of the resident microbiota, termed dysbiosis. In recent years, advanced high-throughput genomic approaches have allowed us to examine the microbiota in an unprecedented manner, revealing novel biological insights about infection-associated dysbiosis at the community and individual species levels. A dysbiotic microbiota is typically reduced in taxonomic diversity and metabolic function, and can harbour pathobionts that exacerbate intestinal inflammation or manifest systemic disease. Dysbiosis can also promote pathogen genome evolution, while allowing the pathogens to persist at high density and transmit to new hosts. A deeper understanding of bacterial pathogenicity in the context of the intestinal microbiota should unveil new approaches for developing diagnostics and therapies for enteropathogens.</p>
<p class="publication"><span class="title">Current opinion in microbiology</span>&nbsp;<span class="year">2014</span>;<span class="volume">17</span>;<span class="pagerange">67-74</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24581695">24581695</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC3969284">3969284</a>; DOI: <a href="http://dx.doi.org/10.1016%2Fj.mib.2013.12.002">10.1016/j.mib.2013.12.002</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Epithelial IL-22RA1-mediated fucosylation promotes intestinal colonization resistance to an opportunistic pathogen.</h4>
<p class="authors"><span class="author">Pham TA</span>, <span class="author">Clare S</span>, <span class="author">Goulding D</span>, <span class="author">Arasteh JM</span>, <span class="author">Stares MD</span>, <span class="author">Browne HP</span>, <span class="author">Keane JA</span>, <span class="author">Page AJ</span>, <span class="author">Kumasaka N</span>, <span class="author">Kane L</span>, <span class="author">Mottram L</span>, <span class="author">Harcourt K</span>, <span class="author">Hale C</span>, <span class="author">Arends MJ</span>, <span class="author">Gaffney DJ</span>, <span class="author">Sanger Mouse Genetics Project</span>, <span class="author">Dougan G</span> and <span class="author">Lawley TD</span></p>
<p class="affiliation">Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, CB10 1SA, UK.</p><p class="abstract">Our intestinal microbiota harbors a diverse microbial community, often containing opportunistic bacteria with virulence potential. However, mutualistic host-microbial interactions prevent disease by opportunistic pathogens through poorly understood mechanisms. We show that the epithelial interleukin-22 receptor IL-22RA1 protects against lethal Citrobacter rodentium infection and chemical-induced colitis by promoting colonization resistance against an intestinal opportunistic bacterium, Enterococcus faecalis. Susceptibility of Il22ra1(-/-) mice to C. rodentium was associated with preferential expansion and epithelial translocation of pathogenic E. faecalis during severe microbial dysbiosis and was ameloriated with antibiotics active against E. faecalis. RNA sequencing analyses of primary colonic organoids showed that IL-22RA1 signaling promotes intestinal fucosylation via induction of the fucosyltransferase Fut2. Additionally, administration of fucosylated oligosaccharides to C. rodentium-challenged Il22ra1(-/-) mice attenuated infection and promoted E. faecalis colonization resistance by restoring the diversity of anaerobic commensal symbionts. These results support a model whereby IL-22RA1 enhances host-microbiota mutualism to limit detrimental overcolonization by opportunistic pathogens.</p>
<p class="grants">Funded by: Medical Research Council; Wellcome Trust</p>
<p class="publication"><span class="title">Cell host &amp; microbe</span>&nbsp;<span class="year">2014</span>;<span class="volume">16</span>;<span class="number">4</span>;<span class="pagerange">504-16</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25263220">25263220</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4190086">4190086</a>; DOI: <a href="http://dx.doi.org/10.1016%2Fj.chom.2014.08.017">10.1016/j.chom.2014.08.017</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">MacroH2A1 isoforms are associated with epigenetic markers for activation of lipogenic genes in fat-induced steatosis.</h4>
<p class="authors"><span class="author">Podrini C</span>, <span class="author">Koffas A</span>, <span class="author">Chokshi S</span>, <span class="author">Lelliott CJ</span>, <span class="author">White JK</span>, <span class="author">Adissu HA</span>, <span class="author">Williams R</span> and <span class="author">Greco A</span></p>
<p class="affiliation">Foundation for Liver Research, Institute of Hepatology, London, United Kingdom;</p><p class="abstract">The importance of epigenetic changes in the development of hepatic steatosis is largely unknown. The histone variant macroH2A1 under alternative splicing gives rise to macroH2A1.1 and macroH2A1.2. In this study, we show that the macroH2A1 isoforms play an important role in the regulation of lipid accumulation in hepatocytes. Hepatoma cell line and immortalized human hepatocytes transiently transfected or knocked down with macroH2A1 isoforms were used as in vitro model of fat-induced steatosis. Gene expressions were analyzed by quantitative PCR array and Western blot. Chromatin immunoprecipitation analysis was performed to check the association of histone H3 lysine 27 trimethylation (H3K27me3) and histone H3 lysine 4 trimethylation (H3K4me3) with the promoter of lipogenic genes. Livers from knockout mice that are resistant to lipid deposition despite a high-fat diet were used for histopathology. We found that macroH2A1.2 is regulated by fat uptake and that its overexpression caused an increase in lipid uptake, triglycerides, and lipogenic genes compared with macroH2A1.1. This suggests that macroH2A1.2 is important for lipid uptake, whereas macroH2A1.1 was found to be protective. The result was supported by a high positivity for macroH2A1.1 in knockout mice for genes targeted by macroH2A1 (Atp5a1 and Fam73b), that under a high-fat diet presented minimal lipidosis. Moreover, macroH2A1 isoforms differentially regulate the expression of lipogenic genes by modulating the association of the active (H3K4me3) and repressive (H3K27me3) histone marks on their promoters. This study underlines the importance of the replacement of noncanonical histones in the regulation of genes involved in lipid metabolism in the progression of steatosis.-Podrini, C., Koffas, A., Chokshi, S., Lelliott, C. J., White, J. K., Adissu, H. A., Williams, R., and Greco, A. MacroH2A1 isoforms are associated with epigenetic markers for activation of lipogenic genes in fat-induced steatosis.</p>
<p class="publication"><span class="title">FASEB journal : official publication of the Federation of American Societies for Experimental Biology</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25526730">25526730</a>; DOI: <a href="http://dx.doi.org/10.1096%2Ffj.14-262717">10.1096/fj.14-262717</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">CtIP-mediated resection is essential for viability and can operate independently of BRCA1.</h4>
<p class="authors"><span class="author">Polato F</span>, <span class="author">Callen E</span>, <span class="author">Wong N</span>, <span class="author">Faryabi R</span>, <span class="author">Bunting S</span>, <span class="author">Chen HT</span>, <span class="author">Kozak M</span>, <span class="author">Kruhlak MJ</span>, <span class="author">Reczek CR</span>, <span class="author">Lee WH</span>, <span class="author">Ludwig T</span>, <span class="author">Baer R</span>, <span class="author">Feigenbaum L</span>, <span class="author">Jackson S</span> and <span class="author">Nussenzweig A</span></p>
<p class="affiliation">Laboratory of Genome Integrity, Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892.</p><p class="abstract">Homologous recombination (HR) is initiated by DNA end resection, a process in which stretches of single-strand DNA (ssDNA) are generated and used for homology search. Factors implicated in resection include nucleases MRE11, EXO1, and DNA2, which process DNA ends into 3&#39; ssDNA overhangs; helicases such as BLM, which unwind DNA; and other proteins such as BRCA1 and CtIP whose functions remain unclear. CDK-mediated phosphorylation of CtIP on T847 is required to promote resection, whereas CDK-dependent phosphorylation of CtIP-S327 is required for interaction with BRCA1. Here, we provide evidence that CtIP functions independently of BRCA1 in promoting DSB end resection. First, using mouse models expressing S327A or T847A mutant CtIP as a sole species, and B cells deficient in CtIP, we show that loss of the CtIP-BRCA1 interaction does not detectably affect resection, maintenance of genomic stability or viability, whereas T847 is essential for these functions. Second, although loss of 53BP1 rescues the embryonic lethality and HR defects in BRCA1-deficient mice, it does not restore viability or genome integrity in CtIP(-/-) mice. Third, the increased resection afforded by loss of 53BP1 and the rescue of BRCA1-deficiency depend on CtIP but not EXO1. Finally, the sensitivity of BRCA1-deficient cells to poly ADP ribose polymerase (PARP) inhibition is partially rescued by the phospho-mimicking mutant CtIP (CtIP-T847E). Thus, in contrast to BRCA1, CtIP has indispensable roles in promoting resection and embryonic development.</p>
<p class="publication"><span class="title">The Journal of experimental medicine</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24842372">24842372</a>; DOI: <a href="http://dx.doi.org/10.1084%2Fjem.20131939">10.1084/jem.20131939</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Diarrhea in young children from low-income countries leads to large-scale alterations in intestinal microbiota composition.</h4>
<p class="authors"><span class="author">Pop M</span>, <span class="author">Walker AW</span>, <span class="author">Paulson J</span>, <span class="author">Lindsay B</span>, <span class="author">Antonio M</span>, <span class="author">Hossain MA</span>, <span class="author">Oundo J</span>, <span class="author">Tamboura B</span>, <span class="author">Mai V</span>, <span class="author">Astrovskaya I</span>, <span class="author">Corrada Bravo H</span>, <span class="author">Rance R</span>, <span class="author">Stares M</span>, <span class="author">Levine MM</span>, <span class="author">Panchalingam S</span>, <span class="author">Kotloff K</span>, <span class="author">Ikumapayi UN</span>, <span class="author">Ebruke C</span>, <span class="author">Adeyemi M</span>, <span class="author">Ahmed D</span>, <span class="author">Ahmed F</span>, <span class="author">Alam MT</span>, <span class="author">Amin R</span>, <span class="author">Siddiqui S</span>, <span class="author">Ochieng JB</span>, <span class="author">Ouma E</span>, <span class="author">Juma J</span>, <span class="author">Mailu E</span>, <span class="author">Omore R</span>, <span class="author">Morris JG</span>, <span class="author">Breiman RF</span>, <span class="author">Saha D</span>, <span class="author">Parkhill J</span>, <span class="author">Nataro JP</span> and <span class="author">Stine OC</span></p><p class="abstract"><strong>Background</strong>: Diarrheal diseases continue to contribute significantly to morbidity and mortality in infants and young children in developing countries. There is an urgent need to better understand the contributions of novel, potentially uncultured, diarrheal pathogens to severe diarrheal disease, as well as distortions in normal gut microbiota composition that might facilitate severe disease.</p><p class="abstract"><strong>Results</strong>: We use high throughput 16S rRNA gene sequencing to compare fecal microbiota composition in children under five years of age who have been diagnosed with moderate to severe diarrhea (MSD) with the microbiota from diarrhea-free controls. Our study includes 992 children from four low-income countries in West and East Africa, and Southeast Asia. Known pathogens, as well as bacteria currently not considered as important diarrhea-causing pathogens, are positively associated with MSD, and these include Escherichia/Shigella, and Granulicatella species, and Streptococcus mitis/pneumoniae groups. In both cases and controls, there tend to be distinct negative correlations between facultative anaerobic lineages and obligate anaerobic lineages. Overall genus-level microbiota composition exhibit a shift in controls from low to high levels of Prevotella and in MSD cases from high to low levels of Escherichia/Shigella in younger versus older children; however, there was significant variation among many genera by both site and age.</p><p class="abstract"><strong>Conclusions</strong>: Our findings expand the current understanding of microbiota-associated diarrhea pathogenicity in young children from developing countries. Our findings are necessarily based on correlative analyses and must be further validated through epidemiological and molecular techniques.</p>
<p class="grants">Funded by: NHGRI NIH HHS: <span class="grant">5R01HG004885</span>, <span class="grant">5R01HG005220</span>, <span class="grant">R01 HG004885</span>; Wellcome Trust: <span class="grant">WT098051</span></p>
<p class="publication"><span class="title">Genome biology</span>&nbsp;<span class="year">2014</span>;<span class="volume">15</span>;<span class="number">6</span>;<span class="pagerange">R76</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24995464">24995464</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4072981">4072981</a>; DOI: <a href="http://dx.doi.org/10.1186%2Fgb-2014-15-6-r76">10.1186/gb-2014-15-6-r76</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Obituary: Professor Frederick Sanger:13 August 1918  19 November 2013</h4>
<p class="authors"><span class="author">Powell, D</span></p>
<p class="publication"><span class="title">Genetics Society News</span>&nbsp;<span class="year">2014</span>;<span class="volume">70</span>;<span class="pagerange">16-18</span></p>
<p class="links">URL: <a title="http://www.genetics.org.uk/Portals/0/Issue%2070.pdf" href="http://www.genetics.org.uk/Portals/0/Issue%2070.pdf">http://www.genetics.org.uk/Portal<span class="print-hide">...</span><span class="print-show">s/0/Issue%2</span>070.pdf</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">PlasmoView: A Web-based Resource to Visualise Global Plasmodium falciparum Genomic Variation.</h4>
<p class="authors"><span class="author">Preston MD</span>, <span class="author">Assefa SA</span>, <span class="author">Ocholla H</span>, <span class="author">Sutherland CJ</span>, <span class="author">Borrmann S</span>, <span class="author">Nzila A</span>, <span class="author">Michon P</span>, <span class="author">Hien TT</span>, <span class="author">Bousema T</span>, <span class="author">Drakeley CJ</span>, <span class="author">Zongo I</span>, <span class="author">Ou&eacute;draogo JB</span>, <span class="author">Djimde AA</span>, <span class="author">Doumbo OK</span>, <span class="author">Nosten F</span>, <span class="author">Fairhurst RM</span>, <span class="author">Conway DJ</span>, <span class="author">Roper C</span> and <span class="author">Clark TG</span></p>
<p class="affiliation">Department of Pathogen Molecular Biology, London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT, United Kingdom.</p><p class="abstract">Malaria is a global public health challenge, with drug resistance a major barrier to disease control and elimination. To meet the urgent need for better treatments and vaccines, a deeper knowledge of Plasmodium biology and malaria epidemiology is required. An improved understanding of the genomic variation of malaria parasites, especially the most virulent Plasmodium falciparum (Pf) species, has the potential to yield new insights in these areas. High-throughput sequencing and genotyping is generating large amounts of genomic data across multiple parasite populations. The resulting ability to identify informative variants, particularly single-nucleotide polymorphisms (SNPs), will lead to the discovery of intra- and inter-population differences and thus enable the development of genetic barcodes for diagnostic assays and clinical studies. Knowledge of genetic variability underlying drug resistance and other differential phenotypes will also facilitate the identification of novel mutations and contribute to surveillance and stratified medicine applications. The PlasmoView interactive web-browsing tool enables the research community to visualise genomic variation and annotation (eg, biological function) in a geographic setting. The first release contains over 600 000 high-quality SNPs in 631 Pf isolates from laboratory strains and four malaria-endemic regions (West Africa, East Africa, Southeast Asia and Oceania).</p>
<p class="publication"><span class="title">The Journal of infectious diseases</span>&nbsp;<span class="year">2014</span>;<span class="volume">209</span>;<span class="number">11</span>;<span class="pagerange">1808-15</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24338354">24338354</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4017360">4017360</a>; DOI: <a href="http://dx.doi.org/10.1093%2Finfdis%2Fjit812">10.1093/infdis/jit812</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">A barcode of organellar genome polymorphisms identifies the geographic origin of Plasmodium falciparum strains.</h4>
<p class="authors"><span class="author">Preston MD</span>, <span class="author">Campino S</span>, <span class="author">Assefa SA</span>, <span class="author">Echeverry DF</span>, <span class="author">Ocholla H</span>, <span class="author">Amambua-Ngwa A</span>, <span class="author">Stewart LB</span>, <span class="author">Conway DJ</span>, <span class="author">Borrmann S</span>, <span class="author">Michon P</span>, <span class="author">Zongo I</span>, <span class="author">Ou&eacute;draogo JB</span>, <span class="author">Djimde AA</span>, <span class="author">Doumbo OK</span>, <span class="author">Nosten F</span>, <span class="author">Pain A</span>, <span class="author">Bousema T</span>, <span class="author">Drakeley CJ</span>, <span class="author">Fairhurst RM</span>, <span class="author">Sutherland CJ</span>, <span class="author">Roper C</span> and <span class="author">Clark TG</span></p>
<p class="affiliation">Immunology and Infection Department, London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK.</p><p class="abstract">Malaria is a major public health problem that is actively being addressed in a global eradication campaign. Increased population mobility through international air travel has elevated the risk of re-introducing parasites to elimination areas and dispersing drug-resistant parasites to new regions. A simple genetic marker that quickly and accurately identifies the geographic origin of infections would be a valuable public health tool for locating the source of imported outbreaks. Here we analyse the mitochondrion and apicoplast genomes of 711 Plasmodium falciparum isolates from 14 countries, and find evidence that they are non-recombining and co-inherited. The high degree of linkage produces a panel of relatively few single-nucleotide polymorphisms (SNPs) that is geographically informative. We design a 23-SNP barcode that is highly predictive (~92%) and easily adapted to aid case management in the field and survey parasite migration worldwide.</p>
<p class="publication"><span class="title">Nature communications</span>&nbsp;<span class="year">2014</span>;<span class="volume">5</span>;<span class="pagerange">4052</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24923250">24923250</a>; DOI: <a href="http://dx.doi.org/10.1038%2Fncomms5052">10.1038/ncomms5052</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Genetic predisposition to increased blood cholesterol and triglyceride lipid levels and risk of Alzheimer disease: a mendelian randomization analysis.</h4>
<p class="authors"><span class="author">Proitsi P</span>, <span class="author">Lupton MK</span>, <span class="author">Velayudhan L</span>, <span class="author">Newhouse S</span>, <span class="author">Fogh I</span>, <span class="author">Tsolaki M</span>, <span class="author">Daniilidou M</span>, <span class="author">Pritchard M</span>, <span class="author">Kloszewska I</span>, <span class="author">Soininen H</span>, <span class="author">Mecocci P</span>, <span class="author">Vellas B</span>, <span class="author">Alzheimer&#39;s Disease Neuroimaging Initiative</span>, <span class="author">Williams J</span>, <span class="author">GERAD1 Consortium</span>, <span class="author">Stewart R</span>, <span class="author">Sham P</span>, <span class="author">Lovestone S</span> and <span class="author">Powell JF</span></p>
<p class="affiliation">King&#39;s College London, Institute of Psychiatry, Psychology and Neuroscience, London, United Kingdom; Department of Psychiatry, State Key Laboratory of Brain and Cognitive Sciences, and Centre for Genomic Sciences, Li Ka Shing Faculty of Medicine, the University of Hong Kong, Hong Kong.</p><p class="abstract"><strong>Background</strong>: Although altered lipid metabolism has been extensively implicated in the pathogenesis of Alzheimer disease (AD) through cell biological, epidemiological, and genetic studies, the molecular mechanisms linking cholesterol and AD pathology are still not well understood and contradictory results have been reported. We have used a Mendelian randomization approach to dissect the causal nature of the association between circulating lipid levels and late onset AD (LOAD) and test the hypothesis that genetically raised lipid levels increase the risk of LOAD.</p><p class="abstract">We included 3,914 patients with LOAD, 1,675 older individuals without LOAD, and 4,989 individuals from the general population from six genome wide studies drawn from a white population (total n=10,578). We constructed weighted genotype risk scores (GRSs) for four blood lipid phenotypes (high-density lipoprotein cholesterol [HDL-c], low-density lipoprotein cholesterol [LDL-c], triglycerides, and total cholesterol) using well-established SNPs in 157 loci for blood lipids reported by Willer and colleagues (2013). Both full GRSs using all SNPs associated with each trait at p&lt;5&times;10-8 and trait specific scores using SNPs associated exclusively with each trait at p&lt;5 &times; 10-8 were developed. We used logistic regression to investigate whether the GRSs were associated with LOAD in each study and results were combined together by meta-analysis. We found no association between any of the full GRSs and LOAD (meta-analysis results: odds ratio [OR]=1.005, 95% CI 0.82-1.24, p&#x200A;=&#x200A;0.962 per 1 unit increase in HDL-c; OR=0.901, 95% CI 0.65-1.25, p=0.530 per 1 unit increase in LDL-c; OR=1.104, 95% CI 0.89-1.37, p=0.362 per 1 unit increase in triglycerides; and OR=0.954, 95% CI 0.76-1.21, p=0.688 per 1 unit increase in total cholesterol). Results for the trait specific scores were similar; however, the trait specific scores explained much smaller phenotypic variance.</p><p class="abstract"><strong>Conclusions</strong>: Genetic predisposition to increased blood cholesterol and triglyceride lipid levels is not associated with elevated LOAD risk. The observed epidemiological associations between abnormal lipid levels and LOAD risk could therefore be attributed to the result of biological pleiotropy or could be secondary to LOAD. Limitations of this study include the small proportion of lipid variance explained by the GRS, biases in case-control ascertainment, and the limitations implicit to Mendelian randomization studies. Future studies should focus on larger LOAD datasets with longitudinal sampled peripheral lipid measures and other markers of lipid metabolism, which have been shown to be altered in LOAD. Please see later in the article for the Editors&#39; Summary.</p>
<p class="grants">Funded by: Canadian Institutes of Health Research; Medical Research Council; NIA NIH HHS: <span class="grant">U01 AG024904</span>; Wellcome Trust</p>
<p class="publication"><span class="title">PLoS medicine</span>&nbsp;<span class="year">2014</span>;<span class="volume">11</span>;<span class="number">9</span>;<span class="pagerange">e1001713</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25226301">25226301</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4165594">4165594</a>; DOI: <a href="http://dx.doi.org/10.1371%2Fjournal.pmed.1001713">10.1371/journal.pmed.1001713</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">A central role for GRB10 in regulation of islet function in man.</h4>
<p class="authors"><span class="author">Prokopenko I</span>, <span class="author">Poon W</span>, <span class="author">M&auml;gi R</span>, <span class="author">Prasad B R</span>, <span class="author">Salehi SA</span>, <span class="author">Almgren P</span>, <span class="author">Osmark P</span>, <span class="author">Bouatia-Naji N</span>, <span class="author">Wierup N</span>, <span class="author">Fall T</span>, <span class="author">Stan&#x10D;&aacute;kov&aacute; A</span>, <span class="author">Barker A</span>, <span class="author">Lagou V</span>, <span class="author">Osmond C</span>, <span class="author">Xie W</span>, <span class="author">Lahti J</span>, <span class="author">Jackson AU</span>, <span class="author">Cheng YC</span>, <span class="author">Liu J</span>, <span class="author">O&#39;Connell JR</span>, <span class="author">Blomstedt PA</span>, <span class="author">Fadista J</span>, <span class="author">Alkayyali S</span>, <span class="author">Dayeh T</span>, <span class="author">Ahlqvist E</span>, <span class="author">Taneera J</span>, <span class="author">Lecoeur C</span>, <span class="author">Kumar A</span>, <span class="author">Hansson O</span>, <span class="author">Hansson K</span>, <span class="author">Voight BF</span>, <span class="author">Kang HM</span>, <span class="author">Levy-Marchal C</span>, <span class="author">Vatin V</span>, <span class="author">Palotie A</span>, <span class="author">Syv&auml;nen AC</span>, <span class="author">Mari A</span>, <span class="author">Weedon MN</span>, <span class="author">Loos RJ</span>, <span class="author">Ong KK</span>, <span class="author">Nilsson P</span>, <span class="author">Isomaa B</span>, <span class="author">Tuomi T</span>, <span class="author">Wareham NJ</span>, <span class="author">Stumvoll M</span>, <span class="author">Widen E</span>, <span class="author">Lakka TA</span>, <span class="author">Langenberg C</span>, <span class="author">T&ouml;njes A</span>, <span class="author">Rauramaa R</span>, <span class="author">Kuusisto J</span>, <span class="author">Frayling TM</span>, <span class="author">Froguel P</span>, <span class="author">Walker M</span>, <span class="author">Eriksson JG</span>, <span class="author">Ling C</span>, <span class="author">Kovacs P</span>, <span class="author">Ingelsson E</span>, <span class="author">McCarthy MI</span>, <span class="author">Shuldiner AR</span>, <span class="author">Silver KD</span>, <span class="author">Laakso M</span>, <span class="author">Groop L</span> and <span class="author">Lyssenko V</span></p>
<p class="affiliation">Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford, United Kingdom; Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United Kingdom; Department of Genomics of Common Disease, School of Public Health, Imperial College London, Hammersmith Hospital, London, United Kingdom.</p><p class="abstract">Variants in the growth factor receptor-bound protein 10 (GRB10) gene were in a GWAS meta-analysis associated with reduced glucose-stimulated insulin secretion and increased risk of type 2 diabetes (T2D) if inherited from the father, but inexplicably reduced fasting glucose when inherited from the mother. GRB10 is a negative regulator of insulin signaling and imprinted in a parent-of-origin fashion in different tissues. GRB10 knock-down in human pancreatic islets showed reduced insulin and glucagon secretion, which together with changes in insulin sensitivity may explain the paradoxical reduction of glucose despite a decrease in insulin secretion. Together, these findings suggest that tissue-specific methylation and possibly imprinting of GRB10 can influence glucose metabolism and contribute to T2D pathogenesis. The data also emphasize the need in genetic studies to consider whether risk alleles are inherited from the mother or the father.</p>
<p class="grants">Funded by: Department of Health: <span class="grant">NF-SI-0512-10135</span>, <span class="grant">NF-SI-0611-10099</span>; Medical Research Council: <span class="grant">G0601261</span>, <span class="grant">MC_U106179471</span>, <span class="grant">MC_U106179472</span>, <span class="grant">MC_UP_A620_1017</span>, <span class="grant">MC_UU_12015/1</span>, <span class="grant">MC_UU_12015/2</span>; NCRR NIH HHS: <span class="grant">M01 RR02719</span>, <span class="grant">M01 RR16500</span>; NHLBI NIH HHS: <span class="grant">U01 HL84756</span>; NIDDK NIH HHS: <span class="grant">P30 DK072488</span>, <span class="grant">P60 DK79637</span>, <span class="grant">R01 DK54261</span>, <span class="grant">R01 DK68495</span>; Wellcome Trust: <span class="grant">083270</span>, <span class="grant">089062</span>, <span class="grant">089062/Z/09/Z</span>, <span class="grant">090367</span>, <span class="grant">090532</span>, <span class="grant">098381</span>, <span class="grant">89061/Z/09/Z</span></p>
<p class="publication"><span class="title">PLoS genetics</span>&nbsp;<span class="year">2014</span>;<span class="volume">10</span>;<span class="number">4</span>;<span class="pagerange">e1004235</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24699409">24699409</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC3974640">3974640</a>; DOI: <a href="http://dx.doi.org/10.1371%2Fjournal.pgen.1004235">10.1371/journal.pgen.1004235</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">A genome-wide association analysis of a broad psychosis phenotype identifies three loci for further investigation.</h4>
<p class="authors"><span class="author">Psychosis Endophenotypes International Consortium</span>, <span class="author">Wellcome Trust Case-Control Consortium 2</span>, <span class="author">Bramon E</span>, <span class="author">Pirinen M</span>, <span class="author">Strange A</span>, <span class="author">Lin K</span>, <span class="author">Freeman C</span>, <span class="author">Bellenguez C</span>, <span class="author">Su Z</span>, <span class="author">Band G</span>, <span class="author">Pearson R</span>, <span class="author">Vukcevic D</span>, <span class="author">Langford C</span>, <span class="author">Deloukas P</span>, <span class="author">Hunt S</span>, <span class="author">Gray E</span>, <span class="author">Dronov S</span>, <span class="author">Potter SC</span>, <span class="author">Tashakkori-Ghanbaria A</span>, <span class="author">Edkins S</span>, <span class="author">Bumpstead SJ</span>, <span class="author">Arranz MJ</span>, <span class="author">Bakker S</span>, <span class="author">Bender S</span>, <span class="author">Bruggeman R</span>, <span class="author">Cahn W</span>, <span class="author">Chandler D</span>, <span class="author">Collier DA</span>, <span class="author">Crespo-Facorro B</span>, <span class="author">Dazzan P</span>, <span class="author">de Haan L</span>, <span class="author">Di Forti M</span>, <span class="author">Dragovi&#x107; M</span>, <span class="author">Giegling I</span>, <span class="author">Hall J</span>, <span class="author">Iyegbe C</span>, <span class="author">Jablensky A</span>, <span class="author">Kahn RS</span>, <span class="author">Kalaydjieva L</span>, <span class="author">Kravariti E</span>, <span class="author">Lawrie S</span>, <span class="author">Linszen DH</span>, <span class="author">Mata I</span>, <span class="author">McDonald C</span>, <span class="author">McIntosh A</span>, <span class="author">Myin-Germeys I</span>, <span class="author">Ophoff RA</span>, <span class="author">Pariante CM</span>, <span class="author">Paunio T</span>, <span class="author">Picchioni M</span>, <span class="author">Psychiatric Genomics Consortium</span>, <span class="author">Ripke S</span>, <span class="author">Rujescu D</span>, <span class="author">Sauer H</span>, <span class="author">Shaikh M</span>, <span class="author">Sussmann J</span>, <span class="author">Suvisaari J</span>, <span class="author">Tosato S</span>, <span class="author">Toulopoulou T</span>, <span class="author">Van Os J</span>, <span class="author">Walshe M</span>, <span class="author">Weisbrod M</span>, <span class="author">Whalley H</span>, <span class="author">Wiersma D</span>, <span class="author">Blackwell JM</span>, <span class="author">Brown MA</span>, <span class="author">Casas JP</span>, <span class="author">Corvin A</span>, <span class="author">Duncanson A</span>, <span class="author">Jankowski JA</span>, <span class="author">Markus HS</span>, <span class="author">Mathew CG</span>, <span class="author">Palmer CN</span>, <span class="author">Plomin R</span>, <span class="author">Rautanen A</span>, <span class="author">Sawcer SJ</span>, <span class="author">Trembath RC</span>, <span class="author">Wood NW</span>, <span class="author">Barroso I</span>, <span class="author">Peltonen L</span>, <span class="author">Lewis CM</span>, <span class="author">Murray RM</span>, <span class="author">Donnelly P</span>, <span class="author">Powell J</span> and <span class="author">Spencer CC</span></p><p class="abstract"><strong>Background</strong>: Genome-wide association studies (GWAS) have identified several loci associated with schizophrenia and/or bipolar disorder. We performed a GWAS of psychosis as a broad syndrome rather than within specific diagnostic categories.</p><p class="abstract"><strong>Methods</strong>: 1239 cases with schizophrenia, schizoaffective disorder, or psychotic bipolar disorder; 857 of their unaffected relatives, and 2739 healthy controls were genotyped with the Affymetrix 6.0 single nucleotide polymorphism (SNP) array. Analyses of 695,193 SNPs were conducted using UNPHASED, which combines information across families and unrelated individuals. We attempted to replicate signals found in 23 genomic regions using existing data on nonoverlapping samples from the Psychiatric GWAS Consortium and Schizophrenia-GENE-plus cohorts (10,352 schizophrenia patients and 24,474 controls).</p><p class="abstract"><strong>Results</strong>: No individual SNP showed compelling evidence for association with psychosis in our data. However, we observed a trend for association with same risk alleles at loci previously associated with schizophrenia (one-sided p = .003). A polygenic score analysis found that the Psychiatric GWAS Consortium&#39;s panel of SNPs associated with schizophrenia significantly predicted disease status in our sample (p = 5 &times; 10(-14)) and explained approximately 2% of the phenotypic variance.</p><p class="abstract"><strong>Conclusions</strong>: Although narrowly defined phenotypes have their advantages, we believe new loci may also be discovered through meta-analysis across broad phenotypes. The novel statistical methodology we introduced to model effect size heterogeneity between studies should help future GWAS that combine association evidence from related phenotypes. Applying these approaches, we highlight three loci that warrant further investigation. We found that SNPs conveying risk for schizophrenia are also predictive of disease status in our data.</p>
<p class="grants">Funded by: Department of Health: <span class="grant">PDA/02/06/016</span>; Medical Research Council: <span class="grant">G0000934</span>, <span class="grant">G0901310</span>, <span class="grant">G1100583</span>; Wellcome Trust: <span class="grant">064971</span>, <span class="grant">068545/Z/02</span>, <span class="grant">072894/Z/03/Z</span>, <span class="grant">075491/Z/04/B</span>, <span class="grant">085475/B/08/Z</span>, <span class="grant">085475/Z/08/Z</span>, <span class="grant">090532</span>, <span class="grant">090532/Z/09/Z</span>, <span class="grant">095552</span>, <span class="grant">097364/Z/11/Z</span></p>
<p class="publication"><span class="title">Biological psychiatry</span>&nbsp;<span class="year">2014</span>;<span class="volume">75</span>;<span class="number">5</span>;<span class="pagerange">386-97</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/23871474">23871474</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC3923972">3923972</a>; DOI: <a href="http://dx.doi.org/10.1016%2Fj.biopsych.2013.03.033">10.1016/j.biopsych.2013.03.033</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">A polygenic burden of rare disruptive mutations in schizophrenia.</h4>
<p class="authors"><span class="author">Purcell SM</span>, <span class="author">Moran JL</span>, <span class="author">Fromer M</span>, <span class="author">Ruderfer D</span>, <span class="author">Solovieff N</span>, <span class="author">Roussos P</span>, <span class="author">O&#39;Dushlaine C</span>, <span class="author">Chambert K</span>, <span class="author">Bergen SE</span>, <span class="author">K&auml;hler A</span>, <span class="author">Duncan L</span>, <span class="author">Stahl E</span>, <span class="author">Genovese G</span>, <span class="author">Fern&aacute;ndez E</span>, <span class="author">Collins MO</span>, <span class="author">Komiyama NH</span>, <span class="author">Choudhary JS</span>, <span class="author">Magnusson PK</span>, <span class="author">Banks E</span>, <span class="author">Shakir K</span>, <span class="author">Garimella K</span>, <span class="author">Fennell T</span>, <span class="author">Depristo M</span>, <span class="author">Grant SG</span>, <span class="author">Haggarty SJ</span>, <span class="author">Gabriel S</span>, <span class="author">Scolnick EM</span>, <span class="author">Lander ES</span>, <span class="author">Hultman CM</span>, <span class="author">Sullivan PF</span>, <span class="author">McCarroll SA</span> and <span class="author">Sklar P</span></p>
<p class="affiliation">1] Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, Massachusetts 02142, USA [2] Division of Psychiatric Genomics, Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, New York 10029, USA [3] Institute for Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, New York, New York 10029, USA [4] Analytic and Translational Genetics Unit, Psychiatric and Neurodevelopmental Genetics Unit, Massachusetts General Hospital, Boston, Massachusetts 02114, USA [5] Medical and Population Genetics Program, Broad Institute of MIT and Harvard, Cambridge, Massachusetts 02142, USA.</p>
<p class="abstract">Schizophrenia is a common disease with a complex aetiology, probably involving multiple and heterogeneous genetic factors. Here, by analysing the exome sequences of 2,536 schizophrenia cases and 2,543 controls, we demonstrate a polygenic burden primarily arising from rare (less than 1 in 10,000), disruptive mutations distributed across many genes. Particularly enriched gene sets include the voltage-gated calcium ion channel and the signalling complex formed by the activity-regulated cytoskeleton-associated scaffold protein (ARC) of the postsynaptic density, sets previously implicated by genome-wide association and copy-number variation studies. Similar to reports in autism, targets of the fragile X mental retardation protein (FMRP, product of FMR1) are enriched for case mutations. No individual gene-based test achieves significance after correction for multiple testing and we do not detect any alleles of moderately low frequency (approximately 0.5 to 1 per cent) and moderately large effect. Taken together, these data suggest that population-based exome sequencing can discover risk alleles and complements established gene-mapping paradigms in neuropsychiatric disease.</p>
<p class="publication"><span class="title">Nature</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24463508">24463508</a>; DOI: <a href="http://dx.doi.org/10.1038%2Fnature12975">10.1038/nature12975</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">A global analysis of Y-chromosomal haplotype diversity for 23 STR loci.</h4>
<p class="authors"><span class="author">Purps J</span>, <span class="author">Siegert S</span>, <span class="author">Willuweit S</span>, <span class="author">Nagy M</span>, <span class="author">Alves C</span>, <span class="author">Salazar R</span>, <span class="author">Angustia SM</span>, <span class="author">Santos LH</span>, <span class="author">Anslinger K</span>, <span class="author">Bayer B</span>, <span class="author">Ayub Q</span>, <span class="author">Wei W</span>, <span class="author">Xue Y</span>, <span class="author">Tyler-Smith C</span>, <span class="author">Bafalluy MB</span>, <span class="author">Mart&iacute;nez-Jarreta B</span>, <span class="author">Egyed B</span>, <span class="author">Balitzki B</span>, <span class="author">Tschumi S</span>, <span class="author">Ballard D</span>, <span class="author">Court DS</span>, <span class="author">Barrantes X</span>, <span class="author">B&auml;&szlig;ler G</span>, <span class="author">Wiest T</span>, <span class="author">Berger B</span>, <span class="author">Niederst&auml;tter H</span>, <span class="author">Parson W</span>, <span class="author">Davis C</span>, <span class="author">Budowle B</span>, <span class="author">Burri H</span>, <span class="author">Borer U</span>, <span class="author">Koller C</span>, <span class="author">Carvalho EF</span>, <span class="author">Domingues PM</span>, <span class="author">Chamoun WT</span>, <span class="author">Coble MD</span>, <span class="author">Hill CR</span>, <span class="author">Corach D</span>, <span class="author">Caputo M</span>, <span class="author">D&#39;Amato ME</span>, <span class="author">Davison S</span>, <span class="author">Decorte R</span>, <span class="author">Larmuseau MH</span>, <span class="author">Ottoni C</span>, <span class="author">Rickards O</span>, <span class="author">Lu D</span>, <span class="author">Jiang C</span>, <span class="author">Dobosz T</span>, <span class="author">Jonkisz A</span>, <span class="author">Frank WE</span>, <span class="author">Furac I</span>, <span class="author">Gehrig C</span>, <span class="author">Castella V</span>, <span class="author">Grskovic B</span>, <span class="author">Haas C</span>, <span class="author">Wobst J</span>, <span class="author">Hadzic G</span>, <span class="author">Drobnic K</span>, <span class="author">Honda K</span>, <span class="author">Hou Y</span>, <span class="author">Zhou D</span>, <span class="author">Li Y</span>, <span class="author">Hu S</span>, <span class="author">Chen S</span>, <span class="author">Immel UD</span>, <span class="author">Lessig R</span>, <span class="author">Jakovski Z</span>, <span class="author">Ilievska T</span>, <span class="author">Klann AE</span>, <span class="author">Garc&iacute;a CC</span>, <span class="author">de Knijff P</span>, <span class="author">Kraaijenbrink T</span>, <span class="author">Kondili A</span>, <span class="author">Miniati P</span>, <span class="author">Vouropoulou M</span>, <span class="author">Kovacevic L</span>, <span class="author">Marjanovic D</span>, <span class="author">Lindner I</span>, <span class="author">Mansour I</span>, <span class="author">Al-Azem M</span>, <span class="author">Andari AE</span>, <span class="author">Marino M</span>, <span class="author">Furfuro S</span>, <span class="author">Locarno L</span>, <span class="author">Mart&iacute;n P</span>, <span class="author">Luque GM</span>, <span class="author">Alonso A</span>, <span class="author">Miranda LS</span>, <span class="author">Moreira H</span>, <span class="author">Mizuno N</span>, <span class="author">Iwashima Y</span>, <span class="author">Neto RS</span>, <span class="author">Nogueira TL</span>, <span class="author">Silva R</span>, <span class="author">Nastainczyk-Wulf M</span>, <span class="author">Edelmann J</span>, <span class="author">Kohl M</span>, <span class="author">Nie S</span>, <span class="author">Wang X</span>, <span class="author">Cheng B</span>, <span class="author">N&uacute;&ntilde;ez C</span>, <span class="author">Pancorbo MM</span>, <span class="author">Olofsson JK</span>, <span class="author">Morling N</span>, <span class="author">Onofri V</span>, <span class="author">Tagliabracci A</span>, <span class="author">Pamjav H</span>, <span class="author">Volgyi A</span>, <span class="author">Barany G</span>, <span class="author">Pawlowski R</span>, <span class="author">Maciejewska A</span>, <span class="author">Pelotti S</span>, <span class="author">Pepinski W</span>, <span class="author">Abreu-Glowacka M</span>, <span class="author">Phillips C</span>, <span class="author">C&aacute;rdenas J</span>, <span class="author">Rey-Gonzalez D</span>, <span class="author">Salas A</span>, <span class="author">Brisighelli F</span>, <span class="author">Capelli C</span>, <span class="author">Toscanini U</span>, <span class="author">Piccinini A</span>, <span class="author">Piglionica M</span>, <span class="author">Baldassarra SL</span>, <span class="author">Ploski R</span>, <span class="author">Konarzewska M</span>, <span class="author">Jastrzebska E</span>, <span class="author">Robino C</span>, <span class="author">Sajantila A</span>, <span class="author">Palo JU</span>, <span class="author">Guevara E</span>, <span class="author">Salvador J</span>, <span class="author">Ungria MC</span>, <span class="author">Rodriguez JJ</span>, <span class="author">Schmidt U</span>, <span class="author">Schlauderer N</span>, <span class="author">Saukko P</span>, <span class="author">Schneider PM</span>, <span class="author">Sirker M</span>, <span class="author">Shin KJ</span>, <span class="author">Oh YN</span>, <span class="author">Skitsa I</span>, <span class="author">Ampati A</span>, <span class="author">Smith TG</span>, <span class="author">Calvit LS</span>, <span class="author">Stenzl V</span>, <span class="author">Capal T</span>, <span class="author">Tillmar A</span>, <span class="author">Nilsson H</span>, <span class="author">Turrina S</span>, <span class="author">De Leo D</span>, <span class="author">Verzeletti A</span>, <span class="author">Cortellini V</span>, <span class="author">Wetton JH</span>, <span class="author">Gwynne GM</span>, <span class="author">Jobling MA</span>, <span class="author">Whittle MR</span>, <span class="author">Sumita DR</span>, <span class="author">Wola&#x144;ska-Nowak P</span>, <span class="author">Yong RY</span>, <span class="author">Krawczak M</span>, <span class="author">Nothnagel M</span> and <span class="author">Roewer L</span></p>
<p class="affiliation">Department of Forensic Genetics, Institute of Legal Medicine and Forensic Sciences, Charit&eacute;-Universit&auml;tsmedizin, Berlin, Germany.</p><p class="abstract">In a worldwide collaborative effort, 19,630 Y-chromosomes were sampled from 129 different populations in 51 countries. These chromosomes were typed for 23 short-tandem repeat (STR) loci (DYS19, DYS389I, DYS389II, DYS390, DYS391, DYS392, DYS393, DYS385ab, DYS437, DYS438, DYS439, DYS448, DYS456, DYS458, DYS635, GATAH4, DYS481, DYS533, DYS549, DYS570, DYS576, and DYS643) and using the PowerPlex Y23 System (PPY23, Promega Corporation, Madison, WI). Locus-specific allelic spectra of these markers were determined and a consistently high level of allelic diversity was observed. A considerable number of null, duplicate and off-ladder alleles were revealed. Standard single-locus and haplotype-based parameters were calculated and compared between subsets of Y-STR markers established for forensic casework. The PPY23 marker set provides substantially stronger discriminatory power than other available kits but at the same time reveals the same general patterns of population structure as other marker sets. A strong correlation was observed between the number of Y-STRs included in a marker set and some of the forensic parameters under study. Interestingly a weak but consistent trend toward smaller genetic distances resulting from larger numbers of markers became apparent.</p>
<p class="grants">Funded by: Wellcome Trust: <span class="grant">087576</span></p>
<p class="publication"><span class="title">Forensic science international. Genetics</span>&nbsp;<span class="year">2014</span>;<span class="volume">12</span>;<span class="pagerange">12-23</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24854874">24854874</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4127773">4127773</a>; DOI: <a href="http://dx.doi.org/10.1016%2Fj.fsigen.2014.04.008">10.1016/j.fsigen.2014.04.008</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">FTO genetic variants, dietary intake, and body mass index: insights from 177,330 individuals.</h4>
<p class="authors"><span class="author">Qi Q</span>, <span class="author">Kilpel&auml;inen TO</span>, <span class="author">Downer MK</span>, <span class="author">Tanaka T</span>, <span class="author">Smith CE</span>, <span class="author">Sluijs I</span>, <span class="author">Sonestedt E</span>, <span class="author">Chu AY</span>, <span class="author">Renstr&ouml;m F</span>, <span class="author">Lin X</span>, <span class="author">Angquist LH</span>, <span class="author">Huang J</span>, <span class="author">Liu Z</span>, <span class="author">Li Y</span>, <span class="author">Asif Ali M</span>, <span class="author">Xu M</span>, <span class="author">Ahluwalia TS</span>, <span class="author">Boer JM</span>, <span class="author">Chen P</span>, <span class="author">Daimon M</span>, <span class="author">Eriksson J</span>, <span class="author">Perola M</span>, <span class="author">Friedlander Y</span>, <span class="author">Gao YT</span>, <span class="author">Heppe DH</span>, <span class="author">Holloway JW</span>, <span class="author">Houston DK</span>, <span class="author">Kanoni S</span>, <span class="author">Kim YM</span>, <span class="author">Laaksonen MA</span>, <span class="author">J&auml;&auml;skel&auml;inen T</span>, <span class="author">Lee NR</span>, <span class="author">Lehtim&auml;ki T</span>, <span class="author">Lemaitre RN</span>, <span class="author">Lu W</span>, <span class="author">Luben RN</span>, <span class="author">Manichaikul A</span>, <span class="author">M&auml;nnist&ouml; S</span>, <span class="author">Marques-Vidal P</span>, <span class="author">Monda KL</span>, <span class="author">Ngwa JS</span>, <span class="author">Perusse L</span>, <span class="author">van Rooij FJ</span>, <span class="author">Xiang YB</span>, <span class="author">Wen W</span>, <span class="author">Wojczynski MK</span>, <span class="author">Zhu J</span>, <span class="author">Borecki IB</span>, <span class="author">Bouchard C</span>, <span class="author">Cai Q</span>, <span class="author">Cooper C</span>, <span class="author">Dedoussis GV</span>, <span class="author">Deloukas P</span>, <span class="author">Ferrucci L</span>, <span class="author">Forouhi NG</span>, <span class="author">Hansen T</span>, <span class="author">Christiansen L</span>, <span class="author">Hofman A</span>, <span class="author">Johansson I</span>, <span class="author">J&oslash;rgensen T</span>, <span class="author">Karasawa S</span>, <span class="author">Khaw KT</span>, <span class="author">Kim MK</span>, <span class="author">Kristiansson K</span>, <span class="author">Li H</span>, <span class="author">Lin X</span>, <span class="author">Liu Y</span>, <span class="author">Lohman KK</span>, <span class="author">Long J</span>, <span class="author">Mikkil&auml; V</span>, <span class="author">Mozaffarian D</span>, <span class="author">North K</span>, <span class="author">Pedersen O</span>, <span class="author">Raitakari O</span>, <span class="author">Rissanen H</span>, <span class="author">Tuomilehto J</span>, <span class="author">van der Schouw YT</span>, <span class="author">Uitterlinden AG</span>, <span class="author">Zillikens MC</span>, <span class="author">Franco OH</span>, <span class="author">Tai ES</span>, <span class="author">Shu XO</span>, <span class="author">Siscovick DS</span>, <span class="author">Toft U</span>, <span class="author">Verschuren WM</span>, <span class="author">Vollenweider P</span>, <span class="author">Wareham NJ</span>, <span class="author">Witteman JC</span>, <span class="author">Zheng W</span>, <span class="author">Ridker PM</span>, <span class="author">Kang JH</span>, <span class="author">Liang L</span>, <span class="author">Jensen MK</span>, <span class="author">Curhan GC</span>, <span class="author">Pasquale LR</span>, <span class="author">Hunter DJ</span>, <span class="author">Mohlke KL</span>, <span class="author">Uusitupa M</span>, <span class="author">Cupples LA</span>, <span class="author">Rankinen T</span>, <span class="author">Orho-Melander M</span>, <span class="author">Chasman DI</span>, <span class="author">Franks PW</span>, <span class="author">S&oslash;rensen TI</span>, <span class="author">Hu FB</span>, <span class="author">Loos RJ</span>, <span class="author">Nettleton J</span> and <span class="author">Qi L</span></p>
<p class="affiliation">Department of Epidemiology, Albert Einstein College of Medicine, Bronx, New York, United States of America Department of Nutrition, Harvard School of Public Health, Boston, Massachusetts, United States of America.</p><p class="abstract">FTO is the strongest known genetic susceptibility locus for obesity. Experimental studies in animals suggest the potential roles of FTO in regulating food intake. The interactive relation among FTO variants, dietary intake, and body mass index (BMI) are complex and results from previous often small-scale studies in humans are highly inconsistent. We performed large-scale analyses based on data from 177,330 adults (154,439 whites, 5,776 African Americans, and 17,115 Asians) from 40 studies to examine: 1) the association between the FTO-rs9939609 variant (or a proxy SNP) and total energy and macronutrient intake; and 2) the interaction between the FTO variant and dietary intake on BMI. The minor allele (A-allele) of the FTO-rs9939609 variant was associated with higher BMI in whites (effect per allele =0.34 [0.31, 0.37] kg/m(2), P=1.9&times;10(-105)), and all participants (0.30 [0.30, 0.35] kg/m(2), P=3.6&times;10(-107)). The BMI-increasing allele of the FTO variant showed a significant association with higher dietary protein intake (effect per allele =0.08[0.06, 0.10]%, P=2.4&times;10(-16)), and relative weak associations with lower total energy intake (-6.4[-10.1, -2.6] kcal/day, P=0.001) and lower dietary carbohydrate intake (-0.07 [-0.11, -0.02]%, P=0.004). The associations with protein (P=7.5&times;10(-9)) and total energy (P =0.002) were attenuated but remained significant after adjustment for BMI. We did not find significant interactions between the FTO variant and dietary intake of total energy, protein, carbohydrate, or fat on BMI. Our findings suggest a positive association between the BMI-increasing allele of FTO variant and higher dietary protein intake and offer insight into potential link between FTO, dietary protein intake and adiposity.</p>
<p class="publication"><span class="title">Human molecular genetics</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25104851">25104851</a>; DOI: <a href="http://dx.doi.org/10.1093%2Fhmg%2Fddu411">10.1093/hmg/ddu411</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">SASI-Seq: sample assurance Spike-Ins, and highly differentiating 384 barcoding for Illumina sequencing.</h4>
<p class="authors"><span class="author">Quail MA</span>, <span class="author">Smith M</span>, <span class="author">Jackson D</span>, <span class="author">Leonard S</span>, <span class="author">Skelly T</span>, <span class="author">Swerdlow HP</span>, <span class="author">Gu Y</span> and <span class="author">Ellis P</span></p>
<p class="affiliation">Wellcome Trust Sanger Institute, Hinxton CB10 1SA, Cambs, UK. <a href="mailto:%6D%71%31%40%73%61%6E%67%65%72.%61%63.%75%6B">&#109;&#113;&#49;&#64;&#115;&#97;&#110;&#103;&#101;&#114;&#46;&#97;&#99;&#46;&#117;&#107;</a>.</p><p class="abstract"><strong>Background</strong>: A minor but significant fraction of samples subjected to next-generation sequencing methods are either mixed-up or cross-contaminated. These events can lead to false or inconclusive results. We have therefore developed SASI-Seq; a process whereby a set of uniquely barcoded DNA fragments are added to samples destined for sequencing. From the final sequencing data, one can verify that all the reads derive from the original sample(s) and not from contaminants or other samples.</p><p class="abstract"><strong>Results</strong>: By adding a mixture of three uniquely barcoded amplicons, of different sizes spanning the range of insert sizes one would normally use for Illumina sequencing, at a spike-in level of approximately 0.1%, we demonstrate that these fragments remain intimately associated with the sample. They can be detected following even the tightest size selection regimes or exome enrichment and can report the occurrence of sample mix-ups and cross-contamination.As a consequence of this work, we have designed a set of 384 eleven-base Illumina barcode sequences that are at least 5 changes apart from each other, allowing for single-error correction and very low levels of barcode misallocation due to sequencing error.</p><p class="abstract"><strong>Conclusion</strong>: SASI-Seq is a simple, inexpensive and flexible tool that enables sample assurance, allows deconvolution of sample mix-ups and reports levels of cross-contamination between samples throughout NGS workflows.</p>
<p class="publication"><span class="title">BMC genomics</span>&nbsp;<span class="year">2014</span>;<span class="volume">15</span>;<span class="number">1</span>;<span class="pagerange">110</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24507442">24507442</a>; DOI: <a href="http://dx.doi.org/10.1186%2F1471-2164-15-110">10.1186/1471-2164-15-110</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Central regulation of bone mass.</h4>
<p class="authors"><span class="author">Quiros-Gonzalez I</span> and <span class="author">Yadav VK</span></p>
<p class="affiliation">Systems Biology of Bone Laboratory, Department of Mouse and Zebrafish Genetics, The Wellcome Trust Sanger Institute, Cambridge CB10 1SA, United Kingdom.</p><p class="abstract">Bones are structures that give the shape and defined features to vertebrates, protect several soft organs and perform multiple endocrine influences on other organs. To achieve these functions bones are first modeled early during life and then constantly remodeled throughout life. The process of bone (re)modeling happens simultaneously at multitude of locations in the skeleton and ensures that vertebrates have a mechanically strong yet a flexible skeleton to the most part of their life. Given the extent of its occurrence in the body, bone remodeling is a highly energy demanding process and is co-ordinated with other physiological processes as diverse as energy metabolism, sleep-wake cycle and reproduction. Neuronal circuits in the brain play a very important role in the coordination of bone remodeling with other organ system functions, and perform this function in sync with environmental and peripheral hormonal cues. In this review, we will focus on the roles of hormonal signals and neural circuits that originate in, or impinge on, the brain in the regulation of bone mass. We will provide herein an updated view of how advances in molecular genetics have refined the neural circuits involved in the regulation of bone mass, from the whole brain level to the specific neuronal populations and their neurotransmitters. This will help to understand the mechanisms whereby vertebrate brain regulates bone mass by fine-tuning metabolic signals that originate in the brain or elsewhere in the body.</p>
<p class="publication"><span class="title">Archives of biochemistry and biophysics</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24950023">24950023</a>; DOI: <a href="http://dx.doi.org/10.1016%2Fj.abb.2014.06.005">10.1016/j.abb.2014.06.005</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">A conditional piggyBac transposition system for genetic screening in mice identifies oncogenic networks in pancreatic cancer.</h4>
<p class="authors"><span class="author">Rad R</span>, <span class="author">Rad L</span>, <span class="author">Wang W</span>, <span class="author">Strong A</span>, <span class="author">Ponstingl H</span>, <span class="author">Bronner IF</span>, <span class="author">Mayho M</span>, <span class="author">Steiger K</span>, <span class="author">Weber J</span>, <span class="author">Hieber M</span>, <span class="author">Veltkamp C</span>, <span class="author">Eser S</span>, <span class="author">Geumann U</span>, <span class="author">Ollinger R</span>, <span class="author">Zukowska M</span>, <span class="author">Barenboim M</span>, <span class="author">Maresch R</span>, <span class="author">Cadi&ntilde;anos J</span>, <span class="author">Friedrich M</span>, <span class="author">Varela I</span>, <span class="author">Constantino-Casas F</span>, <span class="author">Sarver A</span>, <span class="author">Ten Hoeve J</span>, <span class="author">Prosser H</span>, <span class="author">Seidler B</span>, <span class="author">Bauer J</span>, <span class="author">Heikenw&auml;lder M</span>, <span class="author">Metzakopian E</span>, <span class="author">Krug A</span>, <span class="author">Ehmer U</span>, <span class="author">Schneider G</span>, <span class="author">Kn&ouml;sel T</span>, <span class="author">R&uuml;mmele P</span>, <span class="author">Aust D</span>, <span class="author">Gr&uuml;tzmann R</span>, <span class="author">Pilarsky C</span>, <span class="author">Ning Z</span>, <span class="author">Wessels L</span>, <span class="author">Schmid RM</span>, <span class="author">Quail MA</span>, <span class="author">Vassiliou G</span>, <span class="author">Esposito I</span>, <span class="author">Liu P</span>, <span class="author">Saur D</span> and <span class="author">Bradley A</span></p>
<p class="affiliation">1] Department of Medicine II, Klinikum Rechts der Isar, Technische Universit&auml;t M&uuml;nchen, M&uuml;nchen, Germany. [2] German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany. [3] The Wellcome Trust Sanger Institute, Genome Campus, Hinxton, Cambridgeshire, UK.</p><p class="abstract">Here we describe a conditional piggyBac transposition system in mice and report the discovery of large sets of new cancer genes through a pancreatic insertional mutagenesis screen. We identify Foxp1 as an oncogenic transcription factor that drives pancreatic cancer invasion and spread in a mouse model and correlates with lymph node metastasis in human patients with pancreatic cancer. The propensity of piggyBac for open chromatin also enabled genome-wide screening for cancer-relevant noncoding DNA, which pinpointed a Cdkn2a cis-regulatory region. Histologically, we observed different tumor subentities and discovered associated genetic events, including Fign insertions in hepatoid pancreatic cancer. Our studies demonstrate the power of genetic screening to discover cancer drivers that are difficult to identify by other approaches to cancer genome analysis, such as downstream targets of commonly mutated human cancer genes. These piggyBac resources are universally applicable in any tissue context and provide unique experimental access to the genetic complexity of cancer.</p>
<p class="publication"><span class="title">Nature genetics</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25485836">25485836</a>; DOI: <a href="http://dx.doi.org/10.1038%2Fng.3164">10.1038/ng.3164</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">In utero undernourishment perturbs the adult sperm methylome and intergenerational metabolism.</h4>
<p class="authors"><span class="author">Radford EJ</span>, <span class="author">Ito M</span>, <span class="author">Shi H</span>, <span class="author">Corish JA</span>, <span class="author">Yamazawa K</span>, <span class="author">Isganaitis E</span>, <span class="author">Seisenberger S</span>, <span class="author">Hore TA</span>, <span class="author">Reik W</span>, <span class="author">Erkek S</span>, <span class="author">Peters AH</span>, <span class="author">Patti ME</span> and <span class="author">Ferguson-Smith AC</span></p>
<p class="affiliation">Department of Physiology, Development and Neuroscience, University of Cambridge, Downing Street, Cambridge CB2 3EG, UK.</p><p class="abstract">Adverse prenatal environments can promote metabolic disease in offspring and subsequent generations. Animal models and epidemiological data implicate epigenetic inheritance, but the mechanisms remain unknown. In an intergenerational developmental programming model affecting F2 mouse metabolism, we demonstrate that the in utero nutritional environment of F1 embryos alters the germline DNA methylome of F1 adult males in a locus-specific manner. Differentially methylated regions are hypomethylated and enriched in nucleosome-retaining regions. A substantial fraction is resistant to early embryo methylation reprogramming, potentially impacting F2 development. Differential methylation is not maintained in F2 tissues, yet locus-specific expression is perturbed. Thus, in utero nutritional exposures during critical windows of germ cell development can impact the male germline methylome, associated with metabolic disease in offspring.</p>
<p class="publication"><span class="title">Science (New York, N.Y.)</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25011554">25011554</a>; DOI: <a href="http://dx.doi.org/10.1126%2Fscience.1255903">10.1126/science.1255903</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Genome-wide Enrichment Analysis between Endometriosis and Obesity-related Traits Reveals Novel Susceptibility Loci.</h4>
<p class="authors"><span class="author">Rahmioglu N</span>, <span class="author">Macgregor S</span>, <span class="author">Drong AW</span>, <span class="author">Hedman AK</span>, <span class="author">Harris HR</span>, <span class="author">Randall JC</span>, <span class="author">Prokopenko I</span>, <span class="author">The International EndoGene Consortium (IEC)</span>, <span class="author">The GIANT Consortium</span>, <span class="author">Nyholt DR</span>, <span class="author">Morris AP</span>, <span class="author">Montgomery GW</span>, <span class="author">Missmer SA</span>, <span class="author">Lindgren CM</span>, <span class="author">Zondervan KT</span> and <span class="author">The International EndoGene Consortium IEC</span></p>
<p class="affiliation">Wellcome Trust Center for Human Genetics, University of Oxford, Oxford, OX3 7BN, UK.</p><p class="abstract">Endometriosis is a chronic inflammatory condition in women that results in pelvic pain and sub-fertility, and has been associated with decreased body mass index (BMI). Genetic variants contributing to the heritable component have started to emerge from genome-wide association studies (GWAS), although the majority remain unknown. Unexpectedly, we observed an intergenic locus on 7p15.2 that was genome-wide significantly associated with both endometriosis and fat distribution (waist-to-hip ratio adjusted for body mass index; WHRadjBMI) in an independent meta-GWAS of European ancestry individuals. This led us to investigate the potential overlap in genetic variants underlying the aetiology of endometriosis, WHRadjBMI and BMI using GWAS data. Our analyses demonstrated significant enrichment of common variants between fat distribution and endometriosis (P=3.7x10(-3)), which was stronger when we restricted the investigation to more severe (Stage B) cases (P=4.5x10(-4)). However, no genetic enrichment was observed between endometriosis and BMI (P=0.79). In addition to 7p15.2, we identify four more variants with statistically significant evidence of involvement in both endometriosis and WHRadjBMI (in/near KIFAP3, CAB39 L, WNT4, GRB14); two of these, KIFAP3 and CAB39 L, are novel associations for both traits. KIFAP3, WNT4, and 7p15.2 are associated with the WNT signalling pathway; formal pathway analysis confirmed a statistically significant (P=6.41x10(-4)) over-representation of shared associations in developmental processes/WNT signalling between the two traits. Our results demonstrate an example of potential biological pleiotropy that was hitherto unknown, and represent an opportunity for functional follow-up of loci and further cross-phenotype comparisons to assess how fat distribution and endometriosis pathogenesis research fields can inform each other.</p>
<p class="publication"><span class="title">Human molecular genetics</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25296917">25296917</a>; DOI: <a href="http://dx.doi.org/10.1093%2Fhmg%2Fddu516">10.1093/hmg/ddu516</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Generation of primary human intestinal T cell transcriptomes reveals differential expression at genetic risk loci for immune-mediated disease.</h4>
<p class="authors"><span class="author">Raine T</span>, <span class="author">Liu JZ</span>, <span class="author">Anderson CA</span>, <span class="author">Parkes M</span> and <span class="author">Kaser A</span></p>
<p class="affiliation">Department of Medicine, Addenbrooke&#39;s Hospital, University of Cambridge, , Cambridge, UK.</p><p class="abstract"><strong>Objective</strong>: Genome-wide association studies (GWAS) have identified genetic variants within multiple risk loci as predisposing to intestinal inflammatory diseases, including Crohn&#39;s disease, ulcerative colitis and coeliac disease. Most risk variants affect regulation of transcription, but a critical challenge is to identify which genes and which cell types these variants affect. We aimed to characterise whole transcriptomes for each common T lymphocyte subset resident within the gut mucosa, and use these to infer biological insights and highlight candidate genes of interest within GWAS risk loci.</p><p class="abstract"><strong>Design</strong>: We isolated the four major intestinal T cell populations from pinch biopsies from healthy subjects and generated transcriptomes for each. We computationally integrated these transcriptomes with GWAS data from immune-related diseases.</p><p class="abstract"><strong>Results</strong>: Robust, high quality transcriptomic data were generated from 1 ng of RNA from precisely sorted cell subsets. Gene expression patterns clearly differentiated intestinal T cells from counterparts in peripheral blood and revealed distinct signalling pathways for each intestinal T cell subset. Intestinal-specific T cell transcripts were enriched in GWAS risk loci for Crohn&#39;s disease, ulcerative colitis and coeliac disease, but also specific extraintestinal immune-mediated diseases, allowing prediction of novel candidate genes.</p><p class="abstract"><strong>Conclusions</strong>: This is the first report of transcriptomes for minimally manipulated intestinal T lymphocyte subsets in humans. We have demonstrated that careful processing of mucosal biopsies allows the generation of transcriptomes from as few as 1000 highly purified cells with minimal interindividual variation. Bioinformatic integration of transcriptomic data with recent GWAS data identified specific candidate genes and cell types for inflammatory pathologies.</p>
<p class="publication"><span class="title">Gut</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24799394">24799394</a>; DOI: <a href="http://dx.doi.org/10.1136%2Fgutjnl-2013-306657">10.1136/gutjnl-2013-306657</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Monoallelic and Biallelic Mutations in MAB21L2 Cause a Spectrum of Major Eye Malformations.</h4>
<p class="authors"><span class="author">Rainger J</span>, <span class="author">Pehlivan D</span>, <span class="author">Johansson S</span>, <span class="author">Bengani H</span>, <span class="author">Sanchez-Pulido L</span>, <span class="author">Williamson KA</span>, <span class="author">Ture M</span>, <span class="author">Barker H</span>, <span class="author">Rosendahl K</span>, <span class="author">Spranger J</span>, <span class="author">Horn D</span>, <span class="author">Meynert A</span>, <span class="author">Floyd JA</span>, <span class="author">Prescott T</span>, <span class="author">Anderson CA</span>, <span class="author">Rainger JK</span>, <span class="author">Karaca E</span>, <span class="author">Gonzaga-Jauregui C</span>, <span class="author">Jhangiani S</span>, <span class="author">Muzny DM</span>, <span class="author">Seawright A</span>, <span class="author">Soares DC</span>, <span class="author">Kharbanda M</span>, <span class="author">Murday V</span>, <span class="author">Finch A</span>, <span class="author">UK10K</span>, <span class="author">Baylor-Hopkins Center for Mendelian Genomics</span>, <span class="author">Gibbs RA</span>, <span class="author">van Heyningen V</span>, <span class="author">Taylor MS</span>, <span class="author">Yakut T</span>, <span class="author">Knappskog PM</span>, <span class="author">Hurles ME</span>, <span class="author">Ponting CP</span>, <span class="author">Lupski JR</span>, <span class="author">Houge G</span> and <span class="author">FitzPatrick DR</span></p>
<p class="affiliation">Medical Research Council Human Genetics Unit, Medical Research Council Institute of Genetics and Molecular Medicine, Edinburgh EH4 2XU, UK.</p><p class="abstract">We identified four different missense mutations in the single-exon gene MAB21L2 in eight individuals with bilateral eye malformations from five unrelated families via three independent exome sequencing projects. Three mutational events altered the same amino acid (Arg51), and two were identical de novo mutations (c.151C&gt;T [p.Arg51Cys]) in unrelated children with bilateral anophthalmia, intellectual disability, and rhizomelic skeletal dysplasia. c.152G&gt;A (p.Arg51His) segregated with autosomal-dominant bilateral colobomatous microphthalmia in a large multiplex family. The fourth heterozygous mutation (c.145G&gt;A [p.Glu49Lys]) affected an amino acid within two residues of Arg51 in an adult male with bilateral colobomata. In a fifth family, a homozygous mutation (c.740G&gt;A [p.Arg247Gln]) altering a different region of the protein was identified in two male siblings with bilateral retinal colobomata. In mouse embryos, Mab21l2 showed strong expression in the developing eye, pharyngeal arches, and limb bud. As predicted by structural homology, wild-type MAB21L2 bound single-stranded RNA, whereas this activity was lost in all altered forms of the protein. MAB21L2 had no detectable nucleotidyltransferase activity in&nbsp;vitro, and its function remains unknown. Induced expression of wild-type MAB21L2 in human embryonic kidney 293 cells increased phospho-ERK (pERK1/2) signaling. Compared to the wild-type and p.Arg247Gln proteins, the proteins with the Glu49 and Arg51 variants had increased stability. Abnormal persistence of pERK1/2 signaling in MAB21L2-expressing cells during development is a plausible pathogenic mechanism for the heterozygous mutations. The phenotype associated with the homozygous mutation might be a consequence of complete loss of MAB21L2 RNA binding, although the cellular function of this interaction remains unknown.</p>
<p class="publication"><span class="title">American journal of human genetics</span>&nbsp;<span class="year">2014</span>;<span class="volume">94</span>;<span class="number">6</span>;<span class="pagerange">915-23</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24906020">24906020</a>; DOI: <a href="http://dx.doi.org/10.1016%2Fj.ajhg.2014.05.005">10.1016/j.ajhg.2014.05.005</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Characterizing genetic variants for clinical action.</h4>
<p class="authors"><span class="author">Ramos EM</span>, <span class="author">Din-Lovinescu C</span>, <span class="author">Berg JS</span>, <span class="author">Brooks LD</span>, <span class="author">Duncanson A</span>, <span class="author">Dunn M</span>, <span class="author">Good P</span>, <span class="author">Hubbard TJ</span>, <span class="author">Jarvik GP</span>, <span class="author">O&#39;Donnell C</span>, <span class="author">Sherry ST</span>, <span class="author">Aronson N</span>, <span class="author">Biesecker LG</span>, <span class="author">Blumberg B</span>, <span class="author">Calonge N</span>, <span class="author">Colhoun HM</span>, <span class="author">Epstein RS</span>, <span class="author">Flicek P</span>, <span class="author">Gordon ES</span>, <span class="author">Green ED</span>, <span class="author">Green RC</span>, <span class="author">Hurles M</span>, <span class="author">Kawamoto K</span>, <span class="author">Knaus W</span>, <span class="author">Ledbetter DH</span>, <span class="author">Levy HP</span>, <span class="author">Lyon E</span>, <span class="author">Maglott D</span>, <span class="author">McLeod HL</span>, <span class="author">Rahman N</span>, <span class="author">Randhawa G</span>, <span class="author">Wicklund C</span>, <span class="author">Manolio TA</span>, <span class="author">Chisholm RL</span> and <span class="author">Williams MS</span></p><p class="abstract">Genome-wide association studies, DNA sequencing studies, and other genomic studies are finding an increasing number of genetic variants associated with clinical phenotypes that may be useful in developing diagnostic, preventive, and treatment strategies for individual patients. However, few variants have been integrated into routine clinical practice. The reasons for this are several, but two of the most significant are limited evidence about the clinical implications of the variants and a lack of a comprehensive knowledge base that captures genetic variants, their phenotypic associations, and other pertinent phenotypic information that is openly accessible to clinical groups attempting to interpret sequencing data. As the field of medicine begins to incorporate genome-scale analysis into clinical care, approaches need to be developed for collecting and characterizing data on the clinical implications of variants, developing consensus on their actionability, and making this information available for clinical use. The National Human Genome Research Institute (NHGRI) and the Wellcome Trust thus convened a workshop to consider the processes and resources needed to: (1) identify clinically valid genetic variants; (2) decide whether they are actionable and what the action should be; and (3) provide this information for clinical use. This commentary outlines the key discussion points and recommendations from the workshop. &copy; 2014 Wiley Periodicals, Inc.</p>
<p class="publication"><span class="title">American journal of medical genetics. Part C, Seminars in medical genetics</span>&nbsp;<span class="year">2014</span>;<span class="volume">166</span>;<span class="number">1</span>;<span class="pagerange">93-104</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24634402">24634402</a>; DOI: <a href="http://dx.doi.org/10.1002%2Fajmg.c.31386">10.1002/ajmg.c.31386</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Meta-analysis identifies loci affecting levels of the potential osteoarthritis biomarkers sCOMP and uCTX-II with genome wide significance.</h4>
<p class="authors"><span class="author">Ramos YF</span>, <span class="author">Metrustry S</span>, <span class="author">Arden N</span>, <span class="author">Bay-Jensen AC</span>, <span class="author">Beekman M</span>, <span class="author">de Craen AJ</span>, <span class="author">Cupples LA</span>, <span class="author">Esko T</span>, <span class="author">Evangelou E</span>, <span class="author">Felson DT</span>, <span class="author">Hart DJ</span>, <span class="author">Ioannidis JP</span>, <span class="author">Karsdal M</span>, <span class="author">Kloppenburg M</span>, <span class="author">Lafeber F</span>, <span class="author">Metspalu A</span>, <span class="author">Panoutsopoulou K</span>, <span class="author">Slagboom PE</span>, <span class="author">Spector TD</span>, <span class="author">van Spil EW</span>, <span class="author">Uitterlinden AG</span>, <span class="author">Zhu Y</span>, <span class="author">arcOGEN Consortium</span>, <span class="author">TreatOA Collaborators</span>, <span class="author">Valdes AM</span>, <span class="author">van Meurs JB</span> and <span class="author">Meulenbelt I</span></p>
<p class="affiliation">Department of Molecular Epidemiology, LUMC, Leiden, The Netherlands The Netherlands Genomics Initiative-Sponsored Netherlands Consortium for Healthy Aging, Leiden and Rotterdam, The Netherlands.</p><p class="abstract"><strong>Background</strong>: Research for the use of biomarkers in osteoarthritis (OA) is promising, however, adequate discrimination between patients and controls may be hampered due to innate differences. We set out to identify loci influencing levels of serum cartilage oligomeric protein (sCOMP) and urinary C-telopeptide of type II collagen (uCTX-II).</p><p class="abstract"><strong>Methods</strong>: Meta-analysis of genome-wide association studies was applied to standardised residuals of sCOMP (N=3316) and uCTX-II (N=4654) levels available in 6 and 7 studies, respectively, from TreatOA. Effects were estimated using a fixed-effects model. Six promising signals were followed up by de novo genotyping in the Cohort Hip and Cohort Knee study (N = 964). Subsequently, their role in OA susceptibility was investigated in large-scale genome-wide association studies meta-analyses for OA. Differential expression of annotated genes was assessed in cartilage.</p><p class="abstract"><strong>Results</strong>: Genome-wide significant association with sCOMP levels was found for a SNP within MRC1 (rs691461, p = 1.7 &times; 10(-12)) and a SNP within CSMD1 associated with variation in uCTX-II levels with borderline genome-wide significance (rs1983474, p = 8.5 &times; 10(-8)). Indication for association with sCOMP levels was also found for a locus close to the COMP gene itself (rs10038, p = 7.1 &times; 10(-6)). The latter SNP was subsequently found to be associated with hip OA whereas COMP expression appeared responsive to the OA pathophysiology in cartilage.</p><p class="abstract"><strong>Conclusions</strong>: We have identified genetic loci affecting either uCTX-II or sCOMP levels. The genome wide significant association of MRC1 with sCOMP levels was found likely to act independent of OA subtypes. Increased sensitivity of biomarkers with OA may be accomplished by taking genetic variation into account.</p>
<p class="grants">Funded by: Arthritis Research UK: <span class="grant">18030</span>; Wellcome Trust: <span class="grant">091746/Z/10/Z</span>, <span class="grant">ref. 079771</span></p>
<p class="publication"><span class="title">Journal of medical genetics</span>&nbsp;<span class="year">2014</span>;<span class="volume">51</span>;<span class="number">9</span>;<span class="pagerange">596-604</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25057126">25057126</a>; DOI: <a href="http://dx.doi.org/10.1136%2Fjmedgenet-2014-102478">10.1136/jmedgenet-2014-102478</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Plasmid coding sequence-five influences infectivity and virulence in a mouse model of Chlamydia trachomatis urogenital infection.</h4>
<p class="authors"><span class="author">Ramsey KH</span>, <span class="author">Schripsema JH</span>, <span class="author">Smith BJ</span>, <span class="author">Wang Y</span>, <span class="author">Jham BC</span>, <span class="author">O&#39;Hagan KP</span>, <span class="author">Thomson NR</span>, <span class="author">Murthy AK</span>, <span class="author">Skilton RJ</span>, <span class="author">Chu P</span> and <span class="author">Clarke IN</span></p>
<p class="affiliation">Departments of Microbiology &amp; Immunology <a href="mailto:%6B%72%61%6D%73%65%40%6D%69%64%77%65%73%74%65%72%6E.%65%64%75">&#107;&#114;&#97;&#109;&#115;&#101;&#64;&#109;&#105;&#100;&#119;&#101;&#115;&#116;&#101;&#114;&#110;&#46;&#101;&#100;&#117;</a>.</p><p class="abstract">The native plasmid of both Chlamydia muridarum and C. trachomatis has been shown to control virulence and infectivity in mice and in lower primates. We have recently described the development of a plasmid-based genetic transformation protocol for Chlamydia trachomatis that for the first time provides a platform for the molecular dissection of the function of the chlamydial plasmid and its individual genes or coding sequences (CDS). In the present study, we transformed a plasmid-free lymphogranuloma venereum isolate of C. trachomatis, serovar L2, with either the original shuttle vector (pGFP::SW2) or a derivative of pGFP::SW2 carrying a deletion of the plasmid CDS5 gene (pCDS5KO). Female mice were inoculated with these strains either intravaginally or transcervically. We found that transformation of the plasmid-free isolate with the intact pGFP::SW2 vector significantly enhanced infectivity and induction of host inflammatory responses when compared to the plasmid-free parental isolate. Transformation with pCDS5KO resulted in infection courses and inflammatory responses not significantly different from those observed in mice infected with the plasmid-free isolate. These results indicate a critical role of plasmid CDS5 in in vivo fitness and in induction of inflammatory responses. To our knowledge, these are the first in vivo observations ascribing infectivity and virulence to a specific plasmid gene.</p>
<p class="publication"><span class="title">Infection and immunity</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24866804">24866804</a>; DOI: <a href="http://dx.doi.org/10.1128%2FIAI.01795-14">10.1128/IAI.01795-14</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">A genomic island integrated into recA of Vibrio cholerae contains a divergent recA and provides multi-pathway protection from DNA damage.</h4>
<p class="authors"><span class="author">Rapa RA</span>, <span class="author">Islam A</span>, <span class="author">Monahan LG</span>, <span class="author">Mutreja A</span>, <span class="author">Thomson N</span>, <span class="author">Charles IG</span>, <span class="author">Stokes HW</span> and <span class="author">Labbate M</span></p>
<p class="affiliation">ithree Institute, University of Technology, PO Box 123 Broadway, Sydney, NSW, 2007, Australia; Department of Medical and Molecular Biosciences, University of Technology, Sydney, NSW, Australia.</p><p class="abstract">Lateral gene transfer (LGT) has been crucial in the evolution of the cholera pathogen, Vibrio cholerae. The two major virulence factors are present on two different mobile genetic elements, a bacteriophage containing the cholera toxin genes and a genomic island (GI) containing the intestinal adhesin genes. Non-toxigenic V.&thinsp;cholerae in the aquatic environment are a major source of novel DNA that allows the pathogen to morph via LGT. In this study, we report a novel GI from a non-toxigenic V.&thinsp;cholerae strain containing multiple genes involved in DNA repair including the recombination repair gene recA that is 23% divergent from the indigenous recA and genes involved in the translesion synthesis pathway. This is the first report of a GI containing the critical gene recA and the first report of a GI that targets insertion into a specific site within recA. We show that possession of the island in Escherichia coli is protective against DNA damage induced by UV-irradiation and DNA targeting antibiotics. This study highlights the importance of genetic elements such as GIs in the evolution of V.&thinsp;cholerae and emphasizes the importance of environmental strains as a source of novel DNA that can influence the pathogenicity of toxigenic strains.</p>
<p class="publication"><span class="title">Environmental microbiology</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24889424">24889424</a>; DOI: <a href="http://dx.doi.org/10.1111%2F1462-2920.12512">10.1111/1462-2920.12512</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Differential and limited expression of mutant alleles in multiple myeloma.</h4>
<p class="authors"><span class="author">Rashid NU</span>, <span class="author">Sperling AS</span>, <span class="author">Bolli N</span>, <span class="author">Wedge DC</span>, <span class="author">Van Loo P</span>, <span class="author">Tai YT</span>, <span class="author">Shammas MA</span>, <span class="author">Fulciniti M</span>, <span class="author">Samur MK</span>, <span class="author">Richardson PG</span>, <span class="author">Magrangeas F</span>, <span class="author">Minvielle S</span>, <span class="author">Futreal PA</span>, <span class="author">Anderson KC</span>, <span class="author">Avet-Loiseau H</span>, <span class="author">Campbell PJ</span>, <span class="author">Parmigiani G</span> and <span class="author">Munshi NC</span></p>
<p class="affiliation">Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; Department of Biostatistics, Dana-Farber Cancer Institute and Harvard School of Public Health, Boston, MA;</p><p class="abstract">Recent work has delineated mutational profiles in multiple myeloma and reported a median of 52 mutations per patient, as well as a set of commonly mutated genes across multiple patients. In this study, we have used deep sequencing of RNA from a subset of these patients to evaluate the proportion of expressed mutations. We find that the majority of previously identified mutations occur within genes with very low or no detectable expression. On average, 27% (range, 11% to 47%) of mutated alleles are found to be expressed, and among mutated genes that are expressed, there often is allele-specific expression where either the mutant or wild-type allele is suppressed. Even in the absence of an overall change in gene expression, the presence of differential allelic expression within malignant cells highlights the important contribution of RNA-sequencing in identifying clinically significant mutational changes relevant to our understanding of myeloma biology and also for therapeutic applications.</p>
<p class="publication"><span class="title">Blood</span>&nbsp;<span class="year">2014</span>;<span class="volume">124</span>;<span class="number">20</span>;<span class="pagerange">3110-7</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25237203">25237203</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4231420">4231420</a>; DOI: <a href="http://dx.doi.org/10.1182%2Fblood-2014-04-569327">10.1182/blood-2014-04-569327</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Using the MEROPS Database for Proteolytic Enzymes and Their Inhibitors and Substrates.</h4>
<p class="authors"><span class="author">Rawlings ND</span>, <span class="author">Barrett AJ</span> and <span class="author">Bateman A</span></p>
<p class="affiliation">Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, United Kingdom; EMBL European Bioinformatics Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, United Kingdom.</p><p class="abstract">MEROPS is a database of proteolytic enzymes as well as their inhibitors and substrates. Proteolytic enzymes and protein inhibitors are organized into protein domain families. In turn, families are organized into clans. Each peptidase, inhibitor, family, and clan has associated annotation, a multiple sequence alignment, a phylogenetic tree, literature references, and links to other databases. Interactions between proteolytic enzymes and inhibitors and between proteolytic enzymes and substrates are also presented. The entries in MEROPS are available via the World Wide Web. This unit contains detailed information on how to access and utilize the information present in the MEROPS database. Details on running MEROPS both remotely and locally are presented. &copy; 2014 by John Wiley &amp; Sons, Inc.</p>
<p class="publication"><span class="title">Current protocols in bioinformatics / editoral board, Andreas D. Baxevanis ... [et al.]</span>&nbsp;<span class="year">2014</span>;<span class="volume">48</span>;<span class="pagerange">1.25.1-1.25.33</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25501939">25501939</a>; DOI: <a href="http://dx.doi.org/10.1002%2F0471250953.bi0125s48">10.1002/0471250953.bi0125s48</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">MEROPS: the database of proteolytic enzymes, their substrates and inhibitors.</h4>
<p class="authors"><span class="author">Rawlings ND</span>, <span class="author">Waller M</span>, <span class="author">Barrett AJ</span> and <span class="author">Bateman A</span></p>
<p class="affiliation">The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK and Proteins and Protein Families, EMBO European Bioinformatics Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK.</p>
<p class="abstract">Peptidases, their substrates and inhibitors are of great relevance to biology, medicine and biotechnology. The MEROPS database (http://merops.sanger.ac.uk) aims to fulfill the need for an integrated source of information about these. The database has hierarchical classifications in which homologous sets of peptidases and protein inhibitors are grouped into protein species, which are grouped into families, which are in turn grouped into clans. Recent developments include the following. A community annotation project has been instigated in which acknowledged experts are invited to contribute summaries for peptidases. Software has been written to provide an Internet-based data entry form. Contributors are acknowledged on the relevant web page. A new display showing the intron/exon structures of eukaryote peptidase genes and the phasing of the junctions has been implemented. It is now possible to filter the list of peptidases from a completely sequenced bacterial genome for a particular strain of the organism. The MEROPS filing pipeline has been altered to circumvent the restrictions imposed on non-interactive blastp searches, and a HMMER search using specially generated alignments to maximize the distribution of organisms returned in the search results has been added.</p>
<p class="publication"><span class="title">Nucleic acids research</span>&nbsp;<span class="year">2014</span>;<span class="volume">42</span>;<span class="number">1</span>;<span class="pagerange">D503-9</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24157837">24157837</a>; DOI: <a href="http://dx.doi.org/10.1093%2Fnar%2Fgkt953">10.1093/nar/gkt953</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Deciphering the origin of the 2012 cholera epidemic in Guinea by integrating epidemiological and molecular analyses.</h4>
<p class="authors"><span class="author">Rebaudet S</span>, <span class="author">Mengel MA</span>, <span class="author">Koivogui L</span>, <span class="author">Moore S</span>, <span class="author">Mutreja A</span>, <span class="author">Kande Y</span>, <span class="author">Yattara O</span>, <span class="author">Sarr Keita V</span>, <span class="author">Njanpop-Lafourcade BM</span>, <span class="author">Fournier PE</span>, <span class="author">Garnotel E</span>, <span class="author">Keita S</span> and <span class="author">Piarroux R</span></p>
<p class="affiliation">Aix-Marseille Universit&eacute;, UMD 3, Marseille, France.</p><p class="abstract">Cholera is typically considered endemic in West Africa, especially in the Republic of Guinea. However, a three-year lull period was observed from 2009 to 2011, before a new epidemic struck the country in 2012, which was officially responsible for 7,350 suspected cases and 133 deaths. To determine whether cholera re-emerged from the aquatic environment or was rather imported due to human migration, a comprehensive epidemiological and molecular survey was conducted. A spatiotemporal analysis of the national case databases established Kaback Island, located off the southern coast of Guinea, as the initial focus of the epidemic in early February. According to the field investigations, the index case was found to be a fisherman who had recently arrived from a coastal district of neighboring Sierra Leone, where a cholera outbreak had recently occurred. MLVA-based genotype mapping of 38 clinical Vibrio cholerae O1 El Tor isolates sampled throughout the epidemic demonstrated a progressive genetic diversification of the strains from a single genotype isolated on Kaback Island in February, which correlated with spatial epidemic spread. Whole-genome sequencing characterized this strain as an &quot;atypical&quot; El Tor variant. Furthermore, genome-wide SNP-based phylogeny analysis grouped the Guinean strain into a new clade of the third wave of the seventh pandemic, distinct from previously analyzed African strains and directly related to a Bangladeshi isolate. Overall, these results highly suggest that the Guinean 2012 epidemic was caused by a V. cholerae clone that was likely imported from Sierra Leone by an infected individual. These results indicate the importance of promoting the cross-border identification and surveillance of mobile and vulnerable populations, including fishermen, to prevent, detect and control future epidemics in the region. Comprehensive epidemiological investigations should be expanded to better understand cholera dynamics and improve disease control strategies throughout the African continent.</p>
<p class="publication"><span class="title">PLoS neglected tropical diseases</span>&nbsp;<span class="year">2014</span>;<span class="volume">8</span>;<span class="number">6</span>;<span class="pagerange">e2898</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24901522">24901522</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4046952">4046952</a>; DOI: <a href="http://dx.doi.org/10.1371%2Fjournal.pntd.0002898">10.1371/journal.pntd.0002898</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Bioinformatic Analysis of Expression Data to Identify Effector Candidates.</h4>
<p class="authors"><span class="author">Reid AJ</span> and <span class="author">Jones JT</span></p>
<p class="affiliation">Parasite Genomics, Wellcome Trust Sanger Institute, Genome Campus, Cambridge, CB10 1SA, UK, <a href="mailto:%61%72%31%31%40%73%61%6E%67%65%72.%61%63.%75%6B">&#97;&#114;&#49;&#49;&#64;&#115;&#97;&#110;&#103;&#101;&#114;&#46;&#97;&#99;&#46;&#117;&#107;</a>.</p><p class="abstract">Pathogens produce effectors that manipulate the host to the benefit of the pathogen. These effectors are often secreted proteins that are upregulated during the early phases of infection. These properties can be used to identify candidate effectors from genomes and transcriptomes of pathogens. Here we describe commonly used bioinformatic approaches that (1) allow identification of genes encoding predicted secreted proteins within a genome and (2) allow the identification of genes encoding predicted secreted proteins that are upregulated at important stages of the life cycle. Other approaches for bioinformatic identification of effector candidates, including OrthoMCL analysis to identify expanded gene families, are also described.</p>
<p class="publication"><span class="title">Methods in molecular biology (Clifton, N.J.)</span>&nbsp;<span class="year">2014</span>;<span class="volume">1127</span>;<span class="pagerange">17-27</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24643549">24643549</a>; DOI: <a href="http://dx.doi.org/10.1007%2F978-1-62703-986-4_2">10.1007/978-1-62703-986-4_2</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Genomic analysis of the causative agents of coccidiosis in domestic chickens.</h4>
<p class="authors"><span class="author">Reid AJ</span>, <span class="author">Blake DP</span>, <span class="author">Ansari HR</span>, <span class="author">Billington K</span>, <span class="author">Browne HP</span>, <span class="author">Bryant J</span>, <span class="author">Dunn M</span>, <span class="author">Hung SS</span>, <span class="author">Kawahara F</span>, <span class="author">Miranda-Saavedra D</span>, <span class="author">Malas TB</span>, <span class="author">Mourier T</span>, <span class="author">Naghra H</span>, <span class="author">Nair M</span>, <span class="author">Otto TD</span>, <span class="author">Rawlings ND</span>, <span class="author">Rivailler P</span>, <span class="author">Sanchez-Flores A</span>, <span class="author">Sanders M</span>, <span class="author">Subramaniam C</span>, <span class="author">Tay YL</span>, <span class="author">Woo Y</span>, <span class="author">Wu X</span>, <span class="author">Barrell B</span>, <span class="author">Dear PH</span>, <span class="author">Doerig C</span>, <span class="author">Gruber A</span>, <span class="author">Ivens AC</span>, <span class="author">Parkinson J</span>, <span class="author">Rajandream MA</span>, <span class="author">Shirley MW</span>, <span class="author">Wan KL</span>, <span class="author">Berriman M</span>, <span class="author">Tomley FM</span> and <span class="author">Pain A</span></p>
<p class="affiliation">Wellcome Trust Sanger Institute, Genome Campus, Hinxton, Cambridgeshire CB10 1SA, United Kingdom;</p><p class="abstract">Global production of chickens has trebled in the past two decades and they are now the most important source of dietary animal protein worldwide. Chickens are subject to many infectious diseases that reduce their performance and productivity. Coccidiosis, caused by apicomplexan protozoa of the genus Eimeria, is one of the most important poultry diseases. Understanding the biology of Eimeria parasites underpins development of new drugs and vaccines needed to improve global food security. We have produced annotated genome sequences of all seven species of Eimeria that infect domestic chickens, which reveal the full extent of previously described repeat-rich and repeat-poor regions and show that these parasites possess the most repeat-rich proteomes ever described. Furthermore, while no other apicomplexan has been found to possess retrotransposons, Eimeria is home to a family of chromoviruses. Analysis of Eimeria genes involved in basic biology and host-parasite interaction highlights adaptations to a relatively simple developmental life cycle and a complex array of co-expressed surface proteins involved in host cell binding.</p>
<p class="grants">Funded by: Biotechnology and Biological Sciences Research Council: <span class="grant">S17413</span>, <span class="grant">S19705/6</span>; Canadian Institutes of Health Research: <span class="grant">MOP84556</span></p>
<p class="publication"><span class="title">Genome research</span>&nbsp;<span class="year">2014</span>;<span class="volume">24</span>;<span class="number">10</span>;<span class="pagerange">1676-85</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25015382">25015382</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4199364">4199364</a>; DOI: <a href="http://dx.doi.org/10.1101%2Fgr.168955.113">10.1101/gr.168955.113</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Epigenetics: Cellular memory erased in human embryos.</h4>
<p class="authors"><span class="author">Reik W</span> and <span class="author">Kelsey G</span></p>
<p class="affiliation">1] Epigenetics Programme, Babraham Institute, Babraham Research Campus, Cambridge CB22 3AT, UK, and at the Centre for Trophoblast Research, University of Cambridge. [2] Wellcome Trust Sanger Institute, Cambridge.</p>
<p class="publication"><span class="title">Nature</span>&nbsp;<span class="year">2014</span>;<span class="volume">511</span>;<span class="number">7511</span>;<span class="pagerange">540-1</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25079550">25079550</a>; DOI: <a href="http://dx.doi.org/10.1038%2Fnature13648">10.1038/nature13648</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Parallel independent evolution of pathogenicity within the genus Yersinia.</h4>
<p class="authors"><span class="author">Reuter S</span>, <span class="author">Connor TR</span>, <span class="author">Barquist L</span>, <span class="author">Walker D</span>, <span class="author">Feltwell T</span>, <span class="author">Harris SR</span>, <span class="author">Fookes M</span>, <span class="author">Hall ME</span>, <span class="author">Petty NK</span>, <span class="author">Fuchs TM</span>, <span class="author">Corander J</span>, <span class="author">Dufour M</span>, <span class="author">Ringwood T</span>, <span class="author">Savin C</span>, <span class="author">Bouchier C</span>, <span class="author">Martin L</span>, <span class="author">Miettinen M</span>, <span class="author">Shubin M</span>, <span class="author">Riehm JM</span>, <span class="author">Laukkanen-Ninios R</span>, <span class="author">Sihvonen LM</span>, <span class="author">Siitonen A</span>, <span class="author">Skurnik M</span>, <span class="author">Falc&atilde;o JP</span>, <span class="author">Fukushima H</span>, <span class="author">Scholz HC</span>, <span class="author">Prentice MB</span>, <span class="author">Wren BW</span>, <span class="author">Parkhill J</span>, <span class="author">Carniel E</span>, <span class="author">Achtman M</span>, <span class="author">McNally A</span> and <span class="author">Thomson NR</span></p>
<p class="affiliation">Pathogen Research Group, Nottingham Trent University, Nottingham NG11 8NS, United Kingdom.</p><p class="abstract">The genus Yersinia has been used as a model system to study pathogen evolution. Using whole-genome sequencing of all Yersinia species, we delineate the gene complement of the whole genus and define patterns of virulence evolution. Multiple distinct ecological specializations appear to have split pathogenic strains from environmental, nonpathogenic lineages. This split demonstrates that contrary to hypotheses that all pathogenic Yersinia species share a recent common pathogenic ancestor, they have evolved independently but followed parallel evolutionary paths in acquiring the same virulence determinants as well as becoming progressively more limited metabolically. Shared virulence determinants are limited to the virulence plasmid pYV and the attachment invasion locus ail. These acquisitions, together with genomic variations in metabolic pathways, have resulted in the parallel emergence of related pathogens displaying an increasingly specialized lifestyle with a spectrum of virulence potential, an emerging theme in the evolution of other important human pathogens.</p>
<p class="grants">Funded by: Biotechnology and Biological Sciences Research Council: <span class="grant">BB/I022902/1</span>; Wellcome Trust: <span class="grant">098051</span></p>
<p class="publication"><span class="title">Proceedings of the National Academy of Sciences of the United States of America</span>&nbsp;<span class="year">2014</span>;<span class="volume">111</span>;<span class="number">18</span>;<span class="pagerange">6768-73</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24753568">24753568</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4020045">4020045</a>; DOI: <a href="http://dx.doi.org/10.1073%2Fpnas.1317161111">10.1073/pnas.1317161111</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Novel Genetic Associations with Serum Level Metabolites Identified by Phenotype Set Enrichment Analyses.</h4>
<p class="authors"><span class="author">Ried JS</span>, <span class="author">Shin SY</span>, <span class="author">Krumsiek J</span>, <span class="author">Illig T</span>, <span class="author">Theis FJ</span>, <span class="author">Spector TD</span>, <span class="author">Adamski J</span>, <span class="author">Wichmann HE</span>, <span class="author">Strauch K</span>, <span class="author">Soranzo N</span>, <span class="author">Suhre K</span> and <span class="author">Gieger C</span></p>
<p class="affiliation">Institute of Genetic Epidemiology, Helmholtz Zentrum M&uuml;nchen - German Research Center for Environmental Health, 85764 Neuherberg, Germany <a href="mailto:%6A%61%6E%69%6E%61.%72%69%65%64%40%68%65%6C%6D%68%6F%6C%74%7A-%6D%75%65%6E%63%68%65%6E.%64%65">&#106;&#97;&#110;&#105;&#110;&#97;&#46;&#114;&#105;&#101;&#100;&#64;&#104;&#101;&#108;&#109;&#104;&#111;&#108;&#116;&#122;&#45;&#109;&#117;&#101;&#110;&#99;&#104;&#101;&#110;&#46;&#100;&#101;</a>.</p><p class="abstract">Availability of standardized metabolite panels and genome-wide single nucleotide polymorphism (SNP) data endorse the comprehensive analysis of gene-metabolite association. Currently, many studies use genome-wide association analysis to investigate the genetic effects on single metabolites (mGWAS) separately. Such studies have identified several loci that are associated not only with one but with multiple metabolites, facilitated by the fact that metabolite panels often include metabolites of the same or related pathways. Strategies that analyse several phenotypes in a combined way were shown to be able to detect additional genetic loci. One of those methods is the phenotype set enrichment analysis (PSEA) that tests sets of metabolites for enrichment at genes. Here we applied PSEA on two different panels of serum metabolites together with genome-wide data. All analyses were performed as a two-step identification-validation approach, using data from the population-based KORA cohort and the TwinsUK study. In addition to confirming genes that were already known from mGWAS, we were able to identify and validate twelve new genes. Knowledge about gene function was supported by the enriched metabolite sets. For loci with unknown gene functions, the results suggest a function that is interrelated with the metabolites, and hint at the underlying pathways.</p>
<p class="publication"><span class="title">Human molecular genetics</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24927737">24927737</a>; DOI: <a href="http://dx.doi.org/10.1093%2Fhmg%2Fddu301">10.1093/hmg/ddu301</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Structure- and context-based analysis of the GxGYxYP family reveals a new putative class of glycoside hydrolase.</h4>
<p class="authors"><span class="author">Rigden DJ</span>, <span class="author">Eberhardt RY</span>, <span class="author">Gilbert HJ</span>, <span class="author">Xu Q</span>, <span class="author">Chang Y</span> and <span class="author">Godzik A</span></p>
<p class="affiliation">Institute of Integrative Biology, University of Liverpool, Liverpool, UK. <a href="mailto:%64%72%69%67%64%65%6E%40%6C%69%76.%61%63.%75%6B">&#100;&#114;&#105;&#103;&#100;&#101;&#110;&#64;&#108;&#105;&#118;&#46;&#97;&#99;&#46;&#117;&#107;</a>.</p><p class="abstract"><strong>Background</strong>: Gut microbiome metagenomics has revealed many protein families and domains found largely or exclusively in that environment. Proteins containing the GxGYxYP domain are over-represented in the gut microbiota, and are found in Polysaccharide Utilization Loci in the gut symbiont Bacteroides thetaiotaomicron, suggesting their involvement in polysaccharide metabolism, but little else is known of the function of this domain.</p><p class="abstract"><strong>Results</strong>: Genomic context and domain architecture analyses support a role for the GxGYxYP domain in carbohydrate metabolism. Sparse occurrences in eukaryotes are the result of lateral gene transfer. The structure of the GxGYxYP domain-containing protein encoded by the BT2193 locus reveals two structural domains, the first composed of three divergent repeats with no recognisable homology to previously solved structures, the second a more familiar seven-stranded &beta;/&alpha; barrel. Structure-based analyses including conservation mapping localise a presumed functional site to a cleft between the two domains of BT2193. Matching to a catalytic site template from a GH9 cellulase and other analyses point to a putative catalytic triad composed of Glu272, Asp331 and Asp333.</p><p class="abstract"><strong>Conclusions</strong>: We suggest that GxGYxYP-containing proteins constitute a novel glycoside hydrolase family of as yet unknown specificity.</p>
<p class="grants">Funded by: Howard Hughes Medical Institute; NIGMS NIH HHS: <span class="grant">P41GM103393</span>, <span class="grant">U54 GM094586-03</span>; Wellcome Trust: <span class="grant">WT077044/Z/05/Z</span></p>
<p class="publication"><span class="title">BMC bioinformatics</span>&nbsp;<span class="year">2014</span>;<span class="volume">15</span>;<span class="pagerange">196</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24938123">24938123</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4071793">4071793</a>; DOI: <a href="http://dx.doi.org/10.1186%2F1471-2105-15-196">10.1186/1471-2105-15-196</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Urbanicity and lifestyle risk factors for cardiometabolic diseases in rural Uganda: a cross-sectional study.</h4>
<p class="authors"><span class="author">Riha J</span>, <span class="author">Karabarinde A</span>, <span class="author">Ssenyomo G</span>, <span class="author">Allender S</span>, <span class="author">Asiki G</span>, <span class="author">Kamali A</span>, <span class="author">Young EH</span>, <span class="author">Sandhu MS</span> and <span class="author">Seeley J</span></p>
<p class="affiliation">Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom; Wellcome Trust Sanger Institute, Hinxton, United Kingdom.</p><p class="abstract"><strong>Background</strong>: Urban living is associated with unhealthy lifestyles that can increase the risk of cardiometabolic diseases. In sub-Saharan Africa (SSA), where the majority of people live in rural areas, it is still unclear if there is a corresponding increase in unhealthy lifestyles as rural areas adopt urban characteristics. This study examines the distribution of urban characteristics across rural communities in Uganda and their associations with lifestyle risk factors for chronic diseases.</p><p class="abstract">Using data collected in 2011, we examined cross-sectional associations between urbanicity and lifestyle risk factors in rural communities in Uganda, with 7,340 participants aged 13 y and above across 25 villages. Urbanicity was defined according to a multi-component scale, and Poisson regression models were used to examine associations between urbanicity and lifestyle risk factors by quartile of urbanicity. Despite all of the villages not having paved roads and running water, there was marked variation in levels of urbanicity across the villages, largely attributable to differences in economic activity, civil infrastructure, and availability of educational and healthcare services. In regression models, after adjustment for clustering and potential confounders including socioeconomic status, increasing urbanicity was associated with an increase in lifestyle risk factors such as physical inactivity (risk ratio [RR]: 1.19; 95% CI: 1.14, 1.24), low fruit and vegetable consumption (RR: 1.17; 95% CI: 1.10, 1.23), and high body mass index (RR: 1.48; 95% CI: 1.24, 1.77).</p><p class="abstract"><strong>Conclusions</strong>: This study indicates that even across rural communities in SSA, increasing urbanicity is associated with a higher prevalence of lifestyle risk factors for cardiometabolic diseases. This finding highlights the need to consider the health impact of urbanization in rural areas across SSA. Please see later in the article for the Editors&#39; Summary.</p>
<p class="grants">Funded by: Medical Research Council: <span class="grant">G0801566</span>, <span class="grant">G0901213-92157</span>, <span class="grant">MR/K013491/1</span>; NHLBI NIH HHS: <span class="grant">1R01HL115485-01A1</span></p>
<p class="publication"><span class="title">PLoS medicine</span>&nbsp;<span class="year">2014</span>;<span class="volume">11</span>;<span class="number">7</span>;<span class="pagerange">e1001683</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25072243">25072243</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4114555">4114555</a>; DOI: <a href="http://dx.doi.org/10.1371%2Fjournal.pmed.1001683">10.1371/journal.pmed.1001683</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Computational approaches to interpreting genomic sequence variation.</h4>
<p class="authors"><span class="author">Ritchie GR</span> and <span class="author">Flicek P</span></p>
<p class="affiliation">European Molecular Biology Laboratory, European Bioinformatics Institute, Hinxton, Cambridge CB10 1SD UK ; Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA UK.</p><p class="abstract">Identifying sequence variants that play a mechanistic role in human disease and other phenotypes is a fundamental goal in human genetics and will be important in translating the results of variation studies. Experimental validation to confirm that a variant causes the biochemical changes responsible for a given disease or phenotype is considered the gold standard, but this cannot currently be applied to the 3 million or so variants expected in an individual genome. This has prompted the development of a wide variety of computational approaches that use several different sources of information to identify functional variation. Here, we review and assess the limitations of computational techniques for categorizing variants according to functional classes, prioritizing variants for experimental follow-up and generating hypotheses about the possible molecular mechanisms to inform downstream experiments. We discuss the main current bioinformatics approaches to identifying functional variation, including widely used algorithms for coding variation such as SIFT and PolyPhen and also novel techniques for interpreting variation across the genome.</p>
<p class="publication"><span class="title">Genome medicine</span>&nbsp;<span class="year">2014</span>;<span class="volume">6</span>;<span class="number">10</span>;<span class="pagerange">87</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25473426">25473426</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4254438">4254438</a>; DOI: <a href="http://dx.doi.org/10.1186%2Fs13073-014-0087-1">10.1186/s13073-014-0087-1</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Functional annotation of noncoding sequence variants.</h4>
<p class="authors"><span class="author">Ritchie GR</span>, <span class="author">Dunham I</span>, <span class="author">Zeggini E</span> and <span class="author">Flicek P</span></p>
<p class="affiliation">1] European Molecular Biology Laboratory, European Bioinformatics Institute, Hinxton, Cambridge, UK. [2] Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK.</p><p class="abstract">Identifying functionally relevant variants against the background of ubiquitous genetic variation is a major challenge in human genetics. For variants in protein-coding regions, our understanding of the genetic code and splicing allows us to identify likely candidates, but interpreting variants outside genic regions is more difficult. Here we present genome-wide annotation of variants (GWAVA), a tool that supports prioritization of noncoding variants by integrating various genomic and epigenomic annotations.</p>
<p class="grants">Funded by: Wellcome Trust: <span class="grant">095908</span>, <span class="grant">098051</span></p>
<p class="publication"><span class="title">Nature methods</span>&nbsp;<span class="year">2014</span>;<span class="volume">11</span>;<span class="number">3</span>;<span class="pagerange">294-6</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24487584">24487584</a>; DOI: <a href="http://dx.doi.org/10.1038%2Fnmeth.2832">10.1038/nmeth.2832</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Response to &#39;Predicting the diagnosis of autism spectrum disorder using gene pathway analysis&#39;.</h4>
<p class="authors"><span class="author">Robinson EB</span>, <span class="author">Howrigan D</span>, <span class="author">Yang J</span>, <span class="author">Ripke S</span>, <span class="author">Anttila V</span>, <span class="author">Duncan LE</span>, <span class="author">Jostins L</span>, <span class="author">Barrett JC</span>, <span class="author">Medland SE</span>, <span class="author">MacArthur DG</span>, <span class="author">Breen G</span>, <span class="author">O&#39;Donovan MC</span>, <span class="author">Wray NR</span>, <span class="author">Devlin B</span>, <span class="author">Daly MJ</span>, <span class="author">Visscher PM</span>, <span class="author">Sullivan PF</span> and <span class="author">Neale BM</span></p>
<p class="affiliation">1] Analytic and Translational Genetics Unit, Massachusetts General Hospital, Boston, MA, USA [2] Department of Medicine, Harvard Medical School, Boston, MA, USA [3] Medical and Population Genetics Program, Broad Institute for Harvard and MIT, Cambridge, MA, USA.</p>
<p class="grants">Funded by: NCRR NIH HHS: <span class="grant">UL1 RR025005</span>; NHGRI NIH HHS: <span class="grant">U01 HG004402</span>; NHLBI NIH HHS: <span class="grant">R01 HL059367</span>, <span class="grant">R01 HL086694</span>, <span class="grant">R01 HL087641</span></p>
<p class="publication"><span class="title">Molecular psychiatry</span>&nbsp;<span class="year">2014</span>;<span class="volume">19</span>;<span class="number">8</span>;<span class="pagerange">860-1</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24145379">24145379</a>; DOI: <a href="http://dx.doi.org/10.1038%2Fmp.2013.125">10.1038/mp.2013.125</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Improved exome prioritization of disease genes through cross-species phenotype comparison.</h4>
<p class="authors"><span class="author">Robinson PN</span>, <span class="author">K&ouml;hler S</span>, <span class="author">Oellrich A</span>, <span class="author">Sanger Mouse Genetics Project</span>, <span class="author">Wang K</span>, <span class="author">Mungall CJ</span>, <span class="author">Lewis SE</span>, <span class="author">Washington N</span>, <span class="author">Bauer S</span>, <span class="author">Seelow D</span>, <span class="author">Krawitz P</span>, <span class="author">Gilissen C</span>, <span class="author">Haendel M</span> and <span class="author">Smedley D</span></p>
<p class="affiliation">Institute for Medical and Human Genetics, Charit&eacute;-Universit&auml;tsmedizin Berlin, Augustenburger Platz 1, 13353 Berlin, Germany;</p><p class="abstract">Numerous new disease-gene associations have been identified by whole-exome sequencing studies in the last few years. However, many cases remain unsolved due to the sheer number of candidate variants remaining after common filtering strategies such as removing low quality and common variants and those deemed unlikely to be pathogenic. The observation that each of our genomes contains about 100 genuine loss-of-function variants makes identification of the causative mutation problematic when using these strategies alone. We propose using the wealth of genotype to phenotype data that already exists from model organism studies to assess the potential impact of these exome variants. Here, we introduce PHenotypic Interpretation of Variants in Exomes (PHIVE), an algorithm that integrates the calculation of phenotype similarity between human diseases and genetically modified mouse models with evaluation of the variants according to allele frequency, pathogenicity, and mode of inheritance approaches in our Exomiser tool. Large-scale validation of PHIVE analysis using 100,000 exomes containing known mutations demonstrated a substantial improvement (up to 54.1-fold) over purely variant-based (frequency and pathogenicity) methods with the correct gene recalled as the top hit in up to 83% of samples, corresponding to an area under the ROC curve of &gt;95%. We conclude that incorporation of phenotype data can play a vital role in translational bioinformatics and propose that exome sequencing projects should systematically capture clinical phenotypes to take advantage of the strategy presented here.</p>
<p class="grants">Funded by: NIH HHS: <span class="grant">1R24OD011883-01</span>, <span class="grant">R24 OD011883</span>; Wellcome Trust</p>
<p class="publication"><span class="title">Genome research</span>&nbsp;<span class="year">2014</span>;<span class="volume">24</span>;<span class="number">2</span>;<span class="pagerange">340-8</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24162188">24162188</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC3912424">3912424</a>; DOI: <a href="http://dx.doi.org/10.1101%2Fgr.160325.113">10.1101/gr.160325.113</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Cross-species analysis of mouse and human cancer genomes.</h4>
<p class="authors"><span class="author">Robles-Espinoza CD</span> and <span class="author">Adams DJ</span></p>
<p class="affiliation">Experimental Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire CB10 1HH, United Kingdom.</p><p class="abstract">Fundamental advances in our understanding of the human cancer genome have been made over the last five years, driven largely by the development of next-generation sequencing (NGS) technologies. Here we will discuss the tools and technologies that have been used to profile human tumors, how they may be applied to the analysis of the mouse cancer genome, and the results thus far. In addition to mutations that disrupt cancer genes, NGS is also being applied to the analysis of the transcriptome of cancers, and, through the use of techniques such as ChIP-Seq, the protein-DNA landscape is also being revealed. Gaining a comprehensive picture of the mouse cancer genome, at the DNA level and through the analysis of the transcriptome and regulatory landscape, will allow us to &quot;biofilter&quot; for driver genes in more complex human cancers and represents a critical test to determine which mouse cancer models are faithful genetic surrogates of the human disease.</p>
<p class="grants">Funded by: Cancer Research UK: <span class="grant">13031</span></p>
<p class="publication"><span class="title">Cold Spring Harbor protocols</span>&nbsp;<span class="year">2014</span>;<span class="volume">2014</span>;<span class="number">4</span>;<span class="pagerange">350-8</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24173316">24173316</a>; DOI: <a href="http://dx.doi.org/10.1101%2Fpdb.top078824">10.1101/pdb.top078824</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Telomere-regulating Genes and the Telomere Interactome in Familial Cancers.</h4>
<p class="authors"><span class="author">Robles-Espinoza CD</span>, <span class="author">Del Castillo Velasco-Herrera M</span>, <span class="author">Hayward NK</span> and <span class="author">Adams DJ</span></p>
<p class="affiliation">Experimental Cancer Genetics, Wellcome Trust Sanger Institute <a href="mailto:%63%64%72%65%40%73%61%6E%67%65%72.%61%63.%75%6B">&#99;&#100;&#114;&#101;&#64;&#115;&#97;&#110;&#103;&#101;&#114;&#46;&#97;&#99;&#46;&#117;&#107;</a>.</p><p class="abstract">Telomeres are repetitive sequence structures at the ends of linear chromosomes that consist of double-stranded DNA repeats followed by a short single-stranded DNA (ssDNA) protrusion. Telomeres need to be replicated each cell cycle and protected from DNA-processing enzymes, tasks that cells execute using specialized protein complexes such as telomerase (TERT), which aids in telomere maintenance and replication, and the shelterin complex, which protects chromosome ends. These complexes are also able to interact with a variety of other proteins, referred to as the telomere interactome, in order to fulfil their biological functions and control signaling cascades originating from telomeres. Given their essential role in genomic maintenance and cell cycle control, germline mutations in telomere-regulating proteins and their interacting partners have been found to underlie a variety of diseases and cancer-predisposition syndromes. These syndromes can be characterized by progressively shortening telomeres, in which carriers can present with organ failure due to stem cell senescence among other characteristics, or can also present with long or unprotected telomeres, providing an alternative route for cancer formation. This review, summarizes the critical roles that telomere-regulating proteins play in cell cycle control and cell fate and explores the current knowledge on different cancer-predisposing conditions that have been linked to germline defects in these proteins and their interacting partners.</p>
<p class="grants">Funded by: Cancer Research UK: <span class="grant">13031</span></p>
<p class="publication"><span class="title">Molecular cancer research : MCR</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25244922">25244922</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4278843">4278843</a>; DOI: <a href="http://dx.doi.org/10.1158%2F1541-7786.MCR-14-0305">10.1158/1541-7786.MCR-14-0305</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">POT1 loss-of-function variants predispose to familial melanoma.</h4>
<p class="authors"><span class="author">Robles-Espinoza CD</span>, <span class="author">Harland M</span>, <span class="author">Ramsay AJ</span>, <span class="author">Aoude LG</span>, <span class="author">Quesada V</span>, <span class="author">Ding Z</span>, <span class="author">Pooley KA</span>, <span class="author">Pritchard AL</span>, <span class="author">Tiffen JC</span>, <span class="author">Petljak M</span>, <span class="author">Palmer JM</span>, <span class="author">Symmons J</span>, <span class="author">Johansson P</span>, <span class="author">Stark MS</span>, <span class="author">Gartside MG</span>, <span class="author">Snowden H</span>, <span class="author">Montgomery GW</span>, <span class="author">Martin NG</span>, <span class="author">Liu JZ</span>, <span class="author">Choi J</span>, <span class="author">Makowski M</span>, <span class="author">Brown KM</span>, <span class="author">Dunning AM</span>, <span class="author">Keane TM</span>, <span class="author">L&oacute;pez-Ot&iacute;n C</span>, <span class="author">Gruis NA</span>, <span class="author">Hayward NK</span>, <span class="author">Bishop DT</span>, <span class="author">Newton-Bishop JA</span> and <span class="author">Adams DJ</span></p>
<p class="affiliation">1] Experimental Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, UK. [2].</p><p class="abstract">Deleterious germline variants in CDKN2A account for around 40% of familial melanoma cases, and rare variants in CDK4, BRCA2, BAP1 and the promoter of TERT have also been linked to the disease. Here we set out to identify new high-penetrance susceptibility genes by sequencing 184 melanoma cases from 105 pedigrees recruited in the UK, The Netherlands and Australia that were negative for variants in known predisposition genes. We identified families where melanoma cosegregates with loss-of-function variants in the protection of telomeres 1 gene (POT1), with a proportion of family members presenting with an early age of onset and multiple primary tumors. We show that these variants either affect POT1 mRNA splicing or alter key residues in the highly conserved oligonucleotide/oligosaccharide-binding (OB) domains of POT1, disrupting protein-telomere binding and leading to increased telomere length. These findings suggest that POT1 variants predispose to melanoma formation via a direct effect on telomeres.</p>
<p class="grants">Funded by: Cancer Research UK: <span class="grant">13031</span>, <span class="grant">A10123</span>, <span class="grant">C1287/A9540</span>, <span class="grant">C588/A10589</span>, <span class="grant">C588/A4994</span>, <span class="grant">C8197/A10123</span>; Wellcome Trust: <span class="grant">WT091310</span>, <span class="grant">WT098051</span></p>
<p class="publication"><span class="title">Nature genetics</span>&nbsp;<span class="year">2014</span>;<span class="volume">46</span>;<span class="number">5</span>;<span class="pagerange">478-81</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24686849">24686849</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4266105">4266105</a>; DOI: <a href="http://dx.doi.org/10.1038%2Fng.2947">10.1038/ng.2947</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Dihydroceramide Desaturase 1, the gatekeeper of ceramide induced Lipotoxicity.</h4>
<p class="authors"><span class="author">Rodriguez-Cuenca S</span>, <span class="author">Barbarroja N</span> and <span class="author">Vidal-Puig A</span></p>
<p class="affiliation">Metabolic Research Laboratories, Wellcome Trust MRC Institute of Metabolic Science, Addenbrooke&#39;s Hospital, University of Cambridge, Cambridge, UK. Electronic address: <a href="mailto:%61%6A%76%32%32%40%6D%65%64%73%63%68%6C.%63%61%6D.%61%63.%75%6B">&#97;&#106;&#118;&#50;&#50;&#64;&#109;&#101;&#100;&#115;&#99;&#104;&#108;&#46;&#99;&#97;&#109;&#46;&#97;&#99;&#46;&#117;&#107;</a>.</p><p class="abstract">The pathogenic relevance of sphingolipid metabolism is increasingly being recognised. Here we elaborate on a new player within the sphingolipid field: the degs1 enzyme, a recently discovered enzyme that catalyses the final step in the de novo biosynthesis of ceramides controlling the step from dihydroceramides to ceramides. Here, we describe its function, its dysregulation by factors such as oxidative stress, hypoxia and inflammation and provide evidence indicating that dihydroceramides constitute a biologically active molecule from the sphingolipid family with certain differential characteristics with respect to its delta-4 unsaturated counterparts the ceramides. Finally we present pathophysiological scenarios characterised by specific increases in dihydroceramide that challenge the concept that &quot;all ceramides species are the same&quot;. This article is part of a Special Issue entitled Linking transcription to physiology in lipodomics.</p>
<p class="publication"><span class="title">Biochimica et biophysica acta</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25283058">25283058</a>; DOI: <a href="http://dx.doi.org/10.1016%2Fj.bbalip.2014.09.021">10.1016/j.bbalip.2014.09.021</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Assessment of osteoarthritis candidate genes in a meta-analysis of nine genome-wide association studies.</h4>
<p class="authors"><span class="author">Rodriguez-Fontenla C</span>, <span class="author">Calaza M</span>, <span class="author">Evangelou E</span>, <span class="author">Valdes AM</span>, <span class="author">Arden N</span>, <span class="author">Blanco FJ</span>, <span class="author">Carr A</span>, <span class="author">Chapman K</span>, <span class="author">Deloukas P</span>, <span class="author">Doherty M</span>, <span class="author">Esko T</span>, <span class="author">Garc&eacute;s Alet&aacute; CM</span>, <span class="author">Gomez-Reino Carnota JJ</span>, <span class="author">Helgadottir H</span>, <span class="author">Hofman A</span>, <span class="author">Jonsdottir I</span>, <span class="author">Kerkhof HJ</span>, <span class="author">Kloppenburg M</span>, <span class="author">McCaskie A</span>, <span class="author">Ntzani EE</span>, <span class="author">Ollier WE</span>, <span class="author">Oreiro N</span>, <span class="author">Panoutsopoulou K</span>, <span class="author">Ralston SH</span>, <span class="author">Ramos YF</span>, <span class="author">Riancho JA</span>, <span class="author">Rivadeneira F</span>, <span class="author">Slagboom PE</span>, <span class="author">Styrkarsdottir U</span>, <span class="author">Thorsteinsdottir U</span>, <span class="author">Thorleifsson G</span>, <span class="author">Tsezou A</span>, <span class="author">Uitterlinden AG</span>, <span class="author">Wallis GA</span>, <span class="author">Wilkinson JM</span>, <span class="author">Zhai G</span>, <span class="author">Zhu Y</span>, <span class="author">arcOGEN Consortium</span>, <span class="author">Felson DT</span>, <span class="author">Ioannidis JP</span>, <span class="author">Loughlin J</span>, <span class="author">Metspalu A</span>, <span class="author">Meulenbelt I</span>, <span class="author">Stefansson K</span>, <span class="author">van Meurs JB</span>, <span class="author">Zeggini E</span>, <span class="author">Spector TD</span> and <span class="author">Gonzalez A</span></p>
<p class="affiliation">Hospital Clinico Universitario de Santiago, Santiago de Compostela, Spain.</p><p class="abstract"><strong>Objective</strong>: To assess candidate genes for association with osteoarthritis (OA) and identify promising genetic factors and, secondarily, to assess the candidate gene approach in OA.</p><p class="abstract"><strong>Methods</strong>: A total of 199 candidate genes for association with OA were identified using Human Genome Epidemiology (HuGE) Navigator. All of their single-nucleotide polymorphisms (SNPs) with an allele frequency of &gt;5% were assessed by fixed-effects meta-analysis of 9 genome-wide association studies (GWAS) that included 5,636 patients with knee OA and 16,972 control subjects and 4,349 patients with hip OA and 17,836 control subjects of European ancestry. An additional 5,921 individuals were genotyped for significantly associated SNPs in the meta-analysis. After correction for the number of independent tests, P values less than 1.58 &times; 10(-5) were considered significant.</p><p class="abstract"><strong>Results</strong>: SNPs at only 2 of the 199 candidate genes (COL11A1 and VEGF) were associated with OA in the meta-analysis. Two SNPs in COL11A1 showed association with hip OA in the combined analysis: rs4907986 (P = 1.29 &times; 10(-5) , odds ratio [OR] 1.12, 95% confidence interval [95% CI] 1.06-1.17) and rs1241164 (P = 1.47 &times; 10(-5) , OR 0.82, 95% CI 0.74-0.89). The sex-stratified analysis also showed association of COL11A1 SNP rs4908291 in women (P = 1.29 &times; 10(-5) , OR 0.87, 95% CI 0.82-0.92); this SNP showed linkage disequilibrium with rs4907986. A single SNP of VEGF, rs833058, showed association with hip OA in men (P = 1.35 &times; 10(-5) , OR 0.85, 95% CI 0.79-0.91). After additional samples were genotyped, association at one of the COL11A1 signals was reinforced, whereas association at VEGF was slightly weakened.</p><p class="abstract"><strong>Conclusion</strong>: Two candidate genes, COL11A1 and VEGF, were significantly associated with OA in this focused meta-analysis. The remaining candidate genes were not associated.</p>
<p class="publication"><span class="title">Arthritis &amp; rheumatology (Hoboken, N.J.)</span>&nbsp;<span class="year">2014</span>;<span class="volume">66</span>;<span class="number">4</span>;<span class="pagerange">940-9</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24757145">24757145</a>; DOI: <a href="http://dx.doi.org/10.1002%2Fart.38300">10.1002/art.38300</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Genomic confirmation of hybridisation and recent inbreeding in a vector-isolated Leishmania population.</h4>
<p class="authors"><span class="author">Rogers MB</span>, <span class="author">Downing T</span>, <span class="author">Smith BA</span>, <span class="author">Imamura H</span>, <span class="author">Sanders M</span>, <span class="author">Svobodova M</span>, <span class="author">Volf P</span>, <span class="author">Berriman M</span>, <span class="author">Cotton JA</span> and <span class="author">Smith DF</span></p>
<p class="affiliation">Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Cambridge, United Kingdom ; Centre for Immunology and Infection, Department of Biology, University of York, York, United Kingdom.</p><p class="abstract">Although asexual reproduction via clonal propagation has been proposed as the principal reproductive mechanism across parasitic protozoa of the Leishmania genus, sexual recombination has long been suspected, based on hybrid marker profiles detected in field isolates from different geographical locations. The recent experimental demonstration of a sexual cycle in Leishmania within sand flies has confirmed the occurrence of hybridisation, but knowledge of the parasite life cycle in the wild still remains limited. Here, we use whole genome sequencing to investigate the frequency of sexual reproduction in Leishmania, by sequencing the genomes of 11 Leishmania infantum isolates from sand flies and 1 patient isolate in a focus of cutaneous leishmaniasis in the &Ccedil;ukurova province of southeast Turkey. This is the first genome-wide examination of a vector-isolated population of Leishmania parasites. A genome-wide pattern of patchy heterozygosity and SNP density was observed both within individual strains and across the whole group. Comparisons with other Leishmania donovani complex genome sequences suggest that these isolates are derived from a single cross of two diverse strains with subsequent recombination within the population. This interpretation is supported by a statistical model of the genomic variability for each strain compared to the L. infantum reference genome strain as well as genome-wide scans for recombination within the population. Further analysis of these heterozygous blocks indicates that the two parents were phylogenetically distinct. Patterns of linkage disequilibrium indicate that this population reproduced primarily clonally following the original hybridisation event, but that some recombination also occurred. This observation allowed us to estimate the relative rates of sexual and asexual reproduction within this population, to our knowledge the first quantitative estimate of these events during the Leishmania life cycle.</p>
<p class="grants">Funded by: Wellcome Trust: <span class="grant">076355</span>, <span class="grant">085822</span>, <span class="grant">098051</span></p>
<p class="publication"><span class="title">PLoS genetics</span>&nbsp;<span class="year">2014</span>;<span class="volume">10</span>;<span class="number">1</span>;<span class="pagerange">e1004092</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24453988">24453988</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC3894156">3894156</a>; DOI: <a href="http://dx.doi.org/10.1371%2Fjournal.pgen.1004092">10.1371/journal.pgen.1004092</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Vitamin B&#x2081;&#x2082;-dependent taurine synthesis regulates growth and bone mass.</h4>
<p class="authors"><span class="author">Roman-Garcia P</span>, <span class="author">Quiros-Gonzalez I</span>, <span class="author">Mottram L</span>, <span class="author">Lieben L</span>, <span class="author">Sharan K</span>, <span class="author">Wangwiwatsin A</span>, <span class="author">Tubio J</span>, <span class="author">Lewis K</span>, <span class="author">Wilkinson D</span>, <span class="author">Santhanam B</span>, <span class="author">Sarper N</span>, <span class="author">Clare S</span>, <span class="author">Vassiliou GS</span>, <span class="author">Velagapudi VR</span>, <span class="author">Dougan G</span> and <span class="author">Yadav VK</span></p><p class="abstract">Both maternal and offspring-derived factors contribute to lifelong growth and bone mass accrual, although the specific role of maternal deficiencies in the growth and bone mass of offspring is poorly understood. In the present study, we have shown that vitamin B12 (B12) deficiency in a murine genetic model results in severe postweaning growth retardation and osteoporosis, and the severity and time of onset of this phenotype in the offspring depends on the maternal genotype. Using integrated physiological and metabolomic analysis, we determined that B12 deficiency in the offspring decreases liver taurine production and associates with abrogation of a growth hormone/insulin-like growth factor 1 (GH/IGF1) axis. Taurine increased GH-dependent IGF1 synthesis in the liver, which subsequently enhanced osteoblast function, and in B12-deficient offspring, oral administration of taurine rescued their growth retardation and osteoporosis phenotypes. These results identify B12 as an essential vitamin that positively regulates postweaning growth and bone formation through taurine synthesis and suggests potential therapies to increase bone mass.</p>
<p class="grants">Funded by: Wellcome Trust: <span class="grant">098051</span></p>
<p class="publication"><span class="title">The Journal of clinical investigation</span>&nbsp;<span class="year">2014</span>;<span class="volume">124</span>;<span class="number">7</span>;<span class="pagerange">2988-3002</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24911144">24911144</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4071367">4071367</a>; DOI: <a href="http://dx.doi.org/10.1172%2FJCI72606">10.1172/JCI72606</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">A comparison of key aspects of gene regulation in Streptomyces coelicolor and Escherichia coli using nucleotide-resolution transcription maps produced in parallel by global and differential RNA sequencing.</h4>
<p class="authors"><span class="author">Romero DA</span>, <span class="author">Hasan AH</span>, <span class="author">Lin YF</span>, <span class="author">Kime L</span>, <span class="author">Ruiz-Larrabeiti O</span>, <span class="author">Urem M</span>, <span class="author">Bucca G</span>, <span class="author">Mamanova L</span>, <span class="author">Laing EE</span>, <span class="author">van Wezel GP</span>, <span class="author">Smith CP</span>, <span class="author">Kaberdin VR</span> and <span class="author">McDowall KJ</span></p>
<p class="affiliation">Astbury Centre for Structural Molecular Biology, School of Molecular and Cellular Biology, Faculty of Biological Sciences, University of Leeds, Leeds, LS2 9JT, UK.</p><p class="abstract">Streptomyces coelicolor is a model for studying bacteria renowned as the foremost source of natural products used clinically. Post-genomic studies have revealed complex patterns of gene expression and links to growth, morphological development and individual genes. However, the underlying regulation remains largely obscure, but undoubtedly involves steps after transcription initiation. Here we identify sites involved in RNA processing and degradation as well as transcription within a nucleotide-resolution map of the transcriptional landscape. This was achieved by combining RNA-sequencing approaches suited to the analysis of GC-rich organisms. Escherichia coli was analysed in parallel to validate the methodology and allow comparison. Previously, sites of RNA processing and degradation had not been mapped on a transcriptome-wide scale for E. coli. Through examples, we show the value of our approach and data sets. This includes the identification of new layers of transcriptional complexity associated with several key regulators of secondary metabolism and morphological development in S. coelicolor and the identification of host-encoded leaderless mRNA and rRNA processing associated with the generation of specialized ribosomes in E. coli. New regulatory small RNAs were identified for both organisms. Overall the results illustrate the diversity in mechanisms used by different bacterial groups to facilitate and regulate gene expression.</p>
<p class="grants">Funded by: Biotechnology and Biological Sciences Research Council: <span class="grant">BB/I001751/1</span></p>
<p class="publication"><span class="title">Molecular microbiology</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25266672">25266672</a>; DOI: <a href="http://dx.doi.org/10.1111%2Fmmi.12810">10.1111/mmi.12810</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Allele-specific regulation of DISC1 expression by miR-135b-5p.</h4>
<p class="authors"><span class="author">Rossi M</span>, <span class="author">Kilpinen H</span>, <span class="author">Muona M</span>, <span class="author">Surakka I</span>, <span class="author">Ingle C</span>, <span class="author">Lahtinen J</span>, <span class="author">Hennah W</span>, <span class="author">Ripatti S</span> and <span class="author">Hovatta I</span></p>
<p class="affiliation">1] Institute for Molecular Medicine, Finland (FIMM), University of Helsinki, Helsinki, Finland [2] Public Health Genomics Unit, National Institute for Health and Welfare, Helsinki, Finland.</p><p class="abstract">Disrupted-in-schizophrenia-1 (DISC1) gene has been established as a risk factor for various neuropsychiatric phenotypes. Both coding and regulatory variants in DISC1 have been identified and associated with these phenotypes in genetic studies. MicroRNAs (miRNAs) are important regulators of protein coding genes. Since the miRNA-mRNA target recognition mechanism is vulnerable to disruption by DNA polymorphisms, we investigated whether polymorphisms in the DISC1 3&#39;UTR affect binding of miRNAs and lead to allele-specific regulation of DISC1. We identified four predicted polymorphic miRNA target sites in the DISC1 3&#39;UTR, and demonstrated that miR-135b-5p regulates the level of DISC1 mRNA. Moreover, DISC1 regulation by miR-135b-5p is allele specific: miR-135b-5p only binds to the major allele (A) of rs11122396, not to the minor allele (G). Thus, the G allele may be functionally related to the DISC1-associated phenotypes by abolishing regulation by miR-135b-5p, leading to elevated DISC1 levels.</p>
<p class="publication"><span class="title">European journal of human genetics : EJHG</span>&nbsp;<span class="year">2014</span>;<span class="volume">22</span>;<span class="number">6</span>;<span class="pagerange">840-3</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24169524">24169524</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4023220">4023220</a>; DOI: <a href="http://dx.doi.org/10.1038%2Fejhg.2013.246">10.1038/ejhg.2013.246</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Genetic background drives transcriptional variation in human induced pluripotent stem cells.</h4>
<p class="authors"><span class="author">Rouhani F</span>, <span class="author">Kumasaka N</span>, <span class="author">de Brito MC</span>, <span class="author">Bradley A</span>, <span class="author">Vallier L</span> and <span class="author">Gaffney D</span></p>
<p class="affiliation">Wellcome Trust Sanger Institute, Hinxton, Cambridge, United Kingdom.</p><p class="abstract">Human iPS cells have been generated using a diverse range of tissues from a variety of donors using different reprogramming vectors. However, these cell lines are heterogeneous, which presents a limitation for their use in disease modeling and personalized medicine. To explore the basis of this heterogeneity we generated 25 iPS cell lines under normalised conditions from the same set of somatic tissues across a number of donors. RNA-seq data sets from each cell line were compared to identify the majority contributors to transcriptional heterogeneity. We found that genetic differences between individual donors were the major cause of transcriptional variation between lines. In contrast, residual signatures from the somatic cell of origin, so called epigenetic memory, contributed relatively little to transcriptional variation. Thus, underlying genetic background variation is responsible for most heterogeneity between human iPS cell lines. We conclude that epigenetic effects in hIPSCs are minimal, and that hIPSCs are a stable, robust and powerful platform for large-scale studies of the function of genetic differences between individuals. Our data also suggest that future studies using hIPSCs as a model system should focus most effort on collection of large numbers of donors, rather than generating large numbers of lines from the same donor.</p>
<p class="grants">Funded by: Wellcome Trust: <span class="grant">098051</span></p>
<p class="publication"><span class="title">PLoS genetics</span>&nbsp;<span class="year">2014</span>;<span class="volume">10</span>;<span class="number">6</span>;<span class="pagerange">e1004432</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24901476">24901476</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4046971">4046971</a>; DOI: <a href="http://dx.doi.org/10.1371%2Fjournal.pgen.1004432">10.1371/journal.pgen.1004432</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Rapid conversion of EUCOMM/KOMP-CSD alleles in mouse embryos using a cell-permeable Cre recombinase.</h4>
<p class="authors"><span class="author">Ryder E</span>, <span class="author">Doe B</span>, <span class="author">Gleeson D</span>, <span class="author">Houghton R</span>, <span class="author">Dalvi P</span>, <span class="author">Grau E</span>, <span class="author">Habib B</span>, <span class="author">Miklejewska E</span>, <span class="author">Newman S</span>, <span class="author">Sethi D</span>, <span class="author">Sinclair C</span>, <span class="author">Vyas S</span>, <span class="author">Wardle-Jones H</span>, <span class="author">Sanger Mouse Genetics Project</span>, <span class="author">Bottomley J</span>, <span class="author">Bussell J</span>, <span class="author">Galli A</span>, <span class="author">Salisbury J</span> and <span class="author">Ramirez-Solis R</span></p>
<p class="affiliation">The Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, CB10 1SA, UK, <a href="mailto:%65%72%31%40%73%61%6E%67%65%72.%61%63.%75%6B">&#101;&#114;&#49;&#64;&#115;&#97;&#110;&#103;&#101;&#114;&#46;&#97;&#99;&#46;&#117;&#107;</a>.</p>
<p class="abstract">We describe here use of a cell-permeable Cre to efficiently convert the EUCOMM/KOMP-CSD tm1a allele to the tm1b form in preimplantation mouse embryos in a high-throughput manner, consistent with the requirements of the International Mouse Phenotyping Consortium-affiliated NIH KOMP2 project. This method results in rapid allele conversion and minimizes the use of experimental animals when compared to conventional Cre transgenic mouse breeding, resulting in a significant reduction in costs and time with increased welfare benefits.</p>
<p class="publication"><span class="title">Transgenic research</span>&nbsp;<span class="year">2014</span>;<span class="volume">23</span>;<span class="number">1</span>;<span class="pagerange">177-85</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24197666">24197666</a>; DOI: <a href="http://dx.doi.org/10.1007%2Fs11248-013-9764-x">10.1007/s11248-013-9764-x</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Deconstructing pheromone-mediated behavior one layer at a time.</h4>
<p class="authors"><span class="author">S&aacute;nchez-Andrade G</span> and <span class="author">Logan DW</span></p>
<p class="affiliation">Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, UK. <a href="mailto:%64%6C%35%40%73%61%6E%67%65%72.%61%63.%75%6B">&#100;&#108;&#53;&#64;&#115;&#97;&#110;&#103;&#101;&#114;&#46;&#97;&#99;&#46;&#117;&#107;</a>.</p><p class="abstract">The vomeronasal organ, a sensory structure within the nasal cavity of most tetrapods, detects pheromones that influence socio-sexual behavior. It has two neuronal layers, each patterned by distinct receptor sub-families coupled to different G-proteins. Work recently published in this journal found female mice with one layer genetically inactivated are deficient in a surprisingly wide range of reproductive behaviors, providing new insights into how the nose can influence the brain.See research article: http://www.biomedcentral.com/1741-7007/12/31.</p>
<p class="publication"><span class="title">BMC biology</span>&nbsp;<span class="year">2014</span>;<span class="volume">12</span>;<span class="number">1</span>;<span class="pagerange">33</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24884538">24884538</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4037717">4037717</a>; DOI: <a href="http://dx.doi.org/10.1186%2F1741-7007-12-33">10.1186/1741-7007-12-33</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Redundant Mechanisms to Form Silent Chromatin at Pericentromeric Regions Rely on BEND3 and DNA Methylation.</h4>
<p class="authors"><span class="author">Saksouk N</span>, <span class="author">Barth TK</span>, <span class="author">Ziegler-Birling C</span>, <span class="author">Olova N</span>, <span class="author">Nowak A</span>, <span class="author">Rey E</span>, <span class="author">Mateos-Langerak J</span>, <span class="author">Urbach S</span>, <span class="author">Reik W</span>, <span class="author">Torres-Padilla ME</span>, <span class="author">Imhof A</span> and <span class="author">D&eacute;jardin J</span></p>
<p class="affiliation">INSERM AVENIR, Institute of Human Genetics CNRS UPR1142, 141 rue de la Cardonille, 34000 Montpellier, France.</p><p class="abstract">Constitutive heterochromatin is typically defined by high levels of DNA methylation and H3 lysine 9 trimethylation (H3K9Me3), whereas facultative heterochromatin displays DNA hypomethylation and high H3 lysine 27 trimethylation (H3K27Me3). The two chromatin types generally do not coexist at the same loci, suggesting mutual exclusivity. During development or in cancer, pericentromeric regions can adopt either epigenetic state, but the switching mechanism is unknown. We used a quantitative locus purification method to characterize changes in pericentromeric chromatin-associated proteins in mouse embryonic stem cells deficient for either the&nbsp;methyltransferases required for DNA methylation&nbsp;or H3K9Me3. DNA methylation controls heterochromatin architecture and inhibits Polycomb recruitment. BEND3, a protein enriched on pericentromeric chromatin in the absence of DNA methylation or H3K9Me3, allows Polycomb recruitment and H3K27Me3, resulting in a redundant pathway to generate repressive chromatin. This suggests that BEND3 is a key factor in mediating a switch from constitutive to facultative heterochromatin.</p>
<p class="publication"><span class="title">Molecular cell</span>&nbsp;<span class="year">2014</span>;<span class="volume">56</span>;<span class="number">4</span>;<span class="pagerange">580-94</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25457167">25457167</a>; DOI: <a href="http://dx.doi.org/10.1016%2Fj.molcel.2014.10.001">10.1016/j.molcel.2014.10.001</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Sequence of a Complete Chicken BG Haplotype Shows Dynamic Expansion and Contraction of Two Gene Lineages with Particular Expression Patterns.</h4>
<p class="authors"><span class="author">Salomonsen J</span>, <span class="author">Chattaway JA</span>, <span class="author">Chan AC</span>, <span class="author">Parker A</span>, <span class="author">Huguet S</span>, <span class="author">Marston DA</span>, <span class="author">Rogers SL</span>, <span class="author">Wu Z</span>, <span class="author">Smith AL</span>, <span class="author">Staines K</span>, <span class="author">Butter C</span>, <span class="author">Riegert P</span>, <span class="author">Vainio O</span>, <span class="author">Nielsen L</span>, <span class="author">Kaspers B</span>, <span class="author">Griffin DK</span>, <span class="author">Yang F</span>, <span class="author">Zoorob R</span>, <span class="author">Guillemot F</span>, <span class="author">Auffray C</span>, <span class="author">Beck S</span>, <span class="author">Skj&oslash;dt K</span> and <span class="author">Kaufman J</span></p>
<p class="affiliation">Basel Institute for Immunology, Basel, Switzerland; Department of Veterinary Disease Biology, University of Copenhagen, Copenhagen, Denmark; Department of International Health, Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.</p><p class="abstract">Many genes important in immunity are found as multigene families. The butyrophilin genes are members of the B7 family, playing diverse roles in co-regulation and perhaps in antigen presentation. In humans, a fixed number of butyrophilin genes are found in and around the major histocompatibility complex (MHC), and show striking association with particular autoimmune diseases. In chickens, BG genes encode homologues with somewhat different domain organisation. Only a few BG genes have been characterised, one involved in actin-myosin interaction in the intestinal brush border, and another implicated in resistance to viral diseases. We characterise all BG genes in B12 chickens, finding a multigene family organised as tandem repeats in the BG region outside the MHC, a single gene in the MHC (the BF-BL region), and another single gene on a different chromosome. There is a precise cell and tissue expression for each gene, but overall there are two kinds, those expressed by haemopoietic cells and those expressed in tissues (presumably non-haemopoietic cells), correlating with two different kinds of promoters and 5&#39; untranslated regions (5&#39;UTR). However, the multigene family in the BG region contains many hybrid genes, suggesting recombination and/or deletion as major evolutionary forces. We identify BG genes in the chicken whole genome shotgun sequence, as well as by comparison to other haplotypes by fibre fluorescence in situ hybridisation, confirming dynamic expansion and contraction within the BG region. Thus, the BG genes in chickens are undergoing much more rapid evolution compared to their homologues in mammals, for reasons yet to be understood.</p>
<p class="publication"><span class="title">PLoS genetics</span>&nbsp;<span class="year">2014</span>;<span class="volume">10</span>;<span class="number">6</span>;<span class="pagerange">e1004417</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24901252">24901252</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4046983">4046983</a>; DOI: <a href="http://dx.doi.org/10.1371%2Fjournal.pgen.1004417">10.1371/journal.pgen.1004417</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Disruption of the potassium channel regulatory subunit Kcne2 causes iron-deficient anemia.</h4>
<p class="authors"><span class="author">Salsbury G</span>, <span class="author">Cambridge EL</span>, <span class="author">McIntyre Z</span>, <span class="author">Arends MJ</span>, <span class="author">Karp NA</span>, <span class="author">Isherwood C</span>, <span class="author">Shannon C</span>, <span class="author">Hooks Y</span>, <span class="author">The Sanger Mouse Genetics Project</span>, <span class="author">Ramirez-Solis R</span>, <span class="author">Adams DJ</span>, <span class="author">White JK</span> and <span class="author">Speak AO</span></p>
<p class="affiliation">Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire, CB10 1SA, UK.</p><p class="abstract">Iron homeostasis is a dynamic process that is tightly controlled to balance iron uptake, storage and export. Reduction of dietary iron from the ferric to the ferrous form is required for uptake by solute carrier family 11 (proton-coupled divalent metal ion transporters) member 2 (Slc11a2) into the enterocytes. Both processes are proton dependent, and have led to the suggestion of the importance of acidic gastric pH for the absorption of dietary iron. Kcne2, in combination with Kcnq1, form a gastric potassium channel essential for gastric acidification. Deficiency of either Kcne2 or Kcnq1 results in achlorhydia, gastric hyperplasia and neoplasia, but the impact on iron absorption has not been investigated. Here we report that Kcne2 deficient mice, in addition to the previously reported phenotypes, also present with iron-deficient anemia. Interestingly impaired function of KCNQ1 results in iron deficient anemia in Jervell and Lange-Nielsen syndrome patients. We speculate that impaired function of KCNE2 could result in the same clinical phenotype.</p>
<p class="publication"><span class="title">Experimental hematology</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25127743">25127743</a>; DOI: <a href="http://dx.doi.org/10.1016%2Fj.exphem.2014.07.269">10.1016/j.exphem.2014.07.269</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">The food-borne identity.</h4>
<p class="authors"><span class="author">Salter SJ</span></p>
<p class="affiliation">Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1SA, UK.</p>
<p class="publication"><span class="title">Nature reviews. Microbiology</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24975320">24975320</a>; DOI: <a href="http://dx.doi.org/10.1038%2Fnrmicro3313">10.1038/nrmicro3313</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Keeping an eye on P. aeruginosa.</h4>
<p class="authors"><span class="author">Salter SJ</span></p>
<p class="affiliation">Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1SA, UK.</p>
<p class="publication"><span class="title">Nature reviews. Microbiology</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25549963">25549963</a>; DOI: <a href="http://dx.doi.org/10.1038%2Fnrmicro3422">10.1038/nrmicro3422</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Reagent and laboratory contamination can critically impact sequence-based microbiome analyses.</h4>
<p class="authors"><span class="author">Salter SJ</span>, <span class="author">Cox MJ</span>, <span class="author">Turek EM</span>, <span class="author">Calus ST</span>, <span class="author">Cookson WO</span>, <span class="author">Moffatt MF</span>, <span class="author">Turner P</span>, <span class="author">Parkhill J</span>, <span class="author">Loman NJ</span> and <span class="author">Walker AW</span></p>
<p class="affiliation">Pathogen Genomics Group, Wellcome Trust Sanger Institute, Hinxton, UK. <a href="mailto:%73%62%31%38%40%73%61%6E%67%65%72.%61%63.%75%6B">&#115;&#98;&#49;&#56;&#64;&#115;&#97;&#110;&#103;&#101;&#114;&#46;&#97;&#99;&#46;&#117;&#107;</a>.</p><p class="abstract"><strong>Background</strong>: The study of microbial communities has been revolutionised in recent years by the widespread adoption of culture independent analytical techniques such as 16S rRNA gene sequencing and metagenomics. One potential confounder of these sequence-based approaches is the presence of contamination in DNA extraction kits and other laboratory reagents.</p><p class="abstract"><strong>Results</strong>: In this study we demonstrate that contaminating DNA is ubiquitous in commonly used DNA extraction kits and other laboratory reagents, varies greatly in composition between different kits and kit batches, and that this contamination critically impacts results obtained from samples containing a low microbial biomass. Contamination impacts both PCR-based 16S rRNA gene surveys and shotgun metagenomics. We provide an extensive list of potential contaminating genera, and guidelines on how to mitigate the effects of contamination.</p><p class="abstract"><strong>Conclusions</strong>: These results suggest that caution should be advised when applying sequence-based techniques to the study of microbiota present in low biomass environments. Concurrent sequencing of negative control samples is strongly advised.</p>
<p class="publication"><span class="title">BMC biology</span>&nbsp;<span class="year">2014</span>;<span class="volume">12</span>;<span class="number">1</span>;<span class="pagerange">87</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25387460">25387460</a>; DOI: <a href="http://dx.doi.org/10.1186%2Fs12915-014-0087-z">10.1186/s12915-014-0087-z</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">A framework for the interpretation of de novo mutation in human disease.</h4>
<p class="authors"><span class="author">Samocha KE</span>, <span class="author">Robinson EB</span>, <span class="author">Sanders SJ</span>, <span class="author">Stevens C</span>, <span class="author">Sabo A</span>, <span class="author">McGrath LM</span>, <span class="author">Kosmicki JA</span>, <span class="author">Rehnstr&ouml;m K</span>, <span class="author">Mallick S</span>, <span class="author">Kirby A</span>, <span class="author">Wall DP</span>, <span class="author">MacArthur DG</span>, <span class="author">Gabriel SB</span>, <span class="author">DePristo M</span>, <span class="author">Purcell SM</span>, <span class="author">Palotie A</span>, <span class="author">Boerwinkle E</span>, <span class="author">Buxbaum JD</span>, <span class="author">Cook EH</span>, <span class="author">Gibbs RA</span>, <span class="author">Schellenberg GD</span>, <span class="author">Sutcliffe JS</span>, <span class="author">Devlin B</span>, <span class="author">Roeder K</span>, <span class="author">Neale BM</span> and <span class="author">Daly MJ</span></p>
<p class="affiliation">1] Analytic and Translational Genetics Unit, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA. [2] Program in Medical and Population Genetics, Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA. [3] Stanley Center for Psychiatric Research, Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA. [4] Program in Genetics and Genomics, Biological and Biomedical Sciences, Harvard Medical School, Boston, Massachusetts, USA.</p><p class="abstract">Spontaneously arising (de novo) mutations have an important role in medical genetics. For diseases with extensive locus heterogeneity, such as autism spectrum disorders (ASDs), the signal from de novo mutations is distributed across many genes, making it difficult to distinguish disease-relevant mutations from background variation. Here we provide a statistical framework for the analysis of excesses in de novo mutation per gene and gene set by calibrating a model of de novo mutation. We applied this framework to de novo mutations collected from 1,078 ASD family trios, and, whereas we affirmed a significant role for loss-of-function mutations, we found no excess of de novo loss-of-function mutations in cases with IQ above 100, suggesting that the role of de novo mutations in ASDs might reside in fundamental neurodevelopmental processes. We also used our model to identify &sim;1,000 genes that are significantly lacking in functional coding variation in non-ASD samples and are enriched for de novo loss-of-function mutations identified in ASD cases.</p>
<p class="publication"><span class="title">Nature genetics</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25086666">25086666</a>; DOI: <a href="http://dx.doi.org/10.1038%2Fng.3050">10.1038/ng.3050</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Population and single cell genomics reveal the Aire-dependency, relief from Polycomb silencing and distribution of self-antigen expression in thymic epithelia.</h4>
<p class="authors"><span class="author">Sansom SN</span>, <span class="author">Shikama N</span>, <span class="author">Zhanybekova S</span>, <span class="author">Nusspaumer G</span>, <span class="author">Macaulay IC</span>, <span class="author">Deadman ME</span>, <span class="author">Heger A</span>, <span class="author">Ponting CP</span> and <span class="author">Holl&auml;nder GA</span></p>
<p class="affiliation">University of Oxford; <a href="mailto:%73%74%65%70%68%65%6E.%73%61%6E%73%6F%6D%40%6B%65%6E%6E%65%64%79.%6F%78.%61%63.%75%6B">&#115;&#116;&#101;&#112;&#104;&#101;&#110;&#46;&#115;&#97;&#110;&#115;&#111;&#109;&#64;&#107;&#101;&#110;&#110;&#101;&#100;&#121;&#46;&#111;&#120;&#46;&#97;&#99;&#46;&#117;&#107;</a>.</p><p class="abstract">Promiscuous gene expression (PGE) by thymic epithelial cells (TEC) is essential for generating a diverse T cell antigen receptor repertoire tolerant to self-antigens, and thus for avoiding autoimmunity. Nevertheless, the extent and nature of this unusual expression program within TEC populations and single cells are unknown. Using deep transcriptome sequencing of carefully identified mouse TEC subpopulations we discover a program of PGE that is common between medullary (m) and cortical TEC, further elaborated in mature mTEC, and completed in mature mTEC expressing the Autoimmune Regulator gene (Aire). TEC populations are capable of expressing up to 19,293 protein-coding genes, the highest number of genes known to be expressed in any cell type. Remarkably, in mouse mTEC, Aire alone positively regulates 3980 genes which are otherwise tissue-restricted in expression. Notably, the tissue specificities of these genes include known targets of autoimmunity in human AIRE deficiency. Led by an observation that Aire-induced genes are generally characterized by a repressive chromatin state in somatic tissues, we found these genes to be strongly associated with H3K27me3 marks in mTEC. Our findings are consistent with AIRE targeting and inducing the promiscuous expression of genes previously epigenetically silenced by Polycomb group proteins. Comparison of the transcriptomes of 174 single mTEC indicates that Aire-induced genes are expressed stochastically at low cell frequency. Furthermore, when expressed, Aire-dependent transcript levels were 16-fold higher, on average, in individual TEC than in the mTEC population.</p>
<p class="publication"><span class="title">Genome research</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25224068">25224068</a>; DOI: <a href="http://dx.doi.org/10.1101%2Fgr.171645.113">10.1101/gr.171645.113</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Sequence-dependent off-target inhibition of TLR7/8 sensing by synthetic microRNA inhibitors.</h4>
<p class="authors"><span class="author">Sarvestani ST</span>, <span class="author">Stunden HJ</span>, <span class="author">Behlke MA</span>, <span class="author">Forster SC</span>, <span class="author">McCoy CE</span>, <span class="author">Tate MD</span>, <span class="author">Ferrand J</span>, <span class="author">Lennox KA</span>, <span class="author">Latz E</span>, <span class="author">Williams BR</span> and <span class="author">Gantier MP</span></p>
<p class="affiliation">Centre for Cancer Research, MIMR-PHI Institute of Medical Research, Clayton, Victoria 3168, Australia Department of Molecular and Translational Science, Monash University, Clayton, Victoria 3168, Australia.</p><p class="abstract">Anti-microRNA (miRNA) oligonucleotides (AMOs) with 2&#39;-O-Methyl (2&#39;OMe) residues are commonly used to study miRNA function and can achieve high potency, with low cytotoxicity. Not withstanding this, we demonstrate the sequence-dependent capacity of 2&#39;OMe AMOs to inhibit Toll-like receptor (TLR) 7 and 8 sensing of immunostimulatory RNA, independent of their miRNA-targeting function. Through a screen of 29 AMOs targeting common miRNAs, we found a subset of sequences highly inhibitory to TLR7 sensing in mouse macrophages. Interspecies conservation of this inhibitory activity was confirmed on TLR7/8 activity in human peripheral blood mononuclear cells. Significantly, we identified a core motif governing the inhibitory activity of these AMOs, which is present in more than 50 AMOs targeted to human miRNAs in miRBaseV20. DNA/locked nucleic acids (LNA) AMOs synthesized with a phosphorothioate backbone also inhibited TLR7 sensing in a sequence-dependent manner, demonstrating that the off-target effects of AMOs are not restricted to 2&#39;OMe modification. Taken together, our work establishes the potential for off-target effects of AMOs on TLR7/8 function, which should be taken into account in their therapeutic development and in vivo application.</p>
<p class="publication"><span class="title">Nucleic acids research</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25539920">25539920</a>; DOI: <a href="http://dx.doi.org/10.1093%2Fnar%2Fgku1343">10.1093/nar/gku1343</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Impact of infectious diseases consultation on the management of Staphylococcus aureus bacteraemia in children.</h4>
<p class="authors"><span class="author">Saunderson RB</span>, <span class="author">Gouliouris T</span>, <span class="author">Cartwright EJ</span>, <span class="author">Nickerson EJ</span>, <span class="author">Aliyu SH</span>, <span class="author">O&#39;Donnell DR</span>, <span class="author">Kelsall W</span>, <span class="author">Limmathurotsakul D</span>, <span class="author">Peacock SJ</span> and <span class="author">T&ouml;r&ouml;k ME</span></p>
<p class="affiliation">Department of Medicine, University of Cambridge, Cambridge, UK.</p><p class="abstract"><strong>Objectives</strong>: Infectious diseases consultation (IDC) in adults with Staphylococcus aureus bacteraemia (SAB) has been shown to improve management and outcome. The aim of this study was to evaluate the impact of IDC on the management of SAB in children.</p><p class="abstract">Observational cohort study of children with SAB.</p><p class="abstract"><strong>Setting</strong>: Cambridge University Hospitals National Health Service (NHS) Foundation Trust, a large acute NHS Trust in the UK.</p><p class="abstract"><strong>Participants</strong>: All children with SAB admitted to the Cambridge University Hospitals NHS Foundation Trust between 16 July 2006 and 31 December 2012.</p><p class="abstract"><strong>Methods</strong>: Children with SAB between 2006 and 31 October 2009 were managed by routine clinical care (pre-IDC group) and data were collected retrospectively by case notes review. An IDC service for SAB was introduced in November 2009. All children with SAB were reviewed regularly and data were collected prospectively (IDC group) until 31 December 2012. Baseline characteristics, quality metrics and outcome were compared between the pre-IDC group and IDC group.</p><p class="abstract"><strong>Results</strong>: There were 66 episodes of SAB in 63 children-28 patients (30 episodes) in the pre-IDC group, and 35 patients (36 episodes) in the IDC group. The median age was 3.4&#x2005;years (IQR 0.2-10.7&#x2005;years). Patients in the IDC group were more likely to have echocardiography performed, a removable focus of infection identified and to receive a longer course of intravenous antimicrobial therapy. There were no differences in total duration of antibiotic therapy, duration of hospital admission or outcome at 30 or 90&#x2005;days following onset of SAB.</p><p class="abstract"><strong>Conclusions</strong>: IDC resulted in improvements in the investigation and management of SAB in children.</p>
<p class="publication"><span class="title">BMJ open</span>&nbsp;<span class="year">2014</span>;<span class="volume">4</span>;<span class="number">7</span>;<span class="pagerange">e004659</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24989617">24989617</a>; DOI: <a href="http://dx.doi.org/10.1136%2Fbmjopen-2013-004659">10.1136/bmjopen-2013-004659</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">The Yersinia pseudotuberculosis complex: characterization and delineation of a new species, Yersinia wautersii.</h4>
<p class="authors"><span class="author">Savin C</span>, <span class="author">Martin L</span>, <span class="author">Bouchier C</span>, <span class="author">Filali S</span>, <span class="author">Chenau J</span>, <span class="author">Zhou Z</span>, <span class="author">Becher F</span>, <span class="author">Fukushima H</span>, <span class="author">Thomson NR</span>, <span class="author">Scholz HC</span> and <span class="author">Carniel E</span></p>
<p class="affiliation">Yersinia Research Unit and National Reference Laboratory, Institut Pasteur, Paris, France. Electronic address: <a href="mailto:%63%79%72%69%6C.%73%61%76%69%6E%40%70%61%73%74%65%75%72.%66%72">&#99;&#121;&#114;&#105;&#108;&#46;&#115;&#97;&#118;&#105;&#110;&#64;&#112;&#97;&#115;&#116;&#101;&#117;&#114;&#46;&#102;&#114;</a>.</p><p class="abstract">The genus Yersinia contains three species pathogenic for humans, one of which is the enteropathogen Yersinia pseudotuberculosis. A recent analysis by Multi Locus Sequence Typing (MLST) of the &#39;Y. pseudotuberculosis complex&#39; revealed that this complex comprises three distinct populations: the Y. pestis/Y. pseudotuberculosis group, the recently described species Yersinia similis, and a third not yet characterized population designated &#39;Korean Group&#39;, because most strains were isolated in Korea. The aim of this study was to perform an in depth phenotypic and genetic characterization of the three populations composing the Y. pseudotuberculosis complex (excluding Y. pestis, which belonged to the Y. pseudotuberculosis cluster in the MLST analysis). Using a set of strains representative of each group, we found that the three populations had close metabolic properties, but were nonetheless distinguishable based on D-raffinose and D-melibiose fermentation, and on pyrazinamidase activity. Moreover, high-resolution electrospray mass spectrometry highlighted protein peaks characteristic of each population. Their 16S rRNA gene sequences shared high identity (&ge;99.5%), but specific nucleotide signatures for each group were identified. Multi-Locus Sequence Analysis also identified three genetically closely related but distinct populations. Finally, an Average Nucleotide Identity (ANI) analysis performed after sequencing the genomes of a subset of strains of each group also showed that intragroup identity (average for each group &ge;99%) was higher than intergroup diversity (94.6-97.4%). Therefore, all phenotypic and genotypic traits studied concurred with the initial MLST data indicating that the Y. pseudotuberculosis complex comprises a third and clearly distinct population of strains forming a novel Yersinia species that we propose to designate Yersinia wautersii sp. nov. The isolation of some strains from humans, the detection of virulence genes (on the pYV and pVM82 plasmids, or encoding the superantigen ypmA) in some isolates, and the absence of pyrazinamidase activity (a hallmark of pathogenicity in the genus Yersinia) argue for the pathogenic potential of Y. wautersii.</p>
<p class="grants">Funded by: Wellcome Trust: <span class="grant">098051</span></p>
<p class="publication"><span class="title">International journal of medical microbiology : IJMM</span>&nbsp;<span class="year">2014</span>;<span class="volume">304</span>;<span class="number">3-4</span>;<span class="pagerange">452-63</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24598372">24598372</a>; DOI: <a href="http://dx.doi.org/10.1016%2Fj.ijmm.2014.02.002">10.1016/j.ijmm.2014.02.002</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">A next-generation dual-recombinase system for time- and host-specific targeting of pancreatic cancer.</h4>
<p class="authors"><span class="author">Sch&ouml;nhuber N</span>, <span class="author">Seidler B</span>, <span class="author">Schuck K</span>, <span class="author">Veltkamp C</span>, <span class="author">Schachtler C</span>, <span class="author">Zukowska M</span>, <span class="author">Eser S</span>, <span class="author">Feyerabend TB</span>, <span class="author">Paul MC</span>, <span class="author">Eser P</span>, <span class="author">Klein S</span>, <span class="author">Lowy AM</span>, <span class="author">Banerjee R</span>, <span class="author">Yang F</span>, <span class="author">Lee CL</span>, <span class="author">Moding EJ</span>, <span class="author">Kirsch DG</span>, <span class="author">Scheideler A</span>, <span class="author">Alessi DR</span>, <span class="author">Varela I</span>, <span class="author">Bradley A</span>, <span class="author">Kind A</span>, <span class="author">Schnieke AE</span>, <span class="author">Rodewald HR</span>, <span class="author">Rad R</span>, <span class="author">Schmid RM</span>, <span class="author">Schneider G</span> and <span class="author">Saur D</span></p>
<p class="affiliation">Department of Internal Medicine II, Klinikum rechts der Isar, Technische Universit&auml;t M&uuml;nchen, M&uuml;nchen, Germany.</p><p class="abstract">Genetically engineered mouse models (GEMMs) have dramatically improved our understanding of tumor evolution and therapeutic resistance. However, sequential genetic manipulation of gene expression and targeting of the host is almost impossible using conventional Cre-loxP-based models. We have developed an inducible dual-recombinase system by combining flippase-FRT (Flp-FRT) and Cre-loxP recombination technologies to improve GEMMs of pancreatic cancer. This enables investigation of multistep carcinogenesis, genetic manipulation of tumor subpopulations (such as cancer stem cells), selective targeting of the tumor microenvironment and genetic validation of therapeutic targets in autochthonous tumors on a genome-wide scale. As a proof of concept, we performed tumor cell-autonomous and nonautonomous targeting, recapitulated hallmarks of human multistep carcinogenesis, validated genetic therapy by 3-phosphoinositide-dependent protein kinase inactivation as well as cancer cell depletion and show that mast cells in the tumor microenvironment, which had been thought to be key oncogenic players, are dispensable for tumor formation.</p>
<p class="publication"><span class="title">Nature medicine</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25326799">25326799</a>; DOI: <a href="http://dx.doi.org/10.1038%2Fnm.3646">10.1038/nm.3646</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Inferring human population size and separation history from multiple genome sequences.</h4>
<p class="authors"><span class="author">Schiffels S</span> and <span class="author">Durbin R</span></p>
<p class="affiliation">Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, UK.</p><p class="abstract">The availability of complete human genome sequences from populations across the world has given rise to new population genetic inference methods that explicitly model ancestral relationships under recombination and mutation. So far, application of these methods to evolutionary history more recent than 20,000-30,000 years ago and to population separations has been limited. Here we present a new method that overcomes these shortcomings. The multiple sequentially Markovian coalescent (MSMC) analyzes the observed pattern of mutations in multiple individuals, focusing on the first coalescence between any two individuals. Results from applying MSMC to genome sequences from nine populations across the world suggest that the genetic separation of non-African ancestors from African Yoruban ancestors started long before 50,000 years ago and give information about human population history as recent as 2,000 years ago, including the bottleneck in the peopling of the Americas and separations within Africa, East Asia and Europe.</p>
<p class="grants">Funded by: Wellcome Trust: <span class="grant">098051</span></p>
<p class="publication"><span class="title">Nature genetics</span>&nbsp;<span class="year">2014</span>;<span class="volume">46</span>;<span class="number">8</span>;<span class="pagerange">919-25</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24952747">24952747</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4116295">4116295</a>; DOI: <a href="http://dx.doi.org/10.1038%2Fng.3015">10.1038/ng.3015</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">TreeFam v9: a new website, more species and orthology-on-the-fly.</h4>
<p class="authors"><span class="author">Schreiber F</span>, <span class="author">Patricio M</span>, <span class="author">Muffato M</span>, <span class="author">Pignatelli M</span> and <span class="author">Bateman A</span></p>
<p class="affiliation">Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK and European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1SD, UK.</p>
<p class="abstract">TreeFam (http://www.treefam.org) is a database of phylogenetic trees inferred from animal genomes. For every TreeFam family we provide homology predictions together with the evolutionary history of the genes. Here we describe an update of the TreeFam database. The TreeFam project was resurrected in 2012 and has seen two releases since. The latest release (TreeFam 9) was made available in March 2013. It has orthology predictions and gene trees for 109 species in 15 736 families covering 2.2 million sequences. With release 9 we made modifications to our production pipeline and redesigned our website with improved gene tree visualizations and Wikipedia integration. Furthermore, we now provide an HMM-based sequence search that places a user-provided protein sequence into a TreeFam gene tree and provides quick orthology prediction. The tool uses Mafft and RAxML for the fast insertion into a reference alignment and tree, respectively. Besides the aforementioned technical improvements, we present a new approach to visualize gene trees and alternative displays that focuses on showing homology information from a species tree point of view. From release 9 onwards, TreeFam is now hosted at the EBI.</p>
<p class="publication"><span class="title">Nucleic acids research</span>&nbsp;<span class="year">2014</span>;<span class="volume">42</span>;<span class="number">1</span>;<span class="pagerange">D922-5</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24194607">24194607</a>; DOI: <a href="http://dx.doi.org/10.1093%2Fnar%2Fgkt1055">10.1093/nar/gkt1055</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Common genetic variants highlight the role of insulin resistance and body fat distribution in type 2 diabetes, independently of obesity.</h4>
<p class="authors"><span class="author">Scott RA</span>, <span class="author">Fall T</span>, <span class="author">Pasko D</span>, <span class="author">Barker A</span>, <span class="author">Sharp SJ</span>, <span class="author">Arriola L</span>, <span class="author">Balkau B</span>, <span class="author">Barricarte A</span>, <span class="author">Barroso I</span>, <span class="author">Boeing H</span>, <span class="author">Clavel-Chapelon F</span>, <span class="author">Crowe FL</span>, <span class="author">Dekker JM</span>, <span class="author">Fagherazzi G</span>, <span class="author">Ferraninini E</span>, <span class="author">Forouhi NG</span>, <span class="author">Franks PW</span>, <span class="author">Gavrila D</span>, <span class="author">Giedraitis V</span>, <span class="author">Grioni S</span>, <span class="author">Groop LC</span>, <span class="author">Kaaks R</span>, <span class="author">Key TJ</span>, <span class="author">K&uuml;hn T</span>, <span class="author">Lotta L</span>, <span class="author">Nilsson PM</span>, <span class="author">Overvad K</span>, <span class="author">Palli D</span>, <span class="author">Panico S</span>, <span class="author">Quir&oacute;s JR</span>, <span class="author">Rolandsson O</span>, <span class="author">Roswall N</span>, <span class="author">Sacerdote C</span>, <span class="author">Sala N</span>, <span class="author">S&aacute;nchez MJ</span>, <span class="author">Schulze MB</span>, <span class="author">Siddiq A</span>, <span class="author">Slimani N</span>, <span class="author">Sluijs I</span>, <span class="author">Spijkerman AM</span>, <span class="author">Tjonneland A</span>, <span class="author">Tumino R</span>, <span class="author">van der A DL</span>, <span class="author">Yaghootkar H</span>, <span class="author">The RISC study group</span>, <span class="author">The InterAct consortium</span>, <span class="author">McCarthy MI</span>, <span class="author">Semple RK</span>, <span class="author">Riboli E</span>, <span class="author">Walker M</span>, <span class="author">Ingelsson E</span>, <span class="author">Frayling TM</span>, <span class="author">Savage DB</span>, <span class="author">Langenberg C</span> and <span class="author">Wareham NJ</span></p>
<p class="affiliation">MRC Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom <a href="mailto:%72%6F%62%65%72%74.%73%63%6F%74%74%40%6D%72%63-%65%70%69%64.%63%61%6D.%61%63.%75%6B">&#114;&#111;&#98;&#101;&#114;&#116;&#46;&#115;&#99;&#111;&#116;&#116;&#64;&#109;&#114;&#99;&#45;&#101;&#112;&#105;&#100;&#46;&#99;&#97;&#109;&#46;&#97;&#99;&#46;&#117;&#107;</a>.</p><p class="abstract">We aimed to validate genetic variants as instruments for insulin resistance and secretion, to characterise their association with intermediate phenotypes, and to investigate their role in T2D risk among normal-weight, overweight and obese individuals.We investigated the association of genetic scores with euglycaemic-hyperinsulinaemic clamp- and OGTT-based measures of insulin resistance and secretion, and a range of metabolic measures in up to 18,565 individuals. We also studied their association with T2D risk among normal-weight, overweight and obese individuals in up to 8,124 incident T2D cases. The insulin resistance score was associated with lower insulin sensitivity measured by M/I value (&beta; in SDs-per-allele [95%CI]:-0.03[-0.04,-0.01];p=0.004). This score was associated with lower BMI (-0.01[-0.01,-0.0;p=0.02) and gluteofemoral fat-mass : -0.03[-0.05,-0.02;p=1.4x10(-6)), and with higher ALT (0.02[0.01,0.03];p=0.002) and gamma-GT (0.02[0.01,0.03];p=0.001). While the secretion score had a stronger association with T2D in leaner individuals (pinteraction=0.001), we saw no difference in the association of the insulin resistance score with T2D among BMI- or waist-strata(pinteraction&gt;0.31). While insulin resistance is often considered secondary to obesity, the association of the insulin resistance score with lower BMI and adiposity and with incident T2D even among individuals of normal weight highlights the role of insulin resistance and ectopic fat distribution in T2D, independently of body size.</p>
<p class="publication"><span class="title">Diabetes</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24947364">24947364</a>; DOI: <a href="http://dx.doi.org/10.2337%2Fdb14-0319">10.2337/db14-0319</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Genomic analysis of isolates from the UK 2012 pertussis outbreak reveals that vaccine antigen genes are unusually fast evolving.</h4>
<p class="authors"><span class="author">Sealey KL</span>, <span class="author">Harris SR</span>, <span class="author">Fry NK</span>, <span class="author">Hurst LD</span>, <span class="author">Gorringe AR</span>, <span class="author">Parkhill J</span> and <span class="author">Preston A</span></p>
<p class="affiliation">Department of Biology and Biochemistry, University of Bath, Bath, BA2 7AY, U.K Public Health England - Respiratory and Vaccine Preventable Bacteria Reference Unit, 61 Colindale Avenue, NW9 5EQ, London, U.K.</p><p class="abstract">A major outbreak of whooping cough, or pertussis, occurred in 2012 in the U.K, with nearly 10 000 laboratory-confirmed cases and 14 infant deaths attributed to pertussis. A worldwide resurgence of pertussis has been linked to switch to the use of acellular pertussis vaccines and the evolution of B. pertussis away from vaccine-mediated immunity. We have conducted genomic analyses of multiple strains from the UK outbreak. We show that the UK outbreak was polyclonal in nature, caused by multiple distinct but closely related strains. Importantly, we demonstrate that acellular vaccine antigen encoding genes are evolving at higher rates than other surface protein encoding genes. This was true even prior to the introduction of pertussis vaccines, but has become more pronounced since the introduction of the current acellular vaccines. The fast evolution of vaccine antigen genes has serious consequences for the ability of current vaccines to continue to control pertussis.</p>
<p class="publication"><span class="title">The Journal of infectious diseases</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25489002">25489002</a>; DOI: <a href="http://dx.doi.org/10.1093%2Finfdis%2Fjiu665">10.1093/infdis/jiu665</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Re-sequencing Expands Our Understanding of the Phenotypic Impact of Variants at GWAS Loci.</h4>
<p class="authors"><span class="author">Service SK</span>, <span class="author">Teslovich TM</span>, <span class="author">Fuchsberger C</span>, <span class="author">Ramensky V</span>, <span class="author">Yajnik P</span>, <span class="author">Koboldt DC</span>, <span class="author">Larson DE</span>, <span class="author">Zhang Q</span>, <span class="author">Lin L</span>, <span class="author">Welch R</span>, <span class="author">Ding L</span>, <span class="author">McLellan MD</span>, <span class="author">O&#39;Laughlin M</span>, <span class="author">Fronick C</span>, <span class="author">Fulton LL</span>, <span class="author">Magrini V</span>, <span class="author">Swift A</span>, <span class="author">Elliott P</span>, <span class="author">Jarvelin MR</span>, <span class="author">Kaakinen M</span>, <span class="author">McCarthy MI</span>, <span class="author">Peltonen L</span>, <span class="author">Pouta A</span>, <span class="author">Bonnycastle LL</span>, <span class="author">Collins FS</span>, <span class="author">Narisu N</span>, <span class="author">Stringham HM</span>, <span class="author">Tuomilehto J</span>, <span class="author">Ripatti S</span>, <span class="author">Fulton RS</span>, <span class="author">Sabatti C</span>, <span class="author">Wilson RK</span>, <span class="author">Boehnke M</span> and <span class="author">Freimer NB</span></p>
<p class="affiliation">Center for Neurobehavioral Genetics, Semel Institute for Neuroscience and Human Behavior, University of California Los Angeles, Los Angeles, California, United States of America.</p>
<p class="abstract">Genome-wide association studies (GWAS) have identified >500 common variants associated with quantitative metabolic traits, but in aggregate such variants explain at most 20-30% of the heritable component of population variation in these traits. To further investigate the impact of genotypic variation on metabolic traits, we conducted re-sequencing studies in >6,000 members of a Finnish population cohort (The Northern Finland Birth Cohort of 1966 [NFBC]) and a type 2 diabetes case-control sample (The Finland-United States Investigation of NIDDM Genetics [FUSION] study). By sequencing the coding sequence and 5' and 3' untranslated regions of 78 genes at 17 GWAS loci associated with one or more of six metabolic traits (serum levels of fasting HDL-C, LDL-C, total cholesterol, triglycerides, plasma glucose, and insulin), and conducting both single-variant and gene-level association tests, we obtained a more complete understanding of phenotype-genotype associations at eight of these loci. At all eight of these loci, the identification of new associations provides significant evidence for multiple genetic signals to one or more phenotypes, and at two loci, in the genes ABCA1 and CETP, we found significant gene-level evidence of association to non-synonymous variants with MAF<1%. Additionally, two potentially deleterious variants that demonstrated significant associations (rs138726309, a missense variant in G6PC2, and rs28933094, a missense variant in LIPC) were considerably more common in these Finnish samples than in European reference populations, supporting our prior hypothesis that deleterious variants could attain high frequencies in this isolated population, likely due to the effects of population bottlenecks. Our results highlight the value of large, well-phenotyped samples for rare-variant association analysis, and the challenge of evaluating the phenotypic impact of such variants.</p>
<p class="publication"><span class="title">PLoS genetics</span>&nbsp;<span class="year">2014</span>;<span class="volume">10</span>;<span class="number">1</span>;<span class="pagerange">e1004147</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24497850">24497850</a>; DOI: <a href="http://dx.doi.org/10.1371%2Fjournal.pgen.1004147">10.1371/journal.pgen.1004147</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Genomic Epidemiology of Vibrio cholerae O1 Associated with Floods, Pakistan, 2010.</h4>
<p class="authors"><span class="author">Shah MA</span>, <span class="author">Mutreja A</span>, <span class="author">Thomson N</span>, <span class="author">Baker S</span>, <span class="author">Parkhill J</span>, <span class="author">Dougan G</span>, <span class="author">Bokhari H</span> and <span class="author">Wren BW</span></p>
<p class="abstract">In August 2010, Pakistan experienced major floods and a subsequent cholera epidemic. To clarify the population dynamics and transmission of Vibrio cholerae in Pakistan, we sequenced the genomes of all V. cholerae O1 El Tor isolates and compared the sequences to a global collection of 146 V. cholerae strains. Within the global phylogeny, all isolates from Pakistan formed 2 new subclades (PSC-1 and PSC-2), lying in the third transmission wave of the seventh-pandemic lineage that could be distinguished by signature deletions and their antimicrobial susceptibilities. Geographically, PSC-1 isolates originated from the coast, whereas PSC-2 isolates originated from inland areas flooded by the Indus River. Single-nucleotide polymorphism accumulation analysis correlated river flow direction with the spread of PSC-2. We found at least 2 sources of cholera in Pakistan during the 2010 epidemic and illustrate the value of a global genomic data bank in contextualizing cholera outbreaks.</p>
<p class="publication"><span class="title">Emerging infectious diseases</span>&nbsp;<span class="year">2014</span>;<span class="volume">20</span>;<span class="number">1</span>;<span class="pagerange">13-20</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24378019">24378019</a>; DOI: <a href="http://dx.doi.org/10.3201%2F.eid2001.130428">10.3201/.eid2001.130428</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Genetic determinants of glucose-6-phosphate dehydrogenase activity in Kenya.</h4>
<p class="authors"><span class="author">Shah SS</span>, <span class="author">Macharia A</span>, <span class="author">Makale J</span>, <span class="author">Uyoga S</span>, <span class="author">Kivinen K</span>, <span class="author">Craik R</span>, <span class="author">Hubbart C</span>, <span class="author">Wellems TE</span>, <span class="author">Rockett KA</span>, <span class="author">Kwiatkowski DP</span> and <span class="author">Williams TN</span></p><p class="abstract">BackgroundThe relationship between glucose-6-phosphate dehydrogenase (G6PD) deficiency and clinical phenomena such as primaquine-sensitivity and protection from severe malaria remains poorly defined, with past association studies yielding inconsistent and conflicting results. One possibility is that examination of a single genetic variant might underestimate the presence of true effects in the presence of unrecognized functional allelic diversity.MethodsWe systematically examined this possibility in Kenya, conducting a fine-mapping association study of erythrocyte G6PD activity in 1828 Kenyan children across 30 polymorphisms at or around the G6PD locus.ResultsWe demonstrate a strong functional role for c.202G&gt;A (rs1050828), which accounts for the majority of variance in enzyme activity observed (P=1.5&times;10&iquest;200, additive model). Additionally, we identify other common variants that exert smaller, intercorrelated effects independent of c.202G&gt;A, and haplotype analyses suggest that each variant tags one of two haplotype motifs that are opposite in sequence identity and effect direction. We posit that these effects are of biological and possible clinical significance, specifically noting that c.376A&gt;G (rs1050829) augments 202AG heterozygote risk for deficiency trait by two-fold (OR = 2.11 [1.12 - 3.84], P=0.014).ConclusionsOur results suggest that c.202G&gt;A is responsible for the majority of the observed prevalence of G6PD deficiency trait in Kenya, but also identify a novel role for c.376A&gt;G as a genetic modifier which marks a common haplotype that augments the risk conferred to 202AG heterozygotes, suggesting that variation at both loci merits consideration in genetic association studies probing G6PD deficiency-associated clinical phenotypes.</p>
<p class="publication"><span class="title">BMC medical genetics</span>&nbsp;<span class="year">2014</span>;<span class="volume">15</span>;<span class="number">1</span>;<span class="pagerange">93</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25201310">25201310</a>; DOI: <a href="http://dx.doi.org/10.1186%2Fs12881-014-0093-6">10.1186/s12881-014-0093-6</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">TrypanoCyc: a community-led biochemical pathways database for Trypanosoma brucei.</h4>
<p class="authors"><span class="author">Shameer S</span>, <span class="author">Logan-Klumpler FJ</span>, <span class="author">Vinson F</span>, <span class="author">Cottret L</span>, <span class="author">Merlet B</span>, <span class="author">Achcar F</span>, <span class="author">Boshart M</span>, <span class="author">Berriman M</span>, <span class="author">Breitling R</span>, <span class="author">Bringaud F</span>, <span class="author">B&uuml;tikofer P</span>, <span class="author">Cattanach AM</span>, <span class="author">Bannerman-Chukualim B</span>, <span class="author">Creek DJ</span>, <span class="author">Crouch K</span>, <span class="author">de Koning HP</span>, <span class="author">Denise H</span>, <span class="author">Ebikeme C</span>, <span class="author">Fairlamb AH</span>, <span class="author">Ferguson MA</span>, <span class="author">Ginger ML</span>, <span class="author">Hertz-Fowler C</span>, <span class="author">Kerkhoven EJ</span>, <span class="author">M&auml;ser P</span>, <span class="author">Michels PA</span>, <span class="author">Nayak A</span>, <span class="author">Nes DW</span>, <span class="author">Nolan DP</span>, <span class="author">Olsen C</span>, <span class="author">Silva-Franco F</span>, <span class="author">Smith TK</span>, <span class="author">Taylor MC</span>, <span class="author">Tielens AG</span>, <span class="author">Urbaniak MD</span>, <span class="author">van Hellemond JJ</span>, <span class="author">Vincent IM</span>, <span class="author">Wilkinson SR</span>, <span class="author">Wyllie S</span>, <span class="author">Opperdoes FR</span>, <span class="author">Barrett MP</span> and <span class="author">Jourdan F</span></p>
<p class="affiliation">Institut National de la Recherche Agronomique (INRA), UMR1331, TOXALIM (Research Centre in Food Toxicology), Universit&eacute; de Toulouse, Toulouse, France.</p><p class="abstract">The metabolic network of a cell represents the catabolic and anabolic reactions that interconvert small molecules (metabolites) through the activity of enzymes, transporters and non-catalyzed chemical reactions. Our understanding of individual metabolic networks is increasing as we learn more about the enzymes that are active in particular cells under particular conditions and as technologies advance to allow detailed measurements of the cellular metabolome. Metabolic network databases are of increasing importance in allowing us to contextualise data sets emerging from transcriptomic, proteomic and metabolomic experiments. Here we present a dynamic database, TrypanoCyc (http://www.metexplore.fr/trypanocyc/), which describes the generic and condition-specific metabolic network of Trypanosoma brucei, a parasitic protozoan responsible for human and animal African trypanosomiasis. In addition to enabling navigation through the BioCyc-based TrypanoCyc interface, we have also implemented a network-based representation of the information through MetExplore, yielding a novel environment in which to visualise the metabolism of this important parasite.</p>
<p class="publication"><span class="title">Nucleic acids research</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25300491">25300491</a>; DOI: <a href="http://dx.doi.org/10.1093%2Fnar%2Fgku944">10.1093/nar/gku944</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Hypothalamic control of bone metabolism.</h4>
<p class="authors"><span class="author">Sharan K</span> and <span class="author">Yadav VK</span></p>
<p class="affiliation">Systems Biology of Bone Laboratory, Department of Mouse and Zebrafish Genetics, The Wellcome Trust Sanger Institute, Cambridge CB10 1SA, United Kingdom.</p><p class="abstract">Bones are structures in vertebrates that provide support to organs, protect soft organs, and give them shape and defined features, functions that are essential for their survival. To perform these functions, bones are constantly renewed throughout life. The process through which bones are renewed is known as bone remodeling, an energy demanding process sensitive to changes in energy homeostasis of the organism. A close interplay takes place between the diversity of nutritional cues and metabolic signals with different elements of the hypothalamic circuits to co-ordinate energy metabolism with the regulation of bone mass. In this review, we focus on how mouse and human genetics have elucidated the roles of hormonal signals and neural circuits that originate in, or impinge on, the hypothalamus in the regulation of bone mass. This will help to understand the mechanisms whereby regulation of bone is gated and dynamically regulated by the hypothalamus.</p>
<p class="grants">Funded by: Wellcome Trust: <span class="grant">098051</span></p>
<p class="publication"><span class="title">Best practice &amp; research. Clinical endocrinology &amp; metabolism</span>&nbsp;<span class="year">2014</span>;<span class="volume">28</span>;<span class="number">5</span>;<span class="pagerange">713-23</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25256766">25256766</a>; DOI: <a href="http://dx.doi.org/10.1016%2Fj.beem.2014.04.003">10.1016/j.beem.2014.04.003</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Efficient genome modification by CRISPR-Cas9 nickase with minimal off-target effects.</h4>
<p class="authors"><span class="author">Shen B</span>, <span class="author">Zhang W</span>, <span class="author">Zhang J</span>, <span class="author">Zhou J</span>, <span class="author">Wang J</span>, <span class="author">Chen L</span>, <span class="author">Wang L</span>, <span class="author">Hodgkins A</span>, <span class="author">Iyer V</span>, <span class="author">Huang X</span> and <span class="author">Skarnes WC</span></p>
<p class="affiliation">1] Ministry of Education Key Laboratory of Model Animal for Disease Study, Model Animal Research Center of Nanjing University, Nanjing, China. [2].</p><p class="abstract">Bacterial RNA-directed Cas9 endonuclease is a versatile tool for site-specific genome modification in eukaryotes. Co-microinjection of mouse embryos with Cas9 mRNA and single guide RNAs induces on-target and off-target mutations that are transmissible to offspring. However, Cas9 nickase can be used to efficiently mutate genes without detectable damage at known off-target sites. This method is applicable for genome editing of any model organism and minimizes confounding problems of off-target mutations.</p>
<p class="grants">Funded by: Wellcome Trust</p>
<p class="publication"><span class="title">Nature methods</span>&nbsp;<span class="year">2014</span>;<span class="volume">11</span>;<span class="number">4</span>;<span class="pagerange">399-402</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24584192">24584192</a>; DOI: <a href="http://dx.doi.org/10.1038%2Fnmeth.2857">10.1038/nmeth.2857</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Cryptic ecology among host generalist Campylobacter jejuni in domestic animals.</h4>
<p class="authors"><span class="author">Sheppard SK</span>, <span class="author">Cheng L</span>, <span class="author">M&eacute;ric G</span>, <span class="author">de Haan CP</span>, <span class="author">Llarena AK</span>, <span class="author">Marttinen P</span>, <span class="author">Vidal A</span>, <span class="author">Ridley A</span>, <span class="author">Clifton-Hadley F</span>, <span class="author">Connor TR</span>, <span class="author">Strachan NJ</span>, <span class="author">Forbes K</span>, <span class="author">Colles FM</span>, <span class="author">Jolley KA</span>, <span class="author">Bentley SD</span>, <span class="author">Maiden MC</span>, <span class="author">H&auml;nninen ML</span>, <span class="author">Parkhill J</span>, <span class="author">Hanage WP</span> and <span class="author">Corander J</span></p>
<p class="affiliation">Department of Zoology, University of Oxford, The Tinbergen Building, South Parks Road, Oxford, OX1 3PS, UK; Institute of Life Science, College of Medicine, Swansea University, Swansea, SA2 8PP, UK.</p><p class="abstract">Homologous recombination between bacterial strains is theoretically capable of preventing the separation of daughter clusters, and producing cohesive clouds of genotypes in sequence space. However, numerous barriers to recombination are known. Barriers may be essential such as adaptive incompatibility, or ecological, which is associated with the opportunities for recombination in the natural habitat. Campylobacter jejuni is a gut colonizer of numerous animal species and a major human enteric pathogen. We demonstrate that the two major generalist lineages of C. jejuni do not show evidence of recombination with each other in nature, despite having a high degree of host niche overlap and recombining extensively with specialist lineages. However, transformation experiments show that the generalist lineages readily recombine with one another in vitro. This suggests ecological rather than essential barriers to recombination, caused by a cryptic niche structure within the hosts.</p>
<p class="grants">Funded by: Biotechnology and Biological Sciences Research Council; Wellcome Trust</p>
<p class="publication"><span class="title">Molecular ecology</span>&nbsp;<span class="year">2014</span>;<span class="volume">23</span>;<span class="number">10</span>;<span class="pagerange">2442-51</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24689900">24689900</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4237157">4237157</a>; DOI: <a href="http://dx.doi.org/10.1111%2Fmec.12742">10.1111/mec.12742</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Structural genomics analysis of uncharacterized protein families overrepresented in human gut bacteria identifies a novel glycoside hydrolase.</h4>
<p class="authors"><span class="author">Sheydina A</span>, <span class="author">Eberhardt RY</span>, <span class="author">Rigden DJ</span>, <span class="author">Chang Y</span>, <span class="author">Li Z</span>, <span class="author">Zmasek CC</span>, <span class="author">Axelrod HL</span> and <span class="author">Godzik A</span></p>
<p class="affiliation">Joint Center for Structural Genomics, 10550 North Torrey Pines Road, BCC-206, La Jolla, California 92037, USA. <a href="mailto:%61%64%61%6D%40%73%61%6E%66%6F%72%64%62%75%72%6E%68%61%6D.%6F%72%67">&#97;&#100;&#97;&#109;&#64;&#115;&#97;&#110;&#102;&#111;&#114;&#100;&#98;&#117;&#114;&#110;&#104;&#97;&#109;&#46;&#111;&#114;&#103;</a>.</p><p class="abstract"><strong>Background</strong>: Bacteroides spp. form a significant part of our gut microbiome and are well known for optimized metabolism of diverse polysaccharides. Initial analysis of the archetypal Bacteroides thetaiotaomicron genome identified 172 glycosyl hydrolases and a large number of uncharacterized proteins associated with polysaccharide metabolism.</p><p class="abstract"><strong>Results</strong>: BT_1012 from Bacteroides thetaiotaomicron VPI-5482 is a protein of unknown function and a member of a large protein family consisting entirely of uncharacterized proteins. Initial sequence analysis predicted that this protein has two domains, one on the N- and one on the C-terminal. A PSI-BLAST search found over 150 full length and over 90 half size homologs consisting only of the N-terminal domain. The experimentally determined three-dimensional structure of the BT_1012 protein confirms its two-domain architecture and structural analysis of both domains suggests their specific functions. The N-terminal domain is a putative catalytic domain with significant similarity to known glycoside hydrolases, the C-terminal domain has a beta-sandwich fold typically found in C-terminal domains of other glycosyl hydrolases, however these domains are typically involved in substrate binding. We describe the structure of the BT_1012 protein and discuss its sequence-structure relationship and their possible functional implications.</p><p class="abstract"><strong>Conclusions</strong>: Structural and sequence analyses of the BT_1012 protein identifies it as a glycosyl hydrolase, expanding an already impressive catalog of enzymes involved in polysaccharide metabolism in Bacteroides spp. Based on this we have renamed the Pfam families representing the two domains found in the BT_1012 protein, PF13204 and PF12904, as putative glycoside hydrolase and glycoside hydrolase-associated C-terminal domain respectively.</p>
<p class="grants">Funded by: NIGMS NIH HHS: <span class="grant">U54 GM094586</span></p>
<p class="publication"><span class="title">BMC bioinformatics</span>&nbsp;<span class="year">2014</span>;<span class="volume">15</span>;<span class="number">1</span>;<span class="pagerange">112</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24742328">24742328</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4032388">4032388</a>; DOI: <a href="http://dx.doi.org/10.1186%2F1471-2105-15-112">10.1186/1471-2105-15-112</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">An atlas of genetic influences on human blood metabolites.</h4>
<p class="authors"><span class="author">Shin SY</span>, <span class="author">Fauman EB</span>, <span class="author">Petersen AK</span>, <span class="author">Krumsiek J</span>, <span class="author">Santos R</span>, <span class="author">Huang J</span>, <span class="author">Arnold M</span>, <span class="author">Erte I</span>, <span class="author">Forgetta V</span>, <span class="author">Yang TP</span>, <span class="author">Walter K</span>, <span class="author">Menni C</span>, <span class="author">Chen L</span>, <span class="author">Vasquez L</span>, <span class="author">Valdes AM</span>, <span class="author">Hyde CL</span>, <span class="author">Wang V</span>, <span class="author">Ziemek D</span>, <span class="author">Roberts P</span>, <span class="author">Xi L</span>, <span class="author">Grundberg E</span>, <span class="author">Multiple Tissue Human Expression Resource (MuTHER) Consortium</span>, <span class="author">Waldenberger M</span>, <span class="author">Richards JB</span>, <span class="author">Mohney RP</span>, <span class="author">Milburn MV</span>, <span class="author">John SL</span>, <span class="author">Trimmer J</span>, <span class="author">Theis FJ</span>, <span class="author">Overington JP</span>, <span class="author">Suhre K</span>, <span class="author">Brosnan MJ</span>, <span class="author">Gieger C</span>, <span class="author">Kastenm&uuml;ller G</span>, <span class="author">Spector TD</span> and <span class="author">Soranzo N</span></p>
<p class="affiliation">1] Department of Human Genetics, Wellcome Trust Sanger Institute, Hinxton, UK. [2] [3].</p><p class="abstract">Genome-wide association scans with high-throughput metabolic profiling provide unprecedented insights into how genetic variation influences metabolism and complex disease. Here we report the most comprehensive exploration of genetic loci influencing human metabolism thus far, comprising 7,824 adult individuals from 2 European population studies. We report genome-wide significant associations at 145 metabolic loci and their biochemical connectivity with more than 400 metabolites in human blood. We extensively characterize the resulting in vivo blueprint of metabolism in human blood by integrating it with information on gene expression, heritability and overlap with known loci for complex disorders, inborn errors of metabolism and pharmacological targets. We further developed a database and web-based resources for data mining and results visualization. Our findings provide new insights into the role of inherited variation in blood metabolic diversity and identify potential new opportunities for drug development and for understanding disease.</p>
<p class="grants">Funded by: Wellcome Trust: <span class="grant">091310</span>, <span class="grant">098051</span>, <span class="grant">WT091310</span>, <span class="grant">WT098051</span></p>
<p class="publication"><span class="title">Nature genetics</span>&nbsp;<span class="year">2014</span>;<span class="volume">46</span>;<span class="number">6</span>;<span class="pagerange">543-50</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24816252">24816252</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4064254">4064254</a>; DOI: <a href="http://dx.doi.org/10.1038%2Fng.2982">10.1038/ng.2982</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Plasmid deficiency in urogenital isolates of Chlamydia trachomatis reduces infectivity and virulence in a mouse model.</h4>
<p class="authors"><span class="author">Sigar IM</span>, <span class="author">Schripsema JH</span>, <span class="author">Wang Y</span>, <span class="author">Clarke IN</span>, <span class="author">Cutcliffe LT</span>, <span class="author">Seth-Smith HM</span>, <span class="author">Thomson NR</span>, <span class="author">Bjartling C</span>, <span class="author">Unemo M</span>, <span class="author">Persson K</span> and <span class="author">Ramsey KH</span></p>
<p class="affiliation">Microbiology and Immunology Department, Chicago College of Osteopathic Medicine, Midwestern University, Downers Grove, IL, USA.</p><p class="abstract">We hypothesized that the plasmid of urogenital isolates of Chlamydia trachomatis would modulate infectivity and virulence in a mouse model. To test this hypothesis, we infected female mice in the respiratory or urogenital tract with graded doses of a human urogenital isolate of C. trachomatis, serovar F, possessing the cognate plasmid. For comparison, we inoculated mice with a plasmid-free serovar F isolate. Following urogenital inoculation, the plasmid-free isolate displayed significantly reduced infectivity compared with the wild-type strain with the latter yielding a 17-fold lower infectious dose to yield 50% infection. When inoculated via the respiratory tract, the plasmid-free isolate exhibited reduced infectivity and virulence (as measured by weight change) when compared to the wild-type isolate. Further, differences in infectivity, but not in virulence were observed in a C. trachomatis, serovar E isolate with a deletion within the plasmid coding sequence 1 when compared to a serovar E isolate with no mutations in the plasmid. We conclude that plasmid loss reduces virulence and infectivity in this mouse model. These findings further support a role for the chlamydial plasmid in infectivity and virulence in vivo.</p>
<p class="grants">Funded by: Wellcome Trust: <span class="grant">091296</span>, <span class="grant">098051</span></p>
<p class="publication"><span class="title">Pathogens and disease</span>&nbsp;<span class="year">2014</span>;<span class="volume">70</span>;<span class="number">1</span>;<span class="pagerange">61-9</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24022847">24022847</a>; DOI: <a href="http://dx.doi.org/10.1111%2F2049-632X.12086">10.1111/2049-632X.12086</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Dissecting mammalian immunity through mutation.</h4>
<p class="authors"><span class="author">Siggs OM</span></p>
<p class="affiliation">Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK.</p>
<p class="abstract">Although mutation and natural selection have given rise to our immune system, a well-placed mutation can also cripple it, and within an expanding population we are recognizing more and more cases of single-gene mutations that compromise immunity. These mutations are an ideal tool for understanding human immunology, and there are more ways than ever to measure their physiological effects. There are also more ways to create mutations in the laboratory, and to use these resources to systematically define the function of every gene in our genome. This review focuses on the discovery and creation of mutations in the context of mammalian immunity, with an emphasis on the use of genome-wide chemical and CRISPR/Cas9 mutagenesis to reveal gene function.Immunology and Cell Biology advance online publication, 11 February 2014; doi:10.1038/icb.2014.8.</p>
<p class="publication"><span class="title">Immunology and cell biology</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24518983">24518983</a>; DOI: <a href="http://dx.doi.org/10.1038%2Ficb.2014.8">10.1038/icb.2014.8</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Genetic interaction implicates iRhom2 in the regulation of EGF receptor signalling in mice.</h4>
<p class="authors"><span class="author">Siggs OM</span>, <span class="author">Grieve A</span>, <span class="author">Xu H</span>, <span class="author">Bambrough P</span>, <span class="author">Christova Y</span> and <span class="author">Freeman M</span></p>
<p class="affiliation">Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, UK.</p><p class="abstract">iRhoms are closely related to rhomboid intramembrane proteases but lack catalytic activity. In mammals iRhoms are known to regulate the trafficking of TACE, the protease that cleaves the membrane bound inflammatory cytokine TNF. We have mapped a spontaneously occurring mouse mutation with a loss of hair phenotype, curly bare (cub), to the Rhbdf2 locus, which encodes the iRhom2 protein. The cub deletion removes the first 268 amino acids of the iRhom2 protein but is not a loss of function. We have also identified a previously reported suppressor of cub, called Mcub (modifier of curly bare), and find it to be a loss of function allele of the amphiregulin gene (Areg). Amphiregulin is an activating ligand of the epidermal growth factor receptor (EGFR) that, like TNF, is released by TACE. Our results therefore imply a regulatory link between iRhoms and EGFR signalling in mammals. We have tested the model that the cub mutation leads to iRhom2 hyperactivity and consequently excess TACE processing of amphiregulin and elevated EGFR signalling. Our results do not support this hypothesis: we find that, compared to wild-type cells, cub mutant embryonic fibroblasts release less amphiregulin, and that the cub mutant form of iRhom2 is less able than wild type to bind to TACE and promote its maturation.</p>
<p class="publication"><span class="title">Biology open</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25395669">25395669</a>; DOI: <a href="http://dx.doi.org/10.1242%2Fbio.201410116">10.1242/bio.201410116</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">A cascade of DNA-binding proteins for sexual commitment and development in Plasmodium.</h4>
<p class="authors"><span class="author">Sinha A</span>, <span class="author">Hughes KR</span>, <span class="author">Modrzynska KK</span>, <span class="author">Otto TD</span>, <span class="author">Pfander C</span>, <span class="author">Dickens NJ</span>, <span class="author">Religa AA</span>, <span class="author">Bushell E</span>, <span class="author">Graham AL</span>, <span class="author">Cameron R</span>, <span class="author">Kafsack BF</span>, <span class="author">Williams AE</span>, <span class="author">Llin&aacute;s M</span>, <span class="author">Berriman M</span>, <span class="author">Billker O</span> and <span class="author">Waters AP</span></p>
<p class="affiliation">1] Wellcome Trust Centre for Molecular Parasitology, University of Glasgow, Glasgow G12 8QQ, UK [2].</p><p class="abstract">Commitment to and completion of sexual development are essential for malaria parasites (protists of the genus Plasmodium) to be transmitted through mosquitoes. The molecular mechanism(s) responsible for commitment have been hitherto unknown. Here we show that PbAP2-G, a conserved member of the apicomplexan AP2 (ApiAP2) family of DNA-binding proteins, is essential for the commitment of asexually replicating forms to sexual development in Plasmodium berghei, a malaria parasite of rodents. PbAP2-G was identified from mutations in its encoding gene, PBANKA_143750, which account for the loss of sexual development frequently observed in parasites transmitted artificially by blood passage. Systematic gene deletion of conserved ApiAP2 genes in Plasmodium confirmed the role of PbAP2-G and revealed a second ApiAP2 member (PBANKA_103430, here termed PbAP2-G2) that significantly modulates but does not abolish gametocytogenesis, indicating that a cascade of ApiAP2 proteins are involved in commitment to the production and maturation of gametocytes. The data suggest a mechanism of commitment to gametocytogenesis in Plasmodium consistent with a positive feedback loop involving PbAP2-G that could be exploited to prevent the transmission of this pernicious parasite.</p>
<p class="grants">Funded by: Howard Hughes Medical Institute; Medical Research Council: <span class="grant">G0501670</span>; NIAID NIH HHS: <span class="grant">R01 AI076276</span>; NIGMS NIH HHS: <span class="grant">P50 GM071508</span>, <span class="grant">P50GM071508</span>, <span class="grant">T32 GM007388</span>; Wellcome Trust: <span class="grant">083811</span>, <span class="grant">083811/Z/07/Z</span>, <span class="grant">085349</span>, <span class="grant">098051</span></p>
<p class="publication"><span class="title">Nature</span>&nbsp;<span class="year">2014</span>;<span class="volume">507</span>;<span class="number">7491</span>;<span class="pagerange">253-7</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24572359">24572359</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4105895">4105895</a>; DOI: <a href="http://dx.doi.org/10.1038%2Fnature12970">10.1038/nature12970</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Comparative analysis of pseudogenes across three phyla.</h4>
<p class="authors"><span class="author">Sisu C</span>, <span class="author">Pei B</span>, <span class="author">Leng J</span>, <span class="author">Frankish A</span>, <span class="author">Zhang Y</span>, <span class="author">Balasubramanian S</span>, <span class="author">Harte R</span>, <span class="author">Wang D</span>, <span class="author">Rutenberg-Schoenberg M</span>, <span class="author">Clark W</span>, <span class="author">Diekhans M</span>, <span class="author">Rozowsky J</span>, <span class="author">Hubbard T</span>, <span class="author">Harrow J</span> and <span class="author">Gerstein MB</span></p>
<p class="affiliation">Program in Computational Biology and Bioinformatics and Department of Molecular Biophysics and Biochemistry, Yale University, New Haven, CT 06520;</p><p class="abstract">Pseudogenes are degraded fossil copies of genes. Here, we report a comparison of pseudogenes spanning three phyla, leveraging the completed annotations of the human, worm, and fly genomes, which we make available as an online resource. We find that pseudogenes are lineage specific, much more so than protein-coding genes, reflecting the different remodeling processes marking each organism&#39;s genome evolution. The majority of human pseudogenes are processed, resulting from a retrotranspositional burst at the dawn of the primate lineage. This burst can be seen in the largely uniform distribution of pseudogenes across the genome, their preservation in areas with low recombination rates, and their preponderance in highly expressed gene families. In contrast, worm and fly pseudogenes tell a story of numerous duplication events. In worm, these duplications have been preserved through selective sweeps, so we see a large number of pseudogenes associated with highly duplicated families such as chemoreceptors. However, in fly, the large effective population size and high deletion rate resulted in a depletion of the pseudogene complement. Despite large variations between these species, we also find notable similarities. Overall, we identify a broad spectrum of biochemical activity for pseudogenes, with the majority in each organism exhibiting varying degrees of partial activity. In particular, we identify a consistent amount of transcription (&sim;15%) across all species, suggesting a uniform degradation process. Also, we see a uniform decay of pseudogene promoter activity relative to their coding counterparts and identify a number of pseudogenes with conserved upstream sequences and activity, hinting at potential regulatory roles.</p>
<p class="publication"><span class="title">Proceedings of the National Academy of Sciences of the United States of America</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25157146">25157146</a>; DOI: <a href="http://dx.doi.org/10.1073%2Fpnas.1407293111">10.1073/pnas.1407293111</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Luminal Microbes Promote Monocyte-Stem Cell Interactions Across a Healthy Colonic Epithelium.</h4>
<p class="authors"><span class="author">Skoczek DA</span>, <span class="author">Walczysko P</span>, <span class="author">Horn N</span>, <span class="author">Parris A</span>, <span class="author">Clare S</span>, <span class="author">Williams MR</span> and <span class="author">Sobolewski A</span></p>
<p class="affiliation">Gut Health and Food Safety Institute Strategic Program, Institute of Food Research, Norwich, Norfolk NR4 7UA, United Kingdom;</p><p class="abstract">The intestinal epithelium forms a vital barrier between luminal microbes and the underlying mucosal immune system. Epithelial barrier function is maintained by continuous renewal of the epithelium and is pivotal for gut homeostasis. Breaching of the barrier causes mobilization of immune cells to promote epithelial restitution. However, it is not known whether microbes at the luminal surface of a healthy epithelial barrier influence immune cell mobilization to modulate tissue homeostasis. Using a mouse colonic mucosal explant model, we demonstrate that close proximity of luminal microbes to a healthy, intact epithelium results in rapid mucus secretion and movement of Ly6C(+)7/4(+) monocytes closer to epithelial stem cells. These early events are driven by the epithelial MyD88-signaling pathway and result in increased crypt cell proliferation and intestinal stem cell number. Over time, stem cell number and monocyte-crypt stem cell juxtapositioning return to homeostatic levels observed in vivo. We also demonstrate that reduced numbers of tissue Ly6C(+) monocytes can suppress Lgr5EGFP(+) stem cell expression in vivo and abrogate the response to luminal microbes ex vivo. The functional link between monocyte recruitment and increased crypt cell proliferation was further confirmed using a crypt-monocyte coculture model. This work demonstrates that the healthy gut epithelium mediates communication between luminal bacteria and monocytes, and monocytes can modulate crypt stem cell number and promote crypt cell proliferation to help maintain gut homeostasis.</p>
<p class="publication"><span class="title">Journal of immunology (Baltimore, Md. : 1950)</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24907348">24907348</a>; DOI: <a href="http://dx.doi.org/10.4049%2Fjimmunol.1301497">10.4049/jimmunol.1301497</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Single-cell genome-wide bisulfite sequencing for assessing epigenetic heterogeneity.</h4>
<p class="authors"><span class="author">Smallwood SA</span>, <span class="author">Lee HJ</span>, <span class="author">Angermueller C</span>, <span class="author">Krueger F</span>, <span class="author">Saadeh H</span>, <span class="author">Peat J</span>, <span class="author">Andrews SR</span>, <span class="author">Stegle O</span>, <span class="author">Reik W</span> and <span class="author">Kelsey G</span></p>
<p class="affiliation">1] Epigenetics Programme, Babraham Institute, Cambridge, UK. [2].</p><p class="abstract">We report a single-cell bisulfite sequencing (scBS-seq) method that can be used to accurately measure DNA methylation at up to 48.4% of CpG sites. Embryonic stem cells grown in serum or in 2i medium displayed epigenetic heterogeneity, with &#39;2i-like&#39; cells present in serum culture. Integration of 12 individual mouse oocyte datasets largely recapitulated the whole DNA methylome, which makes scBS-seq a versatile tool to explore DNA methylation in rare cells and heterogeneous populations.</p>
<p class="grants">Funded by: Biotechnology and Biological Sciences Research Council: <span class="grant">BB/J004499/1</span>; Medical Research Council: <span class="grant">MR/K011332/1</span>; Wellcome Trust: <span class="grant">095645/Z/11/Z</span></p>
<p class="publication"><span class="title">Nature methods</span>&nbsp;<span class="year">2014</span>;<span class="volume">11</span>;<span class="number">8</span>;<span class="pagerange">817-20</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25042786">25042786</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4117646">4117646</a>; DOI: <a href="http://dx.doi.org/10.1038%2Fnmeth.3035">10.1038/nmeth.3035</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Walking the interactome for candidate prioritization in exome sequencing studies of Mendelian diseases.</h4>
<p class="authors"><span class="author">Smedley D</span>, <span class="author">K&ouml;hler S</span>, <span class="author">Czeschik JC</span>, <span class="author">Amberger J</span>, <span class="author">Bocchini C</span>, <span class="author">Hamosh A</span>, <span class="author">Veldboer J</span>, <span class="author">Zemojtel T</span> and <span class="author">Robinson PN</span></p>
<p class="affiliation">Mouse Informatics Group, The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK, Institute for Medical Genetics and Human Genetics, Charit&eacute;-Universit&auml;tsmedizin Berlin, Augustenburger Platz 1, 13353 Berlin, Genome Informatics Department, Institute of Human Genetics, University Hospital Essen, University of Duisburg-Essen, Hufelandstr. 55, 45122 Essen, Germany, McKusick-Nathans Institute of Genetic Medicine, John Hopkins University School of Medicine, Baltimore, MD 21205, USA, Department of Mathematics and Computer Science, Institute for Bioinformatics, Freie Universit&auml;t Berlin, Takustrasse 9, 14195 Berlin, Germany, Institute of Bioorganic Chemistry, Polish Academy of Sciences, 61-701 Poznan, Poland, Berlin-Brandenburg Center for Regenerative Therapies, Charit&eacute;-Universit&auml;tsmedizin Berlin, Augustenburger Platz 1, 13353 Berlin and Max Planck Institute for Molecular Genetics, Ihnestrasse 73, 14195 Berlin, Germany.</p><p class="abstract">Whole-exome sequencing (WES) has opened up previously unheard of possibilities for identifying novel disease genes in Mendelian disorders, only about half of which have been elucidated to date. However, interpretation of WES data remains challenging.</p><p class="abstract">Here, we analyze protein-protein association (PPA) networks to identify candidate genes in the vicinity of genes previously implicated in a disease. The analysis, using a random-walk with restart (RWR) method, is adapted to the setting of WES by developing a composite variant-gene relevance score based on the rarity, location and predicted pathogenicity of variants and the RWR evaluation of genes harboring the variants. Benchmarking using known disease variants from 88 disease-gene families reveals that the correct gene is ranked among the top 10 candidates in &ge;50% of cases, a figure which we confirmed using a prospective study of disease genes identified in 2012 and PPA data produced before that date. We implement our method in a freely available Web server, ExomeWalker, that displays a ranked list of candidates together with information on PPAs, frequency and predicted pathogenicity of the variants to allow quick and effective searches for candidates that are likely to reward closer investigation. Availability and implementation: http://compbio.charite.de/ExomeWalker CONTACT: : <a href="mailto:%70%65%74%65%72.%72%6F%62%69%6E%73%6F%6E%40%63%68%61%72%69%74%65.%64%65">&#112;&#101;&#116;&#101;&#114;&#46;&#114;&#111;&#98;&#105;&#110;&#115;&#111;&#110;&#64;&#99;&#104;&#97;&#114;&#105;&#116;&#101;&#46;&#100;&#101;</a>.</p>
<p class="publication"><span class="title">Bioinformatics (Oxford, England)</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25078397">25078397</a>; DOI: <a href="http://dx.doi.org/10.1093%2Fbioinformatics%2Fbtu508">10.1093/bioinformatics/btu508</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">IFITM proteins-cellular inhibitors of viral entry.</h4>
<p class="authors"><span class="author">Smith S</span>, <span class="author">Weston S</span>, <span class="author">Kellam P</span> and <span class="author">Marsh M</span></p>
<p class="affiliation">Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton CB10 1SA, UK.</p>
<p class="abstract">Interferon inducible transmembrane (IFITM) proteins are a recently discovered family of cellular anti-viral proteins that restrict the replication of a number of enveloped and non-enveloped viruses. IFITM proteins are located in the plasma membrane and endosomal membranes, the main portals of entry for many viruses. Biochemical and membrane fusion studies suggest IFITM proteins have the ability to inhibit viral entry, possibly by modulating the fluidity of cellular membranes. Here we discuss the IFITM proteins, recent work on their mode of action, and future directions for research.</p>
<p class="publication"><span class="title">Current opinion in virology</span>&nbsp;<span class="year">2014</span>;<span class="volume">4C</span>;<span class="pagerange">71-77</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24480526">24480526</a>; DOI: <a href="http://dx.doi.org/10.1016%2Fj.coviro.2013.11.004">10.1016/j.coviro.2013.11.004</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">DrsG from Streptococcus dysgalactiae subsp. equisimilis Inhibits the Antimicrobial Peptide LL-37.</h4>
<p class="authors"><span class="author">Smyth D</span>, <span class="author">Cameron A</span>, <span class="author">Davies MR</span>, <span class="author">McNeilly C</span>, <span class="author">Hafner L</span>, <span class="author">Sriprakash KS</span> and <span class="author">McMillan DJ</span></p>
<p class="affiliation">Bacterial Pathogenesis Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.</p><p class="abstract">SIC and DRS are related proteins present in only 4 of the &gt;200 Streptococcus pyogenes emm types. These proteins inhibit complement-mediated lysis and/or the activity of certain antimicrobial peptides (AMPs). A gene encoding a homologue of these proteins, herein called DrsG, has been identified in the related bacterium Streptococcus dysgalactiae subsp. equisimilis. Here we show that geographically dispersed isolates representing 14 of 50 emm types examined possess variants of drsG. However, not all isolates within the drsG-positive emm types possess the gene. Sequence comparisons also revealed a high degree of conservation in different S. dysgalactiae subsp. equisimilis emm types. To examine the biological activity of DrsG, recombinant versions of two major DrsG variants, DrsGS and DrsGL, were expressed and purified. Western blot analysis using antisera raised to these proteins demonstrated both variants to be expressed and secreted into culture supernatants. Unlike SIC, but similar to DRS, DrsG does not inhibit complement-mediated lysis. However, like both SIC and DRS, DrsG is a ligand of the cathelicidin LL-37 and is inhibitory to its bactericidal activity in in vitro assays. Conservation of prolines in the C-terminal region also suggests that these residues are important in the biology of this family of proteins. This is the first report demonstrating the activity of an AMP-inhibitory protein in S. dysgalactiae subsp. equisimilis and suggests that inhibition of AMP activity is the primary function of this family of proteins. The acquisition of the complement-inhibitory activity of SIC may reflect its continuing evolution.</p>
<p class="publication"><span class="title">Infection and immunity</span>&nbsp;<span class="year">2014</span>;<span class="volume">82</span>;<span class="number">6</span>;<span class="pagerange">2337-44</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24664506">24664506</a>; DOI: <a href="http://dx.doi.org/10.1128%2FIAI.01411-13">10.1128/IAI.01411-13</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Investigating the Feasibility of Scale up and Automation of Human Induced Pluripotent Stem Cells Cultured in Aggregates in Feeder Free Conditions.</h4>
<p class="authors"><span class="author">Soares F</span>, <span class="author">Chandra A</span>, <span class="author">Thomas R</span>, <span class="author">Pedersen R</span>, <span class="author">Vallier L</span> and <span class="author">Williams D</span></p>
<p class="affiliation">Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute, Anne McLaren Laboratory for Regenerative medicine and Department of Surgery, University of Cambridge, UK; Centre for Biological Engineering, Loughborough University, UK. Electronic address: <a href="mailto:%66%61%63%73%32%40%63%61%6D.%61%63.%75%6B">&#102;&#97;&#99;&#115;&#50;&#64;&#99;&#97;&#109;&#46;&#97;&#99;&#46;&#117;&#107;</a>.</p>
<p class="abstract">The transfer of a laboratory process into a manufacturing facility is one of the most critical steps required for the large scale production of cell-based therapy products. This study describes the first published protocol for scalable automated expansion of human induced pluripotent stem cell lines growing in aggregates in feeder-free and chemically defined medium. Cells were successfully transferred between different sites representative of research and manufacturing settings; and passaged manually and using the CompacT Select automation platform. Modified protocols were developed for the automated system and the management of cells aggregates (clumps) was identified as the critical step. Cellular morphology, pluripotency gene expression and differentiation into the three germ layers have been used compare the outcomes of manual and automated processes.</p>
<p class="publication"><span class="title">Journal of biotechnology</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24440272">24440272</a>; DOI: <a href="http://dx.doi.org/10.1016%2Fj.jbiotec.2013.12.009">10.1016/j.jbiotec.2013.12.009</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Secreted proteomes of different developmental stages of the gastrointestinal nematode Nippostrongylus brasiliensis.</h4>
<p class="authors"><span class="author">Sotillo J</span>, <span class="author">Sanchez-Flores A</span>, <span class="author">Cantacessi C</span>, <span class="author">Harcus Y</span>, <span class="author">Pickering D</span>, <span class="author">Bouchery T</span>, <span class="author">Camberis M</span>, <span class="author">Tang SC</span>, <span class="author">Giacomin P</span>, <span class="author">Mulvenna J</span>, <span class="author">Mitreva M</span>, <span class="author">Berriman M</span>, <span class="author">LeGros G</span>, <span class="author">Maizels RM</span> and <span class="author">Loukas A</span></p>
<p class="affiliation">From the &Dagger;Centre for Biodiscovery and Molecular Development of Therapeutics, Australian Institute for Tropical Health and Medicine, James Cook University, Cairns, Queensland, Australia;</p><p class="abstract">Hookworms infect more than 700 million people worldwide and cause more morbidity than most other human parasitic infections. Nippostrongylus brasiliensis (the rat hookworm) has been used as an experimental model for human hookworm because of its similar life cycle and ease of maintenance in laboratory rodents. Adult N. brasiliensis, like the human hookworm, lives in the intestine of the host and releases excretory/secretory products (ESP), which represent the major host-parasite interface. We performed a comparative proteomic analysis of infective larval (L3) and adult worm stages of N. brasiliensis to gain insights into the molecular bases of host-parasite relationships and determine whether N. brasiliensis could indeed serve as an appropriate model for studying human hookworm infections. Proteomic data were matched to a transcriptomic database assembled from 245,874,892 Illumina reads from different developmental stages (eggs, L3, L4, and adult) of N. brasiliensis yielding&sim;18,426 unigenes with 39,063 possible isoform transcripts. From this analysis, 313 proteins were identified from ESPs by LC-MS/MS-52 in the L3 and 261 in the adult worm. Most of the proteins identified in the study were stage-specific (only 13 proteins were shared by both stages); in particular, two families of proteins-astacin metalloproteases and CAP-domain containing SCP/TAPS-were highly represented in both L3 and adult ESP. These protein families are present in most nematode groups, and where studied, appear to play roles in larval migration and evasion of the host&#39;s immune response. Phylogenetic analyses of defined protein families and global gene similarity analyses showed that N. brasiliensis has a greater degree of conservation with human hookworm than other model nematodes examined. These findings validate the use of N. brasiliensis as a suitable parasite for the study of human hookworm infections in a tractable animal model.</p>
<p class="grants">Funded by: NIAID NIH HHS: <span class="grant">R01 AI081803</span>; NIGMS NIH HHS: <span class="grant">R01 GM097435</span></p>
<p class="publication"><span class="title">Molecular &amp; cellular proteomics : MCP</span>&nbsp;<span class="year">2014</span>;<span class="volume">13</span>;<span class="number">10</span>;<span class="pagerange">2736-51</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24994561">24994561</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4188999">4188999</a>; DOI: <a href="http://dx.doi.org/10.1074%2Fmcp.M114.038950">10.1074/mcp.M114.038950</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">A genome-wide association study and biological pathway analysis of epilepsy prognosis in a prospective cohort of newly treated epilepsy.</h4>
<p class="authors"><span class="author">Speed D</span>, <span class="author">Hoggart C</span>, <span class="author">Petrovski S</span>, <span class="author">Tachmazidou I</span>, <span class="author">Coffey A</span>, <span class="author">Jorgensen A</span>, <span class="author">Eleftherohorinou H</span>, <span class="author">De Iorio M</span>, <span class="author">Todaro M</span>, <span class="author">De T</span>, <span class="author">Smith D</span>, <span class="author">Smith PE</span>, <span class="author">Jackson M</span>, <span class="author">Cooper P</span>, <span class="author">Kellett M</span>, <span class="author">Howell S</span>, <span class="author">Newton M</span>, <span class="author">Yerra R</span>, <span class="author">Tan M</span>, <span class="author">French C</span>, <span class="author">Reuber M</span>, <span class="author">Sills GE</span>, <span class="author">Chadwick D</span>, <span class="author">Pirmohamed M</span>, <span class="author">Bentley D</span>, <span class="author">Scheffer I</span>, <span class="author">Berkovic S</span>, <span class="author">Balding D</span>, <span class="author">Palotie A</span>, <span class="author">Marson A</span>, <span class="author">O&#39;Brien TJ</span> and <span class="author">Johnson MR</span></p>
<p class="affiliation">UCL Genetics Institute, University College London WC1E 6BT, UK.</p><p class="abstract">We present the analysis of a prospective multicentre study to investigate genetic effects on the prognosis of newly treated epilepsy. Patients with a new clinical diagnosis of epilepsy requiring medication were recruited and followed up prospectively. The clinical outcome was defined as freedom from seizures for a minimum of 12 months in accordance with the consensus statement from the International League Against Epilepsy (ILAE). Genetic effects on remission of seizures after starting treatment were analysed with and without adjustment for significant clinical prognostic factors, and the results from each cohort were combined using a fixed-effects meta-analysis. After quality control (QC), we analysed 889 newly treated epilepsy patients using 472 450 genotyped and 6.9 &times; 10(6) imputed single-nucleotide polymorphisms. Suggestive evidence for association (defined as Pmeta &lt; 5.0 &times; 10(-7)) with remission of seizures after starting treatment was observed at three loci: 6p12.2 (rs492146, Pmeta = 2.1 &times; 10(-7), OR[G] = 0.57), 9p23 (rs72700966, Pmeta = 3.1 &times; 10(-7), OR[C] = 2.70) and 15q13.2 (rs143536437, Pmeta = 3.2 &times; 10(-7), OR[C] = 1.92). Genes of biological interest at these loci include PTPRD and ARHGAP11B (encoding functions implicated in neuronal development) and GSTA4 (a phase II biotransformation enzyme). Pathway analysis using two independent methods implicated a number of pathways in the prognosis of epilepsy, including KEGG categories &#39;calcium signaling pathway&#39; and &#39;phosphatidylinositol signaling pathway&#39;. Through a series of power curves, we conclude that it is unlikely any single common variant explains &gt;4.4% of the variation in the outcome of newly treated epilepsy.</p>
<p class="grants">Funded by: Department of Health: <span class="grant">NF-SI-0512-10064</span>; Medical Research Council: <span class="grant">25105</span>, <span class="grant">G0901388</span>, <span class="grant">MR/L006758/1</span>; Wellcome Trust: <span class="grant">WT066056</span></p>
<p class="publication"><span class="title">Human molecular genetics</span>&nbsp;<span class="year">2014</span>;<span class="volume">23</span>;<span class="number">1</span>;<span class="pagerange">247-58</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/23962720">23962720</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC3857947">3857947</a>; DOI: <a href="http://dx.doi.org/10.1093%2Fhmg%2Fddt403">10.1093/hmg/ddt403</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Mouse models of NPM1-mutated acute myeloid leukemia: biological and clinical implications.</h4>
<p class="authors"><span class="author">Sportoletti P</span>, <span class="author">Varasano E</span>, <span class="author">Rossi R</span>, <span class="author">Mupo A</span>, <span class="author">Tiacci E</span>, <span class="author">Vassiliou G</span>, <span class="author">Martelli MP</span> and <span class="author">Falini B</span></p>
<p class="affiliation">Institute of Hematology, University of Perugia, Perugia, Italy.</p><p class="abstract">Acute myeloid leukemia (AML) carrying nucleophosmin (NPM1) mutations displays distinct biological and clinical features that led to its inclusion as a provisional disease entity in the 2008 World Health Organization (WHO) classification of myeloid neoplasms. Studies of the molecular mechanisms underlying the pathogenesis of NPM1-mutated AML have benefited greatly from several mouse models of this leukemia developed over the past few years. Immunocompromised mice xenografted with NPM1-mutated AML served as the first valuable tool for defining the biology of the disease in vivo. Subsequently, genetically engineered mouse models of the NPM1 mutation, including transgenic and knock-in alleles, allowed the generation of mice with a constant genotype and a reproducible phenotype. These models have been critical for investigating the nature of the molecular effects of these mutations, defining the function of leukemic stem cells in NPM1-mutated AML, identifying chemoresistant preleukemic hemopoietic stem cells and unraveling the key molecular events that cooperate with NPM1 mutations to induce AML in vivo. Moreover, they can serve as a platform for the discovery and validation of new antileukemic drugs in vivo. Advances derived from the analysis of these mouse models promise to greatly accelerate the development of new molecularly targeted therapies for patients with NPM1-mutated AML.Leukemia advance online publication, 23 September 2014; doi:10.1038/leu.2014.257.</p>
<p class="publication"><span class="title">Leukemia</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25179729">25179729</a>; DOI: <a href="http://dx.doi.org/10.1038%2Fleu.2014.257">10.1038/leu.2014.257</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Neutrophils recruited by IL-22 in peripheral tissues function as TRAIL-dependent antiviral effectors against MCMV.</h4>
<p class="authors"><span class="author">Stacey MA</span>, <span class="author">Marsden M</span>, <span class="author">Pham N TA</span>, <span class="author">Clare S</span>, <span class="author">Dolton G</span>, <span class="author">Stack G</span>, <span class="author">Jones E</span>, <span class="author">Klenerman P</span>, <span class="author">Gallimore AM</span>, <span class="author">Taylor PR</span>, <span class="author">Snelgrove RJ</span>, <span class="author">Lawley TD</span>, <span class="author">Dougan G</span>, <span class="author">Benedict CA</span>, <span class="author">Jones SA</span>, <span class="author">Wilkinson GW</span> and <span class="author">Humphreys IR</span></p>
<p class="affiliation">Institute of Infection and Immunity, School of Medicine, Cardiff University, Cardiff CF14 4XN, Wales, UK.</p><p class="abstract">During primary infection, murine cytomegalovirus (MCMV) spreads systemically, resulting in virus replication and pathology in multiple organs. This disseminated infection is ultimately controlled, but the underlying immune defense mechanisms are unclear. Investigating the role of the cytokine IL-22 in MCMV infection, we discovered an unanticipated function for neutrophils as potent antiviral effector cells that restrict viral replication and associated pathogenesis in peripheral organs. NK-, NKT-, and T&nbsp;cell-secreted IL-22 orchestrated antiviral neutrophil-mediated responses via induction in stromal nonhematopoietic tissue of the neutrophil-recruiting chemokine CXCL1. The antiviral effector properties of infiltrating neutrophils were directly linked to the expression of TNF-related apoptosis-inducing ligand (TRAIL). Our data identify a role for neutrophils in antiviral defense, and establish a functional link between IL-22 and the control of antiviral neutrophil responses that prevents pathogenic herpesvirus infection in peripheral organs.</p>
<p class="grants">Funded by: Biotechnology and Biological Sciences Research Council: <span class="grant">BBF0098361</span>; Medical Research Council: <span class="grant">G1000236</span>; NIAID NIH HHS: <span class="grant">AI101423</span>, <span class="grant">R01 AI101423</span>; Wellcome Trust: <span class="grant">091663</span>, <span class="grant">WT090323MA</span>, <span class="grant">WT098026MA</span></p>
<p class="publication"><span class="title">Cell host &amp; microbe</span>&nbsp;<span class="year">2014</span>;<span class="volume">15</span>;<span class="number">4</span>;<span class="pagerange">471-83</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24721575">24721575</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC3989063">3989063</a>; DOI: <a href="http://dx.doi.org/10.1016%2Fj.chom.2014.03.003">10.1016/j.chom.2014.03.003</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Development of an antigen microarray for high throughput monoclonal antibody selection.</h4>
<p class="authors"><span class="author">Staudt N</span>, <span class="author">M&uuml;ller-Sienerth N</span> and <span class="author">Wright GJ</span></p>
<p class="affiliation">Cell Surface Signalling Laboratory, Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1HH, United Kingdom. Electronic address: <a href="mailto:%6E%73%38%40%73%61%6E%67%65%72.%61%63.%75%6B">&#110;&#115;&#56;&#64;&#115;&#97;&#110;&#103;&#101;&#114;&#46;&#97;&#99;&#46;&#117;&#107;</a>.</p><p class="abstract">Monoclonal antibodies are valuable laboratory reagents and are increasingly being exploited as therapeutics to treat a range of diseases. Selecting new monoclonal antibodies that are validated to work in particular applications, despite the availability of several different techniques, can be resource intensive with uncertain outcomes. To address this, we have developed an approach that enables early screening of hybridoma supernatants generated from an animal immunised with up to five different antigens followed by cloning of the antibody into a single expression plasmid. While this approach relieved the cellular cloning bottleneck and had the desirable ability to screen antibody function prior to cloning, the small volume of hybridoma supernatant available for screening limited the number of antigens for pooled immunisation. Here, we report the development of an antigen microarray that significantly reduces the volume of supernatant required for functional screening. This approach permits a significant increase in the number of antigens for parallel monoclonal antibody selection from a single animal. Finally, we show the successful use of a convenient small-scale transfection method to rapidly identify plasmids that encode functional cloned antibodies, addressing another bottleneck in this approach. In summary, we show that a hybrid approach of combining established hybridoma antibody technology with refined screening and antibody cloning methods can be used to select monoclonal antibodies of desired functional properties against many different antigens from a single immunised host.</p>
<p class="grants">Funded by: NINDS NIH HHS: <span class="grant">R01 NS063400]</span>; Wellcome Trust: <span class="grant">098051</span></p>
<p class="publication"><span class="title">Biochemical and biophysical research communications</span>&nbsp;<span class="year">2014</span>;<span class="volume">445</span>;<span class="number">4</span>;<span class="pagerange">785-90</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24472540">24472540</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC3989025">3989025</a>; DOI: <a href="http://dx.doi.org/10.1016%2Fj.bbrc.2013.12.033">10.1016/j.bbrc.2013.12.033</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">A panel of recombinant monoclonal antibodies against zebrafish neural receptors and secreted proteins suitable for wholemount immunostaining.</h4>
<p class="authors"><span class="author">Staudt N</span>, <span class="author">M&uuml;ller-Sienerth N</span>, <span class="author">Fane-Dremucheva A</span>, <span class="author">Yusaf SP</span>, <span class="author">Millrine D</span> and <span class="author">Wright GJ</span></p>
<p class="affiliation">Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1HH, UK.</p><p class="abstract">Cell surface receptors and secreted proteins play important roles in neural recognition processes, but because their site of action can be a long distance from neuron cell bodies, antibodies that label these proteins are valuable to understand their function. The zebrafish embryo is a popular vertebrate model for neurobiology, but suffers from a paucity of validated antibody reagents. Here, we use the entire ectodomain of neural zebrafish cell surface or secreted proteins expressed in mammalian cells to select monoclonal antibodies to ten different antigens. The antibodies were characterised by Western blotting and the sensitivity of their epitopes to formalin fixation was determined. The rearranged antigen binding regions of the antibodies were amplified and cloned which enabled expression in a recombinant form from a single plasmid. All ten antibodies gave specific staining patterns within formalin-treated embryonic zebrafish brains, demonstrating that this generalised approach is particularly efficient to elicit antibodies that stain native antigen in fixed wholemount tissue. Finally, we show that additional tags can be easily added to the recombinant antibodies for convenient multiplex staining. The antibodies and the approaches described here will help to address the lack of well-defined antibody reagents in zebrafish research.</p>
<p class="publication"><span class="title">Biochemical and biophysical research communications</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25490391">25490391</a>; DOI: <a href="http://dx.doi.org/10.1016%2Fj.bbrc.2014.11.123">10.1016/j.bbrc.2014.11.123</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Common variant at 16p11.2 conferring risk of psychosis.</h4>
<p class="authors"><span class="author">Steinberg S</span>, <span class="author">de Jong S</span>, <span class="author">Mattheisen M</span>, <span class="author">Costas J</span>, <span class="author">Demontis D</span>, <span class="author">Jamain S</span>, <span class="author">Pietil&auml;inen OP</span>, <span class="author">Lin K</span>, <span class="author">Papiol S</span>, <span class="author">Huttenlocher J</span>, <span class="author">Sigurdsson E</span>, <span class="author">Vassos E</span>, <span class="author">Giegling I</span>, <span class="author">Breuer R</span>, <span class="author">Fraser G</span>, <span class="author">Walker N</span>, <span class="author">Melle I</span>, <span class="author">Djurovic S</span>, <span class="author">Agartz I</span>, <span class="author">Tuulio-Henriksson A</span>, <span class="author">Suvisaari J</span>, <span class="author">L&ouml;nnqvist J</span>, <span class="author">Paunio T</span>, <span class="author">Olsen L</span>, <span class="author">Hansen T</span>, <span class="author">Ingason A</span>, <span class="author">Pirinen M</span>, <span class="author">Strengman E</span>, <span class="author">GROUP</span>, <span class="author">Hougaard DM</span>, <span class="author">Orntoft T</span>, <span class="author">Didriksen M</span>, <span class="author">Hollegaard MV</span>, <span class="author">Nordentoft M</span>, <span class="author">Abramova L</span>, <span class="author">Kaleda V</span>, <span class="author">Arrojo M</span>, <span class="author">Sanju&aacute;n J</span>, <span class="author">Arango C</span>, <span class="author">Etain B</span>, <span class="author">Bellivier F</span>, <span class="author">M&eacute;ary A</span>, <span class="author">Sch&uuml;rhoff F</span>, <span class="author">Szoke A</span>, <span class="author">Ribolsi M</span>, <span class="author">Magni V</span>, <span class="author">Siracusano A</span>, <span class="author">Sperling S</span>, <span class="author">Rossner M</span>, <span class="author">Christiansen C</span>, <span class="author">Kiemeney LA</span>, <span class="author">Franke B</span>, <span class="author">van den Berg LH</span>, <span class="author">Veldink J</span>, <span class="author">Curran S</span>, <span class="author">Bolton P</span>, <span class="author">Poot M</span>, <span class="author">Staal W</span>, <span class="author">Rehnstrom K</span>, <span class="author">Kilpinen H</span>, <span class="author">Freitag CM</span>, <span class="author">Meyer J</span>, <span class="author">Magnusson P</span>, <span class="author">Saemundsen E</span>, <span class="author">Martsenkovsky I</span>, <span class="author">Bikshaieva I</span>, <span class="author">Martsenkovska I</span>, <span class="author">Vashchenko O</span>, <span class="author">Raleva M</span>, <span class="author">Paketchieva K</span>, <span class="author">Stefanovski B</span>, <span class="author">Durmishi N</span>, <span class="author">Pejovic Milovancevic M</span>, <span class="author">Lecic Tosevski D</span>, <span class="author">Silagadze T</span>, <span class="author">Naneishvili N</span>, <span class="author">Mikeladze N</span>, <span class="author">Surguladze S</span>, <span class="author">Vincent JB</span>, <span class="author">Farmer A</span>, <span class="author">Mitchell PB</span>, <span class="author">Wright A</span>, <span class="author">Schofield PR</span>, <span class="author">Fullerton JM</span>, <span class="author">Montgomery GW</span>, <span class="author">Martin NG</span>, <span class="author">Rubino IA</span>, <span class="author">van Winkel R</span>, <span class="author">Kenis G</span>, <span class="author">De Hert M</span>, <span class="author">R&eacute;thelyi JM</span>, <span class="author">Bitter I</span>, <span class="author">Terenius L</span>, <span class="author">J&ouml;nsson EG</span>, <span class="author">Bakker S</span>, <span class="author">van Os J</span>, <span class="author">Jablensky A</span>, <span class="author">Leboyer M</span>, <span class="author">Bramon E</span>, <span class="author">Powell J</span>, <span class="author">Murray R</span>, <span class="author">Corvin A</span>, <span class="author">Gill M</span>, <span class="author">Morris D</span>, <span class="author">O&#39;Neill FA</span>, <span class="author">Kendler K</span>, <span class="author">Riley B</span>, <span class="author">Wellcome Trust Case Control Consortium 2</span>, <span class="author">Craddock N</span>, <span class="author">Owen MJ</span>, <span class="author">O&#39;Donovan MC</span>, <span class="author">Thorsteinsdottir U</span>, <span class="author">Kong A</span>, <span class="author">Ehrenreich H</span>, <span class="author">Carracedo A</span>, <span class="author">Golimbet V</span>, <span class="author">Andreassen OA</span>, <span class="author">B&oslash;rglum AD</span>, <span class="author">Mors O</span>, <span class="author">Mortensen PB</span>, <span class="author">Werge T</span>, <span class="author">Ophoff RA</span>, <span class="author">N&ouml;then MM</span>, <span class="author">Rietschel M</span>, <span class="author">Cichon S</span>, <span class="author">Ruggeri M</span>, <span class="author">Tosato S</span>, <span class="author">Palotie A</span>, <span class="author">St Clair D</span>, <span class="author">Rujescu D</span>, <span class="author">Collier DA</span>, <span class="author">Stefansson H</span> and <span class="author">Stefansson K</span></p>
<p class="affiliation">deCODE genetics, Reykjavik, Iceland.</p>
<p class="abstract">Epidemiological and genetic data support the notion that schizophrenia and bipolar disorder share genetic risk factors. In our previous genome-wide association study, meta-analysis and follow-up (totaling as many as 18206 cases and 42536 controls), we identified four loci showing genome-wide significant association with schizophrenia. Here we consider a mixed schizophrenia and bipolar disorder (psychosis) phenotype (addition of 7469 bipolar disorder cases, 1535 schizophrenia cases, 333 other psychosis cases, 808 unaffected family members and 46160 controls). Combined analysis reveals a novel variant at 16p11.2 showing genome-wide significant association (rs4583255[T]; odds ratio=1.08; P=6.6  10(-11)). The new variant is located within a 593-kb region that substantially increases risk of psychosis when duplicated. In line with the association of the duplication with reduced body mass index (BMI), rs4583255[T] is also associated with lower BMI (P=0.0039 in the public GIANT consortium data set; P=0.00047 in 22651 additional Icelanders).</p>
<p class="grants">Funded by: Medical Research Council: <span class="grant">G0601030</span>; NIMH NIH HHS: <span class="grant">1U24MH081810</span>, <span class="grant">2N01MH080001-001</span>, <span class="grant">MH074027</span>, <span class="grant">N01 MH900001</span>, <span class="grant">R01 MH078075</span>; Wellcome Trust: <span class="grant">075491/Z/04</span>, <span class="grant">085475/B/08/Z</span>, <span class="grant">085475/Z/08/Z</span>, <span class="grant">085475PELTONEN</span>, <span class="grant">098051</span></p>
<p class="publication"><span class="title">Molecular psychiatry</span>&nbsp;<span class="year">2014</span>;<span class="volume">19</span>;<span class="number">1</span>;<span class="pagerange">108-14</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/23164818">23164818</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC3872086">3872086</a>; DOI: <a href="http://dx.doi.org/10.1038%2Fmp.2012.157">10.1038/mp.2012.157</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Comparative genome analysis of Wolbachia strain wAu.</h4>
<p class="authors"><span class="author">Sutton ER</span>, <span class="author">Harris SR</span>, <span class="author">Parkhill J</span> and <span class="author">Sinkins SP</span></p>
<p class="affiliation">Department of Zoology and Peter Medawar Building for Pathogen Research, Nuffield Department of Medicine, University of Oxford, Oxford, UK. <a href="mailto:%73.%73%69%6E%6B%69%6E%73%40%6C%61%6E%63%61%73%74%65%72.%61%63.%75%6B">&#115;&#46;&#115;&#105;&#110;&#107;&#105;&#110;&#115;&#64;&#108;&#97;&#110;&#99;&#97;&#115;&#116;&#101;&#114;&#46;&#97;&#99;&#46;&#117;&#107;</a>.</p><p class="abstract"><strong>Background</strong>: Wolbachia intracellular bacteria can manipulate the reproduction of their arthropod hosts, including inducing sterility between populations known as cytoplasmic incompatibility (CI). Certain strains have been identified that are unable to induce or rescue CI, including wAu from Drosophila. Genome sequencing and comparison with CI-inducing related strain wMel was undertaken in order to better understand the molecular basis of the phenotype.</p><p class="abstract"><strong>Results</strong>: Although the genomes were broadly similar, several rearrangements were identified, particularly in the prophage regions. Many orthologous genes contained single nucleotide polymorphisms (SNPs) between the two strains, but a subset containing major differences that would likely cause inactivation in wAu were identified, including the absence of the wMel ortholog of a gene recently identified as a CI candidate in a proteomic study. The comparative analyses also focused on a family of transcriptional regulator genes implicated in CI in previous work, and revealed numerous differences between the strains, including those that would have major effects on predicted function.</p><p class="abstract"><strong>Conclusions</strong>: The study provides support for existing candidates and novel genes that may be involved in CI, and provides a basis for further functional studies to examine the molecular basis of the phenotype.</p>
<p class="publication"><span class="title">BMC genomics</span>&nbsp;<span class="year">2014</span>;<span class="volume">15</span>;<span class="pagerange">928</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25341639">25341639</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4223829">4223829</a>; DOI: <a href="http://dx.doi.org/10.1186%2F1471-2164-15-928">10.1186/1471-2164-15-928</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Zero tolerance for healthcare-associated MRSA bacteraemia: is it realistic?</h4>
<p class="authors"><span class="author">T&ouml;r&ouml;k ME</span>, <span class="author">Harris SR</span>, <span class="author">Cartwright EJ</span>, <span class="author">Raven KE</span>, <span class="author">Brown NM</span>, <span class="author">Allison ME</span>, <span class="author">Greaves D</span>, <span class="author">Quail MA</span>, <span class="author">Limmathurotsakul D</span>, <span class="author">Holden MT</span>, <span class="author">Parkhill J</span> and <span class="author">Peacock SJ</span></p>
<p class="affiliation">Department of Medicine, University of Cambridge, Cambridge, UK Department of Microbiology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK Public Health England, Clinical Microbiology and Public Health Laboratory, Cambridge, UK <a href="mailto:%65%74%33%31%37%40%6D%65%64%73%63%68%6C.%63%61%6D.%61%63.%75%6B">&#101;&#116;&#51;&#49;&#55;&#64;&#109;&#101;&#100;&#115;&#99;&#104;&#108;&#46;&#99;&#97;&#109;&#46;&#97;&#99;&#46;&#117;&#107;</a>.</p><p class="abstract"><strong>Background</strong>: The term &#39;zero tolerance&#39; has recently been applied to healthcare-associated infections, implying that such events are always preventable. This may not be the case for healthcare-associated infections such as methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia.</p><p class="abstract"><strong>Methods</strong>: We combined information from an epidemiological investigation and bacterial whole-genome sequencing to evaluate a cluster of five MRSA bacteraemia episodes in four patients in a specialist hepatology unit.</p><p class="abstract"><strong>Results</strong>: The five MRSA bacteraemia isolates were highly related by multilocus sequence type (ST) (four isolates were ST22 and one isolate was a single-locus variant, ST2046). Whole-genome sequencing demonstrated unequivocally that the bacteraemia cases were unrelated. Placing the MRSA bacteraemia isolates within a local and global phylogenetic tree of MRSA ST22 genomes demonstrated that the five bacteraemia isolates were highly diverse. This was consistent with the acquisition and importation of MRSA from the wider referral network. Analysis of MRSA carriage and disease in patients within the hepatology service demonstrated a higher risk of both initial MRSA acquisition compared with the nephrology service and a higher risk of progression from MRSA carriage to bacteraemia, compared with patients in nephrology or geriatric services. A root cause analysis failed to reveal any mechanism by which three of five MRSA bacteraemia episodes could have been prevented.</p><p class="abstract"><strong>Conclusions</strong>: This study illustrates the complex nature of MRSA carriage and bacteraemia in patients in a specialized hepatology unit. Despite numerous ongoing interventions to prevent MRSA bacteraemia in healthcare settings, these are unlikely to result in a zero incidence in referral centres that treat highly complex patients.</p>
<p class="publication"><span class="title">The Journal of antimicrobial chemotherapy</span>&nbsp;<span class="year">2014</span>;<span class="volume">69</span>;<span class="number">8</span>;<span class="pagerange">2238-45</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24788657">24788657</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4100711">4100711</a>; DOI: <a href="http://dx.doi.org/10.1093%2Fjac%2Fdku128">10.1093/jac/dku128</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Independent emergence of Plasmodium falciparum artemisinin resistance mutations in Southeast Asia.</h4>
<p class="authors"><span class="author">Takala-Harrison S</span>, <span class="author">Jacob CG</span>, <span class="author">Arze C</span>, <span class="author">Cummings MP</span>, <span class="author">Silva JC</span>, <span class="author">Dondorp AM</span>, <span class="author">Fukuda MM</span>, <span class="author">Hien TT</span>, <span class="author">Mayxay M</span>, <span class="author">Noedl H</span>, <span class="author">Nosten F</span>, <span class="author">Kyaw MP</span>, <span class="author">Nhien NT</span>, <span class="author">Imwong M</span>, <span class="author">Bethell D</span>, <span class="author">Se Y</span>, <span class="author">Lon C</span>, <span class="author">Tyner SD</span>, <span class="author">Saunders DL</span>, <span class="author">Ariey F</span>, <span class="author">Mercereau-Puijalon O</span>, <span class="author">Menard D</span>, <span class="author">Newton PN</span>, <span class="author">Khanthavong M</span>, <span class="author">Hongvanthong B</span>, <span class="author">Starzengruber P</span>, <span class="author">Fuehrer HP</span>, <span class="author">Swoboda P</span>, <span class="author">Khan WA</span>, <span class="author">Phyo AP</span>, <span class="author">Nyunt MM</span>, <span class="author">Nyunt MH</span>, <span class="author">Brown TS</span>, <span class="author">Adams M</span>, <span class="author">Pepin CS</span>, <span class="author">Bailey J</span>, <span class="author">Tan JC</span>, <span class="author">Ferdig MT</span>, <span class="author">Clark TG</span>, <span class="author">Miotto O</span>, <span class="author">MacInnis B</span>, <span class="author">Kwiatkowski DP</span>, <span class="author">White NJ</span>, <span class="author">Ringwald P</span> and <span class="author">Plowe CV</span></p>
<p class="affiliation">Howard Hughes Medical Institute/Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, MD 21201.</p><p class="abstract"><strong>Background</strong>: &emsp;The emergence of artemisinin-resistant Plasmodium falciparum in Southeast Asia threatens malaria treatment efficacy. Mutations in a kelch protein encoded on P. falciparum chromosome 13 (K13) have been associated with resistance in vitro and in field samples from Cambodia.</p><p class="abstract"><strong>Methods</strong>: &emsp;P. falciparum infections from artesunate efficacy trials in Bangladesh, Cambodia, Laos, Myanmar, and Vietnam were genotyped at 33,716 genome-wide single nucleotide polymorphisms (SNPs). Linear mixed models were used to test associations between parasite genotypes and parasite clearance half-lives following artesunate treatment. K13 mutations were tested for association with artemisinin resistance and extended haplotypes on chromosome 13 were examined to determine whether mutations arose focally and spread, or emerged independently.</p><p class="abstract"><strong>Results</strong>: &emsp;The presence of non-reference K13 alleles was associated with prolonged parasite clearance half-life (p=1.97E-12). Parasites with a mutation in any of the K13 kelch domains displayed longer parasite clearance half-lives than parasites with wild-type alleles. Haplotype analysis revealed both population-specific emergence of mutations and independent emergence of the same mutation in different geographic areas.</p><p class="abstract"><strong>Conclusions</strong>: &emsp;K13 appears to be a major determinant of artemisinin resistance throughout Southeast Asia. While we found some evidence of spreading resistance, there was no evidence of resistance moving westward from Cambodia into Myanmar.</p>
<p class="publication"><span class="title">The Journal of infectious diseases</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25180241">25180241</a>; DOI: <a href="http://dx.doi.org/10.1093%2Finfdis%2Fjiu491">10.1093/infdis/jiu491</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Resetting transcription factor control circuitry toward ground-state pluripotency in human.</h4>
<p class="authors"><span class="author">Takashima Y</span>, <span class="author">Guo G</span>, <span class="author">Loos R</span>, <span class="author">Nichols J</span>, <span class="author">Ficz G</span>, <span class="author">Krueger F</span>, <span class="author">Oxley D</span>, <span class="author">Santos F</span>, <span class="author">Clarke J</span>, <span class="author">Mansfield W</span>, <span class="author">Reik W</span>, <span class="author">Bertone P</span> and <span class="author">Smith A</span></p>
<p class="affiliation">Wellcome Trust-Medical Research Council Stem Cell Institute, University of Cambridge, Tennis Court Road, Cambridge CB2 1QR, UK; PRESTO, Japan Science and Technology Agency, 4-1-8 Honcho, Kawaguchi, Saitama, 332-0012, Japan.</p><p class="abstract">Current human pluripotent stem cells lack the transcription factor circuitry that governs the ground state of mouse embryonic stem cells (ESC). Here, we report that short-term expression of two components, NANOG and KLF2, is sufficient to ignite other elements of the network and reset the human pluripotent state. Inhibition of ERK and protein kinase C sustains a transgene-independent rewired state. Reset cells self-renew continuously without ERK signaling, are phenotypically stable, and are karyotypically intact. They differentiate in&nbsp;vitro and form teratomas in&nbsp;vivo. Metabolism is reprogrammed with activation of mitochondrial respiration as in ESC. DNA methylation is dramatically reduced and transcriptome state is globally realigned across multiple cell lines. Depletion of ground-state transcription factors, TFCP2L1 or KLF4, has marginal impact on conventional human pluripotent stem cells but collapses the reset state. These findings demonstrate feasibility of installing and propagating functional control circuitry for ground-state pluripotency in human cells.</p>
<p class="grants">Funded by: Medical Research Council; Wellcome Trust</p>
<p class="publication"><span class="title">Cell</span>&nbsp;<span class="year">2014</span>;<span class="volume">158</span>;<span class="number">6</span>;<span class="pagerange">1254-69</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25215486">25215486</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4162745">4162745</a>; DOI: <a href="http://dx.doi.org/10.1016%2Fj.cell.2014.08.029">10.1016/j.cell.2014.08.029</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Off-target assessment of CRISPR-cas9 guiding RNAs in human iPS and mouse ES cells.</h4>
<p class="authors"><span class="author">Tan EP</span>, <span class="author">Li Y</span>, <span class="author">Velasco-Herrera MD</span>, <span class="author">Yusa K</span> and <span class="author">Bradley A</span></p>
<p class="affiliation">Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK.</p><p class="abstract">The CRIPSR-Cas9 system consists of a site-specific, targetable DNA nuclease that holds great potential in gene editing and genome-wide screening applications. In order to apply the CRISPR-Cas9 system to these assays successfully, the rate at which Cas9 induces DNA breaks at undesired loci must be understood. We characterised the rate of Cas9 off-target activity in typical Cas9 experiments in two human and one mouse cell lines. We analysed the Cas9 cutting activity of 12 gRNAs in both their targeted sites and &sim;90 predicted off-target sites per gRNA. In a Cas9-based knock-out experiment, gRNAs induced detectable Cas9 cutting activity in all on-target sites and in only a few off-target sites genome-wide in human 293FT, human iPS cells and mouse ES cells. Both the cutting rates and DNA repair patterns were highly correlated between the two human cell lines in both on-target and off-target sites. In clonal Cas9 cutting analysis in mouse ES cells, bi-allelic Cas9 cutting was observed with low off-target activity. Our results show that off-target activity of Cas9 is low and predictable by the degree of sequence identity between the gRNA and a potential off-target site. Off-target Cas9 activity can be minimized by selecting gRNAs with few off-target sites of near-complementarity. genesis 00:00-00, 2014. &copy; 2014 Wiley Periodicals, Inc.</p>
<p class="publication"><span class="title">Genesis (New York, N.Y. : 2000)</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25378133">25378133</a>; DOI: <a href="http://dx.doi.org/10.1002%2Fdvg.22835">10.1002/dvg.22835</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Investigating the possible causal association of smoking with depression and anxiety using Mendelian randomisation meta-analysis: the CARTA consortium.</h4>
<p class="authors"><span class="author">Taylor AE</span>, <span class="author">Fluharty ME</span>, <span class="author">Bj&oslash;rngaard JH</span>, <span class="author">Gabrielsen ME</span>, <span class="author">Skorpen F</span>, <span class="author">Marioni RE</span>, <span class="author">Campbell A</span>, <span class="author">Engmann J</span>, <span class="author">Mirza SS</span>, <span class="author">Loukola A</span>, <span class="author">Laatikainen T</span>, <span class="author">Partonen T</span>, <span class="author">Kaakinen M</span>, <span class="author">Ducci F</span>, <span class="author">Cavadino A</span>, <span class="author">Husemoen LL</span>, <span class="author">Ahluwalia TS</span>, <span class="author">Jacobsen RK</span>, <span class="author">Skaaby T</span>, <span class="author">Ebstrup JF</span>, <span class="author">Mortensen EL</span>, <span class="author">Minica CC</span>, <span class="author">Vink JM</span>, <span class="author">Willemsen G</span>, <span class="author">Marques-Vidal P</span>, <span class="author">Dale CE</span>, <span class="author">Amuzu A</span>, <span class="author">Lennon LT</span>, <span class="author">Lahti J</span>, <span class="author">Palotie A</span>, <span class="author">R&auml;ikk&ouml;nen K</span>, <span class="author">Wong A</span>, <span class="author">Paternoster L</span>, <span class="author">Wong AP</span>, <span class="author">Horwood LJ</span>, <span class="author">Murphy M</span>, <span class="author">Johnstone EC</span>, <span class="author">Kennedy MA</span>, <span class="author">Pausova Z</span>, <span class="author">Paus T</span>, <span class="author">Ben-Shlomo Y</span>, <span class="author">Nohr EA</span>, <span class="author">Kuh D</span>, <span class="author">Kivimaki M</span>, <span class="author">Eriksson JG</span>, <span class="author">Morris RW</span>, <span class="author">Casas JP</span>, <span class="author">Preisig M</span>, <span class="author">Boomsma DI</span>, <span class="author">Linneberg A</span>, <span class="author">Power C</span>, <span class="author">Hypp&ouml;nen E</span>, <span class="author">Veijola J</span>, <span class="author">Jarvelin MR</span>, <span class="author">Korhonen T</span>, <span class="author">Tiemeier H</span>, <span class="author">Kumari M</span>, <span class="author">Porteous DJ</span>, <span class="author">Hayward C</span>, <span class="author">Romundstad PR</span>, <span class="author">Smith GD</span> and <span class="author">Munaf&ograve; MR</span></p>
<p class="affiliation">MRC Integrative Epidemiology Unit (IEU) at the University of Bristol, UK UK Centre for Tobacco and Alcohol Studies, School of Experimental Psychology, University of Bristol, Bristol, UK.</p><p class="abstract"><strong>Objectives</strong>: To investigate whether associations of smoking with depression and anxiety are likely to be causal, using a Mendelian randomisation approach.</p><p class="abstract"><strong>Design</strong>: Mendelian randomisation meta-analyses using a genetic variant (rs16969968/rs1051730) as a proxy for smoking heaviness, and observational meta-analyses of the associations of smoking status and smoking heaviness with depression, anxiety and psychological distress.</p><p class="abstract"><strong>Participants</strong>: Current, former and never smokers of European ancestry aged &ge;16&#x2005;years from 25 studies in the Consortium for Causal Analysis Research in Tobacco and Alcohol (CARTA).</p><p class="abstract">Binary definitions of depression, anxiety and psychological distress assessed by clinical interview, symptom scales or self-reported recall of clinician diagnosis.</p><p class="abstract"><strong>Results</strong>: The analytic sample included up to 58&#x2005;176 never smokers, 37&#x2005;428 former smokers and 32&#x2005;028 current smokers (total N=127&#x2005;632). In observational analyses, current smokers had 1.85 times greater odds of depression (95% CI 1.65 to 2.07), 1.71 times greater odds of anxiety (95% CI 1.54 to 1.90) and 1.69 times greater odds of psychological distress (95% CI 1.56 to 1.83) than never smokers. Former smokers also had greater odds of depression, anxiety and psychological distress than never smokers. There was evidence for positive associations of smoking heaviness with depression, anxiety and psychological distress (ORs per cigarette per day: 1.03 (95% CI 1.02 to 1.04), 1.03 (95% CI 1.02 to 1.04) and 1.02 (95% CI 1.02 to 1.03) respectively). In Mendelian randomisation analyses, there was no strong evidence that the minor allele of rs16969968/rs1051730 was associated with depression (OR=1.00, 95% CI 0.95 to 1.05), anxiety (OR=1.02, 95% CI 0.97 to 1.07) or psychological distress (OR=1.02, 95% CI 0.98 to 1.06) in current smokers. Results were similar for former smokers.</p><p class="abstract"><strong>Conclusions</strong>: Findings from Mendelian randomisation analyses do not support a causal role of smoking heaviness in the development of depression and anxiety.</p>
<p class="publication"><span class="title">BMJ open</span>&nbsp;<span class="year">2014</span>;<span class="volume">4</span>;<span class="number">10</span>;<span class="pagerange">e006141</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25293386">25293386</a>; DOI: <a href="http://dx.doi.org/10.1136%2Fbmjopen-2014-006141">10.1136/bmjopen-2014-006141</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Stratification by Smoking Status Reveals an Association of CHRNA5-A3-B4 Genotype with Body Mass Index in Never Smokers.</h4>
<p class="authors"><span class="author">Taylor AE</span>, <span class="author">Morris RW</span>, <span class="author">Fluharty ME</span>, <span class="author">Bjorngaard JH</span>, <span class="author">Asvold BO</span>, <span class="author">Gabrielsen ME</span>, <span class="author">Campbell A</span>, <span class="author">Marioni R</span>, <span class="author">Kumari M</span>, <span class="author">H&auml;llfors J</span>, <span class="author">M&auml;nnist&ouml; S</span>, <span class="author">Marques-Vidal P</span>, <span class="author">Kaakinen M</span>, <span class="author">Cavadino A</span>, <span class="author">Postmus I</span>, <span class="author">Husemoen LL</span>, <span class="author">Skaaby T</span>, <span class="author">Ahluwalia TS</span>, <span class="author">Treur JL</span>, <span class="author">Willemsen G</span>, <span class="author">Dale C</span>, <span class="author">Wannamethee SG</span>, <span class="author">Lahti J</span>, <span class="author">Palotie A</span>, <span class="author">R&auml;ikk&ouml;nen K</span>, <span class="author">Kisialiou A</span>, <span class="author">McConnachie A</span>, <span class="author">Padmanabhan S</span>, <span class="author">Wong A</span>, <span class="author">Dalg&aring;rd C</span>, <span class="author">Paternoster L</span>, <span class="author">Ben-Shlomo Y</span>, <span class="author">Tyrrell J</span>, <span class="author">Horwood J</span>, <span class="author">Fergusson DM</span>, <span class="author">Kennedy MA</span>, <span class="author">Frayling T</span>, <span class="author">Nohr EA</span>, <span class="author">Christiansen L</span>, <span class="author">Ohm Kyvik K</span>, <span class="author">Kuh D</span>, <span class="author">Watt G</span>, <span class="author">Eriksson J</span>, <span class="author">Whincup PH</span>, <span class="author">Vink JM</span>, <span class="author">Boomsma DI</span>, <span class="author">Davey Smith G</span>, <span class="author">Lawlor D</span>, <span class="author">Linneberg A</span>, <span class="author">Ford I</span>, <span class="author">Jukema JW</span>, <span class="author">Power C</span>, <span class="author">Hypp&ouml;nen E</span>, <span class="author">Jarvelin MR</span>, <span class="author">Preisig M</span>, <span class="author">Borodulin K</span>, <span class="author">Kaprio J</span>, <span class="author">Kivimaki M</span>, <span class="author">Smith BH</span>, <span class="author">Hayward C</span>, <span class="author">Romundstad PR</span>, <span class="author">S&oslash;rensen TI</span>, <span class="author">Munaf&ograve; MR</span> and <span class="author">Sattar N</span></p>
<p class="affiliation">MRC Integrative Epidemiology Unit (IEU) at the University of Bristol, Bristol, United Kingdom; UK Centre for Tobacco and Alcohol Research Studies, School of Experimental Psychology, University of Bristol, Bristol, United Kingdom.</p><p class="abstract">We previously used a single nucleotide polymorphism (SNP) in the CHRNA5-A3-B4 gene cluster associated with heaviness of smoking within smokers to confirm the causal effect of smoking in reducing body mass index (BMI) in a Mendelian randomisation analysis. While seeking to extend these findings in a larger sample we found that this SNP is associated with 0.74% lower body mass index (BMI) per minor allele in current smokers (95% CI -0.97 to -0.51, P&#x200A;=&#x200A;2.00&times;10-10), but also unexpectedly found that it was associated with 0.35% higher BMI in never smokers (95% CI +0.18 to +0.52, P&#x200A;=&#x200A;6.38&times;10-5). An interaction test confirmed that these estimates differed from each other (P&#x200A;=&#x200A;4.95&times;10-13). This difference in effects suggests the variant influences BMI both via pathways unrelated to smoking, and via the weight-reducing effects of smoking. It would therefore be essentially undetectable in an unstratified genome-wide association study of BMI, given the opposite association with BMI in never and current smokers. This demonstrates that novel associations may be obscured by hidden population sub-structure. Stratification on well-characterized environmental factors known to impact on health outcomes may therefore reveal novel genetic associations.</p>
<p class="publication"><span class="title">PLoS genetics</span>&nbsp;<span class="year">2014</span>;<span class="volume">10</span>;<span class="number">12</span>;<span class="pagerange">e1004799</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25474695">25474695</a>; DOI: <a href="http://dx.doi.org/10.1371%2Fjournal.pgen.1004799">10.1371/journal.pgen.1004799</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Clinical and pharmacogenomic implications of genetic variation in a Southern Ethiopian population.</h4>
<p class="authors"><span class="author">Tekola-Ayele F</span>, <span class="author">Adeyemo A</span>, <span class="author">Aseffa A</span>, <span class="author">Hailu E</span>, <span class="author">Finan C</span>, <span class="author">Davey G</span>, <span class="author">Rotimi CN</span> and <span class="author">Newport MJ</span></p>
<p class="affiliation">Center for Research on Genomics and Global Health, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA.</p><p class="abstract">Africa is home to genetically diverse human populations. We compared the genetic structure of the Wolaita ethnic population from Southern Ethiopia (WETH, n=120) with HapMap populations using genome-wide variants. We investigated allele frequencies of 443 clinically and pharmacogenomically relevant genetic variants in WETH compared with HapMap populations. We found that WETH were genetically most similar to the Kenya Maasai and least similar to the Japanese in HapMap. Variant alleles associated with increased risk of adverse reactions to drugs used for treating tuberculosis (rs1799929 and rs1495741 in NAT2), thromboembolism (rs7294, rs9923231 and rs9934438 in VKORC1), and HIV/AIDS and solid tumors (rs2242046 in SLC28A1) had significantly higher frequencies in WETH compared with African ancestry HapMap populations. Our results illustrate that clinically relevant pharmacogenomic loci display allele frequency differences among African populations. We conclude that drug dosage guidelines for important global health diseases should be validated in genetically diverse African populations.The Pharmacogenomics Journal advance online publication, 29 July 2014; doi:10.1038/tpj.2014.39.</p>
<p class="publication"><span class="title">The pharmacogenomics journal</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25069476">25069476</a>; DOI: <a href="http://dx.doi.org/10.1038%2Ftpj.2014.39">10.1038/tpj.2014.39</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Differential PfEMP1 Expression Is Associated with Cerebral Malaria Pathology.</h4>
<p class="authors"><span class="author">Tembo DL</span>, <span class="author">Nyoni B</span>, <span class="author">Murikoli RV</span>, <span class="author">Mukaka M</span>, <span class="author">Milner DA</span>, <span class="author">Berriman M</span>, <span class="author">Rogerson SJ</span>, <span class="author">Taylor TE</span>, <span class="author">Molyneux ME</span>, <span class="author">Mandala WL</span>, <span class="author">Craig AG</span> and <span class="author">Montgomery J</span></p>
<p class="affiliation">Malawi-Liverpool-Wellcome Trust Clinical Research Programme, College of Medicine, Blantyre, Malawi; Department of Parasitology, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.</p><p class="abstract">Plasmodium falciparum is unique among human malarias in its ability to sequester in post-capillary venules of host organs. The main variant antigens implicated are the P. falciparum erythrocyte membrane protein 1 (PfEMP1), which can be divided into three major groups (A-C). Our study was a unique examination of sequestered populations of parasites for genetic background and expression of PfEMP1 groups. We collected post-mortem tissue from twenty paediatric hosts with pathologically different forms of cerebral malaria (CM1 and CM2) and parasitaemic controls (PC) to directly examine sequestered populations of parasites in the brain, heart and gut. Use of two different techniques to investigate this question produced divergent results. By quantitative PCR, group A var genes were upregulated in all three organs of CM2 and PC cases. In contrast, in CM1 infections displaying high levels of sequestration but negligible vascular pathology, there was high expression of group B var. Cloning and sequencing of var transcript tags from the same samples indicated a uniformly low expression of group A-like var. Generally, within an organ sample, 1-2 sequences were expressed at dominant levels. 23% of var tags were detected in multiple patients despite the P. falciparum infections being genetically distinct, and two tags were observed in up to seven hosts each with high expression in the brains of 3-4 patients. This study is a novel examination of the sequestered parasites responsible for fatal cerebral malaria and describes expression patterns of the major cytoadherence ligand in three organ-derived populations and three pathological states.</p>
<p class="publication"><span class="title">PLoS pathogens</span>&nbsp;<span class="year">2014</span>;<span class="volume">10</span>;<span class="number">12</span>;<span class="pagerange">e1004537</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25473835">25473835</a>; DOI: <a href="http://dx.doi.org/10.1371%2Fjournal.ppat.1004537">10.1371/journal.ppat.1004537</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Loss-of-function mutations in APOC3, triglycerides, and coronary disease.</h4>
<p class="authors"><span class="author">TG and HDL Working Group of the Exome Sequencing Project, National Heart, Lung, and Blood Institute</span>, <span class="author">Crosby J</span>, <span class="author">Peloso GM</span>, <span class="author">Auer PL</span>, <span class="author">Crosslin DR</span>, <span class="author">Stitziel NO</span>, <span class="author">Lange LA</span>, <span class="author">Lu Y</span>, <span class="author">Tang ZZ</span>, <span class="author">Zhang H</span>, <span class="author">Hindy G</span>, <span class="author">Masca N</span>, <span class="author">Stirrups K</span>, <span class="author">Kanoni S</span>, <span class="author">Do R</span>, <span class="author">Jun G</span>, <span class="author">Hu Y</span>, <span class="author">Kang HM</span>, <span class="author">Xue C</span>, <span class="author">Goel A</span>, <span class="author">Farrall M</span>, <span class="author">Duga S</span>, <span class="author">Merlini PA</span>, <span class="author">Asselta R</span>, <span class="author">Girelli D</span>, <span class="author">Olivieri O</span>, <span class="author">Martinelli N</span>, <span class="author">Yin W</span>, <span class="author">Reilly D</span>, <span class="author">Speliotes E</span>, <span class="author">Fox CS</span>, <span class="author">Hveem K</span>, <span class="author">Holmen OL</span>, <span class="author">Nikpay M</span>, <span class="author">Farlow DN</span>, <span class="author">Assimes TL</span>, <span class="author">Franceschini N</span>, <span class="author">Robinson J</span>, <span class="author">North KE</span>, <span class="author">Martin LW</span>, <span class="author">DePristo M</span>, <span class="author">Gupta N</span>, <span class="author">Escher SA</span>, <span class="author">Jansson JH</span>, <span class="author">Van Zuydam N</span>, <span class="author">Palmer CN</span>, <span class="author">Wareham N</span>, <span class="author">Koch W</span>, <span class="author">Meitinger T</span>, <span class="author">Peters A</span>, <span class="author">Lieb W</span>, <span class="author">Erbel R</span>, <span class="author">Konig IR</span>, <span class="author">Kruppa J</span>, <span class="author">Degenhardt F</span>, <span class="author">Gottesman O</span>, <span class="author">Bottinger EP</span>, <span class="author">O&#39;Donnell CJ</span>, <span class="author">Psaty BM</span>, <span class="author">Ballantyne CM</span>, <span class="author">Abecasis G</span>, <span class="author">Ordovas JM</span>, <span class="author">Melander O</span>, <span class="author">Watkins H</span>, <span class="author">Orho-Melander M</span>, <span class="author">Ardissino D</span>, <span class="author">Loos RJ</span>, <span class="author">McPherson R</span>, <span class="author">Willer CJ</span>, <span class="author">Erdmann J</span>, <span class="author">Hall AS</span>, <span class="author">Samani NJ</span>, <span class="author">Deloukas P</span>, <span class="author">Schunkert H</span>, <span class="author">Wilson JG</span>, <span class="author">Kooperberg C</span>, <span class="author">Rich SS</span>, <span class="author">Tracy RP</span>, <span class="author">Lin DY</span>, <span class="author">Altshuler D</span>, <span class="author">Gabriel S</span>, <span class="author">Nickerson DA</span>, <span class="author">Jarvik GP</span>, <span class="author">Cupples LA</span>, <span class="author">Reiner AP</span>, <span class="author">Boerwinkle E</span> and <span class="author">Kathiresan S</span></p><p class="abstract"><strong>Background</strong>: Plasma triglyceride levels are heritable and are correlated with the risk of coronary heart disease. Sequencing of the protein-coding regions of the human genome (the exome) has the potential to identify rare mutations that have a large effect on phenotype.</p><p class="abstract"><strong>Methods</strong>: We sequenced the protein-coding regions of 18,666 genes in each of 3734 participants of European or African ancestry in the Exome Sequencing Project. We conducted tests to determine whether rare mutations in coding sequence, individually or in aggregate within a gene, were associated with plasma triglyceride levels. For mutations associated with triglyceride levels, we subsequently evaluated their association with the risk of coronary heart disease in 110,970 persons.</p><p class="abstract"><strong>Results</strong>: An aggregate of rare mutations in the gene encoding apolipoprotein C3 (APOC3) was associated with lower plasma triglyceride levels. Among the four mutations that drove this result, three were loss-of-function mutations: a nonsense mutation (R19X) and two splice-site mutations (IVS2+1G&rarr;A and IVS3+1G&rarr;T). The fourth was a missense mutation (A43T). Approximately 1 in 150 persons in the study was a heterozygous carrier of at least one of these four mutations. Triglyceride levels in the carriers were 39% lower than levels in noncarriers (P&lt;1&times;10(-20)), and circulating levels of APOC3 in carriers were 46% lower than levels in noncarriers (P=8&times;10(-10)). The risk of coronary heart disease among 498 carriers of any rare APOC3 mutation was 40% lower than the risk among 110,472 noncarriers (odds ratio, 0.60; 95% confidence interval, 0.47 to 0.75; P=4&times;10(-6)).</p><p class="abstract"><strong>Conclusions</strong>: Rare mutations that disrupt APOC3 function were associated with lower levels of plasma triglycerides and APOC3. Carriers of these mutations were found to have a reduced risk of coronary heart disease. (Funded by the National Heart, Lung, and Blood Institute and others.).</p>
<p class="grants">Funded by: British Heart Foundation; Canadian Institutes of Health Research; NHLBI NIH HHS: <span class="grant">K08-HL114642</span>, <span class="grant">R01HL107816</span>, <span class="grant">RC2 HL-102923</span>, <span class="grant">RC2 HL-102924</span>, <span class="grant">RC2 HL-102925</span>, <span class="grant">RC2 HL-102926</span>, <span class="grant">RC2 HL-103010</span>, <span class="grant">T32HL007208</span></p>
<p class="publication"><span class="title">The New England journal of medicine</span>&nbsp;<span class="year">2014</span>;<span class="volume">371</span>;<span class="number">1</span>;<span class="pagerange">22-31</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24941081">24941081</a>; DOI: <a href="http://dx.doi.org/10.1056%2FNEJMoa1307095">10.1056/NEJMoa1307095</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Genome-wide meta-analysis identifies six novel loci associated with habitual coffee consumption.</h4>
<p class="authors"><span class="author">The Coffee and Caffeine Genetics Consortium</span>, <span class="author">Cornelis MC</span>, <span class="author">Byrne EM</span>, <span class="author">Esko T</span>, <span class="author">Nalls MA</span>, <span class="author">Ganna A</span>, <span class="author">Paynter N</span>, <span class="author">Monda KL</span>, <span class="author">Amin N</span>, <span class="author">Fischer K</span>, <span class="author">Renstrom F</span>, <span class="author">Ngwa JS</span>, <span class="author">Huikari V</span>, <span class="author">Cavadino A</span>, <span class="author">Nolte IM</span>, <span class="author">Teumer A</span>, <span class="author">Yu K</span>, <span class="author">Marques-Vidal P</span>, <span class="author">Rawal R</span>, <span class="author">Manichaikul A</span>, <span class="author">Wojczynski MK</span>, <span class="author">Vink JM</span>, <span class="author">Zhao JH</span>, <span class="author">Burlutsky G</span>, <span class="author">Lahti J</span>, <span class="author">Mikkil&auml; V</span>, <span class="author">Lemaitre RN</span>, <span class="author">Eriksson J</span>, <span class="author">Musani SK</span>, <span class="author">Tanaka T</span>, <span class="author">Geller F</span>, <span class="author">Luan J</span>, <span class="author">Hui J</span>, <span class="author">M&auml;gi R</span>, <span class="author">Dimitriou M</span>, <span class="author">Garcia ME</span>, <span class="author">Ho WK</span>, <span class="author">Wright MJ</span>, <span class="author">Rose LM</span>, <span class="author">Magnusson PK</span>, <span class="author">Pedersen NL</span>, <span class="author">Couper D</span>, <span class="author">Oostra BA</span>, <span class="author">Hofman A</span>, <span class="author">Ikram MA</span>, <span class="author">Tiemeier HW</span>, <span class="author">Uitterlinden AG</span>, <span class="author">van Rooij FJ</span>, <span class="author">Barroso I</span>, <span class="author">Johansson I</span>, <span class="author">Xue L</span>, <span class="author">Kaakinen M</span>, <span class="author">Milani L</span>, <span class="author">Power C</span>, <span class="author">Snieder H</span>, <span class="author">Stolk RP</span>, <span class="author">Baumeister SE</span>, <span class="author">Biffar R</span>, <span class="author">Gu F</span>, <span class="author">Bastardot F</span>, <span class="author">Kutalik Z</span>, <span class="author">Jacobs DR</span>, <span class="author">Forouhi NG</span>, <span class="author">Mihailov E</span>, <span class="author">Lind L</span>, <span class="author">Lindgren C</span>, <span class="author">Micha&euml;lsson K</span>, <span class="author">Morris A</span>, <span class="author">Jensen M</span>, <span class="author">Khaw KT</span>, <span class="author">Luben RN</span>, <span class="author">Wang JJ</span>, <span class="author">M&auml;nnist&ouml; S</span>, <span class="author">Per&auml;l&auml; MM</span>, <span class="author">K&auml;h&ouml;nen M</span>, <span class="author">Lehtim&auml;ki T</span>, <span class="author">Viikari J</span>, <span class="author">Mozaffarian D</span>, <span class="author">Mukamal K</span>, <span class="author">Psaty BM</span>, <span class="author">D&ouml;ring A</span>, <span class="author">Heath AC</span>, <span class="author">Montgomery GW</span>, <span class="author">Dahmen N</span>, <span class="author">Carithers T</span>, <span class="author">Tucker KL</span>, <span class="author">Ferrucci L</span>, <span class="author">Boyd HA</span>, <span class="author">Melbye M</span>, <span class="author">Treur JL</span>, <span class="author">Mellstr&ouml;m D</span>, <span class="author">Hottenga JJ</span>, <span class="author">Prokopenko I</span>, <span class="author">T&ouml;njes A</span>, <span class="author">Deloukas P</span>, <span class="author">Kanoni S</span>, <span class="author">Lorentzon M</span>, <span class="author">Houston DK</span>, <span class="author">Liu Y</span>, <span class="author">Danesh J</span>, <span class="author">Rasheed A</span>, <span class="author">Mason MA</span>, <span class="author">Zonderman AB</span>, <span class="author">Franke L</span>, <span class="author">Kristal BS</span>, <span class="author">International Parkinson&#39;s Disease Genomics Consortium (IPDGC)</span>, <span class="author">North American Brain Expression Consortium (NABEC)</span>, <span class="author">UK Brain Expression Consortium (UKBEC)</span>, <span class="author">Karjalainen J</span>, <span class="author">Reed DR</span>, <span class="author">Westra HJ</span>, <span class="author">Evans MK</span>, <span class="author">Saleheen D</span>, <span class="author">Harris TB</span>, <span class="author">Dedoussis G</span>, <span class="author">Curhan G</span>, <span class="author">Stumvoll M</span>, <span class="author">Beilby J</span>, <span class="author">Pasquale LR</span>, <span class="author">Feenstra B</span>, <span class="author">Bandinelli S</span>, <span class="author">Ordovas JM</span>, <span class="author">Chan AT</span>, <span class="author">Peters U</span>, <span class="author">Ohlsson C</span>, <span class="author">Gieger C</span>, <span class="author">Martin NG</span>, <span class="author">Waldenberger M</span>, <span class="author">Siscovick DS</span>, <span class="author">Raitakari O</span>, <span class="author">Eriksson JG</span>, <span class="author">Mitchell P</span>, <span class="author">Hunter DJ</span>, <span class="author">Kraft P</span>, <span class="author">Rimm EB</span>, <span class="author">Boomsma DI</span>, <span class="author">Borecki IB</span>, <span class="author">Loos RJ</span>, <span class="author">Wareham NJ</span>, <span class="author">Vollenweider P</span>, <span class="author">Caporaso N</span>, <span class="author">Grabe HJ</span>, <span class="author">Neuhouser ML</span>, <span class="author">Wolffenbuttel BH</span>, <span class="author">Hu FB</span>, <span class="author">Hypp&ouml;nen E</span>, <span class="author">J&auml;rvelin MR</span>, <span class="author">Cupples LA</span>, <span class="author">Franks PW</span>, <span class="author">Ridker PM</span>, <span class="author">van Duijn CM</span>, <span class="author">Heiss G</span>, <span class="author">Metspalu A</span>, <span class="author">North KE</span>, <span class="author">Ingelsson E</span>, <span class="author">Nettleton JA</span>, <span class="author">van Dam RM</span> and <span class="author">Chasman DI</span></p>
<p class="affiliation">1] Channing Division of Network Medicine, Brigham and Women&#39;s Hospital, Harvard Medical School, Boston, MA, USA [2] Department of Nutrition, Harvard School of Public Health, Boston, MA, USA.</p><p class="abstract">Coffee, a major dietary source of caffeine, is among the most widely consumed beverages in the world and has received considerable attention regarding health risks and benefits. We conducted a genome-wide (GW) meta-analysis of predominately regular-type coffee consumption (cups per day) among up to 91&thinsp;462 coffee consumers of European ancestry with top single-nucleotide polymorphisms (SNPs) followed-up in ~30&thinsp;062 and 7964 coffee consumers of European and African-American ancestry, respectively. Studies from both stages were combined in a trans-ethnic meta-analysis. Confirmed loci were examined for putative functional and biological relevance. Eight loci, including six novel loci, met GW significance (log10Bayes factor (BF)&gt;5.64) with per-allele effect sizes of 0.03-0.14 cups per day. Six are located in or near genes potentially involved in pharmacokinetics (ABCG2, AHR, POR and CYP1A2) and pharmacodynamics (BDNF and SLC6A4) of caffeine. Two map to GCKR and MLXIPL genes related to metabolic traits but lacking known roles in coffee consumption. Enhancer and promoter histone marks populate the regions of many confirmed loci and several potential regulatory SNPs are highly correlated with the lead SNP of each. SNP alleles near GCKR, MLXIPL, BDNF and CYP1A2 that were associated with higher coffee consumption have previously been associated with smoking initiation, higher adiposity and fasting insulin and glucose but lower blood pressure and favorable lipid, inflammatory and liver enzyme profiles (P&lt;5 &times; 10(-8)).Our genetic findings among European and African-American adults reinforce the role of caffeine in mediating habitual coffee consumption and may point to molecular mechanisms underlying inter-individual variability in pharmacological and health effects of coffee.Molecular Psychiatry advance online publication, 7 October 2014; doi:10.1038/mp.2014.107.</p>
<p class="publication"><span class="title">Molecular psychiatry</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25288136">25288136</a>; DOI: <a href="http://dx.doi.org/10.1038%2Fmp.2014.107">10.1038/mp.2014.107</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Large-scale discovery of novel genetic causes of developmental disorders.</h4>
<p class="authors"><span class="author">The Deciphering Developmental Disorders Study</span> and <span class="author">The Deciphering Developmental Disorders Study</span></p><p class="abstract">Despite three decades of successful, predominantly phenotype-driven discovery of the genetic causes of monogenic disorders, up to half of children with severe developmental disorders of probable genetic origin remain without a genetic diagnosis. Particularly challenging are those disorders rare enough to have eluded recognition as a discrete clinical entity, those with highly variable clinical manifestations, and those that are difficult to distinguish from other, very similar, disorders. Here we demonstrate the power of using an unbiased genotype-driven approach to identify subsets of patients with similar disorders. By studying 1,133 children with severe, undiagnosed developmental disorders, and their parents, using a combination of exome sequencing and array-based detection of chromosomal rearrangements, we discovered 12 novel genes associated with developmental disorders. These newly implicated genes increase by 10% (from 28% to 31%) the proportion of children that could be diagnosed. Clustering of missense mutations in six of these newly implicated genes suggests that normal development is being perturbed by an activating or dominant-negative mechanism. Our findings demonstrate the value of adopting a comprehensive strategy, both genome-wide and nationwide, to elucidate the underlying causes of rare genetic disorders.</p>
<p class="publication"><span class="title">Nature</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25533962">25533962</a>; DOI: <a href="http://dx.doi.org/10.1038%2Fnature14135">10.1038/nature14135</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Inactivating Mutations in NPC1L1 and Protection from Coronary Heart Disease.</h4>
<p class="authors"><span class="author">The Myocardial Infarction Genetics Consortium Investigators</span></p><p class="abstract">Background Ezetimibe lowers plasma levels of low-density lipoprotein (LDL) cholesterol by inhibiting the activity of the Niemann-Pick C1-like 1 (NPC1L1) protein. However, whether such inhibition reduces the risk of coronary heart disease is not known. Human mutations that inactivate a gene encoding a drug target can mimic the action of an inhibitory drug and thus can be used to infer potential effects of that drug. Methods We sequenced the exons of NPC1L1 in 7364 patients with coronary heart disease and in 14,728 controls without such disease who were of European, African, or South Asian ancestry. We identified carriers of inactivating mutations (nonsense, splice-site, or frameshift mutations). In addition, we genotyped a specific inactivating mutation (p.Arg406X) in 22,590 patients with coronary heart disease and in 68,412 controls. We tested the association between the presence of an inactivating mutation and both plasma lipid levels and the risk of coronary heart disease. Results With sequencing, we identified 15 distinct NPC1L1 inactivating mutations; approximately 1 in every 650 persons was a heterozygous carrier for 1 of these mutations. Heterozygous carriers of NPC1L1 inactivating mutations had a mean LDL cholesterol level that was 12 mg per deciliter (0.31 mmol per liter) lower than that in noncarriers (P=0.04). Carrier status was associated with a relative reduction of 53% in the risk of coronary heart disease (odds ratio for carriers, 0.47; 95% confidence interval, 0.25 to 0.87; P=0.008). In total, only 11 of 29,954 patients with coronary heart disease had an inactivating mutation (carrier frequency, 0.04%) in contrast to 71 of 83,140 controls (carrier frequency, 0.09%). Conclusions Naturally occurring mutations that disrupt NPC1L1 function were found to be associated with reduced plasma LDL cholesterol levels and a reduced risk of coronary heart disease. (Funded by the National Institutes of Health and others.).</p>
<p class="publication"><span class="title">The New England journal of medicine</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25390462">25390462</a>; DOI: <a href="http://dx.doi.org/10.1056%2FNEJMoa1405386">10.1056/NEJMoa1405386</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Typhoid fever in Fiji: a reversible plague?</h4>
<p class="authors"><span class="author">Thompson CN</span>, <span class="author">Kama M</span>, <span class="author">Acharya S</span>, <span class="author">Bera U</span>, <span class="author">Clemens J</span>, <span class="author">Crump JA</span>, <span class="author">Dawainavesi A</span>, <span class="author">Dougan G</span>, <span class="author">Edmunds WJ</span>, <span class="author">Fox K</span>, <span class="author">Jenkins K</span>, <span class="author">Khan MI</span>, <span class="author">Koroivueta J</span>, <span class="author">Levine MM</span>, <span class="author">Martin LB</span>, <span class="author">Nilles E</span>, <span class="author">Pitzer VE</span>, <span class="author">Singh S</span>, <span class="author">Raiwalu RV</span>, <span class="author">Baker S</span> and <span class="author">Mulholland K</span></p>
<p class="affiliation">Hospital for Tropical Diseases, Wellcome Trust Major Overseas Programme, Oxford University Clinical Research Unit, Ho Chi Minh City, Vietnam; Centre for Tropical Medicine, Nuffield Department of Clinical Medicine, Oxford University, Oxford, UK.</p><p class="abstract">The country of Fiji, with a population of approximately 870&nbsp;000 people, faces a growing burden of several communicable diseases including the bacterial infection typhoid fever. Surveillance data suggest that typhoid has become increasingly common in rural areas of Fiji and is more frequent amongst young adults. Transmission of the organisms that cause typhoid is facilitated by faecal contamination of food or water and may be influenced by local behavioural practices in Fiji. The Fijian Ministry of Health, with support from Australian Aid, hosted a meeting in August 2012 to develop comprehensive control and prevention strategies for typhoid fever in Fiji. International and local specialists were invited to share relevant data and discuss typhoid control options. The resultant recommendations focused on generating a clearer sense of the epidemiology of typhoid in Fiji and exploring the contribution of potential transmission pathways. Additionally, the panel suggested steps such as ensuring that recommended ciprofloxacin doses are appropriate to reduce the potential for relapse and reinfection in clinical cases, encouraging proper hand hygiene of food and drink handlers, working with water and sanitation agencies to review current sanitation practices and considering a vaccination policy targeting epidemiologically relevant populations.</p>
<p class="publication"><span class="title">Tropical medicine &amp; international health : TM &amp; IH</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25066005">25066005</a>; DOI: <a href="http://dx.doi.org/10.1111%2Ftmi.12367">10.1111/tmi.12367</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Genetic background of extreme violent behavior.</h4>
<p class="authors"><span class="author">Tiihonen J</span>, <span class="author">Rautiainen MR</span>, <span class="author">Ollila HM</span>, <span class="author">Repo-Tiihonen E</span>, <span class="author">Virkkunen M</span>, <span class="author">Palotie A</span>, <span class="author">Pietil&auml;inen O</span>, <span class="author">Kristiansson K</span>, <span class="author">Joukamaa M</span>, <span class="author">Lauerma H</span>, <span class="author">Saarela J</span>, <span class="author">Tyni S</span>, <span class="author">Vartiainen H</span>, <span class="author">Paananen J</span>, <span class="author">Goldman D</span> and <span class="author">Paunio T</span></p>
<p class="affiliation">1] Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden [2] Department of Forensic Psychiatry, University of Eastern Finland, Niuvanniemi Hospital, Kuopio, Finland [3] National Institute for Health and Welfare, Helsinki, Finland.</p><p class="abstract">In developed countries, the majority of all violent crime is committed by a small group of antisocial recidivistic offenders, but no genes have been shown to contribute to recidivistic violent offending or severe violent behavior, such as homicide. Our results, from two independent cohorts of Finnish prisoners, revealed that a monoamine oxidase A (MAOA) low-activity genotype (contributing to low dopamine turnover rate) as well as the CDH13 gene (coding for neuronal membrane adhesion protein) are associated with extremely violent behavior (at least 10 committed homicides, attempted homicides or batteries). No substantial signal was observed for either MAOA or CDH13 among non-violent offenders, indicating that findings were specific for violent offending, and not largely attributable to substance abuse or antisocial personality disorder. These results indicate both low monoamine metabolism and neuronal membrane dysfunction as plausible factors in the etiology of extreme criminal violent behavior, and imply that at least about 5-10% of all severe violent crime in Finland is attributable to the aforementioned MAOA and CDH13 genotypes.Molecular Psychiatry advance online publication, 28 October 2014; doi:10.1038/mp.2014.130.</p>
<p class="publication"><span class="title">Molecular psychiatry</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25349169">25349169</a>; DOI: <a href="http://dx.doi.org/10.1038%2Fmp.2014.130">10.1038/mp.2014.130</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">A rare variant in APOC3 is associated with plasma triglyceride and VLDL levels in Europeans.</h4>
<p class="authors"><span class="author">Timpson NJ</span>, <span class="author">Walter K</span>, <span class="author">Min JL</span>, <span class="author">Tachmazidou I</span>, <span class="author">Malerba G</span>, <span class="author">Shin SY</span>, <span class="author">Chen L</span>, <span class="author">Futema M</span>, <span class="author">Southam L</span>, <span class="author">Iotchkova V</span>, <span class="author">Cocca M</span>, <span class="author">Huang J</span>, <span class="author">Memari Y</span>, <span class="author">McCarthy S</span>, <span class="author">Danecek P</span>, <span class="author">Muddyman D</span>, <span class="author">Mangino M</span>, <span class="author">Menni C</span>, <span class="author">Perry JR</span>, <span class="author">Ring SM</span>, <span class="author">Gaye A</span>, <span class="author">Dedoussis G</span>, <span class="author">Farmaki AE</span>, <span class="author">Burton P</span>, <span class="author">Talmud PJ</span>, <span class="author">Gambaro G</span>, <span class="author">Spector TD</span>, <span class="author">Smith GD</span>, <span class="author">Durbin R</span>, <span class="author">Richards JB</span>, <span class="author">Humphries SE</span>, <span class="author">Zeggini E</span>, <span class="author">Soranzo N</span>, <span class="author">UK1OK Consortium Members</span> and <span class="author">UK1OK Consortium Members</span></p>
<p class="affiliation">MRC Integrative Epidemiology Unit at the University of Bristol, University of Bristol, Oakfield House, Oakfield Grove, Bristol BS8 2BN, UK.</p><p class="abstract">The analysis of rich catalogues of genetic variation from population-based sequencing provides an opportunity to screen for functional effects. Here we report a rare variant in APOC3 (rs138326449-A, minor allele frequency ~0.25% (UK)) associated with plasma triglyceride (TG) levels (-1.43 s.d. (s.e.=0.27 per minor allele (P-value=8.0 &times; 10(-8))) discovered in 3,202 individuals with low read-depth, whole-genome sequence. We replicate this in 12,831 participants from five additional samples of Northern and Southern European origin (-1.0 s.d. (s.e.=0.173), P-value=7.32 &times; 10(-9)). This is consistent with an effect between 0.5 and 1.5 mmol l(-1) dependent on population. We show that a single predicted splice donor variant is responsible for association signals and is independent of known common variants. Analyses suggest an independent relationship between rs138326449 and high-density lipoprotein (HDL) levels. This represents one of the first examples of a rare, large effect variant identified from whole-genome sequencing at a population scale.</p>
<p class="grants">Funded by: British Heart Foundation: <span class="grant">PG008/08</span>; Medical Research Council: <span class="grant">G1001799</span>, <span class="grant">G9815508</span>, <span class="grant">MC_UU_12012/5/B</span>, <span class="grant">MC_UU_12013/1-9</span>, <span class="grant">MC_UU_12013/3</span>; Wellcome Trust: <span class="grant">076113</span>, <span class="grant">091310</span>, <span class="grant">091551</span>, <span class="grant">092731</span>, <span class="grant">095219</span>, <span class="grant">098051</span>, <span class="grant">WT091310</span>, <span class="grant">WT095219MA</span>, <span class="grant">WT098051</span></p>
<p class="publication"><span class="title">Nature communications</span>&nbsp;<span class="year">2014</span>;<span class="volume">5</span>;<span class="pagerange">4871</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25225788">25225788</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4167609">4167609</a>; DOI: <a href="http://dx.doi.org/10.1038%2Fncomms5871">10.1038/ncomms5871</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Simulation and estimation of gene number in a biological pathway using almost complete saturation mutagenesis screening of haploid mouse cells.</h4>
<p class="authors"><span class="author">Tokunaga M</span>, <span class="author">Kokubu C</span>, <span class="author">Maeda Y</span>, <span class="author">Sese J</span>, <span class="author">Horie K</span>, <span class="author">Sugimoto N</span>, <span class="author">Kinoshita T</span>, <span class="author">Yusa K</span> and <span class="author">Takeda J</span></p>
<p class="affiliation">Department of Social and Environmental Medicine, Graduate School of Medicine, Osaka University, 2-2 Yamada-oka, Suita, Osaka 565-0871, Japan. <a href="mailto:%6B%79%31%40%73%61%6E%67%65%72.%61%63.%75%6B">&#107;&#121;&#49;&#64;&#115;&#97;&#110;&#103;&#101;&#114;&#46;&#97;&#99;&#46;&#117;&#107;</a>.</p><p class="abstract"><strong>Background</strong>: Genome-wide saturation mutagenesis and subsequent phenotype-driven screening has been central to a comprehensive understanding of complex biological processes in classical model organisms such as flies, nematodes, and plants. The degree of &quot;saturation&quot; (i.e., the fraction of possible target genes identified) has been shown to be a critical parameter in determining all relevant genes involved in a biological function, without prior knowledge of their products. In mammalian model systems, however, the relatively large scale and labor intensity of experiments have hampered the achievement of actual saturation mutagenesis, especially for recessive traits that require biallelic mutations to manifest detectable phenotypes.</p><p class="abstract"><strong>Results</strong>: By exploiting the recently established haploid mouse embryonic stem cells (ESCs), we present an implementation of almost complete saturation mutagenesis in a mammalian system. The haploid ESCs were mutagenized with the chemical mutagen N-ethyl-N-nitrosourea (ENU) and processed for the screening of mutants defective in various steps of the glycosylphosphatidylinositol-anchor biosynthetic pathway. The resulting 114 independent mutant clones were characterized by a functional complementation assay, and were shown to be defective in any of 20 genes among all 22 known genes essential for this well-characterized pathway. Ten mutants were further validated by whole-exome sequencing. The predominant generation of single-nucleotide substitutions by ENU resulted in a gene mutation rate proportional to the length of the coding sequence, which facilitated the experimental design of saturation mutagenesis screening with the aid of computational simulation.</p><p class="abstract"><strong>Conclusions</strong>: Our study enables mammalian saturation mutagenesis to become a realistic proposition. Computational simulation, combined with a pilot mutagenesis experiment, could serve as a tool for the estimation of the number of genes essential for biological processes such as drug target pathways when a positive selection of mutants is available.</p>
<p class="publication"><span class="title">BMC genomics</span>&nbsp;<span class="year">2014</span>;<span class="volume">15</span>;<span class="number">1</span>;<span class="pagerange">1016</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25418962">25418962</a>; DOI: <a href="http://dx.doi.org/10.1186%2F1471-2164-15-1016">10.1186/1471-2164-15-1016</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Genome sequencing defines phylogeny and spread of methicillin-resistant Staphylococcus aureus in a high transmission setting.</h4>
<p class="authors"><span class="author">Tong SY</span>, <span class="author">Holden MT</span>, <span class="author">Nickerson EK</span>, <span class="author">Cooper BS</span>, <span class="author">K&ouml;ser CU</span>, <span class="author">Cori A</span>, <span class="author">Jombart T</span>, <span class="author">Cauchemez S</span>, <span class="author">Fraser C</span>, <span class="author">Wuthiekanun V</span>, <span class="author">Thaipadungpanit J</span>, <span class="author">Hongsuwan M</span>, <span class="author">Day NP</span>, <span class="author">Limmathurotsakul D</span>, <span class="author">Parkhill J</span> and <span class="author">Peacock SJ</span></p>
<p class="affiliation">The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1SA, United Kingdom; Menzies School of Health Research, Darwin, Northern Territory 0811, Australia;</p><p class="abstract">Methicillin-resistant Staphylococcus aureus (MRSA) is a major cause of nosocomial infection. Whole-genome sequencing of MRSA has been used to define phylogeny and transmission in well-resourced healthcare settings, yet the greatest burden of nosocomial infection occurs in resource-restricted settings where barriers to transmission are lower. Here, we study the flux and genetic diversity of MRSA on ward and individual patient levels in a hospital where transmission was common. We repeatedly screened all patients on two intensive care units for MRSA carriage over a 3-mo period. All MRSA belonged to multilocus sequence type 239 (ST 239). We defined the population structure and charted the spread of MRSA by sequencing 79 isolates from 46 patients and five members of staff, including the first MRSA-positive screen isolates and up to two repeat isolates where available. Phylogenetic analysis identified a flux of distinct ST 239 clades over time in each intensive care unit. In total, five main clades were identified, which varied in the carriage of plasmids encoding antiseptic and antimicrobial resistance determinants. Sequence data confirmed intra- and interwards transmission events and identified individual patients who were colonized by more than one clade. One patient on each unit was the source of numerous transmission events, and deep sampling of one of these cases demonstrated colonization with a &quot;cloud&quot; of related MRSA variants. The application of whole-genome sequencing and analysis provides novel insights into the transmission of MRSA in under-resourced healthcare settings and has relevance to wider global health.</p>
<p class="publication"><span class="title">Genome research</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25491771">25491771</a>; DOI: <a href="http://dx.doi.org/10.1101%2Fgr.174730.114">10.1101/gr.174730.114</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Novel staphylococcal species that form part of a Staphylococcus aureus related complex: the non-pigmented S. argenteus and the non-human primate associated S. schweitzeri sp. nov.</h4>
<p class="authors"><span class="author">Tong SY</span>, <span class="author">Schaumburg F</span>, <span class="author">Ellington MJ</span>, <span class="author">Corander J</span>, <span class="author">Pichon B</span>, <span class="author">Leendertz F</span>, <span class="author">Bentley SD</span>, <span class="author">Parkhill J</span>, <span class="author">Holt DC</span>, <span class="author">Peters G</span> and <span class="author">Giffard PM</span></p>
<p class="affiliation">Menzies School of Health Research; <a href="mailto:%73%74%65%76%65%6E.%74%6F%6E%67%40%6D%65%6E%7A%69%65%73.%65%64%75.%61%75">&#115;&#116;&#101;&#118;&#101;&#110;&#46;&#116;&#111;&#110;&#103;&#64;&#109;&#101;&#110;&#122;&#105;&#101;&#115;&#46;&#101;&#100;&#117;&#46;&#97;&#117;</a>.</p><p class="abstract">We define two new species in the genus Staphylococcus that are phenotypically similar to and have near identical 16S rRNA sequences to S. aureus. However, compared to S. aureus and each other, S. argenteus sp. nov. (type strain MSHR1132T =DSM 28299T, =SSI 89.005T) and S. schweitzeri sp. nov. (type strain FSA084T =DSM 28300T, =SSI 89.004T) demonstrate: 1) at a whole genome level considerable phylogenetic distance, lack of admixture, average nucleotide identity &lt; 95%, and inferred DNA-DNA hybridization &lt;70%; 2) different profiles as determined by MALDI-TOF MS; 3) a non-pigmented phenotype for S. argenteus sp. nov.; 4) S. schweitzeri sp. nov. is not detected by standard nucA PCR; 5) distinct peptidoglycan types compared to S. aureus; 6) a separate ecological niche for S. schweitzeri sp. nov.; and 7) a distinct clinical disease profile for S. argenteus sp. nov. compared to S. aureus.</p>
<p class="publication"><span class="title">International journal of systematic and evolutionary microbiology</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25269845">25269845</a>; DOI: <a href="http://dx.doi.org/10.1099%2Fijs.0.062752-0">10.1099/ijs.0.062752-0</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Complete Genome Sequences of Two Citrobacter rodentium Bacteriophages, CR8 and CR44b.</h4>
<p class="authors"><span class="author">Toribio AL</span>, <span class="author">Pickard D</span>, <span class="author">Cerde&ntilde;o-T&aacute;rraga AM</span>, <span class="author">Petty NK</span>, <span class="author">Thomson N</span>, <span class="author">Salmond G</span> and <span class="author">Dougan G</span></p>
<p class="affiliation"><a href="mailto:%61%6E%61.%74%6F%72%69%62%69%6F%40%63%61%6E%74%61%62.%6E%65%74">&#97;&#110;&#97;&#46;&#116;&#111;&#114;&#105;&#98;&#105;&#111;&#64;&#99;&#97;&#110;&#116;&#97;&#98;&#46;&#110;&#101;&#116;</a>.</p><p class="abstract">The complete genomes of two virulent phages infecting Citrobacter rodentium are reported here for the first time. Both bacteriophages were isolated from local sewage treatment plant effluents. Genome analyses revealed a close relationship between both phages and allowed their classification as members of the Autographivirinae subfamily in the T7-like genus.</p>
<p class="publication"><span class="title">Genome announcements</span>&nbsp;<span class="year">2014</span>;<span class="volume">2</span>;<span class="number">3</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24874665">24874665</a>; DOI: <a href="http://dx.doi.org/10.1128%2FgenomeA.00146-14">10.1128/genomeA.00146-14</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Identification of Antigen-Specific B Cell Receptor Sequences Using Public Repertoire Analysis.</h4>
<p class="authors"><span class="author">Tr&uuml;ck J</span>, <span class="author">Ramasamy MN</span>, <span class="author">Galson JD</span>, <span class="author">Rance R</span>, <span class="author">Parkhill J</span>, <span class="author">Lunter G</span>, <span class="author">Pollard AJ</span> and <span class="author">Kelly DF</span></p>
<p class="affiliation">Oxford Vaccine Group, Department of Paediatrics, University of Oxford and the National Institute for Health Research Oxford Biomedical Research Centre, Oxford OX3 7LE, United Kingdom; <a href="mailto:%6A%6F%68%61%6E%6E%65%73.%74%72%75%63%6B%40%70%61%65%64%69%61%74%72%69%63%73.%6F%78.%61%63.%75%6B">&#106;&#111;&#104;&#97;&#110;&#110;&#101;&#115;&#46;&#116;&#114;&#117;&#99;&#107;&#64;&#112;&#97;&#101;&#100;&#105;&#97;&#116;&#114;&#105;&#99;&#115;&#46;&#111;&#120;&#46;&#97;&#99;&#46;&#117;&#107;</a>.</p><p class="abstract">High-throughput sequencing allows detailed study of the BCR repertoire postimmunization, but it remains unclear to what extent the de novo identification of Ag-specific sequences from the total BCR repertoire is possible. A conjugate vaccine containing Haemophilus influenzae type b (Hib) and group C meningococcal polysaccharides, as well as tetanus toxoid (TT), was used to investigate the BCR repertoire of adult humans following immunization and to test the hypothesis that public or convergent repertoire analysis could identify Ag-specific sequences. A number of Ag-specific BCR sequences have been reported for Hib and TT, which made a vaccine containing these two Ags an ideal immunological stimulus. Analysis of identical CDR3 amino acid sequences that were shared by individuals in the postvaccine repertoire identified a number of known Hib-specific sequences but only one previously described TT sequence. The extension of this analysis to nonidentical, but highly similar, CDR3 amino acid sequences revealed a number of other TT-related sequences. The anti-Hib avidity index postvaccination strongly correlated with the relative frequency of Hib-specific sequences, indicating that the postvaccination public BCR repertoire may be related to more conventional measures of immunogenicity correlating with disease protection. Analysis of public BCR repertoire provided evidence of convergent BCR evolution in individuals exposed to the same Ags. If this finding is confirmed, the public repertoire could be used for rapid and direct identification of protective Ag-specific BCR sequences from peripheral blood.</p>
<p class="publication"><span class="title">Journal of immunology (Baltimore, Md. : 1950)</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25392534">25392534</a>; DOI: <a href="http://dx.doi.org/10.4049%2Fjimmunol.1401405">10.4049/jimmunol.1401405</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">New mini- zincin structures provide a minimal scaffold for members of this metallopeptidase superfamily.</h4>
<p class="authors"><span class="author">Trame CB</span>, <span class="author">Chang Y</span>, <span class="author">Axelrod HL</span>, <span class="author">Eberhardt RY</span>, <span class="author">Coggill P</span>, <span class="author">Punta M</span> and <span class="author">Rawlings ND</span></p>
<p class="affiliation">Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, CB10 1SA, UK. <a href="mailto:%6E%64%72%40%65%62%69.%61%63.%75%6B">&#110;&#100;&#114;&#64;&#101;&#98;&#105;&#46;&#97;&#99;&#46;&#117;&#107;</a>.</p>
<p class="abstract">Background: The Acel_2062 protein from Acidothermus cellulolyticus is a protein of unknown function. Initial sequence analysis predicted that it was a metallopeptidase from the presence of a motif conserved amongst the Asp-zincins, which are peptidases that contain a single, catalytic zinc ion ligated by the histidines and aspartic acid within the motif (HEXXHXXGXXD). The Acel_2062 protein was chosen by the Joint Center for Structural Genomics for crystal structure determination to explore novel protein sequence space and structure-based function annotation.

Results: The crystal structure confirmed that the Acel_2062 protein consisted of a single, zincin-like metallopeptidase-like domain. The Met-turn, a structural feature thought to be important for a Met-zincin because it stabilizes the active site, is absent, and its stabilizing role may have been conferred to the C-terminal Tyr113. In our crystallographic model there are two molecules in the asymmetric unit and from size-exclusion chromatography, the protein dimerizes in solution. A water molecule is present in the putative zinc-binding site in one monomer, which is replaced by one of two observed conformations of His95 in the other.

Conclusions: The Acel_2062 protein is structurally related to the zincins. It contains the minimum structural features of a member of this protein superfamily, and can be described as a "mini- zincin". There is a striking parallel with the structure of a mini-Glu-zincin, which represents the minimum structure of a Glu-zincin (a metallopeptidase in which the third zinc ligand is a glutamic acid). Rather than being an ancestral state, phylogenetic analysis suggests that the mini-zincins are derived from larger proteins.</p>
<p class="publication"><span class="title">BMC bioinformatics</span>&nbsp;<span class="year">2014</span>;<span class="volume">15</span>;<span class="number">1</span>;<span class="pagerange">1</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24383880">24383880</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC3890501">3890501</a>; DOI: <a href="http://dx.doi.org/10.1186%2F1471-2105-15-1">10.1186/1471-2105-15-1</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Naturally Acquired Antibodies Specific for Plasmodium falciparum Reticulocyte-Binding Protein Homologue 5 Inhibit Parasite Growth and Predict Protection From Malaria.</h4>
<p class="authors"><span class="author">Tran TM</span>, <span class="author">Ongoiba A</span>, <span class="author">Coursen J</span>, <span class="author">Crosnier C</span>, <span class="author">Diouf A</span>, <span class="author">Huang CY</span>, <span class="author">Li S</span>, <span class="author">Doumbo S</span>, <span class="author">Doumtabe D</span>, <span class="author">Kone Y</span>, <span class="author">Bathily A</span>, <span class="author">Dia S</span>, <span class="author">Niangaly M</span>, <span class="author">Dara C</span>, <span class="author">Sangala J</span>, <span class="author">Miller LH</span>, <span class="author">Doumbo OK</span>, <span class="author">Kayentao K</span>, <span class="author">Long CA</span>, <span class="author">Miura K</span>, <span class="author">Wright GJ</span>, <span class="author">Traore B</span> and <span class="author">Crompton PD</span></p>
<p class="affiliation">Laboratory of Immunogenetics, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland.</p>
<p class="abstract">Background.Plasmodium falciparum reticulocyte-binding protein homologue 5 (PfRH5) is a blood-stage parasite protein essential for host erythrocyte invasion. PfRH5-specific antibodies raised in animals inhibit parasite growth in vitro, but the relevance of naturally acquired PfRH5-specific antibodies in humans is unclear. Methods.We assessed pre-malaria season PfRH5-specific immunoglobulin G (IgG) levels in 357 Malian children and adults who were uninfected with Plasmodium. Subsequent P. falciparum infections were detected by polymerase chain reaction every 2 weeks and malaria episodes by weekly physical examination and self-referral for 7 months. The primary outcome was time between the first P. falciparum infection and the first febrile malaria episode. PfRH5-specific IgG was assayed for parasite growth-inhibitory activity. Results.The presence of PfRH5-specific IgG at enrollment was associated with a longer time between the first blood-stage infection and the first malaria episode (PfRH5-seropositive median: 71 days, PfRH5-seronegative median: 18 days; P = .001). This association remained significant after adjustment for age and other factors associated with malaria risk/exposure (hazard ratio, .62; P = .02). Concentrated PfRH5-specific IgG purified from Malians inhibited P. falciparum growth in vitro. Conclusions.Naturally acquired PfRH5-specific IgG inhibits parasite growth in vitro and predicts protection from malaria. These findings strongly support efforts to develop PfRH5 as an urgently needed blood-stage malaria vaccine. Clinical Trials RegistrationNCT01322581.</p>
<p class="publication"><span class="title">The Journal of infectious diseases</span>&nbsp;<span class="year">2014</span>;<span class="volume">209</span>;<span class="number">5</span>;<span class="pagerange">789-98</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24133188">24133188</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC3923542">3923542</a>; DOI: <a href="http://dx.doi.org/10.1093%2Finfdis%2Fjit553">10.1093/infdis/jit553</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Summarizing specific profiles in Illumina sequencing from whole-genome amplified DNA.</h4>
<p class="authors"><span class="author">Tsai IJ</span>, <span class="author">Hunt M</span>, <span class="author">Holroyd N</span>, <span class="author">Huckvale T</span>, <span class="author">Berriman M</span> and <span class="author">Kikuchi T</span></p>
<p class="affiliation">Parasite Genomics, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Cambridge CB10 1SA, UK Faculty of Medicine, Division of Parasitology, Department of Infectious Disease, University of Miyazaki, Miyazaki 889-1692, Japan.</p><p class="abstract">Advances in both high-throughput sequencing and whole-genome amplification (WGA) protocols have allowed genomes to be sequenced from femtograms of DNA, for example from individual cells or from precious clinical and archived samples. Using the highly curated Caenorhabditis elegans genome as a reference, we have sequenced and identified errors and biases associated with Illumina library construction, library insert size, different WGA methods and genome features such as GC bias and simple repeat content. Detailed analysis of the reads from amplified libraries revealed characteristics suggesting that majority of amplified fragment ends are identical but inverted versions of each other. Read coverage in amplified libraries is correlated with both tandem and inverted repeat content, while GC content only influences sequencing in long-insert libraries. Nevertheless, single nucleotide polymorphism (SNP) calls and assembly metrics from reads in amplified libraries show comparable results with unamplified libraries. To utilize the full potential of WGA to reveal the real biological interest, this article highlights the importance of recognizing additional sources of errors from amplified sequence reads and discusses the potential implications in downstream analyses.</p>
<p class="grants">Funded by: Wellcome Trust: <span class="grant">WT 098051</span></p>
<p class="publication"><span class="title">DNA research : an international journal for rapid publication of reports on genes and genomes</span>&nbsp;<span class="year">2014</span>;<span class="volume">21</span>;<span class="number">3</span>;<span class="pagerange">243-54</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24353264">24353264</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4060946">4060946</a>; DOI: <a href="http://dx.doi.org/10.1093%2Fdnares%2Fdst054">10.1093/dnares/dst054</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Cellular reprogramming by transcription factor engineering.</h4>
<p class="authors"><span class="author">Tsang JC</span>, <span class="author">Gao X</span>, <span class="author">Lu L</span> and <span class="author">Liu P</span></p>
<p class="affiliation">Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1HH, UK.</p><p class="abstract">Recent researches have identified multiple transcription factors as permissible reprogramming factors to pluripotency and lineage switching. The current standard strategy by ectopic factor overexpression however has intrinsic limitations in studying the reprogramming mechanism. There is a growing interest in engineering novel chimeric reprogramming factors and applying designer transcription factors technology to improve reprogramming efficiency and dissect the process of endogenous pluripotency network reactivation. Here, we provide a concise review on the latest progress in studying cellular reprogramming by transcription factor engineering.</p>
<p class="publication"><span class="title">Current opinion in genetics &amp; development</span>&nbsp;<span class="year">2014</span>;<span class="volume">28C</span>;<span class="pagerange">1-9</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25151337">25151337</a>; DOI: <a href="http://dx.doi.org/10.1016%2Fj.gde.2014.07.001">10.1016/j.gde.2014.07.001</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Cigarette smoking reduces DNA methylation levels at multiple genomic loci but the effect is partially reversible upon cessation.</h4>
<p class="authors"><span class="author">Tsaprouni LG</span>, <span class="author">Yang TP</span>, <span class="author">Bell J</span>, <span class="author">Dick KJ</span>, <span class="author">Kanoni S</span>, <span class="author">Nisbet J</span>, <span class="author">Vi&ntilde;uela A</span>, <span class="author">Grundberg E</span>, <span class="author">Nelson CP</span>, <span class="author">Meduri E</span>, <span class="author">Buil A</span>, <span class="author">Cambien F</span>, <span class="author">Hengstenberg C</span>, <span class="author">Erdmann J</span>, <span class="author">Schunkert H</span>, <span class="author">Goodall AH</span>, <span class="author">Ouwehand WH</span>, <span class="author">Dermitzakis E</span>, <span class="author">Spector TD</span>, <span class="author">Samani NJ</span> and <span class="author">Deloukas P</span></p>
<p class="affiliation">a Wellcome Trust Sanger Institute ; Hinxton , Cambridge , UK.</p><p class="abstract">Smoking is a major risk factor in many diseases. Genome wide association studies have linked genes for nicotine dependence and smoking behavior to increased risk of cardiovascular, pulmonary, and malignant diseases. We conducted an epigenome wide association study in peripheral-blood DNA in 464 individuals (22 current smokers and 263 ex-smokers), using the Human Methylation 450&nbsp;K array. Upon replication in an independent sample of 356 twins (41 current and 104 ex-smokers), we identified 30 probes in 15 distinct loci, all of which reached genome-wide significance in the combined analysis P &lt; 5 &times; 10(-8). All but one probe (cg17024919) remained significant after adjusting for blood cell counts. We replicated all 9 known loci and found an independent signal at CPOX near GPR15. In addition, we found 6 new loci at PRSS23, AVPR1B, PSEN2, LINC00299, RPS6KA2, and KIAA0087. Most of the lead probes (13 out of 15) associated with cigarette smoking, overlapped regions of open chromatin (FAIRE and DNaseI hypersensitive sites) or / and H3K27Ac peaks (ENCODE data set), which mark regulatory elements. The effect of smoking on DNA methylation was partially reversible upon smoking cessation for longer than 3 months. We report the first statistically significant interaction between a SNP (rs2697768) and cigarette smoking on DNA methylation (cg03329539). We provide evidence that the metSNP for cg03329539 regulates expression of the CHRND gene located circa 95&nbsp;Kb downstream of the methylation site. Our findings suggest the existence of dynamic, reversible site-specific methylation changes in response to cigarette smoking , which may contribute to the extended health risks associated with cigarette smoking.</p>
<p class="publication"><span class="title">Epigenetics : official journal of the DNA Methylation Society</span>&nbsp;<span class="year">2014</span>;<span class="volume">9</span>;<span class="number">10</span>;<span class="pagerange">1382-96</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25424692">25424692</a>; DOI: <a href="http://dx.doi.org/10.4161%2F15592294.2014.969637">10.4161/15592294.2014.969637</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Mobile DNA in cancer. Extensive transduction of nonrepetitive DNA mediated by L1 retrotransposition in cancer genomes.</h4>
<p class="authors"><span class="author">Tubio JM</span>, <span class="author">Li Y</span>, <span class="author">Ju YS</span>, <span class="author">Martincorena I</span>, <span class="author">Cooke SL</span>, <span class="author">Tojo M</span>, <span class="author">Gundem G</span>, <span class="author">Pipinikas CP</span>, <span class="author">Zamora J</span>, <span class="author">Raine K</span>, <span class="author">Menzies A</span>, <span class="author">Roman-Garcia P</span>, <span class="author">Fullam A</span>, <span class="author">Gerstung M</span>, <span class="author">Shlien A</span>, <span class="author">Tarpey PS</span>, <span class="author">Papaemmanuil E</span>, <span class="author">Knappskog S</span>, <span class="author">Van Loo P</span>, <span class="author">Ramakrishna M</span>, <span class="author">Davies HR</span>, <span class="author">Marshall J</span>, <span class="author">Wedge DC</span>, <span class="author">Teague JW</span>, <span class="author">Butler AP</span>, <span class="author">Nik-Zainal S</span>, <span class="author">Alexandrov L</span>, <span class="author">Behjati S</span>, <span class="author">Yates LR</span>, <span class="author">Bolli N</span>, <span class="author">Mudie L</span>, <span class="author">Hardy C</span>, <span class="author">Martin S</span>, <span class="author">McLaren S</span>, <span class="author">O&#39;Meara S</span>, <span class="author">Anderson E</span>, <span class="author">Maddison M</span>, <span class="author">Gamble S</span>, <span class="author">ICGC Breast Cancer Group</span>, <span class="author">ICGC Bone Cancer Group</span>, <span class="author">ICGC Prostate Cancer Group</span>, <span class="author">Foster C</span>, <span class="author">Warren AY</span>, <span class="author">Whitaker H</span>, <span class="author">Brewer D</span>, <span class="author">Eeles R</span>, <span class="author">Cooper C</span>, <span class="author">Neal D</span>, <span class="author">Lynch AG</span>, <span class="author">Visakorpi T</span>, <span class="author">Isaacs WB</span>, <span class="author">van&#39;t Veer L</span>, <span class="author">Caldas C</span>, <span class="author">Desmedt C</span>, <span class="author">Sotiriou C</span>, <span class="author">Aparicio S</span>, <span class="author">Foekens JA</span>, <span class="author">Eyfj&ouml;rd JE</span>, <span class="author">Lakhani SR</span>, <span class="author">Thomas G</span>, <span class="author">Myklebost O</span>, <span class="author">Span PN</span>, <span class="author">B&oslash;rresen-Dale AL</span>, <span class="author">Richardson AL</span>, <span class="author">Van de Vijver M</span>, <span class="author">Vincent-Salomon A</span>, <span class="author">Van den Eynden GG</span>, <span class="author">Flanagan AM</span>, <span class="author">Futreal PA</span>, <span class="author">Janes SM</span>, <span class="author">Bova GS</span>, <span class="author">Stratton MR</span>, <span class="author">McDermott U</span> and <span class="author">Campbell PJ</span></p>
<p class="affiliation">Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, UK.</p><p class="abstract">Long interspersed nuclear element-1 (L1) retrotransposons are mobile repetitive elements that are abundant in the human genome. L1 elements propagate through RNA intermediates. In the germ line, neighboring, nonrepetitive sequences are occasionally mobilized by the L1 machinery, a process called 3&#39; transduction. Because 3&#39; transductions are potentially mutagenic, we explored the extent to which they occur somatically during tumorigenesis. Studying cancer genomes from 244 patients, we found that tumors from 53% of the patients had somatic retrotranspositions, of which 24% were 3&#39; transductions. Fingerprinting of donor L1s revealed that a handful of source L1 elements in a tumor can spawn from tens to hundreds of 3&#39; transductions, which can themselves seed further retrotranspositions. The activity of individual L1 elements fluctuated during tumor evolution and correlated with L1 promoter hypomethylation. The 3&#39; transductions disseminated genes, exons, and regulatory elements to new locations, most often to heterochromatic regions of the genome.</p>
<p class="grants">Funded by: Cancer Research UK: <span class="grant">14835</span>, <span class="grant">19556</span>, <span class="grant">C5047/A14835</span>; Department of Health; Wellcome Trust: <span class="grant">WT100183MA</span></p>
<p class="publication"><span class="title">Science (New York, N.Y.)</span>&nbsp;<span class="year">2014</span>;<span class="volume">345</span>;<span class="number">6196</span>;<span class="pagerange">1251343</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25082706">25082706</a>; DOI: <a href="http://dx.doi.org/10.1126%2Fscience.1251343">10.1126/science.1251343</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Chromosome x-wide association study identifies Loci for fasting insulin and height and evidence for incomplete dosage compensation.</h4>
<p class="authors"><span class="author">Tukiainen T</span>, <span class="author">Pirinen M</span>, <span class="author">Sarin AP</span>, <span class="author">Ladenvall C</span>, <span class="author">Kettunen J</span>, <span class="author">Lehtim&auml;ki T</span>, <span class="author">Lokki ML</span>, <span class="author">Perola M</span>, <span class="author">Sinisalo J</span>, <span class="author">Vlachopoulou E</span>, <span class="author">Eriksson JG</span>, <span class="author">Groop L</span>, <span class="author">Jula A</span>, <span class="author">J&auml;rvelin MR</span>, <span class="author">Raitakari OT</span>, <span class="author">Salomaa V</span> and <span class="author">Ripatti S</span></p>
<p class="affiliation">Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland ; Analytic and Translational Genetics Unit, Massachusetts General Hospital, Boston, Massachusetts, United States of America ; Program in Medical and Population Genetics, Broad Institute of Harvard and MIT, Cambridge, Massachusetts, United States of America.</p>
<p class="abstract">The X chromosome (chrX) represents one potential source for the "missing heritability" for complex phenotypes, which thus far has remained underanalyzed in genome-wide association studies (GWAS). Here we demonstrate the benefits of including chrX in GWAS by assessing the contribution of 404,862 chrX SNPs to levels of twelve commonly studied cardiometabolic and anthropometric traits in 19,697 Finnish and Swedish individuals with replication data on 5,032 additional Finns. By using a linear mixed model, we estimate that on average 2.6% of the additive genetic variance in these twelve traits is attributable to chrX, this being in proportion to the number of SNPs in the chromosome. In a chrX-wide association analysis, we identify three novel loci: two for height (rs182838724 near FGF16/ATRX/MAGT1, joint P-value=2.7110(-9), and rs1751138 near ITM2A, P-value=3.0310(-10)) and one for fasting insulin (rs139163435 in Xq23, P-value=5.1810(-9)). Further, we find that effect sizes for variants near ITM2A, a gene implicated in cartilage development, show evidence for a lack of dosage compensation. This observation is further supported by a sex-difference in ITM2A expression in whole blood (P-value=0.00251), and is also in agreement with a previous report showing ITM2A escapes from X chromosome inactivation (XCI) in the majority of women. Hence, our results show one of the first links between phenotypic variation in a population sample and an XCI-escaping locus and pinpoint ITM2A as a potential contributor to the sexual dimorphism in height. In conclusion, our study provides a clear motivation for including chrX in large-scale genetic studies of complex diseases and traits.</p>
<p class="publication"><span class="title">PLoS genetics</span>&nbsp;<span class="year">2014</span>;<span class="volume">10</span>;<span class="number">2</span>;<span class="pagerange">e1004127</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24516404">24516404</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC3916240">3916240</a>; DOI: <a href="http://dx.doi.org/10.1371%2Fjournal.pgen.1004127">10.1371/journal.pgen.1004127</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Pyrazoleamide compounds are potent antimalarials that target Na(+) homeostasis in intraerythrocytic Plasmodium falciparum.</h4>
<p class="authors"><span class="author">Vaidya AB</span>, <span class="author">Morrisey JM</span>, <span class="author">Zhang Z</span>, <span class="author">Das S</span>, <span class="author">Daly TM</span>, <span class="author">Otto TD</span>, <span class="author">Spillman NJ</span>, <span class="author">Wyvratt M</span>, <span class="author">Siegl P</span>, <span class="author">Marfurt J</span>, <span class="author">Wirjanata G</span>, <span class="author">Sebayang BF</span>, <span class="author">Price RN</span>, <span class="author">Chatterjee A</span>, <span class="author">Nagle A</span>, <span class="author">Stasiak M</span>, <span class="author">Charman SA</span>, <span class="author">Angulo-Barturen I</span>, <span class="author">Ferrer S</span>, <span class="author">Bel&eacute;n Jim&eacute;nez-D&iacute;az M</span>, <span class="author">Mart&iacute;nez MS</span>, <span class="author">Gamo FJ</span>, <span class="author">Avery VM</span>, <span class="author">Ruecker A</span>, <span class="author">Delves M</span>, <span class="author">Kirk K</span>, <span class="author">Berriman M</span>, <span class="author">Kortagere S</span>, <span class="author">Burrows J</span>, <span class="author">Fan E</span> and <span class="author">Bergman LW</span></p>
<p class="affiliation">Department of Microbiology and Immunology, Center for Molecular Parasitology, Drexel University College of Medicine, 2900 Queen Lane, Philadelphia, Pennsylvania 190129, USA.</p><p class="abstract">The quest for new antimalarial drugs, especially those with novel modes of action, is essential in the face of emerging drug-resistant parasites. Here we describe a new chemical class of molecules, pyrazoleamides, with potent activity against human malaria parasites and showing remarkably rapid parasite clearance in an in vivo model. Investigations involving pyrazoleamide-resistant parasites, whole-genome sequencing and gene transfers reveal that mutations in two proteins, a calcium-dependent protein kinase (PfCDPK5) and a P-type cation-ATPase (PfATP4), are necessary to impart full resistance to these compounds. A pyrazoleamide compound causes a rapid disruption of Na(+) regulation in blood-stage Plasmodium falciparum parasites. Similar effect on Na(+) homeostasis was recently reported for spiroindolones, which are antimalarials of a chemical class quite distinct from pyrazoleamides. Our results reveal that disruption of Na(+) homeostasis in malaria parasites is a promising mode of antimalarial action mediated by at least two distinct chemical classes.</p>
<p class="publication"><span class="title">Nature communications</span>&nbsp;<span class="year">2014</span>;<span class="volume">5</span>;<span class="pagerange">5521</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25422853">25422853</a>; DOI: <a href="http://dx.doi.org/10.1038%2Fncomms6521">10.1038/ncomms6521</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Heps with pep: direct reprogramming into human hepatocytes.</h4>
<p class="authors"><span class="author">Vallier L</span></p>
<p class="affiliation">Wellcome Trust-Medical Research Council Stem Cell Institute, Anne McLaren Institute for Regenerative Medicine, Department of Surgery, West Forvie Site, Robinson Way, Cambridge CB20SZ, UK; Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK. Electronic address: <a href="mailto:%6C%76%32%32%35%40%63%61%6D.%61%63.%75%6B">&#108;&#118;&#50;&#50;&#53;&#64;&#99;&#97;&#109;&#46;&#97;&#99;&#46;&#117;&#107;</a>.</p><p class="abstract">The limited supply and expansion capacity of primary human hepatocytes presents major challenges for pharmaceutical applications and development of cell-based therapies for liver diseases. Now in Cell Stem Cell, two papers demonstrate efficient direct reprogramming of human fibroblasts into induced hepatocytes, which exhibit metabolic properties similar to primary hepatocytes.</p>
<p class="publication"><span class="title">Cell stem cell</span>&nbsp;<span class="year">2014</span>;<span class="volume">14</span>;<span class="number">3</span>;<span class="pagerange">267-9</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24607399">24607399</a>; DOI: <a href="http://dx.doi.org/10.1016%2Fj.stem.2014.02.010">10.1016/j.stem.2014.02.010</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Harmonization of Neuroticism and Extraversion phenotypes across inventories and cohorts in the Genetics of Personality Consortium: an application of Item Response Theory.</h4>
<p class="authors"><span class="author">van den Berg SM</span>, <span class="author">de Moor MH</span>, <span class="author">McGue M</span>, <span class="author">Pettersson E</span>, <span class="author">Terracciano A</span>, <span class="author">Verweij KJ</span>, <span class="author">Amin N</span>, <span class="author">Derringer J</span>, <span class="author">Esko T</span>, <span class="author">van Grootheest G</span>, <span class="author">Hansell NK</span>, <span class="author">Huffman J</span>, <span class="author">Konte B</span>, <span class="author">Lahti J</span>, <span class="author">Luciano M</span>, <span class="author">Matteson LK</span>, <span class="author">Viktorin A</span>, <span class="author">Wouda J</span>, <span class="author">Agrawal A</span>, <span class="author">Allik J</span>, <span class="author">Bierut L</span>, <span class="author">Broms U</span>, <span class="author">Campbell H</span>, <span class="author">Smith GD</span>, <span class="author">Eriksson JG</span>, <span class="author">Ferrucci L</span>, <span class="author">Franke B</span>, <span class="author">Fox JP</span>, <span class="author">de Geus EJ</span>, <span class="author">Giegling I</span>, <span class="author">Gow AJ</span>, <span class="author">Grucza R</span>, <span class="author">Hartmann AM</span>, <span class="author">Heath AC</span>, <span class="author">Heikkil&auml; K</span>, <span class="author">Iacono WG</span>, <span class="author">Janzing J</span>, <span class="author">Jokela M</span>, <span class="author">Kiemeney L</span>, <span class="author">Lehtim&auml;ki T</span>, <span class="author">Madden PA</span>, <span class="author">Magnusson PK</span>, <span class="author">Northstone K</span>, <span class="author">Nutile T</span>, <span class="author">Ouwens KG</span>, <span class="author">Palotie A</span>, <span class="author">Pattie A</span>, <span class="author">Pesonen AK</span>, <span class="author">Polasek O</span>, <span class="author">Pulkkinen L</span>, <span class="author">Pulkki-R&aring;back L</span>, <span class="author">Raitakari OT</span>, <span class="author">Realo A</span>, <span class="author">Rose RJ</span>, <span class="author">Ruggiero D</span>, <span class="author">Sepp&auml;l&auml; I</span>, <span class="author">Slutske WS</span>, <span class="author">Smyth DC</span>, <span class="author">Sorice R</span>, <span class="author">Starr JM</span>, <span class="author">Sutin AR</span>, <span class="author">Tanaka T</span>, <span class="author">Verhagen J</span>, <span class="author">Vermeulen S</span>, <span class="author">Vuoksimaa E</span>, <span class="author">Widen E</span>, <span class="author">Willemsen G</span>, <span class="author">Wright MJ</span>, <span class="author">Zgaga L</span>, <span class="author">Rujescu D</span>, <span class="author">Metspalu A</span>, <span class="author">Wilson JF</span>, <span class="author">Ciullo M</span>, <span class="author">Hayward C</span>, <span class="author">Rudan I</span>, <span class="author">Deary IJ</span>, <span class="author">R&auml;ikk&ouml;nen K</span>, <span class="author">Arias Vasquez A</span>, <span class="author">Costa PT</span>, <span class="author">Keltikangas-J&auml;rvinen L</span>, <span class="author">van Duijn CM</span>, <span class="author">Penninx BW</span>, <span class="author">Krueger RF</span>, <span class="author">Evans DM</span>, <span class="author">Kaprio J</span>, <span class="author">Pedersen NL</span>, <span class="author">Martin NG</span> and <span class="author">Boomsma DI</span></p>
<p class="affiliation">Department of Research Methodology, Measurement and Data-Analysis, University of Twente, Enschede, The Netherlands, <a href="mailto:%73%74%65%70%68%61%6E%69%65.%76%61%6E%64%65%6E%62%65%72%67%40%75%74%77%65%6E%74%65.%6E%6C">&#115;&#116;&#101;&#112;&#104;&#97;&#110;&#105;&#101;&#46;&#118;&#97;&#110;&#100;&#101;&#110;&#98;&#101;&#114;&#103;&#64;&#117;&#116;&#119;&#101;&#110;&#116;&#101;&#46;&#110;&#108;</a>.</p><p class="abstract">Mega- or meta-analytic studies (e.g. genome-wide association studies) are increasingly used in behavior genetics. An issue in such studies is that phenotypes are often measured by different instruments across study cohorts, requiring harmonization of measures so that more powerful fixed effect meta-analyses can be employed. Within the Genetics of Personality Consortium, we demonstrate for two clinically relevant personality traits, Neuroticism and Extraversion, how Item-Response Theory (IRT) can be applied to map item data from different inventories to the same underlying constructs. Personality item data were analyzed in &gt;160,000 individuals from 23 cohorts across Europe, USA and Australia in which Neuroticism and Extraversion were assessed by nine different personality inventories. Results showed that harmonization was very successful for most personality inventories and moderately successful for some. Neuroticism and Extraversion inventories were largely measurement invariant across cohorts, in particular when comparing cohorts from countries where the same language is spoken. The IRT-based scores for Neuroticism and Extraversion were heritable (48 and 49&nbsp;%, respectively, based on a meta-analysis of six twin cohorts, total N&nbsp;=&nbsp;29,496 and 29,501 twin pairs, respectively) with a significant part of the heritability due to non-additive genetic factors. For Extraversion, these genetic factors qualitatively differ across sexes. We showed that our IRT method can lead to a large increase in sample size and therefore statistical power. The IRT approach may be applied to any mega- or meta-analytic study in which item-based behavioral measures need to be harmonized.</p>
<p class="publication"><span class="title">Behavior genetics</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24828478">24828478</a>; DOI: <a href="http://dx.doi.org/10.1007%2Fs10519-014-9654-x">10.1007/s10519-014-9654-x</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">TMEM129 is a Derlin-1 associated ERAD E3 ligase essential for virus-induced degradation of MHC-I.</h4>
<p class="authors"><span class="author">van den Boomen DJ</span>, <span class="author">Timms RT</span>, <span class="author">Grice GL</span>, <span class="author">Stagg HR</span>, <span class="author">Sk&oslash;dt K</span>, <span class="author">Dougan G</span>, <span class="author">Nathan JA</span> and <span class="author">Lehner PJ</span></p>
<p class="affiliation">Cambridge Institute for Medical Research, Department of Medicine, University of Cambridge, Cambridge CB2 0XY, United Kingdom;</p><p class="abstract">The US11 gene product of human cytomegalovirus promotes viral immune evasion by hijacking the endoplasmic reticulum (ER)-associated degradation (ERAD) pathway. US11 initiates dislocation of newly translocated MHC I from the ER to the cytosol for proteasome-mediated degradation. Despite the critical role for ubiquitin in this degradation pathway, the responsible E3 ligase is unknown. In a forward genetic screen for host ERAD components hijacked by US11 in near-haploid KBM7 cells, we identified TMEM129, an uncharacterized polytopic membrane protein. TMEM129 is essential and rate-limiting for US11-mediated MHC-I degradation and acts as a novel ER resident E3 ubiquitin ligase. TMEM129 contains an unusual cysteine-only RING with intrinsic E3 ligase activity and is recruited to US11 via Derlin-1. Together with its E2 conjugase Ube2J2, TMEM129 is responsible for the ubiquitination, dislocation, and subsequent degradation of US11-associated MHC-I. US11 engages two degradation pathways: a Derlin-1/TMEM129-dependent pathway required for MHC-I degradation and a SEL1L/HRD1-dependent pathway required for &quot;free&quot; US11 degradation. Our data show that TMEM129 is a novel ERAD E3 ligase and the central component of a novel mammalian ERAD complex.</p>
<p class="publication"><span class="title">Proceedings of the National Academy of Sciences of the United States of America</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25030448">25030448</a>; DOI: <a href="http://dx.doi.org/10.1073%2Fpnas.1409099111">10.1073/pnas.1409099111</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">A novel common variant in DCST2 is associated with length in early life and height in adulthood.</h4>
<p class="authors"><span class="author">van der Valk RJ</span>, <span class="author">Kreiner-M&oslash;ller E</span>, <span class="author">Kooijman MN</span>, <span class="author">Guxens M</span>, <span class="author">Stergiakouli E</span>, <span class="author">S&auml;&auml;f A</span>, <span class="author">Bradfield JP</span>, <span class="author">Geller F</span>, <span class="author">Hayes MG</span>, <span class="author">Cousminer DL</span>, <span class="author">K&ouml;rner A</span>, <span class="author">Thiering E</span>, <span class="author">Curtin JA</span>, <span class="author">Myhre R</span>, <span class="author">Huikari V</span>, <span class="author">Joro R</span>, <span class="author">Kerkhof M</span>, <span class="author">Warrington NM</span>, <span class="author">Pitk&auml;nen N</span>, <span class="author">Ntalla I</span>, <span class="author">Horikoshi M</span>, <span class="author">Veijola R</span>, <span class="author">Freathy RM</span>, <span class="author">Teo YY</span>, <span class="author">Barton SJ</span>, <span class="author">Evans DM</span>, <span class="author">Kemp JP</span>, <span class="author">St Pourcain B</span>, <span class="author">Ring SM</span>, <span class="author">Smith GD</span>, <span class="author">Bergstr&ouml;m A</span>, <span class="author">Kull I</span>, <span class="author">Hakonarson H</span>, <span class="author">Mentch FD</span>, <span class="author">Bisgaard H</span>, <span class="author">Chawes B</span>, <span class="author">Stokholm J</span>, <span class="author">Waage J</span>, <span class="author">Eriksen P</span>, <span class="author">Sevelsted A</span>, <span class="author">Melbye M</span>, <span class="author">Early Genetics &amp;amp; Lifecourse Epidemiology (EAGLE) Consortium</span>, <span class="author">van Duijn CM</span>, <span class="author">Medina-Gomez C</span>, <span class="author">Hofman A</span>, <span class="author">de Jongste JC</span>, <span class="author">Taal HR</span>, <span class="author">Uitterlinden AG</span>, <span class="author">Genetic Investigation of ANthropometric Traits (GIANT) Consortium</span>, <span class="author">Armstrong LL</span>, <span class="author">Eriksson J</span>, <span class="author">Palotie A</span>, <span class="author">Bustamante M</span>, <span class="author">Estivill X</span>, <span class="author">Gonzalez JR</span>, <span class="author">Llop S</span>, <span class="author">Kiess W</span>, <span class="author">Mahajan A</span>, <span class="author">Flexeder C</span>, <span class="author">Tiesler CM</span>, <span class="author">Murray CS</span>, <span class="author">Simpson A</span>, <span class="author">Magnus P</span>, <span class="author">Sengpiel V</span>, <span class="author">Hartikainen AL</span>, <span class="author">Keinanen-Kiukaanniemi S</span>, <span class="author">Lewin A</span>, <span class="author">Da Silva Couto Alves A</span>, <span class="author">Blakemore AI</span>, <span class="author">Buxton JL</span>, <span class="author">Kaakinen M</span>, <span class="author">Rodriguez A</span>, <span class="author">Sebert S</span>, <span class="author">Vaarasmaki M</span>, <span class="author">Lakka T</span>, <span class="author">Lindi V</span>, <span class="author">Gehring U</span>, <span class="author">Postma DS</span>, <span class="author">Ang W</span>, <span class="author">Newnham JP</span>, <span class="author">Lyytik&auml;inen LP</span>, <span class="author">Pahkala K</span>, <span class="author">Raitakari OT</span>, <span class="author">Panoutsopoulou K</span>, <span class="author">Zeggini E</span>, <span class="author">Boomsma DI</span>, <span class="author">Groen-Blokhuis M</span>, <span class="author">Ilonen J</span>, <span class="author">Franke L</span>, <span class="author">Hirschhorn JN</span>, <span class="author">Pers TH</span>, <span class="author">Liang L</span>, <span class="author">Huang J</span>, <span class="author">Hocher B</span>, <span class="author">Knip M</span>, <span class="author">Saw SM</span>, <span class="author">Holloway JW</span>, <span class="author">Mel&eacute;n E</span>, <span class="author">Grant SF</span>, <span class="author">Feenstra B</span>, <span class="author">Lowe WL</span>, <span class="author">Wid&eacute;n E</span>, <span class="author">Sergeyev E</span>, <span class="author">Grallert H</span>, <span class="author">Custovic A</span>, <span class="author">Jacobsson B</span>, <span class="author">Jarvelin MR</span>, <span class="author">Atalay M</span>, <span class="author">Koppelman GH</span>, <span class="author">Pennell CE</span>, <span class="author">Niinikoski H</span>, <span class="author">Dedoussis GV</span>, <span class="author">McCarthy MI</span>, <span class="author">Frayling TM</span>, <span class="author">Sunyer J</span>, <span class="author">Timpson NJ</span>, <span class="author">Rivadeneira F</span>, <span class="author">B&oslash;nnelykke K</span>, <span class="author">Jaddoe VW</span> and <span class="author">for the Early Growth Genetics (EGG) Consortium</span></p>
<p class="affiliation">Department of Epidemiology, Erasmus Medical Center, Rotterdam, The Netherlands Department of Paediatrics, Erasmus Medical Center, Rotterdam, The Netherlands The Generation R Study Group, Erasmus Medical Center, Rotterdam, The Netherlands.</p><p class="abstract">Common genetic variants have been identified for adult height, but not much is known about the genetics of skeletal growth in early life. To identify common genetic variants that influence fetal skeletal growth, we meta-analyzed 22 genome-wide association studies (Stage 1; N=28,459). We identified 7 independent top SNPs (P&lt;1x10(-6)) for birth length, of which 3 were novel and 4 were in or near loci known to be associated with adult height (LCORL, PTCH1, GPR126 and HMGA2). The 3 novel SNPs were followed-up in 9 replication studies (Stage 2; N=11,995), with rs905938 in DC-STAMP domain containing 2 (DCST2) genome-wide significantly associated with birth length in a joint analysis (Stages 1+2; &szlig;=0.046, S.E.=0.008, P=2.46x10(-8), explained variance=0.05%). Rs905938 was also associated with infant length (N=28,228; P=5.54x10(-4)) and adult height (N=127,513; P=1.45x10(-5)). DCST2 is a DC-STAMP-like protein family member and DC-STAMP is an osteoclast cell-fusion regulator. Polygenic scores based on 180 SNPs previously associated with human adult stature explained 0.13% of variance in birth length. The same SNPs explained 2.95% of the variance of infant length. Of the 180 known adult height loci, 11 were genome-wide significantly associated with infant length (SF3B4, LCORL, SPAG17, C6orf173, PTCH1, GDF5, ZNFX1, HHIP, ACAN, HLA locus and HMGA2). This study highlights that common variation in DCST2 influences variation in early growth and adult height.</p>
<p class="publication"><span class="title">Human molecular genetics</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25281659">25281659</a>; DOI: <a href="http://dx.doi.org/10.1093%2Fhmg%2Fddu510">10.1093/hmg/ddu510</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Cancer gene discovery goes mobile.</h4>
<p class="authors"><span class="author">van der Weyden L</span>, <span class="author">Ranzani M</span> and <span class="author">Adams DJ</span></p>
<p class="affiliation">Experimental Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, UK.</p><p class="abstract">A new study describes a tool, Lentihop, for somatic insertional mutagenesis in human cells and uses this system in combination with cancer genome data to define new genes and pathways involved in sarcoma development. Gene discovery in this way suggests that we are far from a complete catalog of cancer drivers.</p>
<p class="publication"><span class="title">Nature genetics</span>&nbsp;<span class="year">2014</span>;<span class="volume">46</span>;<span class="number">9</span>;<span class="pagerange">928-929</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25162801">25162801</a>; DOI: <a href="http://dx.doi.org/10.1038%2Fng.3072">10.1038/ng.3072</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">In vivo evolution of antimicrobial resistance in a series of Staphylococcus aureus patient isolates: the entire picture or a cautionary tale?</h4>
<p class="authors"><span class="author">van Hal SJ</span>, <span class="author">Steen JA</span>, <span class="author">Espedido BA</span>, <span class="author">Grimmond SM</span>, <span class="author">Cooper MA</span>, <span class="author">Holden MT</span>, <span class="author">Bentley SD</span>, <span class="author">Gosbell IB</span> and <span class="author">Jensen SO</span></p>
<p class="affiliation">Antibiotic Resistance & Mobile Elements Group, School of Medicine, University of Western Sydney, Sydney, NSW, Australia.</p>
<p class="abstract">Objectives: To obtain an expanded understanding of antibiotic resistance evolution in vivo, particularly in the context of vancomycin exposure.

Methods: The whole genomes of six consecutive methicillin-resistant Staphylococcus aureus blood culture isolates (ST239-MRSA-III) from a single patient exposed to various antimicrobials (over a 77 day period) were sequenced and analysed.

Results: Variant analysis revealed the existence of non-susceptible sub-populations derived from a common susceptible ancestor, with the predominant circulating clone(s) selected for by type and duration of antimicrobial exposure.

Conclusions: This study highlights the dynamic nature of bacterial evolution and that non-susceptible sub-populations can emerge from clouds of variation upon antimicrobial exposure. Diagnostically, this has direct implications for sample selection when using whole-genome sequencing as a tool to guide clinical therapy. In the context of bacteraemia, deep sequencing of bacterial DNA directly from patient blood samples would avoid culture 'bias' and identify mutations associated with circulating non-susceptible sub-populations, some of which may confer cross-resistance to alternate therapies.</p>
<p class="publication"><span class="title">The Journal of antimicrobial chemotherapy</span>&nbsp;<span class="year">2014</span>;<span class="volume">69</span>;<span class="number">2</span>;<span class="pagerange">363-7</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24047554">24047554</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC3886930">3886930</a>; DOI: <a href="http://dx.doi.org/10.1093%2Fjac%2Fdkt354">10.1093/jac/dkt354</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Common genetic variants do not associate with CAD in familial hypercholesterolemia.</h4>
<p class="authors"><span class="author">van Iperen EP</span>, <span class="author">Sivapalaratnam S</span>, <span class="author">Boekholdt SM</span>, <span class="author">Hovingh GK</span>, <span class="author">Maiwald S</span>, <span class="author">Tanck MW</span>, <span class="author">Soranzo N</span>, <span class="author">Stephens JC</span>, <span class="author">Sambrook JG</span>, <span class="author">Levi M</span>, <span class="author">Ouwehand WH</span>, <span class="author">Kastelein JJ</span>, <span class="author">Trip MD</span> and <span class="author">Zwinderman AH</span></p>
<p class="affiliation">1] Department of Clinical Epidemiology, Biostatistics and Bioinformatics, Academic Medical Centre, Amsterdam, The Netherlands [2] Durrer Center for Cardiogenetic Research, Amsterdam, The Netherlands.</p><p class="abstract">In recent years, multiple loci dispersed on the genome have been shown to be associated with coronary artery disease (CAD). We investigated whether these common genetic variants also hold value for CAD prediction in a large cohort of patients with familial hypercholesterolemia (FH). We genotyped a total of 41 single-nucleotide polymorphisms (SNPs) in 1701 FH patients, of whom 482 patients (28.3%) had at least one coronary event during an average follow up of 66 years. The association of each SNP with event-free survival time was calculated with a Cox proportional hazard model. In the cardiovascular disease risk factor adjusted analysis, the most significant SNP was rs1122608:G&gt;T in the SMARCA4 gene near the LDL-receptor (LDLR) gene, with a hazard ratio for CAD risk of 0.74 (95% CI 0.49-0.99; P-value 0.021). However, none of the SNPs reached the Bonferroni threshold. Of all the known CAD loci analyzed, the SMARCA4 locus near the LDLR had the strongest negative association with CAD in this high-risk FH cohort. The effect is contrary to what was expected. None of the other loci showed association with CAD.</p>
<p class="publication"><span class="title">European journal of human genetics : EJHG</span>&nbsp;<span class="year">2014</span>;<span class="volume">22</span>;<span class="number">6</span>;<span class="pagerange">809-13</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24219970">24219970</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4023217">4023217</a>; DOI: <a href="http://dx.doi.org/10.1038%2Fejhg.2013.242">10.1038/ejhg.2013.242</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">The Challenges of Genome-Wide Interaction Studies: Lessons to Learn from the Analysis of HDL Blood Levels.</h4>
<p class="authors"><span class="author">van Leeuwen EM</span>, <span class="author">Smouter FA</span>, <span class="author">Kam-Thong T</span>, <span class="author">Karbalai N</span>, <span class="author">Smith AV</span>, <span class="author">Harris TB</span>, <span class="author">Launer LJ</span>, <span class="author">Sitlani CM</span>, <span class="author">Li G</span>, <span class="author">Brody JA</span>, <span class="author">Bis JC</span>, <span class="author">White CC</span>, <span class="author">Jaiswal A</span>, <span class="author">Oostra BA</span>, <span class="author">Hofman A</span>, <span class="author">Rivadeneira F</span>, <span class="author">Uitterlinden AG</span>, <span class="author">Boerwinkle E</span>, <span class="author">Ballantyne CM</span>, <span class="author">Gudnason V</span>, <span class="author">Psaty BM</span>, <span class="author">Cupples LA</span>, <span class="author">J&auml;rvelin MR</span>, <span class="author">Ripatti S</span>, <span class="author">Isaacs A</span>, <span class="author">M&uuml;ller-Myhsok B</span>, <span class="author">Karssen LC</span> and <span class="author">van Duijn CM</span></p>
<p class="affiliation">Genetic Epidemiology Unit, Department of Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands.</p><p class="abstract">Genome-wide association studies (GWAS) have revealed 74 single nucleotide polymorphisms (SNPs) associated with high-density lipoprotein cholesterol (HDL) blood levels. This study is, to our knowledge, the first genome-wide interaction study (GWIS) to identify SNP&times;SNP interactions associated with HDL levels. We performed a GWIS in the Rotterdam Study (RS) cohort I (RS-I) using the GLIDE tool which leverages the massively parallel computing power of Graphics Processing Units (GPUs) to perform linear regression on all genome-wide pairs of SNPs. By performing a meta-analysis together with Rotterdam Study cohorts II and III (RS-II and RS-III), we were able to filter 181 interaction terms with a p-value&lt;1 &middot; 10-8 that replicated in the two independent cohorts. We were not able to replicate any of these interaction term in the AGES, ARIC, CHS, ERF, FHS and NFBC-66 cohorts (Ntotal&#x200A;=&#x200A;30,011) when adjusting for multiple testing. Our GWIS resulted in the consistent finding of a possible interaction between rs774801 in ARMC8 (ENSG00000114098) and rs12442098 in SPATA8 (ENSG00000185594) being associated with HDL levels. However, p-values do not reach the preset Bonferroni correction of the p-values. Our study suggest that even for highly genetically determined traits such as HDL the sample sizes needed to detect SNP&times;SNP interactions are large and the 2-step filtering approaches do not yield a solution. Here we present our analysis plan and our reservations concerning GWIS.</p>
<p class="publication"><span class="title">PloS one</span>&nbsp;<span class="year">2014</span>;<span class="volume">9</span>;<span class="number">10</span>;<span class="pagerange">e109290</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25329471">25329471</a>; DOI: <a href="http://dx.doi.org/10.1371%2Fjournal.pone.0109290">10.1371/journal.pone.0109290</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Single cell analysis of cancer genomes.</h4>
<p class="authors"><span class="author">Van Loo P</span> and <span class="author">Voet T</span></p>
<p class="affiliation">Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, UK; Department of Human Genetics, VIB and KU Leuven, Leuven, Belgium.</p>
<p class="abstract">Genomic studies have provided key insights into how cancers develop, evolve, metastasize and respond to treatment. Cancers result from an interplay between mutation, selection and clonal expansions. In solid tumours, this Darwinian competition between subclones is also influenced by topological factors. Recent advances have made it possible to study cancers at the single cell level. These methods represent important tools to dissect cancer evolution and provide the potential to considerably change both cancer research and clinical practice. Here we discuss state-of-the-art methods for the isolation of a single cell, whole-genome and whole-transcriptome amplification of the cell's nucleic acids, as well as microarray and massively parallel sequencing analysis of such amplification products. We discuss the strengths and the limitations of the techniques, and explore single-cell methodologies for future cancer research, as well as diagnosis and treatment of the disease.</p>
<p class="publication"><span class="title">Current opinion in genetics &amp;amp; development</span>&nbsp;<span class="year">2014</span>;<span class="volume">24C</span>;<span class="pagerange">82-91</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24531336">24531336</a>; DOI: <a href="http://dx.doi.org/10.1016%2Fj.gde.2013.12.004">10.1016/j.gde.2013.12.004</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">The classical lancefield antigen of group a Streptococcus is a virulence determinant with implications for vaccine design.</h4>
<p class="authors"><span class="author">van Sorge NM</span>, <span class="author">Cole JN</span>, <span class="author">Kuipers K</span>, <span class="author">Henningham A</span>, <span class="author">Aziz RK</span>, <span class="author">Kasirer-Friede A</span>, <span class="author">Lin L</span>, <span class="author">Berends ET</span>, <span class="author">Davies MR</span>, <span class="author">Dougan G</span>, <span class="author">Zhang F</span>, <span class="author">Dahesh S</span>, <span class="author">Shaw L</span>, <span class="author">Gin J</span>, <span class="author">Cunningham M</span>, <span class="author">Merriman JA</span>, <span class="author">H&uuml;tter J</span>, <span class="author">Lepenies B</span>, <span class="author">Rooijakkers SH</span>, <span class="author">Malley R</span>, <span class="author">Walker MJ</span>, <span class="author">Shattil SJ</span>, <span class="author">Schlievert PM</span>, <span class="author">Choudhury B</span> and <span class="author">Nizet V</span></p>
<p class="affiliation">Department of Pediatrics, University of California, San Diego, La Jolla, CA 92093, USA; Medical Microbiology, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands. Electronic address: <a href="mailto:%6E.%76%61%6E%73%6F%72%67%65-%33%40%75%6D%63%75%74%72%65%63%68%74.%6E%6C">&#110;&#46;&#118;&#97;&#110;&#115;&#111;&#114;&#103;&#101;&#45;&#51;&#64;&#117;&#109;&#99;&#117;&#116;&#114;&#101;&#99;&#104;&#116;&#46;&#110;&#108;</a>.</p><p class="abstract">Group A Streptococcus (GAS) is a leading cause of infection-related mortality in humans. All GAS serotypes express the Lancefield group A carbohydrate (GAC), comprising a polyrhamnose backbone with an immunodominant N-acetylglucosamine (GlcNAc) side chain, which is the basis of rapid diagnostic tests. No biological function has been attributed to this conserved antigen. Here we identify and characterize the GAC biosynthesis genes, gacA through gacL. An isogenic mutant of the glycosyltransferase gacI, which is defective for GlcNAc side-chain addition, is attenuated for virulence in two infection models, in association with increased sensitivity to neutrophil killing, platelet-derived antimicrobials in serum, and the cathelicidin antimicrobial peptide LL-37. Antibodies to GAC lacking the GlcNAc side chain and containing only polyrhamnose promoted opsonophagocytic killing of multiple GAS serotypes and protected against systemic GAS challenge after passive immunization. Thus, the Lancefield antigen plays a functional role in GAS pathogenesis, and a deeper understanding of this unique polysaccharide has implications for vaccine development.</p>
<p class="grants">Funded by: NHLBI NIH HHS: <span class="grant">HL35380</span>, <span class="grant">HL5627</span>, <span class="grant">P01 HL107150</span>, <span class="grant">R01 HL056595</span>; NIAID NIH HHS: <span class="grant">AI57153</span>, <span class="grant">R01 AI052453</span>, <span class="grant">R01 AI077780</span>, <span class="grant">R01 AI096837</span>, <span class="grant">U54 AI057153</span></p>
<p class="publication"><span class="title">Cell host &amp; microbe</span>&nbsp;<span class="year">2014</span>;<span class="volume">15</span>;<span class="number">6</span>;<span class="pagerange">729-40</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24922575">24922575</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4078075">4078075</a>; DOI: <a href="http://dx.doi.org/10.1016%2Fj.chom.2014.05.009">10.1016/j.chom.2014.05.009</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Defining the estimated core genome of bacterial populations using a bayesian decision model.</h4>
<p class="authors"><span class="author">van Tonder AJ</span>, <span class="author">Mistry S</span>, <span class="author">Bray JE</span>, <span class="author">Hill DM</span>, <span class="author">Cody AJ</span>, <span class="author">Farmer CL</span>, <span class="author">Klugman KP</span>, <span class="author">von Gottberg A</span>, <span class="author">Bentley SD</span>, <span class="author">Parkhill J</span>, <span class="author">Jolley KA</span>, <span class="author">Maiden MC</span> and <span class="author">Brueggemann AB</span></p>
<p class="affiliation">Nuffield Department of Medicine, The Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, United Kingdom.</p><p class="abstract">The bacterial core genome is of intense interest and the volume of whole genome sequence data in the public domain available to investigate it has increased dramatically. The aim of our study was to develop a model to estimate the bacterial core genome from next-generation whole genome sequencing data and use this model to identify novel genes associated with important biological functions. Five bacterial datasets were analysed, comprising 2096 genomes in total. We developed a Bayesian decision model to estimate the number of core genes, calculated pairwise evolutionary distances (p-distances) based on nucleotide sequence diversity, and plotted the median p-distance for each core gene relative to its genome location. We designed visually-informative genome diagrams to depict areas of interest in genomes. Case studies demonstrated how the model could identify areas for further study, e.g. 25% of the core genes with higher sequence diversity in the Campylobacter jejuni and Neisseria meningitidis genomes encoded hypothetical proteins. The core gene with the highest p-distance value in C. jejuni was annotated in the reference genome as a putative hydrolase, but further work revealed that it shared sequence homology with beta-lactamase/metallo-beta-lactamases (enzymes that provide resistance to a range of broad-spectrum antibiotics) and thioredoxin reductase genes (which reduce oxidative stress and are essential for DNA replication) in other C. jejuni genomes. Our Bayesian model of estimating the core genome is principled, easy to use and can be applied to large genome datasets. This study also highlighted the lack of knowledge currently available for many core genes in bacterial genomes of significant global public health importance.</p>
<p class="publication"><span class="title">PLoS computational biology</span>&nbsp;<span class="year">2014</span>;<span class="volume">10</span>;<span class="number">8</span>;<span class="pagerange">e1003788</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25144616">25144616</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4140633">4140633</a>; DOI: <a href="http://dx.doi.org/10.1371%2Fjournal.pcbi.1003788">10.1371/journal.pcbi.1003788</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Genetic determinants of long-term changes in blood lipid concentrations: 10-year follow-up of the GLACIER study.</h4>
<p class="authors"><span class="author">Varga TV</span>, <span class="author">Sonestedt E</span>, <span class="author">Shungin D</span>, <span class="author">Koivula RW</span>, <span class="author">Hallmans G</span>, <span class="author">Escher SA</span>, <span class="author">Barroso I</span>, <span class="author">Nilsson P</span>, <span class="author">Melander O</span>, <span class="author">Orho-Melander M</span>, <span class="author">Renstr&ouml;m F</span> and <span class="author">Franks PW</span></p>
<p class="affiliation">Department of Clinical Sciences, Genetic and Molecular Epidemiology Unit, Lund University, Sk&aring;ne University Hospital Malm&ouml;, Malm&ouml;, Sweden.</p><p class="abstract">Recent genome-wide meta-analyses identified 157 loci associated with cross-sectional lipid traits. Here we tested whether these loci associate (singly and in trait-specific genetic risk scores [GRS]) with longitudinal changes in total cholesterol (TC) and triglyceride (TG) levels in a population-based prospective cohort from Northern Sweden (the GLACIER Study). We sought replication in a southern Swedish cohort (the MDC Study; N = 2,943). GLACIER Study participants (N = 6,064) were genotyped with the MetaboChip array. Up to 3,495 participants had 10-yr follow-up data available in the GLACIER Study. The TC- and TG-specific GRSs were strongly associated with change in lipid levels (&beta; = 0.02 mmol/l per effect allele per decade follow-up, P = 2.0 &times; 10(-11) for TC; &beta; = 0.02 mmol/l per effect allele per decade follow-up, P = 5.0 &times; 10(-5) for TG). In individual SNP analysis, one TC locus, apolipoprotein E (APOE) rs4420638 (&beta; = 0.12 mmol/l per effect allele per decade follow-up, P = 2.0 &times; 10(-5)), and two TG loci, tribbles pseudokinase 1 (TRIB1) rs2954029 (&beta; = 0.09 mmol/l per effect allele per decade follow-up, P = 5.1 &times; 10(-4)) and apolipoprotein A-I (APOA1) rs6589564 (&beta; = 0.31 mmol/l per effect allele per decade follow-up, P = 1.4 &times; 10(-8)), remained significantly associated with longitudinal changes for the respective traits after correction for multiple testing. An additional 12 loci were nominally associated with TC or TG changes. In replication analyses, the APOE rs4420638, TRIB1 rs2954029, and APOA1 rs6589564 associations were confirmed (P &le; 0.001). In summary, trait-specific GRSs are robustly associated with 10-yr changes in lipid levels and three individual SNPs were strongly associated with 10-yr changes in lipid levels.</p>
<p class="publication"><span class="title">PLoS genetics</span>&nbsp;<span class="year">2014</span>;<span class="volume">10</span>;<span class="number">6</span>;<span class="pagerange">e1004388</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24922540">24922540</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4055682">4055682</a>; DOI: <a href="http://dx.doi.org/10.1371%2Fjournal.pgen.1004388">10.1371/journal.pgen.1004388</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">RNA-seq analysis of the influence of anaerobiosis and FNR on Shigella flexneri.</h4>
<p class="authors"><span class="author">Vergara-Irigaray M</span>, <span class="author">Fookes MC</span>, <span class="author">Thomson NR</span> and <span class="author">Tang CM</span></p>
<p class="affiliation">Sir William Dunn School of Pathology, Oxford University, Oxford, United Kingdom. <a href="mailto:%63%68%72%69%73%74%6F%70%68.%74%61%6E%67%40%70%61%74%68.%6F%78.%61%63.%75%6B">&#99;&#104;&#114;&#105;&#115;&#116;&#111;&#112;&#104;&#46;&#116;&#97;&#110;&#103;&#64;&#112;&#97;&#116;&#104;&#46;&#111;&#120;&#46;&#97;&#99;&#46;&#117;&#107;</a>.</p><p class="abstract"><strong>Background</strong>: Shigella flexneri is an important human pathogen that has to adapt to the anaerobic environment in the gastrointestinal tract to cause dysentery. To define the influence of anaerobiosis on the virulence of Shigella, we performed deep RNA sequencing to identify transcriptomic differences that are induced by anaerobiosis and modulated by the anaerobic Fumarate and Nitrate Reduction regulator, FNR.</p><p class="abstract"><strong>Results</strong>: We found that 528 chromosomal genes were differentially expressed in response to anaerobic conditions; of these, 228 genes were also influenced by FNR. Genes that were up-regulated in anaerobic conditions are involved in carbon transport and metabolism (e.g. ptsG, manX, murQ, cysP, cra), DNA topology and regulation (e.g. ygiP, stpA, hns), host interactions (e.g. yciD, nmpC, slyB, gapA, shf, msbB) and survival within the gastrointestinal tract (e.g. shiA, ospI, adiY, cysP). Interestingly, there was a marked effect of available oxygen on genes involved in Type III secretion system (T3SS), which is required for host cell invasion and pathogenesis. These genes, located on the large Shigella virulence plasmid, were down regulated in anaerobiosis in an FNR-dependent manner. We also confirmed anaerobic induction of csrB and csrC small RNAs in an FNR-independent manner.</p><p class="abstract"><strong>Conclusions</strong>: Anaerobiosis promotes survival and adaption strategies of Shigella, while modulating virulence plasmid genes involved in T3SS-mediated host cell invasion. The influence of FNR on this process is more extensive than previously appreciated, although aside from the virulence plasmid, this transcriptional regulator does not govern expression of genes on other horizontally acquired sequences on the chromosome such as pathogenicity islands.</p>
<p class="grants">Funded by: Wellcome Trust: <span class="grant">098051</span></p>
<p class="publication"><span class="title">BMC genomics</span>&nbsp;<span class="year">2014</span>;<span class="volume">15</span>;<span class="pagerange">438</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24907032">24907032</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4229854">4229854</a>; DOI: <a href="http://dx.doi.org/10.1186%2F1471-2164-15-438">10.1186/1471-2164-15-438</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Genetic diversity in Puerto Rico and its implications for the peopling of the Island and the West Indies.</h4>
<p class="authors"><span class="author">Vilar MG</span>, <span class="author">Melendez C</span>, <span class="author">Sanders AB</span>, <span class="author">Walia A</span>, <span class="author">Gaieski JB</span>, <span class="author">Owings AC</span>, <span class="author">Schurr TG</span> and <span class="author">Genographic Consortium</span></p>
<p class="affiliation">Department of Anthropology, University of Pennsylvania, Philadelphia, PA, 19104-6398.</p><p class="abstract">Puerto Rico and the surrounding islands rest on the eastern fringe of the Caribbean&#39;s Greater Antilles, located less than 100 miles northwest of the Lesser Antilles. Puerto Ricans are genetic descendants of pre-Columbian peoples, as well as peoples of European and African descent through 500 years of migration to the island. To infer these patterns of pre-Columbian and historic peopling of the Caribbean, we characterized genetic diversity in 326 individuals from the southeastern region of Puerto Rico and the island municipality of Vieques. We sequenced the mitochondrial DNA (mtDNA) control region of all of the samples and the complete mitogenomes of 12 of them to infer their putative place of origin. In addition, we genotyped 121 male samples for 25 Y-chromosome single nucleotide polymorphism and 17 STR loci. Approximately 60% of the participants had indigenous mtDNA haplotypes (mostly from haplogroups A2 and C1), while 25% had African and 15% European haplotypes. Three A2 sublineages were unique to the Greater Antilles, one of which was similar to Mesoamerican types, while C1b haplogroups showed links to South America, suggesting that people reached the island from the two distinct continental source areas. However, none of the male participants had indigenous Y-chromosomes, with 85% of them instead being European/Mediterranean and 15% sub-Saharan African in origin. West Eurasian Y-chromosome short tandem repeat haplotypes were quite diverse and showed similarities to those observed in southern Europe, North Africa and the Middle East. These results attest to the distinct, yet equally complex, pasts for the male and female ancestors of modern day Puerto Ricans. Am J Phys Anthropol 155:352-368, 2014. &copy; 2014 Wiley Periodicals, Inc.</p>
<p class="publication"><span class="title">American journal of physical anthropology</span>&nbsp;<span class="year">2014</span>;<span class="volume">155</span>;<span class="number">3</span>;<span class="pagerange">352-68</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25043798">25043798</a>; DOI: <a href="http://dx.doi.org/10.1002%2Fajpa.22569">10.1002/ajpa.22569</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Detecting and measuring selection from gene frequency data.</h4>
<p class="authors"><span class="author">Vitalis R</span>, <span class="author">Gautier M</span>, <span class="author">Dawson KJ</span> and <span class="author">Beaumont MA</span></p>
<p class="affiliation">Institut National de la Recherche Agronomique, Unit&eacute; Mixte de Recherche CBGP, (Inra, Ird, Cirad, Montpellier-SupAgro) 34988 Montferrier-sur-Lez Cedex, France.</p><p class="abstract">The recent advent of high-throughput sequencing and genotyping technologies makes it possible to produce, easily and cost effectively, large amounts of detailed data on the genotype composition of populations. Detecting locus-specific effects may help identify those genes that have been, or are currently, targeted by natural selection. How best to identify these selected regions, loci, or single nucleotides remains a challenging issue. Here, we introduce a new model-based method, called SelEstim, to distinguish putative selected polymorphisms from the background of neutral (or nearly neutral) ones and to estimate the intensity of selection at the former. The underlying population genetic model is a diffusion approximation for the distribution of allele frequency in a population subdivided into a number of demes that exchange migrants. We use a Markov chain Monte Carlo algorithm for sampling from the joint posterior distribution of the model parameters, in a hierarchical Bayesian framework. We present evidence from stochastic simulations, which demonstrates the good power of SelEstim to identify loci targeted by selection and to estimate the strength of selection acting on these loci, within each deme. We also reanalyze a subset of SNP data from the Stanford HGDP-CEPH Human Genome Diversity Cell Line Panel to illustrate the performance of SelEstim on real data. In agreement with previous studies, our analyses point to a very strong signal of positive selection upstream of the LCT gene, which encodes for the enzyme lactase-phlorizin hydrolase and is associated with adult-type hypolactasia. The geographical distribution of the strength of positive selection across the Old World matches the interpolated map of lactase persistence phenotype frequencies, with the strongest selection coefficients in Europe and in the Indus Valley.</p>
<p class="grants">Funded by: Biotechnology and Biological Sciences Research Council: <span class="grant">BBS/B/12776</span></p>
<p class="publication"><span class="title">Genetics</span>&nbsp;<span class="year">2014</span>;<span class="volume">196</span>;<span class="number">3</span>;<span class="pagerange">799-817</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24361938">24361938</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC3948807">3948807</a>; DOI: <a href="http://dx.doi.org/10.1534%2Fgenetics.113.152991">10.1534/genetics.113.152991</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Identification of enterotoxigenic Escherichia coli (ETEC) clades with long-term global distribution.</h4>
<p class="authors"><span class="author">von Mentzer A</span>, <span class="author">Connor TR</span>, <span class="author">Wieler LH</span>, <span class="author">Semmler T</span>, <span class="author">Iguchi A</span>, <span class="author">Thomson NR</span>, <span class="author">Rasko DA</span>, <span class="author">Joffre E</span>, <span class="author">Corander J</span>, <span class="author">Pickard D</span>, <span class="author">Wiklund G</span>, <span class="author">Svennerholm AM</span>, <span class="author">Sj&ouml;ling A</span> and <span class="author">Dougan G</span></p>
<p class="affiliation">1] Department of Microbiology and Immunology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. [2] Wellcome Trust Sanger Institute, Hinxton, UK.</p><p class="abstract">Enterotoxigenic Escherichia coli (ETEC), a major cause of infectious diarrhea, produce heat-stable and/or heat-labile enterotoxins and at least 25 different colonization factors that target the intestinal mucosa. The genes encoding the enterotoxins and most of the colonization factors are located on plasmids found across diverse E. coli serogroups. Whole-genome sequencing of a representative collection of ETEC isolated between 1980 and 2011 identified globally distributed lineages characterized by distinct colonization factor and enterotoxin profiles. Contrary to current notions, these relatively recently emerged lineages might harbor chromosome and plasmid combinations that optimize fitness and transmissibility. These data have implications for understanding, tracking and possibly preventing ETEC disease.</p>
<p class="publication"><span class="title">Nature genetics</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25383970">25383970</a>; DOI: <a href="http://dx.doi.org/10.1038%2Fng.3145">10.1038/ng.3145</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Novel porcine-like human G26P[19] rotavirus identified in hospitalized pediatric diarrhea patients in Ho Chi Minh City.</h4>
<p class="authors"><span class="author">Vu Tra My P</span>, <span class="author">Rabaa MA</span>, <span class="author">Donato C</span>, <span class="author">Cowley D</span>, <span class="author">Vinh Phat V</span>, <span class="author">Thi Ngoc Dung T</span>, <span class="author">Hong Anh P</span>, <span class="author">Vinh H</span>, <span class="author">Bryant JE</span>, <span class="author">Kellam P</span>, <span class="author">Thwaites G</span>, <span class="author">Woolhouse ME</span>, <span class="author">Kirkwood CD</span> and <span class="author">Baker S</span></p>
<p class="affiliation">The Hospital for Tropical Diseases, Wellcome Trust Major Overseas Programme, Vietnam;</p><p class="abstract">During a hospital-based diarrheal disease study conducted in Ho Chi Minh City, Vietnam from 2009-2010, we identified four symptomatic children infected with G26P[19] rotavirus, an atypical variant that has not previously been reported in human gastroenteritis. To determine the genetic structure and investigate the origin of this G26P[19] strain, the whole genome of a representative example was characterized, revealing a novel mixed genotype constellation of G26-P[19]-I5-R1-C1-M1-A8-N1-T1-E1-H1. The genome segments were most closely related to porcine (VP7, VP4, VP6 and NSP1) and Wa-like porcine rotaviruses (VP1-3, NSP2-5). We propose that this G26P[19] strain was a result from a pig-human zoonotic transmission, followed by a limited onward transmission train in humans. The identification of such strains has potential implications for vaccine efficacy in Southeast Asia and outlines the utility of whole genome sequencing for studying rotavirus genetic diversity and zoonotic potential during disease surveillance.</p>
<p class="publication"><span class="title">The Journal of general virology</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25121549">25121549</a>; DOI: <a href="http://dx.doi.org/10.1099%2Fvir.0.068403-0">10.1099/vir.0.068403-0</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">An outpatient, ambulant-design, controlled human infection model using escalating doses of salmonella typhi challenge delivered in sodium bicarbonate solution.</h4>
<p class="authors"><span class="author">Waddington CS</span>, <span class="author">Darton TC</span>, <span class="author">Jones C</span>, <span class="author">Haworth K</span>, <span class="author">Peters A</span>, <span class="author">John T</span>, <span class="author">Thompson BA</span>, <span class="author">Kerridge SA</span>, <span class="author">Kingsley RA</span>, <span class="author">Zhou L</span>, <span class="author">Holt KE</span>, <span class="author">Yu LM</span>, <span class="author">Lockhart S</span>, <span class="author">Farrar JJ</span>, <span class="author">Sztein MB</span>, <span class="author">Dougan G</span>, <span class="author">Angus B</span>, <span class="author">Levine MM</span> and <span class="author">Pollard AJ</span></p>
<p class="affiliation">Oxford Vaccine Group, Department of Paediatrics, University of Oxford.</p><p class="abstract">Background.&emsp;Typhoid fever is a major global health problem, the control of which is hindered by lack of a suitable animal model in which to study Salmonella Typhi infection. Until 1974, a human challenge model advanced understanding of typhoid and was used in vaccine development. We set out to establish a new human challenge model and ascertain the S. Typhi (Quailes strain) inoculum required for an attack rate of 60%-75% in typhoid-naive volunteers when ingested with sodium bicarbonate solution. Methods.&emsp;Groups of healthy consenting adults ingested escalating dose levels of S. Typhi and were closely monitored in an outpatient setting for 2 weeks. Antibiotic treatment was initiated if typhoid diagnosis occurred (temperature &ge;38&deg;C sustained &ge;12 hours or bacteremia) or at day 14 in those remaining untreated. Results.&emsp;Two dose levels (10(3) or 10(4) colony-forming units) were required to achieve the primary objective, resulting in attack rates of 55% (11/20) or 65% (13/20), respectively. Challenge was well tolerated; 4 of 40 participants fulfilled prespecified criteria for severe infection. Most diagnoses (87.5%) were confirmed by blood culture, and asymptomatic bacteremia and stool shedding of S. Typhi was also observed. Participants who developed typhoid infection demonstrated serological responses to flagellin and lipopolysaccharide antigens by day 14; however, no anti-Vi antibody responses were detected. Conclusions.&emsp;Human challenge with a small inoculum of virulent S. Typhi administered in bicarbonate solution can be performed safely using an ambulant-model design to advance understanding of host-pathogen interactions and immunity. This model should expedite development of diagnostics, vaccines, and therapeutics for typhoid control.</p>
<p class="publication"><span class="title">Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</span>&nbsp;<span class="year">2014</span>;<span class="volume">58</span>;<span class="number">9</span>;<span class="pagerange">1230-40</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24519873">24519873</a>; DOI: <a href="http://dx.doi.org/10.1093%2Fcid%2Fciu078">10.1093/cid/ciu078</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Whole Exome Re-Sequencing Implicates CCDC38 and Cilia Structure and Function in Resistance to Smoking Related Airflow Obstruction.</h4>
<p class="authors"><span class="author">Wain LV</span>, <span class="author">Sayers I</span>, <span class="author">Soler Artigas M</span>, <span class="author">Portelli MA</span>, <span class="author">Zeggini E</span>, <span class="author">Obeidat M</span>, <span class="author">Sin DD</span>, <span class="author">Boss&eacute; Y</span>, <span class="author">Nickle D</span>, <span class="author">Brandsma CA</span>, <span class="author">Malarstig A</span>, <span class="author">Vangjeli C</span>, <span class="author">Jelinsky SA</span>, <span class="author">John S</span>, <span class="author">Kilty I</span>, <span class="author">McKeever T</span>, <span class="author">Shrine NR</span>, <span class="author">Cook JP</span>, <span class="author">Patel S</span>, <span class="author">Spector TD</span>, <span class="author">Hollox EJ</span>, <span class="author">Hall IP</span> and <span class="author">Tobin MD</span></p>
<p class="affiliation">University of Leicester, Department of Health Sciences, Leicester, United Kingdom.</p><p class="abstract">Chronic obstructive pulmonary disease (COPD) is a leading cause of global morbidity and mortality and, whilst smoking remains the single most important risk factor, COPD risk is heritable. Of 26 independent genomic regions showing association with lung function in genome-wide association studies, eleven have been reported to show association with airflow obstruction. Although the main risk factor for COPD is smoking, some individuals are observed to have a high forced expired volume in 1 second (FEV1) despite many years of heavy smoking. We hypothesised that these &quot;resistant smokers&quot; may harbour variants which protect against lung function decline caused by smoking and provide insight into the genetic determinants of lung health. We undertook whole exome re-sequencing of 100 heavy smokers who had healthy lung function given their age, sex, height and smoking history and applied three complementary approaches to explore the genetic architecture of smoking resistance. Firstly, we identified novel functional variants in the &quot;resistant smokers&quot; and looked for enrichment of these novel variants within biological pathways. Secondly, we undertook association testing of all exonic variants individually with two independent control sets. Thirdly, we undertook gene-based association testing of all exonic variants. Our strongest signal of association with smoking resistance for a non-synonymous SNP was for rs10859974 (P&#x200A;=&#x200A;2.34&times;10-4) in CCDC38, a gene which has previously been reported to show association with FEV1/FVC, and we demonstrate moderate expression of CCDC38 in bronchial epithelial cells. We identified an enrichment of novel putatively functional variants in genes related to cilia structure and function in resistant smokers. Ciliary function abnormalities are known to be associated with both smoking and reduced mucociliary clearance in patients with COPD. We suggest that genetic influences on the development or function of cilia in the bronchial epithelium may affect growth of cilia or the extent of damage caused by tobacco smoke.</p>
<p class="publication"><span class="title">PLoS genetics</span>&nbsp;<span class="year">2014</span>;<span class="volume">10</span>;<span class="number">5</span>;<span class="pagerange">e1004314</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24786987">24786987</a>; DOI: <a href="http://dx.doi.org/10.1371%2Fjournal.pgen.1004314">10.1371/journal.pgen.1004314</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Adding genomic 'foliage' to the tree of life.</h4>
<p class="authors"><span class="author">Walker A</span></p>
<p class="affiliation">Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1SA, UK.</p>
<p class="publication"><span class="title">Nature reviews. Microbiology</span>&nbsp;<span class="year">2014</span>;<span class="volume">12</span>;<span class="number">2</span>;<span class="pagerange">78</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24429416">24429416</a>; DOI: <a href="http://dx.doi.org/10.1038%2Fnrmicro3203">10.1038/nrmicro3203</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">The genetic basis of plasmid tropism between Chlamydia trachomatis and Chlamydia muridarum.</h4>
<p class="authors"><span class="author">Wang Y</span>, <span class="author">Cutcliffe LT</span>, <span class="author">Skilton RJ</span>, <span class="author">Ramsey KH</span>, <span class="author">Thomson NR</span> and <span class="author">Clarke IN</span></p>
<p class="affiliation">Molecular Microbiology Group, Faculty of Medicine, University of Southampton, Southampton General Hospital, Southampton, UK.</p><p class="abstract">The development of genetic transformation technology for Chlamydia trachomatis using its endogenous plasmid has recently been described. Chlamydia muridarum cannot be transformed by the C.&nbsp;trachomatis plasmid, indicating a barrier between chlamydial species. To determine which regions of the plasmid conferred the species specificity, we used the novel approach of transforming wild-type C.&nbsp;muridarum carrying the endogenous plasmid pNigg and forced recombination with the C.&nbsp;trachomatis vector pGFP::SW2 which carries the complete C.&nbsp;trachomatis plasmid (pSW2). Penicillin and chloramphenicol-resistant transformants expressing the green fluorescent protein were selected. Recovery of plasmids from these transformants showed they were recombinants. The differences between the pSW2 and pNigg allowed identification of the recombination breakpoints and showed that pGFP::SW2 had exchanged a ~&nbsp;1&nbsp;kbp region with pNigg covering CDS 2. The recombinant plasmid (pSW2NiggCDS2) is maintained under antibiotic selection when transformed into plasmid-cured C.&nbsp;muridarum. The ability to select for recombinants in C.&nbsp;muridarum shows that the barrier is not at transformation, but at the level of plasmid replication or maintenance. Our studies show that CDS 2, together with adjoining sequences, is the main determinant of plasmid tropism.</p>
<p class="publication"><span class="title">Pathogens and disease</span>&nbsp;<span class="year">2014</span>;<span class="volume">72</span>;<span class="number">1</span>;<span class="pagerange">19-23</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24700815">24700815</a>; DOI: <a href="http://dx.doi.org/10.1111%2F2049-632X.12175">10.1111/2049-632X.12175</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Voyage to the bottom of the &#39;seaquence&#39;.</h4>
<p class="authors"><span class="author">Wash R</span> and <span class="author">Soria CD</span></p>
<p class="affiliation">Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1SA, UK.</p>
<p class="publication"><span class="title">Nature reviews. Microbiology</span>&nbsp;<span class="year">2014</span>;<span class="volume">12</span>;<span class="number">9</span>;<span class="pagerange">597</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25118883">25118883</a>; DOI: <a href="http://dx.doi.org/10.1038%2Fnrmicro3341">10.1038/nrmicro3341</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Contemporary gene flow between wild An. gambiae s.s. and An. arabiensis.</h4>
<p class="authors"><span class="author">Weetman D</span>, <span class="author">Steen K</span>, <span class="author">Rippon EJ</span>, <span class="author">Mawejje HD</span>, <span class="author">Donnelly MJ</span> and <span class="author">Wilding CS</span></p>
<p class="affiliation">Department of Vector Biology, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool L3 5QA, UK. <a href="mailto:%63.%73.%77%69%6C%64%69%6E%67%40%6C%6A%6D%75.%61%63.%75%6B">&#99;&#46;&#115;&#46;&#119;&#105;&#108;&#100;&#105;&#110;&#103;&#64;&#108;&#106;&#109;&#117;&#46;&#97;&#99;&#46;&#117;&#107;</a>.</p><p class="abstract"><strong>Background</strong>: In areas where the morphologically indistinguishable malaria mosquitoes Anopheles gambiae Giles and An. arabiensis Patton are sympatric, hybrids are detected occasionally via species-diagnostic molecular assays. An. gambiae and An. arabiensis exhibit both pre- and post-reproductive mating barriers, with swarms largely species-specific and male F1 (first-generation) hybrids sterile. Consequently advanced-stage hybrids (back-crosses to parental species), which would represent a route for potentially-adaptive introgression, are expected to be very rare in natural populations. Yet the use of one or two physically linked single-locus diagnostic assays renders them indistinguishable from F1 hybrids and levels of interspecific gene flow are unknown.</p><p class="abstract"><strong>Methods</strong>: We used data from over 350 polymorphic autosomal SNPs to investigate post F1 gene flow via patterns of genomic admixture between An. gambiae and An. arabiensis from eastern Uganda. Simulations were used to investigate the statistical power to detect hybrids with different levels of crossing and to identify the hybrid category significantly admixed genotypes could represent.</p><p class="abstract"><strong>Results</strong>: A range of admixture proportions were detected for 11 field-collected hybrids identified via single-locus species-diagnostic PCRs. Comparison of admixture data with simulations indicated that at least seven of these hybrids were advanced generation crosses, with backcrosses to each species identified. In addition, of 36 individuals typing as An. gambiae or An. arabiensis that exhibited outlying admixture proportions, ten were identified as significantly mixed backcrosses, and at least four of these were second or third generation crosses.</p><p class="abstract"><strong>Conclusions</strong>: Our results show that hybrids detected using standard diagnostics will often be hybrid generations beyond F1, and that in our study area around 5% (95% confidence intervals 3%-9%) of apparently &#39;pure&#39; species samples may also be backcrosses. This is likely an underestimate because of rapidly-declining detection power beyond the first two backcross generations. Post-F1 gene flow occurs at a far from inconsequential rate between An. gambiae and An. arabiensis, and, especially for traits under strong selection, could readily lead to adaptive introgression of genetic variants relevant for vector control.</p>
<p class="grants">Funded by: FIC NIH HHS: <span class="grant">D43-TW00807701A1</span>; NIAID NIH HHS: <span class="grant">R01AI082734-01</span>, <span class="grant">U19AI089674</span></p>
<p class="publication"><span class="title">Parasites &amp; vectors</span>&nbsp;<span class="year">2014</span>;<span class="volume">7</span>;<span class="pagerange">345</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25060488">25060488</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4124135">4124135</a>; DOI: <a href="http://dx.doi.org/10.1186%2F1756-3305-7-345">10.1186/1756-3305-7-345</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">The OMSSAPercolator: An automated tool to validate OMSSA results.</h4>
<p class="authors"><span class="author">Wen B</span>, <span class="author">Li G</span>, <span class="author">Wright JC</span>, <span class="author">Du C</span>, <span class="author">Feng Q</span>, <span class="author">Xu X</span>, <span class="author">Choudhary JS</span> and <span class="author">Wang J</span></p>
<p class="affiliation">BGI-Shenzhen, Shenzhen, P. R. China.</p><p class="abstract">Protein identification by MS/MS is an important technique in proteome studies. The Open Mass Spectrometry Search Algorithm (OMSSA) is an open-source search engine that can be used to identify MS/MS spectra acquired in these experiments. Here, we present a software tool, termed OMSSAPercolator, which interfaces OMSSA with Percolator, a post-search machine learning method for rescoring database search results. We demonstrate that it outperforms the standard OMSSA scoring scheme, and provides reliable significant measurements. OMSSAPercolator is programmed using JAVA and can be readily used as a standalone tool or integrated into existing data analysis pipelines. OMSSAPercolator is freely available and can be downloaded at http://sourceforge.net/projects/omssapercolator/.</p>
<p class="publication"><span class="title">Proteomics</span>&nbsp;<span class="year">2014</span>;<span class="volume">14</span>;<span class="number">9</span>;<span class="pagerange">1011-4</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24504981">24504981</a>; DOI: <a href="http://dx.doi.org/10.1002%2Fpmic.201300393">10.1002/pmic.201300393</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">A genome wide association study of Plasmodium falciparum susceptibility to 22 antimalarial drugs in Kenya.</h4>
<p class="authors"><span class="author">Wendler JP</span>, <span class="author">Okombo J</span>, <span class="author">Amato R</span>, <span class="author">Miotto O</span>, <span class="author">Kiara SM</span>, <span class="author">Mwai L</span>, <span class="author">Pole L</span>, <span class="author">O&#39;Brien J</span>, <span class="author">Manske M</span>, <span class="author">Alcock D</span>, <span class="author">Drury E</span>, <span class="author">Sanders M</span>, <span class="author">Oyola SO</span>, <span class="author">Malangone C</span>, <span class="author">Jyothi D</span>, <span class="author">Miles A</span>, <span class="author">Rockett KA</span>, <span class="author">MacInnis BL</span>, <span class="author">Marsh K</span>, <span class="author">Bejon P</span>, <span class="author">Nzila A</span> and <span class="author">Kwiatkowski DP</span></p>
<p class="affiliation">Medical Research Council (MRC) Centre for Genomics and Global Health, University of Oxford, Oxford, United Kingdom; Wellcome Trust Sanger Institute, Hinxton, Cambridge, United Kingdom; Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United Kingdom.</p><p class="abstract"><strong>Background</strong>: Drug resistance remains a chief concern for malaria control. In order to determine the genetic markers of drug resistant parasites, we tested the genome-wide associations (GWA) of sequence-based genotypes from 35 Kenyan P. falciparum parasites with the activities of 22 antimalarial drugs.</p><p class="abstract">Parasites isolated from children with acute febrile malaria were adapted to culture, and sensitivity was determined by in vitro growth in the presence of anti-malarial drugs. Parasites were genotyped using whole genome sequencing techniques. Associations between 6250 single nucleotide polymorphisms (SNPs) and resistance to individual anti-malarial agents were determined, with false discovery rate adjustment for multiple hypothesis testing. We identified expected associations in the pfcrt region with chloroquine (CQ) activity, and other novel loci associated with amodiaquine, quinazoline, and quinine activities. Signals for CQ and primaquine (PQ) overlap in and around pfcrt, and interestingly the phenotypes are inversely related for these two drugs. We catalog the variation in dhfr, dhps, mdr1, nhe, and crt, including novel SNPs, and confirm the presence of a dhfr-164L quadruple mutant in coastal Kenya. Mutations implicated in sulfadoxine-pyrimethamine resistance are at or near fixation in this sample set.</p><p class="abstract">Sequence-based GWA studies are powerful tools for phenotypic association tests. Using this approach on falciparum parasites from coastal Kenya we identified known and previously unreported genes associated with phenotypic resistance to anti-malarial drugs, and observe in high-resolution haplotype visualizations a possible signature of an inverse selective relationship between CQ and PQ.</p>
<p class="grants">Funded by: Medical Research Council: <span class="grant">G0600718</span>, <span class="grant">G1002624</span>; Wellcome Trust: <span class="grant">090532/Z/09/Z</span>, <span class="grant">090770/Z/09/Z</span>, <span class="grant">092654</span>, <span class="grant">098051</span></p>
<p class="publication"><span class="title">PloS one</span>&nbsp;<span class="year">2014</span>;<span class="volume">9</span>;<span class="number">5</span>;<span class="pagerange">e96486</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24809681">24809681</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4014544">4014544</a>; DOI: <a href="http://dx.doi.org/10.1371%2Fjournal.pone.0096486">10.1371/journal.pone.0096486</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Phenotyping structural abnormalities in mouse embryos using high-resolution episcopic microscopy.</h4>
<p class="authors"><span class="author">Weninger WJ</span>, <span class="author">Geyer SH</span>, <span class="author">Martineau A</span>, <span class="author">Galli A</span>, <span class="author">Adams DJ</span>, <span class="author">Wilson R</span> and <span class="author">Mohun TJ</span></p>
<p class="affiliation">Centre for Anatomy and Cell Biology &amp; MIC, Medical University of Vienna, 1090 Wien, Austria. <a href="mailto:%57%6F%6C%66%67%61%6E%67.%57%65%6E%69%6E%67%65%72%40%6D%65%64%75%6E%69%77%69%65%6E.%61%63.%61%74">&#87;&#111;&#108;&#102;&#103;&#97;&#110;&#103;&#46;&#87;&#101;&#110;&#105;&#110;&#103;&#101;&#114;&#64;&#109;&#101;&#100;&#117;&#110;&#105;&#119;&#105;&#101;&#110;&#46;&#97;&#99;&#46;&#97;&#116;</a>.</p><p class="abstract">The arrival of simple and reliable methods for 3D imaging of mouse embryos has opened the possibility of analysing normal and abnormal development in a far more systematic and comprehensive manner than has hitherto been possible. This will not only help to extend our understanding of normal tissue and organ development but, by applying the same approach to embryos from genetically modified mouse lines, such imaging studies could also transform our knowledge of gene function in embryogenesis and the aetiology of developmental disorders. The International Mouse Phenotyping Consortium is coordinating efforts to phenotype single gene knockouts covering the entire mouse genome, including characterising developmental defects for those knockout lines that prove to be embryonic lethal. Here, we present a pilot study of 34 such lines, utilising high-resolution episcopic microscopy (HREM) for comprehensive 2D and 3D imaging of homozygous null embryos and their wild-type littermates. We present a simple phenotyping protocol that has been developed to take advantage of the high-resolution images obtained by HREM and that can be used to score tissue and organ abnormalities in a reliable manner. Using this approach with embryos at embryonic day 14.5, we show the wide range of structural abnormalities that are likely to be detected in such studies and the variability in phenotypes between sibling homozygous null embryos.</p>
<p class="publication"><span class="title">Disease models &amp; mechanisms</span>&nbsp;<span class="year">2014</span>;<span class="volume">7</span>;<span class="number">10</span>;<span class="pagerange">1143-52</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25256713">25256713</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4174525">4174525</a>; DOI: <a href="http://dx.doi.org/10.1242%2Fdmm.016337">10.1242/dmm.016337</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">A risk-based approach to reducing exposure of staff to laboratory animal allergens.</h4>
<p class="authors"><span class="author">Westall L</span>, <span class="author">Graham IR</span> and <span class="author">Bussell J</span></p>
<p class="affiliation">Wellcome Trust Sanger Institute, Genome Campus, Hinxton, Cambridge, UK.</p><p class="abstract">Within the biomedical research industry, people who work with laboratory animals may be at risk of developing laboratory animal allergy, which can lead to occupational asthma. Under UK and EU laws, employers must prevent or adequately control exposure to any hazardous substance, which includes animal allergens, so far as reasonably practicable, for the protection of all people on the premises. This can be achieved in part by reviewing the risk of allergen exposure in specific areas of a facility and implementing appropriate infrastructure, environmental and performance controls to minimize that risk. The authors describe the approach used at their institution to stratify risk of allergen exposure in various areas of the animal facility and to implement appropriate controls. They also discuss their use of a monitoring program to evaluate allergen concentrations in low- and high-risk areas of the animal facility and explain how the monitoring results can be applied to determine which controls are needed to minimize risk of exposure and to provide a safe working environment.</p>
<p class="publication"><span class="title">Lab animal</span>&nbsp;<span class="year">2014</span>;<span class="volume">44</span>;<span class="number">1</span>;<span class="pagerange">32-8</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25526057">25526057</a>; DOI: <a href="http://dx.doi.org/10.1038%2Flaban.603">10.1038/laban.603</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">The mutational landscapes of genetic and chemical models of Kras-driven lung cancer.</h4>
<p class="authors"><span class="author">Westcott PM</span>, <span class="author">Halliwill KD</span>, <span class="author">To MD</span>, <span class="author">Rashid M</span>, <span class="author">Rust AG</span>, <span class="author">Keane TM</span>, <span class="author">Delrosario R</span>, <span class="author">Jen K</span>, <span class="author">Gurley KE</span>, <span class="author">Kemp CJ</span>, <span class="author">Fredlund E</span>, <span class="author">Quigley DA</span>, <span class="author">Adams DJ</span> and <span class="author">Balmain A</span></p>
<p class="affiliation">1] Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California 94158, USA [2] Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, California 94158, USA.</p><p class="abstract">Next-generation sequencing of human tumours has refined our understanding of the mutational processes operative in cancer initiation and progression, yet major questions remain regarding the factors that induce driver mutations and the processes that shape mutation selection during tumorigenesis. Here we performed whole-exome sequencing on adenomas from three mouse models of non-small-cell lung cancer, which were induced either by exposure to carcinogens (methyl-nitrosourea (MNU) and urethane) or by genetic activation of Kras (Kras(LA2)). Although the MNU-induced tumours carried exactly the same initiating mutation in Kras as seen in the Kras(LA2) model (G12D), MNU tumours had an average of 192 non-synonymous, somatic single-nucleotide variants, compared with only six in tumours from the Kras(LA2) model. By contrast, the Kras(LA2) tumours exhibited a significantly higher level of aneuploidy and copy number alterations compared with the carcinogen-induced tumours, suggesting that carcinogen-induced and genetically engineered models lead to tumour development through different routes. The wild-type allele of Kras has been shown to act as a tumour suppressor in mouse models of non-small-cell lung cancer. We demonstrate that urethane-induced tumours from wild-type mice carry mostly (94%) Kras Q61R mutations, whereas those from Kras heterozygous animals carry mostly (92%) Kras Q61L mutations, indicating a major role for germline Kras status in mutation selection during initiation. The exome-wide mutation spectra in carcinogen-induced tumours overwhelmingly display signatures of the initiating carcinogen, while adenocarcinomas acquire additional C&nbsp;&gt;&nbsp;T mutations at CpG sites. These data provide a basis for understanding results from human tumour genome sequencing, which has identified two broad categories of tumours based on the relative frequency of single-nucleotide variations and copy number alterations, and underline the importance of carcinogen models for understanding the complex mutation spectra seen in human cancers.</p>
<p class="grants">Funded by: NCI NIH HHS: <span class="grant">R01 CA111834</span>, <span class="grant">U01 CA084244</span>, <span class="grant">U01 CA141455</span>, <span class="grant">U01 CA176287</span></p>
<p class="publication"><span class="title">Nature</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25363767">25363767</a>; DOI: <a href="http://dx.doi.org/10.1038%2Fnature13898">10.1038/nature13898</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">A membrane topology model for human interferon inducible transmembrane protein 1.</h4>
<p class="authors"><span class="author">Weston S</span>, <span class="author">Czieso S</span>, <span class="author">White IJ</span>, <span class="author">Smith SE</span>, <span class="author">Kellam P</span> and <span class="author">Marsh M</span></p>
<p class="affiliation">MRC Laboratory for Molecular Cell Biology, University College London, London, United Kingdom.</p><p class="abstract">InterFeron Inducible TransMembrane proteins 1-3 (IFITM1, IFITM2 and IFITM3) are a family of proteins capable of inhibiting the cellular entry of numerous human and animal viruses. IFITM1-3 are unique amongst the currently described viral restriction factors in their apparent ability to block viral entry. This restrictive property is dependant on the localisation of the proteins to plasma and endosomal membranes, which constitute the main portals of viral entry into cells. The topology of the IFITM proteins within cell membranes is an unresolved aspect of their biology. Here we present data from immunofluorescence microscopy, protease cleavage, biotin-labelling and immuno-electron microscopy assays, showing that human IFITM1 has a membrane topology in which the N-terminal domain resides in the cytoplasm, and the C-terminal domain is extracellular. Furthermore, we provide evidence that this topology is conserved for all of the human interferon-induced IFITM proteins. This model is consistent with that recently proposed for murine IFITM3, but differs from that proposed for murine IFITM1.</p>
<p class="grants">Funded by: Medical Research Council: <span class="grant">G1000413</span>; Wellcome Trust: <span class="grant">098051</span></p>
<p class="publication"><span class="title">PloS one</span>&nbsp;<span class="year">2014</span>;<span class="volume">9</span>;<span class="number">8</span>;<span class="pagerange">e104341</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25105503">25105503</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4126714">4126714</a>; DOI: <a href="http://dx.doi.org/10.1371%2Fjournal.pone.0104341">10.1371/journal.pone.0104341</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Selective nuclear export of specific classes of mRNA from mammalian nuclei is promoted by GANP.</h4>
<p class="authors"><span class="author">Wickramasinghe VO</span>, <span class="author">Andrews R</span>, <span class="author">Ellis P</span>, <span class="author">Langford C</span>, <span class="author">Gurdon JB</span>, <span class="author">Stewart M</span>, <span class="author">Venkitaraman AR</span> and <span class="author">Laskey RA</span></p>
<p class="affiliation">MRC Cancer Unit, University of Cambridge, Hutchison/MRC Research Centre, Box 197, Biomedical Campus, Cambridge CB2 0XZ, UK, The Wellcome Trust Sanger Institute, Genome Campus, Hinxton, Cambridge CB10 1SA, UK, Wellcome Trust, Cancer Research UK Gurdon Institute, University of Cambridge, Cambridge CB2 1QN, UK, MRC Laboratory of Molecular Biology, Francis Crick Avenue, Cambridge CB2 0QH, UK and Department of Zoology, University of Cambridge, Downing Street, Cambridge CB2 3EJ, UK.</p><p class="abstract">The nuclear phase of the gene expression pathway culminates in the export of mature messenger RNAs (mRNAs) to the cytoplasm through nuclear pore complexes. GANP (germinal- centre associated nuclear protein) promotes the transfer of mRNAs bound to the transport factor NXF1 to nuclear pore complexes. Here, we demonstrate that GANP, subunit of the TRanscription-EXport-2 (TREX-2) mRNA export complex, promotes selective nuclear export of a specific subset of mRNAs whose transport depends on NXF1. Genome-wide gene expression profiling showed that half of the transcripts whose nuclear export was impaired following NXF1 depletion also showed reduced export when GANP was depleted. GANP-dependent transcripts were highly expressed, yet short-lived, and were highly enriched in those encoding central components of the gene expression machinery such as RNA synthesis and processing factors. After injection into Xenopus oocyte nuclei, representative GANP-dependent transcripts showed faster nuclear export kinetics than representative transcripts that were not influenced by GANP depletion. We propose that GANP promotes the nuclear export of specific classes of mRNAs that may facilitate rapid changes in gene expression.</p>
<p class="grants">Funded by: Department of Health: <span class="grant">U105178939</span>; Medical Research Council: <span class="grant">G1001522</span></p>
<p class="publication"><span class="title">Nucleic acids research</span>&nbsp;<span class="year">2014</span>;<span class="volume">42</span>;<span class="number">8</span>;<span class="pagerange">5059-71</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24510098">24510098</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4005691">4005691</a>; DOI: <a href="http://dx.doi.org/10.1093%2Fnar%2Fgku095">10.1093/nar/gku095</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Single-cell analyses of regulatory network perturbations using enhancer-targeting TALEs suggest novel roles for PU.1 during haematopoietic specification.</h4>
<p class="authors"><span class="author">Wilkinson AC</span>, <span class="author">Kawata VK</span>, <span class="author">Sch&uuml;tte J</span>, <span class="author">Gao X</span>, <span class="author">Antoniou S</span>, <span class="author">Baumann C</span>, <span class="author">Woodhouse S</span>, <span class="author">Hannah R</span>, <span class="author">Tanaka Y</span>, <span class="author">Swiers G</span>, <span class="author">Moignard V</span>, <span class="author">Fisher J</span>, <span class="author">Hidetoshi S</span>, <span class="author">Tijssen MR</span>, <span class="author">de Bruijn MF</span>, <span class="author">Liu P</span> and <span class="author">G&ouml;ttgens B</span></p>
<p class="affiliation">Cambridge Institute for Medical Research and Wellcome Trust-MRC Cambridge Stem Cell Institute, University of Cambridge, Hills Road, Cambridge CB2 0XY, UK.</p><p class="abstract">Transcription factors (TFs) act within wider regulatory networks to control cell identity and fate. Numerous TFs, including Scl (Tal1) and PU.1 (Spi1), are known regulators of developmental and adult haematopoiesis, but how they act within wider TF networks is still poorly understood. Transcription activator-like effectors (TALEs) are a novel class of genetic tool based on the modular DNA-binding domains of Xanthomonas TAL proteins, which enable DNA sequence-specific targeting and the manipulation of endogenous gene expression. Here, we report TALEs engineered to target the PU.1-14kb and Scl+40kb transcriptional enhancers as efficient new tools to perturb the expression of these key haematopoietic TFs. We confirmed the efficiency of these TALEs at the single-cell level using high-throughput RT-qPCR, which also allowed us to assess the consequences of both PU.1 activation and repression on wider TF networks during developmental haematopoiesis. Combined with comprehensive cellular assays, these experiments uncovered novel roles for PU.1 during early haematopoietic specification. Finally, transgenic mouse studies confirmed that the PU.1-14kb element is active at sites of definitive haematopoiesis in vivo and PU.1 is detectable in haemogenic endothelium and early committing blood cells. We therefore establish TALEs as powerful new tools to study the functionality of transcriptional networks that control developmental processes such as early haematopoiesis.</p>
<p class="publication"><span class="title">Development (Cambridge, England)</span>&nbsp;<span class="year">2014</span>;<span class="volume">141</span>;<span class="number">20</span>;<span class="pagerange">4018-30</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25252941">25252941</a>; DOI: <a href="http://dx.doi.org/10.1242%2Fdev.115709">10.1242/dev.115709</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Heterozygous Loss-of-Function Mutations in YAP1 Cause Both Isolated and Syndromic Optic Fissure Closure Defects.</h4>
<p class="authors"><span class="author">Williamson KA</span>, <span class="author">Rainger J</span>, <span class="author">Floyd JA</span>, <span class="author">Ansari M</span>, <span class="author">Meynert A</span>, <span class="author">Aldridge KV</span>, <span class="author">Rainger JK</span>, <span class="author">Anderson CA</span>, <span class="author">Moore AT</span>, <span class="author">Hurles ME</span>, <span class="author">Clarke A</span>, <span class="author">van Heyningen V</span>, <span class="author">Verloes A</span>, <span class="author">Taylor MS</span>, <span class="author">Wilkie AO</span>, <span class="author">UK10K Consortium</span> and <span class="author">Fitzpatrick DR</span></p>
<p class="affiliation">Medical Research Council Human Genetics Unit, Medical Research Council Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh EH4 2XU, UK.</p>
<p class="abstract">Exome sequence analysis of affected individuals from two families with autosomal-dominant inheritance of coloboma identified two different cosegregating heterozygous nonsense mutations (c.370C>T [p.Arg124()] and c. 1066G>T [p.Glu356()]) in YAP1. The phenotypes of the affected families differed in that one included no extraocular features and the other manifested with highly variable multisystem involvement, including hearing loss, intellectual disability, hematuria, and orofacial clefting. A combined LOD score of 4.2 was obtained for the association between YAP1 loss-of-function mutations and the phenotype in these families. YAP1 encodes an effector of the HIPPO-pathway-induced growth response, and whole-mount insitu hybridization in mouse embryos has shown that Yap1 is strongly expressed in the eye, brain, and fusing facial processes. RT-PCR showed that an alternative transcription start site (TSS) in intron 1 of YAP1 and Yap1 is widely used in human and mouse development, respectively. Transcripts from the alternative TSS are predicted to initiate at codon Met179 relative to the canonical transcript (RefSeq NM_001130145). In these alternative transcripts, the c.370C>T mutation in family 1305 is within the 5' UTR and cannot result in nonsense-mediated decay (NMD). The c. 1066G>T mutation in family 132 should result in NMD in transcripts from either TSS. Amelioration of the phenotype by the alternative transcripts provides a plausible explanation for the phenotypic differences between the families.</p>
<p class="publication"><span class="title">American journal of human genetics</span>&nbsp;<span class="year">2014</span>;<span class="volume">94</span>;<span class="number">2</span>;<span class="pagerange">295-302</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24462371">24462371</a>; DOI: <a href="http://dx.doi.org/10.1016%2Fj.ajhg.2014.01.001">10.1016/j.ajhg.2014.01.001</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Integrating non-coding RNAs in JAK-STAT regulatory networks.</h4>
<p class="authors"><span class="author">Witte S</span> and <span class="author">Muljo SA</span></p>
<p class="affiliation">Integrative Immunobiology Unit; Laboratory of Immunology; National Institute of Allergy and Infectious Diseases; National Institutes of Health; Bethesda, MD USA ; Wellcome Trust Sanger Institute; Genome Campus; Hinxton, UK.</p><p class="abstract">Being a well-characterized pathway, JAK-STAT signaling serves as a valuable paradigm for studying the architecture of gene regulatory networks. The discovery of untranslated or non-coding RNAs, namely microRNAs and long non-coding RNAs, provides an opportunity to elucidate their roles in such networks. In principle, these regulatory RNAs can act as downstream effectors of the JAK-STAT pathway and/or affect signaling by regulating the expression of JAK-STAT components. Examples of interactions between signaling pathways and non-coding RNAs have already emerged in basic cell biology and human diseases such as cancer, and can potentially guide the identification of novel biomarkers or drug targets for medicine.</p>
<p class="publication"><span class="title">JAK-STAT</span>&nbsp;<span class="year">2014</span>;<span class="volume">3</span>;<span class="number">1</span>;<span class="pagerange">e28055</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24778925">24778925</a>; DOI: <a href="http://dx.doi.org/10.4161%2Fjkst.28055">10.4161/jkst.28055</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Epigenome-wide DNA methylation in hearing ability: new mechanisms for an old problem.</h4>
<p class="authors"><span class="author">Wolber LE</span>, <span class="author">Steves CJ</span>, <span class="author">Tsai PC</span>, <span class="author">Deloukas P</span>, <span class="author">Spector TD</span>, <span class="author">Bell JT</span> and <span class="author">Williams FM</span></p>
<p class="affiliation">Department of Twin Research and Genetic Epidemiology, King&#39;s College London, London, United Kingdom.</p><p class="abstract">Epigenetic regulation of gene expression has been shown to change over time and may be associated with environmental exposures in common complex traits. Age-related hearing impairment is a complex disorder, known to be heritable, with heritability estimates of 57-70%. Epigenetic regulation might explain the observed difference in age of onset and magnitude of hearing impairment with age. Epigenetic epidemiology studies using unrelated samples can be limited in their ability to detect small effects, and recent epigenetic findings in twins underscore the power of this well matched study design. We investigated the association between venous blood DNA methylation epigenome-wide and hearing ability. Pure-tone audiometry (PTA) and Illumina HumanMethylation array data were obtained from female twin volunteers enrolled in the TwinsUK register. Two study groups were explored: first, an epigenome-wide association scan (EWAS) was performed in a discovery sample (n&#x200A;=&#x200A;115 subjects, age range: 47-83 years, Illumina 27 k array), then replication of the top ten associated probes from the discovery EWAS was attempted in a second unrelated sample (n&#x200A;=&#x200A;203, age range: 41-86 years, Illumina 450 k array). Finally, a set of monozygotic (MZ) twin pairs (n&#x200A;=&#x200A;21 pairs) within the discovery sample (Illumina 27 k array) was investigated in more detail in an MZ discordance analysis. Hearing ability was strongly associated with DNA methylation levels in the promoter regions of several genes, including TCF25 (cg01161216, p&#x200A;=&#x200A;6.6&times;10-6), FGFR1 (cg15791248, p&#x200A;=&#x200A;5.7&times;10-5) and POLE (cg18877514, p&#x200A;=&#x200A;6.3&times;10-5). Replication of these results in a second sample confirmed the presence of differential methylation at TCF25 (p(replication)&#x200A;=&#x200A;6&times;10-5) and POLE (p(replication)&#x200A;=&#x200A;0.016). In the MZ discordance analysis, twins&#39; intrapair difference in hearing ability correlated with DNA methylation differences at ACP6 (cg01377755, r&#x200A;=&#x200A;-0.75, p&#x200A;=&#x200A;1.2&times;10-4) and MEF2D (cg08156349, r&#x200A;=&#x200A;-0.75, p&#x200A;=&#x200A;1.4&times;10-4). Examination of gene expression in skin, suggests an influence of differential methylation on expression, which may account for the variation in hearing ability with age.</p>
<p class="publication"><span class="title">PloS one</span>&nbsp;<span class="year">2014</span>;<span class="volume">9</span>;<span class="number">9</span>;<span class="pagerange">e105729</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25184702">25184702</a>; DOI: <a href="http://dx.doi.org/10.1371%2Fjournal.pone.0105729">10.1371/journal.pone.0105729</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Myelodysplastic syndromes are propagated by rare and distinct human cancer stem cells in vivo.</h4>
<p class="authors"><span class="author">Woll PS</span>, <span class="author">Kj&auml;llquist U</span>, <span class="author">Chowdhury O</span>, <span class="author">Doolittle H</span>, <span class="author">Wedge DC</span>, <span class="author">Thongjuea S</span>, <span class="author">Erlandsson R</span>, <span class="author">Ngara M</span>, <span class="author">Anderson K</span>, <span class="author">Deng Q</span>, <span class="author">Mead AJ</span>, <span class="author">Stenson L</span>, <span class="author">Giustacchini A</span>, <span class="author">Duarte S</span>, <span class="author">Giannoulatou E</span>, <span class="author">Taylor S</span>, <span class="author">Karimi M</span>, <span class="author">Scharenberg C</span>, <span class="author">Mortera-Blanco T</span>, <span class="author">Macaulay IC</span>, <span class="author">Clark SA</span>, <span class="author">Dybedal I</span>, <span class="author">Josefsen D</span>, <span class="author">Fenaux P</span>, <span class="author">Hokland P</span>, <span class="author">Holm MS</span>, <span class="author">Cazzola M</span>, <span class="author">Malcovati L</span>, <span class="author">Tauro S</span>, <span class="author">Bowen D</span>, <span class="author">Boultwood J</span>, <span class="author">Pellagatti A</span>, <span class="author">Pimanda JE</span>, <span class="author">Unnikrishnan A</span>, <span class="author">Vyas P</span>, <span class="author">G&ouml;hring G</span>, <span class="author">Schlegelberger B</span>, <span class="author">Tobiasson M</span>, <span class="author">Kvalheim G</span>, <span class="author">Constantinescu SN</span>, <span class="author">Nerlov C</span>, <span class="author">Nilsson L</span>, <span class="author">Campbell PJ</span>, <span class="author">Sandberg R</span>, <span class="author">Papaemmanuil E</span>, <span class="author">Hellstr&ouml;m-Lindberg E</span>, <span class="author">Linnarsson S</span> and <span class="author">Jacobsen SE</span></p>
<p class="affiliation">Haematopoietic Stem Cell Biology Laboratory, MRC Molecular Haematology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford OX3 9DS, UK.</p><p class="abstract">Evidence for distinct human cancer stem cells (CSCs) remains contentious and the degree to which different cancer cells contribute to propagating malignancies in patients remains unexplored. In low- to intermediate-risk myelodysplastic syndromes (MDS), we establish the existence of rare multipotent MDS stem cells (MDS-SCs), and their hierarchical relationship to lineage-restricted MDS progenitors. All identified somatically acquired genetic lesions were backtracked to distinct MDS-SCs, establishing their distinct MDS-propagating function in vivo. In isolated del(5q)-MDS, acquisition of del(5q) preceded diverse recurrent driver mutations. Sequential analysis in del(5q)-MDS revealed genetic evolution in MDS-SCs and MDS-progenitors prior to leukemic transformation. These findings provide definitive evidence for rare human MDS-SCs in vivo, with extensive implications for the targeting of the cells required and sufficient for MDS-propagation.</p>
<p class="grants">Funded by: Medical Research Council: <span class="grant">G0701761</span>, <span class="grant">G0900892</span>, <span class="grant">G1000729</span>, <span class="grant">MR/L006340/1</span>; Wellcome Trust</p>
<p class="publication"><span class="title">Cancer cell</span>&nbsp;<span class="year">2014</span>;<span class="volume">25</span>;<span class="number">6</span>;<span class="pagerange">794-808</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24835589">24835589</a>; DOI: <a href="http://dx.doi.org/10.1016%2Fj.ccr.2014.03.036">10.1016/j.ccr.2014.03.036</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Inactivating CUX1 mutations promote tumorigenesis.</h4>
<p class="authors"><span class="author">Wong CC</span>, <span class="author">Martincorena I</span>, <span class="author">Rust AG</span>, <span class="author">Rashid M</span>, <span class="author">Alifrangis C</span>, <span class="author">Alexandrov LB</span>, <span class="author">Tiffen JC</span>, <span class="author">Kober C</span>, <span class="author">Chronic Myeloid Disorders Working Group of the International Cancer Genome Consortium</span>, <span class="author">Green AR</span>, <span class="author">Massie CE</span>, <span class="author">Nangalia J</span>, <span class="author">Lempidaki S</span>, <span class="author">D&ouml;hner H</span>, <span class="author">D&ouml;hner K</span>, <span class="author">Bray SJ</span>, <span class="author">McDermott U</span>, <span class="author">Papaemmanuil E</span>, <span class="author">Campbell PJ</span> and <span class="author">Adams DJ</span></p>
<p class="affiliation">1] Experimental Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK. [2] Department of Haematology, University of Cambridge, Hills Road, Cambridge, UK.</p><p class="abstract">A major challenge in cancer genetics is to determine which low-frequency somatic mutations are drivers of tumorigenesis. Here we interrogate the genomes of 7,651 diverse human cancers and find inactivating mutations in the homeodomain transcription factor gene CUX1 (cut-like homeobox 1) in ~1-5% of various tumors. Meta-analysis of CUX1 mutational status in 2,519 cases of myeloid malignancies reveals disruptive mutations associated with poor survival, highlighting the clinical significance of CUX1 loss. In parallel, we validate CUX1 as a bona fide tumor suppressor using mouse transposon-mediated insertional mutagenesis and Drosophila cancer models. We demonstrate that CUX1 deficiency activates phosphoinositide 3-kinase (PI3K) signaling through direct transcriptional downregulation of the PI3K inhibitor PIK3IP1 (phosphoinositide-3-kinase interacting protein 1), leading to increased tumor growth and susceptibility to PI3K-AKT inhibition. Thus, our complementary approaches identify CUX1 as a pan-driver of tumorigenesis and uncover a potential strategy for treating CUX1-mutant tumors.</p>
<p class="grants">Funded by: Cancer Research UK: <span class="grant">13031</span>, <span class="grant">16629</span>, <span class="grant">A13031</span>, <span class="grant">A14356</span>, <span class="grant">A6542</span>, <span class="grant">A6997</span>; Medical Research Council: <span class="grant">G0800034</span>; Wellcome Trust: <span class="grant">079249</span>, <span class="grant">082356</span>, <span class="grant">093867</span>, <span class="grant">100140</span></p>
<p class="publication"><span class="title">Nature genetics</span>&nbsp;<span class="year">2014</span>;<span class="volume">46</span>;<span class="number">1</span>;<span class="pagerange">33-8</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24316979">24316979</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC3874239">3874239</a>; DOI: <a href="http://dx.doi.org/10.1038%2Fng.2846">10.1038/ng.2846</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Defining the role of common variation in the genomic and biological architecture of adult human height.</h4>
<p class="authors"><span class="author">Wood AR</span>, <span class="author">Esko T</span>, <span class="author">Yang J</span>, <span class="author">Vedantam S</span>, <span class="author">Pers TH</span>, <span class="author">Gustafsson S</span>, <span class="author">Chu AY</span>, <span class="author">Estrada K</span>, <span class="author">Luan J</span>, <span class="author">Kutalik Z</span>, <span class="author">Amin N</span>, <span class="author">Buchkovich ML</span>, <span class="author">Croteau-Chonka DC</span>, <span class="author">Day FR</span>, <span class="author">Duan Y</span>, <span class="author">Fall T</span>, <span class="author">Fehrmann R</span>, <span class="author">Ferreira T</span>, <span class="author">Jackson AU</span>, <span class="author">Karjalainen J</span>, <span class="author">Lo KS</span>, <span class="author">Locke AE</span>, <span class="author">M&auml;gi R</span>, <span class="author">Mihailov E</span>, <span class="author">Porcu E</span>, <span class="author">Randall JC</span>, <span class="author">Scherag A</span>, <span class="author">Vinkhuyzen AA</span>, <span class="author">Westra HJ</span>, <span class="author">Winkler TW</span>, <span class="author">Workalemahu T</span>, <span class="author">Zhao JH</span>, <span class="author">Absher D</span>, <span class="author">Albrecht E</span>, <span class="author">Anderson D</span>, <span class="author">Baron J</span>, <span class="author">Beekman M</span>, <span class="author">Demirkan A</span>, <span class="author">Ehret GB</span>, <span class="author">Feenstra B</span>, <span class="author">Feitosa MF</span>, <span class="author">Fischer K</span>, <span class="author">Fraser RM</span>, <span class="author">Goel A</span>, <span class="author">Gong J</span>, <span class="author">Justice AE</span>, <span class="author">Kanoni S</span>, <span class="author">Kleber ME</span>, <span class="author">Kristiansson K</span>, <span class="author">Lim U</span>, <span class="author">Lotay V</span>, <span class="author">Lui JC</span>, <span class="author">Mangino M</span>, <span class="author">Leach IM</span>, <span class="author">Medina-Gomez C</span>, <span class="author">Nalls MA</span>, <span class="author">Nyholt DR</span>, <span class="author">Palmer CD</span>, <span class="author">Pasko D</span>, <span class="author">Pechlivanis S</span>, <span class="author">Prokopenko I</span>, <span class="author">Ried JS</span>, <span class="author">Ripke S</span>, <span class="author">Shungin D</span>, <span class="author">Stanc&aacute;kov&aacute; A</span>, <span class="author">Strawbridge RJ</span>, <span class="author">Sung YJ</span>, <span class="author">Tanaka T</span>, <span class="author">Teumer A</span>, <span class="author">Trompet S</span>, <span class="author">van der Laan SW</span>, <span class="author">van Setten J</span>, <span class="author">Van Vliet-Ostaptchouk JV</span>, <span class="author">Wang Z</span>, <span class="author">Yengo L</span>, <span class="author">Zhang W</span>, <span class="author">Afzal U</span>, <span class="author">Arnl&ouml;v J</span>, <span class="author">Arscott GM</span>, <span class="author">Bandinelli S</span>, <span class="author">Barrett A</span>, <span class="author">Bellis C</span>, <span class="author">Bennett AJ</span>, <span class="author">Berne C</span>, <span class="author">Bl&uuml;her M</span>, <span class="author">Bolton JL</span>, <span class="author">B&ouml;ttcher Y</span>, <span class="author">Boyd HA</span>, <span class="author">Bruinenberg M</span>, <span class="author">Buckley BM</span>, <span class="author">Buyske S</span>, <span class="author">Caspersen IH</span>, <span class="author">Chines PS</span>, <span class="author">Clarke R</span>, <span class="author">Claudi-Boehm S</span>, <span class="author">Cooper M</span>, <span class="author">Daw EW</span>, <span class="author">De Jong PA</span>, <span class="author">Deelen J</span>, <span class="author">Delgado G</span>, <span class="author">Denny JC</span>, <span class="author">Dhonukshe-Rutten R</span>, <span class="author">Dimitriou M</span>, <span class="author">Doney AS</span>, <span class="author">D&ouml;rr M</span>, <span class="author">Eklund N</span>, <span class="author">Eury E</span>, <span class="author">Folkersen L</span>, <span class="author">Garcia ME</span>, <span class="author">Geller F</span>, <span class="author">Giedraitis V</span>, <span class="author">Go AS</span>, <span class="author">Grallert H</span>, <span class="author">Grammer TB</span>, <span class="author">Gr&auml;&szlig;ler J</span>, <span class="author">Gr&ouml;nberg H</span>, <span class="author">de Groot LC</span>, <span class="author">Groves CJ</span>, <span class="author">Haessler J</span>, <span class="author">Hall P</span>, <span class="author">Haller T</span>, <span class="author">Hallmans G</span>, <span class="author">Hannemann A</span>, <span class="author">Hartman CA</span>, <span class="author">Hassinen M</span>, <span class="author">Hayward C</span>, <span class="author">Heard-Costa NL</span>, <span class="author">Helmer Q</span>, <span class="author">Hemani G</span>, <span class="author">Henders AK</span>, <span class="author">Hillege HL</span>, <span class="author">Hlatky MA</span>, <span class="author">Hoffmann W</span>, <span class="author">Hoffmann P</span>, <span class="author">Holmen O</span>, <span class="author">Houwing-Duistermaat JJ</span>, <span class="author">Illig T</span>, <span class="author">Isaacs A</span>, <span class="author">James AL</span>, <span class="author">Jeff J</span>, <span class="author">Johansen B</span>, <span class="author">Johansson A</span>, <span class="author">Jolley J</span>, <span class="author">Juliusdottir T</span>, <span class="author">Junttila J</span>, <span class="author">Kho AN</span>, <span class="author">Kinnunen L</span>, <span class="author">Klopp N</span>, <span class="author">Kocher T</span>, <span class="author">Kratzer W</span>, <span class="author">Lichtner P</span>, <span class="author">Lind L</span>, <span class="author">Lindstr&ouml;m J</span>, <span class="author">Lobbens S</span>, <span class="author">Lorentzon M</span>, <span class="author">Lu Y</span>, <span class="author">Lyssenko V</span>, <span class="author">Magnusson PK</span>, <span class="author">Mahajan A</span>, <span class="author">Maillard M</span>, <span class="author">McArdle WL</span>, <span class="author">McKenzie CA</span>, <span class="author">McLachlan S</span>, <span class="author">McLaren PJ</span>, <span class="author">Menni C</span>, <span class="author">Merger S</span>, <span class="author">Milani L</span>, <span class="author">Moayyeri A</span>, <span class="author">Monda KL</span>, <span class="author">Morken MA</span>, <span class="author">M&uuml;ller G</span>, <span class="author">M&uuml;ller-Nurasyid M</span>, <span class="author">Musk AW</span>, <span class="author">Narisu N</span>, <span class="author">Nauck M</span>, <span class="author">Nolte IM</span>, <span class="author">N&ouml;then MM</span>, <span class="author">Oozageer L</span>, <span class="author">Pilz S</span>, <span class="author">Rayner NW</span>, <span class="author">Renstrom F</span>, <span class="author">Robertson NR</span>, <span class="author">Rose LM</span>, <span class="author">Roussel R</span>, <span class="author">Sanna S</span>, <span class="author">Scharnagl H</span>, <span class="author">Scholtens S</span>, <span class="author">Schumacher FR</span>, <span class="author">Schunkert H</span>, <span class="author">Scott RA</span>, <span class="author">Sehmi J</span>, <span class="author">Seufferlein T</span>, <span class="author">Shi J</span>, <span class="author">Silventoinen K</span>, <span class="author">Smit JH</span>, <span class="author">Smith AV</span>, <span class="author">Smolonska J</span>, <span class="author">Stanton AV</span>, <span class="author">Stirrups K</span>, <span class="author">Stott DJ</span>, <span class="author">Stringham HM</span>, <span class="author">Sundstr&ouml;m J</span>, <span class="author">Swertz MA</span>, <span class="author">Syv&auml;nen AC</span>, <span class="author">Tayo BO</span>, <span class="author">Thorleifsson G</span>, <span class="author">Tyrer JP</span>, <span class="author">van Dijk S</span>, <span class="author">van Schoor NM</span>, <span class="author">van der Velde N</span>, <span class="author">van Heemst D</span>, <span class="author">van Oort FV</span>, <span class="author">Vermeulen SH</span>, <span class="author">Verweij N</span>, <span class="author">Vonk JM</span>, <span class="author">Waite LL</span>, <span class="author">Waldenberger M</span>, <span class="author">Wennauer R</span>, <span class="author">Wilkens LR</span>, <span class="author">Willenborg C</span>, <span class="author">Wilsgaard T</span>, <span class="author">Wojczynski MK</span>, <span class="author">Wong A</span>, <span class="author">Wright AF</span>, <span class="author">Zhang Q</span>, <span class="author">Arveiler D</span>, <span class="author">Bakker SJ</span>, <span class="author">Beilby J</span>, <span class="author">Bergman RN</span>, <span class="author">Bergmann S</span>, <span class="author">Biffar R</span>, <span class="author">Blangero J</span>, <span class="author">Boomsma DI</span>, <span class="author">Bornstein SR</span>, <span class="author">Bovet P</span>, <span class="author">Brambilla P</span>, <span class="author">Brown MJ</span>, <span class="author">Campbell H</span>, <span class="author">Caulfield MJ</span>, <span class="author">Chakravarti A</span>, <span class="author">Collins R</span>, <span class="author">Collins FS</span>, <span class="author">Crawford DC</span>, <span class="author">Cupples LA</span>, <span class="author">Danesh J</span>, <span class="author">de Faire U</span>, <span class="author">den Ruijter HM</span>, <span class="author">Erbel R</span>, <span class="author">Erdmann J</span>, <span class="author">Eriksson JG</span>, <span class="author">Farrall M</span>, <span class="author">Ferrannini E</span>, <span class="author">Ferri&egrave;res J</span>, <span class="author">Ford I</span>, <span class="author">Forouhi NG</span>, <span class="author">Forrester T</span>, <span class="author">Gansevoort RT</span>, <span class="author">Gejman PV</span>, <span class="author">Gieger C</span>, <span class="author">Golay A</span>, <span class="author">Gottesman O</span>, <span class="author">Gudnason V</span>, <span class="author">Gyllensten U</span>, <span class="author">Haas DW</span>, <span class="author">Hall AS</span>, <span class="author">Harris TB</span>, <span class="author">Hattersley AT</span>, <span class="author">Heath AC</span>, <span class="author">Hengstenberg C</span>, <span class="author">Hicks AA</span>, <span class="author">Hindorff LA</span>, <span class="author">Hingorani AD</span>, <span class="author">Hofman A</span>, <span class="author">Hovingh GK</span>, <span class="author">Humphries SE</span>, <span class="author">Hunt SC</span>, <span class="author">Hypponen E</span>, <span class="author">Jacobs KB</span>, <span class="author">Jarvelin MR</span>, <span class="author">Jousilahti P</span>, <span class="author">Jula AM</span>, <span class="author">Kaprio J</span>, <span class="author">Kastelein JJ</span>, <span class="author">Kayser M</span>, <span class="author">Kee F</span>, <span class="author">Keinanen-Kiukaanniemi SM</span>, <span class="author">Kiemeney LA</span>, <span class="author">Kooner JS</span>, <span class="author">Kooperberg C</span>, <span class="author">Koskinen S</span>, <span class="author">Kovacs P</span>, <span class="author">Kraja AT</span>, <span class="author">Kumari M</span>, <span class="author">Kuusisto J</span>, <span class="author">Lakka TA</span>, <span class="author">Langenberg C</span>, <span class="author">Le Marchand L</span>, <span class="author">Lehtim&auml;ki T</span>, <span class="author">Lupoli S</span>, <span class="author">Madden PA</span>, <span class="author">M&auml;nnist&ouml; S</span>, <span class="author">Manunta P</span>, <span class="author">Marette A</span>, <span class="author">Matise TC</span>, <span class="author">McKnight B</span>, <span class="author">Meitinger T</span>, <span class="author">Moll FL</span>, <span class="author">Montgomery GW</span>, <span class="author">Morris AD</span>, <span class="author">Morris AP</span>, <span class="author">Murray JC</span>, <span class="author">Nelis M</span>, <span class="author">Ohlsson C</span>, <span class="author">Oldehinkel AJ</span>, <span class="author">Ong KK</span>, <span class="author">Ouwehand WH</span>, <span class="author">Pasterkamp G</span>, <span class="author">Peters A</span>, <span class="author">Pramstaller PP</span>, <span class="author">Price JF</span>, <span class="author">Qi L</span>, <span class="author">Raitakari OT</span>, <span class="author">Rankinen T</span>, <span class="author">Rao DC</span>, <span class="author">Rice TK</span>, <span class="author">Ritchie M</span>, <span class="author">Rudan I</span>, <span class="author">Salomaa V</span>, <span class="author">Samani NJ</span>, <span class="author">Saramies J</span>, <span class="author">Sarzynski MA</span>, <span class="author">Schwarz PE</span>, <span class="author">Sebert S</span>, <span class="author">Sever P</span>, <span class="author">Shuldiner AR</span>, <span class="author">Sinisalo J</span>, <span class="author">Steinthorsdottir V</span>, <span class="author">Stolk RP</span>, <span class="author">Tardif JC</span>, <span class="author">T&ouml;njes A</span>, <span class="author">Tremblay A</span>, <span class="author">Tremoli E</span>, <span class="author">Virtamo J</span>, <span class="author">Vohl MC</span>, <span class="author">The Electronic Medical Records and Genomics (eMERGE) Consortium</span>, <span class="author">The MIGen Consortium</span>, <span class="author">The PAGE Consortium</span>, <span class="author">The LifeLines Cohort Study</span>, <span class="author">Amouyel P</span>, <span class="author">Asselbergs FW</span>, <span class="author">Assimes TL</span>, <span class="author">Bochud M</span>, <span class="author">Boehm BO</span>, <span class="author">Boerwinkle E</span>, <span class="author">Bottinger EP</span>, <span class="author">Bouchard C</span>, <span class="author">Cauchi S</span>, <span class="author">Chambers JC</span>, <span class="author">Chanock SJ</span>, <span class="author">Cooper RS</span>, <span class="author">de Bakker PI</span>, <span class="author">Dedoussis G</span>, <span class="author">Ferrucci L</span>, <span class="author">Franks PW</span>, <span class="author">Froguel P</span>, <span class="author">Groop LC</span>, <span class="author">Haiman CA</span>, <span class="author">Hamsten A</span>, <span class="author">Hayes MG</span>, <span class="author">Hui J</span>, <span class="author">Hunter DJ</span>, <span class="author">Hveem K</span>, <span class="author">Jukema JW</span>, <span class="author">Kaplan RC</span>, <span class="author">Kivimaki M</span>, <span class="author">Kuh D</span>, <span class="author">Laakso M</span>, <span class="author">Liu Y</span>, <span class="author">Martin NG</span>, <span class="author">M&auml;rz W</span>, <span class="author">Melbye M</span>, <span class="author">Moebus S</span>, <span class="author">Munroe PB</span>, <span class="author">Nj&oslash;lstad I</span>, <span class="author">Oostra BA</span>, <span class="author">Palmer CN</span>, <span class="author">Pedersen NL</span>, <span class="author">Perola M</span>, <span class="author">P&eacute;russe L</span>, <span class="author">Peters U</span>, <span class="author">Powell JE</span>, <span class="author">Power C</span>, <span class="author">Quertermous T</span>, <span class="author">Rauramaa R</span>, <span class="author">Reinmaa E</span>, <span class="author">Ridker PM</span>, <span class="author">Rivadeneira F</span>, <span class="author">Rotter JI</span>, <span class="author">Saaristo TE</span>, <span class="author">Saleheen D</span>, <span class="author">Schlessinger D</span>, <span class="author">Slagboom PE</span>, <span class="author">Snieder H</span>, <span class="author">Spector TD</span>, <span class="author">Strauch K</span>, <span class="author">Stumvoll M</span>, <span class="author">Tuomilehto J</span>, <span class="author">Uusitupa M</span>, <span class="author">van der Harst P</span>, <span class="author">V&ouml;lzke H</span>, <span class="author">Walker M</span>, <span class="author">Wareham NJ</span>, <span class="author">Watkins H</span>, <span class="author">Wichmann HE</span>, <span class="author">Wilson JF</span>, <span class="author">Zanen P</span>, <span class="author">Deloukas P</span>, <span class="author">Heid IM</span>, <span class="author">Lindgren CM</span>, <span class="author">Mohlke KL</span>, <span class="author">Speliotes EK</span>, <span class="author">Thorsteinsdottir U</span>, <span class="author">Barroso I</span>, <span class="author">Fox CS</span>, <span class="author">North KE</span>, <span class="author">Strachan DP</span>, <span class="author">Beckmann JS</span>, <span class="author">Berndt SI</span>, <span class="author">Boehnke M</span>, <span class="author">Borecki IB</span>, <span class="author">McCarthy MI</span>, <span class="author">Metspalu A</span>, <span class="author">Stefansson K</span>, <span class="author">Uitterlinden AG</span>, <span class="author">van Duijn CM</span>, <span class="author">Franke L</span>, <span class="author">Willer CJ</span>, <span class="author">Price AL</span>, <span class="author">Lettre G</span>, <span class="author">Loos RJ</span>, <span class="author">Weedon MN</span>, <span class="author">Ingelsson E</span>, <span class="author">O&#39;Connell JR</span>, <span class="author">Abecasis GR</span>, <span class="author">Chasman DI</span>, <span class="author">Goddard ME</span>, <span class="author">Visscher PM</span>, <span class="author">Hirschhorn JN</span> and <span class="author">Frayling TM</span></p>
<p class="affiliation">Genetics of Complex Traits, University of Exeter Medical School, University of Exeter, Exeter, UK.</p><p class="abstract">Using genome-wide data from 253,288 individuals, we identified 697 variants at genome-wide significance that together explained one-fifth of the heritability for adult height. By testing different numbers of variants in independent studies, we show that the most strongly associated &sim;2,000, &sim;3,700 and &sim;9,500 SNPs explained &sim;21%, &sim;24% and &sim;29% of phenotypic variance. Furthermore, all common variants together captured 60% of heritability. The 697 variants clustered in 423 loci were enriched for genes, pathways and tissue types known to be involved in growth and together implicated genes and pathways not highlighted in earlier efforts, such as signaling by fibroblast growth factors, WNT/&beta;-catenin and chondroitin sulfate-related genes. We identified several genes and pathways not previously connected with human skeletal growth, including mTOR, osteoglycin and binding of hyaluronic acid. Our results indicate a genetic architecture for human height that is characterized by a very large but finite number (thousands) of causal variants.</p>
<p class="publication"><span class="title">Nature genetics</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25282103">25282103</a>; DOI: <a href="http://dx.doi.org/10.1038%2Fng.3097">10.1038/ng.3097</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Genetic diagnosis of developmental disorders in the DDD study: a scalable analysis of genome-wide research data.</h4>
<p class="authors"><span class="author">Wright CF</span>, <span class="author">Fitzgerald TW</span>, <span class="author">Jones WD</span>, <span class="author">Clayton S</span>, <span class="author">McRae JF</span>, <span class="author">van Kogelenberg M</span>, <span class="author">King DA</span>, <span class="author">Ambridge K</span>, <span class="author">Barrett DM</span>, <span class="author">Bayzetinova T</span>, <span class="author">Bevan AP</span>, <span class="author">Bragin E</span>, <span class="author">Chatzimichali EA</span>, <span class="author">Gribble S</span>, <span class="author">Jones P</span>, <span class="author">Krishnappa N</span>, <span class="author">Mason LE</span>, <span class="author">Miller R</span>, <span class="author">Morley KI</span>, <span class="author">Parthiban V</span>, <span class="author">Prigmore E</span>, <span class="author">Rajan D</span>, <span class="author">Sifrim A</span>, <span class="author">Swaminathan GJ</span>, <span class="author">Tivey AR</span>, <span class="author">Middleton A</span>, <span class="author">Parker M</span>, <span class="author">Carter NP</span>, <span class="author">Barrett JC</span>, <span class="author">Hurles ME</span>, <span class="author">FitzPatrick DR</span>, <span class="author">Firth HV</span> and <span class="author">on behalf of the DDD study</span></p>
<p class="affiliation">Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Cambridge, UK. Electronic address: <a href="mailto:%63%61%72%6F%6C%69%6E%65.%77%72%69%67%68%74%40%73%61%6E%67%65%72.%61%63.%75%6B">&#99;&#97;&#114;&#111;&#108;&#105;&#110;&#101;&#46;&#119;&#114;&#105;&#103;&#104;&#116;&#64;&#115;&#97;&#110;&#103;&#101;&#114;&#46;&#97;&#99;&#46;&#117;&#107;</a>.</p><p class="abstract"><strong>Background</strong>: Human genome sequencing has transformed our understanding of genomic variation and its relevance to health and disease, and is now starting to enter clinical practice for the diagnosis of rare diseases. The question of whether and how some categories of genomic findings should be shared with individual research participants is currently a topic of international debate, and development of robust analytical workflows to identify and communicate clinically relevant variants is paramount.</p><p class="abstract"><strong>Methods</strong>: The Deciphering Developmental Disorders (DDD) study has developed a UK-wide patient recruitment network involving over 180 clinicians across all 24 regional genetics services, and has performed genome-wide microarray and whole exome sequencing on children with undiagnosed developmental disorders and their parents. After data analysis, pertinent genomic variants were returned to individual research participants via their local clinical genetics team.</p><p class="abstract"><strong>Findings</strong>: Around 80&#x2008;000 genomic variants were identified from exome sequencing and microarray analysis in each individual, of which on average 400 were rare and predicted to be protein altering. By focusing only on de novo and segregating variants in known developmental disorder genes, we achieved a diagnostic yield of 27% among 1133 previously investigated yet undiagnosed children with developmental disorders, whilst minimising incidental findings. In families with developmentally normal parents, whole exome sequencing of the child and both parents resulted in a 10-fold reduction in the number of potential causal variants that needed clinical evaluation compared to sequencing only the child. Most diagnostic variants identified in known genes were novel and not present in current databases of known disease variation.</p><p class="abstract"><strong>Interpretation</strong>: Implementation of a robust translational genomics workflow is achievable within a large-scale rare disease research study to allow feedback of potentially diagnostic findings to clinicians and research participants. Systematic recording of relevant clinical data, curation of a gene-phenotype knowledge base, and development of clinical decision support software are needed in addition to automated exclusion of almost all variants, which is crucial for scalable prioritisation and review of possible diagnostic variants. However, the resource requirements of development and maintenance of a clinical reporting system within a research setting are substantial.</p><p class="abstract"><strong>Funding</strong>: Health Innovation Challenge Fund, a parallel funding partnership between the Wellcome Trust and the UK Department of Health.</p>
<p class="publication"><span class="title">Lancet</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25529582">25529582</a>; DOI: <a href="http://dx.doi.org/10.1016%2FS0140-6736%2814%2961705-0">10.1016/S0140-6736(14)61705-0</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Plasmodium falciparum Erythrocyte Invasion: Combining Function with Immune Evasion.</h4>
<p class="authors"><span class="author">Wright GJ</span> and <span class="author">Rayner JC</span></p>
<p class="affiliation">Cell Surface Signalling Laboratory, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, United Kingdom; Malaria Programme, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, United Kingdom.</p>
<p class="publication"><span class="title">PLoS pathogens</span>&nbsp;<span class="year">2014</span>;<span class="volume">10</span>;<span class="number">3</span>;<span class="pagerange">e1003943</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24651270">24651270</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC3961354">3961354</a>; DOI: <a href="http://dx.doi.org/10.1371%2Fjournal.ppat.1003943">10.1371/journal.ppat.1003943</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Rolled-up Functionalized Nanomembranes as Three-Dimensional Cavities for Single Cell Studies.</h4>
<p class="authors"><span class="author">Xi W</span>, <span class="author">Schmidt CK</span>, <span class="author">Sanchez S</span>, <span class="author">Gracias DH</span>, <span class="author">Carazo-Salas RE</span>, <span class="author">Jackson SP</span> and <span class="author">Schmidt OG</span></p>
<p class="affiliation">Institute for Integrative Nanosciences, IFW Dresden , Helmholtzstrasse 20, D-01069 Dresden, Germany.</p><p class="abstract">We use micropatterning and strain engineering to encapsulate single living mammalian cells into transparent tubular architectures consisting of three-dimensional (3D) rolled-up nanomembranes. By using optical microscopy, we demonstrate that these structures are suitable for the scrutiny of cellular dynamics within confined 3D-microenvironments. We show that spatial confinement of mitotic mammalian cells inside tubular architectures can perturb metaphase plate formation, delay mitotic progression, and cause chromosomal instability in both a transformed and nontransformed human cell line. These findings could provide important clues into how spatial constraints dictate cellular behavior and function.</p>
<p class="grants">Funded by: Cancer Research UK: <span class="grant">11224</span>; European Research Council: <span class="grant">311529</span></p>
<p class="publication"><span class="title">Nano letters</span>&nbsp;<span class="year">2014</span>;<span class="volume">14</span>;<span class="number">8</span>;<span class="pagerange">4197-204</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24598026">24598026</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4133182">4133182</a>; DOI: <a href="http://dx.doi.org/10.1021%2Fnl4042565">10.1021/nl4042565</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">NetworkAnalyst - integrative approaches for protein-protein interaction network analysis and visual exploration.</h4>
<p class="authors"><span class="author">Xia J</span>, <span class="author">Benner MJ</span> and <span class="author">Hancock RE</span></p>
<p class="affiliation">Department of Microbiology and Immunology, University of British Columbia, Vancouver, Canada Centre for Microbial Diseases and Immunity Research, University of British Columbia, Vancouver, Canada.</p><p class="abstract">Biological network analysis is a powerful approach to gain systems-level understanding of patterns of gene expression in different cell types, disease states and other biological/experimental conditions. Three consecutive steps are required - identification of genes or proteins of interest, network construction and network analysis and visualization. To date, researchers have to learn to use a combination of several tools to accomplish this task. In addition, interactive visualization of large networks has been primarily restricted to locally installed programs. To address these challenges, we have developed NetworkAnalyst, taking advantage of state-of-the-art web technologies, to enable high performance network analysis with rich user experience. NetworkAnalyst integrates all three steps and presents the results via a powerful online network visualization framework. Users can upload gene or protein lists, single or multiple gene expression datasets to perform comprehensive gene annotation and differential expression analysis. Significant genes are mapped to our manually curated protein-protein interaction database to construct relevant networks. The results are presented through standard web browsers for network analysis and interactive exploration. NetworkAnalyst supports common functions for network topology and module analyses. Users can easily search, zoom and highlight nodes or modules, as well as perform functional enrichment analysis on these selections. The networks can be customized with different layouts, colors or node sizes, and exported as PNG, PDF or GraphML files. Comprehensive FAQs, tutorials and context-based tips and instructions are provided. NetworkAnalyst currently supports protein-protein interaction network analysis for human and mouse and is freely available at http://www.networkanalyst.ca.</p>
<p class="publication"><span class="title">Nucleic acids research</span>&nbsp;<span class="year">2014</span>;<span class="volume">42</span>;<span class="number">Web Server issue</span>;<span class="pagerange">W167-74</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24861621">24861621</a>; DOI: <a href="http://dx.doi.org/10.1093%2Fnar%2Fgku443">10.1093/nar/gku443</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Estimating genome-wide significance for whole-genome sequencing studies.</h4>
<p class="authors"><span class="author">Xu C</span>, <span class="author">Tachmazidou I</span>, <span class="author">Walter K</span>, <span class="author">Ciampi A</span>, <span class="author">Zeggini E</span>, <span class="author">Greenwood CM</span> and <span class="author">UK10K Consortium</span></p>
<p class="affiliation">Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Canada; Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Canada.</p><p class="abstract">Although a standard genome-wide significance level has been accepted for the testing of association between common genetic variants and disease, the era of whole-genome sequencing (WGS) requires a new threshold. The allele frequency spectrum of sequence-identified variants is very different from common variants, and the identified rare genetic variation is usually jointly analyzed in a series of genomic windows or regions. In nearby or overlapping windows, these test statistics will be correlated, and the degree of correlation is likely to depend on the choice of window size, overlap, and the test statistic. Furthermore, multiple analyses may be performed using different windows or test statistics. Here we propose an empirical approach for estimating genome-wide significance thresholds for data arising from WGS studies, and we demonstrate that the empirical threshold can be efficiently estimated by extrapolating from calculations performed on a small genomic region. Because analysis of WGS may need to be repeated with different choices of test statistics or windows, this prediction approach makes it computationally feasible to estimate genome-wide significance thresholds for different analysis choices. Based on UK10K whole-genome sequence data, we derive genome-wide significance thresholds ranging between 2.5 &times; 10(-8) and 8 &times; 10(-8) for our analytic choices in window-based testing, and thresholds of 0.6 &times; 10(-8) -1.5 &times; 10(-8) for a combined analytic strategy of testing common variants using single-SNP tests together with rare variants analyzed with our sliding-window test strategy.</p>
<p class="grants">Funded by: Canadian Institutes of Health Research: <span class="grant">MOP-115110</span>; Wellcome Trust: <span class="grant">WT091310</span>, <span class="grant">WT098051</span></p>
<p class="publication"><span class="title">Genetic epidemiology</span>&nbsp;<span class="year">2014</span>;<span class="volume">38</span>;<span class="number">4</span>;<span class="pagerange">281-90</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24676807">24676807</a>; DOI: <a href="http://dx.doi.org/10.1002%2Fgepi.21797">10.1002/gepi.21797</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">PredictProtein-an open resource for online prediction of protein structural and functional features.</h4>
<p class="authors"><span class="author">Yachdav G</span>, <span class="author">Kloppmann E</span>, <span class="author">Kajan L</span>, <span class="author">Hecht M</span>, <span class="author">Goldberg T</span>, <span class="author">Hamp T</span>, <span class="author">H&ouml;nigschmid P</span>, <span class="author">Schafferhans A</span>, <span class="author">Roos M</span>, <span class="author">Bernhofer M</span>, <span class="author">Richter L</span>, <span class="author">Ashkenazy H</span>, <span class="author">Punta M</span>, <span class="author">Schlessinger A</span>, <span class="author">Bromberg Y</span>, <span class="author">Schneider R</span>, <span class="author">Vriend G</span>, <span class="author">Sander C</span>, <span class="author">Ben-Tal N</span> and <span class="author">Rost B</span></p>
<p class="affiliation">Department of Informatics, Bioinformatics &amp; Computational Biology i12, TUM (Technische Universit&auml;t M&uuml;nchen), Garching/Munich 85748, Germany Biosof LLC, New York, NY 10001, USA TUM Graduate School, Center of Doctoral Studies in Informatics and its Applications (CeDoSIA), TUM (Technische Universit&auml;t M&uuml;nchen), Garching/Munich 85748, Germany <a href="mailto:%67%79%61%63%68%64%61%76%40%72%6F%73%74%6C%61%62.%6F%72%67">&#103;&#121;&#97;&#99;&#104;&#100;&#97;&#118;&#64;&#114;&#111;&#115;&#116;&#108;&#97;&#98;&#46;&#111;&#114;&#103;</a>.</p><p class="abstract">PredictProtein is a meta-service for sequence analysis that has been predicting structural and functional features of proteins since 1992. Queried with a protein sequence it returns: multiple sequence alignments, predicted aspects of structure (secondary structure, solvent accessibility, transmembrane helices (TMSEG) and strands, coiled-coil regions, disulfide bonds and disordered regions) and function. The service incorporates analysis methods for the identification of functional regions (ConSurf), homology-based inference of Gene Ontology terms (metastudent), comprehensive subcellular localization prediction (LocTree3), protein-protein binding sites (ISIS2), protein-polynucleotide binding sites (SomeNA) and predictions of the effect of point mutations (non-synonymous SNPs) on protein function (SNAP2). Our goal has always been to develop a system optimized to meet the demands of experimentalists not highly experienced in bioinformatics. To this end, the PredictProtein results are presented as both text and a series of intuitive, interactive and visually appealing figures. The web server and sources are available at http://ppopen.rostlab.org.</p>
<p class="grants">Funded by: NIGMS NIH HHS: <span class="grant">U54 GM095315</span></p>
<p class="publication"><span class="title">Nucleic acids research</span>&nbsp;<span class="year">2014</span>;<span class="volume">42</span>;<span class="number">Web Server issue</span>;<span class="pagerange">W337-43</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24799431">24799431</a>; DOI: <a href="http://dx.doi.org/10.1093%2Fnar%2Fgku366">10.1093/nar/gku366</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Signalling Through Retinoic Acid Receptors is Required for Reprogramming of Both MEFs and EpiSCs to iPSCs.</h4>
<p class="authors"><span class="author">Yang J</span>, <span class="author">Wang W</span>, <span class="author">Ooi J</span>, <span class="author">Campos LS</span>, <span class="author">Lu L</span> and <span class="author">Liu P</span></p>
<p class="affiliation">Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1HH, U. K.</p><p class="abstract">We previously demonstrated that co-expressing retinoic acid receptor gamma (RARG) and liver receptor homolog-1 (LRH1 or NR5A2) with OCT4, MYC, KLF4 and SOX2 (4F) rapidly reprograms mouse embryonic fibroblast cells (MEFs) into induced pluripotent stem cells (iPSCs). Here, we further explore the role of retinoic acid (RA) in reprogramming and report that the six factors (6F) efficiently and directly reprogram MEFs into integration-free iPSCs in defined medium (N2B27) in the absence of feeder cells. Through genetic and chemical approaches, we find that RA signalling is essential, in a highly dose-sensitive manner, for MEF reprogramming. The removal of exogenous RA from N2B27, the inhibition of endogenous RA synthesis or the expression of a dominant-negative form of RARA (RARA-DN) severely impedes reprogramming. By contrast, supplementing N2B27 with various retinoids substantially boosts reprogramming. In addition, when co-expressed with LRH1, RA receptors (RARs) can promote reprogramming in the absence of both exogenous and endogenously synthesised RA. Remarkably, the reprogramming of epiblast stem cells (EpiSCs) into ES cell-like cells also requires low levels of RA, which can modulate Wnt signalling through physical interactions of RARs with &beta;-catenin. These results highlight the important functions of RA signalling in reprogramming somatic cells and primed stem cells to naive pluripotency. This article is protected by copyright. All rights reserved.</p>
<p class="publication"><span class="title">Stem cells (Dayton, Ohio)</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25546009">25546009</a>; DOI: <a href="http://dx.doi.org/10.1002%2Fstem.1926">10.1002/stem.1926</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">The association between circulating lipoprotein(a) and type 2 diabetes: is it causal?</h4>
<p class="authors"><span class="author">Ye Z</span>, <span class="author">Haycock PC</span>, <span class="author">Gurdasani D</span>, <span class="author">Pomilla C</span>, <span class="author">Boekholdt SM</span>, <span class="author">Tsimikas S</span>, <span class="author">Khaw KT</span>, <span class="author">Wareham NJ</span>, <span class="author">Sandhu MS</span> and <span class="author">Forouhi NG</span></p>
<p class="affiliation">MRC Epidemiology Unit, Institute of Metabolic Science, University of Cambridge, Cambridge, U.K.</p><p class="abstract">Epidemiological evidence supports a direct and causal association between lipoprotein(a) [Lp(a)] levels and coronary risk, but the nature of the association between Lp(a) levels and risk of type 2 diabetes (T2D) is unclear. In this study, we assessed the association of Lp(a) levels with risk of incident T2D and tested whether Lp(a) levels are causally linked to T2D. We analyzed data on 18,490 participants from the European Prospective Investigation of Cancer (EPIC)-Norfolk cohort that included adults aged 40-79 years at baseline 1993-1997. During an average 10 years of follow-up, 593 participants developed incident T2D. Cox regression models were used to estimate the association between Lp(a) levels and T2D. In Mendelian randomization analyses, based on EPIC-Norfolk combined with DIAbetes Genetics Replication And Meta-analysis data involving a total of 10,088 diabetes case participants and 68,346 control participants, we used a genetic variant (rs10455872) as an instrument to test whether the association between Lp(a) levels and T2D is causal. In adjusted analyses, there was an inverse association between Lp(a) levels and T2D: hazard ratio was 0.63 (95% CI 0.49-0.81; P trend = 0.003) comparing the top versus bottom quintile of Lp(a). In EPIC-Norfolk, a 1-SD increase in logLp(a) was associated with a lower risk of T2D (odds ratio [OR] 0.88 [95% CI: 0.80-0.95]). However, in Mendelian randomization analyses, a 1-SD increase in logLp(a) due to rs10455872, which explained 26.8% of the variability in Lp(a) levels, was not associated with risk of T2D (OR 1.03 [0.96-1.10]; P = 0.41). These prospective findings demonstrate a strong inverse association of Lp(a) levels with risk of T2D. However, a genetic variant that elevated Lp(a) levels was not associated with risk of T2D, suggesting that elevated Lp(a) levels are not causally associated with a lower risk of T2D.</p>
<p class="grants">Funded by: British Heart Foundation: <span class="grant">PG/08/094/26019</span>; Cancer Research UK; Medical Research Council: <span class="grant">G0801566</span>, <span class="grant">G1000143</span>, <span class="grant">MC_UP_A100_1003</span></p>
<p class="publication"><span class="title">Diabetes</span>&nbsp;<span class="year">2014</span>;<span class="volume">63</span>;<span class="number">1</span>;<span class="pagerange">332-42</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24089516">24089516</a>; DOI: <a href="http://dx.doi.org/10.2337%2Fdb13-1144">10.2337/db13-1144</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Response to Comment on Ye et al. The Association Between Circulating Lipoprotein(a) and Type 2 Diabetes: Is It Causal? Diabetes 2014;63:332-342.</h4>
<p class="authors"><span class="author">Ye Z</span>, <span class="author">Sandhu MS</span> and <span class="author">Forouhi NG</span></p>
<p class="affiliation">MRC Epidemiology Unit, Institute of Metabolic Science, University of Cambridge School of Clinical Medicine, Cambridge, U.K. <a href="mailto:%7A%68%65%6E%67.%79%65%40%6D%72%63-%65%70%69%64.%63%61%6D.%61%63.%75%6B">&#122;&#104;&#101;&#110;&#103;&#46;&#121;&#101;&#64;&#109;&#114;&#99;&#45;&#101;&#112;&#105;&#100;&#46;&#99;&#97;&#109;&#46;&#97;&#99;&#46;&#117;&#107;</a>.</p>
<p class="publication"><span class="title">Diabetes</span>&nbsp;<span class="year">2014</span>;<span class="volume">63</span>;<span class="number">8</span>;<span class="pagerange">e15</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25060897">25060897</a>; DOI: <a href="http://dx.doi.org/10.2337%2Fdb14-0644">10.2337/db14-0644</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Estimation of Epistatic Variance Components and Heritability in Founder Populations and Crosses.</h4>
<p class="authors"><span class="author">Young AI</span> and <span class="author">Durbin R</span></p>
<p class="affiliation">University of Oxford; <a href="mailto:%61%6C%65%78%61%6E%64%65%72.%79%6F%75%6E%67%40%6C%69%6E%63%6F%6C%6E.%6F%78.%61%63.%75%6B">&#97;&#108;&#101;&#120;&#97;&#110;&#100;&#101;&#114;&#46;&#121;&#111;&#117;&#110;&#103;&#64;&#108;&#105;&#110;&#99;&#111;&#108;&#110;&#46;&#111;&#120;&#46;&#97;&#99;&#46;&#117;&#107;</a>.</p><p class="abstract">Genetic association studies have explained only a small proportion of the estimated heritability of complex traits, leaving the remaining heritability &#39;missing&#39;. Genetic interactions have been proposed as an explanation for this, because they lead to overestimates of the heritability and are hard to detect. Whether this explanation is true depends on the proportion of variance attributable to genetic interactions, which is difficult to measure in outbred populations. Founder populations exhibit a greater range of kinship than outbred populations, which helps in fitting the epistatic variance. We extend classic theory to founder populations, giving the covariance between individuals due to epistasis of any order. We recover the classic theory as a limit, and we derive a recently proposed estimator of the narrow sense heritability as a corollary. We extend the variance decomposition to include dominance. We show in simulations that it would be possible to estimate the variance from pairwise interactions with samples of a few thousand from strongly bottlenecked human founder populations, and we provide an analytical approximation of the standard error. Applying these methods to 46 traits measured in a yeast (Saccharomyces cerevisiae) cross, we estimate that pairwise interactions explain 10% of the phenotypic variance on average and that third and higher order interactions explain 14% of the phenotypic variance on average. We search for third order interactions, discovering an interaction that is shared between two traits. Our methods will be relevant to future studies of epistatic variance in founder populations and crosses.</p>
<p class="publication"><span class="title">Genetics</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25326236">25326236</a>; DOI: <a href="http://dx.doi.org/10.1534%2Fgenetics.114.170795">10.1534/genetics.114.170795</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Long term conservation of human metabolic phenotypes and link to heritability.</h4>
<p class="authors"><span class="author">Yousri NA</span>, <span class="author">Kastenm&uuml;ller G</span>, <span class="author">Gieger C</span>, <span class="author">Shin SY</span>, <span class="author">Erte I</span>, <span class="author">Menni C</span>, <span class="author">Peters A</span>, <span class="author">Meisinger C</span>, <span class="author">Mohney RP</span>, <span class="author">Illig T</span>, <span class="author">Adamski J</span>, <span class="author">Soranzo N</span>, <span class="author">Spector TD</span> and <span class="author">Suhre K</span></p>
<p class="affiliation">Department of Physiology and Biophysics, Weill Cornell Medical College in Qatar, Education City, Qatar Foundation, P.O. Box 24144, Doha, Qatar ; Computers and System Engineering Department, Faculty of Engineering, Alexandria University, Alexandria, Egypt.</p><p class="abstract">Changes in an individual&#39;s human metabolic phenotype (metabotype) over time can be indicative of disorder-related modifications. Studies covering several months to a few years have shown that metabolic profiles are often specific for an individual. This &quot;metabolic individuality&quot; and detected changes may contribute to personalized approaches in human health care. However, it is not clear whether such individual metabotypes persist over longer time periods. Here we investigate the conservation of metabotypes characterized by 212 different metabolites of 818 participants from the Cooperative Health Research in the Region of Augsburg; Germany population, taken within a 7-year time interval. For replication, we used paired samples from 83 non-related individuals from the TwinsUK study. Results indicated that over 40&nbsp;% of all study participants could be uniquely identified after 7&nbsp;years based on their metabolic profiles alone. Moreover, 95&nbsp;% of the study participants showed a high degree of metabotype conservation (&gt;70&nbsp;%) whereas the remaining 5&nbsp;% displayed major changes in their metabolic profiles over time. These latter individuals were likely to have undergone important biochemical changes between the two time points. We further show that metabolite conservation was positively associated with heritability (rank correlation 0.74), although there were some notable exceptions. Our results suggest that monitoring changes in metabotypes over several years can trace changes in health status and may provide indications for disease onset. Moreover, our study findings provide a general reference for metabotype conservation over longer time periods that can be used in biomarker discovery studies.</p>
<p class="publication"><span class="title">Metabolomics : Official journal of the Metabolomic Society</span>&nbsp;<span class="year">2014</span>;<span class="volume">10</span>;<span class="number">5</span>;<span class="pagerange">1005-1017</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25177233">25177233</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4145193">4145193</a>; DOI: <a href="http://dx.doi.org/10.1007%2Fs11306-014-0629-y">10.1007/s11306-014-0629-y</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">A comparative encyclopedia of DNA elements in the mouse genome.</h4>
<p class="authors"><span class="author">Yue F</span>, <span class="author">Cheng Y</span>, <span class="author">Breschi A</span>, <span class="author">Vierstra J</span>, <span class="author">Wu W</span>, <span class="author">Ryba T</span>, <span class="author">Sandstrom R</span>, <span class="author">Ma Z</span>, <span class="author">Davis C</span>, <span class="author">Pope BD</span>, <span class="author">Shen Y</span>, <span class="author">Pervouchine DD</span>, <span class="author">Djebali S</span>, <span class="author">Thurman RE</span>, <span class="author">Kaul R</span>, <span class="author">Rynes E</span>, <span class="author">Kirilusha A</span>, <span class="author">Marinov GK</span>, <span class="author">Williams BA</span>, <span class="author">Trout D</span>, <span class="author">Amrhein H</span>, <span class="author">Fisher-Aylor K</span>, <span class="author">Antoshechkin I</span>, <span class="author">DeSalvo G</span>, <span class="author">See LH</span>, <span class="author">Fastuca M</span>, <span class="author">Drenkow J</span>, <span class="author">Zaleski C</span>, <span class="author">Dobin A</span>, <span class="author">Prieto P</span>, <span class="author">Lagarde J</span>, <span class="author">Bussotti G</span>, <span class="author">Tanzer A</span>, <span class="author">Denas O</span>, <span class="author">Li K</span>, <span class="author">Bender MA</span>, <span class="author">Zhang M</span>, <span class="author">Byron R</span>, <span class="author">Groudine MT</span>, <span class="author">McCleary D</span>, <span class="author">Pham L</span>, <span class="author">Ye Z</span>, <span class="author">Kuan S</span>, <span class="author">Edsall L</span>, <span class="author">Wu YC</span>, <span class="author">Rasmussen MD</span>, <span class="author">Bansal MS</span>, <span class="author">Kellis M</span>, <span class="author">Keller CA</span>, <span class="author">Morrissey CS</span>, <span class="author">Mishra T</span>, <span class="author">Jain D</span>, <span class="author">Dogan N</span>, <span class="author">Harris RS</span>, <span class="author">Cayting P</span>, <span class="author">Kawli T</span>, <span class="author">Boyle AP</span>, <span class="author">Euskirchen G</span>, <span class="author">Kundaje A</span>, <span class="author">Lin S</span>, <span class="author">Lin Y</span>, <span class="author">Jansen C</span>, <span class="author">Malladi VS</span>, <span class="author">Cline MS</span>, <span class="author">Erickson DT</span>, <span class="author">Kirkup VM</span>, <span class="author">Learned K</span>, <span class="author">Sloan CA</span>, <span class="author">Rosenbloom KR</span>, <span class="author">Lacerda de Sousa B</span>, <span class="author">Beal K</span>, <span class="author">Pignatelli M</span>, <span class="author">Flicek P</span>, <span class="author">Lian J</span>, <span class="author">Kahveci T</span>, <span class="author">Lee D</span>, <span class="author">Kent WJ</span>, <span class="author">Ramalho Santos M</span>, <span class="author">Herrero J</span>, <span class="author">Notredame C</span>, <span class="author">Johnson A</span>, <span class="author">Vong S</span>, <span class="author">Lee K</span>, <span class="author">Bates D</span>, <span class="author">Neri F</span>, <span class="author">Diegel M</span>, <span class="author">Canfield T</span>, <span class="author">Sabo PJ</span>, <span class="author">Wilken MS</span>, <span class="author">Reh TA</span>, <span class="author">Giste E</span>, <span class="author">Shafer A</span>, <span class="author">Kutyavin T</span>, <span class="author">Haugen E</span>, <span class="author">Dunn D</span>, <span class="author">Reynolds AP</span>, <span class="author">Neph S</span>, <span class="author">Humbert R</span>, <span class="author">Hansen RS</span>, <span class="author">De Bruijn M</span>, <span class="author">Selleri L</span>, <span class="author">Rudensky A</span>, <span class="author">Josefowicz S</span>, <span class="author">Samstein R</span>, <span class="author">Eichler EE</span>, <span class="author">Orkin SH</span>, <span class="author">Levasseur D</span>, <span class="author">Papayannopoulou T</span>, <span class="author">Chang KH</span>, <span class="author">Skoultchi A</span>, <span class="author">Gosh S</span>, <span class="author">Disteche C</span>, <span class="author">Treuting P</span>, <span class="author">Wang Y</span>, <span class="author">Weiss MJ</span>, <span class="author">Blobel GA</span>, <span class="author">Cao X</span>, <span class="author">Zhong S</span>, <span class="author">Wang T</span>, <span class="author">Good PJ</span>, <span class="author">Lowdon RF</span>, <span class="author">Adams LB</span>, <span class="author">Zhou XQ</span>, <span class="author">Pazin MJ</span>, <span class="author">Feingold EA</span>, <span class="author">Wold B</span>, <span class="author">Taylor J</span>, <span class="author">Mortazavi A</span>, <span class="author">Weissman SM</span>, <span class="author">Stamatoyannopoulos JA</span>, <span class="author">Snyder MP</span>, <span class="author">Guigo R</span>, <span class="author">Gingeras TR</span>, <span class="author">Gilbert DM</span>, <span class="author">Hardison RC</span>, <span class="author">Beer MA</span>, <span class="author">Ren B</span> and <span class="author">Mouse ENCODE Consortium</span></p>
<p class="affiliation">1] Ludwig Institute for Cancer Research and University of California, San Diego School of Medicine, 9500 Gilman Drive, La Jolla, California 92093, USA. [2] Department of Biochemistry and Molecular Biology, College of Medicine, The Pennsylvania State University, Hershey, Pennsylvania 17033, USA.</p><p class="abstract">The laboratory mouse shares the majority of its protein-coding genes with humans, making it the premier model organism in biomedical research, yet the two mammals differ in significant ways. To gain greater insights into both shared and species-specific transcriptional and cellular regulatory programs in the mouse, the Mouse ENCODE Consortium has mapped transcription, DNase I hypersensitivity, transcription factor binding, chromatin modifications and replication domains throughout the mouse genome in diverse cell and tissue types. By comparing with the human genome, we not only confirm substantial conservation in the newly annotated potential functional sequences, but also find a large degree of divergence of sequences involved in transcriptional regulation, chromatin state and higher order chromatin organization. Our results illuminate the wide range of evolutionary forces acting on genes and their regulatory regions, and provide a general resource for research into mammalian biology and mechanisms of human diseases.</p>
<p class="grants">Funded by: Howard Hughes Medical Institute; NCI NIH HHS: <span class="grant">F31CA165863</span>; NHGRI NIH HHS: <span class="grant">1U54HG007004</span>, <span class="grant">3RC2HG005602</span>, <span class="grant">R01HG003991</span>, <span class="grant">RC2HG005573</span>; NHLBI NIH HHS: <span class="grant">F32HL110473</span>, <span class="grant">K99HL119617</span>; NICHD NIH HHS: <span class="grant">R01HD043997-09</span>; NIDDK NIH HHS: <span class="grant">R01DK065806</span>; NIGMS NIH HHS: <span class="grant">GM083337</span>, <span class="grant">GM085354</span>; Wellcome Trust: <span class="grant">095908</span></p>
<p class="publication"><span class="title">Nature</span>&nbsp;<span class="year">2014</span>;<span class="volume">515</span>;<span class="number">7527</span>;<span class="pagerange">355-64</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25409824">25409824</a>; DOI: <a href="http://dx.doi.org/10.1038%2Fnature13992">10.1038/nature13992</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">A genome-wide assessment of the role of untagged copy number variants in type 1 diabetes.</h4>
<p class="authors"><span class="author">Zanda M</span>, <span class="author">Onengut-Gumuscu S</span>, <span class="author">Walker N</span>, <span class="author">Shtir C</span>, <span class="author">Gallo D</span>, <span class="author">Wallace C</span>, <span class="author">Smyth D</span>, <span class="author">Todd JA</span>, <span class="author">Hurles ME</span>, <span class="author">Plagnol V</span> and <span class="author">Rich SS</span></p>
<p class="affiliation">University College London (UCL) Genetics Institute (UGI), London, United Kingdom; Wellcome Trust Sanger Institute, Hinxton, United Kingdom.</p><p class="abstract">Genome-wide association studies (GWAS) for type 1 diabetes (T1D) have successfully identified more than 40 independent T1D associated tagging single nucleotide polymorphisms (SNPs). However, owing to technical limitations of copy number variants (CNVs) genotyping assays, the assessment of the role of CNVs has been limited to the subset of these in high linkage disequilibrium with tag SNPs. The contribution of untagged CNVs, often multi-allelic and difficult to genotype using existing assays, to the heritability of T1D remains an open question. To investigate this issue, we designed a custom comparative genetic hybridization array (aCGH) specifically designed to assay untagged CNV loci identified from a variety of sources. To overcome the technical limitations of the case control design for this class of CNVs, we genotyped the Type 1 Diabetes Genetics Consortium (T1DGC) family resource (representing 3,903 transmissions from parents to affected offspring) and used an association testing strategy that does not necessitate obtaining discrete genotypes. Our design targeted 4,309 CNVs, of which 3,410 passed stringent quality control filters. As a positive control, the scan confirmed the known T1D association at the INS locus by direct typing of the 5&#39; variable number of tandem repeat (VNTR) locus. Our results clarify the fact that the disease association is indistinguishable from the two main polymorphic allele classes of the INS VNTR, class I-and class III. We also identified novel technical artifacts resulting into spurious associations at the somatically rearranging loci, T cell receptor, TCRA/TCRD and TCRB, and Immunoglobulin heavy chain, IGH, loci on chromosomes 14q11.2, 7q34 and 14q32.33, respectively. However, our data did not identify novel T1D loci. Our results do not support a major role of untagged CNVs in T1D heritability.</p>
<p class="publication"><span class="title">PLoS genetics</span>&nbsp;<span class="year">2014</span>;<span class="volume">10</span>;<span class="number">5</span>;<span class="pagerange">e1004367</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24875393">24875393</a>; DOI: <a href="http://dx.doi.org/10.1371%2Fjournal.pgen.1004367">10.1371/journal.pgen.1004367</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">The AURORA initiative for metastatic breast cancer.</h4>
<p class="authors"><span class="author">Zardavas D</span>, <span class="author">Maetens M</span>, <span class="author">Irrthum A</span>, <span class="author">Goulioti T</span>, <span class="author">Engelen K</span>, <span class="author">Fumagalli D</span>, <span class="author">Salgado R</span>, <span class="author">Aftimos P</span>, <span class="author">Saini KS</span>, <span class="author">Sotiriou C</span>, <span class="author">Campbell P</span>, <span class="author">Dinh P</span>, <span class="author">von Minckwitz G</span>, <span class="author">Gelber RD</span>, <span class="author">Dowsett M</span>, <span class="author">Di Leo A</span>, <span class="author">Cameron D</span>, <span class="author">Baselga J</span>, <span class="author">Gnant M</span>, <span class="author">Goldhirsch A</span>, <span class="author">Norton L</span> and <span class="author">Piccart M</span></p>
<p class="affiliation">1] Breast International Group Headquarters (BIG-aisbl), Brussels, Belgium [2] Institut Jules Bordet, Universit&eacute; Libre de Bruxelles, Brussels, Belgium.</p><p class="abstract">Metastatic breast cancer is one of the leading causes of cancer-related mortality among women in the Western world. To date most research efforts have focused on the molecular analysis of the primary tumour to dissect the genotypes of the disease. However, accumulating evidence supports a molecular evolution of breast cancer during its life cycle, with metastatic lesions acquiring new molecular aberrations. Recognising this critical gap of knowledge, the Breast International Group is launching AURORA, a large, multinational, collaborative metastatic breast cancer molecular screening programme. Approximately 1300 patients with metastatic breast cancer who have received no more than one line of systemic treatment for advanced disease will, after giving informed consent, donate archived primary tumour tissue, as well as will donate tissue collected prospectively from the biopsy of metastatic lesions and blood. Both tumour tissue types, together with a blood sample, will then be subjected to next generation sequencing for a panel of cancer-related genes. The patients will be treated at the discretion of their treating physicians per standard local practice, and they will be followed for clinical outcome for 10 years. Alternatively, depending on the molecular profiles found, patients will be directed to innovative clinical trials assessing molecularly targeted agents. Samples of outlier patients considered as &#39;exceptional responders&#39; or as &#39;rapid progressors&#39; based on the clinical follow-up will be subjected to deeper molecular characterisation in order to identify new prognostic and predictive biomarkers. AURORA, through its innovative design, will shed light onto some of the unknown areas of metastatic breast cancer, helping to improve the clinical outcome of breast cancer patients.British Journal of Cancer advance online publication, 16 September 2014; doi:10.1038/bjc.2014.341 www.bjcancer.com.</p>
<p class="publication"><span class="title">British journal of cancer</span>&nbsp;<span class="year">2014</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25225904">25225904</a>; DOI: <a href="http://dx.doi.org/10.1038%2Fbjc.2014.341">10.1038/bjc.2014.341</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">What helminth genomes have taught us about parasite evolution.</h4>
<p class="authors"><span class="author">Zarowiecki M</span> and <span class="author">Berriman M</span></p>
<p class="affiliation">Parasite Genomics,Wellcome Trust Sanger Institute,Wellcome Trust Genome Campus,Hinxton,Cambridge CB10 1SA,UK.</p><p class="abstract">SUMMARY The genomes of more than 20 helminths have now been sequenced. Here we perform a meta-analysis of all sequenced genomes of nematodes and Platyhelminthes, and attempt to address the question of what are the defining characteristics of helminth genomes. We find that parasitic worms lack systems for surface antigenic variation, instead maintaining infections using their surfaces as the first line of defence against the host immune system, with several expanded gene families of genes associated with the surface and tegument. Parasite excretory/secretory products evolve rapidly, and proteases even more so, with each parasite exhibiting unique modifications of its protease repertoire. Endoparasitic flatworms show striking losses of metabolic capabilities, not matched by nematodes. All helminths do however exhibit an overall reduction in auxiliary metabolism (biogenesis of co-factors and vitamins). Overall, the prevailing pattern is that there are few commonalities between the genomes of independently evolved parasitic worms, with each parasite having undergone specific adaptations for their particular niche.</p>
<p class="publication"><span class="title">Parasitology</span>&nbsp;<span class="year">2014</span>;<span class="pagerange">1-13</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25482650">25482650</a>; DOI: <a href="http://dx.doi.org/10.1017%2FS0031182014001449">10.1017/S0031182014001449</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Repeated landmass reformation limits diversification in the widespread littoral zone mosquito Anopheles sundaicus sensu lato in the Indo-Oriental Region.</h4>
<p class="authors"><span class="author">Zarowiecki M</span>, <span class="author">Linton YM</span>, <span class="author">Post RJ</span>, <span class="author">Bangs MJ</span>, <span class="author">Htun PT</span>, <span class="author">Hlaing T</span>, <span class="author">Seng CM</span>, <span class="author">Baimai V</span>, <span class="author">Ding TH</span>, <span class="author">Sochantha T</span> and <span class="author">Walton C</span></p>
<p class="affiliation">Parasite Genomics Group, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, CB10 1SA, UK.</p><p class="abstract">Southeast Asia harbours abundant biodiversity, hypothesized to have been generated by Pliocene and Pleistocene climatic and environmental change. Vicariance between the island of Borneo, the remaining Indonesian archipelago and mainland Southeast Asia caused by elevated sea levels during interglacial periods has been proposed to lead to diversification in the littoral zone mosquito Anopheles (Cellia) sundaicus (Rodenwaldt) sensu lato. To test this biogeographical hypothesis, we inferred the population history and assessed gene flow of A.&nbsp;sundaicus s.l. sampled from 18 populations across its pan-Asian species range, using sequences from mitochondrial cytochrome c oxidase subunit 1 (CO1), the internal transcribed spacer 2 (ITS2) and the mannose phosphate isomerase (Mpi) gene. A hypothesis of ecological speciation for A.&nbsp;sundaicus involving divergent adaptation to brackish and freshwater larval habitats was also previously proposed, based on a deficiency of heterozygotes for Mpi allozyme alleles in sympatry. This hypothesis was not supported by Mpi sequence data, which exhibited no fixed differences between brackish and freshwater larval habitats. Mpi and CO1 supported the presence of up to eight genetically distinct population groupings. Counter to the hypothesis of three allopatric species, divergence was often no greater between Borneo, Sumatra/Java and the Southeast Asian mainland than it was between genetic groupings within these landmasses. An isolation-with-migration (IM) model indicates recurrent gene flow between the current major landmasses. Such gene flow would have been possible during glacial periods when the current landmasses merged, presenting opportunities for dispersal along expanding and contracting coastlines. Consequently, Pleistocene climatic variation has proved a homogenizing, rather than diversifying, force for A.&nbsp;sundaicus diversity.</p>
<p class="publication"><span class="title">Molecular ecology</span>&nbsp;<span class="year">2014</span>;<span class="volume">23</span>;<span class="number">10</span>;<span class="pagerange">2573-89</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24750501">24750501</a>; DOI: <a href="http://dx.doi.org/10.1111%2Fmec.12761">10.1111/mec.12761</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Using genetically isolated populations to understand the genomic basis of disease.</h4>
<p class="authors"><span class="author">Zeggini E</span></p>
<p class="affiliation">Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA UK.</p><p class="abstract">Rare variation has a key role in the genetic etiology of complex traits. Genetically isolated populations have been established as a powerful resource for novel locus discovery and they combine advantageous characteristics that can be leveraged to expedite discovery. Genome-wide genotyping approaches coupled with sequencing efforts have transformed the landscape of disease genomics and highlight the potentially significant contribution of studies in founder populations.</p>
<p class="publication"><span class="title">Genome medicine</span>&nbsp;<span class="year">2014</span>;<span class="volume">6</span>;<span class="number">10</span>;<span class="pagerange">83</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25473423">25473423</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4254420">4254420</a>; DOI: <a href="http://dx.doi.org/10.1186%2Fs13073-014-0083-5">10.1186/s13073-014-0083-5</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Effective diagnosis of genetic disease by computational phenotype analysis of the disease-associated genome.</h4>
<p class="authors"><span class="author">Zemojtel T</span>, <span class="author">K&ouml;hler S</span>, <span class="author">Mackenroth L</span>, <span class="author">J&auml;ger M</span>, <span class="author">Hecht J</span>, <span class="author">Krawitz P</span>, <span class="author">Graul-Neumann L</span>, <span class="author">Doelken S</span>, <span class="author">Ehmke N</span>, <span class="author">Spielmann M</span>, <span class="author">Oien NC</span>, <span class="author">Schweiger MR</span>, <span class="author">Kr&uuml;ger U</span>, <span class="author">Frommer G</span>, <span class="author">Fischer B</span>, <span class="author">Kornak U</span>, <span class="author">Fl&ouml;ttmann R</span>, <span class="author">Ardeshirdavani A</span>, <span class="author">Moreau Y</span>, <span class="author">Lewis SE</span>, <span class="author">Haendel M</span>, <span class="author">Smedley D</span>, <span class="author">Horn D</span>, <span class="author">Mundlos S</span> and <span class="author">Robinson PN</span></p>
<p class="affiliation">Institute for Medical Genetics and Human Genetics, Charit&eacute; Universit&auml;tsmedizin Berlin, Augustenburger Platz 1, 13353 Berlin, Germany. Institute of Bioorganic Chemistry, Polish Academy of Sciences, 61-704 Poznan, Poland. Labor Berlin-Charit&eacute; Vivantes GmbH, Humangenetik, F&ouml;hrer Stra&szlig;e 15, 13353 Berlin, Germany.</p><p class="abstract">Less than half of patients with suspected genetic disease receive a molecular diagnosis. We have therefore integrated next-generation sequencing (NGS), bioinformatics, and clinical data into an effective diagnostic workflow. We used variants in the 2741 established Mendelian disease genes [the disease-associated genome (DAG)] to develop a targeted enrichment DAG panel (7.1 Mb), which achieves a coverage of 20-fold or better for 98% of bases. Furthermore, we established a computational method [Phenotypic Interpretation of eXomes (PhenIX)] that evaluated and ranked variants based on pathogenicity and semantic similarity of patients&#39; phenotype described by Human Phenotype Ontology (HPO) terms to those of 3991 Mendelian diseases. In computer simulations, ranking genes based on the variant score put the true gene in first place less than 5% of the time; PhenIX placed the correct gene in first place more than 86% of the time. In a retrospective test of PhenIX on 52 patients with previously identified mutations and known diagnoses, the correct gene achieved a mean rank of 2.1. In a prospective study on 40 individuals without a diagnosis, PhenIX analysis enabled a diagnosis in 11 cases (28%, at a mean rank of 2.4). Thus, the NGS of the DAG followed by phenotype-driven bioinformatic analysis allows quick and effective differential diagnostics in medical genetics.</p>
<p class="publication"><span class="title">Science translational medicine</span>&nbsp;<span class="year">2014</span>;<span class="volume">6</span>;<span class="number">252</span>;<span class="pagerange">252ra123</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25186178">25186178</a>; DOI: <a href="http://dx.doi.org/10.1126%2Fscitranslmed.3009262">10.1126/scitranslmed.3009262</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Towards a comprehensive Plasmodium falciparum merozoite cell surface and secreted recombinant protein library.</h4>
<p class="authors"><span class="author">Zenonos ZA</span>, <span class="author">Rayner JC</span> and <span class="author">Wright GJ</span></p>
<p class="affiliation">Cell Surface Signalling Laboratory, Wellcome Trust Sanger Institute, Cambridge CB10 1SA, UK. <a href="mailto:%67%77%32%40%73%61%6E%67%65%72.%61%63.%75%6B">&#103;&#119;&#50;&#64;&#115;&#97;&#110;&#103;&#101;&#114;&#46;&#97;&#99;&#46;&#117;&#107;</a>.</p><p class="abstract"><strong>Background</strong>: Plasmodium falciparum is the aetiological agent for malaria, a deadly infectious disease for which no vaccine has yet been licensed. The proteins displayed on the merozoite cell surface have long been considered attractive vaccine targets because of their direct exposure to host antibodies; however, progress in understanding the functional role of these targets has been hindered by technical challenges associated with expressing these proteins in a functionally active recombinant form. To address this, a method that enables the systematic expression of functional extracellular Plasmodium proteins was previously developed, and used to create a library of 42 merozoite proteins.</p><p class="abstract"><strong>Methods</strong>: To compile a more comprehensive library of recombinant proteins representing the repertoire of P. falciparum merozoite extracellular proteins for systematic vaccine and functional studies, genome-wide expression profiling was used to identify additional candidates. Candidate proteins were recombinantly produced and their integrity and expression levels were tested by Western blotting and ELISA.</p><p class="abstract"><strong>Results</strong>: Twenty-five additional genes that were upregulated during late schizogony, and predicted to encode secreted and cell surface proteins, were identified and expressed as soluble recombinant proteins. A band consistent with the entire ectodomain was observed by immunoblotting for the majority of the proteins and their expression levels were quantified. By using sera from malaria-exposed immune adults, the immunoreactivity of 20 recombinant proteins was assessed, and most of the merozoite ligands were found to carry heat-labile epitopes. To facilitate systematic comparative studies across the entire library, multiple Plasmodium proteins were simultaneously purified using a custom-made platform.</p><p class="abstract"><strong>Conclusions</strong>: A library of recombinant P. falciparum secreted and cell surface proteins was expanded by 20 additional proteins, which were shown to express at usable levels and contain conformational epitopes. This resource of extracellular P. falciparum merozoite proteins, which now contains 62 full-length ectodomains, will be a valuable tool in elucidating the function of these proteins during the blood stages of infection, and facilitate the comparative assessment of blood stage vaccine candidates.</p>
<p class="grants">Funded by: Wellcome Trust: <span class="grant">098051</span></p>
<p class="publication"><span class="title">Malaria journal</span>&nbsp;<span class="year">2014</span>;<span class="volume">13</span>;<span class="pagerange">93</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24620899">24620899</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC3995786">3995786</a>; DOI: <a href="http://dx.doi.org/10.1186%2F1475-2875-13-93">10.1186/1475-2875-13-93</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Intratumor heterogeneity in localized lung adenocarcinomas delineated by multiregion sequencing.</h4>
<p class="authors"><span class="author">Zhang J</span>, <span class="author">Fujimoto J</span>, <span class="author">Zhang J</span>, <span class="author">Wedge DC</span>, <span class="author">Song X</span>, <span class="author">Zhang J</span>, <span class="author">Seth S</span>, <span class="author">Chow CW</span>, <span class="author">Cao Y</span>, <span class="author">Gumbs C</span>, <span class="author">Gold KA</span>, <span class="author">Kalhor N</span>, <span class="author">Little L</span>, <span class="author">Mahadeshwar H</span>, <span class="author">Moran C</span>, <span class="author">Protopopov A</span>, <span class="author">Sun H</span>, <span class="author">Tang J</span>, <span class="author">Wu X</span>, <span class="author">Ye Y</span>, <span class="author">William WN</span>, <span class="author">Lee JJ</span>, <span class="author">Heymach JV</span>, <span class="author">Hong WK</span>, <span class="author">Swisher S</span>, <span class="author">Wistuba II</span> and <span class="author">Futreal PA</span></p>
<p class="affiliation">Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA. Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.</p><p class="abstract">Cancers are composed of populations of cells with distinct molecular and phenotypic features, a phenomenon termed intratumor heterogeneity (ITH). ITH in lung cancers has not been well studied. We applied multiregion whole-exome sequencing (WES) on 11 localized lung adenocarcinomas. All tumors showed clear evidence of ITH. On average, 76% of all mutations and 20 out of 21 known cancer gene mutations were identified in all regions of individual tumors, which suggested that single-region sequencing may be adequate to identify the majority of known cancer gene mutations in localized lung adenocarcinomas. With a median follow-up of 21 months after surgery, three patients have relapsed, and all three patients had significantly larger fractions of subclonal mutations in their primary tumors than patients without relapse. These data indicate that a larger subclonal mutation fraction may be associated with increased likelihood of postsurgical relapse in patients with localized lung adenocarcinomas.</p>
<p class="grants">Funded by: NCI NIH HHS: <span class="grant">CA016672</span>, <span class="grant">P50CA70907</span>, <span class="grant">T32 CA-009666</span></p>
<p class="publication"><span class="title">Science (New York, N.Y.)</span>&nbsp;<span class="year">2014</span>;<span class="volume">346</span>;<span class="number">6206</span>;<span class="pagerange">256-9</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25301631">25301631</a>; DOI: <a href="http://dx.doi.org/10.1126%2Fscience.1256930">10.1126/science.1256930</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">One-step generation of different immunodeficient mice with multiple gene modifications by CRISPR/Cas9 mediated genome engineering.</h4>
<p class="authors"><span class="author">Zhou J</span>, <span class="author">Shen B</span>, <span class="author">Zhang W</span>, <span class="author">Wang J</span>, <span class="author">Yang J</span>, <span class="author">Chen L</span>, <span class="author">Zhang N</span>, <span class="author">Zhu K</span>, <span class="author">Xu J</span>, <span class="author">Hu B</span>, <span class="author">Leng Q</span> and <span class="author">Huang X</span></p>
<p class="affiliation">MOE Key Laboratory of Model Animal for Disease Study, Model Animal Research Center of Nanjing University, National Resource Center for Mutant Mice, Nanjing 210061, China.</p><p class="abstract">Taking advantage of the multiplexable genome engineering feature of the CRISPR/Cas9 system, we sought to generate different kinds of immunodeficient mouse strains by embryo co-microinjection of Cas9 mRNA and multiple sgRNAs targeting mouse B2m, Il2rg, Prf1, Prkdc, and Rag1. We successfully achieved multiple gene modifications, fragment deletion, double knockout of genes localizing on the same chromosome, and got different kinds of immunodeficient mouse models with different heritable genetic modifications at once, providing a one-step strategy for generating different immunodeficient mice which represents significant time-, labor-, and money-saving advantages over traditional approaches. Meanwhile, we improved the technology by optimizing the concentration of Cas9 and sgRNAs and designing two adjacent sgRNAs targeting one exon for each gene, which greatly increased the targeting efficiency and bi-allelic mutations.</p>
<p class="publication"><span class="title">The international journal of biochemistry &amp; cell biology</span>&nbsp;<span class="year">2014</span>;<span class="volume">46</span>;<span class="pagerange">49-55</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/24269190">24269190</a>; DOI: <a href="http://dx.doi.org/10.1016%2Fj.biocel.2013.10.010">10.1016/j.biocel.2013.10.010</a></p></li><li class="periodical ref-coll ref-closed">
<h4 title="click to show/hide abstract..." class="article">Transient Darwinian selection in Salmonella enterica serovar Paratyphi A during 450 years of global spread of enteric fever.</h4>
<p class="authors"><span class="author">Zhou Z</span>, <span class="author">McCann A</span>, <span class="author">Weill FX</span>, <span class="author">Blin C</span>, <span class="author">Nair S</span>, <span class="author">Wain J</span>, <span class="author">Dougan G</span> and <span class="author">Achtman M</span></p>
<p class="affiliation">Warwick Medical School, University of Warwick, Coventry CV4 7AL, United Kingdom;Environmental Research Institute and Department of Microbiology, University College Cork, Cork, Ireland; <a href="mailto:%7A%68%65%6D%69%6E.%7A%68%6F%75%40%77%61%72%77%69%63%6B.%61%63.%75%6B">&#122;&#104;&#101;&#109;&#105;&#110;&#46;&#122;&#104;&#111;&#117;&#64;&#119;&#97;&#114;&#119;&#105;&#99;&#107;&#46;&#97;&#99;&#46;&#117;&#107;</a> <a href="mailto:%6D.%61%63%68%74%6D%61%6E%40%77%61%72%77%69%63%6B.%61%63.%75%6B">&#109;&#46;&#97;&#99;&#104;&#116;&#109;&#97;&#110;&#64;&#119;&#97;&#114;&#119;&#105;&#99;&#107;&#46;&#97;&#99;&#46;&#117;&#107;</a>.</p><p class="abstract">Multiple epidemic diseases have been designated as emerging or reemerging because the numbers of clinical cases have increased. Emerging diseases are often suspected to be driven by increased virulence or fitness, possibly associated with the gain of novel genes or mutations. However, the time period over which humans have been afflicted by such diseases is only known for very few bacterial pathogens, and the evidence for recently increased virulence or fitness is scanty. Has Darwinian (diversifying) selection at the genomic level recently driven microevolution within bacterial pathogens of humans? Salmonella enterica serovar Paratyphi A is a major cause of enteric fever, with a microbiological history dating to 1898. We identified seven modern lineages among 149 genomes on the basis of 4,584 SNPs in the core genome and estimated that Paratyphi A originated 450 y ago. During that time period, the effective population size has undergone expansion, reduction, and recent expansion. Mutations, some of which inactivate genes, have occurred continuously over the history of Paratyphi A, as has the gain or loss of accessory genes. We also identified 273 mutations that were under Darwinian selection. However, most genetic changes are transient, continuously being removed by purifying selection, and the genome of Paratyphi A has not changed dramatically over centuries. We conclude that Darwinian selection is not responsible for increased frequency of enteric fever and suggest that environmental changes may be more important for the frequency of disease.</p>
<p class="publication"><span class="title">Proceedings of the National Academy of Sciences of the United States of America</span>&nbsp;<span class="year">2014</span>;<span class="volume">111</span>;<span class="number">33</span>;<span class="pagerange">12199-204</span></p>
<p class="links">PUBMED: <a href="http://ukpmc.ac.uk/abstract/MED/25092320">25092320</a>; PMC: <a href="http://ukpmc.ac.uk/articles/PMC4143038">4143038</a>; DOI: <a href="http://dx.doi.org/10.1073%2Fpnas.1411012111">10.1073/pnas.1411012111</a></p></li></ul>
      </div>
    </div>
